data_1nz8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nz8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.502 0.192 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.32 156.61 38.69 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.127 0.489 . . . . 0.0 111.762 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.47 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 82.0 m95 -95.3 95.56 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.653 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.43 ' CD2' HD13 ' A' ' 72' ' ' LEU . 33.0 m-85 -83.4 115.47 22.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.996 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.24 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 t -128.36 161.64 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -90.06 159.96 16.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.2 p -152.45 -174.38 4.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.52 139.22 31.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.09 122.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.86 15.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -92.17 -14.87 28.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.609 0.243 . . . . 0.0 111.245 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -52.42 -46.54 66.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 111.054 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.87 -30.85 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.887 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -30.76 22.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.15 72.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -49.3 78.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.46 50.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.172 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -60.69 -31.63 70.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.8 tp -81.17 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -46.9 -35.42 6.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.315 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -66.22 -47.3 74.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.709 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -39.38 93.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.682 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.504 HD11 HG22 ' A' ' 26' ' ' ILE . 35.2 mm -62.56 -29.79 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -93.59 -29.98 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -44.03 74.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.157 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.0 -30.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 66.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.79 23.23 8.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 0.0 111.046 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.44 -9.14 58.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.8 -29.64 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -51.83 5.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -79.92 128.16 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.419 ' CE2' HG23 ' A' ' 3' ' ' ILE . 26.0 m-85 -113.66 -53.41 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.417 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.0 mt-30 -113.27 157.39 21.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.046 0.45 . . . . 0.0 111.452 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -152.27 71.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.87 150.06 24.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.203 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.3 pt -107.22 131.19 21.89 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.862 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 32.3 Cg_endo -64.16 72.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.605 2.203 . . . . 0.0 112.643 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.821 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.811 0.339 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.81 110.03 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.38 -49.33 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.537 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.439 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 18.9 m-85 -106.76 98.21 20.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.296 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.91 137.05 55.94 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.429 2.086 . . . . 0.0 112.633 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.97 26.07 65.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.704 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -116.4 145.55 43.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.717 0.294 . . . . 0.0 111.087 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.93 112.73 6.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.764 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 6.4 m-85 -88.35 124.22 33.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -130.04 117.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.413 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 6.8 tt0 -79.97 71.8 6.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.939 0.399 . . . . 0.0 110.196 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.0 ptp -90.87 -174.02 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.22 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -132.66 75.45 1.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.836 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 6' ' ' TYR . 86.4 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.39 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.725 0.297 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 174.82 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.508 2.139 . . . . 0.0 112.135 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -87.01 -172.14 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.032 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -21.51 42.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.66 -42.46 56.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 111.285 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -64.67 -39.2 93.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.23 -43.14 99.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.32 -51.49 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.937 0.399 . . . . 0.0 111.058 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.99 -42.63 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.122 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -17.48 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.331 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.08 -15.71 15.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.136 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.1 142.37 95.55 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.857 0.328 . . . . 0.0 110.972 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.94 -20.21 22.16 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.19 36.34 3.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.977 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.682 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.502 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 15.1 mmm-85 . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.425 0.155 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 89.0 Cg_endo -81.72 -169.99 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.598 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -153.34 71.17 6.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.097 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.17 132.74 48.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.11 161.65 17.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.98 153.56 47.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.05 -48.61 20.26 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.532 2.155 . . . . 0.0 112.428 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.29 -31.9 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -81.59 -36.64 28.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.47 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 41.2 t -58.96 -45.7 91.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -27.13 68.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -81.64 -37.31 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.057 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.422 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 8.1 pt -81.33 -20.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -86.94 -33.08 19.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.8 -32.79 73.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.663 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.2 t -80.92 -35.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.903 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 t -60.33 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.809 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.49 42.59 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.628 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 mt -117.29 -56.96 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -30.29 40.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.546 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.446 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.42 0.153 . . . . 0.0 110.766 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -147.91 163.15 37.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 112.105 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 67.8 m95 -94.27 139.3 31.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.671 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 21.0 m-85 -125.64 110.03 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.06 151.19 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.054 0.454 . . . . 0.0 111.745 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.61 162.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 2.5 m-70 -100.31 151.52 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.056 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.4 p -149.14 -178.24 6.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.87 140.67 29.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 t -62.06 125.3 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.71 -37.98 3.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 -21.55 34.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -54.76 -43.15 72.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.06 -46.53 75.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -24.72 36.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.055 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.26 74.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -33.11 71.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 -51.6 23.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.7 -33.26 71.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.1 tp -73.48 -55.01 6.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.58 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -30.34 8.87 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -72.35 -42.88 64.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.726 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -66.57 -34.7 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.666 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -69.47 -31.58 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -32.68 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.52 -41.96 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -80.78 -25.39 37.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.41 5.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.402 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -99.85 28.63 4.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.722 0.296 . . . . 0.0 110.999 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -71.88 -10.54 59.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 15.8 t70 -79.67 -24.88 41.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.01 -54.49 4.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.77 137.9 20.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.707 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.446 ' CE2' HG23 ' A' ' 3' ' ' ILE . 13.1 m-85 -129.93 -56.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.513 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.548 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -109.44 134.37 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.144 0.497 . . . . 0.0 112.067 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.1 m -125.15 99.59 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.284 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 116' ' ' SER . 1.9 tm? -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.5 tt -87.68 125.09 66.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.16 76.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.651 2.234 . . . . 0.0 112.563 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 25.3 p . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.9 mttm . . . . . 0 N--CA 1.459 0.024 0 CA-C-O 120.721 0.296 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.66 116.88 11.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.03 -55.52 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.426 ' CE1' HG23 ' A' ' 112' ' ' ILE . 2.1 m-85 -121.31 79.51 36.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.21 144.28 81.81 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.296 . . . . 0.0 112.671 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.93 18.43 70.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.139 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 15.0 m-85 -129.13 162.7 27.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.35 122.29 8.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.353 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 112' ' ' ILE . 11.6 m-30 -89.59 130.03 35.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.956 0.408 . . . . 0.0 111.217 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -130.73 111.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.548 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -79.71 68.42 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.673 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 10.2 ptm -91.66 -164.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -141.07 71.24 1.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 95.4 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.743 0.306 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.33 151.14 81.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.542 2.161 . . . . 0.0 112.332 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.21 -167.69 1.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -66.12 -27.44 68.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.18 -39.8 60.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.319 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -74.59 -33.27 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -31.41 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.72 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.83 -44.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.9 t -64.42 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.98 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -13.56 62.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.07 -12.78 10.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.051 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.89 159.74 12.65 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.908 0.354 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.99 122.84 9.45 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.543 2.162 . . . . 0.0 112.385 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.71 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.3 mm . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.055 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.514 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 111.406 0.15 . . . . 0.0 111.406 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 82.5 Cg_exo -47.79 127.44 14.32 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.344 2.029 . . . . 0.0 112.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.07 105.26 26.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.271 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.68 124.45 8.2 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.341 2.028 . . . . 0.0 111.997 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.417 HD13 ' CE1' ' A' ' 67' ' ' PHE . 68.2 mt -59.55 134.22 56.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.5 p -76.61 150.79 82.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.81 -31.75 73.85 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.639 2.226 . . . . 0.0 112.271 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.76 -28.39 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -37.09 10.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.468 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 24.5 t -58.63 -29.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.17 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -60.22 -39.25 86.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.88 -55.7 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.498 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.429 HG21 ' CE2' ' A' ' 67' ' ' PHE . 2.3 pp -63.56 -22.14 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.665 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.411 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 1.9 mt -70.41 -39.52 74.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.26 -29.3 67.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.68 -41.19 62.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.457 ' HB3' ' CD2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -60.22 -62.11 2.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 110.581 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.69 36.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.024 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.411 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -112.56 -27.95 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -49.98 11.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.447 -1.196 . . . . 0.0 112.562 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.427 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.492 0.187 . . . . 0.0 110.908 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.05 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.175 0.512 . . . . 0.0 111.832 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.457 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 73.0 m95 -95.56 88.53 5.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 50.6 m-85 -81.27 123.64 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.04 127.12 53.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.94 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.5 p -108.03 159.88 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 111.084 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.482 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 48.3 m-70 -83.86 136.48 34.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -143.55 151.57 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.31 136.6 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.75 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -57.58 111.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.262 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.59 -20.47 32.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.691 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.59 -16.96 15.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.617 0.246 . . . . 0.0 111.308 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -33.92 59.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.83 0.348 . . . . 0.0 111.133 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.82 -31.84 71.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.992 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -26.06 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.176 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -65.89 -30.67 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.86 47.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -62.12 -25.18 67.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.8 tp -86.7 -56.81 3.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -45.91 -37.68 6.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.426 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 -33.62 70.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 mmt-85 -75.64 -32.37 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.636 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 26' ' ' ILE . 32.7 mm -70.39 -31.4 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.734 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -84.04 -30.4 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -42.05 38.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -80.04 -25.58 40.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.962 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.07 66.52 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.468 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -125.82 30.1 5.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.987 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -25.39 68.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.07 -1.79 41.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.365 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -99.47 -58.65 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.755 0.312 . . . . 0.0 110.748 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.45 132.92 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' A' ' 3' ' ' ILE . 3.0 m-85 -127.02 -49.99 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.19 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -117.14 156.66 27.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.107 0.479 . . . . 0.0 111.697 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 m -159.91 114.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -130.04 177.32 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.406 0.622 . . . . 0.0 112.07 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.7 mt -148.56 74.25 10.52 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.785 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 87.9 Cg_exo -41.66 113.78 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.176 2.584 . . . . 0.0 113.59 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.063 179.194 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.893 0.378 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 115.2 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.86 -44.55 96.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.309 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 2.1 m-85 -115.57 76.92 5.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.563 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.54 127.77 16.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.67 2.246 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.66 72.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.579 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 48.7 m-85 -128.89 111.03 12.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.97 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.5 mt -90.9 114.91 27.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.514 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' A' ' 112' ' ' ILE . 6.6 m-30 -82.47 122.85 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -128.87 110.16 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 3.6 tt0 -79.97 69.97 6.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.6 ptp -90.84 -178.13 5.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 t0 -119.53 98.88 6.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 39.4 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.795 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.462 0.172 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 173.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.433 2.089 . . . . 0.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.38 179.19 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.2 -25.21 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.08 -28.89 27.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 111.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -63.76 -48.61 76.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -58.88 -30.26 67.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.69 -49.67 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.184 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.1 t -59.96 -52.68 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttp85 -58.03 -22.84 51.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.52 -32.39 11.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.728 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.7 p -59.13 130.64 86.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.493 0.187 . . . . 0.0 110.99 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.78 -23.87 35.52 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.393 2.062 . . . . 0.0 112.314 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.41 -29.19 46.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.735 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.0 mm . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 111.086 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.475 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.523 0.202 . . . . 0.0 110.964 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 84.7 Cg_endo -81.18 130.43 7.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.502 2.135 . . . . 0.0 112.107 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.6 t -129.68 99.7 20.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.262 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.9 139.14 10.77 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.645 2.23 . . . . 0.0 112.252 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 67' ' ' PHE . 1.2 mp -67.59 156.75 36.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.06 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.6 p -85.44 149.97 53.15 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.757 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -45.98 -49.58 10.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.773 2.316 . . . . 0.0 112.873 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.47 -39.98 85.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.17 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.66 -33.3 47.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 58.4 t -58.79 -31.4 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.237 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -26.01 56.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.33 -29.23 31.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.108 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 67' ' ' PHE . 34.2 pt -80.68 -32.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.111 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' CD2' ' CZ2' ' A' ' 5' ' ' TRP . 97.9 mt -77.5 -25.2 50.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.23 -32.37 61.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.979 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -75.49 -48.2 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.072 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -59.98 4.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 137.14 67.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.597 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.1 mt -129.05 -47.46 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.822 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -61.73 1.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.491 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.392 0.139 . . . . 0.0 110.839 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.01 139.54 52.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.292 0.568 . . . . 0.0 112.092 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.612 ' CH2' ' CD2' ' A' ' 39' ' ' LEU . 25.7 m95 -94.94 96.23 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.047 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 44.9 m-85 -96.67 112.96 24.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.397 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.404 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . . . -108.14 134.88 50.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.753 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.5 p -134.14 160.18 41.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.196 0.522 . . . . 0.0 111.234 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.489 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 5.6 m170 -82.26 147.12 29.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -123.83 -173.83 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mt -87.7 127.61 35.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.72 114.87 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.6 -28.8 11.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.52 -7.78 37.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.622 0.249 . . . . 0.0 111.292 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -55.74 -39.72 71.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -52.45 65.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -14.34 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.359 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.44 -51.21 31.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 111.228 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -56.57 -41.56 77.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.04 -43.35 92.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -62.19 -34.49 76.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.3 tp -84.02 -45.07 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -55.23 -26.41 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -78.32 -47.61 17.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.318 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.02 -27.3 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.352 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.63 -29.35 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -87.38 -31.52 20.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.6 -32.36 67.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.044 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -87.89 5.7 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.53 47.49 86.63 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 mt -111.08 9.63 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.536 0.207 . . . . 0.0 111.266 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -17.25 63.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 0.0 111.259 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.93 -38.53 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.041 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.37 -51.75 33.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.87 117.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 3' ' ' ILE . 31.7 m-85 -100.95 -53.17 3.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.454 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 5.1 mm-40 -107.95 169.89 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.374 0.606 . . . . 0.0 111.651 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.33 73.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.35 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.612 ' CD2' ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -79.55 139.48 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.638 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.429 ' CG2' ' HD2' ' A' ' 41' ' ' PRO . 14.4 mt -100.5 138.3 20.13 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 40' ' ' ILE . 67.9 Cg_endo -72.72 59.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.543 2.162 . . . . 0.0 112.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.1 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.965 0.412 . . . . 0.0 111.317 179.9 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -141.92 121.21 13.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.27 -65.78 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.404 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 6.6 m-85 -103.9 90.42 2.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.763 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.01 123.02 11.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.128 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.39 29.06 54.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.569 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 19.3 m-85 -117.27 177.68 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.2 tp -160.21 148.87 17.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.756 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CE2' HG21 ' A' ' 112' ' ' ILE . 18.2 m-85 -132.5 125.62 31.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -133.04 112.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 37' ' ' GLN . 8.6 tt0 -79.9 72.41 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 110.675 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.412 ' HG3' ' HG ' ' A' ' 72' ' ' LEU . 2.1 ptm -91.37 -166.52 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 1.2 p30 -136.71 78.46 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 110.982 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 35.3 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.637 0.256 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.46 179.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.387 2.058 . . . . 0.0 112.185 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -171.97 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -70.79 -26.2 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.101 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.55 -28.96 34.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.323 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.426 ' CZ2' ' HD3' ' A' ' 101' ' ' PRO . 12.5 t-105 -69.46 -36.15 76.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.7 -30.0 70.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.29 -45.89 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 t -61.45 -50.21 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.056 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -29.91 70.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.58 -27.07 52.63 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.582 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 147.31 97.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.865 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.52 -20.79 35.52 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.378 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.89 -28.1 52.12 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.636 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.9 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.458 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.437 0.161 . . . . 0.0 111.244 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 98.1 Cg_endo -79.93 143.75 16.55 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.348 2.032 . . . . 0.0 112.297 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -127.17 110.68 21.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.252 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.1 132.12 10.25 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.613 2.209 . . . . 0.0 112.239 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.12 147.27 26.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.9 p -90.07 159.48 42.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.22 -27.23 6.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.753 2.302 . . . . 0.0 112.544 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -44.83 74.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.67 -32.4 17.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.5 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 38.7 t -62.22 -28.57 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.342 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -69.34 -28.21 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -51.42 19.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.765 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.412 HG21 ' CE2' ' A' ' 67' ' ' PHE . 1.5 pp -68.01 -13.76 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.77 -40.83 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.857 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.97 -40.35 71.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 t -71.64 -44.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.461 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 15.4 p -56.18 -62.38 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.76 42.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.569 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.425 HD12 HD21 ' A' ' 39' ' ' LEU . 19.1 mt -111.2 -36.01 5.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.17 -34.4 10.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.519 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.46 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.476 0.179 . . . . 0.0 110.764 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 163.88 31.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.473 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 72.9 m95 -88.72 96.27 10.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 4.8 m-85 -79.74 124.52 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.19 134.63 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.533 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 9' ' ' HIS . 0.7 OUTLIER -126.58 -166.97 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 6.5 m-70 -132.87 160.72 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 111.213 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.6 p -156.35 174.75 14.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.53 139.1 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 t -65.34 125.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.16 -28.43 12.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -92.98 -16.52 25.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 111.162 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.79 -36.01 46.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.805 0.336 . . . . 0.0 111.207 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -59.75 -30.81 69.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.07 -28.91 19.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.955 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.52 68.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -53.28 59.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.86 -42.89 89.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -59.76 -31.14 69.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.5 tp -88.96 -48.89 7.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 26' ' ' ILE . 1.7 tm-20 -62.58 -24.19 67.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -80.55 -38.38 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.254 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.37 -22.46 61.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 27' ' ' LYS . 1.1 tp -72.3 -28.89 30.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.016 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' N ' HG23 ' A' ' 26' ' ' ILE . 2.2 tmtt? -89.61 -30.1 18.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.23 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -86.68 -30.29 21.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.76 41.6 4.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.51 25.69 8.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -66.92 -16.78 64.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.251 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.8 -25.69 40.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -79.63 -61.06 2.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 70' ' ' MET . 1.8 pt -79.86 158.86 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 3' ' ' ILE . 20.1 m-85 -143.88 -49.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -118.28 145.7 44.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.376 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -150.04 102.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.76 155.7 24.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.029 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.81 126.82 30.82 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 50.4 Cg_endo -69.27 62.44 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.605 2.203 . . . . 0.0 112.486 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.9 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.056 179.864 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.839 0.352 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -55.5 106.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -62.76 -51.49 66.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.614 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 61' ' ' LEU . 14.6 m-85 -105.77 94.95 9.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.416 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.9 129.05 31.38 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.511 2.141 . . . . 0.0 112.495 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.06 40.36 82.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.56 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 0.8 OUTLIER -124.23 144.41 49.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.003 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.95 124.98 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.721 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 11.2 m-85 -96.39 133.79 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.227 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -142.32 114.17 3.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 7.1 tt0 -79.9 76.28 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.411 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 21.2 ptp -91.63 -168.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.821 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -156.24 91.77 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.741 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 81.7 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.518 0.199 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.5 173.82 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.394 2.063 . . . . 0.0 112.247 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -90.09 -171.08 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.45 -27.81 68.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.99 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.2 -38.67 65.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.209 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.413 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 11.8 t-105 -66.82 -36.5 82.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.25 -32.17 69.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.14 -39.41 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.28 -33.41 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -18.01 62.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.6 -4.21 30.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.023 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.17 133.11 85.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.962 0.381 . . . . 0.0 110.737 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.8 121.2 9.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.152 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.02 -29.56 5.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.593 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.723 0.297 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.416 ' CB ' ' CD2' ' A' ' 6' ' ' TYR . 50.7 Cg_exo -54.07 174.34 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.622 2.215 . . . . 0.0 112.299 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.2 94.07 9.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.221 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.11 130.98 14.84 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.564 2.176 . . . . 0.0 112.404 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 mp -78.99 162.18 26.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.09 156.49 49.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.59 -30.57 89.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.626 2.217 . . . . 0.0 112.271 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.15 -29.01 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.16 -38.19 11.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.473 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 40.0 t -58.95 -35.52 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -25.41 68.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.25 -41.2 25.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.402 HD11 ' CE2' ' A' ' 67' ' ' PHE . 12.1 pt -76.13 -22.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.202 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.411 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 85.6 mt -84.15 -30.18 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 110.758 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -31.01 61.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.6 t -77.2 -38.44 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.789 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 149.12 56.63 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.66 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.411 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 41.5 mt -127.92 -60.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.006 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -34.71 38.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.528 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.437 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.452 0.168 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -154.0 150.19 28.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.267 0.555 . . . . 0.0 112.136 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.579 ' CH2' ' CD2' ' A' ' 39' ' ' LEU . 46.2 m95 -89.91 95.27 10.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.388 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 44.6 m-85 -91.15 116.01 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.85 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.84 143.27 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.453 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -143.34 160.05 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.699 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -131.53 152.74 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.876 0.369 . . . . 0.0 111.164 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -139.81 -165.56 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.794 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 136.03 49.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.982 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 37.2 t -67.32 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.31 -32.02 6.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.432 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -93.59 -22.14 18.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.051 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -32.07 20.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.152 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.47 -48.06 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -27.29 60.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.04 93.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -42.93 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.96 56.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.34 -34.89 78.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.764 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.81 -57.87 4.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.813 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -49.14 -35.21 15.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -69.55 -43.93 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -38.03 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.505 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG21 HD12 ' A' ' 26' ' ' ILE . 48.4 mm -67.69 -30.99 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.639 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -87.11 -29.21 22.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.99 -46.91 70.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -87.33 -25.1 24.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.3 61.5 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.324 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 3.6 mm? -98.86 28.11 4.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.059 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -81.26 21.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.284 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -108.94 -15.73 14.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.979 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' CE2' ' A' ' 36' ' ' PHE . 2.0 mttp -116.69 -45.87 2.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.807 0.337 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.402 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 16.5 mt -80.29 135.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.437 ' CE2' ' CG2' ' A' ' 3' ' ' ILE . 15.6 m-85 -133.06 -60.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.55 133.3 46.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.535 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.12 76.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.271 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.579 ' CD2' ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -80.0 139.41 37.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.119 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.4 ' CG2' ' HD2' ' A' ' 41' ' ' PRO . 27.8 mm -98.93 136.99 20.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD2' ' CG2' ' A' ' 40' ' ' ILE . 80.0 Cg_endo -77.85 55.76 5.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.59 2.193 . . . . 0.0 112.769 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.04 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.845 0.355 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 105.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.2 mt -63.98 -51.57 63.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.786 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.439 ' CE2' HG22 ' A' ' 112' ' ' ILE . 86.8 m-85 -97.58 111.88 59.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.537 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.8 122.2 11.06 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.517 2.145 . . . . 0.0 112.73 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.17 43.65 25.81 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.198 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -117.11 173.99 6.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tp -160.23 152.01 20.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD1' HD11 ' A' ' 104' ' ' LEU . 79.3 m-85 -126.21 120.64 30.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.564 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.35 115.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.626 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.7 tt0 -83.22 70.17 10.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.314 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.4 ptm -91.51 -168.3 2.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.964 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -139.99 49.32 1.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.409 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 4.5 pp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.976 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.682 0.277 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.97 89.3 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.633 2.222 . . . . 0.0 112.718 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 p30 -90.26 -168.41 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.776 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.41 ' HG3' ' CD1' ' A' ' 31' ' ' LEU . 5.7 tp10 56.85 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.66 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . -55.85 -43.35 76.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.312 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.417 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 2.6 t-105 -79.97 -35.55 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -27.65 62.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.981 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.4 -51.69 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.7 t -58.56 -48.61 85.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -23.4 61.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.973 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.38 -26.0 37.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.67 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.7 p -57.78 142.89 77.78 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.639 0.257 . . . . 0.0 110.921 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.73 -14.12 32.76 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.528 2.152 . . . . 0.0 112.558 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.03 -28.08 73.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.657 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 111.18 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.694 0.283 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HG3' ' CZ2' ' A' ' 82' ' ' TRP . 51.8 Cg_exo -54.07 -168.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.668 2.245 . . . . 0.0 112.4 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.22 109.62 6.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.371 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.34 120.39 3.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.217 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.412 HD11 ' CD1' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -68.09 155.43 39.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.161 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.07 166.94 18.3 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -51.33 -27.47 23.78 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.623 2.215 . . . . 0.0 112.443 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.47 -48.2 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.073 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -72.71 -34.31 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.456 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 58.5 t -62.2 -44.63 99.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.222 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -60.48 -26.68 66.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.46 -53.83 9.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.439 HG22 ' CE2' ' A' ' 62' ' ' PHE . 2.5 pp -67.51 -15.3 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.955 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.64 -40.41 25.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.86 -32.98 74.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.067 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.2 t -76.27 -50.03 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.455 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -56.26 -60.49 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.06 42.47 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.1 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.424 HD12 HD22 ' A' ' 39' ' ' LEU . 4.7 mt -109.36 -48.57 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 110.633 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tp -100.67 30.78 3.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.405 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.393 0.139 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.49 157.22 39.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.175 0.512 . . . . 0.0 112.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.508 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 78.5 m95 -98.07 85.75 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.121 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 68.6 m-85 -80.63 124.76 29.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.988 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.84 138.23 33.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.389 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 t -125.16 160.07 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -94.3 132.55 38.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -124.12 177.54 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.954 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.47 132.15 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.81 123.73 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.198 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.29 -27.91 17.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.462 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -104.65 -3.06 24.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.627 0.251 . . . . 0.0 111.376 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -34.07 68.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.769 0.319 . . . . 0.0 111.038 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -58.47 -40.71 83.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.52 -24.72 31.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.28 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -37.29 79.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -53.06 15.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.034 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -59.17 -31.75 69.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.637 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.4 tp -77.14 -57.48 3.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.716 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -49.72 -31.18 10.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -38.66 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.637 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -36.07 72.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.601 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.4 mm -67.44 -31.4 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -30.16 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.33 -32.32 37.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -85.02 -27.26 26.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.8 61.11 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.46 28.69 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -8.07 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.335 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.96 -29.05 39.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -96.11 -55.58 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.718 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -80.02 145.01 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.789 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 35' ' ' ILE . 8.2 m-85 -131.87 -44.45 0.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.132 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.402 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -122.09 154.93 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.619 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.3 t -154.4 67.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.288 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.97 152.3 29.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.263 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 42' ' ' THR . 4.5 tp -108.16 118.34 52.76 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.813 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 46.1 Cg_exo -55.33 80.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.731 2.287 . . . . 0.0 112.528 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' ILE . 58.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.687 0.28 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -103.11 123.65 47.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.0 mt -88.53 -48.62 7.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.515 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 2.7 m-85 -124.58 89.22 52.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.407 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.96 131.53 39.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.667 2.245 . . . . 0.0 112.934 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.18 36.31 92.8 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.153 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.53 150.75 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.905 0.353 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mt -142.78 117.82 10.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.452 ' CE2' ' HG3' ' A' ' 41' ' ' PRO . 12.8 m-85 -82.48 121.04 26.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -128.57 107.5 15.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.436 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.457 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 4.5 tt0 -80.03 70.48 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -91.23 -179.78 5.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.261 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -120.83 89.86 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.846 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.438 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 13.3 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.609 0.243 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.98 92.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.546 2.164 . . . . 0.0 112.221 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 81' ' ' ALA . 18.5 m-80 -90.35 -176.6 4.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 51.4 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . -46.56 -50.88 16.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.821 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.417 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -72.21 -32.38 66.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.063 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -33.36 72.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.993 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.01 -48.18 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.3 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.67 -45.29 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.242 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -62.2 -18.61 61.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.275 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -102.08 -25.19 8.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.809 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 p -59.96 145.06 85.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.66 -25.96 62.62 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.566 2.178 . . . . 0.0 112.218 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.81 -34.15 56.67 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.674 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.5 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.734 0.302 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.59 179.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.31 92.29 24.99 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.235 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 145.04 30.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.621 2.214 . . . . 0.0 112.325 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 169.17 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.06 150.81 44.16 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.767 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.53 -29.34 24.36 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.583 2.189 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.59 -30.97 57.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -90.3 -33.64 16.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.508 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 35.9 t -63.8 -35.48 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.227 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -29.16 66.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -77.92 -40.38 39.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.784 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.437 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 12.4 pt -74.72 -29.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 mt -77.71 -32.58 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.559 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.39 -33.25 74.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.7 t -72.82 -35.29 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.949 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.5 m -64.34 -59.81 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.94 44.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.527 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.7 mt -115.92 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.85 -44.7 20.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.465 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.46 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.362 0.125 . . . . 0.0 110.738 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.0 158.21 44.26 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 112.281 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.533 ' CH2' ' HB3' ' A' ' 37' ' ' GLN . 78.6 m95 -93.22 91.03 7.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.487 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -87.48 99.12 11.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.45 154.97 27.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 t -139.07 159.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.414 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 3.4 m-70 -112.92 135.82 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.2 p -129.11 -177.49 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.01 142.34 27.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.875 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.39 129.81 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.45 -27.5 17.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.02 -20.02 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.578 0.228 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.66 -39.92 74.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.986 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -52.49 -67.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -61.72 -23.22 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.038 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.92 87.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -59.85 -46.97 87.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.08 69.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.36 -43.99 95.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.8 tp -70.62 -48.54 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.51 -17.33 59.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -84.67 -43.92 13.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.001 0.429 . . . . 0.0 110.227 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -23.93 66.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.355 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.43 HG21 ' N ' ' A' ' 27' ' ' LYS . 1.3 tp -67.91 -29.51 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.816 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' N ' HG21 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -92.47 -30.57 15.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.62 62.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -79.91 -30.36 40.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.25 34.5 5.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.474 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.63 25.23 6.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.955 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -19.7 62.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.17 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -79.96 -26.27 40.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.061 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -77.89 -58.89 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.759 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.94 130.91 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 3' ' ' ILE . 8.9 m-85 -117.57 -48.27 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.117 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.584 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -120.79 151.59 39.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -143.8 126.54 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.468 HD13 ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -109.65 135.19 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.409 ' CG2' ' HD2' ' A' ' 41' ' ' PRO . 2.1 mp -90.89 136.41 27.67 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.817 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 40' ' ' ILE . 28.1 Cg_endo -61.62 -15.56 42.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.624 2.216 . . . . 0.0 112.906 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 111.13 -179.749 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.3 pttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.726 0.298 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -71.83 111.28 6.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.004 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.82 -39.65 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.614 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.58 94.07 21.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.99 126.34 18.58 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.384 2.056 . . . . 0.0 112.416 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.93 37.06 93.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -117.93 166.05 12.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.818 0.342 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.08 151.12 19.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.413 ' CD2' HD11 ' A' ' 104' ' ' LEU . 4.7 m-85 -131.71 130.56 42.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.028 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -134.52 117.31 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.496 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.584 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -83.77 65.81 8.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.411 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.8 ptm -91.57 -170.35 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.048 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD1' ' CZ ' ' A' ' 36' ' ' PHE . 6.4 p-10 -144.39 52.3 1.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.651 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.9 -179.891 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.763 0.316 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.45 179.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.492 2.128 . . . . 0.0 112.291 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -89.99 -177.56 5.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.52 -26.71 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.94 -30.06 32.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.293 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.8 t-105 -75.51 -31.01 60.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.57 -30.62 63.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.43 -52.73 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 t -59.9 -43.3 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -69.27 -15.51 63.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.26 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.29 -15.06 20.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.957 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.54 132.19 95.32 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.778 0.289 . . . . 0.0 110.848 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.9 137.12 40.52 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.418 2.078 . . . . 0.0 112.243 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.19 -17.39 58.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.734 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.984 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.677 0.275 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.9 Cg_exo -53.05 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.546 2.164 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -149.25 95.06 3.87 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.287 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.09 128.42 9.86 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.402 2.068 . . . . 0.0 111.912 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.413 HD11 ' CD2' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -79.86 157.87 26.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.19 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.6 p -80.72 160.22 67.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.82 -56.93 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.679 2.253 . . . . 0.0 112.564 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -52.59 -25.72 11.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.231 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -30.81 13.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.493 ' CG2' ' CD1' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -65.83 -29.56 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -32.72 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.477 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.11 -49.02 30.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.311 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.401 ' CD1' HD11 ' A' ' 39' ' ' LEU . 2.7 pp -62.24 -29.56 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.176 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -35.78 73.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.737 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.82 -21.02 64.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.266 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.0 t -71.94 -61.93 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.417 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 11.3 t -52.2 -59.31 4.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.029 0.442 . . . . 0.0 111.001 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.88 42.68 0.17 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.563 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mt -103.63 -31.38 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -56.71 4.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.501 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.425 HG22 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.411 0.148 . . . . 0.0 110.9 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.97 155.82 36.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.412 0.625 . . . . 0.0 112.232 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.459 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 90.6 m95 -95.64 93.52 7.18 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.459 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 95.9 m-85 -86.15 108.58 18.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.839 0.352 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.45 140.24 29.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.115 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 t -132.87 159.68 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.412 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 11.2 m-70 -85.12 157.29 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -153.52 167.12 30.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.12 140.65 36.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.9 121.68 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.121 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.75 -23.42 36.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.734 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -93.23 -28.02 16.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -58.16 -33.96 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -39.82 71.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -90.02 -24.2 21.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.49 -35.47 74.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -59.29 -57.28 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.16 96.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -65.26 -41.55 94.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.834 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.7 tp -66.13 -54.45 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.837 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -34.05 62.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -67.74 -43.75 79.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -41.54 74.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.31 -26.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.871 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -92.71 -31.77 14.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.6 68.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -101.14 -26.56 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.05 81.65 1.36 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.52 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.91 31.05 3.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -0.94 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.604 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -23.61 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.74 0.305 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -106.53 -52.69 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.678 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -79.84 113.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.315 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.425 ' CE2' HG22 ' A' ' 3' ' ' ILE . 25.5 m-85 -107.46 -56.21 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.016 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -113.39 162.39 16.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.332 0.587 . . . . 0.0 112.497 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.01 77.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.773 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.27 167.91 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.397 0.618 . . . . 0.0 112.397 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.6 tt -155.81 74.2 5.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.428 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 82.1 Cg_exo -42.33 128.43 4.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.299 2.666 . . . . 0.0 113.841 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.397 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 tptt . . . . . 0 N--CA 1.457 -0.093 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -37.6 126.03 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.734 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.9 -34.93 15.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.604 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 41' ' ' PRO . 59.5 m-85 -116.45 81.01 10.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.47 144.27 90.09 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.679 2.253 . . . . 0.0 112.076 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.98 24.8 15.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 22.7 m-85 -131.04 117.26 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 110.735 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mt -116.73 116.3 27.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.393 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.65 114.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.467 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 12.8 tt0 -79.7 68.44 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 ptp -91.27 -167.94 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.262 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -142.35 106.37 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.452 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.438 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 23.9 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.534 0.207 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.01 159.23 53.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.258 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -90.12 -179.99 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.97 -32.63 73.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.6 -31.72 64.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.01 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.442 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -64.2 -47.88 78.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -57.07 -30.21 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.16 -54.83 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.1 t -56.62 -37.24 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.64 -20.61 65.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.94 -17.16 12.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.921 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.2 p -55.85 141.02 67.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.775 0.287 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.07 95.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.098 . . . . 0.0 112.279 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.77 -30.29 0.28 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.624 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.988 -179.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.781 0.324 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.442 ' HG3' ' CZ2' ' A' ' 82' ' ' TRP . 50.8 Cg_exo -55.91 -164.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.686 2.258 . . . . 0.0 112.416 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.5 m -158.72 93.44 1.92 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.13 126.36 13.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.51 2.14 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mp -76.57 154.12 34.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -82.34 157.9 67.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -29.84 87.79 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.748 2.299 . . . . 0.0 112.274 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -29.29 65.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 -34.82 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 22.5 t -68.83 -26.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.198 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -73.22 -37.14 66.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -44.49 64.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.9 -23.26 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.418 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -72.46 -31.08 65.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.2 -53.81 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.16 -37.27 61.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -64.95 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.32 42.82 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.418 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 6.0 mt -115.14 -33.83 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.3 tt -94.95 42.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.459 179.884 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.459 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.464 0.173 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.72 143.84 30.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.177 0.513 . . . . 0.0 112.042 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.486 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 63.9 m95 -100.79 92.29 5.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.167 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE2' HD12 ' A' ' 72' ' ' LEU . 58.3 m-85 -91.69 106.2 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.788 0.328 . . . . 0.0 111.33 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.86 124.96 32.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.0 162.05 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -122.66 133.27 54.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -136.78 -174.74 3.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 151.84 23.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.47 124.89 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.82 -27.61 18.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.61 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.07 -27.69 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.98 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.65 -35.11 70.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.98 -39.69 66.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -87.82 -27.94 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.024 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.0 69.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -58.36 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.027 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.87 -47.95 81.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.274 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.11 -40.51 73.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.992 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.6 tp -65.91 -53.41 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -58.77 -45.81 88.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.014 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -58.58 -41.91 86.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -65.38 -46.91 78.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.759 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.1 mt -65.52 -32.05 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.936 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -31.66 39.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -36.54 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -82.64 -24.68 33.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.045 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.66 77.35 1.27 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.376 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.61 38.76 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 110.726 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -8.74 56.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.402 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.2 m-20 -79.99 -28.06 39.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.41 -59.58 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.92 122.02 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 14.1 m-85 -110.0 -45.1 3.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.237 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.479 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.4 mm100 -120.35 170.25 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.218 0.532 . . . . 0.0 111.89 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 t -154.31 88.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.149 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -79.72 157.15 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.6 pt -120.2 145.37 40.03 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.939 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.47 -15.4 45.16 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.651 2.234 . . . . 0.0 113.002 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.075 -179.825 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.8 pttt . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.826 0.346 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 109.18 15.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.429 HD13 ' CG2' ' A' ' 115' ' ' VAL . 47.4 mt -76.41 -68.61 0.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.651 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.406 ' CB ' ' HB2' ' A' ' 65' ' ' TYR . 46.6 m-85 -100.47 96.89 5.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.644 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.61 115.28 2.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.55 2.166 . . . . 0.0 112.635 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.58 38.39 51.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.821 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' HB2' ' CB ' ' A' ' 62' ' ' PHE . 88.1 m-85 -132.61 109.98 10.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.67 137.24 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.549 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.413 ' HB2' ' CB ' ' A' ' 39' ' ' LEU . 3.9 m-85 -106.37 135.59 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -135.08 110.43 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.456 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 tt0 -85.53 74.34 10.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 110.224 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.4 ptp -91.42 -167.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.499 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.469 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.7 t70 -137.48 94.98 2.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.655 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.414 HD12 ' CE2' ' A' ' 6' ' ' TYR . 15.5 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.047 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.529 0.204 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.11 162.1 31.95 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.466 2.111 . . . . 0.0 112.365 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.1 -178.0 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -61.78 -29.49 70.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.41 -44.83 84.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.5 t-105 -61.06 -35.53 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -32.25 72.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.616 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.62 -49.9 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.064 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.17 -38.26 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -71.32 -22.5 61.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.48 20.83 10.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.933 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.95 145.7 37.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.632 0.253 . . . . 0.0 110.844 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.2 84.85 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.486 2.124 . . . . 0.0 112.222 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.37 -32.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.5 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.377 . . . . 0.0 111.017 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.414 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 4.6 mtt85 . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.639 0.257 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 91.5 Cg_exo -44.91 166.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.707 2.271 . . . . 0.0 112.65 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.09 111.47 33.9 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.493 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.01 145.93 10.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.643 2.229 . . . . 0.0 112.239 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.21 171.31 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 111.004 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.1 p -90.06 152.57 46.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.788 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.22 -32.48 70.93 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.722 2.281 . . . . 0.0 112.447 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 -41.4 58.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -78.91 -30.18 44.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 112' ' ' ILE . 66.3 t -62.82 -42.48 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.211 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -36.89 80.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -49.92 30.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.859 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 109' ' ' VAL . 2.8 pt -67.28 -16.38 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.449 HD13 ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -70.61 -32.64 70.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.836 0.35 . . . . 0.0 110.526 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.47 -10.74 57.42 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' CG2' HD13 ' A' ' 61' ' ' LEU . 40.4 t -75.87 -48.59 28.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 111.509 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 4.3 t -65.83 -56.61 11.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.428 . . . . 0.0 110.656 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.81 42.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.405 ' CD1' ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -108.65 -28.3 9.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.36 -31.2 7.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.424 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.435 HG22 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.313 0.102 . . . . 0.0 110.837 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 153.8 37.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.243 0.544 . . . . 0.0 112.206 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.464 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 73.9 m95 -97.46 88.84 4.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.356 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.419 ' CZ ' HD11 ' A' ' 72' ' ' LEU . 50.2 m-85 -79.82 125.58 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.828 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -107.19 148.31 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.67 162.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.528 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 3.0 m-70 -101.37 147.79 25.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.7 p -141.26 -176.96 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.55 130.78 34.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.725 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 p -57.69 118.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.58 -23.5 35.55 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.79 -20.54 18.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.237 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -44.32 70.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.79 -46.03 74.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -79.6 -27.29 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.819 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.8 97.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -49.8 -48.53 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.204 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.48 74.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.67 -38.45 89.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.39 -56.64 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.031 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -41.69 -36.58 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -77.67 -37.87 48.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -75.75 -27.84 58.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.644 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.9 mm -73.44 -30.18 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.626 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -80.86 -29.82 35.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.17 -43.12 44.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -81.65 -3.46 53.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.372 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 81.04 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mt -136.48 23.06 3.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.98 -15.87 58.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.131 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.45 -7.33 59.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.492 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.403 ' NZ ' ' CB ' ' A' ' 81' ' ' ALA . 4.9 ptmm? -115.99 -46.66 2.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.731 0.3 . . . . 0.0 110.854 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.85 108.63 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.652 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.435 ' CE2' HG22 ' A' ' 3' ' ' ILE . 8.5 m-85 -94.5 -60.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.455 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -108.92 146.48 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.108 0.48 . . . . 0.0 111.298 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.51 89.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.55 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.59 166.86 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.9 pt -120.69 134.91 24.33 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.748 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 36.9 Cg_endo -66.16 65.29 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.521 2.147 . . . . 0.0 112.547 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.856 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.772 0.32 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -58.96 102.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.4 mt -73.23 -48.28 36.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 1.7 m-85 -116.64 88.9 26.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.97 125.69 20.03 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.67 2.247 . . . . 0.0 112.779 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.65 35.53 74.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.123 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.403 ' CB ' ' HG3' ' A' ' 41' ' ' PRO . 6.4 m-85 -126.69 164.19 21.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -153.32 120.8 5.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.484 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 12.4 m-85 -94.65 138.09 32.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.561 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mp -141.68 116.1 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.979 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 5.3 tt0 -81.04 66.66 6.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.645 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.4 ptm -91.15 -171.08 2.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -148.48 99.5 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.419 HD11 ' CZ ' ' A' ' 6' ' ' TYR . 9.2 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.545 0.212 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.32 172.52 14.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.4 2.067 . . . . 0.0 112.288 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.35 176.62 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -57.7 -21.36 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.265 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' CB ' ' NZ ' ' A' ' 34' ' ' LYS . . . -53.22 -48.8 67.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.245 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -59.47 -38.36 80.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.05 -51.54 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.7 t -62.65 -48.8 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.045 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -9.33 58.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.361 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.46 24.17 4.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.918 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.32 144.32 74.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.649 0.261 . . . . 0.0 110.707 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.04 96.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.604 2.203 . . . . 0.0 112.695 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.86 52.77 4.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.083 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.581 0.229 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.46 -169.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.582 2.188 . . . . 0.0 112.418 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.44 88.54 4.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.8 148.58 71.49 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.616 2.211 . . . . 0.0 112.379 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 mt -90.0 169.56 11.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.01 148.51 39.7 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.682 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.67 -46.1 35.92 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.686 2.257 . . . . 0.0 112.248 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -64.97 -27.96 69.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -85.73 -37.9 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.464 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 48.2 t -57.65 -29.35 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.104 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -77.94 -28.59 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -79.2 -40.16 31.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.564 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.3 pp -72.06 -24.85 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.87 -34.89 64.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.83 -31.36 59.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.982 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -71.93 -43.08 68.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.132 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -61.59 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.66 43.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.559 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.2 mt -113.38 -35.69 5.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.14 36.27 3.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.776 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.329 -1.261 . . . . 0.0 112.517 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 36' ' ' PHE . 1.3 pp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.773 0.32 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -143.36 161.11 39.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.286 0.565 . . . . 0.0 111.582 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.457 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 94.9 m95 -86.82 86.64 7.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.593 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 57.1 m-85 -79.69 113.54 17.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.376 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -105.43 135.51 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 111.822 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 9' ' ' HIS . 0.6 OUTLIER -125.66 -167.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.399 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.489 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 8.1 m-70 -126.39 167.22 15.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.061 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -151.42 -174.61 4.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.13 133.63 35.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.1 m -58.8 117.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.003 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.41 -28.99 12.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -84.47 -21.18 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 111.195 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.37 -32.29 56.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.126 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -50.95 -60.8 2.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.287 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -75.26 -19.79 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.89 72.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.769 0.319 . . . . 0.0 111.067 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -55.84 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.83 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.58 -32.79 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.0 tp -80.06 -50.28 10.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.97 -52.51 65.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -39.98 75.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -40.14 90.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -62.29 -35.01 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.75 -10.21 40.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.422 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.92 73.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.344 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' ILE . 3.8 mm? -126.12 23.35 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.293 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -79.45 24.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.107 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -110.53 -23.93 10.85 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.883 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -107.96 -42.95 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.706 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mp -84.89 93.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 3' ' ' ILE . 30.4 m-85 -82.0 -49.02 10.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.36 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mt-30 -121.86 156.87 32.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.66 76.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.465 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.02 142.53 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.141 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 42' ' ' THR . 30.4 mm -98.09 110.92 57.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.983 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 31.5 Cg_exo -57.75 79.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.586 2.191 . . . . 0.0 112.437 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 40' ' ' ILE . 16.7 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.656 0.265 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.64 115.21 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.0 mt -90.22 -53.12 4.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 41' ' ' PRO . 18.9 m-85 -114.24 86.13 11.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.369 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.51 119.35 4.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.064 2.51 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.87 -13.67 29.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.778 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 2.5 m-85 -79.94 152.82 29.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.051 0.425 . . . . 0.0 111.412 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 1.2 mt -146.89 121.27 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.548 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.472 ' CE2' ' HG3' ' A' ' 41' ' ' PRO . 6.2 m-85 -91.21 125.4 35.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.24 114.37 14.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.256 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' CB ' ' HB2' ' A' ' 37' ' ' GLN . 28.1 tt0 -79.89 68.81 6.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.2 ptm -91.39 -170.73 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.699 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -129.28 101.0 5.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.723 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 31.7 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.395 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.549 0.214 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.86 -171.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.289 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -89.95 -174.15 4.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -22.87 64.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.32 -46.59 69.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.322 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.8 t-105 -61.24 -38.33 86.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -31.11 69.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.34 -46.27 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.17 -32.83 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -23.05 62.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.036 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -100.39 -8.88 48.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.009 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 p -74.94 114.61 36.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.852 0.326 . . . . 0.0 110.933 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.75 115.48 2.14 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.405 2.07 . . . . 0.0 112.356 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.11 -18.42 5.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.731 0.3 . . . . 0.0 111.096 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 2.0 mmp_? . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.496 0.189 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.3 Cg_exo -67.24 157.68 60.6 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.638 2.225 . . . . 0.0 112.08 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 m -154.17 98.23 2.57 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.426 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 41.4 Cg_exo -56.39 145.24 79.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.421 2.081 . . . . 0.0 112.244 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -83.39 160.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 p -77.04 145.38 73.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.46 -29.24 39.0 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.526 2.151 . . . . 0.0 112.228 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -77.13 -37.34 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.66 -35.73 33.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 36.2 t -60.95 -51.54 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.17 68.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.72 -51.27 17.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.614 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.422 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 22.6 pt -66.48 -19.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.754 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.79 -38.97 61.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.746 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.28 -34.31 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.001 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.3 t -83.91 -33.18 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.253 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -59.84 -60.77 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.22 41.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.645 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.6 mt -120.9 -57.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.75 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.72 31.11 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.332 -1.26 . . . . 0.0 112.432 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.426 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.43 0.157 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.38 150.78 27.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.331 0.586 . . . . 0.0 112.154 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.477 ' CH2' ' CD1' ' A' ' 39' ' ' LEU . 72.1 m95 -92.63 85.96 5.43 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.264 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 57.5 m-85 -81.19 129.06 34.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -111.38 124.7 52.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.354 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 t -101.1 159.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 1.7 m-70 -106.56 151.83 24.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.9 p -157.11 170.25 22.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.23 143.77 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.97 127.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.48 -27.81 17.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.485 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -99.18 -24.0 15.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 111.06 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.45 -53.75 53.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.051 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.42 -41.56 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -72.61 -33.66 66.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.225 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -47.39 -55.56 8.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -43.96 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.972 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mt -69.16 -63.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -40.86 -32.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.749 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -43.32 30.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 110.624 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -77.39 -26.59 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.777 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 26' ' ' ILE . 32.6 mm -83.97 -25.53 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -96.48 -29.91 13.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.82 -44.53 63.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.91 -24.59 40.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.978 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.08 53.32 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.382 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.98 32.04 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -79.17 8.93 5.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -97.48 -21.07 17.34 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -103.66 -55.08 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.49 94.54 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.673 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 3' ' ' ILE . 11.7 m-85 -79.99 -55.33 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.351 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.475 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt-30 -114.36 166.73 11.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.161 0.505 . . . . 0.0 111.709 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.2 t -150.32 89.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' CD1' ' CH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -80.59 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.171 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.4 pt -104.54 104.24 44.13 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.811 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 35.8 Cg_exo -57.67 -9.09 4.94 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.698 2.265 . . . . 0.0 113.147 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 32.8 p . . . . . 0 C--N 1.332 -0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 110.534 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 32.1 mtmt -145.37 92.38 2.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.343 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.12 -51.84 61.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.334 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 41' ' ' PRO . 10.9 m-85 -116.64 81.69 11.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.702 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 53.1 Cg_exo -54.94 141.73 77.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.604 2.203 . . . . 0.0 112.557 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.74 27.36 66.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.774 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 61.8 m-85 -134.23 151.62 51.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 6.0 mt -147.78 126.68 12.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.388 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.416 ' CE2' HD13 ' A' ' 112' ' ' ILE . 8.9 m-85 -93.96 131.66 39.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 111.219 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -138.14 113.99 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.467 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 3.3 tt0 -79.88 71.73 6.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.106 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.4 ' CE ' ' CD2' ' A' ' 72' ' ' LEU . 3.8 ptm -91.66 -171.15 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.342 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -129.71 79.08 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.545 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 20.5 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.775 0.321 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.6 165.87 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.493 2.128 . . . . 0.0 112.281 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -90.11 -177.9 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.69 -28.22 68.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.8 -45.61 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.194 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -62.61 -31.93 72.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -33.63 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.701 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.009 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.24 -39.19 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -74.75 -20.78 59.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.01 6.23 43.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.117 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 p -74.79 143.64 78.67 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.858 0.329 . . . . 0.0 110.672 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.15 104.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.459 2.106 . . . . 0.0 112.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.5 17.51 6.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.791 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.6 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 0.0 110.979 179.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.421 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_exo -49.81 143.35 23.41 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.587 2.191 . . . . 0.0 112.32 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.71 118.95 29.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.92 163.1 13.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.0 112.292 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.411 HD13 ' CD1' ' A' ' 67' ' ' PHE . 1.4 mt -90.0 168.41 12.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 p -88.74 147.04 38.3 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.49 -33.96 93.72 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.249 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -26.71 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -95.48 -36.7 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.476 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 40.9 t -59.39 -31.77 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -59.74 -43.12 94.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -53.91 34.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.67 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.416 HD13 ' CE2' ' A' ' 67' ' ' PHE . 9.9 pt -61.23 -23.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.259 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -36.71 76.74 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.29 -17.71 59.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.5 -60.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.483 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 39' ' ' LEU . 86.1 p -51.81 -59.96 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.79 46.16 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 mt -114.92 -43.82 3.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tp -98.7 30.88 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.428 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.443 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.439 0.162 . . . . 0.0 110.862 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -141.15 147.6 38.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 112.225 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.469 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 78.1 m95 -92.61 93.06 8.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.185 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 72' ' ' LEU . 29.1 m-85 -80.03 112.74 17.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 111.087 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -104.55 145.06 30.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.63 178.24 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -107.91 143.65 36.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 p -138.59 174.19 10.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.93 144.47 25.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.7 m -58.68 119.03 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.047 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -27.76 15.85 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.475 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.04 -30.26 39.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.652 0.263 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -40.14 86.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.58 -43.07 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 tttm -86.99 -25.48 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.88 -30.7 70.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -50.49 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 -41.37 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.45 -44.9 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.52 -47.09 67.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -21.77 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.63 -46.23 14.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.965 0.412 . . . . 0.0 110.289 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -67.31 -23.36 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.413 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -71.06 -28.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' N ' HG22 ' A' ' 26' ' ' ILE . 23.2 ttmt -98.08 -31.93 11.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.37 87.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.421 ' CD2' HG22 ' A' ' 84' ' ' VAL . 15.5 m-85 -82.77 -42.06 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.989 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.99 77.41 1.06 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.18 29.37 0.4 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 110.823 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -15.43 61.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.137 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -24.55 42.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -53.62 6.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.568 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.03 153.06 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.474 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 3' ' ' ILE . 25.8 m-85 -135.38 -54.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 0.0 111.402 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.28 157.92 25.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.382 0.611 . . . . 0.0 111.605 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.39 62.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.06 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.487 ' HG ' ' HB2' ' A' ' 116' ' ' SER . 1.9 tm? -79.58 129.37 34.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.586 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.28 128.36 26.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.666 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 30.7 Cg_endo -63.85 78.84 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.564 2.176 . . . . 0.0 112.635 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.5 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 179.751 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.792 0.33 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -63.66 101.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.62 -31.77 71.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.418 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 9.0 m-85 -139.59 83.97 16.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.631 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.46 139.47 90.25 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.59 2.193 . . . . 0.0 112.509 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.64 72.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.744 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -131.58 136.63 47.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.749 0.309 . . . . 0.0 110.954 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -131.53 128.76 39.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.465 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.451 ' CD2' HD12 ' A' ' 112' ' ' ILE . 5.3 m-85 -99.09 121.63 41.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -125.48 111.43 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -79.9 72.19 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.663 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 ptp -91.63 -163.23 1.01 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.177 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -147.77 89.2 1.73 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.662 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.423 HD11 ' CZ ' ' A' ' 6' ' ' TYR . 11.2 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.704 0.287 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.24 150.25 20.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.513 2.142 . . . . 0.0 112.256 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -165.83 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.81 -21.29 41.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.26 -35.9 19.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.431 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -80.46 -29.72 37.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.07 -28.24 63.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 29' ' ' PHE . 22.7 t -84.83 -51.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.63 -37.36 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -73.97 -26.35 60.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.175 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.5 6.13 60.86 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.008 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 120.68 69.22 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.774 0.287 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 115.18 2.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.26 -13.16 6.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.791 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 111.064 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.405 0.145 . . . . 0.0 111.011 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 100' ' ' ARG . 65.6 Cg_endo -85.12 155.07 11.1 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.698 2.266 . . . . 0.0 111.959 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 63.4 t -155.71 114.61 2.22 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.102 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.62 156.54 40.27 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.476 2.118 . . . . 0.0 112.388 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mp -89.72 147.81 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.95 153.3 94.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.53 -36.45 59.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.55 2.166 . . . . 0.0 112.311 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.63 -35.62 81.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.72 -38.81 20.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.469 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 38.3 t -58.84 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.056 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -53.68 -30.02 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.032 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 -54.91 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.707 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.451 HD12 ' CD2' ' A' ' 67' ' ' PHE . 15.7 pt -66.95 -26.2 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 109' ' ' VAL . 1.1 mp -72.2 -31.33 65.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.249 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -41.88 73.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.64 -27.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.487 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t -52.23 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.96 38.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.349 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 mt -122.31 -37.74 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.88 -34.58 39.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.434 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.434 HG22 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.622 0.248 . . . . 0.0 110.995 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.29 164.0 34.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.98 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.482 ' CH2' ' HB3' ' A' ' 37' ' ' GLN . 76.1 m95 -94.8 132.72 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.419 ' CE2' HD11 ' A' ' 72' ' ' LEU . 28.0 m-85 -119.11 122.81 42.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.803 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.55 131.52 47.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.481 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.59 159.54 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.788 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -94.27 133.52 37.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.046 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.7 p -144.74 -177.5 5.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.14 140.65 29.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.62 123.91 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.52 5.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.235 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -81.57 -18.14 45.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.913 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -44.96 -40.43 6.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.286 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -37.9 80.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -33.74 64.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.58 -43.77 88.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -66.1 -35.98 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.78 -54.92 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.003 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -60.26 -31.68 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.0 tp -74.96 -57.25 4.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.91 -32.39 6.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -71.64 -41.3 68.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -68.23 -39.33 82.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.587 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.438 HG21 HD11 ' A' ' 26' ' ' ILE . 37.5 mm -64.83 -31.46 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.828 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -83.99 -30.17 26.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.65 -44.87 76.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.04 -29.77 39.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.23 43.63 3.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.449 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.84 28.9 4.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 110.825 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -69.54 -13.11 62.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.409 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 1.1 m-20 -79.75 -23.8 42.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -94.56 -56.3 2.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.843 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.01 136.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.669 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.434 ' CE2' HG22 ' A' ' 3' ' ' ILE . 20.1 m-85 -132.27 -64.13 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.449 . . . . 0.0 111.447 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.02 151.74 21.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.82 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 m -159.81 106.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.494 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -118.82 160.45 21.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.378 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 pt -103.54 131.78 21.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 37.1 Cg_endo -65.65 83.28 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.555 2.17 . . . . 0.0 112.806 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.9 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.866 179.756 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 mttm . . . . . 0 CA--C 1.524 -0.024 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -133.1 100.94 5.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 63.1 mt -76.45 -31.71 58.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.652 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 61' ' ' LEU . 2.0 m-85 -140.42 67.65 31.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.557 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.39 120.19 7.89 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.63 2.22 . . . . 0.0 112.213 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 16.07 22.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.661 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.46 154.16 50.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.38 115.02 11.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.529 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 14.5 m-85 -79.83 125.01 29.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.276 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mp -134.03 112.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.142 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.4 tt0 -80.81 74.54 7.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.798 0.333 . . . . 0.0 110.936 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptp -91.24 -169.65 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.011 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -147.02 89.01 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 6' ' ' TYR . 62.6 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.574 0.226 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.08 177.82 8.33 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.477 2.118 . . . . 0.0 112.506 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -90.09 -164.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.64 -27.16 57.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.43 -34.97 37.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.399 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -66.21 -33.75 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.8 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -31.82 72.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.743 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -72.64 -49.58 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.17 -53.85 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp-105 -58.69 -29.35 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.64 -28.13 52.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.532 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.9 p -69.58 130.4 90.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.55 0.214 . . . . 0.0 110.756 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.76 -23.8 28.04 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.418 2.078 . . . . 0.0 112.348 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.78 -27.32 55.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.619 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.0 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 111.115 -179.968 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.453 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.511 0.196 . . . . 0.0 111.019 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 6.1 Cg_exo -79.05 -174.74 2.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.828 2.352 . . . . 0.0 112.226 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -150.74 72.21 8.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.06 133.94 37.69 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.524 2.149 . . . . 0.0 112.522 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mt -88.84 167.85 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.98 148.06 38.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.36 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.513 2.142 . . . . 0.0 112.277 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.97 -27.71 61.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -90.4 -33.5 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.454 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 33.5 t -60.53 -40.73 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.167 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -19.4 62.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -83.34 -44.06 15.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.96 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 109' ' ' VAL . 1.8 pp -74.96 -20.19 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.134 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.473 ' CD2' ' CZ2' ' A' ' 5' ' ' TRP . 97.4 mt -84.95 -34.01 22.54 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.863 0.363 . . . . 0.0 110.591 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -73.13 -28.23 62.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.693 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.0 t -89.51 -31.11 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.999 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 m -60.28 -64.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 149.09 55.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.722 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mt -135.5 -48.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.684 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -4.06 50.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.439 -1.2 . . . . 0.0 112.439 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.432 HG22 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.603 0.239 . . . . 0.0 110.797 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.86 164.68 37.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.258 0.551 . . . . 0.0 111.829 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.437 ' CD1' HG13 ' A' ' 109' ' ' VAL . 79.0 m95 -89.74 129.77 36.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.858 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -112.61 108.35 17.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.286 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.42 137.56 32.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.73 158.16 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.632 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 1.1 m-70 -104.32 132.98 49.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.911 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.8 p -128.04 -173.78 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.66 131.4 41.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -59.17 115.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.41 -28.73 12.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -20.04 35.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.87 -32.62 53.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.855 0.359 . . . . 0.0 111.154 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.65 -38.64 72.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -24.11 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.97 -51.27 70.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.303 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -50.66 -41.46 55.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.41 75.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -65.31 -36.27 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mt -79.5 -54.43 5.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -43.99 -31.32 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.615 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.5 -35.81 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.686 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -79.92 -25.29 40.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.821 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.0 mm -80.73 -28.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.698 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -91.47 -30.33 16.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.33 -42.94 61.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -80.21 -28.09 38.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 58.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.39 30.96 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.97 -10.72 60.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.233 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.406 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -79.97 -24.73 40.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.739 0.304 . . . . 0.0 110.983 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -61.94 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.1 mm -79.96 111.92 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' CE2' HG22 ' A' ' 3' ' ' ILE . 12.3 m-85 -99.53 -58.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.197 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -109.29 146.14 34.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.45 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -153.81 117.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.698 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.1 156.61 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.973 0.416 . . . . 0.0 111.278 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.5 tt -106.76 124.68 34.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.638 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 33.9 Cg_endo -64.7 69.78 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.54 2.16 . . . . 0.0 112.758 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.512 179.642 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.783 0.325 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -51.6 119.17 3.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.9 mt -90.1 -44.09 10.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.432 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 3.7 m-85 -115.73 91.36 29.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.23 117.75 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.909 2.406 . . . . 0.0 112.968 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.92 45.09 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.962 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.402 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -132.29 149.16 52.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.757 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.39 118.0 9.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.478 ' CE2' ' HB ' ' A' ' 112' ' ' ILE . 7.5 m-85 -88.25 133.9 33.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.795 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mt -135.37 111.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.128 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.47 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 7.8 tt0 -79.65 67.22 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.418 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.8 ptm -91.2 -168.6 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.279 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -145.6 108.56 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.777 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.841 -179.933 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.502 0.191 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.76 166.6 28.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.464 2.109 . . . . 0.0 112.345 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.83 173.55 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -59.14 -25.16 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.36 -50.55 67.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.306 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.415 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.0 t-105 -58.3 -42.02 85.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -59.85 -30.87 69.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.1 t -84.07 -52.34 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.13 -49.03 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.46 -11.87 61.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.251 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.83 -17.18 15.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.872 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.7 p -56.47 147.58 48.64 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.717 0.294 . . . . 0.0 110.985 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.48 109.73 1.89 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.587 2.192 . . . . 0.0 112.258 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.56 10.42 9.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.722 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 111.04 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.43 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.657 0.265 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 100' ' ' ARG . 85.6 Cg_exo -42.89 141.62 2.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.78 2.32 . . . . 0.0 112.572 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.8 t -99.92 102.3 17.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.76 150.38 27.29 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.145 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.06 153.91 20.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.6 p -80.97 161.16 64.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.06 -26.89 77.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.696 2.264 . . . . 0.0 112.323 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.85 -31.87 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -88.0 -35.22 17.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 5' ' ' TRP . 58.3 t -58.68 -48.92 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -25.16 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -38.84 26.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.478 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 14.4 pt -78.09 -26.95 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.7 mt -82.11 -26.91 33.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -70.67 -30.09 66.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.9 t -82.6 -38.02 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -62.76 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.21 45.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.557 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.0 mt -128.16 -54.23 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.794 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.37 -31.75 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.503 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.431 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.576 0.227 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.89 159.91 41.26 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 111.705 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.458 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 69.2 m95 -101.05 111.51 23.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 18.9 m-85 -94.96 124.43 39.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.817 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.53 143.67 29.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.434 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.65 162.03 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.073 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -86.79 155.87 20.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.271 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.417 ' CG2' ' CD2' ' A' ' 66' ' ' LEU . 28.6 p -146.56 -176.64 5.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.65 127.81 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.811 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -59.24 102.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.097 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.97 -17.67 27.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.631 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -112.87 2.21 15.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -54.96 -45.07 74.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.822 0.344 . . . . 0.0 111.071 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -54.12 -61.54 2.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -66.08 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.99 -47.43 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.85 0.357 . . . . 0.0 111.05 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -55.53 -41.03 72.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.14 80.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.41 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 mt -83.07 -60.72 2.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -37.53 -34.68 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.778 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -72.85 -51.23 19.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.422 ' NH1' ' CZ ' ' A' ' 29' ' ' PHE . 1.2 mtt-85 -69.31 -24.96 64.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 mm -73.38 -31.06 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.561 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -32.91 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.35 -29.52 65.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.022 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.422 ' CZ ' ' NH1' ' A' ' 25' ' ' ARG . 5.5 m-85 -80.55 -39.59 27.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.78 67.72 0.8 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.947 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.86 34.86 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -13.26 61.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.407 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.64 -22.69 43.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.881 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.5 -49.71 8.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.59 149.48 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.431 ' CE2' HG23 ' A' ' 3' ' ' ILE . 7.8 m-85 -140.12 -47.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.252 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.416 ' HB3' ' CH2' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -118.01 157.53 26.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.098 0.475 . . . . 0.0 111.703 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m -156.56 102.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.566 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -113.23 152.84 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.2 mt -99.24 127.03 35.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.54 78.56 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.536 2.158 . . . . 0.0 112.388 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.0 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.722 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.805 0.336 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -100.73 120.07 39.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.222 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 mt -76.0 -44.91 37.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.458 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -118.9 70.16 9.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.427 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.85 139.07 83.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.754 2.303 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.5 15.39 79.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.19 160.49 37.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.839 0.352 . . . . 0.0 111.179 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.417 ' CD2' ' CG2' ' A' ' 10' ' ' THR . 0.6 OUTLIER -144.91 131.15 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -93.6 123.41 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.2 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.14 116.43 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' HG3' ' NE1' ' A' ' 5' ' ' TRP . 5.7 tt0 -79.74 69.89 6.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.6 ptp -91.0 -166.55 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.811 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -160.06 96.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.363 . . . . 0.0 110.889 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.427 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 51.9 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.762 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.581 0.229 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.64 176.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.07 -170.2 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.974 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -29.05 68.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.86 -27.98 20.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.475 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -78.98 -33.39 45.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.039 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -62.15 -29.73 70.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.42 HG21 ' CD2' ' A' ' 29' ' ' PHE . 20.9 t -82.96 -40.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.9 t -67.05 -45.72 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -15.82 62.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.308 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.0 -18.61 9.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.028 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.19 134.17 87.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.783 0.291 . . . . 0.0 110.945 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.3 -30.05 89.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.47 2.114 . . . . 0.0 112.28 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.06 -33.28 60.59 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.701 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 179.836 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.539 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 10.6 mtm-85 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.459 0.171 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 34.2 Cg_endo -64.49 148.45 90.64 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.292 1.994 . . . . 0.0 112.296 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 m -145.15 89.01 6.56 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.81 133.01 26.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.49 2.127 . . . . 0.0 112.218 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.74 159.07 20.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m -81.2 160.43 65.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.79 -24.86 79.98 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.374 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.44 -37.12 63.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.052 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.37 -37.35 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.8 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.458 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 94.8 t -58.54 -38.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.19 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -25.92 65.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -74.69 -50.62 16.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.707 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 pp -68.16 -16.78 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.422 HD12 ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -79.05 -41.76 28.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -33.16 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.793 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.5 t -73.46 -30.93 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.989 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -70.02 -58.77 3.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 140.97 59.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mt -133.14 -56.7 0.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -50.93 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.535 179.973 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.469 0.175 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -131.35 148.13 52.64 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.325 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.492 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 79.5 m95 -99.95 94.4 6.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.004 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 77.7 m-85 -84.15 126.62 33.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.39 124.78 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.5 p -108.37 159.46 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.193 0.52 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.479 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 21.1 m-70 -96.98 119.11 34.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.6 p -121.84 169.88 10.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -84.84 153.61 22.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.34 120.86 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.31 21.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.529 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -86.0 -25.63 25.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.16 -45.16 79.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 0.0 111.047 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.05 -42.42 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.61 -28.63 45.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.98 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.39 80.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -61.61 -50.87 70.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.63 81.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.1 -37.77 77.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.83 -54.76 5.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.52 -30.54 20.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -44.44 43.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.753 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -73.8 -27.6 61.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 26' ' ' ILE . 36.5 mm -85.98 -16.27 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -108.06 -29.94 8.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.14 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.87 25.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.175 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 25' ' ' ARG . 71.1 m-85 -79.88 -2.99 46.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.335 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 77.47 0.74 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.751 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -134.99 30.96 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.962 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -77.51 6.18 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.338 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.5 -25.27 22.66 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.739 0.304 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -106.14 -58.0 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mm -81.86 110.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.808 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 20.5 m-85 -100.81 -53.15 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.216 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.6 157.43 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 0.0 111.646 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -148.54 67.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.271 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.36 156.8 26.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.429 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 tp -113.78 131.42 23.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.708 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 43.5 Cg_endo -67.86 74.18 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.335 2.024 . . . . 0.0 112.548 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.0 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.944 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tptm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.788 0.327 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -53.81 120.54 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.217 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.18 -40.65 12.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 32.8 m-85 -123.12 76.38 51.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.4 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 46.7 Cg_exo -56.28 141.39 88.66 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.636 2.224 . . . . 0.0 112.496 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.08 20.41 76.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.709 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 96.3 m-85 -131.02 145.02 51.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.21 122.1 22.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.527 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 17.5 m-85 -84.73 115.07 22.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.59 108.81 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.055 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.422 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 3.0 tt0 -79.85 74.3 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.54 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.1 ptp -91.19 -174.35 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.128 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.435 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.7 t0 -125.47 78.15 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.681 0.277 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.61 165.2 32.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.62 2.213 . . . . 0.0 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.87 178.89 7.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -61.86 -18.79 61.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.241 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.74 -46.72 64.13 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.387 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -59.39 -43.79 92.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.44 -30.17 69.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.674 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.41 ' CG1' ' HG2' ' A' ' 25' ' ' ARG . 34.5 t -71.34 -49.51 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -61.23 -45.31 98.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -59.75 -23.12 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.64 -32.86 8.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.756 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.58 146.76 79.38 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.27 -25.07 26.62 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.412 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.74 -25.45 43.95 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.643 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.8 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.8 ptt-85 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.67 0.271 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.63 -166.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.584 2.189 . . . . 0.0 112.061 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 m -143.0 99.37 5.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.01 135.17 16.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.128 . . . . 0.0 112.327 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mt -72.65 169.36 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.6 m -89.14 145.84 35.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.723 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.24 -33.34 97.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.54 2.16 . . . . 0.0 112.393 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.96 -32.91 67.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -34.46 26.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.492 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 48.9 t -57.33 -45.63 85.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -29.99 40.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.15 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -74.93 -52.4 11.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.542 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.435 HD12 ' CD2' ' A' ' 67' ' ' PHE . 11.6 pt -67.85 -19.38 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 mp -77.17 -38.38 51.82 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.479 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -69.67 -27.67 65.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.68 -31.97 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -64.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.89 43.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.662 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.5 mt -120.04 -47.39 2.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.96 -36.55 6.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.351 -1.25 . . . . 0.0 112.485 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.368 0.128 . . . . 0.0 110.91 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 159.37 39.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.386 0.612 . . . . 0.0 112.481 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.495 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 89.7 m95 -97.42 91.77 5.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.476 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 62.7 m-85 -83.67 111.17 18.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.353 . . . . 0.0 110.737 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.48 159.04 16.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.35 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.91 162.99 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.897 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -101.3 149.42 24.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.1 p -149.36 -174.36 4.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.1 141.79 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.98 120.04 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.38 -29.42 10.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -85.71 -23.41 27.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.791 0.329 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -54.84 -34.91 63.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.38 -47.14 79.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.011 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -75.7 -27.13 58.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.84 85.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.195 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -47.25 -48.25 24.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.05 73.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.946 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -67.16 -49.79 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.94 -62.45 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -42.84 -31.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.623 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.25 -39.6 25.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.861 0.363 . . . . 0.0 110.474 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.22 51.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.63 -27.12 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.692 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.45 -31.99 11.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.027 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.06 -46.05 68.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.96 -16.97 54.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.76 49.83 4.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.29 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.68 24.57 5.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -80.3 19.4 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.241 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.2 -21.32 16.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -116.49 -49.22 2.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.797 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.4 mp -79.9 125.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.876 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -116.07 -62.13 1.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.471 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -106.71 156.01 19.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 111.224 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.36 73.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.9 139.44 37.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.277 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -96.43 118.55 65.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.702 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 27.2 Cg_endo -62.31 90.03 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.352 2.034 . . . . 0.0 112.565 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.771 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.799 0.333 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -112.55 113.14 25.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 111.102 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 4.9 mt -90.26 -57.62 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.651 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 69.9 m-85 -119.18 87.54 35.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.603 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.37 115.34 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.673 2.249 . . . . 0.0 112.624 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.05 19.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.788 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -138.03 147.82 44.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.069 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mp -145.5 112.91 6.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 5.1 m-85 -84.96 126.13 33.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 111.201 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.36 115.61 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 1.9 tp-100 -79.75 71.73 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 0.0 110.354 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.423 ' HG3' ' HG ' ' A' ' 72' ' ' LEU . 4.6 ptm -91.56 -177.93 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -121.51 82.84 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 13.7 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.773 0.32 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.21 108.1 2.41 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.697 2.264 . . . . 0.0 112.275 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -90.15 -77.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -54.06 -64.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.604 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.59 -32.85 5.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.853 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -87.44 -29.23 21.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.141 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.81 -29.55 70.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.0 -49.25 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -60.15 -41.24 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.33 -21.85 60.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.02 10.3 37.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.114 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.22 135.93 29.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.814 0.307 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.56 120.6 8.5 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.077 . . . . 0.0 112.258 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.24 -8.96 9.6 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.944 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 111.082 -179.927 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.498 0.19 . . . . 0.0 110.934 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.1 Cg_exo -66.92 -179.53 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.647 2.232 . . . . 0.0 112.151 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.12 81.86 2.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.9 124.7 9.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.68 172.19 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.0 p -90.17 147.78 37.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -50.82 -29.39 26.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.605 2.204 . . . . 0.0 112.261 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.91 -42.43 39.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -74.02 -38.27 64.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.495 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 40.1 t -59.07 -42.53 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -57.54 -31.37 66.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.954 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -56.08 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 67' ' ' PHE . 21.8 pt -63.56 -24.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.9 mp -72.71 -38.9 67.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.18 -33.03 67.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.0 t -79.37 -37.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.2 t -58.46 -63.5 1.26 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.66 54.94 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.537 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.6 mt -133.02 -54.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.37 -31.36 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.405 -1.219 . . . . 0.0 112.535 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.457 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.446 0.165 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.36 150.14 24.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 112.232 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 75.1 m95 -86.09 92.43 8.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.446 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 40.1 m-85 -84.23 114.53 21.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.403 . . . . 0.0 110.87 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.28 154.73 19.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.567 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.35 179.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 16.1 m-70 -130.75 149.86 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.2 p -145.96 -173.84 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.83 149.83 22.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.45 124.45 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -24.77 27.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.624 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.54 -22.73 17.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.0 111.077 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -54.49 -35.56 63.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.19 -30.97 68.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.91 -28.84 18.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -42.05 81.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.094 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -59.77 -38.21 81.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 -44.93 28.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -60.75 -35.08 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 67.5 tp -73.78 -57.91 3.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -29.71 15.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -41.94 71.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.75 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -70.23 -36.89 74.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 26' ' ' ILE . 29.8 mm -74.5 -29.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.93 -36.6 14.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.177 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.95 -44.74 72.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.32 -26.62 35.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.63 70.43 1.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mt -123.3 38.93 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.2 -1.12 24.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.538 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.72 -25.22 41.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -55.05 2.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.4 mm -82.99 127.92 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.636 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 3' ' ' ILE . 23.3 m-85 -120.57 -64.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -102.89 122.29 44.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.433 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 m -114.83 77.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 116' ' ' SER . 2.6 tm? -91.76 127.59 37.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.95 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 42' ' ' THR . 3.4 pt -102.67 128.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.494 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 78.1 Cg_exo -52.2 69.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.991 2.461 . . . . 0.0 113.216 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 40' ' ' ILE . 68.2 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.525 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -67.2 117.63 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.042 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 11.0 mt -81.81 -52.71 6.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 41' ' ' PRO . 2.9 m-85 -129.91 86.89 53.53 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.5 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 147.99 89.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.788 2.325 . . . . 0.0 112.596 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.6 9.1 64.54 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.078 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 22.4 m-85 -119.08 161.97 19.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.977 0.417 . . . . 0.0 111.058 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.49 112.56 3.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.415 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 112' ' ' ILE . 5.9 m-85 -89.44 122.23 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.25 110.49 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.999 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.677 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.74 74.87 6.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.301 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.9 ptm -91.36 -173.19 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.136 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -126.7 82.86 2.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 62.5 mt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.497 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.75 0.309 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.83 139.32 36.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.634 2.223 . . . . 0.0 112.26 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.54 178.54 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -58.93 -23.61 61.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.59 -49.33 67.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.328 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -66.3 -35.09 79.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -60.24 -31.44 70.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.09 -46.96 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.3 t -59.8 -49.32 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -70.82 -18.1 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.031 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.02 -22.67 44.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.793 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 54.4 p -54.1 108.38 1.12 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.586 0.231 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.27 119.27 5.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.77 15.86 19.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.704 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.47 HD12 HG23 ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.664 0.269 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.12 178.87 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.627 2.218 . . . . 0.0 112.078 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.37 96.76 8.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.87 125.55 12.22 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.377 2.052 . . . . 0.0 112.207 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.69 158.87 11.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.044 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m -89.96 147.36 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.89 -31.31 42.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.436 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -31.38 69.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.974 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.09 -31.08 13.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.471 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 22.0 t -66.39 -29.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.213 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -39.38 93.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -52.28 29.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.566 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.428 HG21 ' CE2' ' A' ' 67' ' ' PHE . 2.0 pp -65.06 -21.4 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.69 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.419 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 7.5 mt -69.05 -34.8 75.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -59.66 -22.07 61.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.994 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.6 t -73.89 -56.58 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.243 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.406 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -51.4 -48.46 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.06 21.01 3.57 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.808 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.419 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -83.67 -27.7 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.709 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.19 -42.06 4.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.813 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.473 -179.948 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.411 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.454 0.168 . . . . 0.0 110.858 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -157.88 152.11 24.49 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.217 0.532 . . . . 0.0 111.789 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.487 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 87.1 m95 -94.97 92.72 7.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.568 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 40.1 m-85 -81.48 113.13 19.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 110.786 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -93.84 146.68 23.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.445 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.2 p -123.34 159.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.727 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 5.1 m170 -117.27 103.39 10.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.933 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 p -110.08 -174.29 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.96 150.99 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -71.35 126.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.11 26.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.575 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -23.54 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.064 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.48 -33.43 63.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.059 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.87 -34.74 68.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.07 -28.49 20.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.57 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.093 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -38.51 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.27 79.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.022 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -61.62 -32.02 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.2 tp -76.17 -57.65 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -28.94 10.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.47 -41.63 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -37.7 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 mm -72.53 -30.41 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -89.81 -33.72 16.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.7 -40.01 66.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.91 -26.73 27.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.2 47.51 3.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mt -99.92 40.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.25 -6.38 49.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.406 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.81 -26.12 40.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.995 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.53 -55.38 3.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.715 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.1 mm -88.2 122.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.81 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 10.3 m-85 -112.68 -54.37 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.435 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -111.4 156.5 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.5 t -156.4 75.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.122 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.04 168.06 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.712 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.25 139.41 31.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.805 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 72.3 Cg_endo -77.1 86.4 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.711 2.274 . . . . 0.0 113.202 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.44 ' O ' ' CG1' ' A' ' 115' ' ' VAL . 24.3 p . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.14 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.859 0.361 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -48.53 108.67 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.691 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 71.1 mt -79.6 -31.88 41.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.471 179.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 26.7 m-85 -132.06 69.62 80.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.434 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.01 134.6 60.52 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.681 2.254 . . . . 0.0 112.608 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.31 -2.37 82.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.485 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 3.1 m-85 -106.26 110.87 23.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.946 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -101.27 122.28 43.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.488 179.714 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 41' ' ' PRO . 12.9 m-85 -89.66 119.68 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.73 106.8 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.417 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 8.2 tt0 -79.83 72.99 6.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.434 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -91.11 -174.83 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.194 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.458 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.9 t0 -131.01 110.36 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.447 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 34.8 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.706 0.288 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.45 166.42 2.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.556 2.171 . . . . 0.0 112.235 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -83.52 173.28 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -59.15 -25.44 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.04 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.48 -42.63 74.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.213 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -63.67 -44.01 95.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.95 -37.57 77.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.83 -45.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 t -64.34 -41.04 91.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -22.84 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.036 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.79 -24.27 30.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 78.0 p -58.2 115.99 13.22 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.57 0.224 . . . . 0.0 110.899 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 131.07 39.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.411 2.074 . . . . 0.0 112.293 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.14 59.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.836 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.3 tp . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.979 0.418 . . . . 0.0 111.201 179.99 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.461 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 71.1 mtt85 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.636 0.255 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 51.4 Cg_endo -68.77 136.44 35.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.096 . . . . 0.0 112.248 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.78 87.31 25.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.22 130.38 23.94 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.53 2.154 . . . . 0.0 112.222 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mt -79.16 163.95 24.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.0 t -86.82 140.81 33.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.8 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.78 -30.5 23.2 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 0.0 112.529 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -43.07 73.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.18 -30.53 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.487 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 26.4 t -61.29 -44.11 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -29.03 69.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -76.29 -45.33 33.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.786 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.445 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 20.0 pt -71.88 -26.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.882 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.8 mt -76.86 -36.26 56.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.397 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.65 -27.45 67.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 42' ' ' THR . 25.3 t -77.19 -41.98 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.55 -62.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.074 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 151.08 44.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.559 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mt -119.59 -52.87 2.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.807 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -31.07 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.496 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.426 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.443 0.163 . . . . 0.0 110.796 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -141.19 151.57 43.91 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 112.068 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' A' ' 69' ' ' GLN . 84.6 m95 -98.92 93.61 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.421 ' CZ ' HD11 ' A' ' 72' ' ' LEU . 50.5 m-85 -85.51 126.07 33.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.886 0.374 . . . . 0.0 110.772 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -105.69 142.2 35.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.598 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.71 150.67 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.629 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -94.25 147.88 22.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.969 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -141.01 177.06 8.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.01 141.38 28.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -70.17 104.89 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.41 -27.44 5.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -101.89 -17.39 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 111.206 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.52 -38.73 64.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.103 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -42.63 73.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.943 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.06 92.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -56.55 20.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.57 98.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.55 -43.23 97.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 tp -72.62 -48.79 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -24.76 61.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.072 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -81.82 -44.56 16.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -68.84 -24.99 64.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.204 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -69.45 -28.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.737 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -91.45 -33.65 15.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.971 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.82 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.063 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -79.94 -37.81 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.23 65.26 0.84 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.739 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.57 27.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 0.0 110.881 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -11.71 61.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.3 m-20 -79.7 -29.66 40.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.824 0.345 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -77.16 -49.84 14.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -84.78 109.05 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.6 179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.1 m-85 -94.08 -52.77 4.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.439 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 69' ' ' GLN . 2.0 mt-30 -111.99 156.36 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.79 -179.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.9 m -153.1 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.967 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.57 142.29 29.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.535 -179.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.04 127.56 38.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.604 179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.427 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 26.1 Cg_endo -62.18 75.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.554 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.8 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.856 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.848 0.356 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -92.61 121.7 34.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.23 -49.51 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.728 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.427 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 35.6 m-85 -102.06 97.89 9.18 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.41 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.49 124.46 16.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.547 2.165 . . . . 0.0 112.509 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.71 42.97 99.58 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.83 151.58 48.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.985 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 11.3 mt -147.09 114.23 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.666 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 41' ' ' PRO . 8.4 m-85 -90.33 123.15 33.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.47 113.93 31.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.21 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 4.5 tt0 -80.87 72.88 7.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.5 ptp -91.35 -169.36 2.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.99 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.57 80.2 1.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.771 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.421 HD11 ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.945 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.418 0.151 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -65.67 66.64 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.65 2.234 . . . . 0.0 112.192 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -55.7 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.03 -82.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.04 84.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -83.61 -30.16 27.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -61.62 -31.8 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.8 t -82.57 -44.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.54 -49.98 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.56 -24.52 61.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.72 70.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.827 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.0 120.33 80.41 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.802 0.301 . . . . 0.0 110.7 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.26 -14.18 43.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.475 2.117 . . . . 0.0 112.479 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.56 25.67 21.81 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.626 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.687 0.28 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.96 163.95 31.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.538 2.159 . . . . 0.0 112.17 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 t -125.41 116.41 25.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.32 171.38 17.83 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.452 2.101 . . . . 0.0 112.16 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 67' ' ' PHE . 3.2 mp -89.88 157.42 17.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.895 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -80.36 150.67 71.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.2 -31.58 22.3 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.598 2.199 . . . . 0.0 112.43 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -45.32 24.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.09 -32.58 69.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 112' ' ' ILE . 72.0 t -61.87 -52.41 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.008 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -24.62 66.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.731 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.93 -51.27 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.683 179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 109' ' ' VAL . 2.2 pp -69.78 -15.62 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -36.31 35.94 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.682 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -80.56 -34.88 35.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.8 t -75.38 -46.35 38.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 72.4 m -60.75 -51.17 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.689 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 135.43 64.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.627 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.8 mt -136.74 -49.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.891 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -51.99 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.854 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.333 -1.259 . . . . 0.0 112.482 -179.967 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.469 0.176 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -160.05 160.79 33.59 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 112.134 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.45 ' CH2' ' CB ' ' A' ' 37' ' ' GLN . 89.6 m95 -91.76 90.87 7.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.446 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 58.5 m-85 -83.67 108.72 16.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.11 148.87 27.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.44 -178.9 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.072 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -107.94 137.38 46.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -130.9 -178.62 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.73 120.44 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.5 119.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.072 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -28.83 11.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -0.34 43.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.57 -43.32 25.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.823 0.344 . . . . 0.0 111.224 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -37.89 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.018 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.6 -28.49 20.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.794 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -61.06 2.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -63.02 -38.62 91.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.86 94.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.45 -39.41 93.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.636 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.47 -51.89 52.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.69 -31.58 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.0 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.31 -41.86 69.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -70.5 -37.21 74.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.66 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.4 mm -70.07 -30.35 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.849 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -88.58 -33.32 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.54 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.9 -35.56 32.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 85.96 1.27 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.69 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.09 48.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.31 -7.77 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.358 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 p-10 -79.62 -20.16 47.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.956 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -96.05 -55.55 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.614 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.464 HD12 HG23 ' A' ' 35' ' ' ILE . 32.6 mt -91.36 130.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 33' ' ' ASP . 20.5 m-85 -121.57 -54.8 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.717 -179.369 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.45 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mm100 -117.12 158.38 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 112.345 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.8 t -157.18 83.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.84 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.94 164.0 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.274 0.559 . . . . 0.0 112.207 -178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.83 69.93 16.82 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.094 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HG2' ' CE2' ' A' ' 67' ' ' PHE . 72.5 Cg_exo -41.07 115.45 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.273 2.649 . . . . 0.0 113.749 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.052 179.049 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 119.71 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.3 mt -83.25 -42.61 17.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.364 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 41' ' ' PRO . 26.7 m-85 -122.99 74.32 48.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.873 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.95 142.8 93.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.596 2.197 . . . . 0.0 112.246 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.31 25.23 18.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.625 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.96 112.58 10.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.7 130.08 56.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.477 ' CE2' ' HG2' ' A' ' 41' ' ' PRO . 13.8 m-30 -92.48 130.9 38.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.723 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -130.39 111.46 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.211 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -79.72 70.86 6.31 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 ptm -91.55 -175.84 4.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.293 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -124.11 86.86 2.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.446 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 13.2 mt . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.745 0.307 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.33 173.5 14.39 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.457 2.105 . . . . 0.0 112.436 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.99 -165.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -24.0 54.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.89 -44.62 63.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.369 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.9 t-105 -73.56 -30.19 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -37.7 86.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.06 -40.18 78.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.097 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.4 t -67.14 -45.63 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -63.23 -17.92 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.98 -28.32 8.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.796 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.3 p -58.75 155.84 28.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.24 -25.29 31.15 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.51 -26.24 51.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.59 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.0 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.937 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.542 0.21 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.25 172.07 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.519 2.146 . . . . 0.0 112.309 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 t -128.95 122.97 21.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.22 142.59 15.23 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.529 2.153 . . . . 0.0 112.405 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 mt -74.54 168.96 18.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.79 142.83 29.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.01 -51.24 11.29 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.569 2.179 . . . . 0.0 112.615 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -56.95 -28.19 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -89.99 -36.29 15.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.414 HG13 ' CD1' ' A' ' 5' ' ' TRP . 30.3 t -57.42 -33.13 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.361 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -27.98 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.052 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.96 -34.59 26.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.904 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.468 ' CD1' ' CE2' ' A' ' 67' ' ' PHE . 15.2 pt -81.48 -19.11 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.122 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.416 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 29.9 mt -84.99 -25.08 27.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.719 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.35 -32.91 58.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.81 -37.47 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.54 -52.86 63.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.87 38.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.897 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.416 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 15.8 mt -117.72 -55.68 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.34 -42.82 14.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.516 179.994 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.88 0.371 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -154.96 165.77 35.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.495 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 92.4 m95 -86.56 91.34 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.727 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 79.8 m-85 -87.08 116.42 25.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.422 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -103.5 146.84 27.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.023 0.439 . . . . 0.0 111.763 -179.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.3 p -117.13 159.33 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.584 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.468 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 2.1 m-70 -107.01 142.21 37.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.932 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.5 p -155.12 174.8 14.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.81 162.35 15.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.62 125.85 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.72 -32.06 6.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.533 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.75 -30.72 36.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -37.19 77.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -59.97 -30.85 69.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.17 -29.88 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -50.16 75.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -60.16 -43.05 96.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.34 -51.98 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.67 -31.01 72.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.2 tp -78.23 -56.55 4.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -48.97 -31.29 7.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -43.87 68.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -36.09 82.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.428 HG22 HD11 ' A' ' 26' ' ' ILE . 37.7 mm -64.84 -29.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.997 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.76 -31.38 14.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.52 68.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.414 ' CE2' HG13 ' A' ' 84' ' ' VAL . 15.3 m-85 -80.01 -34.46 38.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.35 59.0 1.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.641 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.66 47.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.809 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -65.69 -15.4 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.308 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.71 -2.34 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -113.13 -59.1 2.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 179.853 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.1 mm -79.95 120.29 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.414 ' CE2' ' O ' ' A' ' 34' ' ' LYS . 63.3 m-85 -116.03 -56.23 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.571 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 69' ' ' GLN . 1.8 mm100 -112.95 156.17 23.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.247 0.546 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.8 t -154.89 79.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.137 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.29 157.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.518 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.1 tt -111.15 120.37 43.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.926 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 30.6 Cg_endo -64.64 80.6 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.545 2.163 . . . . 0.0 112.877 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.607 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.875 0.369 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.08 122.46 11.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.9 mt -80.64 -51.05 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.401 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 33.1 m-85 -111.11 89.65 10.18 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 37.9 Cg_endo -66.69 128.39 18.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 22.87 73.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 97.1 m-85 -129.44 139.78 51.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.701 0.286 . . . . 0.0 110.984 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 4.1 tp -130.89 134.57 46.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 11.5 m-85 -99.85 123.9 44.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.28 112.9 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.432 ' CB ' ' HB2' ' A' ' 37' ' ' GLN . 19.5 tt0 -79.95 72.64 6.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.156 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.8 ptm -91.56 -173.47 3.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.375 -179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -119.22 99.64 6.83 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.922 179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 54.1 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.31 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.685 0.279 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.6 151.88 72.63 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.662 2.241 . . . . 0.0 112.176 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -69.11 -175.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.86 -27.58 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.945 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.03 -29.02 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.345 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.81 -34.72 62.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -68.02 -31.5 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 29' ' ' PHE . 21.7 t -76.99 -45.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.214 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.9 t -59.01 -40.25 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.72 -12.97 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.325 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.95 -15.66 12.64 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.2 p -57.4 112.01 4.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.736 0.268 . . . . 0.0 110.984 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.62 121.43 7.92 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.373 2.049 . . . . 0.0 112.299 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.26 -19.57 17.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.692 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.689 0.281 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.12 172.63 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.97 80.04 1.66 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.413 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HB3' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_endo -77.87 139.76 17.77 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.537 2.158 . . . . 0.0 112.265 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.96 130.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.846 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.32 150.26 93.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.84 -40.0 57.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.577 2.185 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -31.24 72.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -87.64 -34.32 18.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.495 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 22.8 t -61.9 -31.73 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.303 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -64.33 -29.97 71.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -74.36 -47.4 34.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.806 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.416 HD11 ' CE2' ' A' ' 67' ' ' PHE . 17.1 pt -69.8 -27.38 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 mt -74.85 -34.28 62.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -70.23 -32.5 70.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.594 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 t -81.83 -33.3 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -63.63 1.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 145.44 44.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.698 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.6 mt -121.59 -45.44 2.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.749 0.309 . . . . 0.0 110.92 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.22 30.33 2.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.33 -1.261 . . . . 0.0 112.475 -179.957 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.433 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.452 0.168 . . . . 0.0 110.882 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.21 160.3 43.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.165 0.507 . . . . 0.0 111.88 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.465 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 90.0 m95 -93.96 119.8 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.774 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 22.3 m-85 -114.3 105.64 13.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.441 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -99.14 169.09 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.097 0.475 . . . . 0.0 111.724 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 2.4 p -156.26 161.41 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.57 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.506 ' CE1' ' CE2' ' A' ' 65' ' ' TYR . 5.8 m170 -93.43 157.07 16.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.108 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p -150.35 -176.54 5.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.09 145.79 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.16 129.55 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.2 -23.97 31.0 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.618 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.68 -19.62 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.569 0.223 . . . . 0.0 111.167 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.45 -38.45 66.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.7 -36.61 72.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.947 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -24.83 21.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.025 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.24 -38.1 89.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -61.2 -35.15 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 -41.89 34.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.65 -34.88 73.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.8 tp -77.31 -53.01 8.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.09 -35.37 59.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -63.42 -42.11 98.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.682 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -38.15 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.7 mm -64.06 -33.26 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -89.8 -33.81 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -40.4 77.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.07 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -92.32 -24.81 18.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.07 78.29 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.404 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.18 35.26 4.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.89 16.21 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.478 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.8 -12.88 15.71 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.52 0.2 . . . . 0.0 111.115 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -116.28 -44.23 2.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.321 . . . . 0.0 111.125 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.406 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 19.4 tt -82.2 153.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.195 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 28.9 m-85 -143.23 -52.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.413 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.9 mt-30 -120.33 146.52 46.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 111.108 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.22 70.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.222 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -88.69 143.59 26.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.576 -179.121 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 tt -108.58 123.58 36.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.231 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 14.0 Cg_endo -57.84 87.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.659 2.24 . . . . 0.0 112.894 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.2 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.776 179.586 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.802 0.335 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -58.07 108.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.057 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' CD1' ' CG1' ' A' ' 115' ' ' VAL . 39.6 mt -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.409 ' CB ' ' HB2' ' A' ' 65' ' ' TYR . 3.3 m-85 -132.56 88.4 38.97 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.623 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.22 108.4 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.763 2.309 . . . . 0.0 112.857 -179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 47.82 9.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.848 179.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.506 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 62.6 m-85 -144.96 145.15 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 2.3 pp -150.61 120.27 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.413 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.464 ' CD2' ' CD1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -96.25 126.88 41.77 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 111.366 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.13 121.53 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.579 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -79.87 78.9 6.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.362 . . . . 0.0 110.712 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.3 ptp -91.0 -175.71 4.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.244 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 5.9 t0 -122.17 77.88 1.44 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 19.9 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.652 0.263 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.38 104.74 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.666 2.244 . . . . 0.0 112.218 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.2 -167.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.47 -85.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.52 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.95 69.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.591 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.408 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 2.0 t-105 -74.81 -30.51 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.119 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.94 -30.16 69.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.748 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.1 t -84.57 -48.7 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.045 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.72 -49.61 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.48 -22.41 66.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.247 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.38 -22.45 24.47 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.83 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.24 145.73 99.04 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 110.93 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.77 -25.59 28.37 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.469 2.113 . . . . 0.0 112.301 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.38 -28.17 54.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 110.847 -179.978 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.499 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 1.3 mmp_? . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.515 0.198 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.4 Cg_endo -59.46 152.61 60.23 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.437 2.091 . . . . 0.0 112.064 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.35 82.18 31.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.191 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.3 115.6 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.38 2.053 . . . . 0.0 112.091 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -70.57 149.01 47.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.994 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.3 m -87.49 148.31 43.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.88 -37.1 54.95 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.764 2.309 . . . . 0.0 112.458 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -68.93 -29.41 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -91.48 -32.18 15.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.465 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 24.3 t -64.28 -36.67 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.113 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -69.48 -30.73 68.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.942 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -77.91 -42.36 33.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.728 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.464 ' CD1' ' CD2' ' A' ' 67' ' ' PHE . 1.9 pp -74.89 -29.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.411 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 19.0 mt -75.34 -30.68 60.33 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.493 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.12 -27.78 64.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.195 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.429 ' CG1' ' CD1' ' A' ' 61' ' ' LEU . 2.1 t -88.23 -50.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.785 0.326 . . . . 0.0 111.34 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -52.92 -63.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.836 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.21 48.68 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.843 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.411 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 15.7 mt -133.17 5.77 3.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.47 0.176 . . . . 0.0 111.455 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.84 40.69 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.874 0.368 . . . . 0.0 110.809 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.396 -1.225 . . . . 0.0 112.531 -179.987 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.403 HG21 ' HA ' ' A' ' 71' ' ' ASP . 2.7 pp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.518 0.199 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -142.7 169.8 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 112.21 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.463 ' CH2' ' CB ' ' A' ' 37' ' ' GLN . 87.8 m95 -94.05 91.55 6.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.462 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 63.3 m-85 -79.96 116.12 19.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 110.647 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.73 151.5 19.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.709 -179.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -134.51 159.95 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.563 179.671 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.482 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 3.5 m-70 -110.56 87.36 2.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.5 p -83.73 -174.35 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.794 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.72 134.02 34.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -60.47 104.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.61 -30.45 5.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.405 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -92.79 -19.63 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.587 0.232 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.03 -40.73 64.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 111.005 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.32 -37.24 69.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.828 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -89.84 -26.22 20.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.981 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.16 86.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -59.45 -48.01 83.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.88 74.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -60.22 -32.62 71.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.8 tp -78.3 -56.1 4.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.728 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -29.41 2.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.294 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -46.52 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -33.15 68.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.59 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -75.16 -25.21 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -97.78 -29.95 13.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.41 -40.79 64.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.989 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -79.99 -25.34 40.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.39 51.55 1.7 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.48 31.9 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.105 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.59 9.78 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -104.01 -21.71 13.57 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.711 0.291 . . . . 0.0 111.025 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -96.46 -51.23 4.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.677 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pt -79.82 151.25 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.765 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -141.72 -44.96 0.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.344 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 2.6 mt-30 -129.52 158.33 39.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.221 0.534 . . . . 0.0 112.035 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.8 t -154.97 82.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.114 179.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.65 157.94 16.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.62 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.16 124.08 32.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.753 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.452 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 37.5 Cg_endo -66.83 81.1 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.586 2.191 . . . . 0.0 112.855 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.78 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.874 0.369 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -59.93 115.62 3.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.4 mt -72.93 -44.98 60.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.74 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.448 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 41.0 m-85 -119.28 88.26 37.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.616 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.08 136.62 53.07 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.493 2.128 . . . . 0.0 112.313 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.83 22.1 69.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.547 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.19 127.95 52.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.824 0.345 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 124.86 45.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.608 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' A' ' 41' ' ' PRO . 11.4 m-85 -93.19 123.63 36.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -129.42 110.42 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.454 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.402 ' CB ' ' HB2' ' A' ' 37' ' ' GLN . 15.4 tt0 -79.81 72.24 6.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.402 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 25.1 ptp -92.02 -176.85 4.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.851 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.403 ' HA ' HG21 ' A' ' 3' ' ' ILE . 14.5 t0 -118.27 99.23 6.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.703 179.382 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 80.2 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.337 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.606 0.241 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 169.87 17.43 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.482 2.121 . . . . 0.0 112.292 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.38 -165.78 1.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -57.64 -21.46 39.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.88 -44.78 29.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.412 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -68.94 -35.42 76.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.41 -30.19 68.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -79.24 -51.51 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 t -59.84 -46.31 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.163 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -26.83 66.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.71 -27.28 57.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.621 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.7 p -59.89 142.91 88.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.682 0.277 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.87 -13.93 21.6 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.533 2.155 . . . . 0.0 112.627 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.64 -6.41 65.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.047 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.63 0.252 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 112.78 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.511 2.141 . . . . 0.0 112.004 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.95 123.68 62.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.17 148.55 10.44 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.764 2.309 . . . . 0.0 112.202 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.8 141.56 39.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.852 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.62 157.66 79.53 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.1 -35.62 95.19 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.589 2.193 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.44 -29.54 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -87.03 -36.46 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.433 HG22 ' CD1' ' A' ' 5' ' ' TRP . 39.8 t -60.72 -51.98 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.11 -29.56 60.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -53.79 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.576 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' A' ' 67' ' ' PHE . 18.9 pt -66.2 -25.07 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.732 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.9 mp -71.67 -38.07 70.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.486 179.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -30.56 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.704 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.39 -40.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.042 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -58.93 -62.02 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.73 48.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.526 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 27.8 mt -124.12 -45.26 2.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.995 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.48 29.85 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.395 179.988 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.541 0.21 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -153.3 161.9 41.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.826 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.451 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 68.2 m95 -88.49 92.71 9.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.661 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 67.0 m-85 -87.99 114.12 24.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -100.77 147.49 26.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.525 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 t -127.93 160.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.497 ' CE1' ' CE2' ' A' ' 65' ' ' TYR . 3.2 m-70 -114.72 156.58 24.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -156.63 -174.74 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 145.8 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.48 130.5 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.42 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -94.01 -22.05 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 0.0 111.066 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -53.65 -43.78 69.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -33.51 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -80.87 -31.06 35.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.54 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -60.31 -37.67 81.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.973 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.68 -53.76 42.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -30.33 69.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.5 tp -76.3 -56.53 4.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -48.76 -30.33 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -38.4 61.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -73.67 -37.35 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.569 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.4 mm -72.92 -28.05 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.987 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -89.63 -32.8 16.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.773 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -39.55 79.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.993 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.98 -37.29 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.83 41.71 5.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.52 51.18 0.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.79 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.3 -5.15 43.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.4 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -79.69 -24.27 41.85 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.824 179.939 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -94.3 -52.17 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.464 HG23 HD11 ' A' ' 35' ' ' ILE . 34.9 mt -95.16 111.61 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.414 ' CZ ' ' O ' ' A' ' 33' ' ' ASP . 6.5 m-85 -102.46 -60.23 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.382 -179.451 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.39 130.03 49.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 -179.146 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.07 72.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.497 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -83.64 133.47 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.945 -179.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' THR . 0.1 OUTLIER -109.22 124.51 33.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.925 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.504 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 88.1 Cg_exo -49.19 77.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.138 2.559 . . . . 0.0 113.305 -179.652 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 40' ' ' ILE . 36.8 p . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.775 179.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.3 tptt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.604 0.24 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -139.82 113.53 8.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.26 -47.76 9.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 41' ' ' PRO . 7.6 m-85 -135.99 84.36 31.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.584 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.79 141.93 92.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.496 -179.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.86 77.81 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.069 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 6.2 m-85 -117.99 156.74 28.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.8 0.334 . . . . 0.0 110.953 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 5.2 mp -150.64 107.7 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 41' ' ' PRO . 4.4 m-85 -81.79 124.32 29.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.86 114.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 4.6 tt0 -80.71 71.09 7.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 0.0 110.345 179.433 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.3 ptp -91.2 -175.02 4.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -124.32 92.02 3.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.73 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.654 0.264 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.7 171.64 6.79 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.687 2.258 . . . . 0.0 112.235 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 -177.25 5.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.97 -28.91 64.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.16 69.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -59.86 -39.74 86.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.27 -40.22 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.45 -47.87 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.43 -45.33 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.091 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -60.67 -28.99 69.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.68 -31.28 56.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.9 p -60.76 111.35 3.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.616 0.246 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.16 133.73 35.96 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.445 2.097 . . . . 0.0 112.366 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.14 -11.45 48.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.703 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.8 tp . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 -179.943 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.739 0.304 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.13 171.58 14.6 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.205 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.4 m -142.52 101.69 5.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.187 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.79 157.84 54.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.397 2.064 . . . . 0.0 112.169 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -89.99 163.68 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.7 p -86.67 141.38 33.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.95 -33.9 35.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.572 2.181 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.37 -41.63 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -81.58 -31.08 32.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.451 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 58.5 t -63.36 -43.68 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -61.25 -30.42 70.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -52.88 11.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.609 179.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.42 -16.48 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.59 179.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -36.73 68.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.316 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.52 -22.43 44.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.5 t -70.26 -60.93 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.49 -53.66 42.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.42 38.17 0.42 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.545 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.7 mt -100.06 0.62 41.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.591 0.234 . . . . 0.0 111.366 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.8 mp -131.4 -63.02 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.385 -1.23 . . . . 0.0 112.438 -179.959 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.473 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.431 0.158 . . . . 0.0 110.813 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -139.91 163.71 31.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.416 0.627 . . . . 0.0 112.294 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.483 ' CH2' ' HB3' ' A' ' 37' ' ' GLN . 74.7 m95 -91.09 92.21 8.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.583 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.436 ' CD1' ' HG3' ' A' ' 70' ' ' MET . 64.9 m-85 -79.8 107.61 12.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 146.66 26.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.827 -179.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -146.55 177.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.555 179.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.509 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 2.9 m-70 -122.48 160.7 25.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -136.83 158.79 43.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.622 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.26 127.43 27.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.3 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -63.66 128.73 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.852 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.68 -30.63 8.56 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.205 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -97.36 -9.41 27.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 0.0 110.96 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.8 -39.04 4.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 111.238 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -54.94 -44.17 74.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.33 34.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.76 85.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.067 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.0 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.73 -50.97 8.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.099 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.04 -34.86 72.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.3 tp -71.98 -56.96 4.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -33.34 60.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -67.88 -40.9 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.709 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -68.0 -38.25 82.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 mm -69.42 -30.09 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.017 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -89.0 -33.62 17.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.62 68.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.45 -27.07 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.06 56.94 2.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.456 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.88 35.33 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.21 -4.19 37.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.515 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.78 -28.06 40.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.839 0.352 . . . . 0.0 110.77 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -54.29 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.66 94.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.657 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.473 ' CE2' HG23 ' A' ' 3' ' ' ILE . 6.8 m-85 -83.01 -50.05 8.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.483 ' HB3' ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -115.67 138.94 50.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.166 0.508 . . . . 0.0 111.705 -179.207 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.39 138.56 26.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.459 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.557 HD13 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -160.23 155.56 25.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 111.356 -179.731 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 42' ' ' THR . 14.9 tt -114.6 128.26 26.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.473 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 11.2 Cg_endo -55.71 80.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.673 2.248 . . . . 0.0 112.8 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 40' ' ' ILE . 36.6 p . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.48 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -63.72 115.19 4.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.411 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 37.9 mt -90.09 -39.82 12.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.204 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 1.4 m-85 -131.4 95.49 23.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.917 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.16 133.22 48.54 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.527 2.152 . . . . 0.0 112.145 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.54 23.29 62.56 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.793 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.509 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 2.2 m-85 -116.49 154.07 31.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.49 130.92 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.72 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.483 ' CE2' ' HB ' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -109.13 142.72 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.557 179.618 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.32 122.36 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.393 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.3 tt0 -79.81 65.17 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 110.256 179.43 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.436 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 11.6 ptp -91.77 -169.34 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -148.62 80.49 1.44 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.81 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.407 ' HG ' ' CZ ' ' A' ' 6' ' ' TYR . 4.1 pp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.166 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.699 0.285 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.91 177.96 7.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -90.07 -179.98 5.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.33 -24.35 66.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.187 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.28 -47.39 72.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.343 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -59.31 -42.36 91.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.967 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -59.98 -32.21 70.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 t -82.58 -49.17 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.91 -51.28 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.982 179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -66.35 -25.76 66.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.072 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.97 -32.64 63.27 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.701 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.7 p -61.78 143.69 93.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 91.18 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.42 -36.41 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.451 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.14 179.913 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.477 0.179 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.0 Cg_exo -53.99 -171.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.492 2.128 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -150.6 115.46 3.29 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.281 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.0 145.06 66.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.465 2.11 . . . . 0.0 112.068 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -86.29 159.1 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.6 m -89.54 141.66 28.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.66 -37.14 26.74 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 112.574 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -48.74 80.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.07 -33.97 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.455 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 62.3 t -58.5 -50.5 78.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.91 -37.95 54.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.224 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -68.4 -52.69 30.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.669 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.483 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 27.5 pt -66.36 -26.11 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.835 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mp -73.83 -41.16 62.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -23.41 65.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.9 t -76.59 -59.09 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 t -59.4 -57.03 14.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.546 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 135.03 63.13 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.914 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.6 mt -133.46 5.62 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.514 0.197 . . . . 0.0 111.441 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.34 -36.38 11.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.412 -179.941 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.428 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.417 0.151 . . . . 0.0 110.932 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.76 150.13 50.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.276 0.56 . . . . 0.0 111.971 -179.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.497 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 71.8 m95 -99.75 110.14 22.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.529 179.349 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.421 ' CD1' ' HE3' ' A' ' 70' ' ' MET . 30.3 m-85 -99.67 137.08 38.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 0.0 110.722 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.49 146.75 36.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.033 0.444 . . . . 0.0 111.861 -179.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.5 OUTLIER -137.3 159.31 35.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.191 179.583 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -119.58 126.28 50.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.914 -179.857 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -132.06 -177.22 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 141.07 35.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -58.28 114.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.021 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.76 -34.05 5.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.295 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.41 -30.02 37.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 110.762 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.18 -39.15 66.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.12 -41.18 83.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -81.01 -26.69 36.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.61 56.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.152 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -35.44 74.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.81 -57.2 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.94 -36.29 82.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.6 tp -70.09 -47.87 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.765 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.33 -22.13 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -45.97 14.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.877 0.37 . . . . 0.0 110.296 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -68.35 -24.46 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -70.94 -28.07 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -97.39 -31.3 12.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.23 74.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -79.93 -25.61 40.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.987 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 30.19 6.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.287 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -97.04 25.38 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -24.32 66.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.75 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.85 -3.44 47.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.161 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -67.55 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.9 mm -80.71 130.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.711 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 3' ' ' ILE . 10.4 m-85 -124.24 -50.43 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -119.46 161.48 20.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.423 0.63 . . . . 0.0 112.489 -178.522 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.5 t -157.84 110.85 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.956 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -126.16 175.06 8.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.529 0.68 . . . . 0.0 112.292 -178.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.2 pt -161.87 66.95 2.08 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.703 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 62' ' ' PHE . 9.6 Cg_endo -52.88 150.52 22.77 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.451 2.767 . . . . 0.0 114.359 -178.445 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 22.3 p . . . . . 0 N--CA 1.456 -0.165 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.139 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.027 0 CA-C-O 120.696 0.284 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.21 132.97 12.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.274 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 1.1 mt -90.39 -58.82 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 179.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 51.9 m-85 -113.04 64.39 0.88 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.777 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.2 135.46 54.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.562 2.175 . . . . 0.0 112.168 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.91 6.2 72.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 4.7 m-85 -113.69 126.72 55.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.82 116.62 32.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.784 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.437 ' CE2' HD13 ' A' ' 112' ' ' ILE . 14.0 m-30 -90.27 95.3 10.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.25 113.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.279 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 10.5 tt0 -83.21 68.63 9.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.744 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.421 ' HE3' ' CD1' ' A' ' 6' ' ' TYR . 1.9 ptt? -91.45 -165.49 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.473 179.501 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -149.43 84.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.895 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 6' ' ' TYR . 44.0 mt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.004 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.509 0.195 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.92 159.32 2.51 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.414 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -90.05 -169.96 2.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -54.88 -23.58 19.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.62 -52.46 55.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.198 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 -58.06 -30.8 66.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -71.9 -31.03 66.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.798 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.37 -51.41 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.948 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.22 -41.98 79.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -71.87 -22.76 61.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.16 -17.79 64.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.945 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.9 p -58.97 139.32 87.32 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.744 0.272 . . . . 0.0 110.95 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.36 105.48 2.05 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.464 2.109 . . . . 0.0 112.239 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.24 -17.09 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.725 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.642 0.258 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.74 175.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.56 79.33 65.09 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.853 0.358 . . . . 0.0 111.441 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.98 146.1 22.82 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.548 2.165 . . . . 0.0 111.973 179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -85.05 163.87 18.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.753 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.76 150.49 44.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.5 -27.31 7.25 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.638 2.225 . . . . 0.0 112.503 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.85 -46.85 17.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.96 -30.64 63.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.497 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 50.4 t -62.86 -55.18 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.54 -24.95 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.151 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.96 -44.87 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.779 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.437 HD13 ' CE2' ' A' ' 67' ' ' PHE . 27.4 pt -72.43 -28.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.966 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.45 HD21 ' CZ2' ' A' ' 5' ' ' TRP . 25.9 mt -76.24 -30.78 58.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.65 -32.5 69.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.495 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -84.19 -26.42 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.808 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.4 p -68.4 -43.25 77.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.63 4.24 3.95 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.164 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 34.8 mt -80.0 -58.48 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.91 0.355 . . . . 0.0 110.728 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.3 mt -95.07 -29.13 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.493 179.978 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.428 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.442 0.163 . . . . 0.0 110.909 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.0 152.18 49.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.161 0.505 . . . . 0.0 111.855 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.481 ' CZ3' ' CD1' ' A' ' 39' ' ' LEU . 73.0 m95 -97.58 96.76 8.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.637 179.575 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 27.1 m-85 -86.86 123.62 32.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 110.728 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -106.39 159.67 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.568 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -141.49 160.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.821 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -88.9 134.88 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.98 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 p -139.4 160.98 38.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.13 151.13 21.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.49 127.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -25.51 24.54 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.31 -26.9 19.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.71 0.291 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -41.22 76.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.96 -37.84 67.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.973 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -86.71 -29.82 22.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.841 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.19 83.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.024 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.79 -43.58 94.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.54 -42.91 28.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.32 -31.51 69.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.1 tp -82.87 -57.6 3.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.35 -45.31 17.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.439 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -61.11 -41.91 97.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -43.23 91.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 26' ' ' ILE . 35.7 mm -64.39 -28.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.855 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -91.41 -29.72 16.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 -46.46 30.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.339 -179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -79.95 -21.63 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.207 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.13 65.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.176 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.08 26.65 9.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.301 . . . . 0.0 111.154 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -80.19 22.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.38 -21.45 13.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.696 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.2 -48.01 2.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 mp -79.86 128.28 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 33.0 m-85 -115.3 -56.74 2.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.424 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.442 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -115.83 170.02 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 t -157.79 120.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.983 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.483 HD11 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -144.58 150.3 37.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.334 0.588 . . . . 0.0 112.295 -178.533 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 pt -113.05 124.83 30.8 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.568 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.458 ' CG ' ' HB2' ' A' ' 62' ' ' PHE . 50.7 Cg_endo -68.9 85.71 0.49 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.651 2.234 . . . . 0.0 112.885 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 7.1 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.421 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.3 mmtp . . . . . 0 C--O 1.226 -0.169 0 CA-C-O 120.704 0.287 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.51 117.55 19.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.872 0.368 . . . . 0.0 111.028 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 18.1 mt -87.63 -55.45 3.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.458 ' HB2' ' CG ' ' A' ' 41' ' ' PRO . 1.1 m-85 -112.3 91.47 16.45 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 127.8 27.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.475 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.39 40.78 96.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.66 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -133.42 115.28 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -124.01 121.45 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.206 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -97.36 133.9 41.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 111.246 -179.573 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mp -123.56 122.06 64.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.591 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.458 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 2.5 tt0 -79.77 75.66 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptp -90.92 -175.17 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.153 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.468 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.3 t0 -130.52 100.03 5.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 13.9 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.054 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.627 0.251 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.402 ' O ' ' HB3' ' A' ' 82' ' ' TRP . 51.0 Cg_endo -69.08 77.89 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.481 2.121 . . . . 0.0 112.203 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.9 m120 -90.24 -173.06 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 51.91 -84.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.866 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . -46.94 -48.9 21.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.719 -179.719 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.402 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 6.1 t-105 -76.2 -28.87 57.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.79 -37.79 74.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.06 -47.44 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.6 t -59.56 -42.29 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.089 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.67 -19.32 62.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.306 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -120.53 22.57 8.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.62 134.24 72.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.714 0.257 . . . . 0.0 110.821 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.03 -8.61 23.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.414 2.076 . . . . 0.0 112.669 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -103.82 -18.53 13.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.828 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.34 . . . . 0.0 111.056 -179.861 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 1.8 mtt-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.537 0.208 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 5.5 Cg_exo -74.07 116.89 4.8 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.707 2.271 . . . . 0.0 112.006 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 m -115.58 97.39 48.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.262 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.35 123.89 9.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.493 2.129 . . . . 0.0 112.187 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.99 157.98 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.66 151.47 55.62 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.13 -30.25 18.34 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.698 2.266 . . . . 0.0 112.464 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -71.45 -47.44 55.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -74.41 -31.9 62.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 112' ' ' ILE . 48.7 t -61.18 -52.47 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -55.53 -38.46 69.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.21 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -68.79 -46.61 68.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.054 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.455 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 31.1 pt -72.53 -27.09 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.954 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.426 HD21 ' CZ2' ' A' ' 5' ' ' TRP . 15.6 mt -79.45 -29.21 41.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -67.05 -21.76 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.925 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 t -86.31 -54.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.157 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -60.44 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 135.58 64.83 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.903 179.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.411 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 30.4 mt -128.93 -43.78 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 0.0 110.891 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.4 tp -80.14 -63.33 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.572 -179.996 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.417 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.525 0.202 . . . . 1.6499999999999999 110.941 . . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -156.07 155.79 33.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 2.0699999999999998 111.507 -179.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.46 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 93.8 m95 -96.28 96.64 8.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 1.04 110.692 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.48 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 3.3 m-85 -86.17 117.35 24.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 2.2999999999999998 111.029 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.95 147.71 22.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 1.3 111.144 -179.823 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.46 159.96 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 2.2599999999999998 111.025 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -102.01 149.65 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 1.6499999999999999 111.013 -179.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.2 p -151.3 -177.6 6.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 1.4199999999999999 110.86 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.0 139.4 30.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 2.6899999999999999 110.908 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.8 m -62.65 121.71 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 2.75 111.206 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.5 -28.62 12.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.787 -0.721 . . . . 1.8300000000000001 112.402 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -89.68 -21.41 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 3.0299999999999998 111.113 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -53.42 -36.31 61.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 2.5299999999999998 111.046 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -58.68 -30.91 67.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 3.25 110.878 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.79 -30.49 18.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 3.3799999999999999 110.929 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.73 87.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 1.55 111.08 -179.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.42 -49.06 79.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 3.75 110.827 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.95 -46.06 72.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 2.0299999999999998 111.045 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -60.25 -31.1 69.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 2.29 110.824 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.4 tp -81.47 -55.89 4.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 2.0899999999999999 110.85 179.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.02 -32.91 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.236 -0.438 . . . . 2.4500000000000002 111.193 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -71.02 -40.95 71.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 3.8999999999999999 110.734 179.803 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -68.89 -38.13 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 3.8199999999999998 110.675 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 26' ' ' ILE . 35.4 mm -66.76 -31.82 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 2.0299999999999998 110.894 179.728 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -91.19 -29.82 17.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 4.1200000000000001 110.857 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.7 -46.8 68.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 2.2400000000000002 111.174 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -80.03 -28.46 39.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 2.9100000000000001 111.012 179.937 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 66.01 0.98 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 2.0 112.442 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt -122.08 33.41 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 2.3599999999999999 110.88 -179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -72.58 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 2.9300000000000002 111.365 -179.975 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.87 -30.32 40.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 2.7400000000000002 110.891 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 -60.33 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.325 -0.398 . . . . 3.1699999999999999 110.781 179.973 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.6 mt -82.13 128.65 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 2.7000000000000002 111.094 179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 9.0 m-85 -118.02 -54.31 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 2.48 110.986 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -110.88 153.08 25.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.98 0.419 . . . . 1.8700000000000001 111.268 -179.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.47 69.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 2.2999999999999998 110.74 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.93 150.35 30.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 3.1200000000000001 111.034 -179.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.9 mt -109.84 129.29 24.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 3.1000000000000001 110.77 179.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 31.4 Cg_endo -63.64 73.88 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.488 2.125 . . . . 2.6899999999999999 112.394 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.5 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 2.1400000000000001 110.773 -179.993 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.86 0.362 . . . . 3.48 110.706 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -107.05 105.15 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 3.9100000000000001 111.007 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.78 -47.32 47.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 1.76 110.761 179.912 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.406 ' CE1' HG23 ' A' ' 112' ' ' ILE . 9.9 m-85 -122.08 77.75 41.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 2.6299999999999999 110.685 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.05 127.61 26.4 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.624 2.216 . . . . 1.78 112.583 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.86 52.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.84 -0.695 . . . . 1.27 112.799 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -131.24 156.42 45.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 2.75 111.016 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.46 114.34 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 2.3300000000000001 110.596 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.436 ' CE2' HD11 ' A' ' 112' ' ' ILE . 11.1 m-85 -84.24 119.77 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 2.3900000000000001 111.271 -179.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -128.21 112.22 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 1.3400000000000001 110.889 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 6.2 tt0 -79.78 75.69 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 2.0899999999999999 110.521 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 10.3 ptm -91.59 -173.49 3.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 1.8799999999999999 111.119 -179.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.453 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 4.3 t0 -134.07 86.71 2.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 2.0899999999999999 110.929 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.48 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 12.9 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.439 -0.346 . . . . 1.8400000000000001 110.806 179.69 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.62 0.247 . . . . 3.8100000000000001 110.834 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 -172.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.504 2.136 . . . . 1.8300000000000001 112.309 179.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -90.08 -178.63 5.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 3.8500000000000001 110.884 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.11 -21.26 58.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 2.98 111.176 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.57 -31.54 47.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 1.5700000000000001 111.274 -179.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 14.6 t-105 -76.94 -37.41 55.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 1.1200000000000001 110.956 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.58 -29.23 67.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 2.75 110.894 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.2 t -87.11 -51.31 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 1.8500000000000001 111.097 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 t -58.81 -36.83 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 1.3999999999999999 111.01 180.0 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.33 -20.84 59.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 3.5099999999999998 111.106 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.36 9.19 38.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.655 -0.783 . . . . 1.29 113.019 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 p -86.34 141.12 34.46 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.928 0.364 . . . . 1.5900000000000001 110.811 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.29 87.07 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.539 2.159 . . . . 2.1400000000000001 112.208 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.26 -32.74 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 2.0899999999999999 112.493 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.0 mm . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 2.2400000000000002 110.952 -179.957 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.781 0.324 . . . . 6.6600000000000001 110.89 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 75.6 Cg_exo -49.89 163.53 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.687 2.258 . . . . 1.49 112.463 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.0 96.19 40.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 2.5099999999999998 111.2 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.62 120.61 7.23 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.459 2.106 . . . . 1.1699999999999999 112.276 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.43 166.49 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 1.8799999999999999 110.944 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.8 m -89.97 148.68 40.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 2.1299999999999999 110.851 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.61 -30.25 44.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.528 2.152 . . . . 1.51 112.429 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.72 -31.36 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 2.75 110.949 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -88.96 -32.53 17.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 2.46 110.886 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.46 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 20.0 t -63.83 -39.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 1.5700000000000001 111.102 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.4 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 4.7699999999999996 110.945 -179.924 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -54.92 13.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 2.77 110.661 179.872 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.436 HD11 ' CE2' ' A' ' 67' ' ' PHE . 15.6 pt -66.14 -24.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 1.9399999999999999 110.89 179.637 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -74.66 -34.43 62.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 2.4500000000000002 110.535 179.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -78.02 -31.47 50.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.059 -0.519 . . . . 2.6800000000000002 110.748 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.6 t -77.14 -33.05 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 2.1099999999999999 110.949 179.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.52 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 2.52 110.923 179.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.86 45.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 1.78 112.643 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt -125.17 -48.94 1.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 1.99 110.818 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -31.23 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 2.9399999999999999 110.866 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.31 -1.272 . . . . 2.9900000000000002 112.575 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.844 0.354 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -79.94 -167.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.32 156.61 38.69 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.127 0.489 . . . . 0.0 111.762 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.47 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 82.0 m95 -95.3 95.56 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.653 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.43 ' CD2' HD13 ' A' ' 72' ' ' LEU . 33.0 m-85 -83.4 115.47 22.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.996 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.24 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 t -128.36 161.64 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.402 ' NE2' ' CG1' ' A' ' 95' ' ' VAL . 14.8 m-70 -90.06 159.96 16.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.2 p -152.45 -174.38 4.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.52 139.22 31.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.09 122.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.86 15.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -92.17 -14.87 28.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.609 0.243 . . . . 0.0 111.245 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -52.42 -46.54 66.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 111.054 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.87 -30.85 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.887 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -30.76 22.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.15 72.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -49.3 78.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.46 50.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.172 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -60.69 -31.63 70.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.8 tp -81.17 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -46.9 -35.42 6.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.315 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -66.22 -47.3 74.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.709 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -39.38 93.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.682 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.504 HD11 HG22 ' A' ' 26' ' ' ILE . 35.2 mm -62.56 -29.79 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -93.59 -29.98 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -44.03 74.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.157 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.0 -30.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 66.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.79 23.23 8.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 0.0 111.046 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.44 -9.14 58.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.8 -29.64 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -51.83 5.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -79.92 128.16 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.419 ' CE2' HG23 ' A' ' 3' ' ' ILE . 26.0 m-85 -113.66 -53.41 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.417 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.0 mt-30 -113.27 157.39 21.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.046 0.45 . . . . 0.0 111.452 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.5 t -152.27 71.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.87 150.06 24.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.203 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.3 pt -107.22 131.19 21.89 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.862 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 32.3 Cg_endo -64.16 72.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.605 2.203 . . . . 0.0 112.643 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p -147.73 130.69 16.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -79.95 142.05 35.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -96.71 145.04 26.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 m -149.56 116.63 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.81 138.48 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.256 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.91 120.18 10.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.73 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -124.53 149.02 47.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -121.0 -45.35 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -129.85 176.33 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.88 131.91 11.01 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.57 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.48 -45.32 1.33 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -111.16 127.2 55.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.26 137.85 41.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -126.21 115.25 19.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.74 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.78 135.21 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.329 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.39 -179.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.96 138.17 14.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.857 0.361 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -98.2 129.07 44.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.751 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.81 110.03 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.38 -49.33 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.537 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.439 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 18.9 m-85 -106.76 98.21 20.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.296 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.91 137.05 55.94 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.429 2.086 . . . . 0.0 112.633 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.97 26.07 65.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.704 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -116.4 145.55 43.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.717 0.294 . . . . 0.0 111.087 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.93 112.73 6.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.764 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 6.4 m-85 -88.35 124.22 33.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -130.04 117.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 6.8 tt0 -79.97 71.8 6.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.939 0.399 . . . . 0.0 110.196 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.0 ptp -90.87 -174.02 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.22 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -132.66 75.45 1.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.836 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 6' ' ' TYR . 86.4 mt -88.37 7.3 33.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.39 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.72 61.08 3.69 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.611 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.06 -68.29 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 110.768 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.89 -85.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.797 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.24 -70.03 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -110.0 157.95 36.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.876 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 174.82 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.508 2.139 . . . . 0.0 112.135 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -87.01 -172.14 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.032 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -21.51 42.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.66 -42.46 56.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 111.285 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -64.67 -39.2 93.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.23 -43.14 99.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.32 -51.49 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.937 0.399 . . . . 0.0 111.058 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.99 -42.63 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.122 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -17.48 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.331 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.08 -15.71 15.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.136 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.1 142.37 95.55 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.857 0.328 . . . . 0.0 110.972 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.94 -20.21 22.16 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.19 36.34 3.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.977 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 tp -137.31 135.78 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.08 -42.18 3.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.64 -126.6 1.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.548 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 1.4 p90 -153.17 179.15 8.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 0.0 110.769 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.402 ' CG1' ' NE2' ' A' ' 9' ' ' HIS . 10.6 m -55.29 -40.73 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.263 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.83 43.13 7.84 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.491 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.02 -78.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.83 0.348 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.09 -56.79 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.334 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.4 ttp -111.74 -174.23 2.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.782 0.325 . . . . 0.0 110.601 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.502 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 15.1 mmm-85 -81.46 -49.69 0.96 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.352 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 89.0 Cg_endo -81.72 -169.99 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.598 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -153.34 71.17 6.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.097 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.17 132.74 48.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.11 161.65 17.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.98 153.56 47.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.05 -48.61 20.26 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.532 2.155 . . . . 0.0 112.428 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.29 -31.9 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -81.59 -36.64 28.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.47 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 41.2 t -58.96 -45.7 91.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -27.13 68.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -81.64 -37.31 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.057 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.422 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 8.1 pt -81.33 -20.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -86.94 -33.08 19.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.8 -32.79 73.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.663 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.2 t -80.92 -35.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.903 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 t -60.33 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.809 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.49 42.59 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.628 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 mt -117.29 -56.96 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -30.29 40.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.546 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.786 0.326 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.446 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -132.52 -170.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.766 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -147.91 163.15 37.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 112.105 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 67.8 m95 -94.27 139.3 31.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.671 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 21.0 m-85 -125.64 110.03 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.06 151.19 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.054 0.454 . . . . 0.0 111.745 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.61 162.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 2.5 m-70 -100.31 151.52 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.056 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.4 p -149.14 -178.24 6.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.87 140.67 29.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 t -62.06 125.3 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.71 -37.98 3.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 -21.55 34.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -54.76 -43.15 72.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.06 -46.53 75.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -24.72 36.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.055 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.26 74.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -33.11 71.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 -51.6 23.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.7 -33.26 71.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.1 tp -73.48 -55.01 6.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.58 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -30.34 8.87 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -72.35 -42.88 64.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.726 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -66.57 -34.7 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.666 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.0 mm -69.47 -31.58 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -32.68 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.52 -41.96 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -80.78 -25.39 37.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.41 5.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.402 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -99.85 28.63 4.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.722 0.296 . . . . 0.0 110.999 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -71.88 -10.54 59.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 15.8 t70 -79.67 -24.88 41.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.01 -54.49 4.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.77 137.9 20.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.707 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.446 ' CE2' HG23 ' A' ' 3' ' ' ILE . 13.1 m-85 -129.93 -56.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.513 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.548 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -109.44 134.37 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.144 0.497 . . . . 0.0 112.067 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.1 m -125.15 99.59 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.284 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 116' ' ' SER . 1.9 tm? -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.5 tt -87.68 125.09 66.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.16 76.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.651 2.234 . . . . 0.0 112.563 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 25.3 p -159.61 153.06 22.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -92.4 141.51 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.567 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -119.49 108.77 14.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.898 0.38 . . . . 0.0 111.007 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.55 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 3.7 m -137.63 130.36 42.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.01 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -160.3 134.8 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.39 -176.17 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 0.0 110.936 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.51 162.67 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.6 30.97 2.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -31.75 29.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.52 93.43 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.26 -57.93 0.43 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.526 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -125.03 -176.95 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -117.83 160.96 20.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -79.9 154.4 28.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -116.48 -151.46 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.385 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -160.36 -177.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.067 0 CA-C-O 120.905 0.383 . . . . 0.0 111.474 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -90.8 138.22 31.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.9 mttm -102.82 -166.61 1.29 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.707 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.66 116.88 11.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.03 -55.52 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.426 ' CE1' HG23 ' A' ' 112' ' ' ILE . 2.1 m-85 -121.31 79.51 36.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.21 144.28 81.81 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.296 . . . . 0.0 112.671 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.93 18.43 70.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.139 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 15.0 m-85 -129.13 162.7 27.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.35 122.29 8.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.353 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.429 ' CE2' HG21 ' A' ' 112' ' ' ILE . 11.6 m-30 -89.59 130.03 35.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.956 0.408 . . . . 0.0 111.217 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mt -130.73 111.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.548 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -79.71 68.42 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.673 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 10.2 ptm -91.66 -164.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -141.07 71.24 1.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 95.4 mt -80.51 -33.65 36.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.64 74.75 0.15 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -133.47 -77.92 0.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.368 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -91.14 -178.55 5.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.04 -31.62 71.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.5 166.55 26.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.33 151.14 81.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.542 2.161 . . . . 0.0 112.332 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.21 -167.69 1.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -66.12 -27.44 68.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.18 -39.8 60.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.319 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -74.59 -33.27 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -31.41 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.72 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.83 -44.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.9 t -64.42 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.98 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -13.56 62.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.07 -12.78 10.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.051 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.89 159.74 12.65 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.908 0.354 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.99 122.84 9.45 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.543 2.162 . . . . 0.0 112.385 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.71 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.3 mm -84.96 106.63 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.055 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 168.5 63.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.575 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.98 -55.56 0.23 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.706 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.452 ' HB2' ' CG ' ' A' ' 9' ' ' HIS . 1.4 t80 -138.73 -70.21 0.42 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.0 m -84.0 174.59 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.71 67.98 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.333 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.01 -51.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 111.137 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.11 -45.69 0.36 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.37 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -106.31 -29.51 9.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.845 0.355 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -57.02 -44.13 99.66 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.406 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 82.5 Cg_exo -47.79 127.44 14.32 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.344 2.029 . . . . 0.0 112.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.07 105.26 26.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.271 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.68 124.45 8.2 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.341 2.028 . . . . 0.0 111.997 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.417 HD13 ' CE1' ' A' ' 67' ' ' PHE . 68.2 mt -59.55 134.22 56.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.5 p -76.61 150.79 82.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.81 -31.75 73.85 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.639 2.226 . . . . 0.0 112.271 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.76 -28.39 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -37.09 10.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.468 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 24.5 t -58.63 -29.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.17 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -60.22 -39.25 86.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.88 -55.7 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.498 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.429 HG21 ' CE2' ' A' ' 67' ' ' PHE . 2.3 pp -63.56 -22.14 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.665 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.411 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 1.9 mt -70.41 -39.52 74.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.26 -29.3 67.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.68 -41.19 62.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.457 ' HB3' ' CD2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -60.22 -62.11 2.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 110.581 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.69 36.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.024 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.411 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -112.56 -27.95 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -49.98 11.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.447 -1.196 . . . . 0.0 112.562 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 t . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.427 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -138.91 -168.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.908 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.05 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.175 0.512 . . . . 0.0 111.832 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.457 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 73.0 m95 -95.56 88.53 5.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 50.6 m-85 -81.27 123.64 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.04 127.12 53.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.94 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.5 p -108.03 159.88 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 111.084 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.482 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 48.3 m-70 -83.86 136.48 34.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -143.55 151.57 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.31 136.6 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.75 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -57.58 111.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.262 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.59 -20.47 32.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.691 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.59 -16.96 15.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.617 0.246 . . . . 0.0 111.308 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -33.92 59.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.83 0.348 . . . . 0.0 111.133 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.82 -31.84 71.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.992 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -26.06 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.176 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -65.89 -30.67 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.86 47.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -62.12 -25.18 67.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.8 tp -86.7 -56.81 3.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -45.91 -37.68 6.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.426 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 -33.62 70.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 mmt-85 -75.64 -32.37 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.636 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 26' ' ' ILE . 32.7 mm -70.39 -31.4 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.734 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -84.04 -30.4 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -42.05 38.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -80.04 -25.58 40.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.962 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.07 66.52 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.468 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -125.82 30.1 5.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.987 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -25.39 68.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.07 -1.79 41.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.365 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -99.47 -58.65 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.755 0.312 . . . . 0.0 110.748 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.6 mt -81.45 132.92 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' A' ' 3' ' ' ILE . 3.0 m-85 -127.02 -49.99 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.19 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -117.14 156.66 27.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.107 0.479 . . . . 0.0 111.697 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 m -159.91 114.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -130.04 177.32 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.406 0.622 . . . . 0.0 112.07 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.7 mt -148.56 74.25 10.52 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.785 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 87.9 Cg_exo -41.66 113.78 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.176 2.584 . . . . 0.0 113.59 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.4 p -128.25 127.88 43.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.063 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -79.82 135.72 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.878 0.37 . . . . 0.0 111.105 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.54 145.44 48.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.886 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 m -142.68 147.75 20.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -121.65 141.76 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -123.66 149.92 44.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.64 164.93 24.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.21 -47.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.834 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.27 -46.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.06 -22.19 1.93 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.603 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.72 -70.05 1.29 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.66 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -84.08 151.52 24.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 130.93 46.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -117.12 115.21 24.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.0 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.09 139.45 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.475 ' CG2' ' N ' ' A' ' 58' ' ' ARG . 1.3 p -136.5 159.55 37.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.14 0.495 . . . . 0.0 110.99 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.475 ' N ' ' CG2' ' A' ' 57' ' ' VAL . 4.4 mtt85 -129.19 122.14 29.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.788 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -114.82 116.55 28.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.704 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 115.2 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.86 -44.55 96.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.309 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 2.1 m-85 -115.57 76.92 5.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.563 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.54 127.77 16.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.67 2.246 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.66 72.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.579 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 48.7 m-85 -128.89 111.03 12.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.97 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.5 mt -90.9 114.91 27.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.514 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.472 ' CE2' ' CD1' ' A' ' 112' ' ' ILE . 6.6 m-30 -82.47 122.85 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -128.87 110.16 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 3.6 tt0 -79.97 69.97 6.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.6 ptp -90.84 -178.13 5.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 t0 -119.53 98.88 6.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 39.4 mt -128.57 -44.07 1.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.795 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.9 91.5 0.01 OUTLIER Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.624 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -151.25 -46.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -138.92 -174.58 3.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.81 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -77.88 -22.48 49.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.088 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.51 106.87 54.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 173.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.433 2.089 . . . . 0.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.38 179.19 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.2 -25.21 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.08 -28.89 27.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 111.237 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -63.76 -48.61 76.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -58.88 -30.26 67.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -77.69 -49.67 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.184 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.1 t -59.96 -52.68 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttp85 -58.03 -22.84 51.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.52 -32.39 11.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.728 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.7 p -59.13 130.64 86.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.493 0.187 . . . . 0.0 110.99 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.78 -23.87 35.52 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.393 2.062 . . . . 0.0 112.314 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.41 -29.19 46.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.735 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.0 mm -82.89 135.05 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.47 -36.21 5.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.844 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.46 101.66 0.15 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.407 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.424 ' CE2' ' HB ' ' A' ' 8' ' ' VAL . 7.2 m-85 -56.38 -175.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 110.915 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 9' ' ' HIS . 20.8 t -54.97 139.36 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.226 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -99.46 27.52 19.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.605 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -117.16 96.03 5.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 111.027 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.16 -86.5 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.352 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.89 137.49 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 0.0 110.682 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.475 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -66.12 -50.35 51.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.964 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 84.7 Cg_endo -81.18 130.43 7.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.502 2.135 . . . . 0.0 112.107 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.6 t -129.68 99.7 20.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.262 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.9 139.14 10.77 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.645 2.23 . . . . 0.0 112.252 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 67' ' ' PHE . 1.2 mp -67.59 156.75 36.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.06 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.6 p -85.44 149.97 53.15 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.757 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -45.98 -49.58 10.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.773 2.316 . . . . 0.0 112.873 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.47 -39.98 85.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.17 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.66 -33.3 47.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 58.4 t -58.79 -31.4 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.237 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -26.01 56.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.33 -29.23 31.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.108 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.472 ' CD1' ' CE2' ' A' ' 67' ' ' PHE . 34.2 pt -80.68 -32.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.111 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' CD2' ' CZ2' ' A' ' 5' ' ' TRP . 97.9 mt -77.5 -25.2 50.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.23 -32.37 61.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.979 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -75.49 -48.2 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.072 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -59.98 4.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 137.14 67.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.597 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.1 mt -129.05 -47.46 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.822 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -61.73 1.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.491 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.802 0.334 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -133.7 -165.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.01 139.54 52.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.292 0.568 . . . . 0.0 112.092 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.612 ' CH2' ' CD2' ' A' ' 39' ' ' LEU . 25.7 m95 -94.94 96.23 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.047 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 44.9 m-85 -96.67 112.96 24.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.397 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.404 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . . . -108.14 134.88 50.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.753 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.5 p -134.14 160.18 41.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.196 0.522 . . . . 0.0 111.234 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.489 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 5.6 m170 -82.26 147.12 29.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -123.83 -173.83 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mt -87.7 127.61 35.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.72 114.87 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.6 -28.8 11.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.52 -7.78 37.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.622 0.249 . . . . 0.0 111.292 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -55.74 -39.72 71.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -52.45 65.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -14.34 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.359 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.44 -51.21 31.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 111.228 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -56.57 -41.56 77.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.04 -43.35 92.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -62.19 -34.49 76.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.3 tp -84.02 -45.07 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -55.23 -26.41 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -78.32 -47.61 17.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.318 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.02 -27.3 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.352 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.63 -29.35 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -87.38 -31.52 20.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.6 -32.36 67.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.044 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -87.89 5.7 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.53 47.49 86.63 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 mt -111.08 9.63 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.536 0.207 . . . . 0.0 111.266 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -17.25 63.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 0.0 111.259 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.93 -38.53 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.041 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.37 -51.75 33.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.87 117.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 3' ' ' ILE . 31.7 m-85 -100.95 -53.17 3.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.454 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 5.1 mm-40 -107.95 169.89 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.374 0.606 . . . . 0.0 111.651 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.33 73.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.35 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.612 ' CD2' ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -79.55 139.48 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.638 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' CG2' ' HD2' ' A' ' 41' ' ' PRO . 14.4 mt -100.5 138.3 20.13 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 40' ' ' ILE . 67.9 Cg_endo -72.72 59.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.543 2.162 . . . . 0.0 112.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.1 p -139.67 171.37 14.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.965 0.412 . . . . 0.0 111.317 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 8.0 tp10 -103.92 148.71 25.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.8 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -135.88 112.39 9.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.97 120.09 63.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.31 157.54 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.167 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -120.42 -167.5 1.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.05 118.06 19.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -178.65 4.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.39 86.09 5.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.27 53.6 3.82 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.502 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.1 -173.88 46.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.513 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -122.53 119.83 32.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.15 143.56 50.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.34 178.67 7.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.67 -71.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.25 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -160.19 179.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.325 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -139.98 120.54 14.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.967 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -97.08 -160.99 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.358 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -141.92 121.21 13.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.27 -65.78 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.404 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 6.6 m-85 -103.9 90.42 2.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.763 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.01 123.02 11.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.128 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.39 29.06 54.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.569 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 19.3 m-85 -117.27 177.68 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.2 tp -160.21 148.87 17.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.756 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CE2' HG21 ' A' ' 112' ' ' ILE . 18.2 m-85 -132.5 125.62 31.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -133.04 112.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 37' ' ' GLN . 8.6 tt0 -79.9 72.41 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 110.675 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.412 ' HG3' ' HG ' ' A' ' 72' ' ' LEU . 2.1 ptm -91.37 -166.52 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 1.2 p30 -136.71 78.46 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 110.982 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 35.3 mt -99.73 -48.64 4.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.44 -85.37 0.43 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.384 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.9 -80.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 110.859 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 55.63 -175.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -59.78 -33.27 71.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.21 144.45 10.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.815 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.46 179.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.387 2.058 . . . . 0.0 112.185 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -171.97 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -70.79 -26.2 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.101 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.55 -28.96 34.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.323 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.426 ' CZ2' ' HD3' ' A' ' 101' ' ' PRO . 12.5 t-105 -69.46 -36.15 76.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.7 -30.0 70.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.29 -45.89 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 t -61.45 -50.21 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.056 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -29.91 70.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.58 -27.07 52.63 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.582 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 147.31 97.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.865 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.52 -20.79 35.52 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.378 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.89 -28.1 52.12 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.636 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.9 mm -93.27 122.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 t -122.76 -43.65 2.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -137.05 161.3 25.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.453 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -125.16 -177.28 3.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.387 . . . . 0.0 110.833 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.28 -67.09 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.53 -146.09 17.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.393 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.76 49.34 8.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 111.115 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.09 -82.26 1.63 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.93 155.3 35.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.458 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -77.35 -48.74 2.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.244 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 98.1 Cg_endo -79.93 143.75 16.55 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.348 2.032 . . . . 0.0 112.297 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -127.17 110.68 21.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.252 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.1 132.12 10.25 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.613 2.209 . . . . 0.0 112.239 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.12 147.27 26.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.9 p -90.07 159.48 42.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.22 -27.23 6.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.753 2.302 . . . . 0.0 112.544 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -44.83 74.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.67 -32.4 17.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.5 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 38.7 t -62.22 -28.57 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.342 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -69.34 -28.21 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -51.42 19.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.765 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.412 HG21 ' CE2' ' A' ' 67' ' ' PHE . 1.5 pp -68.01 -13.76 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.77 -40.83 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.857 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.97 -40.35 71.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.7 t -71.64 -44.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.461 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 15.4 p -56.18 -62.38 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.76 42.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.569 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.425 HD12 HD21 ' A' ' 39' ' ' LEU . 19.1 mt -111.2 -36.01 5.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.17 -34.4 10.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.519 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.831 0.348 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.46 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -132.05 162.76 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.764 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 163.88 31.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 72.9 m95 -88.72 96.27 10.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 4.8 m-85 -79.74 124.52 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.19 134.63 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.533 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 9' ' ' HIS . 0.7 OUTLIER -126.58 -166.97 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 6.5 m-70 -132.87 160.72 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 111.213 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.6 p -156.35 174.75 14.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.53 139.1 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 t -65.34 125.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.16 -28.43 12.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -92.98 -16.52 25.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 111.162 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.79 -36.01 46.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.805 0.336 . . . . 0.0 111.207 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -59.75 -30.81 69.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.07 -28.91 19.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.955 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.52 68.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -53.28 59.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.86 -42.89 89.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -59.76 -31.14 69.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.5 tp -88.96 -48.89 7.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 26' ' ' ILE . 1.7 tm-20 -62.58 -24.19 67.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -80.55 -38.38 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.254 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.37 -22.46 61.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 27' ' ' LYS . 1.1 tp -72.3 -28.89 30.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.016 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' N ' HG23 ' A' ' 26' ' ' ILE . 2.2 tmtt? -89.61 -30.1 18.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.23 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -86.68 -30.29 21.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.76 41.6 4.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.51 25.69 8.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -66.92 -16.78 64.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.251 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.8 -25.69 40.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -79.63 -61.06 2.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 70' ' ' MET . 1.8 pt -79.86 158.86 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 3' ' ' ILE . 20.1 m-85 -143.88 -49.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -118.28 145.7 44.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.376 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -150.04 102.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.76 155.7 24.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.029 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.81 126.82 30.82 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 50.4 Cg_endo -69.27 62.44 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.605 2.203 . . . . 0.0 112.486 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.9 p -132.45 141.21 48.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.056 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -89.36 148.66 23.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.774 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.55 115.26 13.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.9 m -124.34 120.54 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.324 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 m -146.81 145.72 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.789 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.81 -174.42 4.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.172 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.9 tt -93.02 141.16 28.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.65 149.22 24.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -29.72 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -95.27 -38.58 4.76 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.545 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.82 31.95 0.33 Allowed Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.876 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.1 119.91 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.758 0.313 . . . . 0.0 110.947 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.55 159.03 36.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.689 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -129.46 150.51 50.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.117 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.5 t -105.19 122.28 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.03 155.38 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -149.2 123.52 9.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.815 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -123.5 98.84 6.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -55.5 106.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -62.76 -51.49 66.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.614 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 61' ' ' LEU . 14.6 m-85 -105.77 94.95 9.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.416 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.9 129.05 31.38 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.511 2.141 . . . . 0.0 112.495 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.06 40.36 82.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.56 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 0.8 OUTLIER -124.23 144.41 49.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.003 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.95 124.98 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.721 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 11.2 m-85 -96.39 133.79 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.227 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -142.32 114.17 3.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 7.1 tt0 -79.9 76.28 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.411 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 21.2 ptp -91.63 -168.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.821 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -156.24 91.77 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.741 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 81.7 mt -79.98 -29.38 39.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.33 -49.25 3.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.544 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.69 177.3 8.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -105.81 -25.42 12.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -78.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.413 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -123.12 108.51 32.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.957 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.5 173.82 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.394 2.063 . . . . 0.0 112.247 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -90.09 -171.08 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.45 -27.81 68.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.99 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.2 -38.67 65.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.209 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.413 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 11.8 t-105 -66.82 -36.5 82.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.25 -32.17 69.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.14 -39.41 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.28 -33.41 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -18.01 62.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.6 -4.21 30.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.023 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.17 133.11 85.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.962 0.381 . . . . 0.0 110.737 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.8 121.2 9.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.152 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.02 -29.56 5.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.593 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 tp -80.09 115.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.7 p -137.81 27.14 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.56 159.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.496 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.445 ' HB3' ' CG ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER 178.93 -37.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.975 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.7 m -53.65 -27.13 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.46 -171.28 29.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 57.98 73.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 111.08 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.49 86.62 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.737 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.0 mpp? 61.0 19.58 10.02 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.756 -0.261 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -90.17 153.18 46.66 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.723 0.297 . . . . 0.0 110.988 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.416 ' CB ' ' CD2' ' A' ' 6' ' ' TYR . 50.7 Cg_exo -54.07 174.34 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.622 2.215 . . . . 0.0 112.299 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.2 m -139.2 94.07 9.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.221 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.11 130.98 14.84 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.564 2.176 . . . . 0.0 112.404 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 mp -78.99 162.18 26.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.09 156.49 49.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.59 -30.57 89.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.626 2.217 . . . . 0.0 112.271 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.15 -29.01 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.16 -38.19 11.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.473 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 40.0 t -58.95 -35.52 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -25.41 68.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.25 -41.2 25.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.402 HD11 ' CE2' ' A' ' 67' ' ' PHE . 12.1 pt -76.13 -22.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.202 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.411 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 85.6 mt -84.15 -30.18 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 110.758 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -31.01 61.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.6 t -77.2 -38.44 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.789 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 149.12 56.63 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.66 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.411 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 41.5 mt -127.92 -60.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.006 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -34.71 38.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.528 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.772 0.32 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.437 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -85.48 -170.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.794 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -154.0 150.19 28.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.267 0.555 . . . . 0.0 112.136 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.579 ' CH2' ' CD2' ' A' ' 39' ' ' LEU . 46.2 m95 -89.91 95.27 10.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.388 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 44.6 m-85 -91.15 116.01 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.85 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.84 143.27 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.453 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 t -143.34 160.05 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.699 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -131.53 152.74 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.876 0.369 . . . . 0.0 111.164 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -139.81 -165.56 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.794 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 136.03 49.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.982 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 37.2 t -67.32 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.31 -32.02 6.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.432 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -93.59 -22.14 18.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.051 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -32.07 20.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.152 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.47 -48.06 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -27.29 60.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.04 93.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -42.93 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.96 56.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.34 -34.89 78.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.764 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.81 -57.87 4.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.813 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -49.14 -35.21 15.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -69.55 -43.93 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -38.03 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.505 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG21 HD12 ' A' ' 26' ' ' ILE . 48.4 mm -67.69 -30.99 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.639 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -87.11 -29.21 22.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.99 -46.91 70.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -87.33 -25.1 24.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.3 61.5 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.324 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 3.6 mm? -98.86 28.11 4.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.059 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -81.26 21.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.284 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -108.94 -15.73 14.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.979 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' CE2' ' A' ' 36' ' ' PHE . 2.0 mttp -116.69 -45.87 2.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.807 0.337 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.402 ' CD1' ' CD1' ' A' ' 26' ' ' ILE . 16.5 mt -80.29 135.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' CE2' ' CG2' ' A' ' 3' ' ' ILE . 15.6 m-85 -133.06 -60.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.602 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.55 133.3 46.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.535 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.12 76.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.271 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.579 ' CD2' ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -80.0 139.41 37.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.119 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.4 ' CG2' ' HD2' ' A' ' 41' ' ' PRO . 27.8 mm -98.93 136.99 20.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD2' ' CG2' ' A' ' 40' ' ' ILE . 80.0 Cg_endo -77.85 55.76 5.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.59 2.193 . . . . 0.0 112.769 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 p -126.0 147.3 49.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.04 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.48 172.3 8.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -127.53 107.99 10.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -123.7 161.95 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.075 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.8 m -131.07 109.34 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -130.78 151.45 51.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.781 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -160.07 168.39 25.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.15 -169.35 1.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.866 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.75 -31.51 61.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.75 -81.13 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.24 60.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.556 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.98 24.93 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.46 0.648 . . . . 0.0 111.144 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -158.51 167.93 28.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.759 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -160.03 -52.08 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.9 m -148.91 139.45 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.226 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.19 167.45 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.075 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -134.83 154.94 51.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.64 111.36 9.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 105.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.2 mt -63.98 -51.57 63.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.786 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.439 ' CE2' HG22 ' A' ' 112' ' ' ILE . 86.8 m-85 -97.58 111.88 59.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.537 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.8 122.2 11.06 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.517 2.145 . . . . 0.0 112.73 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.17 43.65 25.81 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.198 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -117.11 173.99 6.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tp -160.23 152.01 20.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD1' HD11 ' A' ' 104' ' ' LEU . 79.3 m-85 -126.21 120.64 30.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.564 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.35 115.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.626 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.7 tt0 -83.22 70.17 10.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.314 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.4 ptm -91.51 -168.3 2.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.964 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -139.99 49.32 1.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.409 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 4.5 pp -79.9 -31.09 40.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.976 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.52 88.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.486 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -98.81 -78.97 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -164.16 -69.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.56 -82.35 0.08 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.21 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 137.68 28.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.98 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.97 89.3 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.633 2.222 . . . . 0.0 112.718 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 p30 -90.26 -168.41 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.776 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.41 ' HG3' ' CD1' ' A' ' 31' ' ' LEU . 5.7 tp10 56.85 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.66 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . -55.85 -43.35 76.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.312 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.417 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 2.6 t-105 -79.97 -35.55 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -27.65 62.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.981 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.4 -51.69 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.7 t -58.56 -48.61 85.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -23.4 61.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.973 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.38 -26.0 37.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.67 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.7 p -57.78 142.89 77.78 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.639 0.257 . . . . 0.0 110.921 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.73 -14.12 32.76 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.528 2.152 . . . . 0.0 112.558 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.03 -28.08 73.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.657 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm -84.52 152.13 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.72 -51.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.22 162.01 22.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -134.42 -177.93 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.7 m -59.14 126.96 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.244 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.77 -17.19 76.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.677 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.74 -28.87 51.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.739 0.304 . . . . 0.0 111.264 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.11 -133.86 1.67 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.435 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -124.24 -48.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.811 0.338 . . . . 0.0 110.839 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -81.06 161.91 61.3 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HG3' ' CZ2' ' A' ' 82' ' ' TRP . 51.8 Cg_exo -54.07 -168.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.668 2.245 . . . . 0.0 112.4 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.22 109.62 6.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.371 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.34 120.39 3.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.217 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.412 HD11 ' CD1' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -68.09 155.43 39.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.161 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.07 166.94 18.3 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -51.33 -27.47 23.78 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.623 2.215 . . . . 0.0 112.443 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.47 -48.2 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.073 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -72.71 -34.31 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.456 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 58.5 t -62.2 -44.63 99.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.222 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -60.48 -26.68 66.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.46 -53.83 9.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.439 HG22 ' CE2' ' A' ' 62' ' ' PHE . 2.5 pp -67.51 -15.3 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.955 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.64 -40.41 25.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.86 -32.98 74.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.067 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.2 t -76.27 -50.03 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.455 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -56.26 -60.49 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.06 42.47 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.1 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.424 HD12 HD22 ' A' ' 39' ' ' LEU . 4.7 mt -109.36 -48.57 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 110.633 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tp -100.67 30.78 3.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.405 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.878 0.371 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.52 -178.97 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.49 157.22 39.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.175 0.512 . . . . 0.0 112.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.508 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 78.5 m95 -98.07 85.75 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.121 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 68.6 m-85 -80.63 124.76 29.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.988 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.84 138.23 33.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.389 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 t -125.16 160.07 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -94.3 132.55 38.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -124.12 177.54 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.954 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.47 132.15 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.81 123.73 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.198 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.29 -27.91 17.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.462 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -104.65 -3.06 24.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.627 0.251 . . . . 0.0 111.376 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -34.07 68.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.769 0.319 . . . . 0.0 111.038 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -58.47 -40.71 83.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.52 -24.72 31.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.28 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -37.29 79.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -53.06 15.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.034 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -59.17 -31.75 69.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.637 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.4 tp -77.14 -57.48 3.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.716 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -49.72 -31.18 10.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -38.66 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.637 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -36.07 72.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.601 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.4 mm -67.44 -31.4 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -30.16 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.33 -32.32 37.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -85.02 -27.26 26.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.8 61.11 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.46 28.69 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -8.07 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.335 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.96 -29.05 39.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -96.11 -55.58 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.718 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -80.02 145.01 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.789 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 35' ' ' ILE . 8.2 m-85 -131.87 -44.45 0.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.132 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.402 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -122.09 154.93 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.619 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.3 t -154.4 67.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.288 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.97 152.3 29.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.263 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 42' ' ' THR . 4.5 tp -108.16 118.34 52.76 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.813 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 46.1 Cg_exo -55.33 80.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.731 2.287 . . . . 0.0 112.528 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' ILE . 58.5 p -158.91 128.12 5.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' CG ' ' HB2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -79.95 107.01 12.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.4 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.02 141.79 40.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.173 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.61 130.23 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.753 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.9 m -137.62 175.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -133.74 -176.72 4.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.31 136.91 52.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -134.29 34.72 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.52 163.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.84 -54.5 4.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.442 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.63 -81.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.44 168.3 27.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 110.887 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -139.74 167.93 20.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.16 153.43 47.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.43 -73.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.29 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 m -160.03 173.34 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.444 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 128.56 4.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HB2' ' CG ' ' A' ' 43' ' ' GLU . 5.3 mtpt -99.38 170.97 8.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.663 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -103.11 123.65 47.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.0 mt -88.53 -48.62 7.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.515 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 2.7 m-85 -124.58 89.22 52.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.407 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.96 131.53 39.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.667 2.245 . . . . 0.0 112.934 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.18 36.31 92.8 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.153 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.53 150.75 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.905 0.353 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mt -142.78 117.82 10.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.452 ' CE2' ' HG3' ' A' ' 41' ' ' PRO . 12.8 m-85 -82.48 121.04 26.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -128.57 107.5 15.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.436 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.457 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 4.5 tt0 -80.03 70.48 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -91.23 -179.78 5.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.261 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -120.83 89.86 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.846 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.438 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 13.3 mt -83.47 -69.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.24 -80.79 1.18 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.48 141.13 28.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 111.016 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.42 31.96 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -84.69 -54.28 4.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -160.08 93.31 1.66 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.98 92.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.546 2.164 . . . . 0.0 112.221 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 81' ' ' ALA . 18.5 m-80 -90.35 -176.6 4.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 51.4 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . -46.56 -50.88 16.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.821 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.417 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -72.21 -32.38 66.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.063 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -33.36 72.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.993 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.01 -48.18 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.3 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.67 -45.29 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.242 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -62.2 -18.61 61.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.275 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -102.08 -25.19 8.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.809 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.5 p -59.96 145.06 85.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.66 -25.96 62.62 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.566 2.178 . . . . 0.0 112.218 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.81 -34.15 56.67 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.674 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.5 mm -97.13 152.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 t -176.51 -39.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 94' ' ' PHE . . . -96.83 -37.57 4.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.512 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 39.6 p90 46.3 -172.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.853 0.358 . . . . 0.0 111.487 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.77 104.33 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.07 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.97 -32.04 82.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.5 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.31 80.47 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.51 -147.07 18.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.41 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -154.86 -57.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.948 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 149.6 88.93 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.006 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.59 179.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.31 92.29 24.99 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.235 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 145.04 30.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.621 2.214 . . . . 0.0 112.325 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 169.17 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.06 150.81 44.16 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.767 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.53 -29.34 24.36 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.583 2.189 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.59 -30.97 57.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -90.3 -33.64 16.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.508 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 35.9 t -63.8 -35.48 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.227 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -29.16 66.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -77.92 -40.38 39.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.784 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.437 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 12.4 pt -74.72 -29.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 mt -77.71 -32.58 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.559 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.39 -33.25 74.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.7 t -72.82 -35.29 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.949 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.5 m -64.34 -59.81 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.94 44.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.527 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.7 mt -115.92 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.85 -44.7 20.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.465 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.814 0.34 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.46 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -133.24 176.25 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.0 158.21 44.26 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 112.281 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.533 ' CH2' ' HB3' ' A' ' 37' ' ' GLN . 78.6 m95 -93.22 91.03 7.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.487 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -87.48 99.12 11.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.45 154.97 27.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 t -139.07 159.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.42 ' CG ' HG12 ' A' ' 95' ' ' VAL . 3.4 m-70 -112.92 135.82 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.2 p -129.11 -177.49 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.01 142.34 27.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.875 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.39 129.81 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.45 -27.5 17.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.02 -20.02 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.578 0.228 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.66 -39.92 74.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.986 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -52.49 -67.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -61.72 -23.22 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.038 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.92 87.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -59.85 -46.97 87.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.08 69.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.36 -43.99 95.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.8 tp -70.62 -48.54 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.51 -17.33 59.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -84.67 -43.92 13.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.001 0.429 . . . . 0.0 110.227 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -23.93 66.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.355 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.43 HG21 ' N ' ' A' ' 27' ' ' LYS . 1.3 tp -67.91 -29.51 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.816 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' N ' HG21 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -92.47 -30.57 15.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.62 62.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -79.91 -30.36 40.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.25 34.5 5.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.474 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.63 25.23 6.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.955 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -19.7 62.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.17 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -79.96 -26.27 40.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.061 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -77.89 -58.89 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.759 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.94 130.91 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' CE2' HG23 ' A' ' 3' ' ' ILE . 8.9 m-85 -117.57 -48.27 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.117 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.584 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -120.79 151.59 39.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 m -143.8 126.54 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.468 HD13 ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -109.65 135.19 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.409 ' CG2' ' HD2' ' A' ' 41' ' ' PRO . 2.1 mp -90.89 136.41 27.67 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.817 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 40' ' ' ILE . 28.1 Cg_endo -61.62 -15.56 42.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.624 2.216 . . . . 0.0 112.906 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.4 p -98.55 137.76 36.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 111.13 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -87.05 150.37 24.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.679 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -119.87 121.23 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.995 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.8 t -144.55 159.75 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.3 p -89.96 125.88 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.172 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -159.92 171.18 19.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.6 tp -138.48 122.3 17.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -128.95 -76.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.956 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -107.97 -165.16 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.845 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.7 27.78 11.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.673 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.95 -28.34 5.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.375 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -135.46 137.1 41.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -146.71 26.18 1.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.337 0.589 . . . . 0.0 111.183 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -136.52 -58.38 0.74 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.871 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -157.39 135.5 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.25 174.18 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 mtt85 -136.06 124.04 22.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.965 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -125.31 113.41 17.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -71.83 111.28 6.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.004 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.82 -39.65 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.614 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.58 94.07 21.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.99 126.34 18.58 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.384 2.056 . . . . 0.0 112.416 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.93 37.06 93.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -117.93 166.05 12.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.818 0.342 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.08 151.12 19.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.413 ' CD2' HD11 ' A' ' 104' ' ' LEU . 4.7 m-85 -131.71 130.56 42.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.028 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -134.52 117.31 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.496 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.584 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -83.77 65.81 8.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.411 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.8 ptm -91.57 -170.35 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.048 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD1' ' CZ ' ' A' ' 36' ' ' PHE . 6.4 p-10 -144.39 52.3 1.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.651 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 pp -79.9 -31.21 40.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.9 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.27 90.57 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.594 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.03 154.49 3.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 110.768 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.16 -171.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -70.52 -30.5 67.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.002 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -138.99 149.22 60.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.45 179.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.492 2.128 . . . . 0.0 112.291 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -89.99 -177.56 5.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.52 -26.71 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.94 -30.06 32.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.293 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.8 t-105 -75.51 -31.01 60.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.57 -30.62 63.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.43 -52.73 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 t -59.9 -43.3 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -69.27 -15.51 63.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.26 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.29 -15.06 20.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.957 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.54 132.19 95.32 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.778 0.289 . . . . 0.0 110.848 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.9 137.12 40.52 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.418 2.078 . . . . 0.0 112.243 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.19 -17.39 58.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.734 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -80.0 -31.96 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.984 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 p 68.42 -61.95 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.294 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.09 83.76 1.66 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.394 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.85 171.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.42 HG12 ' CG ' ' A' ' 9' ' ' HIS . 31.1 m -70.51 -29.69 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.76 26.83 3.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.519 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.22 39.04 1.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 110.963 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.14 -37.14 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 41.5 mtp 69.45 -66.28 0.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.788 0.328 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.39 147.62 67.53 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.759 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.9 Cg_exo -53.05 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.546 2.164 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 p -149.25 95.06 3.87 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.287 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.09 128.42 9.86 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.402 2.068 . . . . 0.0 111.912 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.413 HD11 ' CD2' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -79.86 157.87 26.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.19 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.6 p -80.72 160.22 67.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.82 -56.93 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.679 2.253 . . . . 0.0 112.564 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -52.59 -25.72 11.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.231 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -30.81 13.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.493 ' CG2' ' CD1' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -65.83 -29.56 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -32.72 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.477 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.11 -49.02 30.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.311 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.401 ' CD1' HD11 ' A' ' 39' ' ' LEU . 2.7 pp -62.24 -29.56 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.176 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -35.78 73.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.737 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.82 -21.02 64.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.266 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.0 t -71.94 -61.93 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.417 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 11.3 t -52.2 -59.31 4.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.029 0.442 . . . . 0.0 111.001 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.88 42.68 0.17 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.563 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.3 mt -103.63 -31.38 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -56.71 4.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.501 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.909 0.385 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.425 HG22 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -136.76 -165.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.97 155.82 36.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.412 0.625 . . . . 0.0 112.232 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.459 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 90.6 m95 -95.64 93.52 7.18 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.459 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 95.9 m-85 -86.15 108.58 18.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.839 0.352 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.45 140.24 29.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.115 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 t -132.87 159.68 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.412 ' CD2' HG11 ' A' ' 95' ' ' VAL . 11.2 m-70 -85.12 157.29 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -153.52 167.12 30.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.12 140.65 36.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.9 121.68 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.121 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.75 -23.42 36.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.734 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -93.23 -28.02 16.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -58.16 -33.96 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -39.82 71.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -90.02 -24.2 21.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.49 -35.47 74.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -59.29 -57.28 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.16 96.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -65.26 -41.55 94.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.834 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.7 tp -66.13 -54.45 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.837 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -34.05 62.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -67.74 -43.75 79.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -41.54 74.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.31 -26.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.871 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -92.71 -31.77 14.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.6 68.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -101.14 -26.56 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.05 81.65 1.36 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.52 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.91 31.05 3.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -0.94 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.604 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -23.61 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.74 0.305 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -106.53 -52.69 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.678 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -79.84 113.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.315 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.425 ' CE2' HG22 ' A' ' 3' ' ' ILE . 25.5 m-85 -107.46 -56.21 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.016 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -113.39 162.39 16.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.332 0.587 . . . . 0.0 112.497 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.01 77.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.773 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.27 167.91 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.397 0.618 . . . . 0.0 112.397 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.6 tt -155.81 74.2 5.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.428 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 82.1 Cg_exo -42.33 128.43 4.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.299 2.666 . . . . 0.0 113.841 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.28 160.59 38.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.397 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.6 mt-10 -80.3 107.86 13.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -82.61 114.08 20.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.697 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.93 159.42 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.201 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.93 126.68 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.064 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.22 167.57 22.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mt -137.33 148.31 46.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.1 mmm-85 -81.14 -66.51 0.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -162.23 -56.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.796 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.42 90.75 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.524 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.96 -59.6 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -145.19 153.75 41.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.806 0.336 . . . . 0.0 110.895 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.84 166.89 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -146.6 169.03 19.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.54 145.83 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 t -116.07 159.91 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.025 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.79 111.56 8.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.026 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 1.4 tptt -104.68 99.32 8.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.213 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -37.6 126.03 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.734 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.9 -34.93 15.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.604 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 41' ' ' PRO . 59.5 m-85 -116.45 81.01 10.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.47 144.27 90.09 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.679 2.253 . . . . 0.0 112.076 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.98 24.8 15.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 22.7 m-85 -131.04 117.26 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 110.735 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mt -116.73 116.3 27.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.393 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.65 114.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.467 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 12.8 tt0 -79.7 68.44 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 ptp -91.27 -167.94 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.262 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -142.35 106.37 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.452 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.438 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 23.9 mt -79.85 -1.82 40.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.12 -159.48 28.84 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.748 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -77.76 -77.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -53.58 179.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.74 7.2 31.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.352 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -80.03 123.92 83.26 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.891 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.01 159.23 53.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.258 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -90.12 -179.99 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.97 -32.63 73.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.6 -31.72 64.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.01 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.442 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -64.2 -47.88 78.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -57.07 -30.21 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.16 -54.83 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.1 t -56.62 -37.24 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.64 -20.61 65.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.94 -17.16 12.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.921 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.2 p -55.85 141.02 67.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.775 0.287 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.07 95.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.098 . . . . 0.0 112.279 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.77 -30.29 0.28 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.624 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.5 mm -79.93 131.88 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.988 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.08 -66.14 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.47 30.23 0.13 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.722 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 53.18 -173.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 111.048 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 9' ' ' HIS . 17.3 m -51.97 171.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.316 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.07 -49.3 7.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.542 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.35 39.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.936 0.398 . . . . 0.0 111.191 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -177.61 134.13 2.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.44 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.84 -29.97 11.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.906 0.384 . . . . 0.0 110.928 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -79.6 161.93 65.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.442 ' HG3' ' CZ2' ' A' ' 82' ' ' TRP . 50.8 Cg_exo -55.91 -164.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.686 2.258 . . . . 0.0 112.416 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.5 m -158.72 93.44 1.92 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.13 126.36 13.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.51 2.14 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mp -76.57 154.12 34.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -82.34 157.9 67.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -29.84 87.79 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.748 2.299 . . . . 0.0 112.274 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -29.29 65.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 -34.82 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 22.5 t -68.83 -26.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.198 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -73.22 -37.14 66.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -44.49 64.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.9 -23.26 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.418 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -72.46 -31.08 65.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.2 -53.81 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.16 -37.27 61.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -64.95 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.32 42.82 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.418 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 6.0 mt -115.14 -33.83 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.3 tt -94.95 42.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.459 179.884 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.875 0.369 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.459 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -79.94 -165.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.72 143.84 30.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.177 0.513 . . . . 0.0 112.042 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.486 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 63.9 m95 -100.79 92.29 5.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.167 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CE2' HD12 ' A' ' 72' ' ' LEU . 58.3 m-85 -91.69 106.2 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.788 0.328 . . . . 0.0 111.33 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.86 124.96 32.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.0 162.05 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -122.66 133.27 54.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -136.78 -174.74 3.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 151.84 23.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 p -66.47 124.89 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.82 -27.61 18.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.61 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.07 -27.69 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.98 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.65 -35.11 70.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.98 -39.69 66.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -87.82 -27.94 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.024 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.0 69.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -58.36 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.027 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.87 -47.95 81.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.274 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.11 -40.51 73.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.992 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.6 tp -65.91 -53.41 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -58.77 -45.81 88.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.014 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -58.58 -41.91 86.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -65.38 -46.91 78.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.759 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.1 mt -65.52 -32.05 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.936 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -31.66 39.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -36.54 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -82.64 -24.68 33.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.045 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.66 77.35 1.27 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.376 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.61 38.76 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 110.726 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -8.74 56.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.2 m-20 -79.99 -28.06 39.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.41 -59.58 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.92 122.02 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 14.1 m-85 -110.0 -45.1 3.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.237 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.479 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.4 mm100 -120.35 170.25 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.218 0.532 . . . . 0.0 111.89 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 t -154.31 88.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.149 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -79.72 157.15 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.6 pt -120.2 145.37 40.03 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.939 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.47 -15.4 45.16 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.651 2.234 . . . . 0.0 113.002 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.5 p -87.07 128.79 35.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.075 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 1.3 tt0 -95.05 144.09 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -107.2 141.38 38.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.004 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.84 161.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.108 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.11 91.59 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -159.99 -177.82 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.34 172.79 12.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -149.23 -176.89 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -56.5 153.48 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.06 60.54 1.75 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.461 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 -135.92 13.03 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.514 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -149.15 152.01 35.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -115.81 -171.89 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.773 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -148.32 -65.78 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.18 112.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 t -131.32 160.07 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.03 137.85 34.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 111.011 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -111.57 149.91 30.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 109.18 15.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.429 HD13 ' CG2' ' A' ' 115' ' ' VAL . 47.4 mt -76.41 -68.61 0.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.651 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.406 ' CB ' ' HB2' ' A' ' 65' ' ' TYR . 46.6 m-85 -100.47 96.89 5.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.644 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.61 115.28 2.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.55 2.166 . . . . 0.0 112.635 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.58 38.39 51.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.821 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' HB2' ' CB ' ' A' ' 62' ' ' PHE . 88.1 m-85 -132.61 109.98 10.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.67 137.24 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.549 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.413 ' HB2' ' CB ' ' A' ' 39' ' ' LEU . 3.9 m-85 -106.37 135.59 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -135.08 110.43 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.456 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 tt0 -85.53 74.34 10.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 110.224 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.4 ptp -91.42 -167.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.499 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.469 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.7 t70 -137.48 94.98 2.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.655 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.414 HD12 ' CE2' ' A' ' 6' ' ' TYR . 15.5 mt -79.98 -29.35 39.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.047 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.45 -153.88 27.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.591 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.08 176.05 6.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.986 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.36 177.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.92 6.84 37.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.309 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.93 116.31 60.27 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.868 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.11 162.1 31.95 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.466 2.111 . . . . 0.0 112.365 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.1 -178.0 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -61.78 -29.49 70.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.41 -44.83 84.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.5 t-105 -61.06 -35.53 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -32.25 72.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.616 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.62 -49.9 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.064 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.17 -38.26 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -71.32 -22.5 61.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.48 20.83 10.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.933 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.95 145.7 37.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.632 0.253 . . . . 0.0 110.844 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.2 84.85 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.486 2.124 . . . . 0.0 112.222 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.37 -32.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.5 mm -80.4 122.81 36.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.377 . . . . 0.0 111.017 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -167.94 32.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.17 34.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.533 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 94' ' ' PHE . 44.2 p90 -76.8 103.35 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 0.0 110.808 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG21 ' CG ' ' A' ' 9' ' ' HIS . 11.2 m -90.15 100.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.271 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.37 33.24 5.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.425 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.27 36.88 23.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.948 0.404 . . . . 0.0 111.048 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.94 36.15 29.12 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.371 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -175.24 -168.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.414 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 4.6 mtt85 -53.97 176.66 0.11 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 91.5 Cg_exo -44.91 166.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.707 2.271 . . . . 0.0 112.65 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.09 111.47 33.9 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.493 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.01 145.93 10.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.643 2.229 . . . . 0.0 112.239 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.21 171.31 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 111.004 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.1 p -90.06 152.57 46.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.788 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.22 -32.48 70.93 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.722 2.281 . . . . 0.0 112.447 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 -41.4 58.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -78.91 -30.18 44.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 112' ' ' ILE . 66.3 t -62.82 -42.48 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.211 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -36.89 80.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -49.92 30.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.859 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 109' ' ' VAL . 2.8 pt -67.28 -16.38 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.449 HD13 ' CZ2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -70.61 -32.64 70.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.836 0.35 . . . . 0.0 110.526 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.47 -10.74 57.42 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' CG2' HD13 ' A' ' 61' ' ' LEU . 40.4 t -75.87 -48.59 28.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 111.509 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 4.3 t -65.83 -56.61 11.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.428 . . . . 0.0 110.656 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.81 42.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.405 ' CD1' ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -108.65 -28.3 9.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.36 -31.2 7.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.424 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.883 0.373 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.435 HG22 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -135.12 -165.15 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 153.8 37.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.243 0.544 . . . . 0.0 112.206 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.464 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 73.9 m95 -97.46 88.84 4.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.356 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.419 ' CZ ' HD11 ' A' ' 72' ' ' LEU . 50.2 m-85 -79.82 125.58 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.828 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -107.19 148.31 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.67 162.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.528 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 3.0 m-70 -101.37 147.79 25.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.7 p -141.26 -176.96 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.55 130.78 34.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.725 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 p -57.69 118.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.58 -23.5 35.55 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.79 -20.54 18.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.237 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -44.32 70.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.79 -46.03 74.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -79.6 -27.29 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.819 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.8 97.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -49.8 -48.53 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.204 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.48 74.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.67 -38.45 89.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.39 -56.64 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.031 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -41.69 -36.58 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -77.67 -37.87 48.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -75.75 -27.84 58.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.644 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.9 mm -73.44 -30.18 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.626 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -80.86 -29.82 35.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.17 -43.12 44.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -81.65 -3.46 53.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.372 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 81.04 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mt -136.48 23.06 3.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.98 -15.87 58.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.131 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.45 -7.33 59.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.492 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.403 ' NZ ' ' CB ' ' A' ' 81' ' ' ALA . 4.9 ptmm? -115.99 -46.66 2.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.731 0.3 . . . . 0.0 110.854 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.85 108.63 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.652 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.435 ' CE2' HG22 ' A' ' 3' ' ' ILE . 8.5 m-85 -94.5 -60.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.455 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -108.92 146.48 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.108 0.48 . . . . 0.0 111.298 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.51 89.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.55 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.59 166.86 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.9 pt -120.69 134.91 24.33 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.748 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 36.9 Cg_endo -66.16 65.29 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.521 2.147 . . . . 0.0 112.547 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.9 p -152.28 140.28 20.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -79.92 156.56 27.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.658 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 129.97 16.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.97 155.75 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 p -159.71 115.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.053 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -107.28 158.98 16.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.962 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -141.37 36.87 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.719 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -114.24 -176.48 2.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 66.14 40.32 3.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.4 -134.09 11.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.544 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.57 76.4 0.35 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.518 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -141.33 174.78 10.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.341 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.38 133.92 30.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -128.63 116.95 20.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.948 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 m -110.72 118.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.056 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 t -120.83 159.96 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.05 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -146.72 152.48 38.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.067 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -138.5 92.66 2.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.742 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -58.96 102.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.4 mt -73.23 -48.28 36.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 1.7 m-85 -116.64 88.9 26.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.97 125.69 20.03 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.67 2.247 . . . . 0.0 112.779 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.65 35.53 74.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.123 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.403 ' CB ' ' HG3' ' A' ' 41' ' ' PRO . 6.4 m-85 -126.69 164.19 21.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -153.32 120.8 5.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.484 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 12.4 m-85 -94.65 138.09 32.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.561 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mp -141.68 116.1 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.979 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 5.3 tt0 -81.04 66.66 6.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.645 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.4 ptm -91.15 -171.08 2.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -148.48 99.5 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.419 HD11 ' CZ ' ' A' ' 6' ' ' TYR . 9.2 mt -92.47 -69.99 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.72 -47.48 2.76 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.558 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.79 151.17 43.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 0.0 110.969 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -116.12 -36.83 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -66.34 -41.7 89.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.941 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -160.08 122.68 1.87 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.32 172.52 14.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.4 2.067 . . . . 0.0 112.288 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.35 176.62 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -57.7 -21.36 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.265 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' CB ' ' NZ ' ' A' ' 34' ' ' LYS . . . -53.22 -48.8 67.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.245 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -59.47 -38.36 80.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.05 -51.54 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.7 t -62.65 -48.8 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.045 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -9.33 58.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.361 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.46 24.17 4.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.918 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.32 144.32 74.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.649 0.261 . . . . 0.0 110.707 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.04 96.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.604 2.203 . . . . 0.0 112.695 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.86 52.77 4.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.083 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.409 HG21 ' N ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -101.5 -28.59 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.409 ' N ' HG21 ' A' ' 91' ' ' ILE . 6.7 m 50.61 51.7 16.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.453 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.44 125.26 25.15 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.467 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.446 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 7.5 t80 63.41 142.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.821 0.343 . . . . 0.0 110.81 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -47.65 -62.87 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.585 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 166.33 76.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.476 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -170.33 -52.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 0.0 110.989 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -123.86 168.35 16.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -25.42 10.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.706 0.289 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.93 138.95 83.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.46 -169.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.582 2.188 . . . . 0.0 112.418 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.44 88.54 4.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.8 148.58 71.49 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.616 2.211 . . . . 0.0 112.379 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 mt -90.0 169.56 11.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.01 148.51 39.7 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.682 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.67 -46.1 35.92 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.686 2.257 . . . . 0.0 112.248 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -64.97 -27.96 69.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -85.73 -37.9 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.464 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 48.2 t -57.65 -29.35 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.104 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -77.94 -28.59 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -79.2 -40.16 31.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.564 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.3 pp -72.06 -24.85 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.87 -34.89 64.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.83 -31.36 59.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.982 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -71.93 -43.08 68.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.132 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -61.59 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.66 43.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.559 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.2 mt -113.38 -35.69 5.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.14 36.27 3.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.776 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.329 -1.261 . . . . 0.0 112.517 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.028 0.442 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 36' ' ' PHE . 1.3 pp -110.31 174.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.031 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -143.36 161.11 39.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.286 0.565 . . . . 0.0 111.582 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.457 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 94.9 m95 -86.82 86.64 7.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.593 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 57.1 m-85 -79.69 113.54 17.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.376 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -105.43 135.51 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 111.822 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 9' ' ' HIS . 0.6 OUTLIER -125.66 -167.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.399 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.489 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 8.1 m-70 -126.39 167.22 15.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.061 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -151.42 -174.61 4.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.13 133.63 35.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.1 m -58.8 117.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.003 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.41 -28.99 12.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -84.47 -21.18 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 111.195 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.37 -32.29 56.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.126 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -50.95 -60.8 2.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.287 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -75.26 -19.79 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.89 72.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.769 0.319 . . . . 0.0 111.067 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -55.84 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.83 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.58 -32.79 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.0 tp -80.06 -50.28 10.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.97 -52.51 65.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -39.98 75.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -40.14 90.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -62.29 -35.01 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.75 -10.21 40.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.422 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.92 73.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.344 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' ILE . 3.8 mm? -126.12 23.35 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.293 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -79.45 24.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.107 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -110.53 -23.93 10.85 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.883 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -107.96 -42.95 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.706 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mp -84.89 93.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 3' ' ' ILE . 30.4 m-85 -82.0 -49.02 10.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.36 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.448 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mt-30 -121.86 156.87 32.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.66 76.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.465 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.02 142.53 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.141 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 42' ' ' THR . 30.4 mm -98.09 110.92 57.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.983 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 31.5 Cg_exo -57.75 79.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.586 2.191 . . . . 0.0 112.437 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 40' ' ' ILE . 16.7 p -141.57 164.23 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -106.76 148.33 28.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.585 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.53 144.37 27.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.119 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.65 160.18 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.869 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.15 155.92 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.253 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -132.52 148.51 52.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.59 121.09 39.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.7 ttm-85 -109.98 141.13 43.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.31 122.43 18.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.967 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.07 -117.68 2.37 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.66 36.25 0.74 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -113.87 -174.03 2.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.808 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -138.07 149.73 46.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -149.18 138.23 21.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.69 131.86 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -107.81 171.35 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.04 124.48 43.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 -169.13 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.64 115.21 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.0 mt -90.22 -53.12 4.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 41' ' ' PRO . 18.9 m-85 -114.24 86.13 11.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.369 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.51 119.35 4.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.064 2.51 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.87 -13.67 29.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.778 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 2.5 m-85 -79.94 152.82 29.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.051 0.425 . . . . 0.0 111.412 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 1.2 mt -146.89 121.27 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.548 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.472 ' CE2' ' HG3' ' A' ' 41' ' ' PRO . 6.2 m-85 -91.21 125.4 35.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.24 114.37 14.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.256 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' CB ' ' HB2' ' A' ' 37' ' ' GLN . 28.1 tt0 -79.89 68.81 6.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.2 ptm -91.39 -170.73 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.699 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -129.28 101.0 5.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.723 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 31.7 mt -118.97 6.73 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.395 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.74 61.08 1.0 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.507 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -115.88 -37.87 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 0.0 111.008 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -174.21 -168.69 0.41 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.05 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.38 -34.58 74.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -112.85 116.26 47.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.86 -171.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.289 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -89.95 -174.15 4.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -22.87 64.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.32 -46.59 69.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.322 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.8 t-105 -61.24 -38.33 86.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -31.11 69.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.34 -46.27 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.17 -32.83 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -23.05 62.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.036 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -100.39 -8.88 48.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.009 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 p -74.94 114.61 36.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.852 0.326 . . . . 0.0 110.933 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.75 115.48 2.14 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.405 2.07 . . . . 0.0 112.356 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.11 -18.42 5.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.89 129.72 37.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.731 0.3 . . . . 0.0 111.096 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 m -140.43 125.16 18.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.973 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -81.08 81.87 1.59 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.463 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.83 -57.74 3.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.0 110.956 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -58.29 131.57 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.168 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -104.46 -129.4 6.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.1 46.98 12.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.093 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.47 -126.18 7.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.349 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 176.14 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.801 0.334 . . . . 0.0 110.752 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 2.0 mmp_? -78.9 -46.58 1.76 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.065 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.3 Cg_exo -67.24 157.68 60.6 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.638 2.225 . . . . 0.0 112.08 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 m -154.17 98.23 2.57 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.426 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 41.4 Cg_exo -56.39 145.24 79.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.421 2.081 . . . . 0.0 112.244 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -83.39 160.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 p -77.04 145.38 73.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.46 -29.24 39.0 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.526 2.151 . . . . 0.0 112.228 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -77.13 -37.34 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.66 -35.73 33.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.457 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 36.2 t -60.95 -51.54 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.17 68.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.72 -51.27 17.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.614 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.422 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 22.6 pt -66.48 -19.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.754 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.79 -38.97 61.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.746 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.28 -34.31 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.001 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.3 t -83.91 -33.18 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.253 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -59.84 -60.77 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.22 41.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.645 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.6 mt -120.9 -57.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.75 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.72 31.11 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.332 -1.26 . . . . 0.0 112.432 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.769 0.319 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.426 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -138.3 -165.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.38 150.78 27.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.331 0.586 . . . . 0.0 112.154 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.477 ' CH2' ' CD1' ' A' ' 39' ' ' LEU . 72.1 m95 -92.63 85.96 5.43 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.264 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 72' ' ' LEU . 57.5 m-85 -81.19 129.06 34.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -111.38 124.7 52.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.354 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 t -101.1 159.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 1.7 m-70 -106.56 151.83 24.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.9 p -157.11 170.25 22.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.23 143.77 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.97 127.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.48 -27.81 17.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.485 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -99.18 -24.0 15.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 111.06 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.45 -53.75 53.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.051 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.42 -41.56 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -72.61 -33.66 66.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.225 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -47.39 -55.56 8.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -43.96 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.972 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mt -69.16 -63.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -40.86 -32.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.749 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -43.32 30.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 110.624 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -77.39 -26.59 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.777 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 26' ' ' ILE . 32.6 mm -83.97 -25.53 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -96.48 -29.91 13.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.82 -44.53 63.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.91 -24.59 40.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.978 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.08 53.32 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.382 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.98 32.04 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -79.17 8.93 5.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -97.48 -21.07 17.34 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -103.66 -55.08 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.49 94.54 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.673 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 3' ' ' ILE . 11.7 m-85 -79.99 -55.33 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.351 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.475 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt-30 -114.36 166.73 11.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.161 0.505 . . . . 0.0 111.709 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.2 t -150.32 89.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' CD1' ' CH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -80.59 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.171 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.4 pt -104.54 104.24 44.13 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.811 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 35.8 Cg_exo -57.67 -9.09 4.94 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.698 2.265 . . . . 0.0 113.147 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 32.8 p -92.1 138.33 31.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 110.534 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 1.4 mm-40 -80.23 108.28 13.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.793 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -94.88 110.5 22.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.223 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' VAL . 3.3 m -156.14 113.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.35 160.03 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -144.5 -68.0 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.965 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.27 -175.82 4.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.964 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -120.74 -67.54 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -139.12 132.67 30.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.17 40.72 0.67 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.92 -76.47 0.21 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.404 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.09 142.92 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.99 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -101.49 125.93 48.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.667 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -88.38 -97.7 0.09 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.941 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.5 t -153.79 -140.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 122.498 -0.126 . . . . 0.0 110.674 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 45' ' ' VAL . 27.0 m -157.93 -172.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -91.21 107.58 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -87.09 -175.01 5.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.342 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 32.1 mtmt -145.37 92.38 2.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.343 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.12 -51.84 61.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.334 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 41' ' ' PRO . 10.9 m-85 -116.64 81.69 11.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.702 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 53.1 Cg_exo -54.94 141.73 77.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.604 2.203 . . . . 0.0 112.557 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.74 27.36 66.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.774 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 61.8 m-85 -134.23 151.62 51.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 6.0 mt -147.78 126.68 12.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.388 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.416 ' CE2' HD13 ' A' ' 112' ' ' ILE . 8.9 m-85 -93.96 131.66 39.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 111.219 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -138.14 113.99 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.467 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 3.3 tt0 -79.88 71.73 6.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.106 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.4 ' CE ' ' CD2' ' A' ' 72' ' ' LEU . 3.8 ptm -91.66 -171.15 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.342 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -129.71 79.08 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.545 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 20.5 mt -80.0 -43.34 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.57 110.49 2.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.637 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -167.26 -67.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 110.999 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -117.74 -179.49 3.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.19 -27.69 67.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.971 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.88 148.28 48.17 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.6 165.87 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.493 2.128 . . . . 0.0 112.281 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -90.11 -177.9 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.69 -28.22 68.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.8 -45.61 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.194 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -62.61 -31.93 72.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -33.63 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.701 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.009 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.24 -39.19 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -74.75 -20.78 59.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.01 6.23 43.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.117 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 p -74.79 143.64 78.67 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.858 0.329 . . . . 0.0 110.672 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.15 104.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.459 2.106 . . . . 0.0 112.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.5 17.51 6.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.791 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.6 tp -113.57 103.27 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 0.0 110.979 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.13 -27.94 67.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.972 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.91 57.31 2.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.439 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 63.85 128.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.328 . . . . 0.0 110.942 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.408 ' CG2' ' ND1' ' A' ' 9' ' ' HIS . 35.3 m -79.54 -1.7 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.642 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -55.56 -23.17 34.68 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.68 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 62.66 51.52 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.397 . . . . 0.0 111.031 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.21 45.43 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.531 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.4 ttt -142.47 146.08 34.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -72.66 154.48 91.37 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.421 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_exo -49.81 143.35 23.41 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.587 2.191 . . . . 0.0 112.32 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.71 118.95 29.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.92 163.1 13.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.0 112.292 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.411 HD13 ' CD1' ' A' ' 67' ' ' PHE . 1.4 mt -90.0 168.41 12.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 p -88.74 147.04 38.3 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.49 -33.96 93.72 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.249 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -26.71 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -95.48 -36.7 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.476 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 40.9 t -59.39 -31.77 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -59.74 -43.12 94.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -53.91 34.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.67 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.416 HD13 ' CE2' ' A' ' 67' ' ' PHE . 9.9 pt -61.23 -23.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.259 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -36.71 76.74 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.29 -17.71 59.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.5 -60.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.483 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 39' ' ' LEU . 86.1 p -51.81 -59.96 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.79 46.16 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 mt -114.92 -43.82 3.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tp -98.7 30.88 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.428 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.836 0.35 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.443 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -133.7 -165.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -141.15 147.6 38.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 112.225 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.469 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 78.1 m95 -92.61 93.06 8.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.185 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 72' ' ' LEU . 29.1 m-85 -80.03 112.74 17.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 111.087 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -104.55 145.06 30.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.63 178.24 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.45 ' CG ' ' CB ' ' A' ' 94' ' ' PHE . 11.0 m-70 -107.91 143.65 36.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 p -138.59 174.19 10.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.93 144.47 25.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.7 m -58.68 119.03 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.047 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -27.76 15.85 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.475 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.04 -30.26 39.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.652 0.263 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -40.14 86.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.58 -43.07 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 tttm -86.99 -25.48 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.88 -30.7 70.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -50.49 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 -41.37 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.45 -44.9 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.52 -47.09 67.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -21.77 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.63 -46.23 14.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.965 0.412 . . . . 0.0 110.289 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -67.31 -23.36 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.413 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -71.06 -28.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' N ' HG22 ' A' ' 26' ' ' ILE . 23.2 ttmt -98.08 -31.93 11.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.37 87.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.421 ' CD2' HG22 ' A' ' 84' ' ' VAL . 15.5 m-85 -82.77 -42.06 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.989 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.99 77.41 1.06 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.18 29.37 0.4 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 110.823 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -15.43 61.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.137 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -24.55 42.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -53.62 6.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.568 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.03 153.06 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.474 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 3' ' ' ILE . 25.8 m-85 -135.38 -54.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 0.0 111.402 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.28 157.92 25.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.382 0.611 . . . . 0.0 111.605 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.39 62.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.06 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' HG ' ' HB2' ' A' ' 116' ' ' SER . 1.9 tm? -79.58 129.37 34.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.586 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.28 128.36 26.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.666 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 30.7 Cg_endo -63.85 78.84 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.564 2.176 . . . . 0.0 112.635 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.5 p -141.04 135.49 31.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -82.97 156.5 23.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.787 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -137.01 119.99 16.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.4 m -148.71 164.79 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.85 149.33 33.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -112.45 -63.09 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.98 149.52 23.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.815 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -151.65 -50.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -65.74 157.26 30.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.38 -122.21 5.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.439 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -143.62 28.86 2.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.576 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.75 119.99 28.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -113.95 130.08 56.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -135.8 139.53 43.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.9 m -130.52 123.74 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.062 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.7 t -98.36 155.66 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.255 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.33 113.88 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.725 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -110.24 106.87 16.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -63.66 101.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.62 -31.77 71.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.418 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 9.0 m-85 -139.59 83.97 16.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.631 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.46 139.47 90.25 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.59 2.193 . . . . 0.0 112.509 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.64 72.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.744 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -131.58 136.63 47.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.749 0.309 . . . . 0.0 110.954 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -131.53 128.76 39.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.465 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.451 ' CD2' HD12 ' A' ' 112' ' ' ILE . 5.3 m-85 -99.09 121.63 41.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -125.48 111.43 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -79.9 72.19 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.663 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 ptp -91.63 -163.23 1.01 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.177 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -147.77 89.2 1.73 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.662 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.423 HD11 ' CZ ' ' A' ' 6' ' ' TYR . 11.2 mt -79.98 -16.41 55.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.66 78.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.468 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -156.78 120.96 4.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.705 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 61.85 -175.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.906 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -31.6 61.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -123.1 149.89 58.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.24 150.25 20.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.513 2.142 . . . . 0.0 112.256 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -165.83 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.81 -21.29 41.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.26 -35.9 19.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.431 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -80.46 -29.72 37.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.07 -28.24 63.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 29' ' ' PHE . 22.7 t -84.83 -51.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.63 -37.36 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -73.97 -26.35 60.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.175 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.5 6.13 60.86 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.008 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 120.68 69.22 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.774 0.287 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 115.18 2.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.26 -13.16 6.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.791 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 tp -79.95 132.82 31.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 111.064 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.8 p -123.69 -68.96 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.98 165.0 28.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.523 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.45 ' CB ' ' CG ' ' A' ' 9' ' ' HIS . 1.5 t80 -175.3 -42.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.869 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.404 ' HB ' ' CG2' ' A' ' 102' ' ' VAL . 4.4 m -55.25 100.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.32 -95.56 0.51 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.795 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 63.56 -79.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.321 . . . . 0.0 110.971 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -127.22 -48.56 0.18 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.1 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 ttm -129.1 174.4 9.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -54.24 -51.19 79.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.011 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 100' ' ' ARG . 65.6 Cg_endo -85.12 155.07 11.1 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.698 2.266 . . . . 0.0 111.959 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.404 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 63.4 t -155.71 114.61 2.22 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.102 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.62 156.54 40.27 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.476 2.118 . . . . 0.0 112.388 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mp -89.72 147.81 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.95 153.3 94.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.53 -36.45 59.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.55 2.166 . . . . 0.0 112.311 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.63 -35.62 81.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.72 -38.81 20.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.469 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 38.3 t -58.84 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.056 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -53.68 -30.02 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.032 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 -54.91 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.707 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.451 HD12 ' CD2' ' A' ' 67' ' ' PHE . 15.7 pt -66.95 -26.2 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 109' ' ' VAL . 1.1 mp -72.2 -31.33 65.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.249 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -41.88 73.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.64 -27.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.487 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t -52.23 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.96 38.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.349 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 mt -122.31 -37.74 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.88 -34.58 39.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.434 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.856 0.36 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.434 HG22 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -139.46 178.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.29 164.0 34.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.98 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.482 ' CH2' ' HB3' ' A' ' 37' ' ' GLN . 76.1 m95 -94.8 132.72 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.419 ' CE2' HD11 ' A' ' 72' ' ' LEU . 28.0 m-85 -119.11 122.81 42.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.803 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.55 131.52 47.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.481 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.59 159.54 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.788 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -94.27 133.52 37.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.046 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.7 p -144.74 -177.5 5.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.14 140.65 29.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.62 123.91 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.52 5.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.235 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -81.57 -18.14 45.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.913 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -44.96 -40.43 6.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.286 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -37.9 80.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -33.74 64.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.58 -43.77 88.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -66.1 -35.98 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.78 -54.92 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.003 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -60.26 -31.68 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.0 tp -74.96 -57.25 4.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.91 -32.39 6.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -71.64 -41.3 68.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -68.23 -39.33 82.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.587 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.438 HG21 HD11 ' A' ' 26' ' ' ILE . 37.5 mm -64.83 -31.46 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.828 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -83.99 -30.17 26.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.65 -44.87 76.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.04 -29.77 39.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.23 43.63 3.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.449 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.84 28.9 4.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 110.825 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -69.54 -13.11 62.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.409 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 1.1 m-20 -79.75 -23.8 42.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -94.56 -56.3 2.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.843 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.01 136.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.669 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.434 ' CE2' HG22 ' A' ' 3' ' ' ILE . 20.1 m-85 -132.27 -64.13 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.449 . . . . 0.0 111.447 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.02 151.74 21.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.82 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 m -159.81 106.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.494 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -118.82 160.45 21.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.378 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 pt -103.54 131.78 21.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 37.1 Cg_endo -65.65 83.28 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.555 2.17 . . . . 0.0 112.806 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.9 p -125.06 163.28 22.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.866 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 37.2 tt0 -114.55 20.3 15.46 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.175 0.512 . . . . 0.0 112.139 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.557 ' CB ' ' HA ' ' A' ' 58' ' ' ARG . 3.2 mt-10 -160.48 167.69 26.71 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.515 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 57' ' ' VAL . 3.8 m -160.01 -48.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.702 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 m -159.81 137.63 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.938 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -148.37 160.77 42.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.046 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -114.9 124.74 52.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.73 -178.32 7.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 68.88 -68.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.39 -128.08 0.93 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.589 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.78 30.38 9.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.534 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.72 151.95 24.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.923 0.392 . . . . 0.0 110.795 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -104.07 121.8 43.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -120.43 143.62 48.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.49 135.52 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 44' ' ' GLU . 5.8 m -151.57 152.57 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.584 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.557 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . 10.1 mtt180 -150.56 127.06 10.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.579 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 43' ' ' GLU . 3.5 mttm -92.61 -163.55 1.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -133.1 100.94 5.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 63.1 mt -76.45 -31.71 58.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.652 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 61' ' ' LEU . 2.0 m-85 -140.42 67.65 31.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.557 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.39 120.19 7.89 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.63 2.22 . . . . 0.0 112.213 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 16.07 22.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.661 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.46 154.16 50.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.38 115.02 11.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.529 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 14.5 m-85 -79.83 125.01 29.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.276 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mp -134.03 112.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.142 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.4 tt0 -80.81 74.54 7.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.798 0.333 . . . . 0.0 110.936 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptp -91.24 -169.65 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.011 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -147.02 89.01 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 6' ' ' TYR . 62.6 mt -83.35 -46.09 12.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.37 -29.71 9.81 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.603 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -130.87 162.34 29.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -111.17 -28.8 8.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.961 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.06 -47.2 86.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.001 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -154.16 131.25 5.97 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.941 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.08 177.82 8.33 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.477 2.118 . . . . 0.0 112.506 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -90.09 -164.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.64 -27.16 57.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.43 -34.97 37.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.399 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -66.21 -33.75 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.8 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -31.82 72.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.743 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -72.64 -49.58 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.17 -53.85 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp-105 -58.69 -29.35 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.64 -28.13 52.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.532 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.9 p -69.58 130.4 90.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.55 0.214 . . . . 0.0 110.756 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.76 -23.8 28.04 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.418 2.078 . . . . 0.0 112.348 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.78 -27.32 55.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.619 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.0 mm -90.94 139.24 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 p -113.7 -36.21 4.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.687 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.44 -111.32 0.25 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.432 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.449 ' CE2' ' HA2' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -174.99 175.11 2.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 110.848 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.3 p -53.9 -46.41 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.644 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.449 ' HA2' ' CE2' ' A' ' 94' ' ' PHE . . . 98.07 -31.1 8.33 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.596 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.0 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.721 0.296 . . . . 0.0 111.331 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -134.66 140.64 11.92 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.532 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.3 mmt 58.73 -178.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.721 0.296 . . . . 0.0 110.943 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.453 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -87.6 -50.07 0.44 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.019 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 6.1 Cg_exo -79.05 -174.74 2.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.828 2.352 . . . . 0.0 112.226 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -150.74 72.21 8.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.06 133.94 37.69 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.524 2.149 . . . . 0.0 112.522 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mt -88.84 167.85 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.98 148.06 38.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.36 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.513 2.142 . . . . 0.0 112.277 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.97 -27.71 61.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -90.4 -33.5 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.454 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 33.5 t -60.53 -40.73 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.167 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -19.4 62.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -83.34 -44.06 15.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.96 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 109' ' ' VAL . 1.8 pp -74.96 -20.19 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.134 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' CD2' ' CZ2' ' A' ' 5' ' ' TRP . 97.4 mt -84.95 -34.01 22.54 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.863 0.363 . . . . 0.0 110.591 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -73.13 -28.23 62.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.693 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.0 t -89.51 -31.11 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.999 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 m -60.28 -64.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 149.09 55.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.722 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.2 mt -135.5 -48.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.684 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -4.06 50.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.439 -1.2 . . . . 0.0 112.439 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.813 0.34 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.432 HG22 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -79.94 -179.66 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.86 164.68 37.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.258 0.551 . . . . 0.0 111.829 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.437 ' CD1' HG13 ' A' ' 109' ' ' VAL . 79.0 m95 -89.74 129.77 36.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.858 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -112.61 108.35 17.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.286 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.42 137.56 32.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.73 158.16 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.632 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 1.1 m-70 -104.32 132.98 49.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.911 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.8 p -128.04 -173.78 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.66 131.4 41.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -59.17 115.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.41 -28.73 12.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -20.04 35.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.87 -32.62 53.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.855 0.359 . . . . 0.0 111.154 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.65 -38.64 72.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -24.11 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.97 -51.27 70.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.303 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -50.66 -41.46 55.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.41 75.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -65.31 -36.27 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mt -79.5 -54.43 5.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -43.99 -31.32 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.615 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.5 -35.81 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.686 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -79.92 -25.29 40.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.821 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.0 mm -80.73 -28.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.698 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -91.47 -30.33 16.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.33 -42.94 61.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -80.21 -28.09 38.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 58.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.39 30.96 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.97 -10.72 60.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.233 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -79.97 -24.73 40.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.739 0.304 . . . . 0.0 110.983 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -61.94 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.1 mm -79.96 111.92 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' CE2' HG22 ' A' ' 3' ' ' ILE . 12.3 m-85 -99.53 -58.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.197 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -109.29 146.14 34.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.45 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -153.81 117.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.698 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -126.1 156.61 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.973 0.416 . . . . 0.0 111.278 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.5 tt -106.76 124.68 34.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.638 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 33.9 Cg_endo -64.7 69.78 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.54 2.16 . . . . 0.0 112.758 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 p -141.61 132.6 26.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.512 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -80.06 166.01 21.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.014 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -144.89 110.41 5.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.747 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -153.38 161.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.4 m -85.21 139.05 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' CG ' HG21 ' A' ' 57' ' ' VAL . 17.2 pt-20 -109.77 -46.87 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.129 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.53 -162.89 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.918 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.92 -50.14 0.64 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.832 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 55.27 26.87 9.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.978 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.71 -46.5 2.52 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.366 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.1 44.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.432 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.15 25.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.32 0.581 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -159.62 114.11 2.34 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.757 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -160.13 -43.84 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.234 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.9 t -102.26 117.0 46.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.47 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.417 HG21 ' CG ' ' A' ' 47' ' ' GLU . 5.2 t -124.2 157.39 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.701 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -131.27 130.64 43.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.392 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.72 96.58 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.564 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -51.6 119.17 3.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.9 mt -90.1 -44.09 10.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.432 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 3.7 m-85 -115.73 91.36 29.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.23 117.75 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.909 2.406 . . . . 0.0 112.968 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.92 45.09 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.962 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.402 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -132.29 149.16 52.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.757 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.39 118.0 9.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.478 ' CE2' ' HB ' ' A' ' 112' ' ' ILE . 7.5 m-85 -88.25 133.9 33.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.795 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mt -135.37 111.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.128 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.47 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 7.8 tt0 -79.65 67.22 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.418 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.8 ptm -91.2 -168.6 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.279 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -145.6 108.56 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.777 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 mt -79.92 -68.16 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.33 -66.62 2.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.426 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.54 158.37 29.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.53 -29.98 7.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.029 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.59 -66.71 0.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.984 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -121.91 138.03 28.13 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.76 166.6 28.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.464 2.109 . . . . 0.0 112.345 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.83 173.55 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -59.14 -25.16 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.36 -50.55 67.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.306 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.415 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.0 t-105 -58.3 -42.02 85.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -59.85 -30.87 69.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.1 t -84.07 -52.34 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.13 -49.03 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.46 -11.87 61.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.251 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.83 -17.18 15.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.872 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.7 p -56.47 147.58 48.64 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.717 0.294 . . . . 0.0 110.985 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.48 109.73 1.89 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.587 2.192 . . . . 0.0 112.258 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.56 10.42 9.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.722 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -115.29 140.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 111.04 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -141.16 15.72 2.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.539 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.19 -83.45 0.02 OUTLIER Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.237 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 9' ' ' HIS . 2.3 m-85 66.68 13.01 9.17 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.7 m -89.98 65.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.739 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.82 -11.99 61.42 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.985 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.93 66.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.969 0.414 . . . . 0.0 111.117 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.84 24.38 7.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.6 mtt 62.6 -80.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.806 0.336 . . . . 0.0 110.969 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.43 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -57.29 161.47 5.39 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.878 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 100' ' ' ARG . 85.6 Cg_exo -42.89 141.62 2.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.78 2.32 . . . . 0.0 112.572 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.8 t -99.92 102.3 17.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.76 150.38 27.29 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.145 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.06 153.91 20.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.6 p -80.97 161.16 64.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.06 -26.89 77.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.696 2.264 . . . . 0.0 112.323 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.85 -31.87 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -88.0 -35.22 17.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 5' ' ' TRP . 58.3 t -58.68 -48.92 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -25.16 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.99 -38.84 26.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.478 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 14.4 pt -78.09 -26.95 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.7 mt -82.11 -26.91 33.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -70.67 -30.09 66.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.9 t -82.6 -38.02 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -62.76 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.21 45.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.557 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.0 mt -128.16 -54.23 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.794 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.37 -31.75 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.503 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.841 0.353 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.431 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -138.89 -173.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.743 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.89 159.91 41.26 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 111.705 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.458 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 69.2 m95 -101.05 111.51 23.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 18.9 m-85 -94.96 124.43 39.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.817 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.53 143.67 29.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.434 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 t -140.65 162.03 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.073 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -86.79 155.87 20.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.271 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.417 ' CG2' ' CD2' ' A' ' 66' ' ' LEU . 28.6 p -146.56 -176.64 5.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.65 127.81 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.811 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -59.24 102.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.097 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.97 -17.67 27.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.631 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -112.87 2.21 15.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -54.96 -45.07 74.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.822 0.344 . . . . 0.0 111.071 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -54.12 -61.54 2.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -66.08 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.99 -47.43 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.85 0.357 . . . . 0.0 111.05 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -55.53 -41.03 72.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.14 80.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.41 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 mt -83.07 -60.72 2.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -37.53 -34.68 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.778 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -72.85 -51.23 19.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.422 ' NH1' ' CZ ' ' A' ' 29' ' ' PHE . 1.2 mtt-85 -69.31 -24.96 64.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 mm -73.38 -31.06 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.561 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -32.91 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.35 -29.52 65.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.022 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.422 ' CZ ' ' NH1' ' A' ' 25' ' ' ARG . 5.5 m-85 -80.55 -39.59 27.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.78 67.72 0.8 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.947 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.86 34.86 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -13.26 61.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.407 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.64 -22.69 43.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.881 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.5 -49.71 8.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.59 149.48 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.431 ' CE2' HG23 ' A' ' 3' ' ' ILE . 7.8 m-85 -140.12 -47.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.252 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.416 ' HB3' ' CH2' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -118.01 157.53 26.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.098 0.475 . . . . 0.0 111.703 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m -156.56 102.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.566 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -113.23 152.84 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.2 mt -99.24 127.03 35.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.54 78.56 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.536 2.158 . . . . 0.0 112.388 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.0 p -143.95 167.19 22.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -123.39 107.36 11.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -95.15 137.37 34.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 m -156.22 144.35 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.01 163.05 27.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.269 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -126.43 137.49 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.85 88.91 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.44 150.63 20.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -82.28 111.56 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.964 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.74 -34.56 0.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.546 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.58 40.2 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.473 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -136.35 162.66 32.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.47 124.56 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -114.65 116.6 28.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.6 t -110.98 108.5 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.048 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.5 m -123.42 138.27 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.241 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.67 125.24 9.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -113.0 172.95 6.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.762 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -100.73 120.07 39.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.222 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 44.6 mt -76.0 -44.91 37.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.458 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -118.9 70.16 9.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.427 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.85 139.07 83.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.754 2.303 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.5 15.39 79.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.19 160.49 37.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.839 0.352 . . . . 0.0 111.179 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.417 ' CD2' ' CG2' ' A' ' 10' ' ' THR . 0.6 OUTLIER -144.91 131.15 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -93.6 123.41 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.2 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.14 116.43 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' HG3' ' NE1' ' A' ' 5' ' ' TRP . 5.7 tt0 -79.74 69.89 6.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.6 ptp -91.0 -166.55 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.811 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -160.06 96.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.363 . . . . 0.0 110.889 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.427 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 51.9 mt -83.03 -30.4 28.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.762 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.55 -63.0 4.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.55 146.67 23.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -92.59 -26.53 17.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.98 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -57.07 -78.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.968 0.413 . . . . 0.0 111.065 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -117.69 121.33 31.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.64 176.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.07 -170.2 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.974 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -29.05 68.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.86 -27.98 20.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.475 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -78.98 -33.39 45.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.039 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -62.15 -29.73 70.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG21 ' CD2' ' A' ' 29' ' ' PHE . 20.9 t -82.96 -40.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.9 t -67.05 -45.72 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -15.82 62.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.308 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.0 -18.61 9.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.028 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.19 134.17 87.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.783 0.291 . . . . 0.0 110.945 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.3 -30.05 89.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.47 2.114 . . . . 0.0 112.28 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.06 -33.28 60.59 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.701 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.1 mm -79.92 127.19 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.03 31.27 1.99 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.84 167.07 30.67 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.447 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.423 ' CD2' ' HG2' ' A' ' 100' ' ' ARG . 18.5 p90 -162.19 179.09 8.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.885 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.23 -67.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.997 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.27 -145.54 16.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.511 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 63.21 -81.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.719 0.295 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -162.26 27.32 0.25 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.581 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.77 98.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.539 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 10.6 mtm-85 -57.86 -53.44 65.77 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.279 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 34.2 Cg_endo -64.49 148.45 90.64 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.292 1.994 . . . . 0.0 112.296 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.8 m -145.15 89.01 6.56 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.81 133.01 26.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.49 2.127 . . . . 0.0 112.218 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.74 159.07 20.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.048 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m -81.2 160.43 65.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.79 -24.86 79.98 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.374 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.44 -37.12 63.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.052 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.37 -37.35 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.8 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.458 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 94.8 t -58.54 -38.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.19 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -25.92 65.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -74.69 -50.62 16.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.707 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 pp -68.16 -16.78 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.422 HD12 ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -79.05 -41.76 28.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -33.16 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.793 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.5 t -73.46 -30.93 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.989 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -70.02 -58.77 3.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 140.97 59.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.4 mt -133.14 -56.7 0.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -50.93 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.535 179.973 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.889 0.376 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -137.74 -171.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.702 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -131.35 148.13 52.64 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.325 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 79.5 m95 -99.95 94.4 6.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.004 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 77.7 m-85 -84.15 126.62 33.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -104.39 124.78 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.5 p -108.37 159.46 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.193 0.52 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.479 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 21.1 m-70 -96.98 119.11 34.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.6 p -121.84 169.88 10.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -84.84 153.61 22.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.34 120.86 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.31 21.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.529 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -86.0 -25.63 25.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.16 -45.16 79.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 0.0 111.047 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.05 -42.42 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.61 -28.63 45.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.98 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.39 80.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -61.61 -50.87 70.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.63 81.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.1 -37.77 77.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.83 -54.76 5.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.52 -30.54 20.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -44.44 43.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.753 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -73.8 -27.6 61.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 26' ' ' ILE . 36.5 mm -85.98 -16.27 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -108.06 -29.94 8.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.14 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.87 25.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.175 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' CD2' ' HG3' ' A' ' 25' ' ' ARG . 71.1 m-85 -79.88 -2.99 46.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.335 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 77.47 0.74 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.751 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -134.99 30.96 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.962 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -77.51 6.18 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.338 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.5 -25.27 22.66 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.739 0.304 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -106.14 -58.0 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mm -81.86 110.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.808 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 20.5 m-85 -100.81 -53.15 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.216 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.6 157.43 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 0.0 111.646 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -148.54 67.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.271 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.36 156.8 26.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.429 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.2 tp -113.78 131.42 23.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.708 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 43.5 Cg_endo -67.86 74.18 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.335 2.024 . . . . 0.0 112.548 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.0 p -131.65 133.89 45.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -89.6 154.08 20.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.662 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.26 138.47 50.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.045 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.66 162.12 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.962 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 m -87.45 -31.72 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.44 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.2 167.33 22.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.047 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.03 52.39 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.833 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.49 129.12 4.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.01 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -27.04 62.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.788 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -178.65 53.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.3 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.81 -76.04 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.611 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -127.1 175.39 8.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 0.0 110.951 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -141.89 109.35 5.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -140.47 163.45 32.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.3 p -80.42 123.32 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.39 179.12 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.87 159.91 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -159.93 100.33 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.747 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -53.81 120.54 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.217 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.18 -40.65 12.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 32.8 m-85 -123.12 76.38 51.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 46.7 Cg_exo -56.28 141.39 88.66 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.636 2.224 . . . . 0.0 112.496 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.08 20.41 76.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.709 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 96.3 m-85 -131.02 145.02 51.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.21 122.1 22.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.527 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 17.5 m-85 -84.73 115.07 22.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.59 108.81 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.055 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.422 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 3.0 tt0 -79.85 74.3 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.54 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.1 ptp -91.19 -174.35 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.128 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.435 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.7 t0 -125.47 78.15 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt -95.96 -46.34 6.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.52 -112.96 4.21 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.501 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -96.68 -177.61 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.95 31.38 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.988 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -74.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -156.15 97.99 2.21 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.61 165.2 32.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.62 2.213 . . . . 0.0 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.87 178.89 7.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -61.86 -18.79 61.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.241 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.74 -46.72 64.13 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.387 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -59.39 -43.79 92.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.44 -30.17 69.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.674 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.41 ' CG1' ' HG2' ' A' ' 25' ' ' ARG . 34.5 t -71.34 -49.51 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -61.23 -45.31 98.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -59.75 -23.12 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.64 -32.86 8.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.756 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.58 146.76 79.38 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.27 -25.07 26.62 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.412 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.74 -25.45 43.95 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.643 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.8 mm -89.25 141.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 p -131.3 44.74 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.993 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.5 -122.81 7.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.588 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 99' ' ' MET . 0.6 OUTLIER -154.82 -177.13 6.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.336 . . . . 0.0 110.949 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 13.9 p -56.1 -35.68 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.16 12.18 14.37 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.721 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.95 -29.55 64.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.786 0.327 . . . . 0.0 110.992 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -84.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.53 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.41 ' HA ' ' CE2' ' A' ' 94' ' ' PHE . 1.5 mtp -150.59 -46.57 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.835 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.8 ptt-85 -73.95 154.4 88.85 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.63 -166.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.584 2.189 . . . . 0.0 112.061 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 m -143.0 99.37 5.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.01 135.17 16.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.128 . . . . 0.0 112.327 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mt -72.65 169.36 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.6 m -89.14 145.84 35.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.723 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.24 -33.34 97.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.54 2.16 . . . . 0.0 112.393 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.96 -32.91 67.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -34.46 26.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.492 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 48.9 t -57.33 -45.63 85.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -29.99 40.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.15 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -74.93 -52.4 11.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.542 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.435 HD12 ' CD2' ' A' ' 67' ' ' PHE . 11.6 pt -67.85 -19.38 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 mp -77.17 -38.38 51.82 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.479 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -69.67 -27.67 65.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.4 t -86.68 -31.97 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -64.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.89 43.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.662 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.5 mt -120.04 -47.39 2.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.96 -36.55 6.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.351 -1.25 . . . . 0.0 112.485 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.71 -176.31 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.91 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 159.37 39.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.386 0.612 . . . . 0.0 112.481 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 89.7 m95 -97.42 91.77 5.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.476 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 62.7 m-85 -83.67 111.17 18.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.353 . . . . 0.0 110.737 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.48 159.04 16.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.35 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.91 162.99 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.897 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.415 ' CD2' ' HA ' ' A' ' 95' ' ' VAL . 14.1 m-70 -101.3 149.42 24.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.1 p -149.36 -174.36 4.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.1 141.79 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.98 120.04 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.38 -29.42 10.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -85.71 -23.41 27.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.791 0.329 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -54.84 -34.91 63.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.38 -47.14 79.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.011 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -75.7 -27.13 58.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.84 85.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.195 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -47.25 -48.25 24.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.05 73.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.946 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -67.16 -49.79 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.94 -62.45 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -42.84 -31.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.623 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.25 -39.6 25.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.861 0.363 . . . . 0.0 110.474 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.22 51.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.63 -27.12 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.692 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.45 -31.99 11.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.027 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.06 -46.05 68.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.96 -16.97 54.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.76 49.83 4.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.29 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.68 24.57 5.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -80.3 19.4 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.241 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.2 -21.32 16.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -116.49 -49.22 2.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.797 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.4 mp -79.9 125.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.876 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -116.07 -62.13 1.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.471 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -106.71 156.01 19.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 111.224 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.36 73.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.9 139.44 37.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.277 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -96.43 118.55 65.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.702 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 27.2 Cg_endo -62.31 90.03 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.352 2.034 . . . . 0.0 112.565 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.0 p -135.59 154.98 51.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -84.64 -171.47 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -145.42 130.64 18.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.791 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.55 159.75 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.16 129.45 75.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.99 159.05 42.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.9 mt -124.18 152.97 42.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -127.07 10.95 6.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.438 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 55.21 40.1 31.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.779 0.323 . . . . 0.0 110.997 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.4 121.38 4.4 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.91 -28.85 3.63 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.21 -170.57 3.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.903 0.382 . . . . 0.0 110.908 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.06 177.64 5.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 pm0 -100.37 26.22 6.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -99.06 79.71 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.183 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 t -102.18 160.17 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.32 177.22 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.11 -160.46 0.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.653 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -112.55 113.14 25.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 111.102 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 4.9 mt -90.26 -57.62 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.651 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 69.9 m-85 -119.18 87.54 35.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.603 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.37 115.34 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.673 2.249 . . . . 0.0 112.624 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.05 19.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.788 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -138.03 147.82 44.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.069 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mp -145.5 112.91 6.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 5.1 m-85 -84.96 126.13 33.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 111.201 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.36 115.61 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 1.9 tp-100 -79.75 71.73 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 0.0 110.354 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.423 ' HG3' ' HG ' ' A' ' 72' ' ' LEU . 4.6 ptm -91.56 -177.93 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -121.51 82.84 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 13.7 mt -117.66 -37.44 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.42 106.68 0.71 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.516 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -162.71 -67.46 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.005 0.431 . . . . 0.0 110.843 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 179.69 -38.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.316 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -77.89 -154.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.597 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -131.82 149.0 72.17 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.32 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.21 108.1 2.41 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.697 2.264 . . . . 0.0 112.275 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -90.15 -77.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -54.06 -64.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.604 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.59 -32.85 5.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.853 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.7 t-105 -87.44 -29.23 21.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.141 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.81 -29.55 70.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.0 -49.25 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -60.15 -41.24 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.33 -21.85 60.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.02 10.3 37.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.114 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.22 135.93 29.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.814 0.307 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.56 120.6 8.5 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.077 . . . . 0.0 112.258 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.24 -8.96 9.6 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.944 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.86 79.64 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 111.082 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -60.95 -43.89 98.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.95 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.07 -135.7 1.89 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.561 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -148.99 -176.23 5.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.79 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 38.3 t -54.73 -68.64 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 115.1 28.63 2.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.595 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.62 100.89 4.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.892 0.377 . . . . 0.0 111.014 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.61 -82.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.335 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.2 mtp -100.02 166.42 11.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.753 0.311 . . . . 0.0 110.623 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -68.69 -47.96 32.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.934 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.1 Cg_exo -66.92 -179.53 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.647 2.232 . . . . 0.0 112.151 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.12 81.86 2.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.9 124.7 9.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.68 172.19 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.0 p -90.17 147.78 37.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -50.82 -29.39 26.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.605 2.204 . . . . 0.0 112.261 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.91 -42.43 39.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -74.02 -38.27 64.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.495 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 40.1 t -59.07 -42.53 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -57.54 -31.37 66.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.954 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -56.08 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 67' ' ' PHE . 21.8 pt -63.56 -24.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.9 mp -72.71 -38.9 67.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.18 -33.03 67.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.0 t -79.37 -37.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.2 t -58.46 -63.5 1.26 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.66 54.94 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.537 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 17.6 mt -133.02 -54.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.37 -31.36 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.405 -1.219 . . . . 0.0 112.535 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.789 0.328 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.457 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -135.6 -165.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.36 150.14 24.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 112.232 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 75.1 m95 -86.09 92.43 8.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.446 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 40.1 m-85 -84.23 114.53 21.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.403 . . . . 0.0 110.87 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.28 154.73 19.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.567 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.35 179.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 16.1 m-70 -130.75 149.86 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.2 p -145.96 -173.84 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.83 149.83 22.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.45 124.45 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -24.77 27.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.624 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.54 -22.73 17.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.0 111.077 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -54.49 -35.56 63.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.19 -30.97 68.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.91 -28.84 18.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -42.05 81.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.094 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -59.77 -38.21 81.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 -44.93 28.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -60.75 -35.08 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 67.5 tp -73.78 -57.91 3.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -29.71 15.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -41.94 71.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.75 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -70.23 -36.89 74.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.415 HD12 HG21 ' A' ' 26' ' ' ILE . 29.8 mm -74.5 -29.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.93 -36.6 14.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.177 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.95 -44.74 72.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.32 -26.62 35.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.63 70.43 1.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mt -123.3 38.93 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.2 -1.12 24.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.538 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.72 -25.22 41.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -55.05 2.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.4 mm -82.99 127.92 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.636 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 3' ' ' ILE . 23.3 m-85 -120.57 -64.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -102.89 122.29 44.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.433 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 m -114.83 77.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 116' ' ' SER . 2.6 tm? -91.76 127.59 37.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.95 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 42' ' ' THR . 3.4 pt -102.67 128.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.494 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 78.1 Cg_exo -52.2 69.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.991 2.461 . . . . 0.0 113.216 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 40' ' ' ILE . 68.2 p -158.98 136.18 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.525 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -104.1 105.78 16.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.38 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.3 135.88 44.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.31 122.89 54.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 t -110.89 30.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -176.08 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.42 -169.55 3.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.842 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -170.54 2.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.804 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.81 88.52 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.57 -117.35 0.52 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.484 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -163.33 41.0 0.33 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.41 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -142.77 157.73 44.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.925 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.94 138.11 31.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.61 -169.33 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -144.97 109.41 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.3 t -144.22 159.89 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.94 139.41 23.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.064 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -117.63 121.03 39.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.533 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -67.2 117.63 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.042 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 11.0 mt -81.81 -52.71 6.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 41' ' ' PRO . 2.9 m-85 -129.91 86.89 53.53 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.5 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 147.99 89.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.788 2.325 . . . . 0.0 112.596 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.6 9.1 64.54 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.078 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 22.4 m-85 -119.08 161.97 19.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.977 0.417 . . . . 0.0 111.058 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.49 112.56 3.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.415 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 112' ' ' ILE . 5.9 m-85 -89.44 122.23 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.25 110.49 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.999 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.677 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.74 74.87 6.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.301 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.9 ptm -91.36 -173.19 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.136 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -126.7 82.86 2.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 62.5 mt -90.78 7.39 39.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.497 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.82 92.58 1.22 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.549 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -152.44 -46.3 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.335 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -152.29 -176.85 5.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.994 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.08 -32.64 74.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.93 148.5 35.68 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.83 139.32 36.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.634 2.223 . . . . 0.0 112.26 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.54 178.54 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -58.93 -23.61 61.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.59 -49.33 67.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.328 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -66.3 -35.09 79.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -60.24 -31.44 70.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.09 -46.96 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.3 t -59.8 -49.32 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -70.82 -18.1 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.031 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.02 -22.67 44.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.793 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 54.4 p -54.1 108.38 1.12 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.586 0.231 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.27 119.27 5.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.77 15.86 19.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.704 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.47 HD12 HG23 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -113.67 121.5 65.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 110.926 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -80.17 -64.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.826 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.13 157.95 21.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.595 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 63.66 -169.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.46 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 10.4 m -90.0 -29.74 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.16 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 115.27 -52.12 0.68 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.433 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.92 -30.32 65.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -95.93 -133.52 7.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.562 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.1 mtp -148.52 -64.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.57 155.32 92.66 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.863 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.12 178.87 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.627 2.218 . . . . 0.0 112.078 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.37 96.76 8.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.87 125.55 12.22 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.377 2.052 . . . . 0.0 112.207 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.69 158.87 11.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.044 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m -89.96 147.36 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.89 -31.31 42.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.436 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -31.38 69.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.974 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.09 -31.08 13.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.471 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 22.0 t -66.39 -29.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.213 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -39.38 93.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -52.28 29.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.566 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.428 HG21 ' CE2' ' A' ' 67' ' ' PHE . 2.0 pp -65.06 -21.4 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.69 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.419 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 7.5 mt -69.05 -34.8 75.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -59.66 -22.07 61.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.994 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.6 t -73.89 -56.58 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.243 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.406 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -51.4 -48.46 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.06 21.01 3.57 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.808 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.419 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -83.67 -27.7 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.709 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.19 -42.06 4.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.813 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.473 -179.948 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.411 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -141.68 -165.29 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -157.88 152.11 24.49 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.217 0.532 . . . . 0.0 111.789 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 87.1 m95 -94.97 92.72 7.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.568 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 40.1 m-85 -81.48 113.13 19.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 110.786 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -93.84 146.68 23.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.445 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.2 p -123.34 159.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.727 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 5.1 m170 -117.27 103.39 10.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.933 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 p -110.08 -174.29 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.96 150.99 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -71.35 126.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.11 26.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.575 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -23.54 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.064 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.48 -33.43 63.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.059 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.87 -34.74 68.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.07 -28.49 20.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.57 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.093 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -38.51 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.27 79.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.022 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -61.62 -32.02 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.2 tp -76.17 -57.65 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -28.94 10.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.47 -41.63 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -37.7 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 mm -72.53 -30.41 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -89.81 -33.72 16.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.7 -40.01 66.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.91 -26.73 27.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.2 47.51 3.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mt -99.92 40.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.25 -6.38 49.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.406 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.81 -26.12 40.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.995 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.53 -55.38 3.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.715 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.1 mm -88.2 122.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.81 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 10.3 m-85 -112.68 -54.37 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.435 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -111.4 156.5 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.5 t -156.4 75.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.122 179.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.04 168.06 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.712 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.25 139.41 31.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.805 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 72.3 Cg_endo -77.1 86.4 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.711 2.274 . . . . 0.0 113.202 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.44 ' O ' ' CG1' ' A' ' 115' ' ' VAL . 24.3 p -138.07 128.97 27.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.14 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.595 ' HA ' ' CG1' ' A' ' 115' ' ' VAL . 1.1 tt0 -91.27 22.11 4.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.285 0.564 . . . . 0.0 112.098 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HB3' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -160.83 164.59 31.25 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.395 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' VAL . 1.9 t -144.62 168.7 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.25 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.06 126.7 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.49 -177.26 6.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -82.37 139.53 34.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.15 60.82 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.788 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -135.88 -69.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.03 42.76 1.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.45 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.2 -81.19 0.12 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -160.04 152.82 21.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.07 108.63 13.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.8 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -157.21 170.54 22.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.8 t -153.94 -38.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.76 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 44' ' ' GLU . 29.3 m -156.1 -173.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.7 0.286 . . . . 0.0 111.003 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.567 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . 10.2 mtt180 -122.74 146.08 47.83 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.053 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.6 82.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.362 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -48.53 108.67 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.691 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' CG ' ' HB2' ' A' ' 43' ' ' GLU . 71.1 mt -79.6 -31.88 41.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.471 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 26.7 m-85 -132.06 69.62 80.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.434 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.01 134.6 60.52 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.681 2.254 . . . . 0.0 112.608 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.31 -2.37 82.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.485 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 3.1 m-85 -106.26 110.87 23.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.946 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -101.27 122.28 43.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.488 179.714 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 41' ' ' PRO . 12.9 m-85 -89.66 119.68 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.73 106.8 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.417 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 8.2 tt0 -79.83 72.99 6.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.434 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -91.11 -174.83 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.194 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.458 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.9 t0 -131.01 110.36 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.447 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 34.8 mt -104.72 -34.32 8.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.49 -71.73 2.88 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -124.42 167.89 13.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.873 0.368 . . . . 0.0 111.0 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -97.78 -23.6 15.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.065 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -54.27 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.087 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -113.25 93.54 26.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.957 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.45 166.42 2.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.556 2.171 . . . . 0.0 112.235 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -83.52 173.28 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -59.15 -25.44 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.04 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.48 -42.63 74.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.213 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -63.67 -44.01 95.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.95 -37.57 77.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.83 -45.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 t -64.34 -41.04 91.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -22.84 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.036 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.79 -24.27 30.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 78.0 p -58.2 115.99 13.22 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.57 0.224 . . . . 0.0 110.899 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 131.07 39.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.411 2.074 . . . . 0.0 112.293 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.14 59.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.836 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.3 tp -79.94 108.06 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.979 0.418 . . . . 0.0 111.201 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -113.73 93.27 4.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.754 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.56 112.54 5.07 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.628 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.465 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 1.5 t80 61.85 152.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.938 0.399 . . . . 0.0 111.045 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.6 m -57.2 -30.54 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.0 64.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.362 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.83 100.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.801 0.334 . . . . 0.0 111.149 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.77 -132.4 11.24 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.552 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.66 150.1 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.749 0.309 . . . . 0.0 110.85 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.461 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 71.1 mtt85 -68.0 -57.18 9.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 51.4 Cg_endo -68.77 136.44 35.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.096 . . . . 0.0 112.248 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.78 87.31 25.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.22 130.38 23.94 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.53 2.154 . . . . 0.0 112.222 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mt -79.16 163.95 24.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.0 t -86.82 140.81 33.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.8 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.78 -30.5 23.2 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 0.0 112.529 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -43.07 73.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.18 -30.53 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.487 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 26.4 t -61.29 -44.11 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -29.03 69.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -76.29 -45.33 33.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.786 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.445 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 20.0 pt -71.88 -26.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.882 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.8 mt -76.86 -36.26 56.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.397 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.65 -27.45 67.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.595 ' CG1' ' HA ' ' A' ' 43' ' ' GLU . 25.3 t -77.19 -41.98 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.55 -62.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.074 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 151.08 44.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.559 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mt -119.59 -52.87 2.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.807 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -31.07 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.496 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.831 0.348 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.426 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -137.52 -169.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.796 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -141.19 151.57 43.91 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 112.068 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' A' ' 69' ' ' GLN . 84.6 m95 -98.92 93.61 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.421 ' CZ ' HD11 ' A' ' 72' ' ' LEU . 50.5 m-85 -85.51 126.07 33.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.886 0.374 . . . . 0.0 110.772 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -105.69 142.2 35.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.598 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.71 150.67 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.629 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.42 ' CD2' HG21 ' A' ' 95' ' ' VAL . 11.5 m-70 -94.25 147.88 22.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.969 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -141.01 177.06 8.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.01 141.38 28.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -70.17 104.89 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.41 -27.44 5.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -101.89 -17.39 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 111.206 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.52 -38.73 64.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.103 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -42.63 73.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.943 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.06 92.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -56.55 20.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.57 98.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.55 -43.23 97.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 tp -72.62 -48.79 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -24.76 61.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.072 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -81.82 -44.56 16.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.3 mmt85 -68.84 -24.99 64.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.204 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -69.45 -28.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.737 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -91.45 -33.65 15.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.971 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.82 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.063 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -79.94 -37.81 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.23 65.26 0.84 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.739 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.57 27.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 0.0 110.881 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -11.71 61.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.3 m-20 -79.7 -29.66 40.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.824 0.345 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -77.16 -49.84 14.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -84.78 109.05 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.6 179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.1 m-85 -94.08 -52.77 4.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.439 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 69' ' ' GLN . 2.0 mt-30 -111.99 156.36 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.79 -179.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.9 m -153.1 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.967 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.57 142.29 29.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.535 -179.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.04 127.56 38.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.604 179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.427 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 26.1 Cg_endo -62.18 75.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.554 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.8 p -137.35 142.44 41.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.27 109.39 20.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.818 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -95.7 128.43 42.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.943 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.3 117.52 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.5 m -141.79 144.26 25.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -152.95 165.92 34.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.659 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.93 39.5 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.986 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.1 165.25 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.86 90.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.49 -121.4 6.73 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.472 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.85 -44.86 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.44 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -159.93 173.48 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.846 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.7 -169.25 1.49 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -93.18 129.82 39.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.1 m -98.76 110.47 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.125 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.65 159.71 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 125.3 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.004 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -112.58 175.83 5.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -92.61 121.7 34.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.23 -49.51 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.728 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.427 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 35.6 m-85 -102.06 97.89 9.18 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.41 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.49 124.46 16.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.547 2.165 . . . . 0.0 112.509 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.71 42.97 99.58 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.83 151.58 48.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.985 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 11.3 mt -147.09 114.23 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.666 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 41' ' ' PRO . 8.4 m-85 -90.33 123.15 33.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.47 113.93 31.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.21 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 4.5 tt0 -80.87 72.88 7.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.5 ptp -91.35 -169.36 2.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.99 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.57 80.2 1.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.771 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.421 HD11 ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt -83.39 -71.55 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.74 26.09 16.55 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.657 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.16 137.91 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.777 0.322 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.92 -33.75 14.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.31 -77.65 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.28 117.08 6.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.783 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -65.67 66.64 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.65 2.234 . . . . 0.0 112.192 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -55.7 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.03 -82.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.04 84.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -83.61 -30.16 27.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -61.62 -31.8 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.8 t -82.57 -44.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.9 t -60.54 -49.98 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.56 -24.52 61.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.72 70.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.827 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.0 120.33 80.41 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.802 0.301 . . . . 0.0 110.7 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.26 -14.18 43.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.475 2.117 . . . . 0.0 112.479 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.56 25.67 21.81 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.626 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -113.51 123.85 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 110.873 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -151.0 108.75 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.999 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.87 -91.87 0.12 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.414 ' N ' ' HB2' ' A' ' 9' ' ' HIS . 59.3 t80 59.52 159.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.886 0.374 . . . . 0.0 110.847 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.42 HG21 ' CD2' ' A' ' 9' ' ' HIS . 21.2 t -63.62 139.27 21.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.241 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.72 44.92 2.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.448 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.92 -47.34 3.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.152 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.57 -126.84 0.89 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.506 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.67 -35.53 4.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 0.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -82.91 147.76 55.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.96 163.95 31.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.538 2.159 . . . . 0.0 112.17 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 t -125.41 116.41 25.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.32 171.38 17.83 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.452 2.101 . . . . 0.0 112.16 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 67' ' ' PHE . 3.2 mp -89.88 157.42 17.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.895 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.0 m -80.36 150.67 71.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.2 -31.58 22.3 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.598 2.199 . . . . 0.0 112.43 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -45.32 24.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.09 -32.58 69.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 112' ' ' ILE . 72.0 t -61.87 -52.41 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.008 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -24.62 66.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.731 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -76.93 -51.27 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.683 179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 109' ' ' VAL . 2.2 pp -69.78 -15.62 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -36.31 35.94 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.682 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -80.56 -34.88 35.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.8 t -75.38 -46.35 38.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.004 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 72.4 m -60.75 -51.17 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.689 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 135.43 64.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.627 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.8 mt -136.74 -49.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.891 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -51.99 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.854 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.333 -1.259 . . . . 0.0 112.482 -179.967 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.945 0.402 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.53 -177.41 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -160.05 160.79 33.59 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 112.134 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.45 ' CH2' ' CB ' ' A' ' 37' ' ' GLN . 89.6 m95 -91.76 90.87 7.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.446 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 58.5 m-85 -83.67 108.72 16.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.11 148.87 27.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.44 -178.9 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.072 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.451 ' ND1' ' CD2' ' A' ' 94' ' ' PHE . 27.9 m-70 -107.94 137.38 46.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -130.9 -178.62 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.73 120.44 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.5 119.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.072 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -28.83 11.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -0.34 43.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.57 -43.32 25.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.823 0.344 . . . . 0.0 111.224 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -37.89 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.018 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.6 -28.49 20.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.794 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -61.06 2.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -63.02 -38.62 91.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.86 94.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.45 -39.41 93.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.636 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.1 tp -66.47 -51.89 52.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.69 -31.58 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.0 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.31 -41.86 69.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -70.5 -37.21 74.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.66 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.4 mm -70.07 -30.35 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.849 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -88.58 -33.32 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.54 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.9 -35.56 32.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 85.96 1.27 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.69 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.09 48.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.31 -7.77 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.358 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 p-10 -79.62 -20.16 47.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.956 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -96.05 -55.55 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.614 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.464 HD12 HG23 ' A' ' 35' ' ' ILE . 32.6 mt -91.36 130.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 33' ' ' ASP . 20.5 m-85 -121.57 -54.8 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.717 -179.369 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.45 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mm100 -117.12 158.38 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 112.345 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.8 t -157.18 83.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.84 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.94 164.0 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.274 0.559 . . . . 0.0 112.207 -178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.83 69.93 16.82 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.094 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HG2' ' CE2' ' A' ' 67' ' ' PHE . 72.5 Cg_exo -41.07 115.45 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.273 2.649 . . . . 0.0 113.749 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.2 p -124.86 162.91 23.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.052 179.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -79.8 131.28 35.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.78 0.324 . . . . 0.0 110.647 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -135.43 117.17 15.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 m -154.82 159.83 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.311 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.13 154.01 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.03 -66.95 0.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.19 128.13 37.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -156.26 31.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.964 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.81 -65.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.95 76.75 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.562 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.62 -60.4 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.2 176.2 11.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.302 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -137.59 109.86 7.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -122.81 -177.75 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.5 p -160.12 104.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.005 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 58' ' ' ARG . 1.5 p -87.63 158.47 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.134 0.493 . . . . 0.0 111.038 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.47 ' N ' ' CG2' ' A' ' 57' ' ' VAL . 66.6 mtp180 -140.93 151.4 44.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.158 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -141.43 -154.07 0.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.426 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 119.71 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.3 mt -83.25 -42.61 17.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.364 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 41' ' ' PRO . 26.7 m-85 -122.99 74.32 48.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.873 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.95 142.8 93.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.596 2.197 . . . . 0.0 112.246 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.31 25.23 18.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.625 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.96 112.58 10.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.7 130.08 56.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.477 ' CE2' ' HG2' ' A' ' 41' ' ' PRO . 13.8 m-30 -92.48 130.9 38.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.723 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -130.39 111.46 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.211 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -79.72 70.86 6.31 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 ptm -91.55 -175.84 4.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.293 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -124.11 86.86 2.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.446 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 13.2 mt -79.87 -32.93 40.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.37 -104.95 3.2 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.579 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -123.15 -169.55 1.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.838 0.351 . . . . 0.0 111.022 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.17 -18.77 63.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.31 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.22 -174.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.0 111.157 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.91 140.6 54.28 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.785 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.33 173.5 14.39 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.457 2.105 . . . . 0.0 112.436 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.99 -165.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -24.0 54.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.89 -44.62 63.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.369 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.9 t-105 -73.56 -30.19 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -37.7 86.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.06 -40.18 78.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.097 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.4 t -67.14 -45.63 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -63.23 -17.92 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.98 -28.32 8.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.796 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.3 p -58.75 155.84 28.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.24 -25.29 31.15 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.51 -26.24 51.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.59 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.0 mm -90.99 124.62 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.73 -57.81 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.896 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.06 100.2 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.39 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CD2' ' ND1' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -170.51 -159.01 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.465 0.174 . . . . 0.0 110.756 -179.775 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.0 t -42.63 -74.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.743 0.306 . . . . 0.0 111.805 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -91.13 0.17 75.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.645 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -95.67 35.98 1.32 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.805 0.336 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.19 -48.07 0.55 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.441 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -94.04 -178.57 4.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.701 0.286 . . . . 0.0 110.828 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 -58.9 109.21 1.7 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.25 172.07 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.519 2.146 . . . . 0.0 112.309 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 t -128.95 122.97 21.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.22 142.59 15.23 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.529 2.153 . . . . 0.0 112.405 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 mt -74.54 168.96 18.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.79 142.83 29.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.93 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.01 -51.24 11.29 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.569 2.179 . . . . 0.0 112.615 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -56.95 -28.19 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -89.99 -36.29 15.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.414 HG13 ' CD1' ' A' ' 5' ' ' TRP . 30.3 t -57.42 -33.13 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.361 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -27.98 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.052 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.96 -34.59 26.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.904 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.468 ' CD1' ' CE2' ' A' ' 67' ' ' PHE . 15.2 pt -81.48 -19.11 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.122 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.416 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 29.9 mt -84.99 -25.08 27.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.719 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.35 -32.91 58.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.81 -37.47 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.54 -52.86 63.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.87 38.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.897 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.416 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 15.8 mt -117.72 -55.68 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.34 -42.82 14.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.516 179.994 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.844 0.354 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.7 170.84 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -154.96 165.77 35.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 92.4 m95 -86.56 91.34 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.727 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 79.8 m-85 -87.08 116.42 25.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.422 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -103.5 146.84 27.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.023 0.439 . . . . 0.0 111.763 -179.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.3 p -117.13 159.33 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.584 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.468 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 2.1 m-70 -107.01 142.21 37.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.932 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.5 p -155.12 174.8 14.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.81 162.35 15.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.62 125.85 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.72 -32.06 6.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.533 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.75 -30.72 36.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -37.19 77.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -59.97 -30.85 69.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.17 -29.88 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -50.16 75.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -60.16 -43.05 96.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.34 -51.98 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.67 -31.01 72.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.2 tp -78.23 -56.55 4.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -48.97 -31.29 7.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -43.87 68.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -36.09 82.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.428 HG22 HD11 ' A' ' 26' ' ' ILE . 37.7 mm -64.84 -29.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.997 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.76 -31.38 14.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.52 68.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.414 ' CE2' HG13 ' A' ' 84' ' ' VAL . 15.3 m-85 -80.01 -34.46 38.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.35 59.0 1.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.641 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.66 47.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.809 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -65.69 -15.4 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.308 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.71 -2.34 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -113.13 -59.1 2.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 179.853 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.1 mm -79.95 120.29 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.414 ' CE2' ' O ' ' A' ' 34' ' ' LYS . 63.3 m-85 -116.03 -56.23 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.571 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 69' ' ' GLN . 1.8 mm100 -112.95 156.17 23.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.247 0.546 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.8 t -154.89 79.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.137 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.29 157.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.518 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.1 tt -111.15 120.37 43.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.926 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 30.6 Cg_endo -64.64 80.6 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.545 2.163 . . . . 0.0 112.877 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.4 p -131.0 146.05 52.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.82 169.35 10.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.113 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -138.52 110.75 7.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.684 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -109.01 128.92 64.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.307 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.38 105.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -118.45 143.43 46.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -149.75 164.84 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 -70.36 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.903 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -172.53 162.85 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.86 -103.54 2.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.531 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.07 31.1 0.31 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -109.5 127.2 54.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.924 0.393 . . . . 0.0 110.834 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -132.05 139.88 48.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.08 124.22 41.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.02 93.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.0 163.04 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -125.77 134.37 51.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.074 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.57 120.33 33.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.751 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.08 122.46 11.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.9 mt -80.64 -51.05 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.401 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 33.1 m-85 -111.11 89.65 10.18 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 37.9 Cg_endo -66.69 128.39 18.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 22.87 73.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 97.1 m-85 -129.44 139.78 51.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.701 0.286 . . . . 0.0 110.984 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 4.1 tp -130.89 134.57 46.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 41' ' ' PRO . 11.5 m-85 -99.85 123.9 44.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.28 112.9 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.432 ' CB ' ' HB2' ' A' ' 37' ' ' GLN . 19.5 tt0 -79.95 72.64 6.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.156 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.8 ptm -91.56 -173.47 3.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.375 -179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -119.22 99.64 6.83 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.922 179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 54.1 mt -129.15 6.51 5.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.31 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.93 64.94 1.21 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.525 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.55 114.49 27.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 110.933 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -58.78 -29.33 66.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.958 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.22 -69.02 0.65 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 110.989 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -159.35 157.48 27.2 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.908 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.6 151.88 72.63 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.662 2.241 . . . . 0.0 112.176 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -69.11 -175.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.86 -27.58 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.945 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.03 -29.02 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.345 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.81 -34.72 62.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -68.02 -31.5 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 29' ' ' PHE . 21.7 t -76.99 -45.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.214 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.9 t -59.01 -40.25 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.72 -12.97 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.325 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.95 -15.66 12.64 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.2 p -57.4 112.01 4.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.736 0.268 . . . . 0.0 110.984 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.62 121.43 7.92 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.373 2.049 . . . . 0.0 112.299 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.26 -19.57 17.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.692 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.81 125.39 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -94.59 -29.65 14.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.63 -177.43 42.06 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.446 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.43 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 10.3 p90 -60.6 142.01 56.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 0.0 110.999 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.9 m -56.74 -32.81 39.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.191 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.64 -142.52 13.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.367 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.3 29.98 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.853 0.359 . . . . 0.0 111.122 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.51 -156.06 25.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.493 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.39 -67.8 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.795 0.331 . . . . 0.0 110.823 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -67.28 158.34 82.16 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.12 172.63 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.97 80.04 1.66 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.413 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HB3' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_endo -77.87 139.76 17.77 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.537 2.158 . . . . 0.0 112.265 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.96 130.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.846 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.32 150.26 93.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.84 -40.0 57.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.577 2.185 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -31.24 72.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -87.64 -34.32 18.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.495 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 22.8 t -61.9 -31.73 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.303 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -64.33 -29.97 71.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -74.36 -47.4 34.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.806 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.416 HD11 ' CE2' ' A' ' 67' ' ' PHE . 17.1 pt -69.8 -27.38 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.2 mt -74.85 -34.28 62.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -70.23 -32.5 70.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.594 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 t -81.83 -33.3 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -63.63 1.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 145.44 44.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.698 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.6 mt -121.59 -45.44 2.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.749 0.309 . . . . 0.0 110.92 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.22 30.33 2.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.33 -1.261 . . . . 0.0 112.475 -179.957 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.922 0.391 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.433 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -137.14 -171.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.795 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.21 160.3 43.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.165 0.507 . . . . 0.0 111.88 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.465 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 90.0 m95 -93.96 119.8 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.774 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 22.3 m-85 -114.3 105.64 13.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.441 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -99.14 169.09 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.097 0.475 . . . . 0.0 111.724 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 2.4 p -156.26 161.41 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.57 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.506 ' CE1' ' CE2' ' A' ' 65' ' ' TYR . 5.8 m170 -93.43 157.07 16.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.108 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p -150.35 -176.54 5.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.09 145.79 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.16 129.55 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.2 -23.97 31.0 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.618 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.68 -19.62 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.569 0.223 . . . . 0.0 111.167 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.45 -38.45 66.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.7 -36.61 72.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.947 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -24.83 21.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.025 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.24 -38.1 89.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -61.2 -35.15 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 -41.89 34.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.65 -34.88 73.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.8 tp -77.31 -53.01 8.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.09 -35.37 59.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -63.42 -42.11 98.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.682 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -38.15 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.7 mm -64.06 -33.26 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -89.8 -33.81 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -40.4 77.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.07 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -92.32 -24.81 18.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.07 78.29 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.404 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.18 35.26 4.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.89 16.21 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.478 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.8 -12.88 15.71 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.52 0.2 . . . . 0.0 111.115 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -116.28 -44.23 2.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.321 . . . . 0.0 111.125 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.406 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 19.4 tt -82.2 153.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.195 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 28.9 m-85 -143.23 -52.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.413 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.9 mt-30 -120.33 146.52 46.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 111.108 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.22 70.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.222 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -88.69 143.59 26.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.576 -179.121 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 tt -108.58 123.58 36.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.231 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 14.0 Cg_endo -57.84 87.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.659 2.24 . . . . 0.0 112.894 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.2 p -139.93 117.77 11.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.776 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -81.98 172.13 13.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.001 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.88 135.18 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 t -121.23 158.95 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.108 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -149.26 118.41 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -80.22 -51.16 9.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.667 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.77 129.06 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.29 104.0 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.06 100.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.917 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.17 -90.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.564 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.62 -28.02 3.37 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.556 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -149.94 166.54 29.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -139.19 120.56 14.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -148.77 122.86 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.58 121.1 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.3 t -119.63 159.85 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.165 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.16 116.07 17.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -104.88 123.23 47.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.946 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -58.07 108.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.057 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' CD1' ' CG1' ' A' ' 115' ' ' VAL . 39.6 mt -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.409 ' CB ' ' HB2' ' A' ' 65' ' ' TYR . 3.3 m-85 -132.56 88.4 38.97 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.623 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.22 108.4 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.763 2.309 . . . . 0.0 112.857 -179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 47.82 9.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.848 179.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.506 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 62.6 m-85 -144.96 145.15 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 2.3 pp -150.61 120.27 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.413 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.464 ' CD2' ' CD1' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -96.25 126.88 41.77 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 111.366 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.13 121.53 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.579 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -79.87 78.9 6.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.362 . . . . 0.0 110.712 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.3 ptp -91.0 -175.71 4.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.244 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 5.9 t0 -122.17 77.88 1.44 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 19.9 mt -95.21 -29.39 14.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.938 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.47 81.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.39 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -154.96 -66.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.991 0.424 . . . . 0.0 110.809 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.35 173.55 6.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.825 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.6 -17.07 60.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -139.71 96.37 8.51 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.09 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.38 104.74 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.666 2.244 . . . . 0.0 112.218 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.2 -167.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.47 -85.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.52 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.95 69.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.591 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.408 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 2.0 t-105 -74.81 -30.51 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.119 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.94 -30.16 69.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.748 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.1 t -84.57 -48.7 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.045 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.72 -49.61 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.48 -22.41 66.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.247 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.38 -22.45 24.47 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.83 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.24 145.73 99.04 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 110.93 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.77 -25.59 28.37 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.469 2.113 . . . . 0.0 112.301 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.38 -28.17 54.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.425 HG21 ' CE2' ' A' ' 94' ' ' PHE . 35.6 mm -89.06 126.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 110.847 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 m -164.03 66.13 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.84 -95.37 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.56 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.44 ' CE1' ' HB ' ' A' ' 8' ' ' VAL . 13.1 m-85 62.49 138.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 0.0 110.76 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.406 ' CG2' ' NE2' ' A' ' 9' ' ' HIS . 39.6 t -79.68 141.38 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.2 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.95 -24.87 61.0 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.81 98.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.333 . . . . 0.0 111.151 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.34 -92.93 1.8 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.469 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.2 mmt -117.18 169.16 9.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 110.955 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.499 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 1.3 mmp_? -62.44 -57.21 23.93 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.192 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.4 Cg_endo -59.46 152.61 60.23 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.437 2.091 . . . . 0.0 112.064 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.405 ' CG2' ' CG2' ' A' ' 95' ' ' VAL . 5.7 t -120.35 82.18 31.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.191 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.3 115.6 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.38 2.053 . . . . 0.0 112.091 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -70.57 149.01 47.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.994 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.3 m -87.49 148.31 43.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.88 -37.1 54.95 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.764 2.309 . . . . 0.0 112.458 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -68.93 -29.41 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -91.48 -32.18 15.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.465 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 24.3 t -64.28 -36.67 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.113 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -69.48 -30.73 68.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.942 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -77.91 -42.36 33.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.728 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.464 ' CD1' ' CD2' ' A' ' 67' ' ' PHE . 1.9 pp -74.89 -29.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.411 ' CD2' ' CD1' ' A' ' 118' ' ' LEU . 19.0 mt -75.34 -30.68 60.33 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.493 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.12 -27.78 64.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.195 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.429 ' CG1' ' CD1' ' A' ' 61' ' ' LEU . 2.1 t -88.23 -50.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.785 0.326 . . . . 0.0 111.34 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -52.92 -63.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.836 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.21 48.68 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.843 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.411 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 15.7 mt -133.17 5.77 3.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.47 0.176 . . . . 0.0 111.455 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.84 40.69 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.874 0.368 . . . . 0.0 110.809 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.396 -1.225 . . . . 0.0 112.531 -179.987 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.788 0.328 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.403 HG21 ' HA ' ' A' ' 71' ' ' ASP . 2.7 pp -125.9 168.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.954 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -142.7 169.8 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 112.21 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.463 ' CH2' ' CB ' ' A' ' 37' ' ' GLN . 87.8 m95 -94.05 91.55 6.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.462 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 72' ' ' LEU . 63.3 m-85 -79.96 116.12 19.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 110.647 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.73 151.5 19.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.709 -179.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -134.51 159.95 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.563 179.671 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.482 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 3.5 m-70 -110.56 87.36 2.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.5 p -83.73 -174.35 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.794 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.72 134.02 34.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -60.47 104.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.61 -30.45 5.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.405 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -92.79 -19.63 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.587 0.232 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.03 -40.73 64.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 111.005 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.32 -37.24 69.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.828 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -89.84 -26.22 20.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.981 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.16 86.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -59.45 -48.01 83.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.88 74.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -60.22 -32.62 71.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.8 tp -78.3 -56.1 4.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.728 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -29.41 2.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.294 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -46.52 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -33.15 68.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.59 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mm -75.16 -25.21 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -97.78 -29.95 13.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.41 -40.79 64.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.989 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -79.99 -25.34 40.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.39 51.55 1.7 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.48 31.9 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.105 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.59 9.78 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -104.01 -21.71 13.57 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.711 0.291 . . . . 0.0 111.025 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -96.46 -51.23 4.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.677 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pt -79.82 151.25 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.765 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -141.72 -44.96 0.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.344 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 2.6 mt-30 -129.52 158.33 39.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.221 0.534 . . . . 0.0 112.035 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.8 t -154.97 82.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.114 179.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.65 157.94 16.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.62 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.16 124.08 32.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.753 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.452 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 37.5 Cg_endo -66.83 81.1 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.586 2.191 . . . . 0.0 112.855 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.9 p -139.04 141.11 38.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -117.29 160.86 20.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.968 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.26 134.81 54.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.806 179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.66 135.01 65.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 t -145.89 85.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.145 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -80.28 152.25 29.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mt -97.97 164.47 12.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -149.05 108.46 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 100.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.944 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.92 31.64 69.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.517 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.8 -104.09 2.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.96 143.72 14.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -101.78 149.56 24.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -158.99 140.02 12.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.4 m -116.7 131.16 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.048 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 t -147.73 159.82 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -105.98 140.19 39.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.23 107.1 11.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -59.93 115.62 3.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.4 mt -72.93 -44.98 60.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.74 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.448 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 41.0 m-85 -119.28 88.26 37.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.616 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.08 136.62 53.07 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.493 2.128 . . . . 0.0 112.313 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.83 22.1 69.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.547 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.19 127.95 52.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.824 0.345 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 124.86 45.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.608 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' A' ' 41' ' ' PRO . 11.4 m-85 -93.19 123.63 36.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -129.42 110.42 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.454 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.402 ' CB ' ' HB2' ' A' ' 37' ' ' GLN . 15.4 tt0 -79.81 72.24 6.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.402 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 25.1 ptp -92.02 -176.85 4.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.851 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.403 ' HA ' HG21 ' A' ' 3' ' ' ILE . 14.5 t0 -118.27 99.23 6.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.703 179.382 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 6' ' ' TYR . 80.2 mt -122.91 7.16 9.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.337 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.17 63.03 2.54 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.444 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -98.76 -178.07 3.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.3 -68.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.01 0.433 . . . . 0.0 110.939 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.65 -78.81 0.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.025 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -138.29 166.52 25.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 169.87 17.43 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.482 2.121 . . . . 0.0 112.292 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.38 -165.78 1.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -57.64 -21.46 39.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -47.88 -44.78 29.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.412 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -68.94 -35.42 76.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.41 -30.19 68.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -79.24 -51.51 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.5 t -59.84 -46.31 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.163 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -26.83 66.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.71 -27.28 57.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.621 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.7 p -59.89 142.91 88.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.682 0.277 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.87 -13.93 21.6 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.533 2.155 . . . . 0.0 112.627 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.64 -6.41 65.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.047 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -79.94 -31.97 13.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.941 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 67.75 -68.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.19 58.69 0.19 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.374 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 63.14 176.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.401 ' N ' ' HB2' ' A' ' 9' ' ' HIS . 30.3 m -61.89 -30.08 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.192 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.61 39.96 0.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.16 -29.39 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 111.064 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.73 48.62 4.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.429 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.91 149.79 38.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.348 . . . . 0.0 110.941 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.82 154.31 67.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 112.78 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.511 2.141 . . . . 0.0 112.004 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.95 123.68 62.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.17 148.55 10.44 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.764 2.309 . . . . 0.0 112.202 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.8 141.56 39.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.852 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.62 157.66 79.53 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.1 -35.62 95.19 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.589 2.193 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.44 -29.54 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -87.03 -36.46 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.433 HG22 ' CD1' ' A' ' 5' ' ' TRP . 39.8 t -60.72 -51.98 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.11 -29.56 60.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -53.79 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.576 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' A' ' 67' ' ' PHE . 18.9 pt -66.2 -25.07 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.732 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.9 mp -71.67 -38.07 70.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.486 179.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -30.56 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.704 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.39 -40.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.042 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -58.93 -62.02 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.73 48.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.526 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 27.8 mt -124.12 -45.26 2.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.995 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.48 29.85 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.395 179.988 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.826 0.346 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.52 170.74 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.852 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -153.3 161.9 41.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.826 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.451 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 68.2 m95 -88.49 92.71 9.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.661 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 67.0 m-85 -87.99 114.12 24.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -100.77 147.49 26.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.525 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.1 t -127.93 160.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 179.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.497 ' CE1' ' CE2' ' A' ' 65' ' ' TYR . 3.2 m-70 -114.72 156.58 24.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -156.63 -174.74 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 145.8 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.48 130.5 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.42 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -94.01 -22.05 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 0.0 111.066 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -53.65 -43.78 69.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -33.51 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -80.87 -31.06 35.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.54 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -60.31 -37.67 81.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.973 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.68 -53.76 42.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -30.33 69.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.5 tp -76.3 -56.53 4.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -48.76 -30.33 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -38.4 61.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -73.67 -37.35 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.569 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.4 mm -72.92 -28.05 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.987 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -89.63 -32.8 16.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.773 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -39.55 79.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.993 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.98 -37.29 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.83 41.71 5.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.52 51.18 0.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.79 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.3 -5.15 43.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.4 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -79.69 -24.27 41.85 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.824 179.939 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -94.3 -52.17 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG23 HD11 ' A' ' 35' ' ' ILE . 34.9 mt -95.16 111.61 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.414 ' CZ ' ' O ' ' A' ' 33' ' ' ASP . 6.5 m-85 -102.46 -60.23 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.382 -179.451 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.39 130.03 49.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 -179.146 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.07 72.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.497 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -83.64 133.47 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.945 -179.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' THR . 0.1 OUTLIER -109.22 124.51 33.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.925 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.504 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 88.1 Cg_exo -49.19 77.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.138 2.559 . . . . 0.0 113.305 -179.652 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 40' ' ' ILE . 36.8 p -158.64 152.33 23.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.775 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 5.2 mm-40 -96.44 156.22 16.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.855 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.17 133.79 28.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.758 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.35 116.09 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.184 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -102.48 -161.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.534 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 7.4 tt0 -79.49 143.33 35.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 110.722 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.28 -171.37 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.009 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.86 80.5 1.49 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.883 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -124.3 -54.46 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.59 36.32 0.22 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.429 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.72 27.49 8.99 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.551 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.93 139.12 49.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.895 0.378 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 147.29 18.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -129.5 148.53 51.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.04 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.9 m -142.91 82.39 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 m -159.45 -179.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.26 169.57 17.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.3 tptt -141.23 -165.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.742 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -139.82 113.53 8.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.26 -47.76 9.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 41' ' ' PRO . 7.6 m-85 -135.99 84.36 31.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.584 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.79 141.93 92.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.496 -179.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.86 77.81 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.069 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 6.2 m-85 -117.99 156.74 28.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.8 0.334 . . . . 0.0 110.953 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 5.2 mp -150.64 107.7 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 41' ' ' PRO . 4.4 m-85 -81.79 124.32 29.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.86 114.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 4.6 tt0 -80.71 71.09 7.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 0.0 110.345 179.433 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.3 ptp -91.2 -175.02 4.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -124.32 92.02 3.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.73 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 20.3 mt -95.81 -57.8 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.63 -47.23 2.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.381 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -120.73 163.82 17.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.761 0.315 . . . . 0.0 110.759 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -112.74 -16.58 12.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.339 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -87.13 -33.17 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 0.0 111.163 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.77 94.13 17.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.17 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.7 171.64 6.79 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.687 2.258 . . . . 0.0 112.235 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 -177.25 5.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.97 -28.91 64.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.16 69.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -59.86 -39.74 86.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.27 -40.22 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.45 -47.87 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.43 -45.33 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.091 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -60.67 -28.99 69.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.68 -31.28 56.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.9 p -60.76 111.35 3.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.616 0.246 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.16 133.73 35.96 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.445 2.097 . . . . 0.0 112.366 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.14 -11.45 48.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.703 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.8 tp -79.96 135.71 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.22 -35.05 5.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.93 -26.73 19.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.583 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' CE1' HG11 ' A' ' 102' ' ' VAL . 18.4 t80 -174.38 169.78 3.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.55 -66.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.318 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.26 55.91 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.556 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.56 -46.99 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.38 169.28 24.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.488 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -101.36 -30.6 11.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.736 0.303 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.38 154.75 77.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.13 171.58 14.6 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.205 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 94' ' ' PHE . 6.4 m -142.52 101.69 5.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.187 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.79 157.84 54.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.397 2.064 . . . . 0.0 112.169 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -89.99 163.68 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.7 p -86.67 141.38 33.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.95 -33.9 35.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.572 2.181 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.37 -41.63 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -81.58 -31.08 32.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.451 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 58.5 t -63.36 -43.68 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -61.25 -30.42 70.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -52.88 11.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.609 179.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.42 -16.48 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.59 179.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -36.73 68.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.316 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.52 -22.43 44.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.5 t -70.26 -60.93 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.49 -53.66 42.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.42 38.17 0.42 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.545 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.7 mt -100.06 0.62 41.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.591 0.234 . . . . 0.0 111.366 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.8 mp -131.4 -63.02 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.385 -1.23 . . . . 0.0 112.438 -179.959 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.83 0.347 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.473 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -131.51 174.65 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.813 179.958 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -139.91 163.71 31.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.416 0.627 . . . . 0.0 112.294 -179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.483 ' CH2' ' HB3' ' A' ' 37' ' ' GLN . 74.7 m95 -91.09 92.21 8.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.583 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.436 ' CD1' ' HG3' ' A' ' 70' ' ' MET . 64.9 m-85 -79.8 107.61 12.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 146.66 26.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.827 -179.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -146.55 177.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.555 179.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.509 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 2.9 m-70 -122.48 160.7 25.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -136.83 158.79 43.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.622 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.26 127.43 27.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.3 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -63.66 128.73 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.852 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.68 -30.63 8.56 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.205 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -97.36 -9.41 27.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 0.0 110.96 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.8 -39.04 4.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 111.238 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -54.94 -44.17 74.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.33 34.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.76 85.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.067 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.0 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.73 -50.97 8.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.099 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.04 -34.86 72.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.3 tp -71.98 -56.96 4.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -33.34 60.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -67.88 -40.9 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.709 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -68.0 -38.25 82.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 mm -69.42 -30.09 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.017 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -89.0 -33.62 17.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.62 68.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.45 -27.07 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.06 56.94 2.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.456 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.88 35.33 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.21 -4.19 37.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.515 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.78 -28.06 40.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.839 0.352 . . . . 0.0 110.77 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -54.29 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.66 94.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.657 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.473 ' CE2' HG23 ' A' ' 3' ' ' ILE . 6.8 m-85 -83.01 -50.05 8.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.483 ' HB3' ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -115.67 138.94 50.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.166 0.508 . . . . 0.0 111.705 -179.207 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.39 138.56 26.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.459 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.557 HD13 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -160.23 155.56 25.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 111.356 -179.731 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 42' ' ' THR . 14.9 tt -114.6 128.26 26.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.473 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 11.2 Cg_endo -55.71 80.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.673 2.248 . . . . 0.0 112.8 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 40' ' ' ILE . 36.6 p -159.87 142.64 13.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.48 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.82 145.13 32.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.422 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.28 121.34 12.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.036 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 m -144.02 117.23 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.797 179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -159.98 62.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.034 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -152.82 169.41 22.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -94.38 137.11 33.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -155.78 -46.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -95.48 86.68 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.39 -124.13 34.04 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.32 50.53 0.79 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.542 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.63 151.84 23.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.919 0.39 . . . . 0.0 110.85 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 125.47 37.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.65 115.07 11.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.97 99.88 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.3 m -156.92 174.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.557 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 -142.82 150.48 40.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.737 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.28 105.1 7.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.735 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -63.72 115.19 4.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.411 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 37.9 mt -90.09 -39.82 12.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.204 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 1.4 m-85 -131.4 95.49 23.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.917 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.16 133.22 48.54 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.527 2.152 . . . . 0.0 112.145 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.54 23.29 62.56 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.793 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.509 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 2.2 m-85 -116.49 154.07 31.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.49 130.92 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.72 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.483 ' CE2' ' HB ' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -109.13 142.72 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.557 179.618 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.32 122.36 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.393 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.3 tt0 -79.81 65.17 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 110.256 179.43 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.436 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 11.6 ptp -91.77 -169.34 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -148.62 80.49 1.44 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.81 179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.407 ' HG ' ' CZ ' ' A' ' 6' ' ' TYR . 4.1 pp -113.53 -31.16 6.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.166 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -45.89 94.77 0.01 OUTLIER Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.917 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.44 7.7 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.587 0.232 . . . . 0.0 111.442 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.56 -65.84 0.31 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.96 0.409 . . . . 0.0 111.023 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.85 -69.82 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.139 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -158.94 153.16 19.96 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.91 177.96 7.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -90.07 -179.98 5.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.33 -24.35 66.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.187 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.28 -47.39 72.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.343 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -59.31 -42.36 91.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.967 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -59.98 -32.21 70.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.1 t -82.58 -49.17 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.91 -51.28 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.982 179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -66.35 -25.76 66.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.072 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.97 -32.64 63.27 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.701 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.7 p -61.78 143.69 93.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 91.18 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.42 -36.41 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.451 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.71 122.47 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.4 p -143.84 30.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.26 108.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.405 ' HB3' ' HB2' ' A' ' 9' ' ' HIS . 26.2 t80 -156.2 39.92 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.2 p -90.04 10.93 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.517 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.97 -44.98 2.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.42 68.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.21 -76.23 0.41 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.601 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 mmt -124.37 -43.57 2.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 0.0 110.953 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.19 118.81 70.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.0 Cg_exo -53.99 -171.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.492 2.128 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -150.6 115.46 3.29 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.281 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.0 145.06 66.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.465 2.11 . . . . 0.0 112.068 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -86.29 159.1 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.6 m -89.54 141.66 28.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.66 -37.14 26.74 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 112.574 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -48.74 80.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.07 -33.97 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.455 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 62.3 t -58.5 -50.5 78.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.91 -37.95 54.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.224 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -68.4 -52.69 30.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.669 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.483 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 27.5 pt -66.36 -26.11 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.835 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mp -73.83 -41.16 62.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -23.41 65.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.9 t -76.59 -59.09 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 t -59.4 -57.03 14.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.546 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 135.03 63.13 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.914 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.6 mt -133.46 5.62 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.514 0.197 . . . . 0.0 111.441 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.34 -36.38 11.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.412 -179.941 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.837 0.351 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.428 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -139.39 -170.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.932 179.873 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.76 150.13 50.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.276 0.56 . . . . 0.0 111.971 -179.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.497 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 71.8 m95 -99.75 110.14 22.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.529 179.349 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.421 ' CD1' ' HE3' ' A' ' 70' ' ' MET . 30.3 m-85 -99.67 137.08 38.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 0.0 110.722 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.49 146.75 36.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.033 0.444 . . . . 0.0 111.861 -179.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.5 OUTLIER -137.3 159.31 35.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.191 179.583 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -119.58 126.28 50.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.914 -179.857 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -132.06 -177.22 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 141.07 35.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -58.28 114.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.021 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.76 -34.05 5.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.295 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.41 -30.02 37.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 110.762 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.18 -39.15 66.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.12 -41.18 83.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -81.01 -26.69 36.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.61 56.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.152 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -35.44 74.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.81 -57.2 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.94 -36.29 82.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.6 tp -70.09 -47.87 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.765 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.33 -22.13 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -45.97 14.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.877 0.37 . . . . 0.0 110.296 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -68.35 -24.46 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -70.94 -28.07 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -97.39 -31.3 12.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.23 74.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -79.93 -25.61 40.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.987 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 30.19 6.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.287 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -97.04 25.38 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -24.32 66.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.75 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.85 -3.44 47.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.161 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -67.55 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.9 mm -80.71 130.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.711 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.428 ' CE2' HG21 ' A' ' 3' ' ' ILE . 10.4 m-85 -124.24 -50.43 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -119.46 161.48 20.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.423 0.63 . . . . 0.0 112.489 -178.522 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.5 t -157.84 110.85 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.956 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -126.16 175.06 8.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.529 0.68 . . . . 0.0 112.292 -178.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.2 pt -161.87 66.95 2.08 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.703 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 62' ' ' PHE . 9.6 Cg_endo -52.88 150.52 22.77 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.451 2.767 . . . . 0.0 114.359 -178.445 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 22.3 p -125.2 152.39 44.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.139 179.207 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -79.81 138.65 37.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.975 0.416 . . . . 0.0 111.057 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -104.26 133.69 48.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.769 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -151.19 173.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.152 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 m -126.97 150.36 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.063 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -139.42 154.8 47.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.3 tp -131.79 146.7 52.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.14 174.1 7.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -42.65 94.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.63 106.71 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.474 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.32 -153.27 25.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.443 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -124.17 137.07 54.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.07 172.44 8.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.84 -168.35 1.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.758 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 m -90.08 119.03 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.111 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 m -89.94 159.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -140.06 139.13 35.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.46 141.73 51.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.21 132.97 12.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.274 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 1.1 mt -90.39 -58.82 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 179.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 51.9 m-85 -113.04 64.39 0.88 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.777 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.2 135.46 54.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.562 2.175 . . . . 0.0 112.168 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.91 6.2 72.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 4.7 m-85 -113.69 126.72 55.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.82 116.62 32.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.784 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.437 ' CE2' HD13 ' A' ' 112' ' ' ILE . 14.0 m-30 -90.27 95.3 10.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.25 113.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.279 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 10.5 tt0 -83.21 68.63 9.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.744 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.421 ' HE3' ' CD1' ' A' ' 6' ' ' TYR . 1.9 ptt? -91.45 -165.49 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.473 179.501 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -149.43 84.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.895 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 6' ' ' TYR . 44.0 mt -79.94 -35.11 38.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.72 104.96 0.11 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.497 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.87 167.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.17 32.14 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.813 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -76.91 -78.66 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -145.85 108.89 4.37 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.92 159.32 2.51 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.414 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -90.05 -169.96 2.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -54.88 -23.58 19.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.62 -52.46 55.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.198 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 -58.06 -30.8 66.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -71.9 -31.03 66.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.798 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.37 -51.41 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.948 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.22 -41.98 79.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -71.87 -22.76 61.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.16 -17.79 64.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.945 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.9 p -58.97 139.32 87.32 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.744 0.272 . . . . 0.0 110.95 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.36 105.48 2.05 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.464 2.109 . . . . 0.0 112.239 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.24 -17.09 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.725 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.03 128.47 38.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.5 m -103.63 -28.38 11.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.58 -56.24 1.4 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.262 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -155.39 175.94 13.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.0 110.669 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.99 -67.72 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.404 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.62 78.66 0.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.653 -0.785 . . . . 0.0 112.542 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -175.85 162.55 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.24 91.49 0.58 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.503 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.32 -173.46 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.97 0.414 . . . . 0.0 110.908 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -78.68 162.12 66.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.912 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.74 175.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.56 79.33 65.09 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.853 0.358 . . . . 0.0 111.441 -179.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.98 146.1 22.82 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.548 2.165 . . . . 0.0 111.973 179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -85.05 163.87 18.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.753 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.76 150.49 44.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.5 -27.31 7.25 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.638 2.225 . . . . 0.0 112.503 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.85 -46.85 17.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.96 -30.64 63.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.497 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 50.4 t -62.86 -55.18 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.54 -24.95 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.151 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.96 -44.87 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.779 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.437 HD13 ' CE2' ' A' ' 67' ' ' PHE . 27.4 pt -72.43 -28.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.966 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.45 HD21 ' CZ2' ' A' ' 5' ' ' TRP . 25.9 mt -76.24 -30.78 58.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.65 -32.5 69.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.495 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -84.19 -26.42 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.808 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.4 p -68.4 -43.25 77.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.63 4.24 3.95 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.164 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 34.8 mt -80.0 -58.48 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.91 0.355 . . . . 0.0 110.728 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.3 mt -95.07 -29.13 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.493 179.978 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.705 0.288 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.428 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -136.47 -168.1 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.909 179.968 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.0 152.18 49.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.161 0.505 . . . . 0.0 111.855 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.481 ' CZ3' ' CD1' ' A' ' 39' ' ' LEU . 73.0 m95 -97.58 96.76 8.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.637 179.575 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 27.1 m-85 -86.86 123.62 32.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 110.728 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -106.39 159.67 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.568 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -141.49 160.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.821 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.42 ' CD2' HG22 ' A' ' 95' ' ' VAL . 14.0 m-70 -88.9 134.88 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.98 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 p -139.4 160.98 38.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.13 151.13 21.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.49 127.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -25.51 24.54 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.31 -26.9 19.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.71 0.291 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -41.22 76.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.96 -37.84 67.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.973 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -86.71 -29.82 22.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.841 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.19 83.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.024 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.79 -43.58 94.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.54 -42.91 28.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.32 -31.51 69.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.1 tp -82.87 -57.6 3.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.35 -45.31 17.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.439 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -61.11 -41.91 97.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -43.23 91.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 26' ' ' ILE . 35.7 mm -64.39 -28.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.855 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -91.41 -29.72 16.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 -46.46 30.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.339 -179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -79.95 -21.63 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.207 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.13 65.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.176 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.08 26.65 9.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.301 . . . . 0.0 111.154 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -80.19 22.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.38 -21.45 13.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.696 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.2 -48.01 2.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 mp -79.86 128.28 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 33.0 m-85 -115.3 -56.74 2.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.424 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.442 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -115.83 170.02 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.7 t -157.79 120.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.983 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.483 HD11 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -144.58 150.3 37.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.334 0.588 . . . . 0.0 112.295 -178.533 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 pt -113.05 124.83 30.8 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.568 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.458 ' CG ' ' HB2' ' A' ' 62' ' ' PHE . 50.7 Cg_endo -68.9 85.71 0.49 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.651 2.234 . . . . 0.0 112.885 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 7.1 p -138.46 146.8 42.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.421 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -80.13 156.7 26.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.12 -179.645 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -145.45 108.08 4.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 m -109.54 126.66 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.253 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 t -143.01 144.53 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.091 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.22 166.16 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tp -103.65 147.13 27.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.694 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.72 90.02 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 63.47 -79.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.052 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.16 -55.55 5.67 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.601 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.52 -16.35 2.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.685 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 120.19 23.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.832 0.348 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.99 -178.71 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.823 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.9 131.96 34.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.758 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 m -107.03 97.52 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.274 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.0 t -82.09 159.55 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -144.92 127.28 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.959 0.409 . . . . 0.0 111.225 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.3 mmtp -107.53 -172.3 2.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.396 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.51 117.55 19.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.872 0.368 . . . . 0.0 111.028 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 18.1 mt -87.63 -55.45 3.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.458 ' HB2' ' CG ' ' A' ' 41' ' ' PRO . 1.1 m-85 -112.3 91.47 16.45 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 127.8 27.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.475 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.39 40.78 96.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.66 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -133.42 115.28 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -124.01 121.45 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.206 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -97.36 133.9 41.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 111.246 -179.573 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.6 mp -123.56 122.06 64.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.591 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.458 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 2.5 tt0 -79.77 75.66 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptp -90.92 -175.17 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.153 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.468 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.3 t0 -130.52 100.03 5.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 13.9 mt -108.73 -25.63 10.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.054 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.84 83.59 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.481 179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -163.81 -43.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.378 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.52 169.16 18.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.84 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -87.23 5.8 36.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.395 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -129.23 102.53 18.67 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.402 ' O ' ' HB3' ' A' ' 82' ' ' TRP . 51.0 Cg_endo -69.08 77.89 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.481 2.121 . . . . 0.0 112.203 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.9 m120 -90.24 -173.06 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 51.91 -84.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.866 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 79' ' ' ASN . . . -46.94 -48.9 21.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.719 -179.719 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.402 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 6.1 t-105 -76.2 -28.87 57.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.79 -37.79 74.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.06 -47.44 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.6 t -59.56 -42.29 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.089 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.67 -19.32 62.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.306 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -120.53 22.57 8.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.62 134.24 72.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.714 0.257 . . . . 0.0 110.821 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.03 -8.61 23.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.414 2.076 . . . . 0.0 112.669 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -103.82 -18.53 13.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.828 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -80.63 127.49 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.34 . . . . 0.0 111.056 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.7 m -145.47 110.55 5.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.061 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.24 143.32 7.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -152.12 170.98 18.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 110.931 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 9' ' ' HIS . 25.4 t -71.06 100.26 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.99 70.85 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.446 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.26 42.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.15 -99.5 2.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.414 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.6 ttm -69.61 136.39 51.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.754 0.311 . . . . 0.0 110.773 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 1.8 mtt-85 -82.04 -50.81 0.83 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 5.5 Cg_exo -74.07 116.89 4.8 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.707 2.271 . . . . 0.0 112.006 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 m -115.58 97.39 48.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.262 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.35 123.89 9.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.493 2.129 . . . . 0.0 112.187 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.99 157.98 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.66 151.47 55.62 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.13 -30.25 18.34 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.698 2.266 . . . . 0.0 112.464 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -71.45 -47.44 55.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -74.41 -31.9 62.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 112' ' ' ILE . 48.7 t -61.18 -52.47 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -55.53 -38.46 69.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.21 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -68.79 -46.61 68.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.054 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.455 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 31.1 pt -72.53 -27.09 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.954 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.426 HD21 ' CZ2' ' A' ' 5' ' ' TRP . 15.6 mt -79.45 -29.21 41.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -67.05 -21.76 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.925 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 t -86.31 -54.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.157 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -60.44 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 135.58 64.83 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.903 179.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.411 ' CD1' ' CD2' ' A' ' 113' ' ' LEU . 30.4 mt -128.93 -43.78 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 0.0 110.891 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.4 tp -80.14 -63.33 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.572 -179.996 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.825 0.345 . . . . 3.1299999999999999 111.237 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.417 HG23 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -141.8 -166.43 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 1.6499999999999999 110.941 -179.987 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -156.07 155.79 33.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 2.0699999999999998 111.507 -179.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.46 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 93.8 m95 -96.28 96.64 8.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 1.04 110.692 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.48 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 3.3 m-85 -86.17 117.35 24.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 2.2999999999999998 111.029 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.95 147.71 22.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 1.3 111.144 -179.823 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.46 159.96 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 2.2599999999999998 111.025 179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.427 ' CD2' HG23 ' A' ' 95' ' ' VAL . 10.7 m-70 -102.01 149.65 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 1.6499999999999999 111.013 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.2 p -151.3 -177.6 6.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 1.4199999999999999 110.86 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.0 139.4 30.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 2.6899999999999999 110.908 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.8 m -62.65 121.71 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 2.75 111.206 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.5 -28.62 12.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.787 -0.721 . . . . 1.8300000000000001 112.402 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -89.68 -21.41 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 3.0299999999999998 111.113 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -53.42 -36.31 61.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 2.5299999999999998 111.046 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -58.68 -30.91 67.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 3.25 110.878 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.79 -30.49 18.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 3.3799999999999999 110.929 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.73 87.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 1.55 111.08 -179.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.42 -49.06 79.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 3.75 110.827 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.95 -46.06 72.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 2.0299999999999998 111.045 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -60.25 -31.1 69.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 2.29 110.824 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.4 tp -81.47 -55.89 4.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 2.0899999999999999 110.85 179.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.02 -32.91 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.236 -0.438 . . . . 2.4500000000000002 111.193 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -71.02 -40.95 71.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 3.8999999999999999 110.734 179.803 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -68.89 -38.13 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 3.8199999999999998 110.675 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 26' ' ' ILE . 35.4 mm -66.76 -31.82 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 2.0299999999999998 110.894 179.728 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -91.19 -29.82 17.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 4.1200000000000001 110.857 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.7 -46.8 68.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 2.2400000000000002 111.174 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -80.03 -28.46 39.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 2.9100000000000001 111.012 179.937 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 66.01 0.98 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 2.0 112.442 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mt -122.08 33.41 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 2.3599999999999999 110.88 -179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -72.58 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 2.9300000000000002 111.365 -179.975 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.87 -30.32 40.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 2.7400000000000002 110.891 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 -60.33 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.325 -0.398 . . . . 3.1699999999999999 110.781 179.973 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.6 mt -82.13 128.65 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 2.7000000000000002 111.094 179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 71' ' ' ASP . 9.0 m-85 -118.02 -54.31 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 2.48 110.986 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -110.88 153.08 25.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.98 0.419 . . . . 1.8700000000000001 111.268 -179.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.47 69.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 2.2999999999999998 110.74 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.93 150.35 30.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 3.1200000000000001 111.034 -179.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.9 mt -109.84 129.29 24.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 3.1000000000000001 110.77 179.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 31.4 Cg_endo -63.64 73.88 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.488 2.125 . . . . 2.6899999999999999 112.394 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.5 p -146.34 134.95 22.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 2.1400000000000001 110.773 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -79.98 148.2 31.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 3.0499999999999998 110.873 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -126.11 113.68 17.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 4.29 110.843 179.973 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.47 129.25 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 3.5299999999999998 111.105 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -120.85 109.69 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 4.8399999999999999 111.067 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.83 151.08 22.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 6.1399999999999997 110.855 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.24 101.19 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 6.4500000000000002 110.818 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.89 -177.84 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 9.9800000000000004 110.913 179.931 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.52 -70.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 9.0700000000000003 110.966 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.05 167.12 11.94 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 6.6399999999999997 112.439 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.45 69.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.687 -0.768 . . . . 6.2300000000000004 112.513 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 129.09 22.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 9.1899999999999995 110.874 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.03 114.29 17.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 7.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -96.62 105.18 17.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 6.0999999999999996 110.859 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.87 99.61 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 4.6500000000000004 111.22 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.4 m -102.27 126.47 56.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 2.8399999999999999 111.043 179.898 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.14 126.32 50.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 4.79 110.933 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -101.61 164.07 11.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 3.48 110.706 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -107.05 105.15 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 3.9100000000000001 111.007 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.78 -47.32 47.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 1.76 110.761 179.912 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.406 ' CE1' HG23 ' A' ' 112' ' ' ILE . 9.9 m-85 -122.08 77.75 41.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 2.6299999999999999 110.685 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.05 127.61 26.4 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.624 2.216 . . . . 1.78 112.583 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.86 52.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.84 -0.695 . . . . 1.27 112.799 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -131.24 156.42 45.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 2.75 111.016 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.46 114.34 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 2.3300000000000001 110.596 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.436 ' CE2' HD11 ' A' ' 112' ' ' ILE . 11.1 m-85 -84.24 119.77 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 2.3900000000000001 111.271 -179.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mp -128.21 112.22 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 1.3400000000000001 110.889 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 6.2 tt0 -79.78 75.69 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 2.0899999999999999 110.521 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 10.3 ptm -91.59 -173.49 3.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 1.8799999999999999 111.119 -179.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.453 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 4.3 t0 -134.07 86.71 2.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 2.0899999999999999 110.929 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.48 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 12.9 mt -97.25 -72.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.439 -0.346 . . . . 1.8400000000000001 110.806 179.69 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.94 26.72 19.46 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.848 -0.692 . . . . 2.29 112.745 179.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.93 128.7 37.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.778 0.323 . . . . 4.3499999999999996 110.902 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -79.82 -44.99 19.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 6.7800000000000002 110.96 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -86.74 -77.31 0.32 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.992 -0.549 . . . . 4.6900000000000004 110.839 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -127.56 146.4 58.38 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.001 -0.545 . . . . 3.8100000000000001 110.834 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 -172.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.504 2.136 . . . . 1.8300000000000001 112.309 179.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -90.08 -178.63 5.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 3.8500000000000001 110.884 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.11 -21.26 58.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 2.98 111.176 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.57 -31.54 47.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 1.5700000000000001 111.274 -179.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 14.6 t-105 -76.94 -37.41 55.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 1.1200000000000001 110.956 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.58 -29.23 67.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 2.75 110.894 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.2 t -87.11 -51.31 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 1.8500000000000001 111.097 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 t -58.81 -36.83 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 1.3999999999999999 111.01 180.0 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.33 -20.84 59.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 3.5099999999999998 111.106 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.36 9.19 38.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.655 -0.783 . . . . 1.29 113.019 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 p -86.34 141.12 34.46 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.928 0.364 . . . . 1.5900000000000001 110.811 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.29 87.07 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.539 2.159 . . . . 2.1400000000000001 112.208 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.26 -32.74 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 2.0899999999999999 112.493 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.0 mm -80.05 127.76 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 2.2400000000000002 110.952 -179.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.82 -62.34 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 2.5899999999999999 110.933 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.45 ' O ' ' CG ' ' A' ' 94' ' ' PHE . . . 177.36 49.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 2.9500000000000002 112.625 179.964 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 45.3 p90 44.78 -168.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.761 0.315 . . . . 6.3300000000000001 111.405 179.993 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.427 HG23 ' CD2' ' A' ' 9' ' ' HIS . 22.0 t -47.38 -71.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.571 -0.286 . . . . 3.8999999999999999 111.513 -179.618 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.54 -31.5 3.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 4.0499999999999998 112.387 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.03 -32.88 65.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 4.5199999999999996 111.038 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.34 -101.14 2.66 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.732 -0.747 . . . . 3.7000000000000002 112.481 -179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.42 ' HA ' ' CE1' ' A' ' 94' ' ' PHE . 0.5 OUTLIER -177.35 -62.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.744 0.307 . . . . 6.3300000000000001 110.904 -179.998 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -89.97 174.48 4.7 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 6.6600000000000001 110.89 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 75.6 Cg_exo -49.89 163.53 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.687 2.258 . . . . 1.49 112.463 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.0 96.19 40.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 2.5099999999999998 111.2 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.62 120.61 7.23 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.459 2.106 . . . . 1.1699999999999999 112.276 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.43 166.49 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 1.8799999999999999 110.944 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.8 m -89.97 148.68 40.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 2.1299999999999999 110.851 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.61 -30.25 44.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.528 2.152 . . . . 1.51 112.429 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.72 -31.36 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 2.75 110.949 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -88.96 -32.53 17.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 2.46 110.886 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.46 ' CG1' ' CD1' ' A' ' 5' ' ' TRP . 20.0 t -63.83 -39.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 1.5700000000000001 111.102 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.4 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 4.7699999999999996 110.945 -179.924 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -54.92 13.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 2.77 110.661 179.872 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.436 HD11 ' CE2' ' A' ' 67' ' ' PHE . 15.6 pt -66.14 -24.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 1.9399999999999999 110.89 179.637 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -74.66 -34.43 62.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 2.4500000000000002 110.535 179.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -78.02 -31.47 50.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.059 -0.519 . . . . 2.6800000000000002 110.748 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.6 t -77.14 -33.05 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 2.1099999999999999 110.949 179.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.52 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 2.52 110.923 179.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.86 45.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 1.78 112.643 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt -125.17 -48.94 1.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 1.99 110.818 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -31.23 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 2.9399999999999999 110.866 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.31 -1.272 . . . . 2.9900000000000002 112.575 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.662 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.502 0.192 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.32 156.61 38.69 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.127 0.489 . . . . 0.0 111.762 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.679 ' CD1' HG11 ' A' ' 109' ' ' VAL . 82.0 m95 -95.3 95.56 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.653 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.639 ' CE2' HD12 ' A' ' 72' ' ' LEU . 33.0 m-85 -83.4 115.47 22.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.996 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.24 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 9' ' ' HIS . 6.3 t -128.36 161.64 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.47 ' N ' HG12 ' A' ' 8' ' ' VAL . 14.8 m-70 -90.06 159.96 16.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.599 HG21 ' CD1' ' A' ' 66' ' ' LEU . 62.2 p -152.45 -174.38 4.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD13 ' N ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -85.52 139.22 31.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.502 ' N ' HD13 ' A' ' 11' ' ' LEU . 21.4 t -68.09 122.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.86 15.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -92.17 -14.87 28.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.609 0.243 . . . . 0.0 111.245 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 66' ' ' LEU . 7.3 tm-20 -52.42 -46.54 66.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 111.054 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.87 -30.85 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.887 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -30.76 22.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.15 72.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -49.3 78.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.46 50.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.172 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -60.69 -31.63 70.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.799 HD12 HG21 ' A' ' 88' ' ' THR . 5.8 tp -81.17 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -46.9 -35.42 6.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.315 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -66.22 -47.3 74.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.709 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.41 ' HD2' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -62.68 -39.38 93.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.682 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.2 mm -62.56 -29.79 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -93.59 -29.98 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -44.03 74.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.157 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.0 -30.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 66.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.2 mt -124.79 23.23 8.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 0.0 111.046 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.44 -9.14 58.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.8 -29.64 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -51.83 5.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.803 HD12 HG21 ' A' ' 26' ' ' ILE . 32.3 mt -79.92 128.16 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.662 ' CE2' HG21 ' A' ' 3' ' ' ILE . 26.0 m-85 -113.66 -53.41 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.434 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.0 mt-30 -113.27 157.39 21.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.046 0.45 . . . . 0.0 111.452 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 68' ' ' ILE . 16.5 t -152.27 71.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.8 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.4 mm? -85.87 150.06 24.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.203 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.3 pt -107.22 131.19 21.89 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.862 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 32.3 Cg_endo -64.16 72.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.605 2.203 . . . . 0.0 112.643 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.821 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.811 0.339 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.81 110.03 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.544 HD21 HG11 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -72.38 -49.33 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.537 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.436 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 18.9 m-85 -106.76 98.21 20.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.296 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.91 137.05 55.94 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.429 2.086 . . . . 0.0 112.633 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.97 26.07 65.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.704 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' CD2' ' HB3' ' A' ' 62' ' ' PHE . 14.5 m-85 -116.4 145.55 43.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.717 0.294 . . . . 0.0 111.087 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.781 HD11 ' HG2' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -142.93 112.73 6.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.764 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.675 ' CD2' HD12 ' A' ' 112' ' ' ILE . 6.4 m-85 -88.35 124.22 33.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.576 HG23 HG22 ' A' ' 38' ' ' VAL . 1.2 mp -130.04 117.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 6.8 tt0 -79.97 71.8 6.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.939 0.399 . . . . 0.0 110.196 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 72' ' ' LEU . 13.0 ptp -90.87 -174.02 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.22 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -132.66 75.45 1.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.836 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.639 HD12 ' CE2' ' A' ' 6' ' ' TYR . 86.4 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.39 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.725 0.297 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 174.82 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.508 2.139 . . . . 0.0 112.135 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.436 ' ND2' HD23 ' A' ' 72' ' ' LEU . 7.5 p30 -87.01 -172.14 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.032 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -21.51 42.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -50.66 -42.46 56.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 111.285 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -64.67 -39.2 93.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.23 -43.14 99.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.681 HG21 HD11 ' A' ' 31' ' ' LEU . 21.6 t -59.32 -51.49 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.937 0.399 . . . . 0.0 111.058 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.61 HG12 HD13 ' A' ' 91' ' ' ILE . 21.7 t -61.99 -42.63 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.122 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -17.48 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.331 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.08 -15.71 15.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.136 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.916 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -62.1 142.37 95.55 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.857 0.328 . . . . 0.0 110.972 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 88' ' ' THR . 52.7 Cg_exo -54.94 -20.21 22.16 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.19 36.34 3.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.977 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 88' ' ' THR . 2.1 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.519 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 15.1 mmm-85 . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.425 0.155 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 89.0 Cg_endo -81.72 -169.99 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.598 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -153.34 71.17 6.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.097 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.17 132.74 48.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.591 HD13 ' CD1' ' A' ' 112' ' ' ILE . 0.5 OUTLIER -88.11 161.65 17.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.9 OUTLIER -89.98 153.56 47.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.05 -48.61 20.26 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.532 2.155 . . . . 0.0 112.428 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.29 -31.9 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 112' ' ' ILE . 1.8 mp0 -81.59 -36.64 28.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 105' ' ' SER . 41.2 t -58.96 -45.7 91.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -27.13 68.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.511 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 m80 -81.64 -37.31 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.057 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.675 HD12 ' CD2' ' A' ' 67' ' ' PHE . 8.1 pt -81.33 -20.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.003 HD22 HD12 ' A' ' 118' ' ' LEU . 22.3 mt -86.94 -33.08 19.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.8 -32.79 73.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.663 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.544 HG11 HD21 ' A' ' 61' ' ' LEU . 35.2 t -80.92 -35.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.903 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.8 ' OG ' HD12 ' A' ' 39' ' ' LEU . 1.5 t -60.33 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.809 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.49 42.59 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.628 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.003 HD12 HD22 ' A' ' 113' ' ' LEU . 23.2 mt -117.29 -56.96 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -30.29 40.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.546 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.86 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.42 0.153 . . . . 0.0 110.766 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -147.91 163.15 37.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 112.105 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.774 ' CD1' HG11 ' A' ' 109' ' ' VAL . 67.8 m95 -94.27 139.3 31.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.671 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CE2' HD12 ' A' ' 72' ' ' LEU . 21.0 m-85 -125.64 110.03 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.06 151.19 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.054 0.454 . . . . 0.0 111.745 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.61 162.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.31 151.52 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.056 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.4 p -149.14 -178.24 6.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -89.87 140.67 29.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' H ' HD23 ' A' ' 11' ' ' LEU . 28.3 t -62.06 125.3 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.71 -37.98 3.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 -21.55 34.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -54.76 -43.15 72.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.06 -46.53 75.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -24.72 36.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.055 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.26 74.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -33.11 71.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 -51.6 23.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.7 -33.26 71.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.651 HD11 HG22 ' A' ' 85' ' ' VAL . 56.1 tp -73.48 -55.01 6.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.58 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -30.34 8.87 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -72.35 -42.88 64.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.726 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -66.57 -34.7 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.666 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.842 HG23 ' HB2' ' A' ' 31' ' ' LEU . 36.0 mm -69.47 -31.58 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -32.68 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.52 -41.96 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -80.78 -25.39 37.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.41 5.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.402 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.842 ' HB2' HG23 ' A' ' 26' ' ' ILE . 2.3 mt -99.85 28.63 4.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.722 0.296 . . . . 0.0 110.999 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -71.88 -10.54 59.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 15.8 t70 -79.67 -24.88 41.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.01 -54.49 4.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.2 mp -87.77 137.9 20.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.707 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.86 ' CE2' HG21 ' A' ' 3' ' ' ILE . 13.1 m-85 -129.93 -56.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.513 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.575 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -109.44 134.37 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.144 0.497 . . . . 0.0 112.067 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 38' ' ' VAL . 5.1 m -125.15 99.59 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.284 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.542 HD23 ' HB3' ' A' ' 116' ' ' SER . 1.9 tm? -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.469 ' N ' HD22 ' A' ' 39' ' ' LEU . 16.5 tt -87.68 125.09 66.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' O ' HG23 ' A' ' 42' ' ' THR . 27.6 Cg_endo -62.16 76.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.651 2.234 . . . . 0.0 112.563 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 41' ' ' PRO . 25.3 p . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.9 mttm . . . . . 0 N--CA 1.459 0.024 0 CA-C-O 120.721 0.296 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.8 OUTLIER -138.66 116.88 11.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.03 -55.52 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.627 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.1 m-85 -121.31 79.51 36.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.21 144.28 81.81 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.296 . . . . 0.0 112.671 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.93 18.43 70.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.139 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -129.13 162.7 27.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.35 122.29 8.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.353 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.739 ' CD1' HD11 ' A' ' 104' ' ' LEU . 11.6 m-30 -89.59 130.03 35.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.956 0.408 . . . . 0.0 111.217 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 6' ' ' TYR . 2.3 mt -130.73 111.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.575 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -79.71 68.42 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.673 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.469 ' CE ' HD21 ' A' ' 72' ' ' LEU . 10.2 ptm -91.66 -164.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -141.07 71.24 1.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.585 HD12 ' CE2' ' A' ' 6' ' ' TYR . 95.4 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.743 0.306 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.33 151.14 81.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.542 2.161 . . . . 0.0 112.332 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.21 -167.69 1.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -66.12 -27.44 68.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.853 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -52.18 -39.8 60.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.319 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -74.59 -33.27 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -31.41 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.72 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.83 -44.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 81' ' ' ALA . 28.9 t -64.42 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.98 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -13.56 62.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.07 -12.78 10.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.051 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.637 HG21 ' CD1' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -58.89 159.74 12.65 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.908 0.354 . . . . 0.0 110.891 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.99 122.84 9.45 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.543 2.162 . . . . 0.0 112.385 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.71 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.3 mm . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.055 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.514 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 111.406 0.15 . . . . 0.0 111.406 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 82.5 Cg_exo -47.79 127.44 14.32 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.344 2.029 . . . . 0.0 112.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 102' ' ' VAL . 9.6 p -98.07 105.26 26.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.271 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.68 124.45 8.2 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.341 2.028 . . . . 0.0 111.997 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.739 HD11 ' CD1' ' A' ' 67' ' ' PHE . 68.2 mt -59.55 134.22 56.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.928 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.5 p -76.61 150.79 82.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.81 -31.75 73.85 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.639 2.226 . . . . 0.0 112.271 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.76 -28.39 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -37.09 10.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 105' ' ' SER . 24.5 t -58.63 -29.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.17 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -60.22 -39.25 86.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.88 -55.7 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.498 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.627 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.3 pp -63.56 -22.14 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.665 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.866 ' CD2' HD12 ' A' ' 118' ' ' LEU . 1.9 mt -70.41 -39.52 74.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.26 -29.3 67.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.68 -41.19 62.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.542 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -60.22 -62.11 2.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 110.581 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.717 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 132.69 36.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.024 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.866 HD12 ' CD2' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -112.56 -27.95 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -49.98 11.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.447 -1.196 . . . . 0.0 112.562 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.617 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.492 0.187 . . . . 0.0 110.908 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.05 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.175 0.512 . . . . 0.0 111.832 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.919 ' CZ2' HD21 ' A' ' 113' ' ' LEU . 73.0 m95 -95.56 88.53 5.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.466 ' CE2' HD12 ' A' ' 72' ' ' LEU . 50.6 m-85 -81.27 123.64 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.04 127.12 53.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.94 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 91' ' ' ILE . 1.5 p -108.03 159.88 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 111.084 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.482 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 63.9 m80 -83.86 136.48 34.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -143.55 151.57 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.31 136.6 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.75 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -57.58 111.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.262 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.59 -20.47 32.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.691 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.59 -16.96 15.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.617 0.246 . . . . 0.0 111.308 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -33.92 59.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.83 0.348 . . . . 0.0 111.133 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.82 -31.84 71.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.992 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -26.06 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.176 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -65.89 -30.67 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.86 47.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -62.12 -25.18 67.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.58 HD11 HG22 ' A' ' 85' ' ' VAL . 25.8 tp -86.7 -56.81 3.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -45.91 -37.68 6.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.426 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 -33.62 70.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.875 ' HG3' HG22 ' A' ' 88' ' ' THR . 4.9 mmt-85 -75.64 -32.37 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.636 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.837 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.7 mm -70.39 -31.4 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.734 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -84.04 -30.4 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -42.05 38.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -80.04 -25.58 40.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.962 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.07 66.52 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.468 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.837 ' HB2' HG23 ' A' ' 26' ' ' ILE . 1.5 mt -125.82 30.1 5.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.987 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -25.39 68.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.07 -1.79 41.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.365 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -99.47 -58.65 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.755 0.312 . . . . 0.0 110.748 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.441 HD12 HG21 ' A' ' 26' ' ' ILE . 37.6 mt -81.45 132.92 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 3' ' ' ILE . 3.0 m-85 -127.02 -49.99 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.19 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -117.14 156.66 27.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.107 0.479 . . . . 0.0 111.697 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.707 ' O ' HD22 ' A' ' 39' ' ' LEU . 3.6 m -159.91 114.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.841 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.5 mm? -130.04 177.32 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.406 0.622 . . . . 0.0 112.07 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 42' ' ' THR . 28.7 mt -148.56 74.25 10.52 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.785 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 87.9 Cg_exo -41.66 113.78 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.176 2.584 . . . . 0.0 113.59 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 40' ' ' ILE . 29.4 p . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.063 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.893 0.378 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HG3' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -57.48 115.2 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.582 HD12 HG11 ' A' ' 115' ' ' VAL . 17.9 mt -61.86 -44.55 96.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.309 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 41' ' ' PRO . 2.1 m-85 -115.57 76.92 5.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.563 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.54 127.77 16.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.67 2.246 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.66 72.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.579 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -128.89 111.03 12.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.97 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 66' ' ' LEU . 18.5 mt -90.9 114.91 27.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.514 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.742 ' CE2' HD12 ' A' ' 112' ' ' ILE . 6.6 m-30 -82.47 122.85 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -128.87 110.16 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 3.6 tt0 -79.97 69.97 6.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.686 ' SD ' HD11 ' A' ' 72' ' ' LEU . 15.6 ptp -90.84 -178.13 5.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.487 ' O ' HD23 ' A' ' 72' ' ' LEU . 3.4 t0 -119.53 98.88 6.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.686 HD11 ' SD ' ' A' ' 70' ' ' MET . 39.4 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.795 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.462 0.172 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 173.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.433 2.089 . . . . 0.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.38 179.19 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.2 -25.21 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.754 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.08 -28.89 27.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 111.237 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -63.76 -48.61 76.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -58.88 -30.26 67.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.796 HG21 HD11 ' A' ' 31' ' ' LEU . 21.6 t -77.69 -49.67 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.184 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 81' ' ' ALA . 39.1 t -59.96 -52.68 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttp85 -58.03 -22.84 51.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.52 -32.39 11.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.728 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.875 HG22 ' HG3' ' A' ' 25' ' ' ARG . 65.7 p -59.13 130.64 86.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.493 0.187 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.78 -23.87 35.52 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.393 2.062 . . . . 0.0 112.314 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.41 -29.19 46.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.735 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.525 HD12 HG21 ' A' ' 8' ' ' VAL . 40.0 mm . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.476 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.523 0.202 . . . . 0.0 110.964 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 84.7 Cg_endo -81.18 130.43 7.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.502 2.135 . . . . 0.0 112.107 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.6 t -129.68 99.7 20.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.262 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.9 139.14 10.77 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.645 2.23 . . . . 0.0 112.252 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.889 HD22 HD13 ' A' ' 112' ' ' ILE . 1.2 mp -67.59 156.75 36.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.06 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.91 ' O ' HG23 ' A' ' 109' ' ' VAL . 47.6 p -85.44 149.97 53.15 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.757 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -45.98 -49.58 10.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.773 2.316 . . . . 0.0 112.873 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.47 -39.98 85.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.17 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.66 -33.3 47.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 105' ' ' SER . 58.4 t -58.79 -31.4 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.237 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -26.01 56.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.728 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -82.33 -29.23 31.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.108 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.889 HD13 HD22 ' A' ' 104' ' ' LEU . 34.2 pt -80.68 -32.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.111 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.955 HD22 HD12 ' A' ' 118' ' ' LEU . 97.9 mt -77.5 -25.2 50.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.23 -32.37 61.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.979 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 111' ' ' HIS . 21.3 t -75.49 -48.2 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.072 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.841 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -58.48 -59.98 4.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 137.14 67.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.597 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.955 HD12 HD22 ' A' ' 113' ' ' LEU . 23.1 mt -129.05 -47.46 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.822 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -61.73 1.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.491 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.807 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.392 0.139 . . . . 0.0 110.839 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.01 139.54 52.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.292 0.568 . . . . 0.0 112.092 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 1.097 ' CH2' HD22 ' A' ' 39' ' ' LEU . 25.7 m95 -94.94 96.23 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.047 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.466 ' O ' HD12 ' A' ' 68' ' ' ILE . 44.9 m-85 -96.67 112.96 24.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.397 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.426 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -108.14 134.88 50.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.753 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.695 HG21 HD12 ' A' ' 91' ' ' ILE . 1.5 p -134.14 160.18 41.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.196 0.522 . . . . 0.0 111.234 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.509 ' CE1' ' CE2' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -82.26 147.12 29.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.97 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -123.83 -173.83 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mt -87.7 127.61 35.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.72 114.87 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.6 -28.8 11.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.52 -7.78 37.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.622 0.249 . . . . 0.0 111.292 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -55.74 -39.72 71.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -52.45 65.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -14.34 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.359 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.536 ' HB1' ' CA ' ' A' ' 90' ' ' GLY . . . -70.44 -51.21 31.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 111.228 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -56.57 -41.56 77.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.04 -43.35 92.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -62.19 -34.49 76.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD13 HG21 ' A' ' 88' ' ' THR . 26.3 tp -84.02 -45.07 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.574 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.4 tt0 -55.23 -26.41 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -78.32 -47.61 17.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.318 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.02 -27.3 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.352 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.732 HG12 HD13 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -70.63 -29.35 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -87.38 -31.52 20.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.6 -32.36 67.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.044 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -87.89 5.7 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.53 47.49 86.63 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 26' ' ' ILE . 8.8 mt -111.08 9.63 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.536 0.207 . . . . 0.0 111.266 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -17.25 63.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 0.0 111.259 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.93 -38.53 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.041 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.37 -51.75 33.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.732 HD13 HG12 ' A' ' 26' ' ' ILE . 4.8 mp -79.87 117.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.807 ' CE2' HG21 ' A' ' 3' ' ' ILE . 31.7 m-85 -100.95 -53.17 3.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.472 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 5.1 mm-40 -107.95 169.89 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.374 0.606 . . . . 0.0 111.651 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.3 p -156.33 73.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.35 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.097 HD22 ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -79.55 139.48 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.638 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.614 HG22 HG23 ' A' ' 42' ' ' THR . 14.4 mt -100.5 138.3 20.13 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 40' ' ' ILE . 67.9 Cg_endo -72.72 59.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.543 2.162 . . . . 0.0 112.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.614 HG23 HG22 ' A' ' 40' ' ' ILE . 44.1 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.965 0.412 . . . . 0.0 111.317 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -141.92 121.21 13.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.971 HD11 HG11 ' A' ' 115' ' ' VAL . 2.1 mt -90.27 -65.78 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.592 ' HE2' HG22 ' A' ' 112' ' ' ILE . 6.6 m-85 -103.9 90.42 2.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.763 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.01 123.02 11.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.128 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.39 29.06 54.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.569 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.509 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 19.3 m-85 -117.27 177.68 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.2 tp -160.21 148.87 17.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.756 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.656 ' CE2' HG21 ' A' ' 112' ' ' ILE . 18.2 m-85 -132.5 125.62 31.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.572 HG22 HG23 ' A' ' 35' ' ' ILE . 1.3 mp -133.04 112.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.53 ' NE2' HD11 ' A' ' 3' ' ' ILE . 8.6 tt0 -79.9 72.41 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 110.675 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.419 ' HG3' ' HG ' ' A' ' 72' ' ' LEU . 2.1 ptm -91.37 -166.52 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 1.2 p30 -136.71 78.46 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 110.982 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.432 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 35.3 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.637 0.256 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.46 179.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.387 2.058 . . . . 0.0 112.185 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -171.97 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -70.79 -26.2 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.101 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.873 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.55 -28.96 34.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.323 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 101' ' ' PRO . 12.5 t-105 -69.46 -36.15 76.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.7 -30.0 70.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.583 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -82.29 -45.89 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.7 t -61.45 -50.21 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.056 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -29.91 70.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.58 -27.07 52.63 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.582 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.531 HG21 HD13 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -69.32 147.31 97.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.865 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.52 -20.79 35.52 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.378 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' CA ' ' HB1' ' A' ' 18' ' ' ALA . . . -55.89 -28.1 52.12 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.636 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 8' ' ' VAL . 41.9 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.437 0.161 . . . . 0.0 111.244 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 98.1 Cg_endo -79.93 143.75 16.55 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.348 2.032 . . . . 0.0 112.297 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -127.17 110.68 21.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.252 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 96.4 Cg_endo -79.1 132.12 10.25 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.613 2.209 . . . . 0.0 112.239 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.694 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.9 mp -86.12 147.27 26.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.858 ' O ' HG23 ' A' ' 109' ' ' VAL . 18.9 p -90.07 159.48 42.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.22 -27.23 6.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.753 2.302 . . . . 0.0 112.544 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -44.83 74.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.67 -32.4 17.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 105' ' ' SER . 38.7 t -62.22 -28.57 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.342 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -69.34 -28.21 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.648 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -72.54 -51.42 19.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.765 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.855 HD12 HD23 ' A' ' 39' ' ' LEU . 1.5 pp -68.01 -13.76 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.692 HD23 ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -83.77 -40.83 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.857 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.97 -40.35 71.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 61' ' ' LEU . 5.7 t -71.64 -44.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.487 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 15.4 p -56.18 -62.38 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.76 42.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.569 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.692 ' HB2' HD23 ' A' ' 113' ' ' LEU . 19.1 mt -111.2 -36.01 5.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -98.17 -34.4 10.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.519 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.459 HG22 ' HB2' ' A' ' 71' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.476 0.179 . . . . 0.0 110.764 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 163.88 31.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.874 ' CD1' HG11 ' A' ' 109' ' ' VAL . 72.9 m95 -88.72 96.27 10.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 4.8 m-85 -79.74 124.52 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -114.19 134.63 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.533 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.654 HG21 ' CD1' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -126.58 -166.97 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.626 ' N ' HG13 ' A' ' 8' ' ' VAL . 2.7 m80 -132.87 160.72 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 111.213 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.6 p -156.35 174.75 14.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.53 139.1 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 t -65.34 125.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.16 -28.43 12.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -92.98 -16.52 25.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 111.162 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.79 -36.01 46.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.805 0.336 . . . . 0.0 111.207 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -59.75 -30.81 69.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.07 -28.91 19.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.955 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.52 68.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -53.28 59.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.86 -42.89 89.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -59.76 -31.14 69.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.67 HD11 HG22 ' A' ' 85' ' ' VAL . 55.5 tp -88.96 -48.89 7.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.792 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.7 tm-20 -62.58 -24.19 67.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -80.55 -38.38 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.254 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.37 -22.46 61.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 23' ' ' GLU . 1.1 tp -72.3 -28.89 30.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.016 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -89.61 -30.1 18.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.23 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -86.68 -30.29 21.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.76 41.6 4.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -101.51 25.69 8.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -66.92 -16.78 64.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.251 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.8 -25.69 40.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -79.63 -61.06 2.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 70' ' ' MET . 1.8 pt -79.86 158.86 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.1 m-85 -143.88 -49.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -118.28 145.7 44.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.376 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.622 ' CG1' HG23 ' A' ' 68' ' ' ILE . 3.0 m -150.04 102.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.876 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.698 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.4 mm? -112.76 155.7 24.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.029 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.519 HG22 HG23 ' A' ' 42' ' ' THR . 3.6 mp -103.81 126.82 30.82 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 50.4 Cg_endo -69.27 62.44 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.605 2.203 . . . . 0.0 112.486 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.519 HG23 HG22 ' A' ' 40' ' ' ILE . 55.9 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.056 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.839 0.352 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -55.5 106.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.531 HD21 HG11 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -62.76 -51.49 66.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.614 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 61' ' ' LEU . 14.6 m-85 -105.77 94.95 9.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.416 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.9 129.05 31.38 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.511 2.141 . . . . 0.0 112.495 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.06 40.36 82.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.56 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -124.23 144.41 49.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.003 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.95 124.98 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.721 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.2 m-85 -96.39 133.79 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.227 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.622 HG23 ' CG1' ' A' ' 38' ' ' VAL . 3.1 mp -142.32 114.17 3.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 7.1 tt0 -79.9 76.28 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 35' ' ' ILE . 21.2 ptp -91.63 -168.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.821 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 3' ' ' ILE . 21.6 t0 -156.24 91.77 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.741 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 81.7 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.518 0.199 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.5 173.82 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.394 2.063 . . . . 0.0 112.247 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -90.09 -171.08 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.45 -27.81 68.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.99 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.782 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.2 -38.67 65.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.209 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.426 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 11.8 t-105 -66.82 -36.5 82.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.25 -32.17 69.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -85.14 -39.41 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.9 t -71.28 -33.41 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -18.01 62.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.6 -4.21 30.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.023 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -71.17 133.11 85.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.962 0.381 . . . . 0.0 110.737 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.8 121.2 9.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.152 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.02 -29.56 5.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.593 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 88' ' ' THR . 2.5 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.723 0.297 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.426 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.7 Cg_exo -54.07 174.34 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.622 2.215 . . . . 0.0 112.299 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 102' ' ' VAL . 13.2 m -139.2 94.07 9.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.221 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.11 130.98 14.84 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.564 2.176 . . . . 0.0 112.404 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 5' ' ' TRP . 3.3 mp -78.99 162.18 26.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.916 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -89.09 156.49 49.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.926 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.59 -30.57 89.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.626 2.217 . . . . 0.0 112.271 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.15 -29.01 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.16 -38.19 11.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.916 HG23 ' O ' ' A' ' 105' ' ' SER . 40.0 t -58.95 -35.52 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -25.41 68.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.754 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -80.25 -41.2 25.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.783 HD12 ' CD2' ' A' ' 67' ' ' PHE . 12.1 pt -76.13 -22.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.202 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 118' ' ' LEU . 85.6 mt -84.15 -30.18 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 110.758 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -31.01 61.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 111' ' ' HIS . 23.6 t -77.2 -38.44 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.789 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 149.12 56.63 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.66 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.048 HD12 HD22 ' A' ' 113' ' ' LEU . 41.5 mt -127.92 -60.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.006 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -34.71 38.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.528 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.578 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.452 0.168 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -154.0 150.19 28.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.267 0.555 . . . . 0.0 112.136 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 1.075 ' CH2' HD22 ' A' ' 39' ' ' LEU . 46.2 m95 -89.91 95.27 10.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.388 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.687 ' CE2' HD11 ' A' ' 72' ' ' LEU . 44.6 m-85 -91.15 116.01 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.85 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -100.84 143.27 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.453 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 9' ' ' HIS . 14.7 t -143.34 160.05 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.699 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.46 ' N ' HG12 ' A' ' 8' ' ' VAL . 8.1 p-80 -131.53 152.74 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.876 0.369 . . . . 0.0 111.164 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -139.81 -165.56 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.794 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -70.53 136.03 49.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.982 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' H ' HD13 ' A' ' 11' ' ' LEU . 37.2 t -67.32 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.31 -32.02 6.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.432 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -93.59 -22.14 18.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.051 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -32.07 20.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.152 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.47 -48.06 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -27.29 60.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.04 93.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -42.93 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.96 56.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.34 -34.89 78.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.764 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.585 HD11 HG22 ' A' ' 85' ' ' VAL . 16.0 tp -69.81 -57.87 4.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.813 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -49.14 -35.21 15.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -69.55 -43.93 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -38.03 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.505 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.812 HG23 ' HB2' ' A' ' 31' ' ' LEU . 48.4 mm -67.69 -30.99 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.639 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -87.11 -29.21 22.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.99 -46.91 70.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -87.33 -25.1 24.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.3 61.5 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.324 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 84' ' ' VAL . 3.6 mm? -98.86 28.11 4.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.059 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -81.26 21.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.284 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -108.94 -15.73 14.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.979 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.843 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 2.0 mttp -116.69 -45.87 2.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.807 0.337 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.668 ' CD1' HD12 ' A' ' 26' ' ' ILE . 16.5 mt -80.29 135.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 3' ' ' ILE . 15.6 m-85 -133.06 -60.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.655 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.55 133.3 46.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.535 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.1 p -128.12 76.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.271 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.075 HD22 ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -80.0 139.41 37.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.119 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.413 HG23 ' HD2' ' A' ' 41' ' ' PRO . 27.8 mm -98.93 136.99 20.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 62' ' ' PHE . 80.0 Cg_endo -77.85 55.76 5.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.59 2.193 . . . . 0.0 112.769 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 115' ' ' VAL . 3.0 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.04 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.845 0.355 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 105.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.773 HD12 HG11 ' A' ' 115' ' ' VAL . 23.2 mt -63.98 -51.57 63.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.786 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 41' ' ' PRO . 86.8 m-85 -97.58 111.88 59.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.537 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 62' ' ' PHE . 18.0 Cg_endo -59.8 122.2 11.06 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.517 2.145 . . . . 0.0 112.73 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.17 43.65 25.81 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.198 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . 1.8 m-85 -117.11 173.99 6.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.635 HD23 HD11 ' A' ' 68' ' ' ILE . 7.5 tp -160.23 152.01 20.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' A' ' 112' ' ' ILE . 79.3 m-85 -126.21 120.64 30.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.564 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.635 HD11 HD23 ' A' ' 66' ' ' LEU . 1.1 mp -130.35 115.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.626 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.7 tt0 -83.22 70.17 10.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.314 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.725 ' SD ' HD23 ' A' ' 72' ' ' LEU . 5.4 ptm -91.51 -168.3 2.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.964 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -139.99 49.32 1.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.725 HD23 ' SD ' ' A' ' 70' ' ' MET . 4.5 pp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.976 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.682 0.277 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 85.4 Cg_endo -81.97 89.3 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.633 2.222 . . . . 0.0 112.718 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 p30 -90.26 -168.41 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.776 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 84' ' ' VAL . 5.7 tp10 56.85 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.66 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.843 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . . . -55.85 -43.35 76.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.312 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.446 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 2.6 t-105 -79.97 -35.55 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -27.65 62.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.981 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 31' ' ' LEU . 21.5 t -87.4 -51.69 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.7 t -58.56 -48.61 85.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -23.4 61.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.973 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.38 -26.0 37.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.67 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 84' ' ' VAL . 47.7 p -57.78 142.89 77.78 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.639 0.257 . . . . 0.0 110.921 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.73 -14.12 32.76 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.528 2.152 . . . . 0.0 112.558 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.03 -28.08 73.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.657 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 111.18 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.694 0.283 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HG3' ' CZ2' ' A' ' 82' ' ' TRP . 51.8 Cg_exo -54.07 -168.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.668 2.245 . . . . 0.0 112.4 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.22 109.62 6.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.371 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.34 120.39 3.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.217 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -68.09 155.43 39.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.161 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.835 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -90.07 166.94 18.3 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -51.33 -27.47 23.78 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.623 2.215 . . . . 0.0 112.443 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.47 -48.2 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.073 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -72.71 -34.31 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 105' ' ' SER . 58.5 t -62.2 -44.63 99.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.222 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -60.48 -26.68 66.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.46 -53.83 9.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.649 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 2.5 pp -67.51 -15.3 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.955 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.747 HD13 HG12 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -80.64 -40.41 25.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.86 -32.98 74.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.067 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.773 HG11 HD12 ' A' ' 61' ' ' LEU . 32.2 t -76.27 -50.03 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.474 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -56.26 -60.49 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.06 42.47 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.1 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.48 ' CB ' HD23 ' A' ' 113' ' ' LEU . 4.7 mt -109.36 -48.57 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 110.633 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tp -100.67 30.78 3.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.405 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.541 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.393 0.139 . . . . 0.0 110.853 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.49 157.22 39.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.175 0.512 . . . . 0.0 112.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.786 ' CD1' HG11 ' A' ' 109' ' ' VAL . 78.5 m95 -98.07 85.75 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.121 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.858 ' CE2' HD12 ' A' ' 72' ' ' LEU . 68.6 m-85 -80.63 124.76 29.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.988 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.572 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . -95.84 138.23 33.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.389 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.556 HG11 HD12 ' A' ' 91' ' ' ILE . 15.4 t -125.16 160.07 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.461 ' N ' HG12 ' A' ' 8' ' ' VAL . 17.8 m-70 -94.3 132.55 38.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.832 HG21 HD12 ' A' ' 66' ' ' LEU . 20.7 p -124.12 177.54 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.47 132.15 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.81 123.73 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.198 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.29 -27.91 17.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.462 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -104.65 -3.06 24.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.627 0.251 . . . . 0.0 111.376 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.551 ' OE1' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -57.38 -34.07 68.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.769 0.319 . . . . 0.0 111.038 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -58.47 -40.71 83.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.52 -24.72 31.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.28 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -37.29 79.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -53.06 15.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.034 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -59.17 -31.75 69.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.637 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.742 HD11 HG22 ' A' ' 85' ' ' VAL . 18.4 tp -77.14 -57.48 3.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.716 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -49.72 -31.18 10.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -38.66 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.637 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -36.07 72.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.601 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 35' ' ' ILE . 38.4 mm -67.44 -31.4 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -30.16 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.33 -32.32 37.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -85.02 -27.26 26.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.8 61.11 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.892 HD11 HG21 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -119.46 28.69 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.943 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -8.07 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.335 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.96 -29.05 39.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -96.11 -55.58 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.718 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -80.02 145.01 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.789 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.823 ' N ' HD13 ' A' ' 35' ' ' ILE . 8.2 m-85 -131.87 -44.45 0.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.132 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -122.09 154.93 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.619 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.708 HG23 HD11 ' A' ' 35' ' ' ILE . 26.3 t -154.4 67.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.288 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.669 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.6 mm? -79.97 152.3 29.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.263 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.551 HD11 ' OE1' ' A' ' 15' ' ' GLU . 4.5 tp -108.16 118.34 52.76 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.813 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 46.1 Cg_exo -55.33 80.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.731 2.287 . . . . 0.0 112.528 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 60' ' ' LYS . 58.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 42' ' ' THR . 5.3 mtpt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.687 0.28 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 42' ' ' THR . 8.1 mttm -103.11 123.65 47.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.048 HD11 HG11 ' A' ' 115' ' ' VAL . 10.0 mt -88.53 -48.62 7.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.515 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 62' ' ' PHE . 2.7 m-85 -124.58 89.22 52.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.407 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.96 131.53 39.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.667 2.245 . . . . 0.0 112.934 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 9' ' ' HIS . . . 62.18 36.31 92.8 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.153 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.53 150.75 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.905 0.353 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.832 HD12 HG21 ' A' ' 10' ' ' THR . 4.4 mt -142.78 117.82 10.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.834 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 112' ' ' ILE . 12.8 m-85 -82.48 121.04 26.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.4 mp -128.57 107.5 15.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.436 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 4.5 tt0 -80.03 70.48 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -91.23 -179.78 5.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.261 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -120.83 89.86 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.846 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.858 HD12 ' CE2' ' A' ' 6' ' ' TYR . 13.3 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.609 0.243 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.98 92.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.546 2.164 . . . . 0.0 112.221 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 81' ' ' ALA . 18.5 m-80 -90.35 -176.6 4.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 51.4 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -46.56 -50.88 16.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.821 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -72.21 -32.38 66.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.063 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -33.36 72.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.993 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.892 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -90.01 -48.18 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.3 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 81' ' ' ALA . 38.0 t -61.67 -45.29 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.242 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -62.2 -18.61 61.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.275 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -102.08 -25.19 8.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.809 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.729 HG21 HD12 ' A' ' 22' ' ' LEU . 1.5 p -59.96 145.06 85.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.66 -25.96 62.62 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.566 2.178 . . . . 0.0 112.218 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.81 -34.15 56.67 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.674 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.556 HD12 HG11 ' A' ' 8' ' ' VAL . 35.5 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.734 0.302 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 76.9 Cg_exo -50.59 179.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 7' ' ' ALA . 6.3 m -133.31 92.29 24.99 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.235 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 145.04 30.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.621 2.214 . . . . 0.0 112.325 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.686 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -89.94 169.17 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -90.06 150.81 44.16 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.767 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.53 -29.34 24.36 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.583 2.189 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.59 -30.97 57.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 112' ' ' ILE . 48.9 tt0 -90.3 -33.64 16.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 105' ' ' SER . 35.9 t -63.8 -35.48 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.227 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -29.16 66.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.67 ' O ' HG23 ' A' ' 115' ' ' VAL . 15.2 m80 -77.92 -40.38 39.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.784 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 12.4 pt -74.72 -29.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.032 HD22 HD12 ' A' ' 118' ' ' LEU . 62.9 mt -77.71 -32.58 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.559 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.39 -33.25 74.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 1.048 HG11 HD11 ' A' ' 61' ' ' LEU . 22.7 t -72.82 -35.29 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.949 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.669 ' HB3' HD12 ' A' ' 39' ' ' LEU . 13.5 m -64.34 -59.81 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.94 44.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.527 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.032 HD12 HD22 ' A' ' 113' ' ' LEU . 12.7 mt -115.92 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.85 -44.7 20.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.465 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.362 0.125 . . . . 0.0 110.738 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.0 158.21 44.26 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 112.281 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 1.001 ' CH2' HD12 ' A' ' 39' ' ' LEU . 78.6 m95 -93.22 91.03 7.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.487 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.675 ' O ' HD12 ' A' ' 68' ' ' ILE . 51.8 m-85 -87.48 99.12 11.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -80.45 154.97 27.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.733 HG11 HD11 ' A' ' 91' ' ' ILE . 14.3 t -139.07 159.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.48 ' N ' HG12 ' A' ' 8' ' ' VAL . 1.5 m80 -112.92 135.82 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 91' ' ' ILE . 62.2 p -129.11 -177.49 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.01 142.34 27.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.875 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.39 129.81 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.45 -27.5 17.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.02 -20.02 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.578 0.228 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 12.2 pt-20 -56.66 -39.92 74.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.986 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -52.49 -67.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -61.72 -23.22 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.038 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -59.33 -46.92 87.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -59.85 -46.97 87.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.08 69.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.36 -43.99 95.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.76 HD11 HG22 ' A' ' 85' ' ' VAL . 37.8 tp -70.62 -48.54 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.852 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.4 tt0 -62.51 -17.33 59.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -84.67 -43.92 13.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.001 0.429 . . . . 0.0 110.227 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -23.93 66.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.355 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 23' ' ' GLU . 1.3 tp -67.91 -29.51 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.816 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 -30.57 15.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.62 62.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -79.91 -30.36 40.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.25 34.5 5.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.474 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.63 25.23 6.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.955 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -19.7 62.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.17 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -79.96 -26.27 40.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.061 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -77.89 -58.89 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.759 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.888 HD11 ' CG1' ' A' ' 38' ' ' VAL . 9.2 tt -79.94 130.91 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 3' ' ' ILE . 8.9 m-85 -117.57 -48.27 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.117 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.609 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -120.79 151.59 39.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.888 ' CG1' HD11 ' A' ' 35' ' ' ILE . 17.4 m -143.8 126.54 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.001 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -109.65 135.19 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 40' ' ' ILE . 2.1 mp -90.89 136.41 27.67 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.817 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.866 ' O ' HD12 ' A' ' 61' ' ' LEU . 28.1 Cg_endo -61.62 -15.56 42.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.624 2.216 . . . . 0.0 112.906 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 60' ' ' LYS . 16.4 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 111.13 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.3 pttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.726 0.298 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 42' ' ' THR . 1.5 mttt -71.83 111.28 6.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.004 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -89.82 -39.65 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.614 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.406 ' HB3' ' CG ' ' A' ' 65' ' ' TYR . 33.3 m-85 -111.58 94.07 21.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.99 126.34 18.58 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.384 2.056 . . . . 0.0 112.416 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.93 37.06 93.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.414 ' CE1' ' CD2' ' A' ' 9' ' ' HIS . 3.0 m-85 -117.93 166.05 12.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.818 0.342 . . . . 0.0 110.97 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.441 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -160.08 151.12 19.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.415 ' HB2' ' CB ' ' A' ' 39' ' ' LEU . 4.7 m-85 -131.71 130.56 42.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.028 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.675 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.7 mp -134.52 117.31 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.496 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.609 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -83.77 65.81 8.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.411 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.437 ' CE ' HD23 ' A' ' 72' ' ' LEU . 5.8 ptm -91.57 -170.35 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.048 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD1' ' CZ ' ' A' ' 36' ' ' PHE . 6.4 p-10 -144.39 52.3 1.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.651 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 72' ' ' LEU . 4.5 pp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.9 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.763 0.316 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.45 179.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.492 2.128 . . . . 0.0 112.291 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -89.99 -177.56 5.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.52 -26.71 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.712 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -52.94 -30.06 32.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.293 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.428 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.8 t-105 -75.51 -31.01 60.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.57 -30.62 63.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.569 HG21 HD11 ' A' ' 31' ' ' LEU . 21.5 t -79.43 -52.73 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.76 HG22 HD11 ' A' ' 22' ' ' LEU . 34.1 t -59.9 -43.3 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -69.27 -15.51 63.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.26 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.29 -15.06 20.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.957 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.77 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -64.54 132.19 95.32 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.778 0.289 . . . . 0.0 110.848 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.9 137.12 40.52 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.418 2.078 . . . . 0.0 112.243 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.19 -17.39 58.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.734 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.984 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.677 0.275 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.428 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.9 Cg_exo -53.05 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.546 2.164 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.8 p -149.25 95.06 3.87 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.287 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.09 128.42 9.86 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.402 2.068 . . . . 0.0 111.912 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -79.86 157.87 26.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.19 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.6 p -80.72 160.22 67.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.525 ' O ' HG12 ' A' ' 109' ' ' VAL . 35.9 Cg_exo -59.82 -56.93 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.679 2.253 . . . . 0.0 112.564 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -52.59 -25.72 11.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.231 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -30.81 13.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -65.83 -29.56 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -32.72 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.477 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.11 -49.02 30.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.311 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.578 ' CD1' HD13 ' A' ' 39' ' ' LEU . 2.7 pp -62.24 -29.56 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.176 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.563 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -59.09 -35.78 73.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.737 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.82 -21.02 64.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.266 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.658 ' CG1' HD11 ' A' ' 61' ' ' LEU . 38.0 t -71.94 -61.93 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.421 ' HB2' HD23 ' A' ' 39' ' ' LEU . 11.3 t -52.2 -59.31 4.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.029 0.442 . . . . 0.0 111.001 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.88 42.68 0.17 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.563 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.563 HD12 ' HG ' ' A' ' 113' ' ' LEU . 5.3 mt -103.63 -31.38 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -80.0 -56.71 4.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.501 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.631 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.411 0.148 . . . . 0.0 110.9 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.97 155.82 36.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.412 0.625 . . . . 0.0 112.232 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.774 ' CD1' HG11 ' A' ' 109' ' ' VAL . 90.6 m95 -95.64 93.52 7.18 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.459 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.814 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 95.9 m-85 -86.15 108.58 18.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.839 0.352 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -93.45 140.24 29.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.115 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 9' ' ' HIS . 14.2 t -132.87 159.68 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.469 ' N ' HG12 ' A' ' 8' ' ' VAL . 11.2 m-70 -85.12 157.29 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -153.52 167.12 30.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.12 140.65 36.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.2 p -67.9 121.68 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.121 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.75 -23.42 36.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.734 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -93.23 -28.02 16.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -58.16 -33.96 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -39.82 71.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -90.02 -24.2 21.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -59.49 -35.47 74.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -59.29 -57.28 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.16 96.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -65.26 -41.55 94.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.834 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.874 HD11 HG22 ' A' ' 85' ' ' VAL . 56.7 tp -66.13 -54.45 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.837 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -34.05 62.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -67.74 -43.75 79.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -41.54 74.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.892 ' HA ' HD12 ' A' ' 31' ' ' LEU . 1.1 mp -70.31 -26.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.871 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -92.71 -31.77 14.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.6 68.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -101.14 -26.56 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.05 81.65 1.36 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.52 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.9 mt -134.91 31.05 3.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -0.94 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.604 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -23.61 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.74 0.305 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 3.3 mtmm -106.53 -52.69 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.678 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.416 HD11 ' HB1' ' A' ' 81' ' ' ALA . 32.3 mt -79.84 113.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.315 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 3' ' ' ILE . 25.5 m-85 -107.46 -56.21 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.016 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.467 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -113.39 162.39 16.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.332 0.587 . . . . 0.0 112.497 -178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.3 p -160.01 77.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.773 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.014 HD11 HD21 ' A' ' 118' ' ' LEU . 4.6 mm? -89.27 167.91 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.397 0.618 . . . . 0.0 112.397 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.598 ' O ' HG23 ' A' ' 40' ' ' ILE . 1.6 tt -155.81 74.2 5.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.008 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.444 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 82.1 Cg_exo -42.33 128.43 4.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.299 2.666 . . . . 0.0 113.841 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.397 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 tptt . . . . . 0 N--CA 1.457 -0.093 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -37.6 126.03 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.734 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.802 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.7 mt -89.9 -34.93 15.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.604 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CE2' HG22 ' A' ' 112' ' ' ILE . 59.5 m-85 -116.45 81.01 10.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 61' ' ' LEU . 24.0 Cg_exo -63.47 144.27 90.09 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.679 2.253 . . . . 0.0 112.076 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.98 24.8 15.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 22.7 m-85 -131.04 117.26 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 110.735 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mt -116.73 116.3 27.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.393 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.2 mp -117.65 114.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.467 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 12.8 tt0 -79.7 68.44 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 ptp -91.27 -167.94 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.262 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -142.35 106.37 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.452 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.814 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 23.9 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.534 0.207 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.617 ' HA ' HD22 ' A' ' 72' ' ' LEU . 57.1 Cg_endo -71.01 159.23 53.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.258 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' A' ' 81' ' ' ALA . 23.2 p30 -90.12 -179.99 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.02 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.554 ' HG3' HD22 ' A' ' 31' ' ' LEU . 15.2 pt-20 -61.97 -32.63 73.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -56.6 -31.72 64.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.01 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.457 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -64.2 -47.88 78.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -57.07 -30.21 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -80.16 -54.83 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.99 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.874 HG22 HD11 ' A' ' 22' ' ' LEU . 24.1 t -56.62 -37.24 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.64 -20.61 65.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.94 -17.16 12.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.921 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.543 HG21 ' CD1' ' A' ' 22' ' ' LEU . 29.2 p -55.85 141.02 67.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.775 0.287 . . . . 0.0 111.095 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 52.7 Cg_exo -55.07 95.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.098 . . . . 0.0 112.279 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.77 -30.29 0.28 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.624 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.988 -179.917 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.781 0.324 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.529 ' O ' HG13 ' A' ' 102' ' ' VAL . 50.8 Cg_exo -55.91 -164.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.686 2.258 . . . . 0.0 112.416 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 101' ' ' PRO . 4.5 m -158.72 93.44 1.92 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.13 126.36 13.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.51 2.14 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 7' ' ' ALA . 4.5 mp -76.57 154.12 34.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.881 ' O ' HG23 ' A' ' 109' ' ' VAL . 3.5 m -82.34 157.9 67.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -29.84 87.79 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.748 2.299 . . . . 0.0 112.274 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -29.29 65.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 -34.82 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 105' ' ' SER . 22.5 t -68.83 -26.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.198 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -73.22 -37.14 66.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -44.49 64.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.614 HG22 ' CE2' ' A' ' 62' ' ' PHE . 2.6 pp -67.9 -23.26 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.802 HD23 HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -72.46 -31.08 65.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.2 -53.81 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.802 HG11 ' CD1' ' A' ' 61' ' ' LEU . 21.3 t -58.16 -37.27 61.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.709 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -55.97 -64.95 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.32 42.82 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.014 HD21 HD11 ' A' ' 39' ' ' LEU . 6.0 mt -115.14 -33.83 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 119' ' ' LEU . 1.3 tt -94.95 42.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.459 179.884 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.544 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.464 0.173 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.72 143.84 30.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.177 0.513 . . . . 0.0 112.042 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.856 ' CH2' HD12 ' A' ' 39' ' ' LEU . 63.9 m95 -100.79 92.29 5.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.167 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.688 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 58.3 m-85 -91.69 106.2 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.788 0.328 . . . . 0.0 111.33 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.86 124.96 32.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.558 HG11 HD12 ' A' ' 91' ' ' ILE . 5.2 t -100.0 162.05 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -122.66 133.27 54.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -136.78 -174.74 3.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 151.84 23.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.1 p -66.47 124.89 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.82 -27.61 18.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.61 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.07 -27.69 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.98 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.65 -35.11 70.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.98 -39.69 66.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -87.82 -27.94 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.024 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.0 69.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -58.36 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.027 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.87 -47.95 81.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.274 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.11 -40.51 73.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.992 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.927 HD11 HG22 ' A' ' 85' ' ' VAL . 31.6 tp -65.91 -53.41 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -58.77 -45.81 88.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.014 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -58.58 -41.91 86.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.658 ' HG3' HG22 ' A' ' 88' ' ' THR . 8.7 mmt85 -65.38 -46.91 78.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.759 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.788 HG23 HD12 ' A' ' 31' ' ' LEU . 81.1 mt -65.52 -32.05 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.936 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -31.66 39.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -36.54 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -82.64 -24.68 33.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.045 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.615 ' O ' HD23 ' A' ' 31' ' ' LEU . . . 87.66 77.35 1.27 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.376 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -139.61 38.76 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 110.726 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -8.74 56.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.402 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.2 m-20 -79.99 -28.06 39.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.41 -59.58 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.766 HG12 HG21 ' A' ' 26' ' ' ILE . 1.1 pt -79.92 122.02 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 3' ' ' ILE . 14.1 m-85 -110.0 -45.1 3.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.237 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.5 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.3 mm-40 -120.35 170.25 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.218 0.532 . . . . 0.0 111.89 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 t -154.31 88.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.149 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.856 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -79.72 157.15 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.758 HD12 ' OG1' ' A' ' 42' ' ' THR . 7.6 pt -120.2 145.37 40.03 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.939 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.47 -15.4 45.16 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.651 2.234 . . . . 0.0 113.002 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.758 ' OG1' HD12 ' A' ' 40' ' ' ILE . 80.5 p . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.075 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.8 pttt . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.826 0.346 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.741 ' HG3' HG22 ' A' ' 42' ' ' THR . 0.0 OUTLIER -81.37 109.18 15.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.408 HD12 HG21 ' A' ' 115' ' ' VAL . 47.4 mt -76.41 -68.61 0.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.651 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.412 ' CB ' ' HB2' ' A' ' 65' ' ' TYR . 46.6 m-85 -100.47 96.89 5.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.644 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.61 115.28 2.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.55 2.166 . . . . 0.0 112.635 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.58 38.39 51.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.821 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HB2' ' CB ' ' A' ' 62' ' ' PHE . 88.1 m-85 -132.61 109.98 10.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD21 ' HB ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -103.67 137.24 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.549 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.685 ' CE2' HD12 ' A' ' 112' ' ' ILE . 3.9 m-85 -106.37 135.59 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -135.08 110.43 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.638 HE21 ' HE1' ' A' ' 5' ' ' TRP . 15.5 tt0 -85.53 74.34 10.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 110.224 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.4 ptp -91.42 -167.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.499 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.471 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.7 t70 -137.48 94.98 2.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.655 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.688 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 15.5 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.047 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.529 0.204 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HA ' HD22 ' A' ' 72' ' ' LEU . 72.1 Cg_endo -77.11 162.1 31.95 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.466 2.111 . . . . 0.0 112.365 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.1 -178.0 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -61.78 -29.49 70.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -57.41 -44.83 84.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.444 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.5 t-105 -61.06 -35.53 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -32.25 72.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.616 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 31' ' ' LEU . 21.5 t -87.62 -49.9 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.064 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.927 HG22 HD11 ' A' ' 22' ' ' LEU . 25.2 t -57.17 -38.26 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -71.32 -22.5 61.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.48 20.83 10.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.933 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.658 HG22 ' HG3' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -87.95 145.7 37.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.632 0.253 . . . . 0.0 110.844 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.2 84.85 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.486 2.124 . . . . 0.0 112.222 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.37 -32.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.558 HD12 HG11 ' A' ' 8' ' ' VAL . 47.5 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.377 . . . . 0.0 111.017 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.411 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 4.6 mtt85 . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.639 0.257 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.444 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 91.5 Cg_exo -44.91 166.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.707 2.271 . . . . 0.0 112.65 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.09 111.47 33.9 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.493 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.01 145.93 10.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.643 2.229 . . . . 0.0 112.239 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.613 ' N ' HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -87.21 171.31 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 111.004 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.807 ' O ' HG23 ' A' ' 109' ' ' VAL . 24.1 p -90.06 152.57 46.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.788 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.22 -32.48 70.93 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.722 2.281 . . . . 0.0 112.447 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 -41.4 58.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -78.91 -30.18 44.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 105' ' ' SER . 66.3 t -62.82 -42.48 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.211 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -36.89 80.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -49.92 30.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.859 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.685 HD12 ' CE2' ' A' ' 67' ' ' PHE . 2.8 pt -67.28 -16.38 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.821 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -70.61 -32.64 70.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.836 0.35 . . . . 0.0 110.526 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.47 -10.74 57.42 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.408 HG21 HD12 ' A' ' 61' ' ' LEU . 40.4 t -75.87 -48.59 28.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 111.509 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 4.3 t -65.83 -56.61 11.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.428 . . . . 0.0 110.656 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.621 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 142.81 42.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.821 HD12 ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -108.65 -28.3 9.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.36 -31.2 7.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.424 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.313 0.102 . . . . 0.0 110.837 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 153.8 37.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.243 0.544 . . . . 0.0 112.206 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.831 ' HE1' HE21 ' A' ' 69' ' ' GLN . 73.9 m95 -97.46 88.84 4.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.356 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.765 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 50.2 m-85 -79.82 125.58 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.828 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -107.19 148.31 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 9' ' ' HIS . 21.7 t -135.67 162.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.528 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.52 ' N ' HG12 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -101.37 147.79 25.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.7 p -141.26 -176.96 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.55 130.78 34.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.725 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.0 p -57.69 118.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.58 -23.5 35.55 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.79 -20.54 18.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.237 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -44.32 70.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.79 -46.03 74.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -79.6 -27.29 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.819 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.8 97.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -49.8 -48.53 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.204 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.48 74.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.67 -38.45 89.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.532 HD22 HG21 ' A' ' 88' ' ' THR . 2.1 mt -74.39 -56.64 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.031 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -41.69 -36.58 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -77.67 -37.87 48.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -75.75 -27.84 58.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.644 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 31' ' ' LEU . 37.9 mm -73.44 -30.18 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.626 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -80.86 -29.82 35.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.17 -43.12 44.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -81.65 -3.46 53.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.372 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 81.04 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.607 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.2 mt -136.48 23.06 3.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.98 -15.87 58.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.131 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.45 -7.33 59.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.492 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' CE ' ' HB2' ' A' ' 81' ' ' ALA . 4.9 ptmm? -115.99 -46.66 2.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.731 0.3 . . . . 0.0 110.854 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.85 108.63 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.652 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 3' ' ' ILE . 8.5 m-85 -94.5 -60.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.455 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -108.92 146.48 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.108 0.48 . . . . 0.0 111.298 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG22 HG23 ' A' ' 68' ' ' ILE . 21.6 t -146.51 89.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.55 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 118' ' ' LEU . 4.5 mm? -102.59 166.86 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.429 HD12 ' OG1' ' A' ' 42' ' ' THR . 19.9 pt -120.69 134.91 24.33 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.748 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 36.9 Cg_endo -66.16 65.29 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.521 2.147 . . . . 0.0 112.547 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.429 ' OG1' HD12 ' A' ' 40' ' ' ILE . 35.9 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.772 0.32 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 42' ' ' THR . 1.9 mtmt -58.96 102.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.809 HD11 HG11 ' A' ' 115' ' ' VAL . 77.4 mt -73.23 -48.28 36.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 62' ' ' PHE . 1.7 m-85 -116.64 88.9 26.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.97 125.69 20.03 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.67 2.247 . . . . 0.0 112.779 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.65 35.53 74.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.123 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 66' ' ' LEU . 6.4 m-85 -126.69 164.19 21.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -153.32 120.8 5.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.484 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.771 ' CD1' HD11 ' A' ' 104' ' ' LEU . 12.4 m-85 -94.65 138.09 32.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.561 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 38' ' ' VAL . 2.2 mp -141.68 116.1 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.979 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.831 HE21 ' HE1' ' A' ' 5' ' ' TRP . 20.1 tt0 -81.04 66.66 6.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.645 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.499 ' CE ' HD21 ' A' ' 72' ' ' LEU . 3.4 ptm -91.15 -171.08 2.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -148.48 99.5 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.765 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 9.2 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.545 0.212 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.32 172.52 14.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.4 2.067 . . . . 0.0 112.288 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.35 176.62 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -57.7 -21.36 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.265 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.22 -48.8 67.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.245 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -59.47 -38.36 80.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -86.05 -51.54 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 81' ' ' ALA . 22.7 t -62.65 -48.8 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.045 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -9.33 58.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.361 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.46 24.17 4.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.918 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -76.32 144.32 74.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.649 0.261 . . . . 0.0 110.707 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.04 96.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.604 2.203 . . . . 0.0 112.695 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.86 52.77 4.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.083 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.581 0.229 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.46 -169.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.582 2.188 . . . . 0.0 112.418 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.44 88.54 4.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.8 148.58 71.49 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.616 2.211 . . . . 0.0 112.379 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.771 HD11 ' CD1' ' A' ' 67' ' ' PHE . 8.9 mt -90.0 169.56 11.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.901 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -90.01 148.51 39.7 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.682 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.67 -46.1 35.92 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.686 2.257 . . . . 0.0 112.248 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -64.97 -27.96 69.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -85.73 -37.9 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 105' ' ' SER . 48.2 t -57.65 -29.35 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.104 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -77.94 -28.59 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.805 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.5 t-160 -79.2 -40.16 31.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.564 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.477 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.3 pp -72.06 -24.85 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.8 ' CD2' HD12 ' A' ' 118' ' ' LEU . 20.0 mt -73.87 -34.89 64.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.83 -31.36 59.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.982 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.809 HG11 HD11 ' A' ' 61' ' ' LEU . 25.0 t -71.93 -43.08 68.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.132 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.691 ' HB2' HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -58.68 -61.59 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.913 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.66 43.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.559 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.8 HD12 ' CD2' ' A' ' 113' ' ' LEU . 16.2 mt -113.38 -35.69 5.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.14 36.27 3.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.776 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.329 -1.261 . . . . 0.0 112.517 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.824 HG21 ' CE1' ' A' ' 36' ' ' PHE . 1.3 pp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.773 0.32 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -143.36 161.11 39.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.286 0.565 . . . . 0.0 111.582 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.681 ' O ' HD12 ' A' ' 104' ' ' LEU . 94.9 m95 -86.82 86.64 7.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.593 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.673 ' O ' HD12 ' A' ' 68' ' ' ILE . 57.1 m-85 -79.69 113.54 17.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.376 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -105.43 135.51 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 111.822 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 9' ' ' HIS . 0.6 OUTLIER -125.66 -167.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.399 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.631 ' N ' HG13 ' A' ' 8' ' ' VAL . 2.8 m80 -126.39 167.22 15.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.061 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -151.42 -174.61 4.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.13 133.63 35.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 12' ' ' VAL . 26.1 m -58.8 117.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.003 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.41 -28.99 12.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -84.47 -21.18 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 111.195 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -54.37 -32.29 56.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.126 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -50.95 -60.8 2.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.287 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -75.26 -19.79 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . . . -67.2 -31.89 72.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.769 0.319 . . . . 0.0 111.067 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.742 ' HD2' HD11 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -59.82 -55.84 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.83 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.58 -32.79 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.489 HD12 HG21 ' A' ' 88' ' ' THR . 58.0 tp -80.06 -50.28 10.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' OE1' HG11 ' A' ' 38' ' ' VAL . 12.6 tp10 -59.97 -52.51 65.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.104 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -39.98 75.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -40.14 90.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.566 HG12 HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -62.29 -35.01 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.75 -10.21 40.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.422 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 81.92 73.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.344 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 80' ' ' GLU . 3.8 mm? -126.12 23.35 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.293 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -79.45 24.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.107 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.53 -23.93 10.85 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.883 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -107.96 -42.95 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.706 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.663 HD11 ' HB1' ' A' ' 81' ' ' ALA . 4.3 mp -84.89 93.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.824 ' CE1' HG21 ' A' ' 3' ' ' ILE . 30.4 m-85 -82.0 -49.02 10.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.36 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.465 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mt-30 -121.86 156.87 32.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.2 p -153.66 76.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.465 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.935 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.3 mm? -80.02 142.53 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.141 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.545 HD12 ' CG ' ' A' ' 19' ' ' LYS . 30.4 mm -98.09 110.92 57.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.983 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 31.5 Cg_exo -57.75 79.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.586 2.191 . . . . 0.0 112.437 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 16.7 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.429 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.656 0.265 . . . . 0.0 110.852 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.64 115.21 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 115' ' ' VAL . 76.0 mt -90.22 -53.12 4.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.53 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 18.9 m-85 -114.24 86.13 11.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.369 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.51 119.35 4.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.064 2.51 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.87 -13.67 29.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.778 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.519 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 2.5 m-85 -79.94 152.82 29.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.051 0.425 . . . . 0.0 111.412 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.742 HD11 ' HD2' ' A' ' 19' ' ' LYS . 1.2 mt -146.89 121.27 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.548 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.776 ' CD2' HD12 ' A' ' 112' ' ' ILE . 6.2 m-85 -91.21 125.4 35.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.0 OUTLIER -136.24 114.37 14.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.256 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.599 ' CG ' HD13 ' A' ' 3' ' ' ILE . 17.7 tt0 -79.89 68.81 6.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.2 ptm -91.39 -170.73 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.699 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.482 ' CB ' HG22 ' A' ' 3' ' ' ILE . 16.9 t0 -129.28 101.0 5.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.723 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.568 HD12 ' CG ' ' A' ' 6' ' ' TYR . 31.7 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.395 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.549 0.214 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.86 -171.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.289 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -89.95 -174.15 4.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.588 ' HG3' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -60.8 -22.87 64.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.663 ' HB1' HD11 ' A' ' 35' ' ' ILE . . . -53.32 -46.59 69.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.322 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.8 t-105 -61.24 -38.33 86.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -31.11 69.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.44 HG21 ' CD2' ' A' ' 31' ' ' LEU . 21.5 t -81.34 -46.27 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.643 HG12 HG13 ' A' ' 91' ' ' ILE . 22.0 t -64.17 -32.83 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -23.05 62.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.036 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -100.39 -8.88 48.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.009 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.489 HG21 HD12 ' A' ' 22' ' ' LEU . 1.2 p -74.94 114.61 36.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.852 0.326 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.75 115.48 2.14 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.405 2.07 . . . . 0.0 112.356 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.11 -18.42 5.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.643 HG13 HG12 ' A' ' 85' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.731 0.3 . . . . 0.0 111.096 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 2.0 mmp_? . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.496 0.189 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.3 Cg_exo -67.24 157.68 60.6 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.638 2.225 . . . . 0.0 112.08 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 102' ' ' VAL . 5.9 m -154.17 98.23 2.57 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 41.4 Cg_exo -56.39 145.24 79.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.421 2.081 . . . . 0.0 112.244 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.727 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.9 mp -83.39 160.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.878 ' O ' HG23 ' A' ' 109' ' ' VAL . 60.0 p -77.04 145.38 73.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.46 -29.24 39.0 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.526 2.151 . . . . 0.0 112.228 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -77.13 -37.34 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.66 -35.73 33.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 105' ' ' SER . 36.2 t -60.95 -51.54 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.17 68.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.471 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -73.72 -51.27 17.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.614 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.776 HD12 ' CD2' ' A' ' 67' ' ' PHE . 22.6 pt -66.48 -19.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.754 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.885 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.79 -38.97 61.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.746 179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.28 -34.31 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.001 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 61' ' ' LEU . 11.3 t -83.91 -33.18 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.253 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.935 ' HB3' HD12 ' A' ' 39' ' ' LEU . 4.2 m -59.84 -60.77 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.22 41.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.645 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.885 HD12 ' HG ' ' A' ' 113' ' ' LEU . 45.6 mt -120.9 -57.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.75 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.72 31.11 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.332 -1.26 . . . . 0.0 112.432 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.606 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.43 0.157 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.38 150.78 27.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.331 0.586 . . . . 0.0 112.154 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 1.025 ' CH2' HD12 ' A' ' 39' ' ' LEU . 72.1 m95 -92.63 85.96 5.43 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.264 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.601 ' CE1' HD12 ' A' ' 72' ' ' LEU . 57.5 m-85 -81.19 129.06 34.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -111.38 124.7 52.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.354 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.516 HG11 HD11 ' A' ' 91' ' ' ILE . 13.6 t -101.1 159.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.474 ' N ' HG12 ' A' ' 8' ' ' VAL . 1.7 m-70 -106.56 151.83 24.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.9 p -157.11 170.25 22.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.23 143.77 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.97 127.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.48 -27.81 17.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.485 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -99.18 -24.0 15.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 111.06 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.45 -53.75 53.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.051 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.42 -41.56 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -72.61 -33.66 66.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.225 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -47.39 -55.56 8.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -43.96 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.972 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mt -69.16 -63.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -40.86 -32.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.749 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -43.32 30.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 110.624 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -77.39 -26.59 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.777 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.529 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.6 mm -83.97 -25.53 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -96.48 -29.91 13.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.82 -44.53 63.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.91 -24.59 40.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.978 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.08 53.32 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.382 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.529 ' HB2' HG23 ' A' ' 26' ' ' ILE . 2.9 mm? -99.98 32.04 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.963 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -79.17 8.93 5.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -97.48 -21.07 17.34 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -103.66 -55.08 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.596 HG23 ' CG2' ' A' ' 68' ' ' ILE . 18.8 mm -81.49 94.54 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.673 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.606 ' CE2' HG21 ' A' ' 3' ' ' ILE . 11.7 m-85 -79.99 -55.33 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.351 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.498 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt-30 -114.36 166.73 11.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.161 0.505 . . . . 0.0 111.709 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.2 t -150.32 89.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.025 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -80.59 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.171 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.594 HD12 ' O ' ' A' ' 42' ' ' THR . 1.4 pt -104.54 104.24 44.13 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.811 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 35.8 Cg_exo -57.67 -9.09 4.94 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.698 2.265 . . . . 0.0 113.147 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.594 ' O ' HD12 ' A' ' 40' ' ' ILE . 32.8 p . . . . . 0 C--N 1.332 -0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 110.534 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 32.1 mtmt -145.37 92.38 2.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.343 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' HG21 ' A' ' 115' ' ' VAL . 15.1 mt -64.12 -51.84 61.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.334 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 41' ' ' PRO . 10.9 m-85 -116.64 81.69 11.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.702 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 53.1 Cg_exo -54.94 141.73 77.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.604 2.203 . . . . 0.0 112.557 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.74 27.36 66.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.774 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 61.8 m-85 -134.23 151.62 51.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 6.0 mt -147.78 126.68 12.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.388 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.909 ' CD2' HD12 ' A' ' 112' ' ' ILE . 8.9 m-85 -93.96 131.66 39.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 111.219 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.596 ' CG2' HG23 ' A' ' 35' ' ' ILE . 1.3 mp -138.14 113.99 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 13.0 tt0 -79.88 71.73 6.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.106 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.607 ' CE ' HD21 ' A' ' 72' ' ' LEU . 3.8 ptm -91.66 -171.15 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.342 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -129.71 79.08 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.545 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.607 HD21 ' CE ' ' A' ' 70' ' ' MET . 20.5 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.775 0.321 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.6 165.87 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.493 2.128 . . . . 0.0 112.281 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 81' ' ' ALA . 8.1 p-10 -90.11 -177.9 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.69 -28.22 68.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . . . -54.8 -45.61 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.194 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -62.61 -31.93 72.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -33.63 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.701 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.009 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.559 ' O ' HG21 ' A' ' 91' ' ' ILE . 21.9 t -59.24 -39.19 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -74.75 -20.78 59.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.01 6.23 43.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.117 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.865 ' O ' HG22 ' A' ' 91' ' ' ILE . 12.7 p -74.79 143.64 78.67 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.858 0.329 . . . . 0.0 110.672 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.15 104.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.459 2.106 . . . . 0.0 112.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.5 17.51 6.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.791 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.865 HG22 ' O ' ' A' ' 88' ' ' THR . 7.6 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 0.0 110.979 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.441 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_exo -49.81 143.35 23.41 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.587 2.191 . . . . 0.0 112.32 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.71 118.95 29.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.92 163.1 13.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.0 112.292 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.494 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.4 mt -90.0 168.41 12.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.918 ' O ' HG23 ' A' ' 109' ' ' VAL . 57.4 p -88.74 147.04 38.3 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.49 -33.96 93.72 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.249 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -26.71 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -95.48 -36.7 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.952 HG11 ' CD1' ' A' ' 5' ' ' TRP . 40.9 t -59.39 -31.77 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -59.74 -43.12 94.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -53.91 34.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.67 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.909 HD12 ' CD2' ' A' ' 67' ' ' PHE . 9.9 pt -61.23 -23.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.259 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.797 ' HA ' HD21 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -59.57 -36.71 76.74 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.29 -17.71 59.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 61' ' ' LEU . 21.4 t -77.5 -60.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.483 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.544 ' HB3' HD23 ' A' ' 39' ' ' LEU . 86.1 p -51.81 -59.96 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.513 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 139.79 46.16 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.742 HD12 ' HG ' ' A' ' 113' ' ' LEU . 2.6 mt -114.92 -43.82 3.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tp -98.7 30.88 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.428 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.75 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.439 0.162 . . . . 0.0 110.862 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -141.15 147.6 38.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 112.225 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.705 ' CZ2' HD11 ' A' ' 113' ' ' LEU . 78.1 m95 -92.61 93.06 8.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.185 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.873 ' CE2' HD12 ' A' ' 72' ' ' LEU . 29.1 m-85 -80.03 112.74 17.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 111.087 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -104.55 145.06 30.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.63 178.24 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -107.91 143.65 36.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 p -138.59 174.19 10.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.93 144.47 25.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 12' ' ' VAL . 30.7 m -58.68 119.03 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -27.76 15.85 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.475 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.04 -30.26 39.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.652 0.263 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -40.14 86.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.58 -43.07 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 tttm -86.99 -25.48 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.88 -30.7 70.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' NZ ' HD11 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -63.36 -50.49 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 -41.37 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.45 -44.9 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.52 -47.09 67.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.773 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -57.86 -21.77 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.63 -46.23 14.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.965 0.412 . . . . 0.0 110.289 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -67.31 -23.36 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.413 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -71.06 -28.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -98.08 -31.93 11.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.37 87.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -82.77 -42.06 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' C ' HD23 ' A' ' 31' ' ' LEU . . . 106.99 77.41 1.06 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -155.18 29.37 0.4 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 110.823 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -15.43 61.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.137 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -24.55 42.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -53.62 6.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.568 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.03 153.06 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.474 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.75 ' CE2' HG21 ' A' ' 3' ' ' ILE . 25.8 m-85 -135.38 -54.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 0.0 111.402 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.28 157.92 25.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.382 0.611 . . . . 0.0 111.605 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.39 62.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.06 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' A' ' 116' ' ' SER . 1.9 tm? -79.58 129.37 34.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.586 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.482 HG22 HG23 ' A' ' 42' ' ' THR . 1.8 mp -105.28 128.36 26.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.666 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 30.7 Cg_endo -63.85 78.84 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.564 2.176 . . . . 0.0 112.635 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.482 HG23 HG22 ' A' ' 40' ' ' ILE . 48.5 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.792 0.33 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -63.66 101.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.949 HD11 HG11 ' A' ' 115' ' ' VAL . 83.1 mt -61.62 -31.77 71.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 9.0 m-85 -139.59 83.97 16.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.631 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.46 139.47 90.25 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.59 2.193 . . . . 0.0 112.509 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.64 72.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.744 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -131.58 136.63 47.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.749 0.309 . . . . 0.0 110.954 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -131.53 128.76 39.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.465 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.967 ' CD2' HD12 ' A' ' 112' ' ' ILE . 5.3 m-85 -99.09 121.63 41.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.4 mp -125.48 111.43 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.537 ' NE2' HD11 ' A' ' 3' ' ' ILE . 4.7 tt0 -79.9 72.19 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.663 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 ptp -91.63 -163.23 1.01 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.177 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -147.77 89.2 1.73 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.662 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.873 HD12 ' CE2' ' A' ' 6' ' ' TYR . 11.2 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.704 0.287 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.24 150.25 20.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.513 2.142 . . . . 0.0 112.256 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -165.83 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.468 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.3 pt-20 -57.81 -21.29 41.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.164 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -49.26 -35.9 19.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.431 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -80.46 -29.72 37.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.07 -28.24 63.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 80' ' ' GLU . 22.7 t -84.83 -51.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 81' ' ' ALA . 39.2 t -58.63 -37.36 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -73.97 -26.35 60.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.175 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.5 6.13 60.86 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.008 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 120.68 69.22 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.774 0.287 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 115.18 2.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.26 -13.16 6.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.791 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 111.064 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.572 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.405 0.145 . . . . 0.0 111.011 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 100' ' ' ARG . 65.6 Cg_endo -85.12 155.07 11.1 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.698 2.266 . . . . 0.0 111.959 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 63.4 t -155.71 114.61 2.22 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.102 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.62 156.54 40.27 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.476 2.118 . . . . 0.0 112.388 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.2 mp -89.72 147.81 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -70.95 153.3 94.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.53 -36.45 59.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.55 2.166 . . . . 0.0 112.311 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.63 -35.62 81.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.72 -38.81 20.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 105' ' ' SER . 38.3 t -58.84 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.056 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -53.68 -30.02 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.032 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 -54.91 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.707 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.967 HD12 ' CD2' ' A' ' 67' ' ' PHE . 15.7 pt -66.95 -26.2 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 ' CZ2' ' A' ' 5' ' ' TRP . 1.1 mp -72.2 -31.33 65.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.249 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -41.88 73.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.949 HG11 HD11 ' A' ' 61' ' ' LEU . 19.1 t -84.64 -27.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.481 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t -52.23 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.819 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 150.96 38.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.349 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.819 HD23 ' C ' ' A' ' 117' ' ' GLY . 2.4 mt -122.31 -37.74 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.88 -34.58 39.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.434 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.581 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.622 0.248 . . . . 0.0 110.995 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.29 164.0 34.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.98 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.882 ' CZ2' HD21 ' A' ' 113' ' ' LEU . 76.1 m95 -94.8 132.72 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.814 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 28.0 m-85 -119.11 122.81 42.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.803 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -101.55 131.52 47.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.481 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 HD12 ' A' ' 91' ' ' ILE . 15.6 t -117.59 159.54 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.788 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.477 ' N ' HG12 ' A' ' 8' ' ' VAL . 15.8 m-70 -94.27 133.52 37.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.046 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.51 HG21 HD13 ' A' ' 66' ' ' LEU . 36.7 p -144.74 -177.5 5.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.14 140.65 29.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.1 p -60.62 123.91 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.52 5.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.235 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -81.57 -18.14 45.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.913 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -44.96 -40.43 6.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.286 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -37.9 80.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -33.74 64.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.58 -43.77 88.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -66.1 -35.98 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.78 -54.92 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.003 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -60.26 -31.68 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.577 HD12 HG21 ' A' ' 88' ' ' THR . 38.0 tp -74.96 -57.25 4.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.91 -32.39 6.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -71.64 -41.3 68.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.761 ' HG3' HG22 ' A' ' 88' ' ' THR . 2.3 mmp_? -68.23 -39.33 82.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.587 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.767 ' HA ' HD12 ' A' ' 31' ' ' LEU . 37.5 mm -64.83 -31.46 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.828 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -83.99 -30.17 26.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.65 -44.87 76.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.04 -29.77 39.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.23 43.63 3.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.449 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.918 HD11 HG21 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -99.84 28.9 4.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 110.825 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -69.54 -13.11 62.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.409 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 1.1 m-20 -79.75 -23.8 42.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.565 ' CE ' ' HB2' ' A' ' 81' ' ' ALA . 13.8 mtpp -94.56 -56.3 2.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.843 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.01 136.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.669 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.1 m-85 -132.27 -64.13 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.449 . . . . 0.0 111.447 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -101.02 151.74 21.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.82 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.7 HG12 HG23 ' A' ' 68' ' ' ILE . 5.2 m -159.81 106.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.494 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.734 HD11 HD21 ' A' ' 118' ' ' LEU . 4.4 mm? -118.82 160.45 21.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.378 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 pt -103.54 131.78 21.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 37.1 Cg_endo -65.65 83.28 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.555 2.17 . . . . 0.0 112.806 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.9 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.866 179.756 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 mttm . . . . . 0 CA--C 1.524 -0.024 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -133.1 100.94 5.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.788 HD11 HG11 ' A' ' 115' ' ' VAL . 63.1 mt -76.45 -31.71 58.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.652 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.0 m-85 -140.42 67.65 31.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.557 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.39 120.19 7.89 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.63 2.22 . . . . 0.0 112.213 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 16.07 22.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.661 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.46 154.16 50.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 10' ' ' THR . 0.3 OUTLIER -136.38 115.02 11.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.529 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.882 ' CD2' HD13 ' A' ' 112' ' ' ILE . 14.5 m-85 -79.83 125.01 29.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.276 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 38' ' ' VAL . 1.9 mp -134.03 112.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.142 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.4 tt0 -80.81 74.54 7.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.798 0.333 . . . . 0.0 110.936 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptp -91.24 -169.65 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.011 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -147.02 89.01 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.814 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 62.6 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.574 0.226 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.08 177.82 8.33 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.477 2.118 . . . . 0.0 112.506 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -90.09 -164.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.64 -27.16 57.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.565 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . . . -51.43 -34.97 37.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.399 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -66.21 -33.75 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.8 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -31.82 72.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.743 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -72.64 -49.58 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.85 HG12 HG13 ' A' ' 91' ' ' ILE . 21.6 t -58.17 -53.85 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp-105 -58.69 -29.35 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.64 -28.13 52.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.532 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 84' ' ' VAL . 44.9 p -69.58 130.4 90.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.55 0.214 . . . . 0.0 110.756 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.76 -23.8 28.04 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.418 2.078 . . . . 0.0 112.348 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.78 -27.32 55.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.619 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.85 HG13 HG12 ' A' ' 85' ' ' VAL . 38.0 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.427 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.511 0.196 . . . . 0.0 111.019 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 6.1 Cg_exo -79.05 -174.74 2.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.828 2.352 . . . . 0.0 112.226 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -150.74 72.21 8.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.06 133.94 37.69 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.524 2.149 . . . . 0.0 112.522 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 67' ' ' PHE . 3.2 mt -88.84 167.85 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -89.98 148.06 38.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.36 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.513 2.142 . . . . 0.0 112.277 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.97 -27.71 61.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -90.4 -33.5 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 105' ' ' SER . 33.5 t -60.53 -40.73 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.167 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -19.4 62.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.743 ' O ' HG23 ' A' ' 115' ' ' VAL . 44.5 m-70 -83.34 -44.06 15.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.96 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.882 HD13 ' CD2' ' A' ' 67' ' ' PHE . 1.8 pp -74.96 -20.19 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.134 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.882 HD21 ' CZ2' ' A' ' 5' ' ' TRP . 97.4 mt -84.95 -34.01 22.54 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.863 0.363 . . . . 0.0 110.591 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -73.13 -28.23 62.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.693 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 HD11 ' A' ' 61' ' ' LEU . 16.0 t -89.51 -31.11 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.999 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.67 ' HB3' HD12 ' A' ' 39' ' ' LEU . 3.2 m -60.28 -64.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 149.09 55.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.722 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.734 HD21 HD11 ' A' ' 39' ' ' LEU . 1.2 mt -135.5 -48.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.684 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -4.06 50.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.439 -1.2 . . . . 0.0 112.439 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.63 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.603 0.239 . . . . 0.0 110.797 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.86 164.68 37.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.258 0.551 . . . . 0.0 111.829 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.692 ' HH2' HD23 ' A' ' 39' ' ' LEU . 79.0 m95 -89.74 129.77 36.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.858 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.497 ' OH ' HD12 ' A' ' 72' ' ' LEU . 4.7 m-30 -112.61 108.35 17.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.286 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.42 137.56 32.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.73 158.16 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.632 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -104.32 132.98 49.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.911 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.8 p -128.04 -173.78 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.66 131.4 41.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 12' ' ' VAL . 19.1 m -59.17 115.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.41 -28.73 12.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -20.04 35.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.543 ' OE2' HD12 ' A' ' 40' ' ' ILE . 1.5 tm-20 -53.87 -32.62 53.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.855 0.359 . . . . 0.0 111.154 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.65 -38.64 72.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -24.11 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.97 -51.27 70.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.303 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -50.66 -41.46 55.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.41 75.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -65.31 -36.27 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.476 HD22 HG21 ' A' ' 88' ' ' THR . 2.5 mt -79.5 -54.43 5.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -43.99 -31.32 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.615 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.5 -35.81 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.686 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -79.92 -25.29 40.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.821 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.793 ' HA ' HD12 ' A' ' 31' ' ' LEU . 38.0 mm -80.73 -28.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.698 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -91.47 -30.33 16.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.33 -42.94 61.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -80.21 -28.09 38.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 58.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -114.39 30.96 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.97 -10.72 60.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.233 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.406 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -79.97 -24.73 40.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.739 0.304 . . . . 0.0 110.983 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -61.94 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 68' ' ' ILE . 18.1 mm -79.96 111.92 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.63 ' CE2' HG21 ' A' ' 3' ' ' ILE . 12.3 m-85 -99.53 -58.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.197 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -109.29 146.14 34.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.45 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' HD22 ' A' ' 39' ' ' LEU . 22.5 t -153.81 117.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.698 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.692 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.4 mm? -126.1 156.61 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.973 0.416 . . . . 0.0 111.278 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.543 HD12 ' OE2' ' A' ' 15' ' ' GLU . 3.5 tt -106.76 124.68 34.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.638 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 33.9 Cg_endo -64.7 69.78 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.54 2.16 . . . . 0.0 112.758 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.512 179.642 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.783 0.325 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -51.6 119.17 3.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.853 HD11 HG11 ' A' ' 115' ' ' VAL . 28.9 mt -90.1 -44.09 10.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 3.7 m-85 -115.73 91.36 29.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.23 117.75 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.909 2.406 . . . . 0.0 112.968 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.92 45.09 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.962 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.29 149.16 52.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.757 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.39 118.0 9.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.932 ' CD2' HD12 ' A' ' 112' ' ' ILE . 7.5 m-85 -88.25 133.9 33.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.795 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 35' ' ' ILE . 5.3 mt -135.37 111.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.128 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.668 HE21 ' HE1' ' A' ' 5' ' ' TRP . 23.9 tt0 -79.65 67.22 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.418 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.402 ' CB ' HD13 ' A' ' 35' ' ' ILE . 2.8 ptm -91.2 -168.6 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.279 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -145.6 108.56 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.777 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.497 HD12 ' OH ' ' A' ' 6' ' ' TYR . 4.4 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.502 0.191 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.76 166.6 28.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.464 2.109 . . . . 0.0 112.345 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.83 173.55 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 84' ' ' VAL . 9.1 pt-20 -59.14 -25.16 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.36 -50.55 67.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.306 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.431 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.0 t-105 -58.3 -42.02 85.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -59.85 -30.87 69.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.855 ' O ' HG23 ' A' ' 88' ' ' THR . 22.1 t -84.07 -52.34 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.694 ' O ' HG21 ' A' ' 91' ' ' ILE . 23.5 t -62.13 -49.03 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.46 -11.87 61.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.251 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.83 -17.18 15.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.872 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.871 ' O ' HG22 ' A' ' 91' ' ' ILE . 30.7 p -56.47 147.58 48.64 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.717 0.294 . . . . 0.0 110.985 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.48 109.73 1.89 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.587 2.192 . . . . 0.0 112.258 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.56 10.42 9.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.722 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.871 HG22 ' O ' ' A' ' 88' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 111.04 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.456 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.657 0.265 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 100' ' ' ARG . 85.6 Cg_exo -42.89 141.62 2.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.78 2.32 . . . . 0.0 112.572 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.8 t -99.92 102.3 17.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.76 150.38 27.29 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.145 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -90.06 153.91 20.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.851 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.6 p -80.97 161.16 64.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.06 -26.89 77.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.696 2.264 . . . . 0.0 112.323 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.85 -31.87 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 112' ' ' ILE . 12.4 tt0 -88.0 -35.22 17.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 105' ' ' SER . 58.3 t -58.68 -48.92 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -25.16 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -80.99 -38.84 26.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.959 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.932 HD12 ' CD2' ' A' ' 67' ' ' PHE . 14.4 pt -78.09 -26.95 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.991 HD22 HD12 ' A' ' 118' ' ' LEU . 90.7 mt -82.11 -26.91 33.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -70.67 -30.09 66.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.853 HG11 HD11 ' A' ' 61' ' ' LEU . 27.9 t -82.6 -38.02 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.656 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -59.25 -62.76 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.632 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 153.21 45.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.557 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.991 HD12 HD22 ' A' ' 113' ' ' LEU . 12.0 mt -128.16 -54.23 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.794 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.37 -31.75 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.503 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.64 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.576 0.227 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.89 159.91 41.26 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 111.705 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.606 ' CD1' HG11 ' A' ' 109' ' ' VAL . 69.2 m95 -101.05 111.51 23.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.69 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 18.9 m-85 -94.96 124.43 39.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.817 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.613 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . -99.53 143.67 29.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.434 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' HD23 ' A' ' 66' ' ' LEU . 6.1 t -140.65 162.03 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.073 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.476 ' N ' HG12 ' A' ' 8' ' ' VAL . 10.2 m170 -86.79 155.87 20.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.271 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.681 ' CG2' HD22 ' A' ' 66' ' ' LEU . 28.6 p -146.56 -176.64 5.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.65 127.81 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.811 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 12' ' ' VAL . 18.6 m -59.24 102.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.097 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.97 -17.67 27.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.631 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -112.87 2.21 15.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 37.3 tt0 -54.96 -45.07 74.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.822 0.344 . . . . 0.0 111.071 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -54.12 -61.54 2.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -66.08 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -58.99 -47.43 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.85 0.357 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -55.53 -41.03 72.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.14 80.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.41 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.413 HD22 ' CB ' ' A' ' 88' ' ' THR . 2.8 mt -83.07 -60.72 2.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -37.53 -34.68 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.778 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -72.85 -51.23 19.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.71 ' HD3' HG22 ' A' ' 88' ' ' THR . 1.2 mtt-85 -69.31 -24.96 64.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.478 HG21 ' CD1' ' A' ' 35' ' ' ILE . 31.9 mm -73.38 -31.06 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.561 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -32.91 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.35 -29.52 65.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.022 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.422 ' CZ ' ' NH1' ' A' ' 25' ' ' ARG . 5.5 m-85 -80.55 -39.59 27.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.78 67.72 0.8 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.947 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.845 HD13 ' HA ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -144.86 34.86 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -13.26 61.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.407 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.64 -22.69 43.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.881 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.5 -49.71 8.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.478 ' CD1' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -95.59 149.48 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.64 ' CE2' HG21 ' A' ' 3' ' ' ILE . 7.8 m-85 -140.12 -47.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.252 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 1.8 tt0 -118.01 157.53 26.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.098 0.475 . . . . 0.0 111.703 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.507 HG12 HG23 ' A' ' 68' ' ' ILE . 2.6 m -156.56 102.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.566 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.985 HD11 HD21 ' A' ' 118' ' ' LEU . 4.3 mm? -113.23 152.84 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.2 mt -99.24 127.03 35.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 26.7 Cg_endo -62.54 78.56 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.536 2.158 . . . . 0.0 112.388 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.594 HG22 ' CG ' ' A' ' 60' ' ' LYS . 42.0 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.805 0.336 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.594 ' CG ' HG22 ' A' ' 42' ' ' THR . 8.5 mtmt -100.73 120.07 39.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.852 HD11 HG11 ' A' ' 115' ' ' VAL . 44.6 mt -76.0 -44.91 37.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.458 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.526 ' CE1' HG22 ' A' ' 112' ' ' ILE . 3.5 m-85 -118.9 70.16 9.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.427 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.85 139.07 83.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.754 2.303 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.5 15.39 79.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.19 160.49 37.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.839 0.352 . . . . 0.0 111.179 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.778 ' CD1' HD11 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -144.91 131.15 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.651 ' CD2' HD13 ' A' ' 112' ' ' ILE . 17.3 m-85 -93.6 123.41 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.2 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.778 HD11 ' CD1' ' A' ' 66' ' ' LEU . 1.6 mt -126.14 116.43 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 5.7 tt0 -79.74 69.89 6.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.6 ptp -91.0 -166.55 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.811 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -160.06 96.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.363 . . . . 0.0 110.889 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.69 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 51.9 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.762 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.581 0.229 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.64 176.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.477 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -90.07 -170.2 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.974 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -29.05 68.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.845 ' HA ' HD13 ' A' ' 31' ' ' LEU . . . -52.86 -27.98 20.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.475 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -78.98 -33.39 45.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.039 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -62.15 -29.73 70.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.9 t -82.96 -40.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 81' ' ' ALA . 31.9 t -67.05 -45.72 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -15.82 62.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.308 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.0 -18.61 9.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.028 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.71 HG22 ' HD3' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -59.19 134.17 87.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.783 0.291 . . . . 0.0 110.945 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 88' ' ' THR . 31.6 Cg_exo -58.3 -30.05 89.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.47 2.114 . . . . 0.0 112.28 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.06 -33.28 60.59 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.701 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 179.836 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 10.6 mtm-85 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.459 0.171 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 34.2 Cg_endo -64.49 148.45 90.64 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.292 1.994 . . . . 0.0 112.296 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 7' ' ' ALA . 7.8 m -145.15 89.01 6.56 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.81 133.01 26.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.49 2.127 . . . . 0.0 112.218 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.6 OUTLIER -84.74 159.07 20.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.048 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.2 m -81.2 160.43 65.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.79 -24.86 79.98 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.374 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.44 -37.12 63.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.052 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.37 -37.35 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.8 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 105' ' ' SER . 94.8 t -58.54 -38.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.19 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -25.92 65.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 115' ' ' VAL . 13.0 m-70 -74.69 -50.62 16.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.707 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.651 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.4 pp -68.16 -16.78 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.701 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -79.05 -41.76 28.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -33.16 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.793 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.852 HG11 HD11 ' A' ' 61' ' ' LEU . 33.5 t -73.46 -30.93 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.989 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.729 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.2 m -70.02 -58.77 3.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 140.97 59.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 39' ' ' LEU . 4.4 mt -133.14 -56.7 0.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -79.87 -50.93 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.535 179.973 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.73 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.469 0.175 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -131.35 148.13 52.64 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.325 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.9 ' CD1' HG11 ' A' ' 109' ' ' VAL . 79.5 m95 -99.95 94.4 6.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.004 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.468 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 77.7 m-85 -84.15 126.62 33.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -104.39 124.78 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.5 p -108.37 159.46 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.193 0.52 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.479 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 21.1 m-70 -96.98 119.11 34.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.6 p -121.84 169.88 10.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.2 mm? -84.84 153.61 22.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 12' ' ' VAL . 12.1 p -66.34 120.86 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.31 21.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.529 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -86.0 -25.63 25.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.16 -45.16 79.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 0.0 111.047 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.05 -42.42 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.61 -28.63 45.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.98 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.487 ' HB1' ' HA3' ' A' ' 90' ' ' GLY . . . -65.14 -35.39 80.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -61.61 -50.87 70.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.63 81.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.1 -37.77 77.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.83 -54.76 5.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.52 -30.54 20.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -44.44 43.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.753 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -73.8 -27.6 61.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.98 -16.27 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -108.06 -29.94 8.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.14 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.87 25.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.175 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CD2' ' HG3' ' A' ' 25' ' ' ARG . 71.1 m-85 -79.88 -2.99 46.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.335 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 76.11 77.47 0.74 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.751 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 30' ' ' GLY . 2.4 mm? -134.99 30.96 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.962 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -77.51 6.18 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.338 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.5 -25.27 22.66 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.739 0.304 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -106.14 -58.0 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mm -81.86 110.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.808 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.5 m-85 -100.81 -53.15 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.216 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.414 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -116.6 157.43 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 0.0 111.646 -179.406 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -148.54 67.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.271 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.819 HD11 HD21 ' A' ' 118' ' ' LEU . 3.8 mm? -80.36 156.8 26.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.429 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.522 HD12 ' HD2' ' A' ' 41' ' ' PRO . 4.2 tp -113.78 131.42 23.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.708 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 40' ' ' ILE . 43.5 Cg_endo -67.86 74.18 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.335 2.024 . . . . 0.0 112.548 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.0 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.944 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tptm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.788 0.327 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -53.81 120.54 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.217 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.832 HD11 HG11 ' A' ' 115' ' ' VAL . 48.0 mt -90.18 -40.65 12.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 32.8 m-85 -123.12 76.38 51.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.4 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 46.7 Cg_exo -56.28 141.39 88.66 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.636 2.224 . . . . 0.0 112.496 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.08 20.41 76.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.709 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 96.3 m-85 -131.02 145.02 51.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -134.21 122.1 22.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.527 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.477 ' CE2' HD12 ' A' ' 112' ' ' ILE . 17.5 m-85 -84.73 115.07 22.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.3 mp -123.59 108.81 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.055 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.423 ' HG2' ' CG1' ' A' ' 3' ' ' ILE . 16.3 tt0 -79.85 74.3 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.54 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.1 ptp -91.19 -174.35 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.128 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.7 t0 -125.47 78.15 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.468 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.681 0.277 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.61 165.2 32.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.62 2.213 . . . . 0.0 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.87 178.89 7.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.607 ' O ' HG23 ' A' ' 84' ' ' VAL . 6.0 pt-20 -61.86 -18.79 61.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.241 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.74 -46.72 64.13 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.387 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -59.39 -43.79 92.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.44 -30.17 69.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.674 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 80' ' ' GLU . 34.5 t -71.34 -49.51 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.838 HG12 HG13 ' A' ' 91' ' ' ILE . 19.3 t -61.23 -45.31 98.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -59.75 -23.12 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.64 -32.86 8.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.756 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.58 146.76 79.38 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.27 -25.07 26.62 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.412 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.487 ' HA3' ' HB1' ' A' ' 18' ' ' ALA . . . -55.74 -25.45 43.95 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.643 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.838 HG13 HG12 ' A' ' 85' ' ' VAL . 37.8 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.8 ptt-85 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.67 0.271 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.63 -166.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.584 2.189 . . . . 0.0 112.061 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 102' ' ' VAL . 5.9 m -143.0 99.37 5.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.01 135.17 16.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.128 . . . . 0.0 112.327 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' A' ' 5' ' ' TRP . 1.9 mt -72.65 169.36 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.91 ' O ' HG23 ' A' ' 109' ' ' VAL . 6.6 m -89.14 145.84 35.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.723 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.24 -33.34 97.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.54 2.16 . . . . 0.0 112.393 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.96 -32.91 67.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -34.46 26.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 105' ' ' SER . 48.9 t -57.33 -45.63 85.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -29.99 40.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.15 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.429 ' O ' HG23 ' A' ' 115' ' ' VAL . 20.6 t60 -74.93 -52.4 11.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.542 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.477 HD12 ' CE2' ' A' ' 67' ' ' PHE . 11.6 pt -67.85 -19.38 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.852 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.2 mp -77.17 -38.38 51.82 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.479 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -69.67 -27.67 65.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.832 HG11 HD11 ' A' ' 61' ' ' LEU . 22.4 t -86.68 -31.97 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.565 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -60.08 -64.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.491 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 150.89 43.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.662 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.852 HD12 ' HG ' ' A' ' 113' ' ' LEU . 13.5 mt -120.04 -47.39 2.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.96 -36.55 6.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.351 -1.25 . . . . 0.0 112.485 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.71 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.368 0.128 . . . . 0.0 110.91 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 159.37 39.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.386 0.612 . . . . 0.0 112.481 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.898 ' CD1' HG11 ' A' ' 109' ' ' VAL . 89.7 m95 -97.42 91.77 5.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.476 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.815 ' O ' HD12 ' A' ' 68' ' ' ILE . 62.7 m-85 -83.67 111.17 18.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.353 . . . . 0.0 110.737 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . -90.48 159.04 16.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.35 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.91 162.99 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.897 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -101.3 149.42 24.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.1 p -149.36 -174.36 4.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.1 141.79 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 12' ' ' VAL . 12.2 p -66.98 120.04 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.38 -29.42 10.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -85.71 -23.41 27.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.791 0.329 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -54.84 -34.91 63.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.38 -47.14 79.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.011 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -75.7 -27.13 58.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.84 85.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.195 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -47.25 -48.25 24.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.05 73.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.946 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -67.16 -49.79 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.94 -62.45 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -42.84 -31.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.623 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.25 -39.6 25.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.861 0.363 . . . . 0.0 110.474 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.22 51.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.63 -27.12 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.692 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.45 -31.99 11.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.027 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.06 -46.05 68.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.96 -16.97 54.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.76 49.83 4.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.29 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 80' ' ' GLU . 3.1 mm? -96.68 24.57 5.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -80.3 19.4 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.241 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.2 -21.32 16.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -116.49 -49.22 2.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.797 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.471 HG23 ' CG2' ' A' ' 68' ' ' ILE . 5.4 mp -79.9 125.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.876 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HE2' HG21 ' A' ' 3' ' ' ILE . 20.3 m-85 -116.07 -62.13 1.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.491 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -106.71 156.01 19.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 111.224 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.5 p -150.36 73.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.847 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.5 mm? -79.9 139.44 37.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.277 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.423 HG22 HG23 ' A' ' 42' ' ' THR . 33.5 mm -96.43 118.55 65.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.702 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 27.2 Cg_endo -62.31 90.03 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.352 2.034 . . . . 0.0 112.565 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 40.0 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.447 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.799 0.333 . . . . 0.0 110.653 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -112.55 113.14 25.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 111.102 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.011 HD11 HG11 ' A' ' 115' ' ' VAL . 4.9 mt -90.26 -57.62 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.651 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 69.9 m-85 -119.18 87.54 35.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.603 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.37 115.34 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.673 2.249 . . . . 0.0 112.624 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.05 19.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.788 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.462 ' C ' HD12 ' A' ' 66' ' ' LEU . 25.3 m-85 -138.03 147.82 44.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.069 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 65' ' ' TYR . 3.9 mp -145.5 112.91 6.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.844 ' CD2' HD12 ' A' ' 112' ' ' ILE . 5.1 m-85 -84.96 126.13 33.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 111.201 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -130.36 115.61 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 1.9 tp-100 -79.75 71.73 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 0.0 110.354 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.698 ' HE2' HD21 ' A' ' 72' ' ' LEU . 4.6 ptm -91.56 -177.93 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' OD1' HG22 ' A' ' 3' ' ' ILE . 22.8 t70 -121.51 82.84 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.728 HD22 ' HB3' ' A' ' 78' ' ' PRO . 13.7 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.773 0.32 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.728 ' HB3' HD22 ' A' ' 72' ' ' LEU . 61.0 Cg_endo -72.21 108.1 2.41 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.697 2.264 . . . . 0.0 112.275 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -90.15 -77.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.506 ' HB3' HD11 ' A' ' 31' ' ' LEU . 13.5 mt-10 -54.06 -64.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.604 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.723 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -47.59 -32.85 5.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.853 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.401 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 4.7 t-105 -87.44 -29.23 21.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.141 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.81 -29.55 70.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.0 -49.25 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 81' ' ' ALA . 37.3 t -60.15 -41.24 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.33 -21.85 60.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.02 10.3 37.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.114 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.22 135.93 29.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.814 0.307 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.56 120.6 8.5 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.077 . . . . 0.0 112.258 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.24 -8.96 9.6 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.944 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 91' ' ' ILE . 7.8 tp . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 111.082 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.498 0.19 . . . . 0.0 110.934 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.1 Cg_exo -66.92 -179.53 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.647 2.232 . . . . 0.0 112.151 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.82 HG13 ' HB3' ' A' ' 7' ' ' ALA . 7.3 p -160.12 81.86 2.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.9 124.7 9.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.633 HD22 ' H ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -78.68 172.19 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 109' ' ' VAL . 79.0 p -90.17 147.78 37.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -50.82 -29.39 26.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.605 2.204 . . . . 0.0 112.261 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.91 -42.43 39.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -74.02 -38.27 64.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.898 HG11 ' CD1' ' A' ' 5' ' ' TRP . 40.1 t -59.07 -42.53 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -57.54 -31.37 66.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.954 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -70.04 -56.08 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.844 HD12 ' CD2' ' A' ' 67' ' ' PHE . 21.8 pt -63.56 -24.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.91 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.9 mp -72.71 -38.9 67.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.721 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.18 -33.03 67.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 1.011 HG11 HD11 ' A' ' 61' ' ' LEU . 13.0 t -79.37 -37.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.847 ' OG ' HD12 ' A' ' 39' ' ' LEU . 8.2 t -58.46 -63.5 1.26 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.858 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 150.66 54.94 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.537 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.91 HD12 ' HG ' ' A' ' 113' ' ' LEU . 17.6 mt -133.02 -54.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.37 -31.36 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.405 -1.219 . . . . 0.0 112.535 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.724 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.446 0.165 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.36 150.14 24.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 112.232 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.771 ' CD1' HG11 ' A' ' 109' ' ' VAL . 75.1 m95 -86.09 92.43 8.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.446 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.804 ' CE2' HD12 ' A' ' 72' ' ' LEU . 40.1 m-85 -84.23 114.53 21.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.403 . . . . 0.0 110.87 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.28 154.73 19.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.567 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 66' ' ' LEU . 13.8 m -142.35 179.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 16.1 m-70 -130.75 149.86 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.2 p -145.96 -173.84 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.83 149.83 22.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.6 p -71.45 124.45 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -24.77 27.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.624 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.54 -22.73 17.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.0 111.077 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -54.49 -35.56 63.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.19 -30.97 68.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.91 -28.84 18.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -42.05 81.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.094 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HG3' HG21 ' A' ' 40' ' ' ILE . 2.6 tmtt? -59.77 -38.21 81.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 -44.93 28.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -60.75 -35.08 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 85' ' ' VAL . 67.5 tp -73.78 -57.91 3.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -29.71 15.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -41.94 71.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.75 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HD3' HG22 ' A' ' 88' ' ' THR . 3.1 mpt_? -70.23 -36.89 74.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.89 ' HA ' HD12 ' A' ' 31' ' ' LEU . 29.8 mm -74.5 -29.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.93 -36.6 14.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.177 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.95 -44.74 72.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.32 -26.62 35.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.63 70.43 1.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 26' ' ' ILE . 2.2 mt -123.3 38.93 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 110.857 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.2 -1.12 24.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.538 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.72 -25.22 41.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -55.05 2.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.458 HD13 ' CB ' ' A' ' 70' ' ' MET . 26.4 mm -82.99 127.92 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.636 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 3' ' ' ILE . 23.3 m-85 -120.57 -64.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -102.89 122.29 44.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.433 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 38' ' ' VAL . 6.6 m -114.83 77.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.607 HD23 ' OG ' ' A' ' 116' ' ' SER . 2.6 tm? -91.76 127.59 37.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.95 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 42' ' ' THR . 3.4 pt -102.67 128.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 78.1 Cg_exo -52.2 69.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.991 2.461 . . . . 0.0 113.216 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 40' ' ' ILE . 68.2 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.525 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -67.2 117.63 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.042 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.689 ' CD1' HG21 ' A' ' 115' ' ' VAL . 11.0 mt -81.81 -52.71 6.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.742 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.9 m-85 -129.91 86.89 53.53 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.5 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 147.99 89.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.788 2.325 . . . . 0.0 112.596 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.6 9.1 64.54 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.078 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 22.4 m-85 -119.08 161.97 19.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.977 0.417 . . . . 0.0 111.058 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -154.49 112.56 3.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.415 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CD1' HD11 ' A' ' 104' ' ' LEU . 5.9 m-85 -89.44 122.23 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -129.25 110.49 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.999 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.74 74.87 6.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.301 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.458 ' CB ' HD13 ' A' ' 35' ' ' ILE . 20.9 ptm -91.36 -173.19 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.136 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -126.7 82.86 2.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.804 HD12 ' CE2' ' A' ' 6' ' ' TYR . 62.5 mt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.497 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.75 0.309 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.83 139.32 36.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.634 2.223 . . . . 0.0 112.26 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.54 178.54 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 84' ' ' VAL . 4.2 pt-20 -58.93 -23.61 61.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.59 -49.33 67.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.328 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -66.3 -35.09 79.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -60.24 -31.44 70.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 88' ' ' THR . 21.8 t -85.09 -46.96 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 81' ' ' ALA . 36.3 t -59.8 -49.32 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -70.82 -18.1 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.031 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.02 -22.67 44.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.793 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 84' ' ' VAL . 54.4 p -54.1 108.38 1.12 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.586 0.231 . . . . 0.0 111.079 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.27 119.27 5.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.77 15.86 19.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.704 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.536 HD13 ' C ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.664 0.269 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.12 178.87 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.627 2.218 . . . . 0.0 112.078 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.37 96.76 8.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.87 125.55 12.22 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.377 2.052 . . . . 0.0 112.207 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 67' ' ' PHE . 1.2 mt -60.69 158.87 11.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.044 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.2 m -89.96 147.36 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.89 -31.31 42.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.436 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -31.38 69.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.974 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.09 -31.08 13.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 105' ' ' SER . 22.0 t -66.39 -29.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.213 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -39.38 93.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -52.28 29.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.566 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.742 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.0 pp -65.06 -21.4 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.69 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.729 HD22 HD12 ' A' ' 118' ' ' LEU . 7.5 mt -69.05 -34.8 75.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -59.66 -22.07 61.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.994 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.689 HG21 ' CD1' ' A' ' 61' ' ' LEU . 23.6 t -73.89 -56.58 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.243 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.607 ' OG ' HD23 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -51.4 -48.46 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.06 21.01 3.57 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.808 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.729 HD12 HD22 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -83.67 -27.7 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.709 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.19 -42.06 4.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.813 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.473 -179.948 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.494 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.454 0.168 . . . . 0.0 110.858 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -157.88 152.11 24.49 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.217 0.532 . . . . 0.0 111.789 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.779 ' CD1' HG11 ' A' ' 109' ' ' VAL . 87.1 m95 -94.97 92.72 7.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.568 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.945 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 40.1 m-85 -81.48 113.13 19.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 110.786 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -93.84 146.68 23.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.445 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.2 p -123.34 159.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.727 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.587 ' HE1' HG11 ' A' ' 102' ' ' VAL . 0.9 OUTLIER -117.27 103.39 10.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.933 -179.817 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 p -110.08 -174.29 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.96 150.99 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -71.35 126.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.11 26.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.575 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -23.54 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.064 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.48 -33.43 63.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.059 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.87 -34.74 68.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.07 -28.49 20.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.57 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.093 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.736 ' HB3' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -60.1 -38.51 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -179.973 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.27 79.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.022 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -61.62 -32.02 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.576 HD11 HG22 ' A' ' 85' ' ' VAL . 64.2 tp -76.17 -57.65 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -28.94 10.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.47 -41.63 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -37.7 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.798 HG23 ' HB2' ' A' ' 31' ' ' LEU . 35.0 mm -72.53 -30.41 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -89.81 -33.72 16.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.7 -40.01 66.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.91 -26.73 27.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.2 47.51 3.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.798 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.5 mt -99.92 40.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.25 -6.38 49.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.406 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.81 -26.12 40.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.995 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.648 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -95.53 -55.38 3.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.715 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.41 HG23 ' CG2' ' A' ' 68' ' ' ILE . 11.1 mm -88.2 122.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.81 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.494 ' CE2' HG21 ' A' ' 3' ' ' ILE . 10.3 m-85 -112.68 -54.37 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.454 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -111.4 156.5 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.544 HG22 HG23 ' A' ' 68' ' ' ILE . 38.5 t -156.4 75.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.122 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.734 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.5 mm? -91.04 168.06 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.712 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.719 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -123.25 139.41 31.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.805 179.597 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 72.3 Cg_endo -77.1 86.4 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.711 2.274 . . . . 0.0 113.202 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.797 ' O ' HG12 ' A' ' 115' ' ' VAL . 24.3 p . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.14 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.859 0.361 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 41' ' ' PRO . 54.3 mttt -48.53 108.67 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.691 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.473 HD12 HG11 ' A' ' 115' ' ' VAL . 71.1 mt -79.6 -31.88 41.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.471 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 26.7 m-85 -132.06 69.62 80.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.434 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.01 134.6 60.52 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.681 2.254 . . . . 0.0 112.608 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.31 -2.37 82.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -106.26 110.87 23.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -101.27 122.28 43.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.488 179.714 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.728 ' CD2' HD12 ' A' ' 112' ' ' ILE . 12.9 m-85 -89.66 119.68 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.2 mp -127.73 106.8 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 8.2 tt0 -79.83 72.99 6.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.434 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -91.11 -174.83 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.194 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.459 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.9 t0 -131.01 110.36 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.945 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 34.8 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.706 0.288 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.45 166.42 2.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.556 2.171 . . . . 0.0 112.235 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -83.52 173.28 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 84' ' ' VAL . 11.6 pt-20 -59.15 -25.44 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.04 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.812 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -55.48 -42.63 74.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.213 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -63.67 -44.01 95.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.95 -37.57 77.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -72.83 -45.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 81' ' ' ALA . 26.9 t -64.34 -41.04 91.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -22.84 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.036 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.79 -24.27 30.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 84' ' ' VAL . 78.0 p -58.2 115.99 13.22 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.57 0.224 . . . . 0.0 110.899 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 131.07 39.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.411 2.074 . . . . 0.0 112.293 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.14 59.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.836 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 88' ' ' THR . 5.3 tp . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.979 0.418 . . . . 0.0 111.201 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.508 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 71.1 mtt85 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.636 0.255 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 51.4 Cg_endo -68.77 136.44 35.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.096 . . . . 0.0 112.248 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.1 p -135.78 87.31 25.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.979 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.22 130.38 23.94 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.53 2.154 . . . . 0.0 112.222 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mt -79.16 163.95 24.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.917 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.0 t -86.82 140.81 33.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.8 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.78 -30.5 23.2 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 0.0 112.529 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -43.07 73.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.18 -30.53 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 105' ' ' SER . 26.4 t -61.29 -44.11 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -29.03 69.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.701 ' O ' HG23 ' A' ' 115' ' ' VAL . 11.6 m-70 -76.29 -45.33 33.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.786 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.728 HD12 ' CD2' ' A' ' 67' ' ' PHE . 20.0 pt -71.88 -26.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.882 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.912 HD22 HD12 ' A' ' 118' ' ' LEU . 70.8 mt -76.86 -36.26 56.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.397 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.65 -27.45 67.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 42' ' ' THR . 25.3 t -77.19 -41.98 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.734 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -57.55 -62.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.074 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.467 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 151.08 44.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.559 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.912 HD12 HD22 ' A' ' 113' ' ' LEU . 7.6 mt -119.59 -52.87 2.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.807 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -31.07 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.496 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.694 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.443 0.163 . . . . 0.0 110.796 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -141.19 151.57 43.91 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 112.068 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.634 ' HE1' HE21 ' A' ' 69' ' ' GLN . 84.6 m95 -98.92 93.61 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.704 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 50.5 m-85 -85.51 126.07 33.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.886 0.374 . . . . 0.0 110.772 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -105.69 142.2 35.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.598 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.71 150.67 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.629 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -94.25 147.88 22.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.969 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -141.01 177.06 8.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.01 141.38 28.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 12' ' ' VAL . 6.0 m -70.17 104.89 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.41 -27.44 5.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -101.89 -17.39 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 111.206 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.52 -38.73 64.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.103 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -42.63 73.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.943 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.06 92.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -56.55 20.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.57 98.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.55 -43.23 97.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 tp -72.62 -48.79 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.716 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -58.54 -24.76 61.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.072 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -81.82 -44.56 16.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HG3' HG22 ' A' ' 88' ' ' THR . 8.3 mmt85 -68.84 -24.99 64.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.204 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -69.45 -28.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.737 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.45 -33.65 15.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.82 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.063 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -79.94 -37.81 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.23 65.26 0.84 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.739 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 35' ' ' ILE . 1.1 pt? -149.57 27.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 0.0 110.881 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -11.71 61.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.3 m-20 -79.7 -29.66 40.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.824 0.345 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -77.16 -49.84 14.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.773 HD11 HD12 ' A' ' 31' ' ' LEU . 4.1 mp -84.78 109.05 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.694 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.1 m-85 -94.08 -52.77 4.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.439 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.405 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -111.99 156.36 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.79 -179.256 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.857 HG12 HG23 ' A' ' 68' ' ' ILE . 3.9 m -153.1 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.967 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.926 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.2 mm? -85.57 142.29 29.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.535 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.516 HG22 HG23 ' A' ' 42' ' ' THR . 3.7 mp -97.04 127.56 38.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.604 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 26.1 Cg_endo -62.18 75.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.554 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.693 HG22 ' HG2' ' A' ' 60' ' ' LYS . 60.8 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.2 ptmt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.848 0.356 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.693 ' HG2' HG22 ' A' ' 42' ' ' THR . 4.1 mmtm -92.61 121.7 34.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.772 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.0 mt -79.23 -49.51 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.728 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.458 ' CE1' HG22 ' A' ' 112' ' ' ILE . 35.6 m-85 -102.06 97.89 9.18 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.41 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.49 124.46 16.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.547 2.165 . . . . 0.0 112.509 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.71 42.97 99.58 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.83 151.58 48.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.985 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 11.3 mt -147.09 114.23 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.666 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD2' HD13 ' A' ' 112' ' ' ILE . 8.4 m-85 -90.33 123.15 33.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 38' ' ' VAL . 1.2 mp -128.47 113.93 31.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.634 HE21 ' HE1' ' A' ' 5' ' ' TRP . 17.3 tt0 -80.87 72.88 7.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.467 ' SD ' HD21 ' A' ' 72' ' ' LEU . 21.5 ptp -91.35 -169.36 2.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.99 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.57 80.2 1.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.771 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.704 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.945 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.418 0.151 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HB3' HD22 ' A' ' 72' ' ' LEU . 18.4 Cg_exo -65.67 66.64 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.65 2.234 . . . . 0.0 112.192 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -55.7 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 60.03 -82.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.945 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -58.43 -41.04 84.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -83.61 -30.16 27.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -61.62 -31.8 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 80' ' ' GLU . 32.8 t -82.57 -44.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 81' ' ' ALA . 35.9 t -60.54 -49.98 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.56 -24.52 61.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.72 70.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.827 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -79.0 120.33 80.41 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.802 0.301 . . . . 0.0 110.7 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.26 -14.18 43.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.475 2.117 . . . . 0.0 112.479 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.56 25.67 21.81 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.626 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.687 0.28 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.96 163.95 31.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.538 2.159 . . . . 0.0 112.17 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 t -125.41 116.41 25.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.32 171.38 17.83 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.452 2.101 . . . . 0.0 112.16 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.592 ' HB2' HG22 ' A' ' 109' ' ' VAL . 3.2 mp -89.88 157.42 17.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.895 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.859 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.0 m -80.36 150.67 71.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.2 -31.58 22.3 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.598 2.199 . . . . 0.0 112.43 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -45.32 24.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.09 -32.58 69.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 105' ' ' SER . 72.0 t -61.87 -52.41 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.008 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -24.62 66.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.731 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -76.93 -51.27 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.683 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.608 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.2 pp -69.78 -15.62 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.855 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.04 -36.31 35.94 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.682 179.477 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -80.56 -34.88 35.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.772 HG11 ' CD1' ' A' ' 61' ' ' LEU . 27.8 t -75.38 -46.35 38.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.004 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.926 ' HB3' HD12 ' A' ' 39' ' ' LEU . 72.4 m -60.75 -51.17 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.689 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.47 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.43 64.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.627 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.855 HD12 ' HG ' ' A' ' 113' ' ' LEU . 21.8 mt -136.74 -49.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.891 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -51.99 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.854 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.333 -1.259 . . . . 0.0 112.482 -179.967 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.521 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.469 0.176 . . . . 0.0 110.901 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -160.05 160.79 33.59 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 112.134 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.666 ' HH2' HD23 ' A' ' 39' ' ' LEU . 89.6 m95 -91.76 90.87 7.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.967 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 58.5 m-85 -83.67 108.72 16.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.11 148.87 27.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.467 HG22 HD11 ' A' ' 68' ' ' ILE . 26.9 m -140.44 -178.9 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.072 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -107.94 137.38 46.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -130.9 -178.62 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.73 120.44 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.2 p -58.5 119.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.072 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -28.83 11.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -0.34 43.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.57 -43.32 25.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.823 0.344 . . . . 0.0 111.224 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -37.89 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.018 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.6 -28.49 20.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.794 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -61.06 2.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB3' HD11 ' A' ' 66' ' ' LEU . 2.1 pttp -63.02 -38.62 91.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.86 94.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.45 -39.41 93.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.636 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.694 ' CD1' HG21 ' A' ' 88' ' ' THR . 64.1 tp -66.47 -51.89 52.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.69 -31.58 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.0 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.31 -41.86 69.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -70.5 -37.21 74.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.66 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.745 HD12 HD11 ' A' ' 31' ' ' LEU . 41.4 mm -70.07 -30.35 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.849 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -88.58 -33.32 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.54 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.9 -35.56 32.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 85.96 1.27 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.69 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -153.09 48.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.821 179.793 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.31 -7.77 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.358 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 p-10 -79.62 -20.16 47.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.956 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -96.05 -55.55 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.614 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 HG21 ' A' ' 26' ' ' ILE . 32.6 mt -91.36 130.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.5 m-85 -121.57 -54.8 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.717 -179.369 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.45 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mm100 -117.12 158.38 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 112.345 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.746 HG22 HG23 ' A' ' 68' ' ' ILE . 38.8 t -157.18 83.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.84 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.666 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.6 mm? -95.94 164.0 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.274 0.559 . . . . 0.0 112.207 -178.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.753 HG22 ' HG ' ' A' ' 66' ' ' LEU . 1.3 pp -143.83 69.93 16.82 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.094 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HG2' ' CE2' ' A' ' 67' ' ' PHE . 72.5 Cg_exo -41.07 115.45 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.273 2.649 . . . . 0.0 113.749 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.448 HG23 HD12 ' A' ' 40' ' ' ILE . 17.2 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.052 179.049 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.423 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.4 mtpt . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 119.71 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.739 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.3 mt -83.25 -42.61 17.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.364 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 41' ' ' PRO . 26.7 m-85 -122.99 74.32 48.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.873 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.95 142.8 93.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.596 2.197 . . . . 0.0 112.246 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.31 25.23 18.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.625 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.96 112.58 10.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.753 ' HG ' HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -113.7 130.08 56.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.967 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.988 ' CE2' HD12 ' A' ' 112' ' ' ILE . 13.8 m-30 -92.48 130.9 38.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.723 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.746 HG23 HG22 ' A' ' 38' ' ' VAL . 1.2 mp -130.39 111.46 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.211 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -79.72 70.86 6.31 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 ptm -91.55 -175.84 4.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.293 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -124.11 86.86 2.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.967 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 13.2 mt . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.745 0.307 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.33 173.5 14.39 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.457 2.105 . . . . 0.0 112.436 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.99 -165.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.589 ' OE2' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -57.7 -24.0 54.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -51.89 -44.62 63.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.369 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.9 t-105 -73.56 -30.19 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -37.7 86.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 88' ' ' THR . 34.8 t -70.06 -40.18 78.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 81' ' ' ALA . 34.4 t -67.14 -45.63 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -63.23 -17.92 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.98 -28.32 8.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.796 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.694 HG21 ' CD1' ' A' ' 22' ' ' LEU . 16.3 p -58.75 155.84 28.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.24 -25.29 31.15 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.51 -26.24 51.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.59 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.0 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.937 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.542 0.21 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.25 172.07 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.519 2.146 . . . . 0.0 112.309 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 t -128.95 122.97 21.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.22 142.59 15.23 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.529 2.153 . . . . 0.0 112.405 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' A' ' 112' ' ' ILE . 2.0 mt -74.54 168.96 18.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -89.79 142.83 29.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.93 179.935 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.01 -51.24 11.29 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.569 2.179 . . . . 0.0 112.615 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -56.95 -28.19 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -89.99 -36.29 15.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 105' ' ' SER . 30.3 t -57.42 -33.13 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.361 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -27.98 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.052 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -82.96 -34.59 26.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.904 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.988 HD12 ' CE2' ' A' ' 67' ' ' PHE . 15.2 pt -81.48 -19.11 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.122 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.071 HD22 HD12 ' A' ' 118' ' ' LEU . 29.9 mt -84.99 -25.08 27.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.719 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.35 -32.91 58.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.739 HG11 ' CD1' ' A' ' 61' ' ' LEU . 22.6 t -77.81 -37.47 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.182 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -57.54 -52.86 63.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.87 38.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.897 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.071 HD12 HD22 ' A' ' 113' ' ' LEU . 15.8 mt -117.72 -55.68 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.34 -42.82 14.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.516 179.994 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.732 HD13 ' HG2' ' A' ' 69' ' ' GLN . 2.0 pp . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.88 0.371 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -154.96 165.77 35.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.924 ' CD1' HG11 ' A' ' 109' ' ' VAL . 92.4 m95 -86.56 91.34 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.727 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.767 ' O ' HD12 ' A' ' 68' ' ' ILE . 79.8 m-85 -87.08 116.42 25.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.422 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -103.5 146.84 27.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.023 0.439 . . . . 0.0 111.763 -179.252 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.3 p -117.13 159.33 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.584 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.468 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 2.1 m-70 -107.01 142.21 37.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.932 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.5 p -155.12 174.8 14.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.81 162.35 15.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.62 125.85 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.72 -32.06 6.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.533 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.75 -30.72 36.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.564 ' CD ' HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -59.32 -37.19 77.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -59.97 -30.85 69.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.17 -29.88 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -50.16 75.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HB3' HD21 ' A' ' 66' ' ' LEU . 4.7 ptmt -60.16 -43.05 96.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.34 -51.98 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.67 -31.01 72.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.716 HD11 HG22 ' A' ' 85' ' ' VAL . 60.2 tp -78.23 -56.55 4.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -48.97 -31.29 7.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -43.87 68.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -36.09 82.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.742 ' HA ' HD21 ' A' ' 31' ' ' LEU . 37.7 mm -64.84 -29.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.997 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.76 -31.38 14.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.52 68.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CE2' HG13 ' A' ' 84' ' ' VAL . 15.3 m-85 -80.01 -34.46 38.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.35 59.0 1.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.641 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -122.66 47.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.809 179.938 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -65.69 -15.4 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.308 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.71 -2.34 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -113.13 -59.1 2.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 179.853 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.607 HG13 HD12 ' A' ' 26' ' ' ILE . 30.1 mm -79.95 120.29 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.719 ' CE2' HG21 ' A' ' 3' ' ' ILE . 63.3 m-85 -116.03 -56.23 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.571 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HB2' ' CB ' ' A' ' 69' ' ' GLN . 1.8 mm100 -112.95 156.17 23.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.247 0.546 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.816 HG22 HG23 ' A' ' 68' ' ' ILE . 24.8 t -154.89 79.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.137 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.853 HD21 HD11 ' A' ' 118' ' ' LEU . 3.5 mm? -87.29 157.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.518 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 40' ' ' ILE . 16.1 tt -111.15 120.37 43.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.926 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 30.6 Cg_endo -64.64 80.6 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.545 2.163 . . . . 0.0 112.877 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.445 HG23 HG12 ' A' ' 40' ' ' ILE . 11.4 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.875 0.369 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.08 122.46 11.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.837 HD11 HG11 ' A' ' 115' ' ' VAL . 20.9 mt -80.64 -51.05 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.4 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 33.1 m-85 -111.11 89.65 10.18 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 37.9 Cg_endo -66.69 128.39 18.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 22.87 73.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 97.1 m-85 -129.44 139.78 51.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.701 0.286 . . . . 0.0 110.984 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' A' ' 19' ' ' LYS . 4.1 tp -130.89 134.57 46.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.726 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.5 m-85 -99.85 123.9 44.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.816 HG23 HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -134.28 112.9 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 179.882 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.732 ' HG2' HD13 ' A' ' 3' ' ' ILE . 34.6 tt0 -79.95 72.64 6.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.156 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.636 ' SD ' HD11 ' A' ' 72' ' ' LEU . 15.8 ptm -91.56 -173.47 3.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.375 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.717 ' CA ' HG22 ' A' ' 3' ' ' ILE . 32.8 t0 -119.22 99.64 6.83 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.922 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.636 HD11 ' SD ' ' A' ' 70' ' ' MET . 54.1 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.31 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.685 0.279 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.6 151.88 72.63 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.662 2.241 . . . . 0.0 112.176 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.402 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . 1.3 m-80 -69.11 -175.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.86 -27.58 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.945 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.03 -29.02 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.345 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.81 -34.72 62.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -68.02 -31.5 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 88' ' ' THR . 21.7 t -76.99 -45.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.214 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 81' ' ' ALA . 37.9 t -59.01 -40.25 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.72 -12.97 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.325 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.95 -15.66 12.64 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.805 ' O ' HG22 ' A' ' 91' ' ' ILE . 40.2 p -57.4 112.01 4.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.736 0.268 . . . . 0.0 110.984 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.62 121.43 7.92 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.373 2.049 . . . . 0.0 112.299 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.26 -19.57 17.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.692 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 88' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.689 0.281 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.12 172.63 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.97 80.04 1.66 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.413 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.414 ' HB3' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_endo -77.87 139.76 17.77 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.537 2.158 . . . . 0.0 112.265 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.628 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.6 OUTLIER -84.96 130.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.846 179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.907 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -64.32 150.26 93.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.84 -40.0 57.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.577 2.185 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -31.24 72.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -87.64 -34.32 18.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.924 HG11 ' CD1' ' A' ' 5' ' ' TRP . 22.8 t -61.9 -31.73 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.303 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -64.33 -29.97 71.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.5 t60 -74.36 -47.4 34.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.806 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.726 HD12 ' CD2' ' A' ' 67' ' ' PHE . 17.1 pt -69.8 -27.38 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.033 HD22 HD12 ' A' ' 118' ' ' LEU . 14.2 mt -74.85 -34.28 62.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -70.23 -32.5 70.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.594 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.837 HG11 HD11 ' A' ' 61' ' ' LEU . 22.5 t -81.83 -33.3 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -61.32 -63.63 1.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.586 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 145.44 44.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.698 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.033 HD12 HD22 ' A' ' 113' ' ' LEU . 12.6 mt -121.59 -45.44 2.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.749 0.309 . . . . 0.0 110.92 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.22 30.33 2.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.33 -1.261 . . . . 0.0 112.475 -179.957 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.661 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.452 0.168 . . . . 0.0 110.882 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.21 160.3 43.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.165 0.507 . . . . 0.0 111.88 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.896 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 90.0 m95 -93.96 119.8 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.774 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.964 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 22.3 m-85 -114.3 105.64 13.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.441 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -99.14 169.09 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.097 0.475 . . . . 0.0 111.724 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.649 HG11 HD12 ' A' ' 91' ' ' ILE . 2.4 p -156.26 161.41 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.57 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.505 ' N ' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -93.43 157.07 16.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.108 -179.672 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p -150.35 -176.54 5.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.09 145.79 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.16 129.55 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.2 -23.97 31.0 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.618 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.68 -19.62 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.569 0.223 . . . . 0.0 111.167 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.45 -38.45 66.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.7 -36.61 72.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.947 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -24.83 21.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.025 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.24 -38.1 89.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -61.2 -35.15 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 -41.89 34.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.65 -34.88 73.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HG21 ' A' ' 88' ' ' THR . 36.8 tp -77.31 -53.01 8.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.09 -35.37 59.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -63.42 -42.11 98.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.682 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HD3' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -66.17 -38.15 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 179.8 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.8 HG23 ' HB2' ' A' ' 31' ' ' LEU . 46.7 mm -64.06 -33.26 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -89.8 -33.81 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -40.4 77.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.07 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.417 ' CE2' ' HG3' ' A' ' 25' ' ' ARG . 29.3 m-85 -92.32 -24.81 18.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 88.07 78.29 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.404 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.8 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.9 mm? -123.18 35.26 4.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.89 16.21 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.478 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.8 -12.88 15.71 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.52 0.2 . . . . 0.0 111.115 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 2.3 mptt -116.28 -44.23 2.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.321 . . . . 0.0 111.125 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.675 HD11 HG22 ' A' ' 38' ' ' VAL . 19.4 tt -82.2 153.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.195 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.661 ' CE2' HG21 ' A' ' 3' ' ' ILE . 28.9 m-85 -143.23 -52.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.431 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.9 mt-30 -120.33 146.52 46.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 111.108 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.706 HG22 HG23 ' A' ' 68' ' ' ILE . 3.5 t -143.22 70.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.222 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.896 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -88.69 143.59 26.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.576 -179.121 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 42' ' ' THR . 4.9 tt -108.58 123.58 36.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.231 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 14.0 Cg_endo -57.84 87.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.659 2.24 . . . . 0.0 112.894 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.512 HG23 HG12 ' A' ' 40' ' ' ILE . 76.2 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.776 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.802 0.335 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -58.07 108.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.057 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.891 HD11 ' CG1' ' A' ' 115' ' ' VAL . 39.6 mt -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.474 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 3.3 m-85 -132.56 88.4 38.97 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.623 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.22 108.4 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.763 2.309 . . . . 0.0 112.857 -179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 47.82 9.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.848 179.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.444 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 62.6 m-85 -144.96 145.15 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.593 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.3 pp -150.61 120.27 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.413 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.963 ' CD2' HD13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -96.25 126.88 41.77 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 111.366 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -119.13 121.53 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.579 179.73 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -79.87 78.9 6.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.362 . . . . 0.0 110.712 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 72' ' ' LEU . 20.3 ptp -91.0 -175.71 4.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.244 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 5.9 t0 -122.17 77.88 1.44 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.964 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 19.9 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.652 0.263 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.38 104.74 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.666 2.244 . . . . 0.0 112.218 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.2 -167.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.7 OUTLIER 56.47 -85.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.52 179.609 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.823 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.41 -44.95 69.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.591 -179.478 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.411 ' HA ' ' CE3' ' A' ' 82' ' ' TRP . 2.0 t-105 -74.81 -30.51 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.119 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.94 -30.16 69.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.748 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 80' ' ' GLU . 23.1 t -84.57 -48.7 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.045 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 81' ' ' ALA . 36.8 t -59.72 -49.61 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.48 -22.41 66.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.247 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.38 -22.45 24.47 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.83 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.632 HG22 ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -65.24 145.73 99.04 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 110.93 -179.878 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.77 -25.59 28.37 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.469 2.113 . . . . 0.0 112.301 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.38 -28.17 54.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.649 HD12 HG11 ' A' ' 8' ' ' VAL . 35.6 mm . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 1.3 mmp_? . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.515 0.198 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.4 Cg_endo -59.46 152.61 60.23 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.437 2.091 . . . . 0.0 112.064 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.35 82.18 31.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.191 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.3 115.6 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.38 2.053 . . . . 0.0 112.091 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -70.57 149.01 47.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.994 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.896 ' O ' HG23 ' A' ' 109' ' ' VAL . 56.3 m -87.49 148.31 43.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.88 -37.1 54.95 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.764 2.309 . . . . 0.0 112.458 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -68.93 -29.41 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 112' ' ' ILE . 3.5 tt0 -91.48 -32.18 15.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 105' ' ' SER . 24.3 t -64.28 -36.67 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.113 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.411 ' HG3' HD13 ' A' ' 119' ' ' LEU . 2.5 ttt-85 -69.48 -30.73 68.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.942 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.665 ' O ' HG23 ' A' ' 115' ' ' VAL . 7.9 t-80 -77.91 -42.36 33.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.728 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.963 HD13 ' CD2' ' A' ' 67' ' ' PHE . 1.9 pp -74.89 -29.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.884 ' CD2' HD12 ' A' ' 118' ' ' LEU . 19.0 mt -75.34 -30.68 60.33 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.493 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.12 -27.78 64.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.195 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.891 ' CG1' HD11 ' A' ' 61' ' ' LEU . 2.1 t -88.23 -50.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.785 0.326 . . . . 0.0 111.34 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.698 ' CB ' HD23 ' A' ' 39' ' ' LEU . 33.8 t -52.92 -63.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.836 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.904 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 142.21 48.68 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.843 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.904 HD23 ' O ' ' A' ' 117' ' ' GLY . 15.7 mt -133.17 5.77 3.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.47 0.176 . . . . 0.0 111.455 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.411 HD13 ' HG3' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -135.84 40.69 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.874 0.368 . . . . 0.0 110.809 179.931 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.396 -1.225 . . . . 0.0 112.531 -179.987 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 69' ' ' GLN . 2.7 pp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.518 0.199 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -142.7 169.8 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 112.21 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.664 ' HH2' HD23 ' A' ' 39' ' ' LEU . 87.8 m95 -94.05 91.55 6.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.462 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.688 ' O ' HD12 ' A' ' 68' ' ' ILE . 63.3 m-85 -79.96 116.12 19.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 110.647 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.73 151.5 19.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.709 -179.333 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -134.51 159.95 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.563 179.671 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.482 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 2.5 m80 -110.56 87.36 2.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.5 p -83.73 -174.35 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.794 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.72 134.02 34.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 12' ' ' VAL . 4.9 m -60.47 104.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.61 -30.45 5.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.405 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -92.79 -19.63 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.587 0.232 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.03 -40.73 64.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 111.005 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.32 -37.24 69.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.828 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -89.84 -26.22 20.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.981 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.16 86.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -59.45 -48.01 83.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.88 74.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -60.22 -32.62 71.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.769 HD12 HG21 ' A' ' 88' ' ' THR . 8.8 tp -78.3 -56.1 4.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.728 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -29.41 2.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.294 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -46.52 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -33.15 68.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.59 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.498 HG23 ' HB2' ' A' ' 31' ' ' LEU . 34.3 mm -75.16 -25.21 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -97.78 -29.95 13.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.41 -40.79 64.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.989 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -79.99 -25.34 40.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.39 51.55 1.7 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.595 HD11 ' CG ' ' A' ' 80' ' ' GLU . 3.4 mm? -104.48 31.9 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.59 9.78 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -104.01 -21.71 13.57 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.711 0.291 . . . . 0.0 111.025 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HG3' HD12 ' A' ' 31' ' ' LEU . 2.2 mtpt -96.46 -51.23 4.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.677 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pt -79.82 151.25 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.765 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.717 ' HE2' HG21 ' A' ' 3' ' ' ILE . 56.4 m-85 -141.72 -44.96 0.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.344 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 2.6 mt-30 -129.52 158.33 39.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.221 0.534 . . . . 0.0 112.035 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 68' ' ' ILE . 20.8 t -154.97 82.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.114 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.85 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.5 mm? -92.65 157.94 16.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.62 -179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.16 124.08 32.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.753 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 37.5 Cg_endo -66.83 81.1 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.586 2.191 . . . . 0.0 112.855 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.588 HG22 ' HG2' ' A' ' 60' ' ' LYS . 15.9 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.874 0.369 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.588 ' HG2' HG22 ' A' ' 42' ' ' THR . 9.4 mtmm -59.93 115.62 3.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.852 ' CD1' HG11 ' A' ' 115' ' ' VAL . 37.4 mt -72.93 -44.98 60.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.74 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 41.0 m-85 -119.28 88.26 37.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.616 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.08 136.62 53.07 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.493 2.128 . . . . 0.0 112.313 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.83 22.1 69.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.547 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.19 127.95 52.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.824 0.345 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 124.86 45.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.608 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.978 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.4 m-85 -93.19 123.63 36.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.1 mp -129.42 110.42 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.454 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.904 ' HG2' HD13 ' A' ' 3' ' ' ILE . 30.4 tt0 -79.81 72.24 6.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.091 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.595 ' SD ' HD11 ' A' ' 72' ' ' LEU . 25.1 ptp -92.02 -176.85 4.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.851 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.577 ' HA ' HG22 ' A' ' 3' ' ' ILE . 14.5 t0 -118.27 99.23 6.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.703 179.382 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.595 HD11 ' SD ' ' A' ' 70' ' ' MET . 80.2 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.337 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.606 0.241 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 169.87 17.43 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.482 2.121 . . . . 0.0 112.292 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.38 -165.78 1.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.5 pt-20 -57.64 -21.46 39.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -47.88 -44.78 29.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.412 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -68.94 -35.42 76.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.41 -30.19 68.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 88' ' ' THR . 22.9 t -79.24 -51.51 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.5 t -59.84 -46.31 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -26.83 66.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.71 -27.28 57.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.621 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.769 HG21 HD12 ' A' ' 22' ' ' LEU . 45.7 p -59.89 142.91 88.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.682 0.277 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.87 -13.93 21.6 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.533 2.155 . . . . 0.0 112.627 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.64 -6.41 65.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.047 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.889 HD13 ' O ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.63 0.252 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 112.78 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.511 2.141 . . . . 0.0 112.004 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.95 123.68 62.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.17 148.55 10.44 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.764 2.309 . . . . 0.0 112.202 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -77.8 141.56 39.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.852 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.9 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -77.62 157.66 79.53 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.948 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.1 -35.62 95.19 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.589 2.193 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.44 -29.54 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -87.03 -36.46 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 105' ' ' SER . 39.8 t -60.72 -51.98 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 HD21 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -56.11 -29.56 60.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -53.79 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.576 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.978 HD12 ' CD2' ' A' ' 67' ' ' PHE . 18.9 pt -66.2 -25.07 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.732 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.861 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.9 mp -71.67 -38.07 70.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.486 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -30.56 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.704 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.852 HG11 ' CD1' ' A' ' 61' ' ' LEU . 21.8 t -83.39 -40.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.042 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.85 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.9 m -58.93 -62.02 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.566 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 144.73 48.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.526 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.861 HD12 ' HG ' ' A' ' 113' ' ' LEU . 27.8 mt -124.12 -45.26 2.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.995 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.42 HD21 HH11 ' A' ' 110' ' ' ARG . 0.1 OUTLIER -98.48 29.85 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.395 179.988 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.54 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.541 0.21 . . . . 0.0 110.852 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -153.3 161.9 41.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.826 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.632 ' CZ2' HD11 ' A' ' 113' ' ' LEU . 68.2 m95 -88.49 92.71 9.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.661 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.841 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 67.0 m-85 -87.99 114.12 24.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -100.77 147.49 26.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.525 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 9' ' ' HIS . 16.1 t -127.93 160.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.541 ' CD2' ' CZ ' ' A' ' 65' ' ' TYR . 1.7 m80 -114.72 156.58 24.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -156.63 -174.74 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 145.8 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.48 130.5 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.42 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -94.01 -22.05 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 0.0 111.066 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -53.65 -43.78 69.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -33.51 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -80.87 -31.06 35.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.54 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -60.31 -37.67 81.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.973 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.68 -53.76 42.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -30.33 69.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.535 HD11 HG22 ' A' ' 85' ' ' VAL . 31.5 tp -76.3 -56.53 4.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -48.76 -30.33 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -38.4 61.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.56 ' HG3' HG22 ' A' ' 88' ' ' THR . 21.9 mmt180 -73.67 -37.35 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.569 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.836 HD12 HD11 ' A' ' 31' ' ' LEU . 41.4 mm -72.92 -28.05 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.987 179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -89.63 -32.8 16.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.773 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -39.55 79.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.993 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.98 -37.29 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.83 41.71 5.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.836 HD11 HD12 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -99.52 51.18 0.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.79 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.3 -5.15 43.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.4 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -79.69 -24.27 41.85 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.824 179.939 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -94.3 -52.17 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.9 mt -95.16 111.61 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.5 m-85 -102.46 -60.23 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.382 -179.451 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.39 130.03 49.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 -179.146 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.8 p -126.07 72.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.497 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.688 HD23 ' OG ' ' A' ' 116' ' ' SER . 2.5 tm? -83.64 133.47 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.945 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' THR . 0.1 OUTLIER -109.22 124.51 33.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.925 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 88.1 Cg_exo -49.19 77.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.138 2.559 . . . . 0.0 113.305 -179.652 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 40' ' ' ILE . 36.8 p . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.775 179.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.3 tptt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.604 0.24 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -139.82 113.53 8.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 115' ' ' VAL . 3.6 mt -85.26 -47.76 9.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CE1' HG22 ' A' ' 112' ' ' ILE . 7.6 m-85 -135.99 84.36 31.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.584 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.79 141.93 92.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.496 -179.643 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.86 77.81 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.069 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.541 ' CZ ' ' CD2' ' A' ' 9' ' ' HIS . 6.2 m-85 -117.99 156.74 28.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.8 0.334 . . . . 0.0 110.953 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD12 ' C ' ' A' ' 65' ' ' TYR . 5.2 mp -150.64 107.7 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.68 ' CD1' HD11 ' A' ' 104' ' ' LEU . 4.4 m-85 -81.79 124.32 29.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.0 OUTLIER -127.86 114.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 23.7 tt0 -80.71 71.09 7.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 0.0 110.345 179.433 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.3 ptp -91.2 -175.02 4.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.434 ' OD1' HG22 ' A' ' 3' ' ' ILE . 26.6 t70 -124.32 92.02 3.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.73 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.841 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.654 0.264 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.7 171.64 6.79 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.687 2.258 . . . . 0.0 112.235 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 -177.25 5.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.97 -28.91 64.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.53 -41.16 69.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -59.86 -39.74 86.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.27 -40.22 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -65.45 -47.87 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.7 t -63.43 -45.33 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.091 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.413 ' HA ' HG21 ' A' ' 91' ' ' ILE . 2.1 ttt180 -60.67 -28.99 69.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.68 -31.28 56.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 25' ' ' ARG . 20.9 p -60.76 111.35 3.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.616 0.246 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.16 133.73 35.96 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.445 2.097 . . . . 0.0 112.366 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.14 -11.45 48.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.703 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.413 HG21 ' HA ' ' A' ' 86' ' ' ARG . 8.8 tp . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.739 0.304 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.13 171.58 14.6 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.205 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 102' ' ' VAL . 6.4 m -142.52 101.69 5.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.187 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.79 157.84 54.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.397 2.064 . . . . 0.0 112.169 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.68 HD11 ' CD1' ' A' ' 67' ' ' PHE . 16.2 mt -89.99 163.68 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.7 p -86.67 141.38 33.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.95 -33.9 35.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.572 2.181 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.37 -41.63 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -81.58 -31.08 32.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 105' ' ' SER . 58.5 t -63.36 -43.68 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -61.25 -30.42 70.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -52.88 11.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.609 179.816 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.595 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.5 pp -66.42 -16.48 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.59 179.423 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.757 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -72.65 -36.73 68.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.316 179.173 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.52 -22.43 44.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.767 HG21 HD13 ' A' ' 61' ' ' LEU . 38.5 t -70.26 -60.93 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.688 ' OG ' HD23 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -52.49 -53.66 42.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.42 38.17 0.42 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.545 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.757 HD12 ' HG ' ' A' ' 113' ' ' LEU . 2.7 mt -100.06 0.62 41.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.591 0.234 . . . . 0.0 111.366 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 113' ' ' LEU . 2.8 mp -131.4 -63.02 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.385 -1.23 . . . . 0.0 112.438 -179.959 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.819 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.431 0.158 . . . . 0.0 110.813 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 103' ' ' PRO . 2.1 mt-10 -139.91 163.71 31.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.416 0.627 . . . . 0.0 112.294 -179.318 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.872 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 74.7 m95 -91.09 92.21 8.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.583 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.548 ' O ' HD12 ' A' ' 68' ' ' ILE . 64.9 m-85 -79.8 107.61 12.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.895 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -87.0 146.66 26.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -146.55 177.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.555 179.626 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.454 ' CE1' ' CE1' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -122.48 160.7 25.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.126 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -136.83 158.79 43.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.622 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.26 127.43 27.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.3 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -63.66 128.73 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.852 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.68 -30.63 8.56 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.205 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -97.36 -9.41 27.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 0.0 110.96 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.8 -39.04 4.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 111.238 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -54.94 -44.17 74.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.33 34.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.76 85.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.067 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.0 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.73 -50.97 8.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.099 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.04 -34.86 72.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.639 HD11 HG13 ' A' ' 85' ' ' VAL . 41.3 tp -71.98 -56.96 4.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -33.34 60.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -67.88 -40.9 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.709 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.666 ' HG3' HG22 ' A' ' 88' ' ' THR . 2.1 mmt180 -68.0 -38.25 82.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.0 mm -69.42 -30.09 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.017 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -89.0 -33.62 17.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.62 68.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.45 -27.07 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.06 56.94 2.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.456 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -103.88 35.33 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 0.0 110.846 -179.916 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.21 -4.19 37.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.515 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.78 -28.06 40.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.839 0.352 . . . . 0.0 110.77 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -54.29 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.686 HG23 ' CG2' ' A' ' 68' ' ' ILE . 2.5 mp -86.66 94.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.657 179.557 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.819 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.8 m-85 -83.01 -50.05 8.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.486 ' HB3' ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -115.67 138.94 50.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.166 0.508 . . . . 0.0 111.705 -179.207 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.39 138.56 26.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.459 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.872 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -160.23 155.56 25.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 111.356 -179.731 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.47 ' N ' HD22 ' A' ' 39' ' ' LEU . 14.9 tt -114.6 128.26 26.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 11.2 Cg_endo -55.71 80.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.673 2.248 . . . . 0.0 112.8 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 41' ' ' PRO . 36.6 p . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.48 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -63.72 115.19 4.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.832 ' CD1' HG21 ' A' ' 115' ' ' VAL . 37.9 mt -90.09 -39.82 12.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.204 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 1.4 m-85 -131.4 95.49 23.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.917 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.16 133.22 48.54 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.527 2.152 . . . . 0.0 112.145 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.54 23.29 62.56 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.793 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.669 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.2 m-85 -116.49 154.07 31.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -160.49 130.92 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.72 179.802 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.782 ' HD2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.13 142.72 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.557 179.618 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.686 ' CG2' HG23 ' A' ' 35' ' ' ILE . 2.7 mp -138.32 122.36 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.393 -179.644 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 27.4 tt0 -79.81 65.17 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 110.256 179.43 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.781 ' SD ' HD23 ' A' ' 72' ' ' LEU . 11.6 ptp -91.77 -169.34 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' CG ' HG22 ' A' ' 3' ' ' ILE . 5.2 t0 -148.62 80.49 1.44 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.81 179.64 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.781 HD23 ' SD ' ' A' ' 70' ' ' MET . 4.1 pp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.166 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.699 0.285 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.91 177.96 7.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -90.07 -179.98 5.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.2 tp10 -61.33 -24.35 66.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.187 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.28 -47.39 72.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.343 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.452 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -59.31 -42.36 91.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.967 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -59.98 -32.21 70.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 31' ' ' LEU . 24.1 t -82.58 -49.17 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.6 t -59.91 -51.28 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.982 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -66.35 -25.76 66.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.072 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.97 -32.64 63.27 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.701 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 25' ' ' ARG . 81.7 p -61.78 143.69 93.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 91.18 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.42 -36.41 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.451 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.14 179.913 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.477 0.179 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.0 Cg_exo -53.99 -171.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.492 2.128 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -150.6 115.46 3.29 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.281 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 4' ' ' GLU . 15.6 Cg_exo -68.0 145.06 66.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.465 2.11 . . . . 0.0 112.068 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.1 mp -86.29 159.1 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 69.6 m -89.54 141.66 28.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.66 -37.14 26.74 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 112.574 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -48.74 80.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.07 -33.97 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 62.3 t -58.5 -50.5 78.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.91 -37.95 54.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.224 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.459 ' O ' HG23 ' A' ' 115' ' ' VAL . 3.0 m-70 -68.4 -52.69 30.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.669 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.748 HD12 ' CD2' ' A' ' 67' ' ' PHE . 27.5 pt -66.36 -26.11 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.835 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.746 ' HG ' HD12 ' A' ' 118' ' ' LEU . 3.2 mp -73.83 -41.16 62.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -23.41 65.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.832 HG21 ' CD1' ' A' ' 61' ' ' LEU . 33.9 t -76.59 -59.09 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.7 ' HB2' HD23 ' A' ' 39' ' ' LEU . 1.5 t -59.4 -57.03 14.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.546 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.03 63.13 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.914 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.746 HD12 ' HG ' ' A' ' 113' ' ' LEU . 12.6 mt -133.46 5.62 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.514 0.197 . . . . 0.0 111.441 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.34 -36.38 11.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.412 -179.941 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.629 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.417 0.151 . . . . 0.0 110.932 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.76 150.13 50.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.276 0.56 . . . . 0.0 111.971 -179.278 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.699 ' CD1' HG11 ' A' ' 109' ' ' VAL . 71.8 m95 -99.75 110.14 22.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.529 179.349 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 30.3 m-85 -99.67 137.08 38.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 0.0 110.722 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.538 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . -111.49 146.75 36.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.033 0.444 . . . . 0.0 111.861 -179.407 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.5 OUTLIER -137.3 159.31 35.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.191 179.583 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -119.58 126.28 50.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.914 -179.857 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -132.06 -177.22 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 141.07 35.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -58.28 114.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.021 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.76 -34.05 5.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.295 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.41 -30.02 37.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 110.762 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.18 -39.15 66.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.12 -41.18 83.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -81.01 -26.69 36.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.61 56.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.152 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -35.44 74.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.81 -57.2 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.94 -36.29 82.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.488 HD11 HG22 ' A' ' 85' ' ' VAL . 59.6 tp -70.09 -47.87 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.765 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.707 ' O ' HG22 ' A' ' 26' ' ' ILE . 31.3 mt-10 -59.33 -22.13 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -45.97 14.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.877 0.37 . . . . 0.0 110.296 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -68.35 -24.46 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.4 tp -70.94 -28.07 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -97.39 -31.3 12.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.23 74.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -79.93 -25.61 40.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.987 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 30.19 6.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.287 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.6 mt -97.04 25.38 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -24.32 66.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.75 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.85 -3.44 47.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.161 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.727 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -100.01 -67.55 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 179.813 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.681 HD12 HG21 ' A' ' 68' ' ' ILE . 28.9 mm -80.71 130.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.711 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 3' ' ' ILE . 10.4 m-85 -124.24 -50.43 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -119.46 161.48 20.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.423 0.63 . . . . 0.0 112.489 -178.522 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.564 ' O ' HD22 ' A' ' 39' ' ' LEU . 40.5 t -157.84 110.85 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.956 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 116' ' ' SER . 4.1 mm? -126.16 175.06 8.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.529 0.68 . . . . 0.0 112.292 -178.743 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 39' ' ' LEU . 9.2 pt -161.87 66.95 2.08 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.703 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 62' ' ' PHE . 9.6 Cg_endo -52.88 150.52 22.77 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.451 2.767 . . . . 0.0 114.359 -178.445 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 60' ' ' LYS . 22.3 p . . . . . 0 N--CA 1.456 -0.165 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.139 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.027 0 CA-C-O 120.696 0.284 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.711 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.0 OUTLIER -47.21 132.97 12.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.274 -179.909 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 1.1 mt -90.39 -58.82 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 179.541 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 51.9 m-85 -113.04 64.39 0.88 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.777 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.2 135.46 54.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.562 2.175 . . . . 0.0 112.168 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.91 6.2 72.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 4.7 m-85 -113.69 126.72 55.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.82 116.62 32.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.784 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.758 ' CD2' HD12 ' A' ' 112' ' ' ILE . 14.0 m-30 -90.27 95.3 10.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.681 HG21 HD12 ' A' ' 35' ' ' ILE . 4.1 mt -95.25 113.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.279 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.662 HE21 ' HE1' ' A' ' 5' ' ' TRP . 35.1 tt0 -83.21 68.63 9.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.744 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.577 ' HE2' ' HG ' ' A' ' 72' ' ' LEU . 1.9 ptt? -91.45 -165.49 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.473 179.501 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -149.43 84.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.895 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.585 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 44.0 mt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.004 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.509 0.195 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.92 159.32 2.51 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.414 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -90.05 -169.96 2.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 84' ' ' VAL . 34.0 tt0 -54.88 -23.58 19.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.727 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . . . -52.62 -52.46 55.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.198 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 -58.06 -30.8 66.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -71.9 -31.03 66.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.798 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 31' ' ' LEU . 29.9 t -83.37 -51.41 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.948 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.4 t -57.22 -41.98 79.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.478 ' HA ' HG21 ' A' ' 91' ' ' ILE . 1.3 ttt180 -71.87 -22.76 61.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.16 -17.79 64.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.945 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.443 HG21 HD13 ' A' ' 22' ' ' LEU . 73.9 p -58.97 139.32 87.32 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.744 0.272 . . . . 0.0 110.95 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.36 105.48 2.05 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.464 2.109 . . . . 0.0 112.239 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.24 -17.09 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.725 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.642 0.258 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.74 175.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.5 p -132.56 79.33 65.09 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.853 0.358 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.98 146.1 22.82 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.548 2.165 . . . . 0.0 111.973 179.642 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.672 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -85.05 163.87 18.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.753 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -89.76 150.49 44.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.5 -27.31 7.25 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.638 2.225 . . . . 0.0 112.503 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.85 -46.85 17.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.96 -30.64 63.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 105' ' ' SER . 50.4 t -62.86 -55.18 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.506 ' HD2' HD11 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -55.54 -24.95 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.151 -179.898 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -77.96 -44.87 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.779 179.89 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.758 HD12 ' CD2' ' A' ' 67' ' ' PHE . 27.4 pt -72.43 -28.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.966 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.69 HD22 HD12 ' A' ' 118' ' ' LEU . 25.9 mt -76.24 -30.78 58.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.65 -32.5 69.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.495 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' HIS . 25.5 t -84.19 -26.42 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.808 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.861 ' HB2' HD12 ' A' ' 39' ' ' LEU . 20.4 p -68.4 -43.25 77.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.63 4.24 3.95 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.164 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.69 HD12 HD22 ' A' ' 113' ' ' LEU . 34.8 mt -80.0 -58.48 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.91 0.355 . . . . 0.0 110.728 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.506 HD11 ' HD2' ' A' ' 110' ' ' ARG . 71.3 mt -95.07 -29.13 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.493 179.978 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.671 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.442 0.163 . . . . 0.0 110.909 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.0 152.18 49.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.161 0.505 . . . . 0.0 111.855 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.893 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 73.0 m95 -97.58 96.76 8.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.637 179.575 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.976 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 27.1 m-85 -86.86 123.62 32.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 110.728 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -106.39 159.67 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.568 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 91' ' ' ILE . 10.6 t -141.49 160.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.472 ' N ' HG12 ' A' ' 8' ' ' VAL . 14.0 m-70 -88.9 134.88 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.98 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 p -139.4 160.98 38.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.13 151.13 21.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.49 127.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -25.51 24.54 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.31 -26.9 19.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.71 0.291 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' HB2' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -56.52 -41.22 76.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.96 -37.84 67.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.973 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -86.71 -29.82 22.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.841 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.19 83.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.024 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.79 -43.58 94.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.54 -42.91 28.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.32 -31.51 69.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 88' ' ' THR . 21.1 tp -82.87 -57.6 3.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.35 -45.31 17.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.439 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -61.11 -41.91 97.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -43.23 91.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.661 HG23 ' HB2' ' A' ' 31' ' ' LEU . 35.7 mm -64.39 -28.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.855 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -91.41 -29.72 16.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 -46.46 30.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.339 -179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -79.95 -21.63 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.207 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.13 65.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.176 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.661 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.8 mm? -115.08 26.65 9.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.301 . . . . 0.0 111.154 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -80.19 22.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.38 -21.45 13.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.696 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.2 -48.01 2.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.9 mp -79.86 128.28 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.671 ' CE2' HG21 ' A' ' 3' ' ' ILE . 33.0 m-85 -115.3 -56.74 2.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.424 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -115.83 170.02 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 68' ' ' ILE . 34.7 t -157.79 120.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.983 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.893 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -144.58 150.3 37.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.334 0.588 . . . . 0.0 112.295 -178.533 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 pt -113.05 124.83 30.8 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.568 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' CG ' ' HB2' ' A' ' 62' ' ' PHE . 50.7 Cg_endo -68.9 85.71 0.49 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.651 2.234 . . . . 0.0 112.885 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 7.1 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.421 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.557 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.3 mmtp . . . . . 0 C--O 1.226 -0.169 0 CA-C-O 120.704 0.287 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.51 117.55 19.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.872 0.368 . . . . 0.0 111.028 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.858 ' CD1' HG11 ' A' ' 115' ' ' VAL . 18.1 mt -87.63 -55.45 3.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.668 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 1.1 m-85 -112.3 91.47 16.45 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 127.8 27.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.475 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.39 40.78 96.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.66 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -133.42 115.28 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -124.01 121.45 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.206 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.736 ' HD2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -97.36 133.9 41.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 111.246 -179.573 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.6 mp -123.56 122.06 64.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.591 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.455 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 2.5 tt0 -79.77 75.66 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptp -90.92 -175.17 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.153 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.461 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.3 t0 -130.52 100.03 5.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.976 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 13.9 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.054 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.627 0.251 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 82' ' ' TRP . 51.0 Cg_endo -69.08 77.89 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.481 2.121 . . . . 0.0 112.203 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.9 m120 -90.24 -173.06 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 51.91 -84.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.866 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -46.94 -48.9 21.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.719 -179.719 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 6.1 t-105 -76.2 -28.87 57.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.79 -37.79 74.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 31' ' ' LEU . 21.6 t -90.06 -47.44 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 81' ' ' ALA . 57.6 t -59.56 -42.29 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.089 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.67 -19.32 62.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.306 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -120.53 22.57 8.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.611 HG21 HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -75.62 134.24 72.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.714 0.257 . . . . 0.0 110.821 179.924 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.03 -8.61 23.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.414 2.076 . . . . 0.0 112.669 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -103.82 -18.53 13.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.828 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.639 HD11 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.34 . . . . 0.0 111.056 -179.861 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 1.8 mtt-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.537 0.208 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 5.5 Cg_exo -74.07 116.89 4.8 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.707 2.271 . . . . 0.0 112.006 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 102' ' ' VAL . 4.6 m -115.58 97.39 48.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.262 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.35 123.89 9.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.493 2.129 . . . . 0.0 112.187 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.77 HD22 HD13 ' A' ' 112' ' ' ILE . 2.2 mp -71.99 157.98 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -85.66 151.47 55.62 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 -179.935 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.13 -30.25 18.34 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.698 2.266 . . . . 0.0 112.464 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -71.45 -47.44 55.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -74.41 -31.9 62.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 48.7 t -61.18 -52.47 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -55.53 -38.46 69.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.21 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -68.79 -46.61 68.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.054 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.77 HD13 HD22 ' A' ' 104' ' ' LEU . 31.1 pt -72.53 -27.09 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.954 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.052 HD22 HD12 ' A' ' 118' ' ' LEU . 15.6 mt -79.45 -29.21 41.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -67.05 -21.76 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.925 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.858 HG11 ' CD1' ' A' ' 61' ' ' LEU . 13.7 t -86.31 -54.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.157 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.688 ' HB2' HD23 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -55.88 -60.44 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.672 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.58 64.83 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.903 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.052 HD12 HD22 ' A' ' 113' ' ' LEU . 30.4 mt -128.93 -43.78 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 0.0 110.891 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.4 tp -80.14 -63.33 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.572 -179.996 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.544 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.525 0.202 . . . . 1.16 110.941 . . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -156.07 155.79 33.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 2.07 111.507 -179.751 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.844 ' CD1' HG11 ' A' ' 109' ' ' VAL . 93.8 m95 -96.28 96.64 8.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.95 110.692 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.953 ' CE2' HD12 ' A' ' 72' ' ' LEU . 3.3 m-85 -86.17 117.35 24.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 1.43 111.029 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -92.95 147.71 22.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.72 111.144 -179.823 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.613 HG11 HD12 ' A' ' 91' ' ' ILE . 15.2 t -134.46 159.96 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 1.69 111.025 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.475 ' N ' HG12 ' A' ' 8' ' ' VAL . 10.7 m-70 -102.01 149.65 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 1.36 111.013 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.2 p -151.3 -177.6 6.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 1.11 110.86 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.0 139.4 30.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 2.2 110.908 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 12' ' ' VAL . 28.8 m -62.65 121.71 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 2.26 111.206 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.5 -28.62 12.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.787 -0.721 . . . . 1.76 112.402 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -89.68 -21.41 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 2.52 111.113 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -53.42 -36.31 61.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 2.53 111.046 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -58.68 -30.91 67.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 3.25 110.878 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.79 -30.49 18.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 2.99 110.929 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.73 87.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 1.33 111.08 -179.984 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.456 ' NZ ' HD11 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -60.42 -49.06 79.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 3.36 110.827 179.995 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.95 -46.06 72.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 1.7 111.045 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -60.25 -31.1 69.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 1.9 110.824 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.729 HD11 HG22 ' A' ' 85' ' ' VAL . 54.4 tp -81.47 -55.89 4.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 1.62 110.85 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.02 -32.91 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.236 -0.438 . . . . 2.45 111.193 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -71.02 -40.95 71.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 3.51 110.734 179.803 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.733 ' HG3' HG22 ' A' ' 88' ' ' THR . 13.5 mmt180 -68.89 -38.13 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 3.38 110.675 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.889 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.4 mm -66.76 -31.82 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 1.49 110.894 179.728 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -91.19 -29.82 17.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 3.61 110.857 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.7 -46.8 68.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 2.06 111.174 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -80.03 -28.46 39.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 2.29 111.012 179.937 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 66.01 0.98 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 1.84 112.442 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.889 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.7 mt -122.08 33.41 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 1.86 110.88 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -72.58 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 2.67 111.365 -179.975 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.87 -30.32 40.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 2.74 110.891 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 -60.33 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.325 -0.398 . . . . 2.77 110.781 179.973 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 26' ' ' ILE . 31.6 mt -82.13 128.65 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 2.11 111.094 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 3' ' ' ILE . 9.0 m-85 -118.02 -54.31 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 1.69 110.986 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.416 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -110.88 153.08 25.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.98 0.419 . . . . 1.62 111.268 -179.759 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.47 69.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 1.74 110.74 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.775 HD21 HD11 ' A' ' 118' ' ' LEU . 4.4 mm? -79.93 150.35 30.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 2.62 111.034 -179.764 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 42' ' ' THR . 18.9 mt -109.84 129.29 24.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 2.62 110.77 179.769 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 31.4 Cg_endo -63.64 73.88 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.488 2.125 . . . . 2.22 112.394 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.489 HG23 HG22 ' A' ' 40' ' ' ILE . 42.5 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 1.75 110.773 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.86 0.362 . . . . 3.15 110.706 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -107.05 105.15 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 3.5 111.007 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.039 HD11 HG11 ' A' ' 115' ' ' VAL . 78.5 mt -72.78 -47.32 47.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 1.34 110.761 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 112' ' ' ILE . 9.9 m-85 -122.08 77.75 41.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 1.83 110.685 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.05 127.61 26.4 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.624 2.216 . . . . 1.55 112.583 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.86 52.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.84 -0.695 . . . . 1.23 112.799 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -131.24 156.42 45.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 1.92 111.016 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.46 114.34 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 1.77 110.596 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.871 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.1 m-85 -84.24 119.77 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 1.55 111.271 -179.76 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.1 mp -128.21 112.22 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.74 110.889 179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.485 ' NE2' ' CZ2' ' A' ' 5' ' ' TRP . 19.6 tt0 -79.78 75.69 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 1.77 110.521 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.558 ' CE ' HD21 ' A' ' 72' ' ' LEU . 10.3 ptm -91.59 -173.49 3.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 1.28 111.119 -179.772 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 4.3 t0 -134.07 86.71 2.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 2.09 110.929 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.953 HD12 ' CE2' ' A' ' 6' ' ' TYR . 12.9 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.439 -0.346 . . . . 1.69 110.806 179.69 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.62 0.247 . . . . 3.81 110.834 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 -172.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.504 2.136 . . . . 1.83 112.309 179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -90.08 -178.63 5.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 3.55 110.884 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.11 -21.26 58.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 2.98 111.176 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.821 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.57 -31.54 47.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 1.18 111.274 -179.843 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.435 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 14.6 t-105 -76.94 -37.41 55.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 1.05 110.956 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.58 -29.23 67.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 2.75 110.894 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG21 HD11 ' A' ' 31' ' ' LEU . 29.2 t -87.11 -51.31 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 1.31 111.097 -179.938 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 81' ' ' ALA . 33.2 t -58.81 -36.83 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.94 111.01 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.33 -20.84 59.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 2.92 111.106 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.36 9.19 38.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.655 -0.783 . . . . 1.27 113.019 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.733 HG22 ' HG3' ' A' ' 25' ' ' ARG . 1.1 p -86.34 141.12 34.46 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.928 0.364 . . . . 1.11 110.811 179.97 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.29 87.07 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.539 2.159 . . . . 2.01 112.208 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.26 -32.74 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 1.79 112.493 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.613 HD12 HG11 ' A' ' 8' ' ' VAL . 47.0 mm . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 1.72 110.952 -179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.781 0.324 . . . . 6.21 110.89 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.435 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 75.6 Cg_exo -49.89 163.53 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.687 2.258 . . . . 1.11 112.463 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.0 96.19 40.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 1.98 111.2 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.62 120.61 7.23 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.459 2.106 . . . . 0.95 112.276 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 104' ' ' LEU . 3.1 mp -65.43 166.49 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 1.36 110.944 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 13.8 m -89.97 148.68 40.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 1.66 110.851 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.61 -30.25 44.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.528 2.152 . . . . 1.27 112.429 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.72 -31.36 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 2.75 110.949 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -88.96 -32.53 17.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 2.46 110.886 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 20.0 t -63.83 -39.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 1.07 111.102 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.4 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 3.94 110.945 -179.924 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.716 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -68.49 -54.92 13.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 2.25 110.661 179.872 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.871 HD12 ' CD2' ' A' ' 67' ' ' PHE . 15.6 pt -66.14 -24.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 1.36 110.89 179.637 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.858 ' CD2' HD12 ' A' ' 118' ' ' LEU . 5.4 mt -74.66 -34.43 62.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 1.94 110.535 179.662 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -78.02 -31.47 50.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.059 -0.519 . . . . 2.68 110.748 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 1.039 HG11 HD11 ' A' ' 61' ' ' LEU . 34.6 t -77.14 -33.05 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 1.72 110.949 179.813 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.555 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -62.52 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 2.11 110.923 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.729 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 143.86 45.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 1.78 112.643 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.858 HD12 ' CD2' ' A' ' 113' ' ' LEU . 1.6 mt -125.17 -48.94 1.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 1.99 110.818 179.86 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -31.23 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 2.44 110.866 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.31 -1.272 . . . . 2.99 112.575 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.844 0.354 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.662 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -79.94 -167.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.32 156.61 38.69 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.127 0.489 . . . . 0.0 111.762 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.679 ' CD1' HG11 ' A' ' 109' ' ' VAL . 82.0 m95 -95.3 95.56 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.653 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.639 ' CE2' HD12 ' A' ' 72' ' ' LEU . 33.0 m-85 -83.4 115.47 22.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.996 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.24 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 9' ' ' HIS . 6.3 t -128.36 161.64 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.55 ' NE2' HG12 ' A' ' 95' ' ' VAL . 14.8 m-70 -90.06 159.96 16.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.599 HG21 ' CD1' ' A' ' 66' ' ' LEU . 62.2 p -152.45 -174.38 4.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.522 HD23 HG21 ' A' ' 92' ' ' THR . 0.2 OUTLIER -85.52 139.22 31.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' N ' HD13 ' A' ' 11' ' ' LEU . 21.4 t -68.09 122.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.86 15.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -92.17 -14.87 28.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.609 0.243 . . . . 0.0 111.245 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 66' ' ' LEU . 7.3 tm-20 -52.42 -46.54 66.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 111.054 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.87 -30.85 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.887 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -30.76 22.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.15 72.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -49.3 78.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.46 50.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.172 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -60.69 -31.63 70.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.799 HD12 HG21 ' A' ' 88' ' ' THR . 5.8 tp -81.17 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -46.9 -35.42 6.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.315 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -66.22 -47.3 74.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.709 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.41 ' HD2' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -62.68 -39.38 93.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.682 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.2 mm -62.56 -29.79 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -93.59 -29.98 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -44.03 74.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.157 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.0 -30.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 66.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.2 mt -124.79 23.23 8.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 0.0 111.046 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.44 -9.14 58.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.8 -29.64 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -51.83 5.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.803 HD12 HG21 ' A' ' 26' ' ' ILE . 32.3 mt -79.92 128.16 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.662 ' CE2' HG21 ' A' ' 3' ' ' ILE . 26.0 m-85 -113.66 -53.41 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.434 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.0 mt-30 -113.27 157.39 21.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.046 0.45 . . . . 0.0 111.452 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 68' ' ' ILE . 16.5 t -152.27 71.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.8 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.4 mm? -85.87 150.06 24.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.203 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.3 pt -107.22 131.19 21.89 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.862 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 32.3 Cg_endo -64.16 72.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.605 2.203 . . . . 0.0 112.643 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p -147.73 130.69 16.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -79.95 142.05 35.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -96.71 145.04 26.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 45' ' ' VAL . 15.7 m -149.56 116.63 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.81 138.48 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.256 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.91 120.18 10.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.73 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -124.53 149.02 47.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -121.0 -45.35 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -129.85 176.33 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.88 131.91 11.01 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.57 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.48 -45.32 1.33 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -111.16 127.2 55.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.26 137.85 41.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -126.21 115.25 19.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.74 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.78 135.21 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.329 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.39 -179.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.96 138.17 14.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.857 0.361 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -98.2 129.07 44.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.751 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.81 110.03 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.544 HD21 HG11 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -72.38 -49.33 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.537 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.436 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 18.9 m-85 -106.76 98.21 20.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.296 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.91 137.05 55.94 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.429 2.086 . . . . 0.0 112.633 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.97 26.07 65.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.704 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' CD2' ' HB3' ' A' ' 62' ' ' PHE . 14.5 m-85 -116.4 145.55 43.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.717 0.294 . . . . 0.0 111.087 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.781 HD11 ' HG2' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -142.93 112.73 6.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.764 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.675 ' CD2' HD12 ' A' ' 112' ' ' ILE . 6.4 m-85 -88.35 124.22 33.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.576 HG23 HG22 ' A' ' 38' ' ' VAL . 1.2 mp -130.04 117.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 6.8 tt0 -79.97 71.8 6.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.939 0.399 . . . . 0.0 110.196 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 72' ' ' LEU . 13.0 ptp -90.87 -174.02 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.22 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -132.66 75.45 1.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.836 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.639 HD12 ' CE2' ' A' ' 6' ' ' TYR . 86.4 mt -88.37 7.3 33.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.39 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.72 61.08 3.69 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.611 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.06 -68.29 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 110.768 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.89 -85.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.797 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.24 -70.03 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -110.0 157.95 36.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.876 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 174.82 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.508 2.139 . . . . 0.0 112.135 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.436 ' ND2' HD23 ' A' ' 72' ' ' LEU . 7.5 p30 -87.01 -172.14 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.032 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -21.51 42.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -50.66 -42.46 56.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 111.285 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -64.67 -39.2 93.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.23 -43.14 99.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.681 HG21 HD11 ' A' ' 31' ' ' LEU . 21.6 t -59.32 -51.49 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.937 0.399 . . . . 0.0 111.058 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.61 HG12 HD13 ' A' ' 91' ' ' ILE . 21.7 t -61.99 -42.63 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.122 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -17.48 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.331 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.08 -15.71 15.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.136 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.916 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -62.1 142.37 95.55 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.857 0.328 . . . . 0.0 110.972 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 88' ' ' THR . 52.7 Cg_exo -54.94 -20.21 22.16 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.19 36.34 3.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.977 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 88' ' ' THR . 2.1 tp -137.31 135.78 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.522 HG21 HD23 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -112.08 -42.18 3.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.64 -126.6 1.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.548 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 94' ' ' PHE . 1.4 p90 -153.17 179.15 8.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 0.0 110.769 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.55 HG12 ' NE2' ' A' ' 9' ' ' HIS . 10.6 m -55.29 -40.73 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.263 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.83 43.13 7.84 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.491 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.02 -78.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.83 0.348 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.09 -56.79 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.334 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.4 ttp -111.74 -174.23 2.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.782 0.325 . . . . 0.0 110.601 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 15.1 mmm-85 -81.46 -49.69 0.96 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.352 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 89.0 Cg_endo -81.72 -169.99 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.598 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -153.34 71.17 6.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.097 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.17 132.74 48.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.591 HD13 ' CD1' ' A' ' 112' ' ' ILE . 0.5 OUTLIER -88.11 161.65 17.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.9 OUTLIER -89.98 153.56 47.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.05 -48.61 20.26 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.532 2.155 . . . . 0.0 112.428 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.29 -31.9 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 112' ' ' ILE . 1.8 mp0 -81.59 -36.64 28.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 105' ' ' SER . 41.2 t -58.96 -45.7 91.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -27.13 68.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.511 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 m80 -81.64 -37.31 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.057 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.675 HD12 ' CD2' ' A' ' 67' ' ' PHE . 8.1 pt -81.33 -20.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.003 HD22 HD12 ' A' ' 118' ' ' LEU . 22.3 mt -86.94 -33.08 19.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.8 -32.79 73.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.663 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.544 HG11 HD21 ' A' ' 61' ' ' LEU . 35.2 t -80.92 -35.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.903 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.8 ' OG ' HD12 ' A' ' 39' ' ' LEU . 1.5 t -60.33 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.809 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.49 42.59 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.628 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.003 HD12 HD22 ' A' ' 113' ' ' LEU . 23.2 mt -117.29 -56.96 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -30.29 40.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.546 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.786 0.326 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.86 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -132.52 -170.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.766 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -147.91 163.15 37.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 112.105 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.774 ' CD1' HG11 ' A' ' 109' ' ' VAL . 67.8 m95 -94.27 139.3 31.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.671 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CE2' HD12 ' A' ' 72' ' ' LEU . 21.0 m-85 -125.64 110.03 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.06 151.19 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.054 0.454 . . . . 0.0 111.745 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.61 162.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.569 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.6 OUTLIER -100.31 151.52 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.056 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.4 p -149.14 -178.24 6.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -89.87 140.67 29.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' H ' HD23 ' A' ' 11' ' ' LEU . 28.3 t -62.06 125.3 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.71 -37.98 3.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 -21.55 34.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -54.76 -43.15 72.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.06 -46.53 75.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -24.72 36.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.055 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.26 74.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -33.11 71.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 -51.6 23.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.7 -33.26 71.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.651 HD11 HG22 ' A' ' 85' ' ' VAL . 56.1 tp -73.48 -55.01 6.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.58 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -30.34 8.87 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -72.35 -42.88 64.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.726 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -66.57 -34.7 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.666 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.842 HG23 ' HB2' ' A' ' 31' ' ' LEU . 36.0 mm -69.47 -31.58 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -32.68 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.52 -41.96 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -80.78 -25.39 37.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.41 5.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.402 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.842 ' HB2' HG23 ' A' ' 26' ' ' ILE . 2.3 mt -99.85 28.63 4.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.722 0.296 . . . . 0.0 110.999 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -71.88 -10.54 59.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 15.8 t70 -79.67 -24.88 41.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.01 -54.49 4.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.2 mp -87.77 137.9 20.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.707 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.86 ' CE2' HG21 ' A' ' 3' ' ' ILE . 13.1 m-85 -129.93 -56.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.513 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.575 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -109.44 134.37 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.144 0.497 . . . . 0.0 112.067 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 38' ' ' VAL . 5.1 m -125.15 99.59 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.284 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.542 HD23 ' HB3' ' A' ' 116' ' ' SER . 1.9 tm? -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.469 ' N ' HD22 ' A' ' 39' ' ' LEU . 16.5 tt -87.68 125.09 66.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' O ' HG23 ' A' ' 42' ' ' THR . 27.6 Cg_endo -62.16 76.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.651 2.234 . . . . 0.0 112.563 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 41' ' ' PRO . 25.3 p -159.61 153.06 22.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -92.4 141.51 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.567 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -119.49 108.77 14.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.898 0.38 . . . . 0.0 111.007 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 3.7 m -137.63 130.36 42.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.01 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -160.3 134.8 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.39 -176.17 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 0.0 110.936 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.51 162.67 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.6 30.97 2.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -31.75 29.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.52 93.43 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.26 -57.93 0.43 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.526 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -125.03 -176.95 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -117.83 160.96 20.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -79.9 154.4 28.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -116.48 -151.46 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.385 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 56' ' ' VAL . 3.1 m -160.36 -177.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.067 0 CA-C-O 120.905 0.383 . . . . 0.0 111.474 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -90.8 138.22 31.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.9 mttm -102.82 -166.61 1.29 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.707 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.8 OUTLIER -138.66 116.88 11.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.03 -55.52 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.627 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.1 m-85 -121.31 79.51 36.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.21 144.28 81.81 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.296 . . . . 0.0 112.671 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.93 18.43 70.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.139 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -129.13 162.7 27.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.35 122.29 8.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.353 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.739 ' CD1' HD11 ' A' ' 104' ' ' LEU . 11.6 m-30 -89.59 130.03 35.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.956 0.408 . . . . 0.0 111.217 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 6' ' ' TYR . 2.3 mt -130.73 111.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.575 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -79.71 68.42 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.673 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.469 ' CE ' HD21 ' A' ' 72' ' ' LEU . 10.2 ptm -91.66 -164.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -141.07 71.24 1.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.585 HD12 ' CE2' ' A' ' 6' ' ' TYR . 95.4 mt -80.51 -33.65 36.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.64 74.75 0.15 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -133.47 -77.92 0.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.368 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -91.14 -178.55 5.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.04 -31.62 71.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.5 166.55 26.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.33 151.14 81.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.542 2.161 . . . . 0.0 112.332 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.21 -167.69 1.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -66.12 -27.44 68.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.853 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -52.18 -39.8 60.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.319 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -74.59 -33.27 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -31.41 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.72 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.83 -44.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 81' ' ' ALA . 28.9 t -64.42 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.98 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -13.56 62.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.07 -12.78 10.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.051 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.637 HG21 ' CD1' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -58.89 159.74 12.65 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.908 0.354 . . . . 0.0 110.891 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.99 122.84 9.45 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.543 2.162 . . . . 0.0 112.385 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.71 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' A' ' 92' ' ' THR . 45.3 mm -84.96 106.63 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.055 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER 168.5 63.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.575 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.98 -55.56 0.23 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.706 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.569 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 1.4 t80 -138.73 -70.21 0.42 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.544 HG22 ' HD1' ' A' ' 9' ' ' HIS . 30.0 m -84.0 174.59 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.71 67.98 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.333 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.01 -51.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 111.137 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.11 -45.69 0.36 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.37 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -106.31 -29.51 9.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.845 0.355 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -57.02 -44.13 99.66 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.406 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 82.5 Cg_exo -47.79 127.44 14.32 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.344 2.029 . . . . 0.0 112.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 102' ' ' VAL . 9.6 p -98.07 105.26 26.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.271 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.68 124.45 8.2 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.341 2.028 . . . . 0.0 111.997 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.739 HD11 ' CD1' ' A' ' 67' ' ' PHE . 68.2 mt -59.55 134.22 56.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.928 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.5 p -76.61 150.79 82.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.81 -31.75 73.85 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.639 2.226 . . . . 0.0 112.271 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.76 -28.39 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -37.09 10.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 105' ' ' SER . 24.5 t -58.63 -29.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.17 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -60.22 -39.25 86.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.88 -55.7 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.498 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.627 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.3 pp -63.56 -22.14 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.665 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.866 ' CD2' HD12 ' A' ' 118' ' ' LEU . 1.9 mt -70.41 -39.52 74.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.26 -29.3 67.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.68 -41.19 62.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.542 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -60.22 -62.11 2.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 110.581 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.717 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 132.69 36.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.024 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.866 HD12 ' CD2' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -112.56 -27.95 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -49.98 11.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.447 -1.196 . . . . 0.0 112.562 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 t . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.91 -168.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.908 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.05 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.175 0.512 . . . . 0.0 111.832 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.919 ' CZ2' HD21 ' A' ' 113' ' ' LEU . 73.0 m95 -95.56 88.53 5.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.466 ' CE2' HD12 ' A' ' 72' ' ' LEU . 50.6 m-85 -81.27 123.64 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.04 127.12 53.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.94 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 91' ' ' ILE . 1.5 p -108.03 159.88 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 111.084 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.504 ' CE1' HG22 ' A' ' 95' ' ' VAL . 63.9 m80 -83.86 136.48 34.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -143.55 151.57 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.31 136.6 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.75 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -57.58 111.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.262 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.59 -20.47 32.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.691 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.59 -16.96 15.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.617 0.246 . . . . 0.0 111.308 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -33.92 59.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.83 0.348 . . . . 0.0 111.133 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.82 -31.84 71.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.992 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -26.06 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.176 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -65.89 -30.67 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.86 47.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -62.12 -25.18 67.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.58 HD11 HG22 ' A' ' 85' ' ' VAL . 25.8 tp -86.7 -56.81 3.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -45.91 -37.68 6.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.426 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 -33.62 70.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.875 ' HG3' HG22 ' A' ' 88' ' ' THR . 4.9 mmt-85 -75.64 -32.37 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.636 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.837 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.7 mm -70.39 -31.4 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.734 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -84.04 -30.4 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -42.05 38.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -80.04 -25.58 40.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.962 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.07 66.52 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.468 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.837 ' HB2' HG23 ' A' ' 26' ' ' ILE . 1.5 mt -125.82 30.1 5.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.987 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -25.39 68.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.07 -1.79 41.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.365 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -99.47 -58.65 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.755 0.312 . . . . 0.0 110.748 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.441 HD12 HG21 ' A' ' 26' ' ' ILE . 37.6 mt -81.45 132.92 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 3' ' ' ILE . 3.0 m-85 -127.02 -49.99 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.19 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -117.14 156.66 27.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.107 0.479 . . . . 0.0 111.697 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.707 ' O ' HD22 ' A' ' 39' ' ' LEU . 3.6 m -159.91 114.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.841 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.5 mm? -130.04 177.32 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.406 0.622 . . . . 0.0 112.07 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 42' ' ' THR . 28.7 mt -148.56 74.25 10.52 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.785 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 87.9 Cg_exo -41.66 113.78 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.176 2.584 . . . . 0.0 113.59 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 40' ' ' ILE . 29.4 p -128.25 127.88 43.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.063 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.805 ' OE2' HD21 ' A' ' 61' ' ' LEU . 1.8 tp10 -79.82 135.72 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.878 0.37 . . . . 0.0 111.105 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.54 145.44 48.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.886 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 m -142.68 147.75 20.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.58 ' HA ' HG12 ' A' ' 56' ' ' VAL . 10.3 p -121.65 141.76 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -123.66 149.92 44.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.64 164.93 24.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.21 -47.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.834 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.27 -46.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.06 -22.19 1.93 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.603 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.72 -70.05 1.29 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.66 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -84.08 151.52 24.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 130.93 46.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -117.12 115.21 24.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.0 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 46' ' ' VAL . 31.6 m -138.09 139.45 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.995 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.475 ' CG2' ' N ' ' A' ' 58' ' ' ARG . 1.3 p -136.5 159.55 37.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.14 0.495 . . . . 0.0 110.99 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.475 ' N ' ' CG2' ' A' ' 57' ' ' VAL . 4.4 mtt85 -129.19 122.14 29.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.788 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HG3' ' HB3' ' A' ' 43' ' ' GLU . 1.8 ptmm? -114.82 116.55 28.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.704 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HG3' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -57.48 115.2 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.805 HD21 ' OE2' ' A' ' 43' ' ' GLU . 17.9 mt -61.86 -44.55 96.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.309 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 41' ' ' PRO . 2.1 m-85 -115.57 76.92 5.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.563 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.54 127.77 16.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.67 2.246 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.66 72.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.579 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -128.89 111.03 12.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.97 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 66' ' ' LEU . 18.5 mt -90.9 114.91 27.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.514 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.742 ' CE2' HD12 ' A' ' 112' ' ' ILE . 6.6 m-30 -82.47 122.85 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -128.87 110.16 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 3.6 tt0 -79.97 69.97 6.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.686 ' SD ' HD11 ' A' ' 72' ' ' LEU . 15.6 ptp -90.84 -178.13 5.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.487 ' O ' HD23 ' A' ' 72' ' ' LEU . 3.4 t0 -119.53 98.88 6.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.686 HD11 ' SD ' ' A' ' 70' ' ' MET . 39.4 mt -128.57 -44.07 1.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.795 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.9 91.5 0.01 OUTLIER Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.624 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -151.25 -46.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -138.92 -174.58 3.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.81 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -77.88 -22.48 49.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.088 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.51 106.87 54.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 173.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.433 2.089 . . . . 0.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.38 179.19 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.2 -25.21 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.754 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.08 -28.89 27.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 111.237 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -63.76 -48.61 76.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -58.88 -30.26 67.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.796 HG21 HD11 ' A' ' 31' ' ' LEU . 21.6 t -77.69 -49.67 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.184 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 81' ' ' ALA . 39.1 t -59.96 -52.68 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttp85 -58.03 -22.84 51.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.52 -32.39 11.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.728 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.875 HG22 ' HG3' ' A' ' 25' ' ' ARG . 65.7 p -59.13 130.64 86.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.493 0.187 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.78 -23.87 35.52 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.393 2.062 . . . . 0.0 112.314 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.41 -29.19 46.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.735 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.525 HD12 HG21 ' A' ' 8' ' ' VAL . 40.0 mm -82.89 135.05 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 111.086 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.47 -36.21 5.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.844 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.46 101.66 0.15 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.407 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.44 ' CE2' ' HB ' ' A' ' 8' ' ' VAL . 7.2 m-85 -56.38 -175.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 110.915 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.8 HG21 ' CG2' ' A' ' 102' ' ' VAL . 20.8 t -54.97 139.36 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.226 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -99.46 27.52 19.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.605 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.527 ' H ' HG12 ' A' ' 95' ' ' VAL . . . -117.16 96.03 5.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 111.027 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.16 -86.5 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.352 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.89 137.49 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 0.0 110.682 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.476 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -66.12 -50.35 51.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.964 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 84.7 Cg_endo -81.18 130.43 7.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.502 2.135 . . . . 0.0 112.107 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.8 ' CG2' HG21 ' A' ' 95' ' ' VAL . 37.6 t -129.68 99.7 20.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.262 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.9 139.14 10.77 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.645 2.23 . . . . 0.0 112.252 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.889 HD22 HD13 ' A' ' 112' ' ' ILE . 1.2 mp -67.59 156.75 36.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.06 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.91 ' O ' HG23 ' A' ' 109' ' ' VAL . 47.6 p -85.44 149.97 53.15 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.757 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -45.98 -49.58 10.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.773 2.316 . . . . 0.0 112.873 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.47 -39.98 85.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.17 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.66 -33.3 47.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 105' ' ' SER . 58.4 t -58.79 -31.4 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.237 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -26.01 56.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.728 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -82.33 -29.23 31.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.108 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.889 HD13 HD22 ' A' ' 104' ' ' LEU . 34.2 pt -80.68 -32.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.111 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.955 HD22 HD12 ' A' ' 118' ' ' LEU . 97.9 mt -77.5 -25.2 50.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.23 -32.37 61.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.979 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 111' ' ' HIS . 21.3 t -75.49 -48.2 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.072 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.841 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -58.48 -59.98 4.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 137.14 67.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.597 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.955 HD12 HD22 ' A' ' 113' ' ' LEU . 23.1 mt -129.05 -47.46 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.822 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -61.73 1.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.491 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.802 0.334 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.807 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -133.7 -165.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.01 139.54 52.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.292 0.568 . . . . 0.0 112.092 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 1.097 ' CH2' HD22 ' A' ' 39' ' ' LEU . 25.7 m95 -94.94 96.23 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.047 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.466 ' O ' HD12 ' A' ' 68' ' ' ILE . 44.9 m-85 -96.67 112.96 24.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.397 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.426 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -108.14 134.88 50.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.753 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.695 HG21 HD12 ' A' ' 91' ' ' ILE . 1.5 p -134.14 160.18 41.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.196 0.522 . . . . 0.0 111.234 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.578 ' HE1' HG22 ' A' ' 95' ' ' VAL . 0.8 OUTLIER -82.26 147.12 29.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.97 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -123.83 -173.83 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mt -87.7 127.61 35.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.72 114.87 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.6 -28.8 11.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.52 -7.78 37.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.622 0.249 . . . . 0.0 111.292 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -55.74 -39.72 71.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -52.45 65.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -14.34 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.359 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.536 ' HB1' ' CA ' ' A' ' 90' ' ' GLY . . . -70.44 -51.21 31.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 111.228 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -56.57 -41.56 77.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.04 -43.35 92.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -62.19 -34.49 76.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD13 HG21 ' A' ' 88' ' ' THR . 26.3 tp -84.02 -45.07 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.574 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.4 tt0 -55.23 -26.41 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -78.32 -47.61 17.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.318 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.02 -27.3 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.352 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.732 HG12 HD13 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -70.63 -29.35 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -87.38 -31.52 20.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.6 -32.36 67.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.044 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -87.89 5.7 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.53 47.49 86.63 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 26' ' ' ILE . 8.8 mt -111.08 9.63 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.536 0.207 . . . . 0.0 111.266 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -17.25 63.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 0.0 111.259 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.93 -38.53 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.041 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.37 -51.75 33.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.732 HD13 HG12 ' A' ' 26' ' ' ILE . 4.8 mp -79.87 117.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.807 ' CE2' HG21 ' A' ' 3' ' ' ILE . 31.7 m-85 -100.95 -53.17 3.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.472 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 5.1 mm-40 -107.95 169.89 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.374 0.606 . . . . 0.0 111.651 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.3 p -156.33 73.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.35 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.097 HD22 ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -79.55 139.48 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.638 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.614 HG22 HG23 ' A' ' 42' ' ' THR . 14.4 mt -100.5 138.3 20.13 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 40' ' ' ILE . 67.9 Cg_endo -72.72 59.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.543 2.162 . . . . 0.0 112.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.614 HG23 HG22 ' A' ' 40' ' ' ILE . 44.1 p -139.67 171.37 14.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.965 0.412 . . . . 0.0 111.317 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.638 ' HA ' HG12 ' A' ' 115' ' ' VAL . 8.0 tp10 -103.92 148.71 25.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.8 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -135.88 112.39 9.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.97 120.09 63.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.458 HG22 ' N ' ' A' ' 47' ' ' GLU . 7.5 p -102.31 157.54 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.167 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.604 ' HB2' HG22 ' A' ' 56' ' ' VAL . 2.2 mt-10 -120.42 -167.5 1.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.05 118.06 19.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -178.65 4.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.39 86.09 5.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.27 53.6 3.82 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.502 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.1 -173.88 46.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.513 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -122.53 119.83 32.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.15 143.56 50.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.34 178.67 7.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.604 HG22 ' HB2' ' A' ' 47' ' ' GLU . 24.9 t -120.67 -71.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.25 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 56' ' ' VAL . 3.1 m -160.19 179.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.325 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -139.98 120.54 14.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.967 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -97.08 -160.99 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.358 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -141.92 121.21 13.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.971 HD11 HG11 ' A' ' 115' ' ' VAL . 2.1 mt -90.27 -65.78 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.592 ' HE2' HG22 ' A' ' 112' ' ' ILE . 6.6 m-85 -103.9 90.42 2.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.763 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.01 123.02 11.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.128 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.39 29.06 54.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.569 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.509 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 19.3 m-85 -117.27 177.68 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.2 tp -160.21 148.87 17.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.756 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.656 ' CE2' HG21 ' A' ' 112' ' ' ILE . 18.2 m-85 -132.5 125.62 31.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.572 HG22 HG23 ' A' ' 35' ' ' ILE . 1.3 mp -133.04 112.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.53 ' NE2' HD11 ' A' ' 3' ' ' ILE . 8.6 tt0 -79.9 72.41 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 110.675 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.419 ' HG3' ' HG ' ' A' ' 72' ' ' LEU . 2.1 ptm -91.37 -166.52 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 1.2 p30 -136.71 78.46 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 110.982 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.432 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 35.3 mt -99.73 -48.64 4.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.44 -85.37 0.43 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.384 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.9 -80.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 110.859 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 55.63 -175.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -59.78 -33.27 71.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.21 144.45 10.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.815 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.46 179.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.387 2.058 . . . . 0.0 112.185 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -171.97 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -70.79 -26.2 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.101 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.873 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.55 -28.96 34.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.323 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 101' ' ' PRO . 12.5 t-105 -69.46 -36.15 76.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.7 -30.0 70.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.583 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -82.29 -45.89 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.7 t -61.45 -50.21 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.056 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -29.91 70.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.58 -27.07 52.63 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.582 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.531 HG21 HD13 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -69.32 147.31 97.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.865 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.52 -20.79 35.52 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.378 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' CA ' ' HB1' ' A' ' 18' ' ' ALA . . . -55.89 -28.1 52.12 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.636 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 8' ' ' VAL . 41.9 mm -93.27 122.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 t -122.76 -43.65 2.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -137.05 161.3 25.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.453 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -125.16 -177.28 3.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.387 . . . . 0.0 110.833 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.578 HG22 ' HE1' ' A' ' 9' ' ' HIS . 21.3 t -80.28 -67.09 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.53 -146.09 17.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.393 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.76 49.34 8.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 111.115 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.09 -82.26 1.63 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.93 155.3 35.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -77.35 -48.74 2.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.244 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 98.1 Cg_endo -79.93 143.75 16.55 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.348 2.032 . . . . 0.0 112.297 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.403 HG21 ' HB ' ' A' ' 95' ' ' VAL . 31.8 t -127.17 110.68 21.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.252 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 96.4 Cg_endo -79.1 132.12 10.25 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.613 2.209 . . . . 0.0 112.239 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.694 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.9 mp -86.12 147.27 26.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.858 ' O ' HG23 ' A' ' 109' ' ' VAL . 18.9 p -90.07 159.48 42.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.22 -27.23 6.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.753 2.302 . . . . 0.0 112.544 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -44.83 74.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.67 -32.4 17.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 105' ' ' SER . 38.7 t -62.22 -28.57 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.342 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -69.34 -28.21 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.648 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -72.54 -51.42 19.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.765 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.855 HD12 HD23 ' A' ' 39' ' ' LEU . 1.5 pp -68.01 -13.76 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.692 HD23 ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -83.77 -40.83 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.857 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.97 -40.35 71.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 61' ' ' LEU . 5.7 t -71.64 -44.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.487 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 15.4 p -56.18 -62.38 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.76 42.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.569 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.692 ' HB2' HD23 ' A' ' 113' ' ' LEU . 19.1 mt -111.2 -36.01 5.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -98.17 -34.4 10.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.519 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.831 0.348 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -132.05 162.76 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.764 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 163.88 31.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.874 ' CD1' HG11 ' A' ' 109' ' ' VAL . 72.9 m95 -88.72 96.27 10.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 4.8 m-85 -79.74 124.52 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -114.19 134.63 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.533 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.654 HG21 ' CD1' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -126.58 -166.97 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.626 ' N ' HG13 ' A' ' 8' ' ' VAL . 2.7 m80 -132.87 160.72 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 111.213 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.6 p -156.35 174.75 14.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.53 139.1 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 t -65.34 125.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.16 -28.43 12.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -92.98 -16.52 25.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 111.162 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.79 -36.01 46.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.805 0.336 . . . . 0.0 111.207 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -59.75 -30.81 69.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.07 -28.91 19.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.955 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.52 68.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -53.28 59.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.86 -42.89 89.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -59.76 -31.14 69.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.67 HD11 HG22 ' A' ' 85' ' ' VAL . 55.5 tp -88.96 -48.89 7.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.792 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.7 tm-20 -62.58 -24.19 67.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -80.55 -38.38 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.254 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.37 -22.46 61.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 23' ' ' GLU . 1.1 tp -72.3 -28.89 30.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.016 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -89.61 -30.1 18.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.23 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -86.68 -30.29 21.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.76 41.6 4.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -101.51 25.69 8.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -66.92 -16.78 64.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.251 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.8 -25.69 40.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -79.63 -61.06 2.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 70' ' ' MET . 1.8 pt -79.86 158.86 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.1 m-85 -143.88 -49.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -118.28 145.7 44.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.376 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.622 ' CG1' HG23 ' A' ' 68' ' ' ILE . 3.0 m -150.04 102.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.876 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.698 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.4 mm? -112.76 155.7 24.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.029 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.519 HG22 HG23 ' A' ' 42' ' ' THR . 3.6 mp -103.81 126.82 30.82 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 50.4 Cg_endo -69.27 62.44 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.605 2.203 . . . . 0.0 112.486 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.519 HG23 HG22 ' A' ' 40' ' ' ILE . 55.9 p -132.45 141.21 48.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.056 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -89.36 148.66 23.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.774 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.55 115.26 13.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 45' ' ' VAL . 32.9 m -124.34 120.54 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.324 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 56' ' ' VAL . 3.7 m -146.81 145.72 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.81 -174.42 4.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.172 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 49' ' ' ARG . 4.9 tt -93.02 141.16 28.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.705 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -87.65 149.22 24.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -29.72 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -95.27 -38.58 4.76 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.545 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.82 31.95 0.33 Allowed Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.876 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.1 119.91 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.758 0.313 . . . . 0.0 110.947 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.55 159.03 36.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.689 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -129.46 150.51 50.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.117 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.532 HG13 ' CG1' ' A' ' 46' ' ' VAL . 36.5 t -105.19 122.28 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.03 155.38 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -149.2 123.52 9.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.815 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -123.5 98.84 6.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -55.5 106.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.531 HD21 HG11 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -62.76 -51.49 66.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.614 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 61' ' ' LEU . 14.6 m-85 -105.77 94.95 9.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.416 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.9 129.05 31.38 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.511 2.141 . . . . 0.0 112.495 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.06 40.36 82.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.56 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -124.23 144.41 49.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.003 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.95 124.98 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.721 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.2 m-85 -96.39 133.79 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.227 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.622 HG23 ' CG1' ' A' ' 38' ' ' VAL . 3.1 mp -142.32 114.17 3.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 7.1 tt0 -79.9 76.28 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 35' ' ' ILE . 21.2 ptp -91.63 -168.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.821 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 3' ' ' ILE . 21.6 t0 -156.24 91.77 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.741 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 81.7 mt -79.98 -29.38 39.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.33 -49.25 3.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.544 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.69 177.3 8.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -105.81 -25.42 12.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -78.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.413 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -123.12 108.51 32.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.957 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.5 173.82 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.394 2.063 . . . . 0.0 112.247 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -90.09 -171.08 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.45 -27.81 68.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.99 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.782 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.2 -38.67 65.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.209 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.426 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 11.8 t-105 -66.82 -36.5 82.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.25 -32.17 69.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -85.14 -39.41 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.9 t -71.28 -33.41 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -18.01 62.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.6 -4.21 30.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.023 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -71.17 133.11 85.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.962 0.381 . . . . 0.0 110.737 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.8 121.2 9.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.152 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.02 -29.56 5.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.593 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 88' ' ' THR . 2.5 tp -80.09 115.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.7 p -137.81 27.14 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.56 159.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.496 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.461 ' HB3' ' CG ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER 178.93 -37.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.975 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 100' ' ' ARG . 19.7 m -53.65 -27.13 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.407 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.46 -171.28 29.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 57.98 73.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 111.08 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.49 86.62 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.737 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.0 mpp? 61.0 19.58 10.02 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.756 -0.261 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.618 ' O ' HG21 ' A' ' 95' ' ' VAL . 2.3 ptt180 -90.17 153.18 46.66 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.723 0.297 . . . . 0.0 110.988 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.426 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.7 Cg_exo -54.07 174.34 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.622 2.215 . . . . 0.0 112.299 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.568 HG22 HG11 ' A' ' 95' ' ' VAL . 13.2 m -139.2 94.07 9.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.221 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.11 130.98 14.84 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.564 2.176 . . . . 0.0 112.404 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 5' ' ' TRP . 3.3 mp -78.99 162.18 26.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.916 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -89.09 156.49 49.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.926 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.59 -30.57 89.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.626 2.217 . . . . 0.0 112.271 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.15 -29.01 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.16 -38.19 11.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.916 HG23 ' O ' ' A' ' 105' ' ' SER . 40.0 t -58.95 -35.52 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -25.41 68.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.754 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -80.25 -41.2 25.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.783 HD12 ' CD2' ' A' ' 67' ' ' PHE . 12.1 pt -76.13 -22.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.202 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 118' ' ' LEU . 85.6 mt -84.15 -30.18 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 110.758 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -31.01 61.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 111' ' ' HIS . 23.6 t -77.2 -38.44 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.789 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 149.12 56.63 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.66 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.048 HD12 HD22 ' A' ' 113' ' ' LEU . 41.5 mt -127.92 -60.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.006 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -34.71 38.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.528 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.772 0.32 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.578 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -85.48 -170.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.794 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -154.0 150.19 28.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.267 0.555 . . . . 0.0 112.136 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 1.075 ' CH2' HD22 ' A' ' 39' ' ' LEU . 46.2 m95 -89.91 95.27 10.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.388 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.687 ' CE2' HD11 ' A' ' 72' ' ' LEU . 44.6 m-85 -91.15 116.01 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.85 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -100.84 143.27 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.453 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 9' ' ' HIS . 14.7 t -143.34 160.05 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.699 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.46 ' N ' HG12 ' A' ' 8' ' ' VAL . 4.2 p80 -131.53 152.74 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.876 0.369 . . . . 0.0 111.164 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -139.81 -165.56 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.794 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -70.53 136.03 49.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.982 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.48 ' H ' HD13 ' A' ' 11' ' ' LEU . 37.2 t -67.32 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.31 -32.02 6.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.432 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -93.59 -22.14 18.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.051 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -32.07 20.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.152 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.47 -48.06 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -27.29 60.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.04 93.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -42.93 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.96 56.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.34 -34.89 78.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.764 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.585 HD11 HG22 ' A' ' 85' ' ' VAL . 16.0 tp -69.81 -57.87 4.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.813 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -49.14 -35.21 15.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -69.55 -43.93 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -38.03 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.505 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.812 HG23 ' HB2' ' A' ' 31' ' ' LEU . 48.4 mm -67.69 -30.99 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.639 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -87.11 -29.21 22.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.99 -46.91 70.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -87.33 -25.1 24.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.3 61.5 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.324 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 84' ' ' VAL . 3.6 mm? -98.86 28.11 4.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.059 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -81.26 21.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.284 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -108.94 -15.73 14.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.979 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.843 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 2.0 mttp -116.69 -45.87 2.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.807 0.337 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.668 ' CD1' HD12 ' A' ' 26' ' ' ILE . 16.5 mt -80.29 135.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 3' ' ' ILE . 15.6 m-85 -133.06 -60.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.655 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.55 133.3 46.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.535 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.1 p -128.12 76.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.271 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.075 HD22 ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -80.0 139.41 37.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.119 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.413 HG23 ' HD2' ' A' ' 41' ' ' PRO . 27.8 mm -98.93 136.99 20.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 62' ' ' PHE . 80.0 Cg_endo -77.85 55.76 5.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.59 2.193 . . . . 0.0 112.769 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 115' ' ' VAL . 3.0 p -126.0 147.3 49.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.04 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.548 ' HG2' HG13 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -95.48 172.3 8.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -127.53 107.99 10.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.935 HG23 HG23 ' A' ' 57' ' ' VAL . 5.0 m -123.7 161.95 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.075 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 46' ' ' VAL . 30.8 m -131.07 109.34 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -130.78 151.45 51.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.781 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -160.07 168.39 25.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.15 -169.35 1.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.866 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.75 -31.51 61.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.75 -81.13 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.24 60.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.556 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.98 24.93 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.46 0.648 . . . . 0.0 111.144 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -158.51 167.93 28.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.759 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 56' ' ' VAL . 1.3 pt-20 -160.03 -52.08 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 55' ' ' GLU . 16.9 m -148.91 139.45 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.226 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.935 HG23 HG23 ' A' ' 45' ' ' VAL . 15.3 m -141.19 167.45 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.075 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -134.83 154.94 51.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.64 111.36 9.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 105.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.773 HD12 HG11 ' A' ' 115' ' ' VAL . 23.2 mt -63.98 -51.57 63.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.786 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 41' ' ' PRO . 86.8 m-85 -97.58 111.88 59.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.537 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 62' ' ' PHE . 18.0 Cg_endo -59.8 122.2 11.06 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.517 2.145 . . . . 0.0 112.73 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.17 43.65 25.81 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.198 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . 1.8 m-85 -117.11 173.99 6.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.635 HD23 HD11 ' A' ' 68' ' ' ILE . 7.5 tp -160.23 152.01 20.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' A' ' 112' ' ' ILE . 79.3 m-85 -126.21 120.64 30.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.564 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.635 HD11 HD23 ' A' ' 66' ' ' LEU . 1.1 mp -130.35 115.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.626 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.7 tt0 -83.22 70.17 10.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.314 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.725 ' SD ' HD23 ' A' ' 72' ' ' LEU . 5.4 ptm -91.51 -168.3 2.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.964 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -139.99 49.32 1.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.725 HD23 ' SD ' ' A' ' 70' ' ' MET . 4.5 pp -79.9 -31.09 40.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.976 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.509 ' N ' HD12 ' A' ' 72' ' ' LEU . . . -57.52 88.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.486 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -98.81 -78.97 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -164.16 -69.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.56 -82.35 0.08 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.21 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 137.68 28.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.98 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 85.4 Cg_endo -81.97 89.3 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.633 2.222 . . . . 0.0 112.718 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 p30 -90.26 -168.41 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.776 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 84' ' ' VAL . 5.7 tp10 56.85 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.66 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.843 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . . . -55.85 -43.35 76.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.312 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.446 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 2.6 t-105 -79.97 -35.55 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -27.65 62.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.981 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 31' ' ' LEU . 21.5 t -87.4 -51.69 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.7 t -58.56 -48.61 85.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -23.4 61.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.973 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.38 -26.0 37.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.67 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 84' ' ' VAL . 47.7 p -57.78 142.89 77.78 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.639 0.257 . . . . 0.0 110.921 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.73 -14.12 32.76 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.528 2.152 . . . . 0.0 112.558 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.03 -28.08 73.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.657 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm -84.52 152.13 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.72 -51.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.22 162.01 22.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -134.42 -177.93 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.576 HG21 HG13 ' A' ' 102' ' ' VAL . 4.7 m -59.14 126.96 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.244 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.77 -17.19 76.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.677 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.74 -28.87 51.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.739 0.304 . . . . 0.0 111.264 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.11 -133.86 1.67 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.435 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -124.24 -48.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.811 0.338 . . . . 0.0 110.839 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -81.06 161.91 61.3 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HG3' ' CZ2' ' A' ' 82' ' ' TRP . 51.8 Cg_exo -54.07 -168.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.668 2.245 . . . . 0.0 112.4 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.576 HG13 HG21 ' A' ' 95' ' ' VAL . 5.2 m -141.22 109.62 6.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.371 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.34 120.39 3.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.217 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -68.09 155.43 39.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.161 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.835 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -90.07 166.94 18.3 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -51.33 -27.47 23.78 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.623 2.215 . . . . 0.0 112.443 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.47 -48.2 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.073 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -72.71 -34.31 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 105' ' ' SER . 58.5 t -62.2 -44.63 99.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.222 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -60.48 -26.68 66.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.46 -53.83 9.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.649 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 2.5 pp -67.51 -15.3 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.955 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.747 HD13 HG12 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -80.64 -40.41 25.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.86 -32.98 74.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.067 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.773 HG11 HD12 ' A' ' 61' ' ' LEU . 32.2 t -76.27 -50.03 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.474 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -56.26 -60.49 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.06 42.47 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.1 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.48 ' CB ' HD23 ' A' ' 113' ' ' LEU . 4.7 mt -109.36 -48.57 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 110.633 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tp -100.67 30.78 3.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.405 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.878 0.371 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.664 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.52 -178.97 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.49 157.22 39.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.175 0.512 . . . . 0.0 112.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.786 ' CD1' HG11 ' A' ' 109' ' ' VAL . 78.5 m95 -98.07 85.75 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.121 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.858 ' CE2' HD12 ' A' ' 72' ' ' LEU . 68.6 m-85 -80.63 124.76 29.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.988 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.572 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . -95.84 138.23 33.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.389 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.556 HG11 HD12 ' A' ' 91' ' ' ILE . 15.4 t -125.16 160.07 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.461 ' N ' HG12 ' A' ' 8' ' ' VAL . 17.8 m-70 -94.3 132.55 38.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.832 HG21 HD12 ' A' ' 66' ' ' LEU . 20.7 p -124.12 177.54 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.47 132.15 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.81 123.73 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.198 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.29 -27.91 17.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.462 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -104.65 -3.06 24.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.627 0.251 . . . . 0.0 111.376 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.551 ' OE1' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -57.38 -34.07 68.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.769 0.319 . . . . 0.0 111.038 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -58.47 -40.71 83.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.52 -24.72 31.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.28 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -37.29 79.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -53.06 15.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.034 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -59.17 -31.75 69.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.637 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.742 HD11 HG22 ' A' ' 85' ' ' VAL . 18.4 tp -77.14 -57.48 3.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.716 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -49.72 -31.18 10.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -38.66 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.637 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -36.07 72.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.601 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 35' ' ' ILE . 38.4 mm -67.44 -31.4 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -30.16 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.33 -32.32 37.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -85.02 -27.26 26.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.8 61.11 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.892 HD11 HG21 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -119.46 28.69 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.943 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -8.07 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.335 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.96 -29.05 39.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -96.11 -55.58 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.718 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -80.02 145.01 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.789 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.823 ' N ' HD13 ' A' ' 35' ' ' ILE . 8.2 m-85 -131.87 -44.45 0.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.132 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -122.09 154.93 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.619 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.708 HG23 HD11 ' A' ' 35' ' ' ILE . 26.3 t -154.4 67.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.288 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.669 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.6 mm? -79.97 152.3 29.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.263 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.551 HD11 ' OE1' ' A' ' 15' ' ' GLU . 4.5 tp -108.16 118.34 52.76 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.813 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 46.1 Cg_exo -55.33 80.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.731 2.287 . . . . 0.0 112.528 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 60' ' ' LYS . 58.5 p -158.91 128.12 5.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -79.95 107.01 12.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.4 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.02 141.79 40.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.173 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.61 130.23 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.753 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' HA ' HG23 ' A' ' 56' ' ' VAL . 34.9 m -137.62 175.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' C ' HD22 ' A' ' 48' ' ' LEU . 1.6 mt-10 -133.74 -176.72 4.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD22 ' C ' ' A' ' 47' ' ' GLU . 4.2 mm? -114.31 136.91 52.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -134.29 34.72 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.52 163.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.84 -54.5 4.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.442 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.63 -81.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.44 168.3 27.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 110.887 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -139.74 167.93 20.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -129.16 153.43 47.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.578 HG12 HG22 ' A' ' 57' ' ' VAL . 25.4 t -130.43 -73.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.29 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.578 HG22 HG12 ' A' ' 56' ' ' VAL . 3.8 m -160.03 173.34 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.444 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 128.56 4.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 42' ' ' THR . 5.3 mtpt -99.38 170.97 8.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.663 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 42' ' ' THR . 8.1 mttm -103.11 123.65 47.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.048 HD11 HG11 ' A' ' 115' ' ' VAL . 10.0 mt -88.53 -48.62 7.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.515 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 62' ' ' PHE . 2.7 m-85 -124.58 89.22 52.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.407 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.96 131.53 39.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.667 2.245 . . . . 0.0 112.934 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 9' ' ' HIS . . . 62.18 36.31 92.8 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.153 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.53 150.75 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.905 0.353 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.832 HD12 HG21 ' A' ' 10' ' ' THR . 4.4 mt -142.78 117.82 10.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.834 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 112' ' ' ILE . 12.8 m-85 -82.48 121.04 26.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.4 mp -128.57 107.5 15.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.436 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 4.5 tt0 -80.03 70.48 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -91.23 -179.78 5.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.261 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -120.83 89.86 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.846 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.858 HD12 ' CE2' ' A' ' 6' ' ' TYR . 13.3 mt -83.47 -69.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.24 -80.79 1.18 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.48 141.13 28.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 111.016 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.42 31.96 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -84.69 -54.28 4.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -160.08 93.31 1.66 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.98 92.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.546 2.164 . . . . 0.0 112.221 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 81' ' ' ALA . 18.5 m-80 -90.35 -176.6 4.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 51.4 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -46.56 -50.88 16.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.821 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -72.21 -32.38 66.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.063 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -33.36 72.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.993 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.892 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -90.01 -48.18 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.3 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 81' ' ' ALA . 38.0 t -61.67 -45.29 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.242 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -62.2 -18.61 61.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.275 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -102.08 -25.19 8.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.809 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.729 HG21 HD12 ' A' ' 22' ' ' LEU . 1.5 p -59.96 145.06 85.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.66 -25.96 62.62 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.566 2.178 . . . . 0.0 112.218 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.81 -34.15 56.67 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.674 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.556 HD12 HG11 ' A' ' 8' ' ' VAL . 35.5 mm -97.13 152.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 t -176.51 -39.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 94' ' ' PHE . . . -96.83 -37.57 4.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.512 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 39.6 p90 46.3 -172.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.853 0.358 . . . . 0.0 111.487 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 95' ' ' VAL . 29.1 m -66.77 104.33 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.07 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.97 -32.04 82.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.5 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.31 80.47 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.51 -147.07 18.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.41 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -154.86 -57.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.948 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 149.6 88.93 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.006 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 76.9 Cg_exo -50.59 179.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 7' ' ' ALA . 6.3 m -133.31 92.29 24.99 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.235 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 145.04 30.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.621 2.214 . . . . 0.0 112.325 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.686 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -89.94 169.17 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -90.06 150.81 44.16 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.767 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.53 -29.34 24.36 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.583 2.189 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.59 -30.97 57.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 112' ' ' ILE . 48.9 tt0 -90.3 -33.64 16.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 105' ' ' SER . 35.9 t -63.8 -35.48 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.227 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -29.16 66.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.67 ' O ' HG23 ' A' ' 115' ' ' VAL . 15.2 m80 -77.92 -40.38 39.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.784 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 12.4 pt -74.72 -29.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.032 HD22 HD12 ' A' ' 118' ' ' LEU . 62.9 mt -77.71 -32.58 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.559 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.39 -33.25 74.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 1.048 HG11 HD11 ' A' ' 61' ' ' LEU . 22.7 t -72.82 -35.29 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.949 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.669 ' HB3' HD12 ' A' ' 39' ' ' LEU . 13.5 m -64.34 -59.81 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.94 44.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.527 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.032 HD12 HD22 ' A' ' 113' ' ' LEU . 12.7 mt -115.92 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.85 -44.7 20.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.465 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.814 0.34 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -133.24 176.25 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.0 158.21 44.26 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 112.281 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 1.001 ' CH2' HD12 ' A' ' 39' ' ' LEU . 78.6 m95 -93.22 91.03 7.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.487 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.675 ' O ' HD12 ' A' ' 68' ' ' ILE . 51.8 m-85 -87.48 99.12 11.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -80.45 154.97 27.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.733 HG11 HD11 ' A' ' 91' ' ' ILE . 14.3 t -139.07 159.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.519 ' CD2' HG13 ' A' ' 95' ' ' VAL . 1.5 m80 -112.92 135.82 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 91' ' ' ILE . 62.2 p -129.11 -177.49 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.01 142.34 27.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.875 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.39 129.81 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.45 -27.5 17.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.02 -20.02 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.578 0.228 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 12.2 pt-20 -56.66 -39.92 74.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.986 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -52.49 -67.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -61.72 -23.22 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.038 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -59.33 -46.92 87.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -59.85 -46.97 87.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.08 69.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.36 -43.99 95.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.76 HD11 HG22 ' A' ' 85' ' ' VAL . 37.8 tp -70.62 -48.54 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.852 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.4 tt0 -62.51 -17.33 59.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -84.67 -43.92 13.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.001 0.429 . . . . 0.0 110.227 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -23.93 66.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.355 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 23' ' ' GLU . 1.3 tp -67.91 -29.51 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.816 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 -30.57 15.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.62 62.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -79.91 -30.36 40.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.25 34.5 5.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.474 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.63 25.23 6.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.955 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -19.7 62.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.17 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -79.96 -26.27 40.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.061 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -77.89 -58.89 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.759 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.888 HD11 ' CG1' ' A' ' 38' ' ' VAL . 9.2 tt -79.94 130.91 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 3' ' ' ILE . 8.9 m-85 -117.57 -48.27 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.117 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.609 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -120.79 151.59 39.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.888 ' CG1' HD11 ' A' ' 35' ' ' ILE . 17.4 m -143.8 126.54 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.001 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -109.65 135.19 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 40' ' ' ILE . 2.1 mp -90.89 136.41 27.67 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.817 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.866 ' O ' HD12 ' A' ' 61' ' ' LEU . 28.1 Cg_endo -61.62 -15.56 42.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.624 2.216 . . . . 0.0 112.906 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 60' ' ' LYS . 16.4 p -98.55 137.76 36.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 111.13 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HB2' HD21 ' A' ' 61' ' ' LEU . 5.0 tt0 -87.05 150.37 24.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.679 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -119.87 121.23 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.995 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 56' ' ' VAL . 14.8 t -144.55 159.75 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.466 ' N ' HG12 ' A' ' 45' ' ' VAL . 13.3 p -89.96 125.88 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.172 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -159.92 171.18 19.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.6 tp -138.48 122.3 17.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -128.95 -76.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.956 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -107.97 -165.16 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.845 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.7 27.78 11.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.673 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.95 -28.34 5.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.375 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -135.46 137.1 41.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -146.71 26.18 1.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.337 0.589 . . . . 0.0 111.183 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -136.52 -58.38 0.74 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.871 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 45' ' ' VAL . 12.6 p -157.39 135.5 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.25 174.18 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 mtt85 -136.06 124.04 22.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.965 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -125.31 113.41 17.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 42' ' ' THR . 1.5 mttt -71.83 111.28 6.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.004 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -89.82 -39.65 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.614 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.406 ' HB3' ' CG ' ' A' ' 65' ' ' TYR . 33.3 m-85 -111.58 94.07 21.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.99 126.34 18.58 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.384 2.056 . . . . 0.0 112.416 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.93 37.06 93.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.414 ' CE1' ' CD2' ' A' ' 9' ' ' HIS . 3.0 m-85 -117.93 166.05 12.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.818 0.342 . . . . 0.0 110.97 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.441 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -160.08 151.12 19.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.415 ' HB2' ' CB ' ' A' ' 39' ' ' LEU . 4.7 m-85 -131.71 130.56 42.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.028 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.675 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.7 mp -134.52 117.31 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.496 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.609 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -83.77 65.81 8.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.411 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.437 ' CE ' HD23 ' A' ' 72' ' ' LEU . 5.8 ptm -91.57 -170.35 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.048 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD1' ' CZ ' ' A' ' 36' ' ' PHE . 6.4 p-10 -144.39 52.3 1.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.651 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 73' ' ' GLY . 4.5 pp -79.9 -31.21 40.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.9 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.726 ' N ' HD12 ' A' ' 72' ' ' LEU . . . -55.27 90.57 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.594 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.03 154.49 3.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 110.768 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.16 -171.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -70.52 -30.5 67.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.002 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -138.99 149.22 60.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.45 179.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.492 2.128 . . . . 0.0 112.291 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -89.99 -177.56 5.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.52 -26.71 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.712 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -52.94 -30.06 32.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.293 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.428 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.8 t-105 -75.51 -31.01 60.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.57 -30.62 63.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.569 HG21 HD11 ' A' ' 31' ' ' LEU . 21.5 t -79.43 -52.73 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.76 HG22 HD11 ' A' ' 22' ' ' LEU . 34.1 t -59.9 -43.3 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -69.27 -15.51 63.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.26 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.29 -15.06 20.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.957 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.77 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -64.54 132.19 95.32 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.778 0.289 . . . . 0.0 110.848 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.9 137.12 40.52 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.418 2.078 . . . . 0.0 112.243 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.19 -17.39 58.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.734 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.897 HD13 ' O ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -80.0 -31.96 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.984 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 p 68.42 -61.95 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.294 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.09 83.76 1.66 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.394 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.85 171.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 9' ' ' HIS . 31.1 m -70.51 -29.69 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.76 26.83 3.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.519 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.22 39.04 1.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 110.963 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.14 -37.14 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 41.5 mtp 69.45 -66.28 0.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.788 0.328 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.39 147.62 67.53 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.759 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.428 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.9 Cg_exo -53.05 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.546 2.164 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.8 p -149.25 95.06 3.87 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.287 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.09 128.42 9.86 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.402 2.068 . . . . 0.0 111.912 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -79.86 157.87 26.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.19 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.6 p -80.72 160.22 67.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.525 ' O ' HG12 ' A' ' 109' ' ' VAL . 35.9 Cg_exo -59.82 -56.93 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.679 2.253 . . . . 0.0 112.564 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -52.59 -25.72 11.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.231 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -30.81 13.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -65.83 -29.56 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -32.72 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.477 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.11 -49.02 30.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.311 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.578 ' CD1' HD13 ' A' ' 39' ' ' LEU . 2.7 pp -62.24 -29.56 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.176 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.563 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -59.09 -35.78 73.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.737 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.82 -21.02 64.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.266 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.658 ' CG1' HD11 ' A' ' 61' ' ' LEU . 38.0 t -71.94 -61.93 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.421 ' HB2' HD23 ' A' ' 39' ' ' LEU . 11.3 t -52.2 -59.31 4.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.029 0.442 . . . . 0.0 111.001 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.88 42.68 0.17 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.563 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.563 HD12 ' HG ' ' A' ' 113' ' ' LEU . 5.3 mt -103.63 -31.38 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -80.0 -56.71 4.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.501 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.909 0.385 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.683 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.76 -165.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.97 155.82 36.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.412 0.625 . . . . 0.0 112.232 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.774 ' CD1' HG11 ' A' ' 109' ' ' VAL . 90.6 m95 -95.64 93.52 7.18 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.459 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.814 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 95.9 m-85 -86.15 108.58 18.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.839 0.352 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -93.45 140.24 29.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.115 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 9' ' ' HIS . 14.2 t -132.87 159.68 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.653 ' NE2' HG12 ' A' ' 95' ' ' VAL . 11.2 m-70 -85.12 157.29 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -153.52 167.12 30.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.12 140.65 36.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.2 p -67.9 121.68 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.121 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.75 -23.42 36.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.734 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -93.23 -28.02 16.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -58.16 -33.96 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -39.82 71.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -90.02 -24.2 21.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -59.49 -35.47 74.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -59.29 -57.28 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.16 96.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -65.26 -41.55 94.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.834 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.874 HD11 HG22 ' A' ' 85' ' ' VAL . 56.7 tp -66.13 -54.45 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.837 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -34.05 62.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -67.74 -43.75 79.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -41.54 74.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.892 ' HA ' HD12 ' A' ' 31' ' ' LEU . 1.1 mp -70.31 -26.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.871 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -92.71 -31.77 14.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.6 68.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -101.14 -26.56 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.05 81.65 1.36 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.52 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.9 mt -134.91 31.05 3.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -0.94 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.604 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -23.61 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.74 0.305 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 3.3 mtmm -106.53 -52.69 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.678 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.416 HD11 ' HB1' ' A' ' 81' ' ' ALA . 32.3 mt -79.84 113.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.315 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 3' ' ' ILE . 25.5 m-85 -107.46 -56.21 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.016 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.467 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -113.39 162.39 16.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.332 0.587 . . . . 0.0 112.497 -178.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.3 p -160.01 77.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.773 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.014 HD11 HD21 ' A' ' 118' ' ' LEU . 4.6 mm? -89.27 167.91 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.397 0.618 . . . . 0.0 112.397 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.598 ' O ' HG23 ' A' ' 40' ' ' ILE . 1.6 tt -155.81 74.2 5.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.008 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.444 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 82.1 Cg_exo -42.33 128.43 4.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.299 2.666 . . . . 0.0 113.841 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.28 160.59 38.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.397 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.6 mt-10 -80.3 107.86 13.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -82.61 114.08 20.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.697 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 46' ' ' VAL . 13.7 t -106.93 159.42 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.201 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.462 ' N ' HG12 ' A' ' 45' ' ' VAL . 11.2 p -145.93 126.68 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.064 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.22 167.57 22.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 54' ' ' LYS . 5.8 mt -137.33 148.31 46.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.1 mmm-85 -81.14 -66.51 0.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -162.23 -56.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.796 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.42 90.75 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.524 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.96 -59.6 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -145.19 153.75 41.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.806 0.336 . . . . 0.0 110.895 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HB3' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.84 166.89 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -146.6 169.03 19.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.54 145.83 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.7 t -116.07 159.91 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.481 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -137.79 111.56 8.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.026 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 1.4 tptt -104.68 99.32 8.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.213 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -37.6 126.03 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.734 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.802 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.7 mt -89.9 -34.93 15.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.604 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CE2' HG22 ' A' ' 112' ' ' ILE . 59.5 m-85 -116.45 81.01 10.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 61' ' ' LEU . 24.0 Cg_exo -63.47 144.27 90.09 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.679 2.253 . . . . 0.0 112.076 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.98 24.8 15.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 22.7 m-85 -131.04 117.26 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 110.735 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mt -116.73 116.3 27.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.393 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.2 mp -117.65 114.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.467 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 12.8 tt0 -79.7 68.44 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 ptp -91.27 -167.94 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.262 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -142.35 106.37 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.452 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.814 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 23.9 mt -79.85 -1.82 40.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.12 -159.48 28.84 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.748 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -77.76 -77.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -53.58 179.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.74 7.2 31.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.352 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -80.03 123.92 83.26 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.891 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.617 ' HA ' HD22 ' A' ' 72' ' ' LEU . 57.1 Cg_endo -71.01 159.23 53.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.258 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' A' ' 81' ' ' ALA . 23.2 p30 -90.12 -179.99 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.02 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.554 ' HG3' HD22 ' A' ' 31' ' ' LEU . 15.2 pt-20 -61.97 -32.63 73.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -56.6 -31.72 64.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.01 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.457 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -64.2 -47.88 78.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -57.07 -30.21 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -80.16 -54.83 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.99 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.874 HG22 HD11 ' A' ' 22' ' ' LEU . 24.1 t -56.62 -37.24 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.64 -20.61 65.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.94 -17.16 12.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.921 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.543 HG21 ' CD1' ' A' ' 22' ' ' LEU . 29.2 p -55.85 141.02 67.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.775 0.287 . . . . 0.0 111.095 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 52.7 Cg_exo -55.07 95.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.098 . . . . 0.0 112.279 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.77 -30.29 0.28 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.624 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.5 mm -79.93 131.88 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.988 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.08 -66.14 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.47 30.23 0.13 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.722 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 53.18 -173.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 111.048 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.653 HG12 ' NE2' ' A' ' 9' ' ' HIS . 17.3 m -51.97 171.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.316 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.07 -49.3 7.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.542 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.35 39.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.936 0.398 . . . . 0.0 111.191 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -177.61 134.13 2.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.44 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.84 -29.97 11.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.906 0.384 . . . . 0.0 110.928 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -79.6 161.93 65.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.529 ' O ' HG13 ' A' ' 102' ' ' VAL . 50.8 Cg_exo -55.91 -164.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.686 2.258 . . . . 0.0 112.416 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 101' ' ' PRO . 4.5 m -158.72 93.44 1.92 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.13 126.36 13.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.51 2.14 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 7' ' ' ALA . 4.5 mp -76.57 154.12 34.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.881 ' O ' HG23 ' A' ' 109' ' ' VAL . 3.5 m -82.34 157.9 67.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -29.84 87.79 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.748 2.299 . . . . 0.0 112.274 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -29.29 65.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 -34.82 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 105' ' ' SER . 22.5 t -68.83 -26.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.198 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -73.22 -37.14 66.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -44.49 64.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.614 HG22 ' CE2' ' A' ' 62' ' ' PHE . 2.6 pp -67.9 -23.26 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.802 HD23 HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -72.46 -31.08 65.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.2 -53.81 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.802 HG11 ' CD1' ' A' ' 61' ' ' LEU . 21.3 t -58.16 -37.27 61.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.709 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -55.97 -64.95 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.32 42.82 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.014 HD21 HD11 ' A' ' 39' ' ' LEU . 6.0 mt -115.14 -33.83 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 119' ' ' LEU . 1.3 tt -94.95 42.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.459 179.884 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.875 0.369 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.544 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -79.94 -165.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.72 143.84 30.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.177 0.513 . . . . 0.0 112.042 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.856 ' CH2' HD12 ' A' ' 39' ' ' LEU . 63.9 m95 -100.79 92.29 5.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.167 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.688 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 58.3 m-85 -91.69 106.2 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.788 0.328 . . . . 0.0 111.33 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.86 124.96 32.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.558 HG11 HD12 ' A' ' 91' ' ' ILE . 5.2 t -100.0 162.05 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.513 ' CG ' HG22 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -122.66 133.27 54.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -136.78 -174.74 3.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 151.84 23.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.1 p -66.47 124.89 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.82 -27.61 18.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.61 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.07 -27.69 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.98 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.65 -35.11 70.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.98 -39.69 66.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -87.82 -27.94 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.024 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.0 69.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -58.36 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.027 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.87 -47.95 81.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.274 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.11 -40.51 73.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.992 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.927 HD11 HG22 ' A' ' 85' ' ' VAL . 31.6 tp -65.91 -53.41 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -58.77 -45.81 88.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.014 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -58.58 -41.91 86.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.658 ' HG3' HG22 ' A' ' 88' ' ' THR . 8.7 mmt85 -65.38 -46.91 78.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.759 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.788 HG23 HD12 ' A' ' 31' ' ' LEU . 81.1 mt -65.52 -32.05 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.936 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -31.66 39.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -36.54 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -82.64 -24.68 33.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.045 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.615 ' O ' HD23 ' A' ' 31' ' ' LEU . . . 87.66 77.35 1.27 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.376 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -139.61 38.76 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 110.726 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -8.74 56.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.2 m-20 -79.99 -28.06 39.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.41 -59.58 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.766 HG12 HG21 ' A' ' 26' ' ' ILE . 1.1 pt -79.92 122.02 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 3' ' ' ILE . 14.1 m-85 -110.0 -45.1 3.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.237 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.5 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.3 mm-40 -120.35 170.25 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.218 0.532 . . . . 0.0 111.89 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 t -154.31 88.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.149 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.856 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -79.72 157.15 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.758 HD12 ' OG1' ' A' ' 42' ' ' THR . 7.6 pt -120.2 145.37 40.03 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.939 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.47 -15.4 45.16 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.651 2.234 . . . . 0.0 113.002 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.758 ' OG1' HD12 ' A' ' 40' ' ' ILE . 80.5 p -87.07 128.79 35.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.075 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' A' ' 61' ' ' LEU . 1.3 tt0 -95.05 144.09 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -107.2 141.38 38.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.004 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.84 161.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.108 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.11 91.59 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -159.99 -177.82 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.34 172.79 12.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -149.23 -176.89 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -56.5 153.48 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.06 60.54 1.75 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.461 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 -135.92 13.03 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.514 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -149.15 152.01 35.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -115.81 -171.89 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.773 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -148.32 -65.78 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.18 112.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.7 t -131.32 160.07 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.466 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -140.03 137.85 34.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 111.011 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -111.57 149.91 30.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.741 ' HG3' HG22 ' A' ' 42' ' ' THR . 0.0 OUTLIER -81.37 109.18 15.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 43' ' ' GLU . 47.4 mt -76.41 -68.61 0.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.651 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.412 ' CB ' ' HB2' ' A' ' 65' ' ' TYR . 46.6 m-85 -100.47 96.89 5.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.644 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.61 115.28 2.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.55 2.166 . . . . 0.0 112.635 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.58 38.39 51.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.821 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HB2' ' CB ' ' A' ' 62' ' ' PHE . 88.1 m-85 -132.61 109.98 10.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD21 ' HB ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -103.67 137.24 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.549 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.685 ' CE2' HD12 ' A' ' 112' ' ' ILE . 3.9 m-85 -106.37 135.59 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -135.08 110.43 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.638 HE21 ' HE1' ' A' ' 5' ' ' TRP . 15.5 tt0 -85.53 74.34 10.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 110.224 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.4 ptp -91.42 -167.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.499 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.471 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.7 t70 -137.48 94.98 2.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.655 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.688 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 15.5 mt -79.98 -29.35 39.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.047 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.45 -153.88 27.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.591 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.08 176.05 6.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.986 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.36 177.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.92 6.84 37.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.309 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.93 116.31 60.27 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.868 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HA ' HD22 ' A' ' 72' ' ' LEU . 72.1 Cg_endo -77.11 162.1 31.95 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.466 2.111 . . . . 0.0 112.365 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.1 -178.0 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -61.78 -29.49 70.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -57.41 -44.83 84.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.444 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.5 t-105 -61.06 -35.53 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -32.25 72.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.616 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 31' ' ' LEU . 21.5 t -87.62 -49.9 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.064 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.927 HG22 HD11 ' A' ' 22' ' ' LEU . 25.2 t -57.17 -38.26 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -71.32 -22.5 61.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.48 20.83 10.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.933 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.658 HG22 ' HG3' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -87.95 145.7 37.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.632 0.253 . . . . 0.0 110.844 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.2 84.85 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.486 2.124 . . . . 0.0 112.222 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.37 -32.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.558 HD12 HG11 ' A' ' 8' ' ' VAL . 47.5 mm -80.4 122.81 36.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.377 . . . . 0.0 111.017 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -167.94 32.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.17 34.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.533 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.458 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 44.2 p90 -76.8 103.35 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 0.0 110.808 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG22 ' CG ' ' A' ' 9' ' ' HIS . 11.2 m -90.15 100.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.271 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.37 33.24 5.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.425 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.27 36.88 23.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.948 0.404 . . . . 0.0 111.048 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.94 36.15 29.12 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.371 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -175.24 -168.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.411 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 4.6 mtt85 -53.97 176.66 0.11 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.444 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 91.5 Cg_exo -44.91 166.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.707 2.271 . . . . 0.0 112.65 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.09 111.47 33.9 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.493 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.01 145.93 10.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.643 2.229 . . . . 0.0 112.239 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.613 ' N ' HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -87.21 171.31 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 111.004 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.807 ' O ' HG23 ' A' ' 109' ' ' VAL . 24.1 p -90.06 152.57 46.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.788 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.22 -32.48 70.93 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.722 2.281 . . . . 0.0 112.447 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 -41.4 58.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -78.91 -30.18 44.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 105' ' ' SER . 66.3 t -62.82 -42.48 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.211 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -36.89 80.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -49.92 30.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.859 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.685 HD12 ' CE2' ' A' ' 67' ' ' PHE . 2.8 pt -67.28 -16.38 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.821 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -70.61 -32.64 70.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.836 0.35 . . . . 0.0 110.526 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.47 -10.74 57.42 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 43' ' ' GLU . 40.4 t -75.87 -48.59 28.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 111.509 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 4.3 t -65.83 -56.61 11.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.428 . . . . 0.0 110.656 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.621 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 142.81 42.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.821 HD12 ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -108.65 -28.3 9.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.36 -31.2 7.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.424 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.883 0.373 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -135.12 -165.15 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 153.8 37.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.243 0.544 . . . . 0.0 112.206 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.831 ' HE1' HE21 ' A' ' 69' ' ' GLN . 73.9 m95 -97.46 88.84 4.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.356 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.765 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 50.2 m-85 -79.82 125.58 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.828 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -107.19 148.31 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 9' ' ' HIS . 21.7 t -135.67 162.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.528 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.803 ' CD2' HG13 ' A' ' 95' ' ' VAL . 0.8 OUTLIER -101.37 147.79 25.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.7 p -141.26 -176.96 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.55 130.78 34.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.725 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.0 p -57.69 118.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.58 -23.5 35.55 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.79 -20.54 18.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.237 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -44.32 70.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.79 -46.03 74.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -79.6 -27.29 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.819 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.8 97.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -49.8 -48.53 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.204 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.48 74.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.67 -38.45 89.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.532 HD22 HG21 ' A' ' 88' ' ' THR . 2.1 mt -74.39 -56.64 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.031 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -41.69 -36.58 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -77.67 -37.87 48.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -75.75 -27.84 58.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.644 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 31' ' ' LEU . 37.9 mm -73.44 -30.18 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.626 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -80.86 -29.82 35.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.17 -43.12 44.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -81.65 -3.46 53.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.372 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 81.04 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.607 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.2 mt -136.48 23.06 3.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.98 -15.87 58.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.131 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.45 -7.33 59.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.492 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' CE ' ' HB2' ' A' ' 81' ' ' ALA . 4.9 ptmm? -115.99 -46.66 2.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.731 0.3 . . . . 0.0 110.854 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.85 108.63 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.652 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 3' ' ' ILE . 8.5 m-85 -94.5 -60.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.455 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -108.92 146.48 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.108 0.48 . . . . 0.0 111.298 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG22 HG23 ' A' ' 68' ' ' ILE . 21.6 t -146.51 89.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.55 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 118' ' ' LEU . 4.5 mm? -102.59 166.86 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.429 HD12 ' OG1' ' A' ' 42' ' ' THR . 19.9 pt -120.69 134.91 24.33 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.748 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 36.9 Cg_endo -66.16 65.29 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.521 2.147 . . . . 0.0 112.547 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.429 ' OG1' HD12 ' A' ' 40' ' ' ILE . 35.9 p -152.28 140.28 20.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HA ' HG12 ' A' ' 115' ' ' VAL . 14.0 tt0 -79.92 156.56 27.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.658 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 129.97 16.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.97 155.75 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.8 p -159.71 115.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.053 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -107.28 158.98 16.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.962 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.681 ' H ' HD23 ' A' ' 48' ' ' LEU . 1.8 pt? -141.37 36.87 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.719 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -114.24 -176.48 2.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 66.14 40.32 3.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.4 -134.09 11.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.544 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.57 76.4 0.35 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.518 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -141.33 174.78 10.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.341 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.38 133.92 30.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -128.63 116.95 20.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.948 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 m -110.72 118.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.056 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.8 t -120.83 159.96 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.05 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.472 ' N ' HG12 ' A' ' 57' ' ' VAL . 5.8 mtt180 -146.72 152.48 38.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.067 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -138.5 92.66 2.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.742 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 42' ' ' THR . 1.9 mtmt -58.96 102.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.809 HD11 HG11 ' A' ' 115' ' ' VAL . 77.4 mt -73.23 -48.28 36.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 62' ' ' PHE . 1.7 m-85 -116.64 88.9 26.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.97 125.69 20.03 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.67 2.247 . . . . 0.0 112.779 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.65 35.53 74.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.123 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 66' ' ' LEU . 6.4 m-85 -126.69 164.19 21.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -153.32 120.8 5.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.484 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.771 ' CD1' HD11 ' A' ' 104' ' ' LEU . 12.4 m-85 -94.65 138.09 32.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.561 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 38' ' ' VAL . 2.2 mp -141.68 116.1 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.979 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.831 HE21 ' HE1' ' A' ' 5' ' ' TRP . 20.1 tt0 -81.04 66.66 6.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.645 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.499 ' CE ' HD21 ' A' ' 72' ' ' LEU . 3.4 ptm -91.15 -171.08 2.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -148.48 99.5 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.765 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 9.2 mt -92.47 -69.99 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.72 -47.48 2.76 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.558 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.79 151.17 43.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 0.0 110.969 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -116.12 -36.83 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -66.34 -41.7 89.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.941 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -160.08 122.68 1.87 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.32 172.52 14.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.4 2.067 . . . . 0.0 112.288 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.35 176.62 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -57.7 -21.36 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.265 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.22 -48.8 67.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.245 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -59.47 -38.36 80.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -86.05 -51.54 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 81' ' ' ALA . 22.7 t -62.65 -48.8 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.045 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -9.33 58.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.361 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.46 24.17 4.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.918 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -76.32 144.32 74.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.649 0.261 . . . . 0.0 110.707 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.04 96.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.604 2.203 . . . . 0.0 112.695 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.86 52.77 4.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.083 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -101.5 -28.59 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m 50.61 51.7 16.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.453 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.44 125.26 25.15 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.467 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.5 t80 63.41 142.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.821 0.343 . . . . 0.0 110.81 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.803 HG13 ' CD2' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -47.65 -62.87 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.585 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.527 ' H ' HG23 ' A' ' 95' ' ' VAL . . . 166.33 76.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.476 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -170.33 -52.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 0.0 110.989 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -123.86 168.35 16.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -25.42 10.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.706 0.289 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.93 138.95 83.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.46 -169.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.582 2.188 . . . . 0.0 112.418 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.44 88.54 4.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.8 148.58 71.49 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.616 2.211 . . . . 0.0 112.379 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.771 HD11 ' CD1' ' A' ' 67' ' ' PHE . 8.9 mt -90.0 169.56 11.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.901 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -90.01 148.51 39.7 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.682 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.67 -46.1 35.92 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.686 2.257 . . . . 0.0 112.248 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -64.97 -27.96 69.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -85.73 -37.9 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 105' ' ' SER . 48.2 t -57.65 -29.35 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.104 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -77.94 -28.59 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.805 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.5 t-160 -79.2 -40.16 31.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.564 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.477 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.3 pp -72.06 -24.85 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.8 ' CD2' HD12 ' A' ' 118' ' ' LEU . 20.0 mt -73.87 -34.89 64.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.83 -31.36 59.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.982 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.809 HG11 HD11 ' A' ' 61' ' ' LEU . 25.0 t -71.93 -43.08 68.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.132 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.691 ' HB2' HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -58.68 -61.59 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.913 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.66 43.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.559 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.8 HD12 ' CD2' ' A' ' 113' ' ' LEU . 16.2 mt -113.38 -35.69 5.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.14 36.27 3.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.776 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.329 -1.261 . . . . 0.0 112.517 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.028 0.442 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.824 HG21 ' CE1' ' A' ' 36' ' ' PHE . 1.3 pp -110.31 174.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.031 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -143.36 161.11 39.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.286 0.565 . . . . 0.0 111.582 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.681 ' O ' HD12 ' A' ' 104' ' ' LEU . 94.9 m95 -86.82 86.64 7.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.593 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.673 ' O ' HD12 ' A' ' 68' ' ' ILE . 57.1 m-85 -79.69 113.54 17.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.376 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -105.43 135.51 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 111.822 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 9' ' ' HIS . 0.6 OUTLIER -125.66 -167.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.399 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.631 ' N ' HG13 ' A' ' 8' ' ' VAL . 8.1 m-70 -126.39 167.22 15.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.061 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -151.42 -174.61 4.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.13 133.63 35.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 12' ' ' VAL . 26.1 m -58.8 117.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.003 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.41 -28.99 12.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -84.47 -21.18 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 111.195 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -54.37 -32.29 56.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.126 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -50.95 -60.8 2.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.287 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -75.26 -19.79 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . . . -67.2 -31.89 72.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.769 0.319 . . . . 0.0 111.067 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.742 ' HD2' HD11 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -59.82 -55.84 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.83 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.58 -32.79 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.489 HD12 HG21 ' A' ' 88' ' ' THR . 58.0 tp -80.06 -50.28 10.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' OE1' HG11 ' A' ' 38' ' ' VAL . 12.6 tp10 -59.97 -52.51 65.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.104 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -39.98 75.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -40.14 90.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.566 HG12 HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -62.29 -35.01 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.75 -10.21 40.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.422 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 81.92 73.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.344 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 80' ' ' GLU . 3.8 mm? -126.12 23.35 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.293 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -79.45 24.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.107 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.53 -23.93 10.85 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.883 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -107.96 -42.95 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.706 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.663 HD11 ' HB1' ' A' ' 81' ' ' ALA . 4.3 mp -84.89 93.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.824 ' CE1' HG21 ' A' ' 3' ' ' ILE . 30.4 m-85 -82.0 -49.02 10.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.36 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mt-30 -121.86 156.87 32.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.2 p -153.66 76.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.465 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.935 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.3 mm? -80.02 142.53 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.141 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.545 HD12 ' CG ' ' A' ' 19' ' ' LYS . 30.4 mm -98.09 110.92 57.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.983 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 31.5 Cg_exo -57.75 79.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.586 2.191 . . . . 0.0 112.437 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 16.7 p -141.57 164.23 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.501 ' HB2' HD21 ' A' ' 61' ' ' LEU . 2.6 tt0 -106.76 148.33 28.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.585 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.53 144.37 27.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.119 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.502 HG21 ' HD3' ' A' ' 59' ' ' LYS . 15.5 t -149.65 160.18 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 56' ' ' VAL . 26.9 m -126.15 155.92 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.253 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -132.52 148.51 52.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.59 121.09 39.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.7 ttm-85 -109.98 141.13 43.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.31 122.43 18.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.967 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.07 -117.68 2.37 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.66 36.25 0.74 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -113.87 -174.03 2.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.808 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -138.07 149.73 46.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -149.18 138.23 21.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 46' ' ' VAL . 16.0 m -139.69 131.86 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -107.81 171.35 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.04 124.48 43.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HD3' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.64 -169.13 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.64 115.21 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 115' ' ' VAL . 76.0 mt -90.22 -53.12 4.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.53 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 18.9 m-85 -114.24 86.13 11.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.369 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.51 119.35 4.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.064 2.51 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.87 -13.67 29.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.778 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 2.5 m-85 -79.94 152.82 29.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.051 0.425 . . . . 0.0 111.412 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.742 HD11 ' HD2' ' A' ' 19' ' ' LYS . 1.2 mt -146.89 121.27 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.548 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.776 ' CD2' HD12 ' A' ' 112' ' ' ILE . 6.2 m-85 -91.21 125.4 35.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.0 OUTLIER -136.24 114.37 14.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.256 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.599 ' CG ' HD13 ' A' ' 3' ' ' ILE . 17.7 tt0 -79.89 68.81 6.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.2 ptm -91.39 -170.73 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.699 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.482 ' CB ' HG22 ' A' ' 3' ' ' ILE . 16.9 t0 -129.28 101.0 5.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.723 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.568 HD12 ' CG ' ' A' ' 6' ' ' TYR . 31.7 mt -118.97 6.73 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.395 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.74 61.08 1.0 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.507 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -115.88 -37.87 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 0.0 111.008 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -174.21 -168.69 0.41 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.05 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.38 -34.58 74.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -112.85 116.26 47.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.86 -171.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.289 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -89.95 -174.15 4.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.588 ' HG3' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -60.8 -22.87 64.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.663 ' HB1' HD11 ' A' ' 35' ' ' ILE . . . -53.32 -46.59 69.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.322 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.8 t-105 -61.24 -38.33 86.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -31.11 69.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.44 HG21 ' CD2' ' A' ' 31' ' ' LEU . 21.5 t -81.34 -46.27 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.643 HG12 HG13 ' A' ' 91' ' ' ILE . 22.0 t -64.17 -32.83 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -23.05 62.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.036 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -100.39 -8.88 48.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.009 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.489 HG21 HD12 ' A' ' 22' ' ' LEU . 1.2 p -74.94 114.61 36.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.852 0.326 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.75 115.48 2.14 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.405 2.07 . . . . 0.0 112.356 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.11 -18.42 5.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.643 HG13 HG12 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -79.89 129.72 37.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.731 0.3 . . . . 0.0 111.096 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.586 ' N ' HD13 ' A' ' 91' ' ' ILE . 1.6 m -140.43 125.16 18.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.973 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -81.08 81.87 1.59 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.463 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.83 -57.74 3.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.0 110.956 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.83 HG21 HG22 ' A' ' 102' ' ' VAL . 3.5 m -58.29 131.57 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.168 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -104.46 -129.4 6.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.1 46.98 12.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.093 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.47 -126.18 7.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.349 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 176.14 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.801 0.334 . . . . 0.0 110.752 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.672 ' O ' HG23 ' A' ' 95' ' ' VAL . 2.0 mmp_? -78.9 -46.58 1.76 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.065 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.3 Cg_exo -67.24 157.68 60.6 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.638 2.225 . . . . 0.0 112.08 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.83 HG22 HG21 ' A' ' 95' ' ' VAL . 5.9 m -154.17 98.23 2.57 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 41.4 Cg_exo -56.39 145.24 79.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.421 2.081 . . . . 0.0 112.244 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.727 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.9 mp -83.39 160.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.878 ' O ' HG23 ' A' ' 109' ' ' VAL . 60.0 p -77.04 145.38 73.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.46 -29.24 39.0 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.526 2.151 . . . . 0.0 112.228 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -77.13 -37.34 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.66 -35.73 33.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 105' ' ' SER . 36.2 t -60.95 -51.54 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.17 68.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.471 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -73.72 -51.27 17.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.614 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.776 HD12 ' CD2' ' A' ' 67' ' ' PHE . 22.6 pt -66.48 -19.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.754 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.885 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.79 -38.97 61.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.746 179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.28 -34.31 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.001 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 61' ' ' LEU . 11.3 t -83.91 -33.18 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.253 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.935 ' HB3' HD12 ' A' ' 39' ' ' LEU . 4.2 m -59.84 -60.77 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.22 41.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.645 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.885 HD12 ' HG ' ' A' ' 113' ' ' LEU . 45.6 mt -120.9 -57.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.75 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.72 31.11 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.332 -1.26 . . . . 0.0 112.432 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.769 0.319 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.642 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.3 -165.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.38 150.78 27.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.331 0.586 . . . . 0.0 112.154 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 1.025 ' CH2' HD12 ' A' ' 39' ' ' LEU . 72.1 m95 -92.63 85.96 5.43 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.264 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.601 ' CE1' HD12 ' A' ' 72' ' ' LEU . 57.5 m-85 -81.19 129.06 34.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -111.38 124.7 52.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.354 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.516 HG11 HD11 ' A' ' 91' ' ' ILE . 13.6 t -101.1 159.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.872 ' HB2' HG13 ' A' ' 95' ' ' VAL . 1.7 m-70 -106.56 151.83 24.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.9 p -157.11 170.25 22.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.23 143.77 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.97 127.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.48 -27.81 17.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.485 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -99.18 -24.0 15.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 111.06 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.45 -53.75 53.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.051 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.42 -41.56 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -72.61 -33.66 66.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.225 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -47.39 -55.56 8.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -43.96 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.972 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mt -69.16 -63.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -40.86 -32.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.749 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -43.32 30.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 110.624 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -77.39 -26.59 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.777 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.529 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.6 mm -83.97 -25.53 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -96.48 -29.91 13.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.82 -44.53 63.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.91 -24.59 40.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.978 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.08 53.32 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.382 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.529 ' HB2' HG23 ' A' ' 26' ' ' ILE . 2.9 mm? -99.98 32.04 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.963 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -79.17 8.93 5.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -97.48 -21.07 17.34 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -103.66 -55.08 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.596 HG23 ' CG2' ' A' ' 68' ' ' ILE . 18.8 mm -81.49 94.54 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.673 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.606 ' CE2' HG21 ' A' ' 3' ' ' ILE . 11.7 m-85 -79.99 -55.33 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.351 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.498 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt-30 -114.36 166.73 11.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.161 0.505 . . . . 0.0 111.709 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.2 t -150.32 89.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.025 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -80.59 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.171 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.594 HD12 ' O ' ' A' ' 42' ' ' THR . 1.4 pt -104.54 104.24 44.13 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.811 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 35.8 Cg_exo -57.67 -9.09 4.94 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.698 2.265 . . . . 0.0 113.147 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.594 ' O ' HD12 ' A' ' 40' ' ' ILE . 32.8 p -92.1 138.33 31.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 110.534 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 1.4 mm-40 -80.23 108.28 13.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.793 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' HG13 ' A' ' 45' ' ' VAL . 50.9 mt-10 -94.88 110.5 22.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.223 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.563 HG23 ' HB ' ' A' ' 56' ' ' VAL . 3.3 m -156.14 113.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 47' ' ' GLU . 11.0 p -160.35 160.03 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' HG22 ' A' ' 46' ' ' VAL . 17.7 tp10 -144.5 -68.0 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.965 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.27 -175.82 4.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.964 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -120.74 -67.54 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -139.12 132.67 30.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.17 40.72 0.67 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.92 -76.47 0.21 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.404 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.09 142.92 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.99 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -101.49 125.93 48.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.667 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.41 ' HB2' ' CB ' ' A' ' 47' ' ' GLU . 6.0 tt0 -88.38 -97.7 0.09 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.941 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 45' ' ' VAL . 1.5 t -153.79 -140.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 122.498 -0.126 . . . . 0.0 110.674 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 45' ' ' VAL . 27.0 m -157.93 -172.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -91.21 107.58 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -87.09 -175.01 5.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.342 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 32.1 mtmt -145.37 92.38 2.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.343 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' HG21 ' A' ' 115' ' ' VAL . 15.1 mt -64.12 -51.84 61.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.334 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 41' ' ' PRO . 10.9 m-85 -116.64 81.69 11.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.702 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 53.1 Cg_exo -54.94 141.73 77.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.604 2.203 . . . . 0.0 112.557 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.74 27.36 66.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.774 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 61.8 m-85 -134.23 151.62 51.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 6.0 mt -147.78 126.68 12.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.388 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.909 ' CD2' HD12 ' A' ' 112' ' ' ILE . 8.9 m-85 -93.96 131.66 39.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 111.219 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.596 ' CG2' HG23 ' A' ' 35' ' ' ILE . 1.3 mp -138.14 113.99 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 13.0 tt0 -79.88 71.73 6.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.106 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.607 ' CE ' HD21 ' A' ' 72' ' ' LEU . 3.8 ptm -91.66 -171.15 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.342 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -129.71 79.08 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.545 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.607 HD21 ' CE ' ' A' ' 70' ' ' MET . 20.5 mt -80.0 -43.34 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.57 110.49 2.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.637 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -167.26 -67.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 110.999 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -117.74 -179.49 3.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.19 -27.69 67.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.971 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.88 148.28 48.17 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.6 165.87 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.493 2.128 . . . . 0.0 112.281 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 81' ' ' ALA . 8.1 p-10 -90.11 -177.9 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.69 -28.22 68.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . . . -54.8 -45.61 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.194 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -62.61 -31.93 72.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -33.63 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.701 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.009 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.559 ' O ' HG21 ' A' ' 91' ' ' ILE . 21.9 t -59.24 -39.19 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -74.75 -20.78 59.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.01 6.23 43.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.117 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.865 ' O ' HG22 ' A' ' 91' ' ' ILE . 12.7 p -74.79 143.64 78.67 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.858 0.329 . . . . 0.0 110.672 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.15 104.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.459 2.106 . . . . 0.0 112.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.5 17.51 6.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.791 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.865 HG22 ' O ' ' A' ' 88' ' ' THR . 7.6 tp -113.57 103.27 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 0.0 110.979 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.13 -27.94 67.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.972 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.91 57.31 2.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.439 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 63.85 128.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.328 . . . . 0.0 110.942 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.872 HG13 ' HB2' ' A' ' 9' ' ' HIS . 35.3 m -79.54 -1.7 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.642 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -55.56 -23.17 34.68 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.68 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 62.66 51.52 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.397 . . . . 0.0 111.031 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.21 45.43 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.531 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.4 ttt -142.47 146.08 34.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -72.66 154.48 91.37 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.441 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_exo -49.81 143.35 23.41 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.587 2.191 . . . . 0.0 112.32 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.71 118.95 29.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.92 163.1 13.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.0 112.292 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.494 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.4 mt -90.0 168.41 12.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.918 ' O ' HG23 ' A' ' 109' ' ' VAL . 57.4 p -88.74 147.04 38.3 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.49 -33.96 93.72 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.249 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -26.71 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -95.48 -36.7 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.952 HG11 ' CD1' ' A' ' 5' ' ' TRP . 40.9 t -59.39 -31.77 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -59.74 -43.12 94.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -53.91 34.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.67 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.909 HD12 ' CD2' ' A' ' 67' ' ' PHE . 9.9 pt -61.23 -23.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.259 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.797 ' HA ' HD21 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -59.57 -36.71 76.74 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.29 -17.71 59.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 61' ' ' LEU . 21.4 t -77.5 -60.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.483 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.544 ' HB3' HD23 ' A' ' 39' ' ' LEU . 86.1 p -51.81 -59.96 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.513 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 139.79 46.16 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.742 HD12 ' HG ' ' A' ' 113' ' ' LEU . 2.6 mt -114.92 -43.82 3.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tp -98.7 30.88 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.428 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.836 0.35 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.75 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -133.7 -165.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -141.15 147.6 38.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 112.225 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.705 ' CZ2' HD11 ' A' ' 113' ' ' LEU . 78.1 m95 -92.61 93.06 8.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.185 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.873 ' CE2' HD12 ' A' ' 72' ' ' LEU . 29.1 m-85 -80.03 112.74 17.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 111.087 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -104.55 145.06 30.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.63 178.24 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.648 ' CE1' HG13 ' A' ' 95' ' ' VAL . 4.6 m80 -107.91 143.65 36.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 p -138.59 174.19 10.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.93 144.47 25.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 12' ' ' VAL . 30.7 m -58.68 119.03 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -27.76 15.85 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.475 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.04 -30.26 39.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.652 0.263 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -40.14 86.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.58 -43.07 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 tttm -86.99 -25.48 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.88 -30.7 70.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' NZ ' HD11 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -63.36 -50.49 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 -41.37 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.45 -44.9 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.52 -47.09 67.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.773 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -57.86 -21.77 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.63 -46.23 14.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.965 0.412 . . . . 0.0 110.289 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -67.31 -23.36 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.413 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -71.06 -28.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -98.08 -31.93 11.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.37 87.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -82.77 -42.06 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' C ' HD23 ' A' ' 31' ' ' LEU . . . 106.99 77.41 1.06 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -155.18 29.37 0.4 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 110.823 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -15.43 61.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.137 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -24.55 42.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -53.62 6.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.568 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.03 153.06 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.474 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.75 ' CE2' HG21 ' A' ' 3' ' ' ILE . 25.8 m-85 -135.38 -54.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 0.0 111.402 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.28 157.92 25.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.382 0.611 . . . . 0.0 111.605 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.39 62.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.06 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' A' ' 116' ' ' SER . 1.9 tm? -79.58 129.37 34.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.586 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.482 HG22 HG23 ' A' ' 42' ' ' THR . 1.8 mp -105.28 128.36 26.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.666 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 30.7 Cg_endo -63.85 78.84 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.564 2.176 . . . . 0.0 112.635 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.482 HG23 HG22 ' A' ' 40' ' ' ILE . 48.5 p -141.04 135.49 31.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -82.97 156.5 23.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.787 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -137.01 119.99 16.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.4 m -148.71 164.79 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.85 149.33 33.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -112.45 -63.09 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.98 149.52 23.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.815 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -151.65 -50.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -65.74 157.26 30.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.38 -122.21 5.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.439 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -143.62 28.86 2.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.576 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.75 119.99 28.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -113.95 130.08 56.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -135.8 139.53 43.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 56' ' ' VAL . 28.9 m -130.52 123.74 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.062 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.7 t -98.36 155.66 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.255 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.33 113.88 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.725 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -110.24 106.87 16.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -63.66 101.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.949 HD11 HG11 ' A' ' 115' ' ' VAL . 83.1 mt -61.62 -31.77 71.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 9.0 m-85 -139.59 83.97 16.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.631 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.46 139.47 90.25 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.59 2.193 . . . . 0.0 112.509 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.64 72.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.744 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -131.58 136.63 47.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.749 0.309 . . . . 0.0 110.954 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -131.53 128.76 39.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.465 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.967 ' CD2' HD12 ' A' ' 112' ' ' ILE . 5.3 m-85 -99.09 121.63 41.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.4 mp -125.48 111.43 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.537 ' NE2' HD11 ' A' ' 3' ' ' ILE . 4.7 tt0 -79.9 72.19 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.663 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 ptp -91.63 -163.23 1.01 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.177 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -147.77 89.2 1.73 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.662 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.873 HD12 ' CE2' ' A' ' 6' ' ' TYR . 11.2 mt -79.98 -16.41 55.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.66 78.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.468 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -156.78 120.96 4.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.705 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 61.85 -175.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.906 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -31.6 61.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -123.1 149.89 58.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.24 150.25 20.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.513 2.142 . . . . 0.0 112.256 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -165.83 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.468 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.3 pt-20 -57.81 -21.29 41.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.164 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -49.26 -35.9 19.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.431 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -80.46 -29.72 37.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.07 -28.24 63.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 80' ' ' GLU . 22.7 t -84.83 -51.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 81' ' ' ALA . 39.2 t -58.63 -37.36 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -73.97 -26.35 60.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.175 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.5 6.13 60.86 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.008 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 120.68 69.22 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.774 0.287 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 115.18 2.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.26 -13.16 6.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.791 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 tp -79.95 132.82 31.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 111.064 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.8 p -123.69 -68.96 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.98 165.0 28.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.523 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.45 ' CB ' ' CG ' ' A' ' 9' ' ' HIS . 1.5 t80 -175.3 -42.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.869 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 100' ' ' ARG . 4.4 m -55.25 100.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.32 -95.56 0.51 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.795 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 63.56 -79.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.321 . . . . 0.0 110.971 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -127.22 -48.56 0.18 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.1 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.402 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 1.3 ttm -129.1 174.4 9.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -54.24 -51.19 79.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.011 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 100' ' ' ARG . 65.6 Cg_endo -85.12 155.07 11.1 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.698 2.266 . . . . 0.0 111.959 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.417 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 63.4 t -155.71 114.61 2.22 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.102 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.62 156.54 40.27 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.476 2.118 . . . . 0.0 112.388 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.2 mp -89.72 147.81 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -70.95 153.3 94.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.53 -36.45 59.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.55 2.166 . . . . 0.0 112.311 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.63 -35.62 81.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.72 -38.81 20.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 105' ' ' SER . 38.3 t -58.84 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.056 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -53.68 -30.02 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.032 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 -54.91 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.707 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.967 HD12 ' CD2' ' A' ' 67' ' ' PHE . 15.7 pt -66.95 -26.2 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 ' CZ2' ' A' ' 5' ' ' TRP . 1.1 mp -72.2 -31.33 65.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.249 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -41.88 73.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.949 HG11 HD11 ' A' ' 61' ' ' LEU . 19.1 t -84.64 -27.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.481 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t -52.23 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.819 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 150.96 38.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.349 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.819 HD23 ' C ' ' A' ' 117' ' ' GLY . 2.4 mt -122.31 -37.74 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.88 -34.58 39.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.434 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.856 0.36 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.655 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -139.46 178.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.29 164.0 34.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.98 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.882 ' CZ2' HD21 ' A' ' 113' ' ' LEU . 76.1 m95 -94.8 132.72 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.814 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 28.0 m-85 -119.11 122.81 42.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.803 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -101.55 131.52 47.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.481 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 HD12 ' A' ' 91' ' ' ILE . 15.6 t -117.59 159.54 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.788 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.477 ' N ' HG12 ' A' ' 8' ' ' VAL . 15.8 m-70 -94.27 133.52 37.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.046 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.51 HG21 HD13 ' A' ' 66' ' ' LEU . 36.7 p -144.74 -177.5 5.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.14 140.65 29.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.1 p -60.62 123.91 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.52 5.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.235 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -81.57 -18.14 45.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.913 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -44.96 -40.43 6.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.286 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -37.9 80.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -33.74 64.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.58 -43.77 88.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -66.1 -35.98 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.78 -54.92 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.003 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -60.26 -31.68 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.577 HD12 HG21 ' A' ' 88' ' ' THR . 38.0 tp -74.96 -57.25 4.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.91 -32.39 6.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -71.64 -41.3 68.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.761 ' HG3' HG22 ' A' ' 88' ' ' THR . 2.3 mmp_? -68.23 -39.33 82.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.587 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.767 ' HA ' HD12 ' A' ' 31' ' ' LEU . 37.5 mm -64.83 -31.46 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.828 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -83.99 -30.17 26.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.65 -44.87 76.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.04 -29.77 39.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.23 43.63 3.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.449 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.918 HD11 HG21 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -99.84 28.9 4.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 110.825 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -69.54 -13.11 62.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.409 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 1.1 m-20 -79.75 -23.8 42.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.565 ' CE ' ' HB2' ' A' ' 81' ' ' ALA . 13.8 mtpp -94.56 -56.3 2.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.843 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.01 136.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.669 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.1 m-85 -132.27 -64.13 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.449 . . . . 0.0 111.447 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -101.02 151.74 21.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.82 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.7 HG12 HG23 ' A' ' 68' ' ' ILE . 5.2 m -159.81 106.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.494 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.734 HD11 HD21 ' A' ' 118' ' ' LEU . 4.4 mm? -118.82 160.45 21.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.378 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 pt -103.54 131.78 21.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 37.1 Cg_endo -65.65 83.28 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.555 2.17 . . . . 0.0 112.806 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.9 p -125.06 163.28 22.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.866 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.716 ' CG ' HD21 ' A' ' 61' ' ' LEU . 37.2 tt0 -114.55 20.3 15.46 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.175 0.512 . . . . 0.0 112.139 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 58' ' ' ARG . 3.2 mt-10 -160.48 167.69 26.71 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.515 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 56' ' ' VAL . 3.8 m -160.01 -48.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.702 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 45' ' ' VAL . 5.6 m -159.81 137.63 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.938 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -148.37 160.77 42.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.046 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -114.9 124.74 52.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.73 -178.32 7.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 68.88 -68.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.39 -128.08 0.93 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.589 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.78 30.38 9.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.534 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.72 151.95 24.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.923 0.392 . . . . 0.0 110.795 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -104.07 121.8 43.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -120.43 143.62 48.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 45' ' ' VAL . 11.8 p -109.49 135.52 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.184 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 44' ' ' GLU . 5.8 m -151.57 152.57 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.584 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.566 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . 10.1 mtt180 -150.56 127.06 10.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.579 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 43' ' ' GLU . 3.5 mttm -92.61 -163.55 1.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -133.1 100.94 5.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.788 HD11 HG11 ' A' ' 115' ' ' VAL . 63.1 mt -76.45 -31.71 58.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.652 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.0 m-85 -140.42 67.65 31.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.557 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.39 120.19 7.89 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.63 2.22 . . . . 0.0 112.213 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 16.07 22.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.661 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.46 154.16 50.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 10' ' ' THR . 0.3 OUTLIER -136.38 115.02 11.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.529 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.882 ' CD2' HD13 ' A' ' 112' ' ' ILE . 14.5 m-85 -79.83 125.01 29.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.276 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 38' ' ' VAL . 1.9 mp -134.03 112.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.142 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.4 tt0 -80.81 74.54 7.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.798 0.333 . . . . 0.0 110.936 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptp -91.24 -169.65 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.011 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -147.02 89.01 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.814 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 62.6 mt -83.35 -46.09 12.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.37 -29.71 9.81 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.603 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -130.87 162.34 29.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -111.17 -28.8 8.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.961 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.06 -47.2 86.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.001 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -154.16 131.25 5.97 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.941 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.08 177.82 8.33 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.477 2.118 . . . . 0.0 112.506 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -90.09 -164.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.64 -27.16 57.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.565 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . . . -51.43 -34.97 37.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.399 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -66.21 -33.75 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.8 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -31.82 72.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.743 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -72.64 -49.58 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.85 HG12 HG13 ' A' ' 91' ' ' ILE . 21.6 t -58.17 -53.85 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp-105 -58.69 -29.35 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.64 -28.13 52.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.532 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 84' ' ' VAL . 44.9 p -69.58 130.4 90.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.55 0.214 . . . . 0.0 110.756 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.76 -23.8 28.04 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.418 2.078 . . . . 0.0 112.348 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.78 -27.32 55.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.619 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.85 HG13 HG12 ' A' ' 85' ' ' VAL . 38.0 mm -90.94 139.24 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 111.115 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 p -113.7 -36.21 4.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.687 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.44 -111.32 0.25 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.432 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.449 ' CE2' ' HA2' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -174.99 175.11 2.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 110.848 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 96' ' ' GLY . 14.3 p -53.9 -46.41 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.644 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 98.07 -31.1 8.33 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.596 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.0 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.721 0.296 . . . . 0.0 111.331 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -134.66 140.64 11.92 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.532 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.3 mmt 58.73 -178.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.721 0.296 . . . . 0.0 110.943 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.427 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -87.6 -50.07 0.44 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.019 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 6.1 Cg_exo -79.05 -174.74 2.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.828 2.352 . . . . 0.0 112.226 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -150.74 72.21 8.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.06 133.94 37.69 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.524 2.149 . . . . 0.0 112.522 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 67' ' ' PHE . 3.2 mt -88.84 167.85 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -89.98 148.06 38.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.36 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.513 2.142 . . . . 0.0 112.277 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.97 -27.71 61.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -90.4 -33.5 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 105' ' ' SER . 33.5 t -60.53 -40.73 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.167 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -19.4 62.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.743 ' O ' HG23 ' A' ' 115' ' ' VAL . 44.5 m-70 -83.34 -44.06 15.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.96 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.882 HD13 ' CD2' ' A' ' 67' ' ' PHE . 1.8 pp -74.96 -20.19 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.134 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.882 HD21 ' CZ2' ' A' ' 5' ' ' TRP . 97.4 mt -84.95 -34.01 22.54 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.863 0.363 . . . . 0.0 110.591 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -73.13 -28.23 62.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.693 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 HD11 ' A' ' 61' ' ' LEU . 16.0 t -89.51 -31.11 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.999 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.67 ' HB3' HD12 ' A' ' 39' ' ' LEU . 3.2 m -60.28 -64.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 149.09 55.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.722 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.734 HD21 HD11 ' A' ' 39' ' ' LEU . 1.2 mt -135.5 -48.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.684 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -4.06 50.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.439 -1.2 . . . . 0.0 112.439 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.813 0.34 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.63 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -79.94 -179.66 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.86 164.68 37.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.258 0.551 . . . . 0.0 111.829 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.692 ' HH2' HD23 ' A' ' 39' ' ' LEU . 79.0 m95 -89.74 129.77 36.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.858 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.497 ' OH ' HD12 ' A' ' 72' ' ' LEU . 4.7 m-30 -112.61 108.35 17.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.286 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.42 137.56 32.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.73 158.16 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.632 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -104.32 132.98 49.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.911 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.8 p -128.04 -173.78 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.66 131.4 41.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 12' ' ' VAL . 19.1 m -59.17 115.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.41 -28.73 12.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -20.04 35.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.543 ' OE2' HD12 ' A' ' 40' ' ' ILE . 1.5 tm-20 -53.87 -32.62 53.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.855 0.359 . . . . 0.0 111.154 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.65 -38.64 72.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -24.11 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.97 -51.27 70.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.303 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -50.66 -41.46 55.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.41 75.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -65.31 -36.27 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.476 HD22 HG21 ' A' ' 88' ' ' THR . 2.5 mt -79.5 -54.43 5.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -43.99 -31.32 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.615 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.5 -35.81 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.686 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -79.92 -25.29 40.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.821 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.793 ' HA ' HD12 ' A' ' 31' ' ' LEU . 38.0 mm -80.73 -28.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.698 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -91.47 -30.33 16.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.33 -42.94 61.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -80.21 -28.09 38.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 58.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -114.39 30.96 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.97 -10.72 60.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.233 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -79.97 -24.73 40.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.739 0.304 . . . . 0.0 110.983 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -61.94 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 68' ' ' ILE . 18.1 mm -79.96 111.92 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.63 ' CE2' HG21 ' A' ' 3' ' ' ILE . 12.3 m-85 -99.53 -58.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.197 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -109.29 146.14 34.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.45 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' HD22 ' A' ' 39' ' ' LEU . 22.5 t -153.81 117.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.698 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.692 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.4 mm? -126.1 156.61 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.973 0.416 . . . . 0.0 111.278 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.543 HD12 ' OE2' ' A' ' 15' ' ' GLU . 3.5 tt -106.76 124.68 34.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.638 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 33.9 Cg_endo -64.7 69.78 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.54 2.16 . . . . 0.0 112.758 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 p -141.61 132.6 26.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.512 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HA ' HG12 ' A' ' 115' ' ' VAL . 10.9 tt0 -80.06 166.01 21.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.014 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -144.89 110.41 5.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.747 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 46' ' ' VAL . 6.5 t -153.38 161.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 55' ' ' GLU . 30.4 m -85.21 139.05 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.521 ' HB3' HG21 ' A' ' 57' ' ' VAL . 17.2 pt-20 -109.77 -46.87 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.129 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.53 -162.89 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.918 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.92 -50.14 0.64 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.832 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 55.27 26.87 9.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.978 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.71 -46.5 2.52 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.366 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.1 44.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.432 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.15 25.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.32 0.581 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -159.62 114.11 2.34 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.757 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.814 ' O ' HG12 ' A' ' 46' ' ' VAL . 2.8 pt-20 -160.13 -43.84 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.234 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.56 HG23 ' HG3' ' A' ' 55' ' ' GLU . 27.9 t -102.26 117.0 46.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.47 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 47' ' ' GLU . 5.2 t -124.2 157.39 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.701 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -131.27 130.64 43.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.392 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.72 96.58 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.564 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -51.6 119.17 3.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.853 HD11 HG11 ' A' ' 115' ' ' VAL . 28.9 mt -90.1 -44.09 10.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 3.7 m-85 -115.73 91.36 29.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.23 117.75 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.909 2.406 . . . . 0.0 112.968 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.92 45.09 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.962 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.29 149.16 52.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.757 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.39 118.0 9.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.932 ' CD2' HD12 ' A' ' 112' ' ' ILE . 7.5 m-85 -88.25 133.9 33.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.795 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 35' ' ' ILE . 5.3 mt -135.37 111.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.128 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.668 HE21 ' HE1' ' A' ' 5' ' ' TRP . 23.9 tt0 -79.65 67.22 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.418 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.402 ' CB ' HD13 ' A' ' 35' ' ' ILE . 2.8 ptm -91.2 -168.6 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.279 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -145.6 108.56 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.777 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.497 HD12 ' OH ' ' A' ' 6' ' ' TYR . 4.4 mt -79.92 -68.16 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.841 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.33 -66.62 2.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.426 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.54 158.37 29.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.53 -29.98 7.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.029 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.59 -66.71 0.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.984 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -121.91 138.03 28.13 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.76 166.6 28.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.464 2.109 . . . . 0.0 112.345 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.83 173.55 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 84' ' ' VAL . 9.1 pt-20 -59.14 -25.16 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.36 -50.55 67.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.306 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.431 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.0 t-105 -58.3 -42.02 85.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -59.85 -30.87 69.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.855 ' O ' HG23 ' A' ' 88' ' ' THR . 22.1 t -84.07 -52.34 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.694 ' O ' HG21 ' A' ' 91' ' ' ILE . 23.5 t -62.13 -49.03 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.46 -11.87 61.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.251 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.83 -17.18 15.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.872 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.871 ' O ' HG22 ' A' ' 91' ' ' ILE . 30.7 p -56.47 147.58 48.64 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.717 0.294 . . . . 0.0 110.985 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.48 109.73 1.89 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.587 2.192 . . . . 0.0 112.258 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.56 10.42 9.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.722 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.871 HG22 ' O ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -115.29 140.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 111.04 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -141.16 15.72 2.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.539 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.19 -83.45 0.02 OUTLIER Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.237 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 9' ' ' HIS . 2.3 m-85 66.68 13.01 9.17 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.617 ' HB ' HG23 ' A' ' 102' ' ' VAL . 5.7 m -89.98 65.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.739 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.82 -11.99 61.42 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.985 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB3' HG21 ' A' ' 102' ' ' VAL . . . -68.93 66.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.969 0.414 . . . . 0.0 111.117 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.84 24.38 7.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.6 mtt 62.6 -80.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.806 0.336 . . . . 0.0 110.969 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.456 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -57.29 161.47 5.39 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.878 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 100' ' ' ARG . 85.6 Cg_exo -42.89 141.62 2.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.78 2.32 . . . . 0.0 112.572 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.949 HG21 ' HB3' ' A' ' 97' ' ' ALA . 24.8 t -99.92 102.3 17.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.76 150.38 27.29 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.145 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -90.06 153.91 20.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.851 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.6 p -80.97 161.16 64.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.06 -26.89 77.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.696 2.264 . . . . 0.0 112.323 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.85 -31.87 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 112' ' ' ILE . 12.4 tt0 -88.0 -35.22 17.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 105' ' ' SER . 58.3 t -58.68 -48.92 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -25.16 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -80.99 -38.84 26.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.959 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.932 HD12 ' CD2' ' A' ' 67' ' ' PHE . 14.4 pt -78.09 -26.95 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.991 HD22 HD12 ' A' ' 118' ' ' LEU . 90.7 mt -82.11 -26.91 33.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -70.67 -30.09 66.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.853 HG11 HD11 ' A' ' 61' ' ' LEU . 27.9 t -82.6 -38.02 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.656 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -59.25 -62.76 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.632 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 153.21 45.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.557 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.991 HD12 HD22 ' A' ' 113' ' ' LEU . 12.0 mt -128.16 -54.23 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.794 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.37 -31.75 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.503 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.841 0.353 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.728 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.89 -173.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.743 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.89 159.91 41.26 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 111.705 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.606 ' CD1' HG11 ' A' ' 109' ' ' VAL . 69.2 m95 -101.05 111.51 23.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.69 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 18.9 m-85 -94.96 124.43 39.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.817 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.613 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . -99.53 143.67 29.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.434 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' HD23 ' A' ' 66' ' ' LEU . 6.1 t -140.65 162.03 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.073 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.476 ' N ' HG12 ' A' ' 8' ' ' VAL . 10.2 m170 -86.79 155.87 20.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.271 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.681 ' CG2' HD22 ' A' ' 66' ' ' LEU . 28.6 p -146.56 -176.64 5.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.65 127.81 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.811 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 12' ' ' VAL . 18.6 m -59.24 102.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.097 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.97 -17.67 27.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.631 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -112.87 2.21 15.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 37.3 tt0 -54.96 -45.07 74.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.822 0.344 . . . . 0.0 111.071 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -54.12 -61.54 2.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -66.08 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -58.99 -47.43 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.85 0.357 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -55.53 -41.03 72.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.14 80.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.41 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.413 HD22 ' CB ' ' A' ' 88' ' ' THR . 2.8 mt -83.07 -60.72 2.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -37.53 -34.68 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.778 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -72.85 -51.23 19.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.71 ' HD3' HG22 ' A' ' 88' ' ' THR . 1.2 mtt-85 -69.31 -24.96 64.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.478 HG21 ' CD1' ' A' ' 35' ' ' ILE . 31.9 mm -73.38 -31.06 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.561 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -32.91 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.35 -29.52 65.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.022 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.422 ' CZ ' ' NH1' ' A' ' 25' ' ' ARG . 5.5 m-85 -80.55 -39.59 27.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.78 67.72 0.8 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.947 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.845 HD13 ' HA ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -144.86 34.86 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -13.26 61.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.407 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.64 -22.69 43.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.881 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.5 -49.71 8.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.478 ' CD1' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -95.59 149.48 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.64 ' CE2' HG21 ' A' ' 3' ' ' ILE . 7.8 m-85 -140.12 -47.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.252 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 1.8 tt0 -118.01 157.53 26.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.098 0.475 . . . . 0.0 111.703 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.507 HG12 HG23 ' A' ' 68' ' ' ILE . 2.6 m -156.56 102.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.566 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.985 HD11 HD21 ' A' ' 118' ' ' LEU . 4.3 mm? -113.23 152.84 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.2 mt -99.24 127.03 35.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 26.7 Cg_endo -62.54 78.56 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.536 2.158 . . . . 0.0 112.388 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.594 HG22 ' CG ' ' A' ' 60' ' ' LYS . 42.0 p -143.95 167.19 22.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HA ' HG12 ' A' ' 115' ' ' VAL . 3.8 pt-20 -123.39 107.36 11.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' O ' HG13 ' A' ' 45' ' ' VAL . 1.3 tt0 -95.15 137.37 34.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 44' ' ' GLU . 13.7 m -156.22 144.35 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' ' 56' ' ' VAL . 28.9 m -139.01 163.05 27.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.269 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -126.43 137.49 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.85 88.91 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.44 150.63 20.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -82.28 111.56 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.964 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.74 -34.56 0.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.546 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.58 40.2 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.473 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -136.35 162.66 32.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.47 124.56 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -114.65 116.6 28.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.623 ' HA ' HG12 ' A' ' 46' ' ' VAL . 26.6 t -110.98 108.5 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.048 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.5 m -123.42 138.27 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.241 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.67 125.24 9.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' HG3' ' CG ' ' A' ' 43' ' ' GLU . 4.8 ptpt -113.0 172.95 6.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.762 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.594 ' CG ' HG22 ' A' ' 42' ' ' THR . 8.5 mtmt -100.73 120.07 39.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.852 HD11 HG11 ' A' ' 115' ' ' VAL . 44.6 mt -76.0 -44.91 37.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.458 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.526 ' CE1' HG22 ' A' ' 112' ' ' ILE . 3.5 m-85 -118.9 70.16 9.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.427 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.85 139.07 83.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.754 2.303 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.5 15.39 79.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.19 160.49 37.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.839 0.352 . . . . 0.0 111.179 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.778 ' CD1' HD11 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -144.91 131.15 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.651 ' CD2' HD13 ' A' ' 112' ' ' ILE . 17.3 m-85 -93.6 123.41 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.2 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.778 HD11 ' CD1' ' A' ' 66' ' ' LEU . 1.6 mt -126.14 116.43 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 5.7 tt0 -79.74 69.89 6.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.6 ptp -91.0 -166.55 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.811 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -160.06 96.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.363 . . . . 0.0 110.889 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.69 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 51.9 mt -83.03 -30.4 28.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.762 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.55 -63.0 4.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.55 146.67 23.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -92.59 -26.53 17.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.98 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -57.07 -78.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.968 0.413 . . . . 0.0 111.065 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -117.69 121.33 31.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.64 176.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.477 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -90.07 -170.2 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.974 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -29.05 68.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.845 ' HA ' HD13 ' A' ' 31' ' ' LEU . . . -52.86 -27.98 20.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.475 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -78.98 -33.39 45.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.039 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -62.15 -29.73 70.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.9 t -82.96 -40.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 81' ' ' ALA . 31.9 t -67.05 -45.72 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -15.82 62.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.308 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.0 -18.61 9.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.028 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.71 HG22 ' HD3' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -59.19 134.17 87.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.783 0.291 . . . . 0.0 110.945 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 88' ' ' THR . 31.6 Cg_exo -58.3 -30.05 89.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.47 2.114 . . . . 0.0 112.28 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.06 -33.28 60.59 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.701 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.1 mm -79.92 127.19 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.03 31.27 1.99 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.84 167.07 30.67 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.447 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.444 ' CD2' ' HG2' ' A' ' 100' ' ' ARG . 18.5 p90 -162.19 179.09 8.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.885 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG22 ' NE2' ' A' ' 9' ' ' HIS . 38.5 t -66.23 -67.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.997 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.27 -145.54 16.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.511 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 63.21 -81.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.719 0.295 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -162.26 27.32 0.25 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.581 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.77 98.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 10.6 mtm-85 -57.86 -53.44 65.77 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.279 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 34.2 Cg_endo -64.49 148.45 90.64 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.292 1.994 . . . . 0.0 112.296 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 7' ' ' ALA . 7.8 m -145.15 89.01 6.56 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.81 133.01 26.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.49 2.127 . . . . 0.0 112.218 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.6 OUTLIER -84.74 159.07 20.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.048 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.2 m -81.2 160.43 65.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.79 -24.86 79.98 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.374 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.44 -37.12 63.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.052 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.37 -37.35 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.8 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 105' ' ' SER . 94.8 t -58.54 -38.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.19 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -25.92 65.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 115' ' ' VAL . 13.0 m-70 -74.69 -50.62 16.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.707 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.651 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.4 pp -68.16 -16.78 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.701 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -79.05 -41.76 28.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -33.16 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.793 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.852 HG11 HD11 ' A' ' 61' ' ' LEU . 33.5 t -73.46 -30.93 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.989 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.729 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.2 m -70.02 -58.77 3.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 140.97 59.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 39' ' ' LEU . 4.4 mt -133.14 -56.7 0.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -79.87 -50.93 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.535 179.973 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.889 0.376 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.73 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -137.74 -171.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.702 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -131.35 148.13 52.64 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.325 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.9 ' CD1' HG11 ' A' ' 109' ' ' VAL . 79.5 m95 -99.95 94.4 6.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.004 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.468 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 77.7 m-85 -84.15 126.62 33.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -104.39 124.78 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.5 p -108.37 159.46 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.193 0.52 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.605 ' CE1' HG23 ' A' ' 95' ' ' VAL . 21.1 m-70 -96.98 119.11 34.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.6 p -121.84 169.88 10.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.2 mm? -84.84 153.61 22.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 12' ' ' VAL . 12.1 p -66.34 120.86 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.31 21.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.529 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -86.0 -25.63 25.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.16 -45.16 79.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 0.0 111.047 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.05 -42.42 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.61 -28.63 45.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.98 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.487 ' HB1' ' HA3' ' A' ' 90' ' ' GLY . . . -65.14 -35.39 80.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -61.61 -50.87 70.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.63 81.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.1 -37.77 77.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.83 -54.76 5.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.52 -30.54 20.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -44.44 43.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.753 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -73.8 -27.6 61.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.98 -16.27 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -108.06 -29.94 8.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.14 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.87 25.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.175 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CD2' ' HG3' ' A' ' 25' ' ' ARG . 71.1 m-85 -79.88 -2.99 46.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.335 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 76.11 77.47 0.74 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.751 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 30' ' ' GLY . 2.4 mm? -134.99 30.96 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.962 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -77.51 6.18 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.338 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.5 -25.27 22.66 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.739 0.304 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -106.14 -58.0 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mm -81.86 110.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.808 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.5 m-85 -100.81 -53.15 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.216 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.414 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -116.6 157.43 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 0.0 111.646 -179.406 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -148.54 67.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.271 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.819 HD11 HD21 ' A' ' 118' ' ' LEU . 3.8 mm? -80.36 156.8 26.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.429 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.522 HD12 ' HD2' ' A' ' 41' ' ' PRO . 4.2 tp -113.78 131.42 23.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.708 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 40' ' ' ILE . 43.5 Cg_endo -67.86 74.18 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.335 2.024 . . . . 0.0 112.548 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.0 p -131.65 133.89 45.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HA ' HG12 ' A' ' 115' ' ' VAL . 8.9 tp10 -89.6 154.08 20.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.662 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.26 138.47 50.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.045 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 46' ' ' VAL . 3.0 t -119.66 162.12 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.962 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.735 HG23 ' CD ' ' A' ' 47' ' ' GLU . 4.8 m -87.45 -31.72 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.44 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.735 ' CD ' HG23 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -144.2 167.33 22.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.047 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.874 HD12 HG11 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -146.03 52.39 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.833 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.49 129.12 4.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.01 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -27.04 62.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.788 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -178.65 53.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.3 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.81 -76.04 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.611 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -127.1 175.39 8.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 0.0 110.951 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -141.89 109.35 5.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -140.47 163.45 32.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 56' ' ' VAL . 12.3 p -80.42 123.32 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.874 HG11 HD12 ' A' ' 48' ' ' LEU . 17.7 m -121.39 179.12 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.87 159.91 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -159.93 100.33 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.747 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -53.81 120.54 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.217 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.832 HD11 HG11 ' A' ' 115' ' ' VAL . 48.0 mt -90.18 -40.65 12.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 32.8 m-85 -123.12 76.38 51.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 46.7 Cg_exo -56.28 141.39 88.66 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.636 2.224 . . . . 0.0 112.496 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.08 20.41 76.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.709 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 96.3 m-85 -131.02 145.02 51.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -134.21 122.1 22.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.527 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.477 ' CE2' HD12 ' A' ' 112' ' ' ILE . 17.5 m-85 -84.73 115.07 22.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.3 mp -123.59 108.81 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.055 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.423 ' HG2' ' CG1' ' A' ' 3' ' ' ILE . 16.3 tt0 -79.85 74.3 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.54 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.1 ptp -91.19 -174.35 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.128 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.7 t0 -125.47 78.15 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.468 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt -95.96 -46.34 6.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.52 -112.96 4.21 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.501 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -96.68 -177.61 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.95 31.38 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.988 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -74.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -156.15 97.99 2.21 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.61 165.2 32.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.62 2.213 . . . . 0.0 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.87 178.89 7.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.607 ' O ' HG23 ' A' ' 84' ' ' VAL . 6.0 pt-20 -61.86 -18.79 61.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.241 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.74 -46.72 64.13 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.387 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -59.39 -43.79 92.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.44 -30.17 69.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.674 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 80' ' ' GLU . 34.5 t -71.34 -49.51 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.838 HG12 HG13 ' A' ' 91' ' ' ILE . 19.3 t -61.23 -45.31 98.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -59.75 -23.12 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.64 -32.86 8.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.756 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.58 146.76 79.38 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.27 -25.07 26.62 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.412 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.487 ' HA3' ' HB1' ' A' ' 18' ' ' ALA . . . -55.74 -25.45 43.95 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.643 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.838 HG13 HG12 ' A' ' 85' ' ' VAL . 37.8 mm -89.25 141.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 p -131.3 44.74 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.993 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.5 -122.81 7.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.588 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 99' ' ' MET . 0.6 OUTLIER -154.82 -177.13 6.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.336 . . . . 0.0 110.949 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.605 HG23 ' CE1' ' A' ' 9' ' ' HIS . 13.9 p -56.1 -35.68 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.16 12.18 14.37 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.721 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.527 ' H ' HG13 ' A' ' 95' ' ' VAL . . . -71.95 -29.55 64.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.786 0.327 . . . . 0.0 110.992 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -84.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.53 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.422 ' HA ' ' CE2' ' A' ' 94' ' ' PHE . 1.5 mtp -150.59 -46.57 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.835 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.8 ptt-85 -73.95 154.4 88.85 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.63 -166.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.584 2.189 . . . . 0.0 112.061 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 102' ' ' VAL . 5.9 m -143.0 99.37 5.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.01 135.17 16.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.128 . . . . 0.0 112.327 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' A' ' 5' ' ' TRP . 1.9 mt -72.65 169.36 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.91 ' O ' HG23 ' A' ' 109' ' ' VAL . 6.6 m -89.14 145.84 35.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.723 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.24 -33.34 97.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.54 2.16 . . . . 0.0 112.393 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.96 -32.91 67.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -34.46 26.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 105' ' ' SER . 48.9 t -57.33 -45.63 85.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -29.99 40.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.15 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.429 ' O ' HG23 ' A' ' 115' ' ' VAL . 20.6 t60 -74.93 -52.4 11.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.542 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.477 HD12 ' CE2' ' A' ' 67' ' ' PHE . 11.6 pt -67.85 -19.38 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.852 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.2 mp -77.17 -38.38 51.82 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.479 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -69.67 -27.67 65.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.832 HG11 HD11 ' A' ' 61' ' ' LEU . 22.4 t -86.68 -31.97 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.565 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -60.08 -64.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.491 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 150.89 43.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.662 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.852 HD12 ' HG ' ' A' ' 113' ' ' LEU . 13.5 mt -120.04 -47.39 2.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.96 -36.55 6.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.351 -1.25 . . . . 0.0 112.485 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.71 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.71 -176.31 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.91 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 159.37 39.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.386 0.612 . . . . 0.0 112.481 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.898 ' CD1' HG11 ' A' ' 109' ' ' VAL . 89.7 m95 -97.42 91.77 5.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.476 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.815 ' O ' HD12 ' A' ' 68' ' ' ILE . 62.7 m-85 -83.67 111.17 18.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.353 . . . . 0.0 110.737 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . -90.48 159.04 16.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.35 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.91 162.99 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.897 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.577 ' CE1' ' HA ' ' A' ' 95' ' ' VAL . 8.1 m80 -101.3 149.42 24.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.1 p -149.36 -174.36 4.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.1 141.79 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 12' ' ' VAL . 12.2 p -66.98 120.04 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.38 -29.42 10.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -85.71 -23.41 27.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.791 0.329 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -54.84 -34.91 63.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.38 -47.14 79.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.011 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -75.7 -27.13 58.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.84 85.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.195 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -47.25 -48.25 24.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.05 73.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.946 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -67.16 -49.79 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.94 -62.45 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -42.84 -31.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.623 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.25 -39.6 25.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.861 0.363 . . . . 0.0 110.474 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.22 51.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.63 -27.12 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.692 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.45 -31.99 11.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.027 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.06 -46.05 68.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.96 -16.97 54.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.76 49.83 4.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.29 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 80' ' ' GLU . 3.1 mm? -96.68 24.57 5.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -80.3 19.4 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.241 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.2 -21.32 16.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -116.49 -49.22 2.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.797 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.471 HG23 ' CG2' ' A' ' 68' ' ' ILE . 5.4 mp -79.9 125.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.876 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HE2' HG21 ' A' ' 3' ' ' ILE . 20.3 m-85 -116.07 -62.13 1.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.491 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -106.71 156.01 19.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 111.224 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.5 p -150.36 73.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.847 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.5 mm? -79.9 139.44 37.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.277 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.423 HG22 HG23 ' A' ' 42' ' ' THR . 33.5 mm -96.43 118.55 65.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.702 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 27.2 Cg_endo -62.31 90.03 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.352 2.034 . . . . 0.0 112.565 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 40.0 p -135.59 154.98 51.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 18.0 mt-10 -84.64 -171.47 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -145.42 130.64 18.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.791 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 46' ' ' VAL . 14.4 t -126.55 159.75 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.478 ' N ' HG12 ' A' ' 45' ' ' VAL . 10.8 p -121.16 129.45 75.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.062 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.99 159.05 42.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.9 mt -124.18 152.97 42.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -127.07 10.95 6.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.438 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 55.21 40.1 31.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.779 0.323 . . . . 0.0 110.997 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.4 121.38 4.4 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.91 -28.85 3.63 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.21 -170.57 3.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.903 0.382 . . . . 0.0 110.908 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.623 ' HB3' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -124.06 177.64 5.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 pm0 -100.37 26.22 6.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 54' ' ' LYS . 16.2 m -99.06 79.71 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.183 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 58' ' ' ARG . 17.4 t -102.18 160.17 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.962 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.479 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -128.32 177.22 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.447 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -160.11 -160.46 0.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.653 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -112.55 113.14 25.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 111.102 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.011 HD11 HG11 ' A' ' 115' ' ' VAL . 4.9 mt -90.26 -57.62 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.651 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 69.9 m-85 -119.18 87.54 35.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.603 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.37 115.34 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.673 2.249 . . . . 0.0 112.624 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.05 19.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.788 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.462 ' C ' HD12 ' A' ' 66' ' ' LEU . 25.3 m-85 -138.03 147.82 44.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.069 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 65' ' ' TYR . 3.9 mp -145.5 112.91 6.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.844 ' CD2' HD12 ' A' ' 112' ' ' ILE . 5.1 m-85 -84.96 126.13 33.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 111.201 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -130.36 115.61 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 1.9 tp-100 -79.75 71.73 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 0.0 110.354 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.698 ' HE2' HD21 ' A' ' 72' ' ' LEU . 4.6 ptm -91.56 -177.93 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' OD1' HG22 ' A' ' 3' ' ' ILE . 22.8 t70 -121.51 82.84 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.728 HD22 ' HB3' ' A' ' 78' ' ' PRO . 13.7 mt -117.66 -37.44 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.42 106.68 0.71 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.516 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -162.71 -67.46 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.005 0.431 . . . . 0.0 110.843 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 179.69 -38.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.316 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -77.89 -154.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.597 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -131.82 149.0 72.17 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.32 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.728 ' HB3' HD22 ' A' ' 72' ' ' LEU . 61.0 Cg_endo -72.21 108.1 2.41 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.697 2.264 . . . . 0.0 112.275 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -90.15 -77.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.506 ' HB3' HD11 ' A' ' 31' ' ' LEU . 13.5 mt-10 -54.06 -64.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.604 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.723 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -47.59 -32.85 5.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.853 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.401 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 4.7 t-105 -87.44 -29.23 21.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.141 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.81 -29.55 70.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.0 -49.25 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 81' ' ' ALA . 37.3 t -60.15 -41.24 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.33 -21.85 60.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.02 10.3 37.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.114 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.22 135.93 29.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.814 0.307 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.56 120.6 8.5 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.077 . . . . 0.0 112.258 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.24 -8.96 9.6 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.944 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 91' ' ' ILE . 7.8 tp -79.86 79.64 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 111.082 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -60.95 -43.89 98.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.95 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.07 -135.7 1.89 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.561 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -148.99 -176.23 5.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.79 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.912 HG21 ' HB ' ' A' ' 102' ' ' VAL . 38.3 t -54.73 -68.64 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 115.1 28.63 2.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.595 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.62 100.89 4.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.892 0.377 . . . . 0.0 111.014 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.61 -82.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.335 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.2 mtp -100.02 166.42 11.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.753 0.311 . . . . 0.0 110.623 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -68.69 -47.96 32.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.934 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.1 Cg_exo -66.92 -179.53 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.647 2.232 . . . . 0.0 112.151 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.912 ' HB ' HG21 ' A' ' 95' ' ' VAL . 7.3 p -160.12 81.86 2.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.9 124.7 9.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.633 HD22 ' H ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -78.68 172.19 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 109' ' ' VAL . 79.0 p -90.17 147.78 37.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -50.82 -29.39 26.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.605 2.204 . . . . 0.0 112.261 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.91 -42.43 39.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -74.02 -38.27 64.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.898 HG11 ' CD1' ' A' ' 5' ' ' TRP . 40.1 t -59.07 -42.53 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -57.54 -31.37 66.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.954 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -70.04 -56.08 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.844 HD12 ' CD2' ' A' ' 67' ' ' PHE . 21.8 pt -63.56 -24.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.91 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.9 mp -72.71 -38.9 67.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.721 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.18 -33.03 67.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 1.011 HG11 HD11 ' A' ' 61' ' ' LEU . 13.0 t -79.37 -37.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.847 ' OG ' HD12 ' A' ' 39' ' ' LEU . 8.2 t -58.46 -63.5 1.26 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.858 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 150.66 54.94 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.537 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.91 HD12 ' HG ' ' A' ' 113' ' ' LEU . 17.6 mt -133.02 -54.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.37 -31.36 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.405 -1.219 . . . . 0.0 112.535 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.789 0.328 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.724 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -135.6 -165.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.36 150.14 24.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 112.232 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.771 ' CD1' HG11 ' A' ' 109' ' ' VAL . 75.1 m95 -86.09 92.43 8.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.446 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.804 ' CE2' HD12 ' A' ' 72' ' ' LEU . 40.1 m-85 -84.23 114.53 21.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.403 . . . . 0.0 110.87 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.28 154.73 19.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.567 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 66' ' ' LEU . 13.8 m -142.35 179.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 16.1 m-70 -130.75 149.86 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.2 p -145.96 -173.84 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.83 149.83 22.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.6 p -71.45 124.45 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -24.77 27.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.624 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.54 -22.73 17.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.0 111.077 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -54.49 -35.56 63.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.19 -30.97 68.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.91 -28.84 18.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -42.05 81.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.094 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HG3' HG21 ' A' ' 40' ' ' ILE . 2.6 tmtt? -59.77 -38.21 81.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 -44.93 28.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -60.75 -35.08 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 85' ' ' VAL . 67.5 tp -73.78 -57.91 3.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -29.71 15.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -41.94 71.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.75 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HD3' HG22 ' A' ' 88' ' ' THR . 3.1 mpt_? -70.23 -36.89 74.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.89 ' HA ' HD12 ' A' ' 31' ' ' LEU . 29.8 mm -74.5 -29.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.93 -36.6 14.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.177 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.95 -44.74 72.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.32 -26.62 35.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.63 70.43 1.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 26' ' ' ILE . 2.2 mt -123.3 38.93 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 110.857 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.2 -1.12 24.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.538 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.72 -25.22 41.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -55.05 2.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.458 HD13 ' CB ' ' A' ' 70' ' ' MET . 26.4 mm -82.99 127.92 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.636 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 3' ' ' ILE . 23.3 m-85 -120.57 -64.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -102.89 122.29 44.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.433 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 38' ' ' VAL . 6.6 m -114.83 77.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.607 HD23 ' OG ' ' A' ' 116' ' ' SER . 2.6 tm? -91.76 127.59 37.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.95 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 42' ' ' THR . 3.4 pt -102.67 128.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 78.1 Cg_exo -52.2 69.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.991 2.461 . . . . 0.0 113.216 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 40' ' ' ILE . 68.2 p -158.98 136.18 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.525 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -104.1 105.78 16.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.38 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.3 135.88 44.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.31 122.89 54.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 46' ' ' VAL . 16.5 t -110.89 30.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -176.08 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.42 -169.55 3.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.842 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -170.54 2.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.804 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.81 88.52 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.57 -117.35 0.52 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.484 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -163.33 41.0 0.33 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.41 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -142.77 157.73 44.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.925 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.94 138.11 31.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.61 -169.33 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.588 ' O ' HG13 ' A' ' 56' ' ' VAL . 10.6 p -144.97 109.41 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.3 t -144.22 159.89 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.479 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -147.94 139.41 23.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.064 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -117.63 121.03 39.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.533 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -67.2 117.63 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.042 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.689 ' CD1' HG21 ' A' ' 115' ' ' VAL . 11.0 mt -81.81 -52.71 6.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.742 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.9 m-85 -129.91 86.89 53.53 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.5 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 147.99 89.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.788 2.325 . . . . 0.0 112.596 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.6 9.1 64.54 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.078 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 22.4 m-85 -119.08 161.97 19.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.977 0.417 . . . . 0.0 111.058 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -154.49 112.56 3.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.415 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CD1' HD11 ' A' ' 104' ' ' LEU . 5.9 m-85 -89.44 122.23 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -129.25 110.49 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.999 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.74 74.87 6.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.301 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.458 ' CB ' HD13 ' A' ' 35' ' ' ILE . 20.9 ptm -91.36 -173.19 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.136 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -126.7 82.86 2.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.804 HD12 ' CE2' ' A' ' 6' ' ' TYR . 62.5 mt -90.78 7.39 39.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.497 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.82 92.58 1.22 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.549 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -152.44 -46.3 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.335 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -152.29 -176.85 5.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.994 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.08 -32.64 74.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.93 148.5 35.68 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.83 139.32 36.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.634 2.223 . . . . 0.0 112.26 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.54 178.54 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 84' ' ' VAL . 4.2 pt-20 -58.93 -23.61 61.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.59 -49.33 67.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.328 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -66.3 -35.09 79.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -60.24 -31.44 70.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 88' ' ' THR . 21.8 t -85.09 -46.96 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 81' ' ' ALA . 36.3 t -59.8 -49.32 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -70.82 -18.1 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.031 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.02 -22.67 44.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.793 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 84' ' ' VAL . 54.4 p -54.1 108.38 1.12 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.586 0.231 . . . . 0.0 111.079 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.27 119.27 5.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.77 15.86 19.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.704 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -113.67 121.5 65.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 110.926 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.62 ' N ' HD13 ' A' ' 91' ' ' ILE . 1.4 m -80.17 -64.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.826 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.13 157.95 21.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.595 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 63.66 -169.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.473 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 10.4 m -90.0 -29.74 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.16 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 115.27 -52.12 0.68 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.433 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.92 -30.32 65.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -95.93 -133.52 7.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.562 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.1 mtp -148.52 -64.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.57 155.32 92.66 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.863 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.12 178.87 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.627 2.218 . . . . 0.0 112.078 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.37 96.76 8.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.87 125.55 12.22 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.377 2.052 . . . . 0.0 112.207 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 67' ' ' PHE . 1.2 mt -60.69 158.87 11.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.044 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.2 m -89.96 147.36 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.89 -31.31 42.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.436 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -31.38 69.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.974 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.09 -31.08 13.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 105' ' ' SER . 22.0 t -66.39 -29.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.213 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -39.38 93.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -52.28 29.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.566 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.742 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.0 pp -65.06 -21.4 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.69 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.729 HD22 HD12 ' A' ' 118' ' ' LEU . 7.5 mt -69.05 -34.8 75.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -59.66 -22.07 61.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.994 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.689 HG21 ' CD1' ' A' ' 61' ' ' LEU . 23.6 t -73.89 -56.58 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.243 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.607 ' OG ' HD23 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -51.4 -48.46 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.06 21.01 3.57 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.808 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.729 HD12 HD22 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -83.67 -27.7 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.709 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.19 -42.06 4.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.813 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.473 -179.948 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -141.68 -165.29 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -157.88 152.11 24.49 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.217 0.532 . . . . 0.0 111.789 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.779 ' CD1' HG11 ' A' ' 109' ' ' VAL . 87.1 m95 -94.97 92.72 7.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.568 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.945 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 40.1 m-85 -81.48 113.13 19.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 110.786 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -93.84 146.68 23.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.445 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.2 p -123.34 159.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.727 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.727 ' HD2' HG13 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -117.27 103.39 10.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.933 -179.817 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 p -110.08 -174.29 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.96 150.99 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -71.35 126.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.11 26.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.575 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -23.54 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.064 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.48 -33.43 63.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.059 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.87 -34.74 68.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.07 -28.49 20.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.57 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.093 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.736 ' HB3' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -60.1 -38.51 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -179.973 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.27 79.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.022 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -61.62 -32.02 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.576 HD11 HG22 ' A' ' 85' ' ' VAL . 64.2 tp -76.17 -57.65 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -28.94 10.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.47 -41.63 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -37.7 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.798 HG23 ' HB2' ' A' ' 31' ' ' LEU . 35.0 mm -72.53 -30.41 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -89.81 -33.72 16.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.7 -40.01 66.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.91 -26.73 27.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.2 47.51 3.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.798 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.5 mt -99.92 40.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.25 -6.38 49.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.406 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.81 -26.12 40.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.995 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.648 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -95.53 -55.38 3.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.715 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.41 HG23 ' CG2' ' A' ' 68' ' ' ILE . 11.1 mm -88.2 122.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.81 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.494 ' CE2' HG21 ' A' ' 3' ' ' ILE . 10.3 m-85 -112.68 -54.37 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.454 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -111.4 156.5 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.544 HG22 HG23 ' A' ' 68' ' ' ILE . 38.5 t -156.4 75.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.122 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.734 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.5 mm? -91.04 168.06 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.712 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.719 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -123.25 139.41 31.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.805 179.597 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 72.3 Cg_endo -77.1 86.4 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.711 2.274 . . . . 0.0 113.202 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.797 ' O ' HG12 ' A' ' 115' ' ' VAL . 24.3 p -138.07 128.97 27.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.14 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.614 ' HA ' ' CG1' ' A' ' 115' ' ' VAL . 1.1 tt0 -91.27 22.11 4.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.285 0.564 . . . . 0.0 112.098 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.607 ' HB3' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -160.83 164.59 31.25 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.395 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 46' ' ' VAL . 1.9 t -144.62 168.7 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.25 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.529 ' H ' HG12 ' A' ' 45' ' ' VAL . 9.3 p -127.06 126.7 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.49 -177.26 6.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -82.37 139.53 34.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.15 60.82 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.788 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -135.88 -69.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.03 42.76 1.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.45 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.2 -81.19 0.12 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -160.04 152.82 21.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.07 108.63 13.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.8 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -157.21 170.54 22.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 46' ' ' VAL . 21.8 t -153.94 -38.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.76 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 44' ' ' GLU . 29.3 m -156.1 -173.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.7 0.286 . . . . 0.0 111.003 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.607 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . 10.2 mtt180 -122.74 146.08 47.83 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.053 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -112.6 82.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.362 179.828 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 41' ' ' PRO . 54.3 mttt -48.53 108.67 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.691 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 43' ' ' GLU . 71.1 mt -79.6 -31.88 41.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.471 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 26.7 m-85 -132.06 69.62 80.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.434 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.01 134.6 60.52 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.681 2.254 . . . . 0.0 112.608 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.31 -2.37 82.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -106.26 110.87 23.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -101.27 122.28 43.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.488 179.714 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.728 ' CD2' HD12 ' A' ' 112' ' ' ILE . 12.9 m-85 -89.66 119.68 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.2 mp -127.73 106.8 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 8.2 tt0 -79.83 72.99 6.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.434 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -91.11 -174.83 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.194 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.459 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.9 t0 -131.01 110.36 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.945 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 34.8 mt -104.72 -34.32 8.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.49 -71.73 2.88 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -124.42 167.89 13.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.873 0.368 . . . . 0.0 111.0 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -97.78 -23.6 15.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.065 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -54.27 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.087 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -113.25 93.54 26.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.957 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.45 166.42 2.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.556 2.171 . . . . 0.0 112.235 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -83.52 173.28 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 84' ' ' VAL . 11.6 pt-20 -59.15 -25.44 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.04 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.812 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -55.48 -42.63 74.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.213 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -63.67 -44.01 95.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.95 -37.57 77.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -72.83 -45.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 81' ' ' ALA . 26.9 t -64.34 -41.04 91.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -22.84 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.036 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.79 -24.27 30.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 84' ' ' VAL . 78.0 p -58.2 115.99 13.22 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.57 0.224 . . . . 0.0 110.899 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 131.07 39.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.411 2.074 . . . . 0.0 112.293 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.14 59.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.836 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 88' ' ' THR . 5.3 tp -79.94 108.06 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.979 0.418 . . . . 0.0 111.201 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -113.73 93.27 4.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.754 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.56 112.54 5.07 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.628 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.5 t80 61.85 152.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.938 0.399 . . . . 0.0 111.045 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.727 HG13 ' HD2' ' A' ' 9' ' ' HIS . 12.6 m -57.2 -30.54 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.0 64.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.362 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.83 100.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.801 0.334 . . . . 0.0 111.149 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.77 -132.4 11.24 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.552 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.66 150.1 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.749 0.309 . . . . 0.0 110.85 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.508 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 71.1 mtt85 -68.0 -57.18 9.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 51.4 Cg_endo -68.77 136.44 35.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.096 . . . . 0.0 112.248 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.1 p -135.78 87.31 25.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.979 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.22 130.38 23.94 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.53 2.154 . . . . 0.0 112.222 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mt -79.16 163.95 24.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.917 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.0 t -86.82 140.81 33.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.8 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.78 -30.5 23.2 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 0.0 112.529 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -43.07 73.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.18 -30.53 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 105' ' ' SER . 26.4 t -61.29 -44.11 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -29.03 69.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.701 ' O ' HG23 ' A' ' 115' ' ' VAL . 11.6 m-70 -76.29 -45.33 33.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.786 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.728 HD12 ' CD2' ' A' ' 67' ' ' PHE . 20.0 pt -71.88 -26.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.882 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.912 HD22 HD12 ' A' ' 118' ' ' LEU . 70.8 mt -76.86 -36.26 56.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.397 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.65 -27.45 67.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 42' ' ' THR . 25.3 t -77.19 -41.98 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.734 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -57.55 -62.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.074 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.467 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 151.08 44.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.559 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.912 HD12 HD22 ' A' ' 113' ' ' LEU . 7.6 mt -119.59 -52.87 2.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.807 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -31.07 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.496 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.831 0.348 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.694 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -137.52 -169.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.796 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -141.19 151.57 43.91 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 112.068 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.634 ' HE1' HE21 ' A' ' 69' ' ' GLN . 84.6 m95 -98.92 93.61 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.704 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 50.5 m-85 -85.51 126.07 33.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.886 0.374 . . . . 0.0 110.772 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -105.69 142.2 35.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.598 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.71 150.67 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.629 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 95' ' ' VAL . 5.4 m80 -94.25 147.88 22.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.969 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -141.01 177.06 8.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.01 141.38 28.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 12' ' ' VAL . 6.0 m -70.17 104.89 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.41 -27.44 5.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -101.89 -17.39 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 111.206 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.52 -38.73 64.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.103 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -42.63 73.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.943 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.06 92.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -56.55 20.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.57 98.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.55 -43.23 97.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 tp -72.62 -48.79 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.716 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -58.54 -24.76 61.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.072 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -81.82 -44.56 16.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HG3' HG22 ' A' ' 88' ' ' THR . 8.3 mmt85 -68.84 -24.99 64.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.204 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -69.45 -28.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.737 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.45 -33.65 15.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.82 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.063 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -79.94 -37.81 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.23 65.26 0.84 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.739 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 35' ' ' ILE . 1.1 pt? -149.57 27.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 0.0 110.881 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -11.71 61.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.3 m-20 -79.7 -29.66 40.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.824 0.345 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -77.16 -49.84 14.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.773 HD11 HD12 ' A' ' 31' ' ' LEU . 4.1 mp -84.78 109.05 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.694 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.1 m-85 -94.08 -52.77 4.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.439 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.405 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -111.99 156.36 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.79 -179.256 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.857 HG12 HG23 ' A' ' 68' ' ' ILE . 3.9 m -153.1 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.967 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.926 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.2 mm? -85.57 142.29 29.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.535 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.516 HG22 HG23 ' A' ' 42' ' ' THR . 3.7 mp -97.04 127.56 38.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.604 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 26.1 Cg_endo -62.18 75.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.554 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.693 HG22 ' HG2' ' A' ' 60' ' ' LYS . 60.8 p -137.35 142.44 41.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.586 ' HA ' HG12 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -91.27 109.39 20.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.818 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -95.7 128.43 42.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.943 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 45' ' ' VAL . 27.4 m -132.3 117.52 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.5 m -141.79 144.26 25.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -152.95 165.92 34.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.659 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 48' ' ' LEU . 2.0 pp -139.93 39.5 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.986 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.1 165.25 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.86 90.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.49 -121.4 6.73 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.472 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.85 -44.86 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.44 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 2.3 mtmt -159.93 173.48 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.846 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.7 -169.25 1.49 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -93.18 129.82 39.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 56' ' ' VAL . 27.1 m -98.76 110.47 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.125 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.65 159.71 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 125.3 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.004 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.2 ptmt -112.58 175.83 5.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.693 ' HG2' HG22 ' A' ' 42' ' ' THR . 4.1 mmtm -92.61 121.7 34.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.772 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.0 mt -79.23 -49.51 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.728 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.458 ' CE1' HG22 ' A' ' 112' ' ' ILE . 35.6 m-85 -102.06 97.89 9.18 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.41 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.49 124.46 16.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.547 2.165 . . . . 0.0 112.509 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.71 42.97 99.58 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.83 151.58 48.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.985 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 11.3 mt -147.09 114.23 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.666 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD2' HD13 ' A' ' 112' ' ' ILE . 8.4 m-85 -90.33 123.15 33.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 38' ' ' VAL . 1.2 mp -128.47 113.93 31.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.634 HE21 ' HE1' ' A' ' 5' ' ' TRP . 17.3 tt0 -80.87 72.88 7.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.467 ' SD ' HD21 ' A' ' 72' ' ' LEU . 21.5 ptp -91.35 -169.36 2.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.99 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.57 80.2 1.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.771 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.704 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt -83.39 -71.55 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.74 26.09 16.55 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.657 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.16 137.91 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.777 0.322 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.92 -33.75 14.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.31 -77.65 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.28 117.08 6.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.783 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HB3' HD22 ' A' ' 72' ' ' LEU . 18.4 Cg_exo -65.67 66.64 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.65 2.234 . . . . 0.0 112.192 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -55.7 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 60.03 -82.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.945 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -58.43 -41.04 84.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -83.61 -30.16 27.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -61.62 -31.8 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 80' ' ' GLU . 32.8 t -82.57 -44.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 81' ' ' ALA . 35.9 t -60.54 -49.98 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.56 -24.52 61.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.72 70.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.827 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -79.0 120.33 80.41 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.802 0.301 . . . . 0.0 110.7 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.26 -14.18 43.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.475 2.117 . . . . 0.0 112.479 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.56 25.67 21.81 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.626 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.593 HD13 ' N ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -113.51 123.85 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 110.873 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.593 ' N ' HD13 ' A' ' 91' ' ' ILE . 5.1 m -151.0 108.75 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.999 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.87 -91.87 0.12 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.425 ' N ' ' HB2' ' A' ' 9' ' ' HIS . 59.3 t80 59.52 159.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.886 0.374 . . . . 0.0 110.847 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.461 ' HA ' ' CE1' ' A' ' 9' ' ' HIS . 21.2 t -63.62 139.27 21.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.241 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.72 44.92 2.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.448 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.92 -47.34 3.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.152 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.57 -126.84 0.89 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.506 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.67 -35.53 4.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 0.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -82.91 147.76 55.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.96 163.95 31.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.538 2.159 . . . . 0.0 112.17 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 t -125.41 116.41 25.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.32 171.38 17.83 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.452 2.101 . . . . 0.0 112.16 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.592 ' HB2' HG22 ' A' ' 109' ' ' VAL . 3.2 mp -89.88 157.42 17.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.895 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.859 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.0 m -80.36 150.67 71.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.2 -31.58 22.3 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.598 2.199 . . . . 0.0 112.43 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -45.32 24.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.09 -32.58 69.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 105' ' ' SER . 72.0 t -61.87 -52.41 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.008 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -24.62 66.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.731 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -76.93 -51.27 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.683 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.608 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.2 pp -69.78 -15.62 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.855 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.04 -36.31 35.94 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.682 179.477 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -80.56 -34.88 35.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.772 HG11 ' CD1' ' A' ' 61' ' ' LEU . 27.8 t -75.38 -46.35 38.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.004 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.926 ' HB3' HD12 ' A' ' 39' ' ' LEU . 72.4 m -60.75 -51.17 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.689 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.47 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.43 64.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.627 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.855 HD12 ' HG ' ' A' ' 113' ' ' LEU . 21.8 mt -136.74 -49.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.891 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -51.99 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.854 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.333 -1.259 . . . . 0.0 112.482 -179.967 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.945 0.402 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.53 -177.41 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -160.05 160.79 33.59 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 112.134 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.666 ' HH2' HD23 ' A' ' 39' ' ' LEU . 89.6 m95 -91.76 90.87 7.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.967 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 58.5 m-85 -83.67 108.72 16.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.11 148.87 27.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.905 HG12 ' HA3' ' A' ' 96' ' ' GLY . 26.9 m -140.44 -178.9 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.072 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.451 ' ND1' ' CD2' ' A' ' 94' ' ' PHE . 27.9 m-70 -107.94 137.38 46.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -130.9 -178.62 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.73 120.44 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.2 p -58.5 119.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.072 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -28.83 11.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -0.34 43.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.57 -43.32 25.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.823 0.344 . . . . 0.0 111.224 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -37.89 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.018 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.6 -28.49 20.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.794 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -61.06 2.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB3' HD11 ' A' ' 66' ' ' LEU . 2.1 pttp -63.02 -38.62 91.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.86 94.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.45 -39.41 93.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.636 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.694 ' CD1' HG21 ' A' ' 88' ' ' THR . 64.1 tp -66.47 -51.89 52.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.69 -31.58 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.0 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.31 -41.86 69.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -70.5 -37.21 74.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.66 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.745 HD12 HD11 ' A' ' 31' ' ' LEU . 41.4 mm -70.07 -30.35 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.849 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -88.58 -33.32 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.54 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.9 -35.56 32.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 85.96 1.27 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.69 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -153.09 48.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.821 179.793 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.31 -7.77 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.358 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 p-10 -79.62 -20.16 47.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.956 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -96.05 -55.55 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.614 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 HG21 ' A' ' 26' ' ' ILE . 32.6 mt -91.36 130.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.5 m-85 -121.57 -54.8 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.717 -179.369 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.45 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mm100 -117.12 158.38 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 112.345 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.746 HG22 HG23 ' A' ' 68' ' ' ILE . 38.8 t -157.18 83.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.84 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.666 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.6 mm? -95.94 164.0 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.274 0.559 . . . . 0.0 112.207 -178.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.753 HG22 ' HG ' ' A' ' 66' ' ' LEU . 1.3 pp -143.83 69.93 16.82 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.094 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HG2' ' CE2' ' A' ' 67' ' ' PHE . 72.5 Cg_exo -41.07 115.45 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.273 2.649 . . . . 0.0 113.749 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.448 HG23 HD12 ' A' ' 40' ' ' ILE . 17.2 p -124.86 162.91 23.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.052 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 58' ' ' ARG . 1.8 tm-20 -79.8 131.28 35.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.78 0.324 . . . . 0.0 110.647 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' O ' HG13 ' A' ' 45' ' ' VAL . 45.4 mt-10 -135.43 117.17 15.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 44' ' ' GLU . 5.4 m -154.82 159.83 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.311 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.514 HG11 ' HD2' ' A' ' 49' ' ' ARG . 11.2 p -100.13 154.01 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.064 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -104.03 -66.95 0.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 179.938 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.19 128.13 37.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.514 ' HD2' HG11 ' A' ' 46' ' ' VAL . 4.3 ttt-85 -156.26 31.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.964 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.81 -65.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.95 76.75 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.562 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.62 -60.4 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.2 176.2 11.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.302 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -137.59 109.86 7.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -122.81 -177.75 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.5 p -160.12 104.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.005 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 58' ' ' ARG . 1.5 p -87.63 158.47 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.134 0.493 . . . . 0.0 111.038 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.47 ' N ' ' CG2' ' A' ' 57' ' ' VAL . 66.6 mtp180 -140.93 151.4 44.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.158 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.423 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.4 mtpt -141.43 -154.07 0.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.426 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 119.71 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.739 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.3 mt -83.25 -42.61 17.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.364 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 41' ' ' PRO . 26.7 m-85 -122.99 74.32 48.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.873 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.95 142.8 93.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.596 2.197 . . . . 0.0 112.246 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.31 25.23 18.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.625 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.96 112.58 10.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.753 ' HG ' HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -113.7 130.08 56.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.967 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.988 ' CE2' HD12 ' A' ' 112' ' ' ILE . 13.8 m-30 -92.48 130.9 38.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.723 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.746 HG23 HG22 ' A' ' 38' ' ' VAL . 1.2 mp -130.39 111.46 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.211 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -79.72 70.86 6.31 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 ptm -91.55 -175.84 4.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.293 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -124.11 86.86 2.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.967 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 13.2 mt -79.87 -32.93 40.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.37 -104.95 3.2 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.579 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -123.15 -169.55 1.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.838 0.351 . . . . 0.0 111.022 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.17 -18.77 63.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.31 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.22 -174.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.0 111.157 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.91 140.6 54.28 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.785 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.33 173.5 14.39 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.457 2.105 . . . . 0.0 112.436 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.99 -165.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.589 ' OE2' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -57.7 -24.0 54.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -51.89 -44.62 63.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.369 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.9 t-105 -73.56 -30.19 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -37.7 86.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 88' ' ' THR . 34.8 t -70.06 -40.18 78.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 81' ' ' ALA . 34.4 t -67.14 -45.63 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -63.23 -17.92 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.98 -28.32 8.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.796 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.694 HG21 ' CD1' ' A' ' 22' ' ' LEU . 16.3 p -58.75 155.84 28.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.24 -25.29 31.15 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.51 -26.24 51.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.59 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.602 HG23 ' CA ' ' A' ' 97' ' ' ALA . 47.0 mm -90.99 124.62 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.73 -57.81 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.896 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.06 100.2 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.39 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.48 ' N ' ' HB3' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -170.51 -159.01 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.465 0.174 . . . . 0.0 110.756 -179.775 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.732 ' CG1' HG23 ' A' ' 102' ' ' VAL . 41.0 t -42.63 -74.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.743 0.306 . . . . 0.0 111.805 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.905 ' HA3' HG12 ' A' ' 8' ' ' VAL . . . -91.13 0.17 75.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.645 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.602 ' CA ' HG23 ' A' ' 91' ' ' ILE . . . -95.67 35.98 1.32 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.805 0.336 . . . . 0.0 111.099 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.19 -48.07 0.55 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.441 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -94.04 -178.57 4.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.701 0.286 . . . . 0.0 110.828 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 -58.9 109.21 1.7 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.41 ' HA ' HG12 ' A' ' 95' ' ' VAL . 38.0 Cg_exo -57.25 172.07 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.519 2.146 . . . . 0.0 112.309 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.732 HG23 ' CG1' ' A' ' 95' ' ' VAL . 31.3 t -128.95 122.97 21.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.22 142.59 15.23 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.529 2.153 . . . . 0.0 112.405 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' A' ' 112' ' ' ILE . 2.0 mt -74.54 168.96 18.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -89.79 142.83 29.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.93 179.935 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.01 -51.24 11.29 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.569 2.179 . . . . 0.0 112.615 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -56.95 -28.19 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -89.99 -36.29 15.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 105' ' ' SER . 30.3 t -57.42 -33.13 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.361 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -27.98 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.052 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -82.96 -34.59 26.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.904 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.988 HD12 ' CE2' ' A' ' 67' ' ' PHE . 15.2 pt -81.48 -19.11 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.122 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.071 HD22 HD12 ' A' ' 118' ' ' LEU . 29.9 mt -84.99 -25.08 27.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.719 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.35 -32.91 58.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.739 HG11 ' CD1' ' A' ' 61' ' ' LEU . 22.6 t -77.81 -37.47 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.182 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -57.54 -52.86 63.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.87 38.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.897 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.071 HD12 HD22 ' A' ' 113' ' ' LEU . 15.8 mt -117.72 -55.68 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.34 -42.82 14.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.516 179.994 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.844 0.354 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.732 HD13 ' HG2' ' A' ' 69' ' ' GLN . 2.0 pp -136.7 170.84 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -154.96 165.77 35.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.924 ' CD1' HG11 ' A' ' 109' ' ' VAL . 92.4 m95 -86.56 91.34 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.727 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.767 ' O ' HD12 ' A' ' 68' ' ' ILE . 79.8 m-85 -87.08 116.42 25.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.422 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -103.5 146.84 27.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.023 0.439 . . . . 0.0 111.763 -179.252 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.3 p -117.13 159.33 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.584 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.677 ' CB ' HG13 ' A' ' 95' ' ' VAL . 2.1 m-70 -107.01 142.21 37.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.932 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.5 p -155.12 174.8 14.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.81 162.35 15.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.62 125.85 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.72 -32.06 6.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.533 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.75 -30.72 36.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.564 ' CD ' HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -59.32 -37.19 77.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -59.97 -30.85 69.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.17 -29.88 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -50.16 75.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HB3' HD21 ' A' ' 66' ' ' LEU . 4.7 ptmt -60.16 -43.05 96.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.34 -51.98 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.67 -31.01 72.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.716 HD11 HG22 ' A' ' 85' ' ' VAL . 60.2 tp -78.23 -56.55 4.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -48.97 -31.29 7.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -43.87 68.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -36.09 82.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.742 ' HA ' HD21 ' A' ' 31' ' ' LEU . 37.7 mm -64.84 -29.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.997 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.76 -31.38 14.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.52 68.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CE2' HG13 ' A' ' 84' ' ' VAL . 15.3 m-85 -80.01 -34.46 38.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.35 59.0 1.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.641 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -122.66 47.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.809 179.938 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -65.69 -15.4 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.308 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.71 -2.34 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -113.13 -59.1 2.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 179.853 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.607 HG13 HD12 ' A' ' 26' ' ' ILE . 30.1 mm -79.95 120.29 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.719 ' CE2' HG21 ' A' ' 3' ' ' ILE . 63.3 m-85 -116.03 -56.23 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.571 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HB2' ' CB ' ' A' ' 69' ' ' GLN . 1.8 mm100 -112.95 156.17 23.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.247 0.546 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.816 HG22 HG23 ' A' ' 68' ' ' ILE . 24.8 t -154.89 79.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.137 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.853 HD21 HD11 ' A' ' 118' ' ' LEU . 3.5 mm? -87.29 157.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.518 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 40' ' ' ILE . 16.1 tt -111.15 120.37 43.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.926 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 30.6 Cg_endo -64.64 80.6 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.545 2.163 . . . . 0.0 112.877 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.445 HG23 HG12 ' A' ' 40' ' ' ILE . 11.4 p -131.0 146.05 52.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.823 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -95.82 169.35 10.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.113 -179.787 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -138.52 110.75 7.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.684 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.784 HG23 HG23 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -109.01 128.92 64.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.307 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 55' ' ' GLU . 7.6 p -155.38 105.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.906 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -118.45 143.43 46.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -149.75 164.84 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 -70.36 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.903 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -172.53 162.85 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.86 -103.54 2.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.531 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.07 31.1 0.31 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -109.5 127.2 54.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.924 0.393 . . . . 0.0 110.834 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -132.05 139.88 48.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -125.08 124.22 41.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.99 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.02 93.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.784 HG23 HG23 ' A' ' 45' ' ' VAL . 16.2 m -137.0 163.04 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -125.77 134.37 51.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.074 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.57 120.33 33.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.751 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.08 122.46 11.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.837 HD11 HG11 ' A' ' 115' ' ' VAL . 20.9 mt -80.64 -51.05 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.4 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 33.1 m-85 -111.11 89.65 10.18 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 37.9 Cg_endo -66.69 128.39 18.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 22.87 73.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 97.1 m-85 -129.44 139.78 51.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.701 0.286 . . . . 0.0 110.984 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' A' ' 19' ' ' LYS . 4.1 tp -130.89 134.57 46.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.726 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.5 m-85 -99.85 123.9 44.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.816 HG23 HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -134.28 112.9 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 179.882 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.732 ' HG2' HD13 ' A' ' 3' ' ' ILE . 34.6 tt0 -79.95 72.64 6.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.156 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.636 ' SD ' HD11 ' A' ' 72' ' ' LEU . 15.8 ptm -91.56 -173.47 3.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.375 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.717 ' CA ' HG22 ' A' ' 3' ' ' ILE . 32.8 t0 -119.22 99.64 6.83 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.922 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.636 HD11 ' SD ' ' A' ' 70' ' ' MET . 54.1 mt -129.15 6.51 5.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.31 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.93 64.94 1.21 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.525 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.55 114.49 27.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 110.933 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -58.78 -29.33 66.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.958 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.22 -69.02 0.65 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 110.989 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -159.35 157.48 27.2 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.908 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.6 151.88 72.63 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.662 2.241 . . . . 0.0 112.176 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.402 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . 1.3 m-80 -69.11 -175.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.86 -27.58 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.945 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.03 -29.02 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.345 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.81 -34.72 62.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -68.02 -31.5 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 88' ' ' THR . 21.7 t -76.99 -45.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.214 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 81' ' ' ALA . 37.9 t -59.01 -40.25 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.72 -12.97 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.325 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.95 -15.66 12.64 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.805 ' O ' HG22 ' A' ' 91' ' ' ILE . 40.2 p -57.4 112.01 4.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.736 0.268 . . . . 0.0 110.984 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.62 121.43 7.92 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.373 2.049 . . . . 0.0 112.299 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.26 -19.57 17.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.692 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -79.81 125.39 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 179.978 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -94.59 -29.65 14.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.63 -177.43 42.06 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.446 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.44 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 10.3 p90 -60.6 142.01 56.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 0.0 110.999 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.677 HG13 ' CB ' ' A' ' 9' ' ' HIS . 12.9 m -56.74 -32.81 39.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.191 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.64 -142.52 13.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.367 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.3 29.98 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.853 0.359 . . . . 0.0 111.122 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.51 -156.06 25.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.493 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.39 -67.8 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.795 0.331 . . . . 0.0 110.823 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -67.28 158.34 82.16 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.12 172.63 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.97 80.04 1.66 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.413 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.414 ' HB3' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_endo -77.87 139.76 17.77 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.537 2.158 . . . . 0.0 112.265 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.628 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.6 OUTLIER -84.96 130.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.846 179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.907 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -64.32 150.26 93.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.84 -40.0 57.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.577 2.185 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -31.24 72.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -87.64 -34.32 18.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.924 HG11 ' CD1' ' A' ' 5' ' ' TRP . 22.8 t -61.9 -31.73 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.303 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -64.33 -29.97 71.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.5 t60 -74.36 -47.4 34.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.806 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.726 HD12 ' CD2' ' A' ' 67' ' ' PHE . 17.1 pt -69.8 -27.38 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.033 HD22 HD12 ' A' ' 118' ' ' LEU . 14.2 mt -74.85 -34.28 62.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -70.23 -32.5 70.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.594 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.837 HG11 HD11 ' A' ' 61' ' ' LEU . 22.5 t -81.83 -33.3 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -61.32 -63.63 1.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.586 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 145.44 44.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.698 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.033 HD12 HD22 ' A' ' 113' ' ' LEU . 12.6 mt -121.59 -45.44 2.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.749 0.309 . . . . 0.0 110.92 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.22 30.33 2.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.33 -1.261 . . . . 0.0 112.475 -179.957 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.922 0.391 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.698 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -137.14 -171.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.795 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.21 160.3 43.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.165 0.507 . . . . 0.0 111.88 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.896 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 90.0 m95 -93.96 119.8 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.774 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.964 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 22.3 m-85 -114.3 105.64 13.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.441 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -99.14 169.09 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.097 0.475 . . . . 0.0 111.724 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.649 HG11 HD12 ' A' ' 91' ' ' ILE . 2.4 p -156.26 161.41 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.57 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.606 ' CE1' ' CG2' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -93.43 157.07 16.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.108 -179.672 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p -150.35 -176.54 5.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.09 145.79 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.16 129.55 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.2 -23.97 31.0 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.618 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.68 -19.62 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.569 0.223 . . . . 0.0 111.167 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.45 -38.45 66.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.7 -36.61 72.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.947 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -24.83 21.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.025 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.24 -38.1 89.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -61.2 -35.15 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 -41.89 34.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.65 -34.88 73.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HG21 ' A' ' 88' ' ' THR . 36.8 tp -77.31 -53.01 8.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.09 -35.37 59.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -63.42 -42.11 98.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.682 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HD3' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -66.17 -38.15 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 179.8 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.8 HG23 ' HB2' ' A' ' 31' ' ' LEU . 46.7 mm -64.06 -33.26 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -89.8 -33.81 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -40.4 77.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.07 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' CE2' ' HG3' ' A' ' 25' ' ' ARG . 29.3 m-85 -92.32 -24.81 18.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 88.07 78.29 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.404 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.8 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.9 mm? -123.18 35.26 4.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.89 16.21 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.478 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.8 -12.88 15.71 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.52 0.2 . . . . 0.0 111.115 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 2.3 mptt -116.28 -44.23 2.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.321 . . . . 0.0 111.125 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.675 HD11 HG22 ' A' ' 38' ' ' VAL . 19.4 tt -82.2 153.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.195 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.661 ' CE2' HG21 ' A' ' 3' ' ' ILE . 28.9 m-85 -143.23 -52.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.431 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.9 mt-30 -120.33 146.52 46.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 111.108 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.706 HG22 HG23 ' A' ' 68' ' ' ILE . 3.5 t -143.22 70.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.222 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.896 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -88.69 143.59 26.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.576 -179.121 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 42' ' ' THR . 4.9 tt -108.58 123.58 36.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.231 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 14.0 Cg_endo -57.84 87.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.659 2.24 . . . . 0.0 112.894 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.512 HG23 HG12 ' A' ' 40' ' ' ILE . 76.2 p -139.93 117.77 11.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.776 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' CD ' HD21 ' A' ' 61' ' ' LEU . 7.6 tt0 -81.98 172.13 13.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.001 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.88 135.18 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 46' ' ' VAL . 11.4 t -121.23 158.95 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' N ' HG12 ' A' ' 45' ' ' VAL . 21.4 t -149.26 118.41 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -80.22 -51.16 9.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.667 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD13 ' N ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -140.77 129.06 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.778 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.708 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -113.29 104.0 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.06 100.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.917 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.17 -90.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.564 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.62 -28.02 3.37 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.556 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -149.94 166.54 29.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -139.19 120.56 14.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -148.77 122.86 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 56' ' ' VAL . 11.0 p -130.58 121.1 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.011 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.3 t -119.63 159.85 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.165 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.478 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -130.16 116.07 17.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -104.88 123.23 47.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.946 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -58.07 108.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.057 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.891 HD11 ' CG1' ' A' ' 115' ' ' VAL . 39.6 mt -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.474 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 3.3 m-85 -132.56 88.4 38.97 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.623 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.22 108.4 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.763 2.309 . . . . 0.0 112.857 -179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 47.82 9.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.848 179.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.444 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 62.6 m-85 -144.96 145.15 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.593 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.3 pp -150.61 120.27 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.413 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.963 ' CD2' HD13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -96.25 126.88 41.77 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 111.366 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -119.13 121.53 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.579 179.73 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -79.87 78.9 6.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.362 . . . . 0.0 110.712 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 72' ' ' LEU . 20.3 ptp -91.0 -175.71 4.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.244 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 5.9 t0 -122.17 77.88 1.44 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.964 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 19.9 mt -95.21 -29.39 14.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.938 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.47 81.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.39 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -154.96 -66.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.991 0.424 . . . . 0.0 110.809 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.35 173.55 6.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.825 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.6 -17.07 60.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -139.71 96.37 8.51 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.09 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.38 104.74 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.666 2.244 . . . . 0.0 112.218 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.2 -167.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.7 OUTLIER 56.47 -85.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.52 179.609 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.823 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.41 -44.95 69.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.591 -179.478 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.411 ' HA ' ' CE3' ' A' ' 82' ' ' TRP . 2.0 t-105 -74.81 -30.51 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.119 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.94 -30.16 69.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.748 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 80' ' ' GLU . 23.1 t -84.57 -48.7 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.045 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 81' ' ' ALA . 36.8 t -59.72 -49.61 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.48 -22.41 66.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.247 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.38 -22.45 24.47 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.83 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.632 HG22 ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -65.24 145.73 99.04 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 110.93 -179.878 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.77 -25.59 28.37 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.469 2.113 . . . . 0.0 112.301 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.38 -28.17 54.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.649 HD12 HG11 ' A' ' 8' ' ' VAL . 35.6 mm -89.06 126.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 110.847 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 m -164.03 66.13 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.84 -95.37 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.56 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 91' ' ' ILE . 13.1 m-85 62.49 138.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 0.0 110.76 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.752 HG23 HG21 ' A' ' 102' ' ' VAL . 39.6 t -79.68 141.38 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.2 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.95 -24.87 61.0 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.702 ' H ' HG12 ' A' ' 95' ' ' VAL . . . -55.81 98.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.333 . . . . 0.0 111.151 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.34 -92.93 1.8 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.469 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.2 mmt -117.18 169.16 9.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 110.955 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 1.3 mmp_? -62.44 -57.21 23.93 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.192 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.4 Cg_endo -59.46 152.61 60.23 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.437 2.091 . . . . 0.0 112.064 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.752 HG21 HG23 ' A' ' 95' ' ' VAL . 5.7 t -120.35 82.18 31.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.191 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.3 115.6 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.38 2.053 . . . . 0.0 112.091 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -70.57 149.01 47.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.994 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.896 ' O ' HG23 ' A' ' 109' ' ' VAL . 56.3 m -87.49 148.31 43.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.88 -37.1 54.95 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.764 2.309 . . . . 0.0 112.458 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -68.93 -29.41 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 112' ' ' ILE . 3.5 tt0 -91.48 -32.18 15.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 105' ' ' SER . 24.3 t -64.28 -36.67 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.113 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.411 ' HG3' HD13 ' A' ' 119' ' ' LEU . 2.5 ttt-85 -69.48 -30.73 68.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.942 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.665 ' O ' HG23 ' A' ' 115' ' ' VAL . 7.9 t-80 -77.91 -42.36 33.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.728 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.963 HD13 ' CD2' ' A' ' 67' ' ' PHE . 1.9 pp -74.89 -29.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.884 ' CD2' HD12 ' A' ' 118' ' ' LEU . 19.0 mt -75.34 -30.68 60.33 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.493 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.12 -27.78 64.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.195 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.891 ' CG1' HD11 ' A' ' 61' ' ' LEU . 2.1 t -88.23 -50.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.785 0.326 . . . . 0.0 111.34 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.698 ' CB ' HD23 ' A' ' 39' ' ' LEU . 33.8 t -52.92 -63.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.836 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.904 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 142.21 48.68 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.843 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.904 HD23 ' O ' ' A' ' 117' ' ' GLY . 15.7 mt -133.17 5.77 3.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.47 0.176 . . . . 0.0 111.455 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.411 HD13 ' HG3' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -135.84 40.69 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.874 0.368 . . . . 0.0 110.809 179.931 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.396 -1.225 . . . . 0.0 112.531 -179.987 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.788 0.328 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 69' ' ' GLN . 2.7 pp -125.9 168.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.954 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -142.7 169.8 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 112.21 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.664 ' HH2' HD23 ' A' ' 39' ' ' LEU . 87.8 m95 -94.05 91.55 6.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.462 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.688 ' O ' HD12 ' A' ' 68' ' ' ILE . 63.3 m-85 -79.96 116.12 19.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 110.647 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.73 151.5 19.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.709 -179.333 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -134.51 159.95 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.563 179.671 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.562 ' CG ' HG13 ' A' ' 95' ' ' VAL . 2.5 m80 -110.56 87.36 2.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.5 p -83.73 -174.35 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.794 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.72 134.02 34.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 12' ' ' VAL . 4.9 m -60.47 104.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.61 -30.45 5.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.405 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -92.79 -19.63 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.587 0.232 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.03 -40.73 64.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 111.005 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.32 -37.24 69.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.828 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -89.84 -26.22 20.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.981 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.16 86.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -59.45 -48.01 83.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.88 74.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -60.22 -32.62 71.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.769 HD12 HG21 ' A' ' 88' ' ' THR . 8.8 tp -78.3 -56.1 4.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.728 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -29.41 2.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.294 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -46.52 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -33.15 68.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.59 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.498 HG23 ' HB2' ' A' ' 31' ' ' LEU . 34.3 mm -75.16 -25.21 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -97.78 -29.95 13.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.41 -40.79 64.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.989 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -79.99 -25.34 40.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.39 51.55 1.7 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.595 HD11 ' CG ' ' A' ' 80' ' ' GLU . 3.4 mm? -104.48 31.9 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.59 9.78 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -104.01 -21.71 13.57 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.711 0.291 . . . . 0.0 111.025 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HG3' HD12 ' A' ' 31' ' ' LEU . 2.2 mtpt -96.46 -51.23 4.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.677 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pt -79.82 151.25 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.765 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.717 ' HE2' HG21 ' A' ' 3' ' ' ILE . 56.4 m-85 -141.72 -44.96 0.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.344 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 2.6 mt-30 -129.52 158.33 39.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.221 0.534 . . . . 0.0 112.035 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 68' ' ' ILE . 20.8 t -154.97 82.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.114 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.85 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.5 mm? -92.65 157.94 16.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.62 -179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.16 124.08 32.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.753 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 37.5 Cg_endo -66.83 81.1 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.586 2.191 . . . . 0.0 112.855 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.588 HG22 ' HG2' ' A' ' 60' ' ' LYS . 15.9 p -139.04 141.11 38.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.683 ' HG3' HG13 ' A' ' 115' ' ' VAL . 53.0 tt0 -117.29 160.86 20.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.968 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.26 134.81 54.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.806 179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.559 HG13 ' HG2' ' A' ' 59' ' ' LYS . 27.0 m -124.66 135.01 65.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 56' ' ' VAL . 20.5 t -145.89 85.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.145 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -80.28 152.25 29.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mt -97.97 164.47 12.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -149.05 108.46 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 100.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.944 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.92 31.64 69.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.517 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.8 -104.09 2.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.96 143.72 14.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -101.78 149.56 24.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -158.99 140.02 12.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG12 HG22 ' A' ' 46' ' ' VAL . 12.4 m -116.7 131.16 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.048 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.7 t -147.73 159.82 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.472 ' N ' HG12 ' A' ' 57' ' ' VAL . 77.1 mtt85 -105.98 140.19 39.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.559 ' HG2' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -122.23 107.1 11.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 179.953 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.588 ' HG2' HG22 ' A' ' 42' ' ' THR . 9.4 mtmm -59.93 115.62 3.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.852 ' CD1' HG11 ' A' ' 115' ' ' VAL . 37.4 mt -72.93 -44.98 60.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.74 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 41.0 m-85 -119.28 88.26 37.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.616 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.08 136.62 53.07 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.493 2.128 . . . . 0.0 112.313 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.83 22.1 69.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.547 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.19 127.95 52.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.824 0.345 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 124.86 45.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.608 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.978 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.4 m-85 -93.19 123.63 36.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.1 mp -129.42 110.42 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.454 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.904 ' HG2' HD13 ' A' ' 3' ' ' ILE . 30.4 tt0 -79.81 72.24 6.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.091 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.595 ' SD ' HD11 ' A' ' 72' ' ' LEU . 25.1 ptp -92.02 -176.85 4.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.851 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.577 ' HA ' HG22 ' A' ' 3' ' ' ILE . 14.5 t0 -118.27 99.23 6.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.703 179.382 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.595 HD11 ' SD ' ' A' ' 70' ' ' MET . 80.2 mt -122.91 7.16 9.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.337 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.17 63.03 2.54 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.444 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -98.76 -178.07 3.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.3 -68.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.01 0.433 . . . . 0.0 110.939 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.65 -78.81 0.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.025 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -138.29 166.52 25.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 169.87 17.43 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.482 2.121 . . . . 0.0 112.292 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.38 -165.78 1.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.5 pt-20 -57.64 -21.46 39.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -47.88 -44.78 29.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.412 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -68.94 -35.42 76.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.41 -30.19 68.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 88' ' ' THR . 22.9 t -79.24 -51.51 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.5 t -59.84 -46.31 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -26.83 66.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.71 -27.28 57.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.621 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.769 HG21 HD12 ' A' ' 22' ' ' LEU . 45.7 p -59.89 142.91 88.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.682 0.277 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.87 -13.93 21.6 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.533 2.155 . . . . 0.0 112.627 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.64 -6.41 65.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.047 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.889 HD13 ' O ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -79.94 -31.97 13.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.941 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 67.75 -68.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.19 58.69 0.19 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.374 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 63.14 176.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.562 HG13 ' CG ' ' A' ' 9' ' ' HIS . 30.3 m -61.89 -30.08 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.192 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.61 39.96 0.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.16 -29.39 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 111.064 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.73 48.62 4.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.429 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.91 149.79 38.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.348 . . . . 0.0 110.941 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.82 154.31 67.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 112.78 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.511 2.141 . . . . 0.0 112.004 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.95 123.68 62.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.17 148.55 10.44 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.764 2.309 . . . . 0.0 112.202 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -77.8 141.56 39.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.852 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.9 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -77.62 157.66 79.53 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.948 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.1 -35.62 95.19 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.589 2.193 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.44 -29.54 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -87.03 -36.46 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 105' ' ' SER . 39.8 t -60.72 -51.98 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 HD21 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -56.11 -29.56 60.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -53.79 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.576 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.978 HD12 ' CD2' ' A' ' 67' ' ' PHE . 18.9 pt -66.2 -25.07 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.732 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.861 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.9 mp -71.67 -38.07 70.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.486 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -30.56 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.704 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.852 HG11 ' CD1' ' A' ' 61' ' ' LEU . 21.8 t -83.39 -40.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.042 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.85 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.9 m -58.93 -62.02 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.566 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 144.73 48.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.526 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.861 HD12 ' HG ' ' A' ' 113' ' ' LEU . 27.8 mt -124.12 -45.26 2.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.995 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.42 HD21 HH11 ' A' ' 110' ' ' ARG . 0.1 OUTLIER -98.48 29.85 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.395 179.988 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.826 0.346 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -117.52 170.74 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.852 179.792 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -153.3 161.9 41.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.826 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.632 ' CZ2' HD11 ' A' ' 113' ' ' LEU . 68.2 m95 -88.49 92.71 9.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.661 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.841 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 67.0 m-85 -87.99 114.12 24.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -100.77 147.49 26.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.525 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 9' ' ' HIS . 16.1 t -127.93 160.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.497 ' CE1' ' CE2' ' A' ' 65' ' ' TYR . 3.2 m-70 -114.72 156.58 24.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -156.63 -174.74 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 145.8 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.48 130.5 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.42 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -94.01 -22.05 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 0.0 111.066 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -53.65 -43.78 69.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -33.51 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -80.87 -31.06 35.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.54 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -60.31 -37.67 81.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.973 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.68 -53.76 42.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -30.33 69.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.535 HD11 HG22 ' A' ' 85' ' ' VAL . 31.5 tp -76.3 -56.53 4.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -48.76 -30.33 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -38.4 61.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.56 ' HG3' HG22 ' A' ' 88' ' ' THR . 21.9 mmt180 -73.67 -37.35 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.569 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.836 HD12 HD11 ' A' ' 31' ' ' LEU . 41.4 mm -72.92 -28.05 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.987 179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -89.63 -32.8 16.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.773 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -39.55 79.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.993 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.98 -37.29 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.83 41.71 5.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.836 HD11 HD12 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -99.52 51.18 0.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.79 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.3 -5.15 43.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.4 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -79.69 -24.27 41.85 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.824 179.939 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -94.3 -52.17 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.9 mt -95.16 111.61 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.5 m-85 -102.46 -60.23 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.382 -179.451 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.39 130.03 49.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 -179.146 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.8 p -126.07 72.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.497 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.688 HD23 ' OG ' ' A' ' 116' ' ' SER . 2.5 tm? -83.64 133.47 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.945 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' THR . 0.1 OUTLIER -109.22 124.51 33.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.925 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 88.1 Cg_exo -49.19 77.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.138 2.559 . . . . 0.0 113.305 -179.652 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 40' ' ' ILE . 36.8 p -158.64 152.33 23.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.775 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.621 ' OE2' HD21 ' A' ' 61' ' ' LEU . 5.2 mm-40 -96.44 156.22 16.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.855 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.17 133.79 28.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.758 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 45' ' ' VAL . 15.4 m -126.35 116.09 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.184 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.666 HG13 ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -102.48 -161.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.534 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.666 ' N ' HG13 ' A' ' 46' ' ' VAL . 7.4 tt0 -79.49 143.33 35.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 110.722 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.28 -171.37 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.009 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.86 80.5 1.49 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.883 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -124.3 -54.46 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.59 36.32 0.22 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.429 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.72 27.49 8.99 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.551 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.93 139.12 49.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.895 0.378 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' CB ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -158.98 147.29 18.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -129.5 148.53 51.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.04 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 57' ' ' VAL . 7.9 m -142.91 82.39 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 56' ' ' VAL . 5.4 m -159.45 -179.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.26 169.57 17.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.3 tptt -141.23 -165.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.742 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -139.82 113.53 8.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 115' ' ' VAL . 3.6 mt -85.26 -47.76 9.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CE1' HG22 ' A' ' 112' ' ' ILE . 7.6 m-85 -135.99 84.36 31.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.584 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.79 141.93 92.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.496 -179.643 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.86 77.81 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.069 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 6.2 m-85 -117.99 156.74 28.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.8 0.334 . . . . 0.0 110.953 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD12 ' C ' ' A' ' 65' ' ' TYR . 5.2 mp -150.64 107.7 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.68 ' CD1' HD11 ' A' ' 104' ' ' LEU . 4.4 m-85 -81.79 124.32 29.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.0 OUTLIER -127.86 114.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 23.7 tt0 -80.71 71.09 7.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 0.0 110.345 179.433 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.3 ptp -91.2 -175.02 4.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.434 ' OD1' HG22 ' A' ' 3' ' ' ILE . 26.6 t70 -124.32 92.02 3.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.73 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.841 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 20.3 mt -95.81 -57.8 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.63 -47.23 2.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.381 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -120.73 163.82 17.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.761 0.315 . . . . 0.0 110.759 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -112.74 -16.58 12.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.339 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -87.13 -33.17 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 0.0 111.163 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.77 94.13 17.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.17 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.7 171.64 6.79 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.687 2.258 . . . . 0.0 112.235 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 -177.25 5.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.97 -28.91 64.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.53 -41.16 69.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -59.86 -39.74 86.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.27 -40.22 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -65.45 -47.87 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.7 t -63.43 -45.33 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.091 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.413 ' HA ' HG21 ' A' ' 91' ' ' ILE . 2.1 ttt180 -60.67 -28.99 69.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.68 -31.28 56.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 25' ' ' ARG . 20.9 p -60.76 111.35 3.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.616 0.246 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.16 133.73 35.96 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.445 2.097 . . . . 0.0 112.366 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.14 -11.45 48.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.703 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.413 HG21 ' HA ' ' A' ' 86' ' ' ARG . 8.8 tp -79.96 135.71 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.22 -35.05 5.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.93 -26.73 19.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.583 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.586 ' HE1' HG21 ' A' ' 102' ' ' VAL . 18.4 t80 -174.38 169.78 3.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.404 ' N ' ' HB2' ' A' ' 9' ' ' HIS . 21.4 t -56.55 -66.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.318 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.26 55.91 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.556 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.56 -46.99 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.38 169.28 24.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.488 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -101.36 -30.6 11.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.736 0.303 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.38 154.75 77.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.13 171.58 14.6 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.205 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.586 HG21 ' HE1' ' A' ' 94' ' ' PHE . 6.4 m -142.52 101.69 5.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.187 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.79 157.84 54.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.397 2.064 . . . . 0.0 112.169 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.68 HD11 ' CD1' ' A' ' 67' ' ' PHE . 16.2 mt -89.99 163.68 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.7 p -86.67 141.38 33.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.95 -33.9 35.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.572 2.181 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.37 -41.63 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -81.58 -31.08 32.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 105' ' ' SER . 58.5 t -63.36 -43.68 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -61.25 -30.42 70.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -52.88 11.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.609 179.816 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.595 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.5 pp -66.42 -16.48 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.59 179.423 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.757 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -72.65 -36.73 68.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.316 179.173 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.52 -22.43 44.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.767 HG21 HD13 ' A' ' 61' ' ' LEU . 38.5 t -70.26 -60.93 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.688 ' OG ' HD23 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -52.49 -53.66 42.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.42 38.17 0.42 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.545 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.757 HD12 ' HG ' ' A' ' 113' ' ' LEU . 2.7 mt -100.06 0.62 41.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.591 0.234 . . . . 0.0 111.366 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 113' ' ' LEU . 2.8 mp -131.4 -63.02 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.385 -1.23 . . . . 0.0 112.438 -179.959 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.83 0.347 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.819 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -131.51 174.65 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.813 179.958 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 103' ' ' PRO . 2.1 mt-10 -139.91 163.71 31.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.416 0.627 . . . . 0.0 112.294 -179.318 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.872 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 74.7 m95 -91.09 92.21 8.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.583 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.548 ' O ' HD12 ' A' ' 68' ' ' ILE . 64.9 m-85 -79.8 107.61 12.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.895 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -87.0 146.66 26.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -146.55 177.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.555 179.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.499 ' CE1' ' O ' ' A' ' 94' ' ' PHE . 0.5 OUTLIER -122.48 160.7 25.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.126 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -136.83 158.79 43.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.622 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.26 127.43 27.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.3 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -63.66 128.73 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.852 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.68 -30.63 8.56 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.205 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -97.36 -9.41 27.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 0.0 110.96 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.8 -39.04 4.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 111.238 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -54.94 -44.17 74.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.33 34.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.76 85.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.067 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.0 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.73 -50.97 8.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.099 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.04 -34.86 72.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.639 HD11 HG13 ' A' ' 85' ' ' VAL . 41.3 tp -71.98 -56.96 4.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -33.34 60.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -67.88 -40.9 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.709 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.666 ' HG3' HG22 ' A' ' 88' ' ' THR . 2.1 mmt180 -68.0 -38.25 82.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.0 mm -69.42 -30.09 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.017 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -89.0 -33.62 17.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.62 68.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.45 -27.07 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.06 56.94 2.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.456 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -103.88 35.33 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 0.0 110.846 -179.916 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.21 -4.19 37.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.515 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.78 -28.06 40.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.839 0.352 . . . . 0.0 110.77 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -54.29 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.686 HG23 ' CG2' ' A' ' 68' ' ' ILE . 2.5 mp -86.66 94.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.657 179.557 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.819 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.8 m-85 -83.01 -50.05 8.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.486 ' HB3' ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -115.67 138.94 50.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.166 0.508 . . . . 0.0 111.705 -179.207 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.39 138.56 26.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.459 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.872 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -160.23 155.56 25.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 111.356 -179.731 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.47 ' N ' HD22 ' A' ' 39' ' ' LEU . 14.9 tt -114.6 128.26 26.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 11.2 Cg_endo -55.71 80.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.673 2.248 . . . . 0.0 112.8 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 41' ' ' PRO . 36.6 p -159.87 142.64 13.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.48 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.731 ' HG2' HG13 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -79.82 145.13 32.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.422 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.28 121.34 12.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.036 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 45' ' ' VAL . 14.1 m -144.02 117.23 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.797 179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.4 p -159.98 62.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.034 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -152.82 169.41 22.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -94.38 137.11 33.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -155.78 -46.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -95.48 86.68 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.39 -124.13 34.04 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.32 50.53 0.79 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.542 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.63 151.84 23.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.919 0.39 . . . . 0.0 110.85 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 125.47 37.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.65 115.07 11.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 56' ' ' VAL . 9.2 p -122.97 99.88 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 56' ' ' VAL . 19.3 m -156.92 174.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.557 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 -142.82 150.48 40.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.737 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -130.28 105.1 7.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.735 179.956 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -63.72 115.19 4.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.832 ' CD1' HG21 ' A' ' 115' ' ' VAL . 37.9 mt -90.09 -39.82 12.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.204 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 1.4 m-85 -131.4 95.49 23.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.917 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.16 133.22 48.54 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.527 2.152 . . . . 0.0 112.145 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.54 23.29 62.56 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.793 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.669 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.2 m-85 -116.49 154.07 31.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -160.49 130.92 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.72 179.802 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.782 ' HD2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.13 142.72 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.557 179.618 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.686 ' CG2' HG23 ' A' ' 35' ' ' ILE . 2.7 mp -138.32 122.36 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.393 -179.644 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 27.4 tt0 -79.81 65.17 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 110.256 179.43 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.781 ' SD ' HD23 ' A' ' 72' ' ' LEU . 11.6 ptp -91.77 -169.34 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' CG ' HG22 ' A' ' 3' ' ' ILE . 5.2 t0 -148.62 80.49 1.44 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.81 179.64 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.781 HD23 ' SD ' ' A' ' 70' ' ' MET . 4.1 pp -113.53 -31.16 6.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.166 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -45.89 94.77 0.01 OUTLIER Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.917 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.44 7.7 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.587 0.232 . . . . 0.0 111.442 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.56 -65.84 0.31 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.96 0.409 . . . . 0.0 111.023 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.85 -69.82 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.139 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -158.94 153.16 19.96 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.91 177.96 7.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -90.07 -179.98 5.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.2 tp10 -61.33 -24.35 66.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.187 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.28 -47.39 72.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.343 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.452 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -59.31 -42.36 91.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.967 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -59.98 -32.21 70.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 31' ' ' LEU . 24.1 t -82.58 -49.17 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.6 t -59.91 -51.28 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.982 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -66.35 -25.76 66.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.072 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.97 -32.64 63.27 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.701 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 25' ' ' ARG . 81.7 p -61.78 143.69 93.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 91.18 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.42 -36.41 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.451 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.71 122.47 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.4 p -143.84 30.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.26 108.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.499 ' O ' ' CE1' ' A' ' 9' ' ' HIS . 26.2 t80 -156.2 39.92 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 95' ' ' VAL . 14.2 p -90.04 10.93 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.517 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.97 -44.98 2.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.42 68.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.21 -76.23 0.41 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.601 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 mmt -124.37 -43.57 2.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 0.0 110.953 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.19 118.81 70.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.0 Cg_exo -53.99 -171.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.492 2.128 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.472 ' HB ' HG21 ' A' ' 95' ' ' VAL . 43.5 t -150.6 115.46 3.29 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.281 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 4' ' ' GLU . 15.6 Cg_exo -68.0 145.06 66.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.465 2.11 . . . . 0.0 112.068 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.1 mp -86.29 159.1 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 69.6 m -89.54 141.66 28.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.66 -37.14 26.74 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 112.574 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -48.74 80.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.07 -33.97 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 62.3 t -58.5 -50.5 78.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.91 -37.95 54.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.224 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.459 ' O ' HG23 ' A' ' 115' ' ' VAL . 3.0 m-70 -68.4 -52.69 30.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.669 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.748 HD12 ' CD2' ' A' ' 67' ' ' PHE . 27.5 pt -66.36 -26.11 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.835 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.746 ' HG ' HD12 ' A' ' 118' ' ' LEU . 3.2 mp -73.83 -41.16 62.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -23.41 65.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.832 HG21 ' CD1' ' A' ' 61' ' ' LEU . 33.9 t -76.59 -59.09 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.7 ' HB2' HD23 ' A' ' 39' ' ' LEU . 1.5 t -59.4 -57.03 14.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.546 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.03 63.13 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.914 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.746 HD12 ' HG ' ' A' ' 113' ' ' LEU . 12.6 mt -133.46 5.62 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.514 0.197 . . . . 0.0 111.441 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.34 -36.38 11.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.412 -179.941 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.837 0.351 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.724 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -139.39 -170.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.932 179.873 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.76 150.13 50.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.276 0.56 . . . . 0.0 111.971 -179.278 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.699 ' CD1' HG11 ' A' ' 109' ' ' VAL . 71.8 m95 -99.75 110.14 22.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.529 179.349 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 30.3 m-85 -99.67 137.08 38.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 0.0 110.722 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . -111.49 146.75 36.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.033 0.444 . . . . 0.0 111.861 -179.407 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.5 OUTLIER -137.3 159.31 35.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.191 179.583 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -119.58 126.28 50.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.914 -179.857 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -132.06 -177.22 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 141.07 35.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -58.28 114.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.021 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.76 -34.05 5.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.295 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.41 -30.02 37.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 110.762 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.18 -39.15 66.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.12 -41.18 83.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -81.01 -26.69 36.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.61 56.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.152 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -35.44 74.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.81 -57.2 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.94 -36.29 82.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.488 HD11 HG22 ' A' ' 85' ' ' VAL . 59.6 tp -70.09 -47.87 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.765 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.707 ' O ' HG22 ' A' ' 26' ' ' ILE . 31.3 mt-10 -59.33 -22.13 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -45.97 14.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.877 0.37 . . . . 0.0 110.296 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -68.35 -24.46 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.4 tp -70.94 -28.07 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -97.39 -31.3 12.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.23 74.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -79.93 -25.61 40.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.987 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 30.19 6.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.287 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.6 mt -97.04 25.38 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -24.32 66.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.75 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.85 -3.44 47.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.161 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.727 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -100.01 -67.55 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 179.813 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.681 HD12 HG21 ' A' ' 68' ' ' ILE . 28.9 mm -80.71 130.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.711 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 3' ' ' ILE . 10.4 m-85 -124.24 -50.43 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -119.46 161.48 20.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.423 0.63 . . . . 0.0 112.489 -178.522 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.564 ' O ' HD22 ' A' ' 39' ' ' LEU . 40.5 t -157.84 110.85 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.956 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 116' ' ' SER . 4.1 mm? -126.16 175.06 8.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.529 0.68 . . . . 0.0 112.292 -178.743 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 39' ' ' LEU . 9.2 pt -161.87 66.95 2.08 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.703 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 62' ' ' PHE . 9.6 Cg_endo -52.88 150.52 22.77 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.451 2.767 . . . . 0.0 114.359 -178.445 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 60' ' ' LYS . 22.3 p -125.2 152.39 44.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.139 179.207 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' OE2' HD21 ' A' ' 61' ' ' LEU . 2.7 tp10 -79.81 138.65 37.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.975 0.416 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -104.26 133.69 48.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.769 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.031 HG23 HG23 ' A' ' 57' ' ' VAL . 4.5 m -151.19 173.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.152 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.987 HG12 HG12 ' A' ' 56' ' ' VAL . 14.1 m -126.97 150.36 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.063 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -139.42 154.8 47.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.3 tp -131.79 146.7 52.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.14 174.1 7.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -42.65 94.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.63 106.71 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.474 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.32 -153.27 25.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.443 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -124.17 137.07 54.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.07 172.44 8.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.84 -168.35 1.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.758 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.987 HG12 HG12 ' A' ' 46' ' ' VAL . 4.0 m -90.08 119.03 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 1.031 HG23 HG23 ' A' ' 45' ' ' VAL . 9.1 m -89.94 159.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -140.06 139.13 35.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.46 141.73 51.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.711 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.0 OUTLIER -47.21 132.97 12.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.274 -179.909 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.602 HD21 ' OE2' ' A' ' 43' ' ' GLU . 1.1 mt -90.39 -58.82 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 179.541 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 51.9 m-85 -113.04 64.39 0.88 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.777 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.2 135.46 54.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.562 2.175 . . . . 0.0 112.168 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.91 6.2 72.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 4.7 m-85 -113.69 126.72 55.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.82 116.62 32.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.784 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.758 ' CD2' HD12 ' A' ' 112' ' ' ILE . 14.0 m-30 -90.27 95.3 10.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.681 HG21 HD12 ' A' ' 35' ' ' ILE . 4.1 mt -95.25 113.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.279 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.662 HE21 ' HE1' ' A' ' 5' ' ' TRP . 35.1 tt0 -83.21 68.63 9.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.744 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.577 ' HE2' ' HG ' ' A' ' 72' ' ' LEU . 1.9 ptt? -91.45 -165.49 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.473 179.501 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -149.43 84.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.895 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.585 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 44.0 mt -79.94 -35.11 38.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.72 104.96 0.11 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.497 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.87 167.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.17 32.14 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.813 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -76.91 -78.66 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -145.85 108.89 4.37 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.92 159.32 2.51 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.414 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -90.05 -169.96 2.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 84' ' ' VAL . 34.0 tt0 -54.88 -23.58 19.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.727 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . . . -52.62 -52.46 55.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.198 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 -58.06 -30.8 66.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -71.9 -31.03 66.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.798 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 31' ' ' LEU . 29.9 t -83.37 -51.41 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.948 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.4 t -57.22 -41.98 79.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.478 ' HA ' HG21 ' A' ' 91' ' ' ILE . 1.3 ttt180 -71.87 -22.76 61.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.16 -17.79 64.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.945 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.443 HG21 HD13 ' A' ' 22' ' ' LEU . 73.9 p -58.97 139.32 87.32 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.744 0.272 . . . . 0.0 110.95 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.36 105.48 2.05 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.464 2.109 . . . . 0.0 112.239 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.24 -17.09 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.725 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.643 HD13 ' N ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -80.03 128.47 38.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 -179.881 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.439 ' N ' HD13 ' A' ' 91' ' ' ILE . 38.5 m -103.63 -28.38 11.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.643 ' N ' HD13 ' A' ' 91' ' ' ILE . . . 96.58 -56.24 1.4 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.262 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 101' ' ' PRO . 8.5 m-85 -155.39 175.94 13.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.0 110.669 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.99 -67.72 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.404 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.62 78.66 0.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.653 -0.785 . . . . 0.0 112.542 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -175.85 162.55 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.24 91.49 0.58 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.503 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.32 -173.46 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.97 0.414 . . . . 0.0 110.908 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -78.68 162.12 66.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.912 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.419 ' HA ' ' CE2' ' A' ' 94' ' ' PHE . 78.5 Cg_exo -49.74 175.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.5 p -132.56 79.33 65.09 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.853 0.358 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.98 146.1 22.82 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.548 2.165 . . . . 0.0 111.973 179.642 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.672 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -85.05 163.87 18.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.753 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -89.76 150.49 44.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.5 -27.31 7.25 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.638 2.225 . . . . 0.0 112.503 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.85 -46.85 17.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.96 -30.64 63.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 105' ' ' SER . 50.4 t -62.86 -55.18 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.506 ' HD2' HD11 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -55.54 -24.95 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.151 -179.898 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -77.96 -44.87 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.779 179.89 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.758 HD12 ' CD2' ' A' ' 67' ' ' PHE . 27.4 pt -72.43 -28.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.966 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.69 HD22 HD12 ' A' ' 118' ' ' LEU . 25.9 mt -76.24 -30.78 58.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.65 -32.5 69.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.495 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' HIS . 25.5 t -84.19 -26.42 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.808 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.861 ' HB2' HD12 ' A' ' 39' ' ' LEU . 20.4 p -68.4 -43.25 77.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.63 4.24 3.95 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.164 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.69 HD12 HD22 ' A' ' 113' ' ' LEU . 34.8 mt -80.0 -58.48 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.91 0.355 . . . . 0.0 110.728 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.506 HD11 ' HD2' ' A' ' 110' ' ' ARG . 71.3 mt -95.07 -29.13 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.493 179.978 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.705 0.288 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.712 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.47 -168.1 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.909 179.968 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.0 152.18 49.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.161 0.505 . . . . 0.0 111.855 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.893 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 73.0 m95 -97.58 96.76 8.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.637 179.575 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.976 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 27.1 m-85 -86.86 123.62 32.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 110.728 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -106.39 159.67 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.568 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 91' ' ' ILE . 10.6 t -141.49 160.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.634 ' NE2' HG22 ' A' ' 95' ' ' VAL . 14.0 m-70 -88.9 134.88 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.98 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 p -139.4 160.98 38.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.13 151.13 21.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.49 127.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -25.51 24.54 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.31 -26.9 19.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.71 0.291 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' HB2' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -56.52 -41.22 76.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.96 -37.84 67.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.973 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -86.71 -29.82 22.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.841 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.19 83.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.024 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.79 -43.58 94.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.54 -42.91 28.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.32 -31.51 69.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 88' ' ' THR . 21.1 tp -82.87 -57.6 3.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.35 -45.31 17.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.439 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -61.11 -41.91 97.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -43.23 91.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.661 HG23 ' HB2' ' A' ' 31' ' ' LEU . 35.7 mm -64.39 -28.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.855 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -91.41 -29.72 16.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 -46.46 30.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.339 -179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -79.95 -21.63 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.207 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.13 65.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.176 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.661 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.8 mm? -115.08 26.65 9.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.301 . . . . 0.0 111.154 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -80.19 22.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.38 -21.45 13.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.696 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.2 -48.01 2.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.9 mp -79.86 128.28 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.671 ' CE2' HG21 ' A' ' 3' ' ' ILE . 33.0 m-85 -115.3 -56.74 2.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.424 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -115.83 170.02 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 68' ' ' ILE . 34.7 t -157.79 120.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.983 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.893 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -144.58 150.3 37.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.334 0.588 . . . . 0.0 112.295 -178.533 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 pt -113.05 124.83 30.8 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.568 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' CG ' ' HB2' ' A' ' 62' ' ' PHE . 50.7 Cg_endo -68.9 85.71 0.49 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.651 2.234 . . . . 0.0 112.885 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 7.1 p -138.46 146.8 42.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.421 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -80.13 156.7 26.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.12 -179.645 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -145.45 108.08 4.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 m -109.54 126.66 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.253 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.849 HG22 HG12 ' A' ' 56' ' ' VAL . 16.5 t -143.01 144.53 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.091 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.22 166.16 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tp -103.65 147.13 27.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.694 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.72 90.02 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 63.47 -79.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.052 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.16 -55.55 5.67 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.601 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.52 -16.35 2.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.685 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 120.19 23.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.832 0.348 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.99 -178.71 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.823 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.9 131.96 34.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.758 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.849 HG12 HG22 ' A' ' 46' ' ' VAL . 3.2 m -107.03 97.52 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.274 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 58' ' ' ARG . 13.0 t -82.09 159.55 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.463 ' N ' HG12 ' A' ' 57' ' ' VAL . 4.9 mtp180 -144.92 127.28 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.959 0.409 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.557 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.3 mmtp -107.53 -172.3 2.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.396 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.51 117.55 19.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.872 0.368 . . . . 0.0 111.028 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.858 ' CD1' HG11 ' A' ' 115' ' ' VAL . 18.1 mt -87.63 -55.45 3.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.668 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 1.1 m-85 -112.3 91.47 16.45 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 127.8 27.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.475 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.39 40.78 96.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.66 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -133.42 115.28 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -124.01 121.45 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.206 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.736 ' HD2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -97.36 133.9 41.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 111.246 -179.573 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.6 mp -123.56 122.06 64.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.591 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.455 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 2.5 tt0 -79.77 75.66 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptp -90.92 -175.17 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.153 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.461 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.3 t0 -130.52 100.03 5.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.976 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 13.9 mt -108.73 -25.63 10.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.054 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.84 83.59 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.481 179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -163.81 -43.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.378 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.52 169.16 18.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.84 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -87.23 5.8 36.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.395 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -129.23 102.53 18.67 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 82' ' ' TRP . 51.0 Cg_endo -69.08 77.89 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.481 2.121 . . . . 0.0 112.203 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.9 m120 -90.24 -173.06 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 51.91 -84.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.866 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -46.94 -48.9 21.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.719 -179.719 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 6.1 t-105 -76.2 -28.87 57.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.79 -37.79 74.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 31' ' ' LEU . 21.6 t -90.06 -47.44 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 81' ' ' ALA . 57.6 t -59.56 -42.29 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.089 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.67 -19.32 62.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.306 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -120.53 22.57 8.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.611 HG21 HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -75.62 134.24 72.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.714 0.257 . . . . 0.0 110.821 179.924 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.03 -8.61 23.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.414 2.076 . . . . 0.0 112.669 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -103.82 -18.53 13.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.828 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.639 HD11 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -80.63 127.49 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.34 . . . . 0.0 111.056 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.535 ' N ' HD13 ' A' ' 91' ' ' ILE . 18.7 m -145.47 110.55 5.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.24 143.32 7.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -152.12 170.98 18.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 110.931 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.65 HG21 ' CG1' ' A' ' 102' ' ' VAL . 25.4 t -71.06 100.26 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.99 70.85 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.446 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.26 42.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.15 -99.5 2.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.414 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.6 ttm -69.61 136.39 51.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.754 0.311 . . . . 0.0 110.773 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 1.8 mtt-85 -82.04 -50.81 0.83 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 5.5 Cg_exo -74.07 116.89 4.8 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.707 2.271 . . . . 0.0 112.006 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.65 ' CG1' HG21 ' A' ' 95' ' ' VAL . 4.6 m -115.58 97.39 48.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.262 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.35 123.89 9.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.493 2.129 . . . . 0.0 112.187 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.77 HD22 HD13 ' A' ' 112' ' ' ILE . 2.2 mp -71.99 157.98 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -85.66 151.47 55.62 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 -179.935 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.13 -30.25 18.34 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.698 2.266 . . . . 0.0 112.464 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -71.45 -47.44 55.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -74.41 -31.9 62.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 48.7 t -61.18 -52.47 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -55.53 -38.46 69.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.21 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -68.79 -46.61 68.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.054 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.77 HD13 HD22 ' A' ' 104' ' ' LEU . 31.1 pt -72.53 -27.09 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.954 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.052 HD22 HD12 ' A' ' 118' ' ' LEU . 15.6 mt -79.45 -29.21 41.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -67.05 -21.76 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.925 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.858 HG11 ' CD1' ' A' ' 61' ' ' LEU . 13.7 t -86.31 -54.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.157 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.688 ' HB2' HD23 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -55.88 -60.44 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.672 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.58 64.83 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.903 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.052 HD12 HD22 ' A' ' 113' ' ' LEU . 30.4 mt -128.93 -43.78 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 0.0 110.891 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.4 tp -80.14 -63.33 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.572 -179.996 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.825 0.345 . . . . 2.74 111.237 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.615 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -141.8 -166.43 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 1.16 110.941 -179.987 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -156.07 155.79 33.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 2.07 111.507 -179.751 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.844 ' CD1' HG11 ' A' ' 109' ' ' VAL . 93.8 m95 -96.28 96.64 8.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.95 110.692 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.953 ' CE2' HD12 ' A' ' 72' ' ' LEU . 3.3 m-85 -86.17 117.35 24.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 1.43 111.029 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -92.95 147.71 22.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.72 111.144 -179.823 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.613 HG11 HD12 ' A' ' 91' ' ' ILE . 15.2 t -134.46 159.96 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 1.69 111.025 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.475 ' N ' HG12 ' A' ' 8' ' ' VAL . 10.7 m-70 -102.01 149.65 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 1.36 111.013 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.2 p -151.3 -177.6 6.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 1.11 110.86 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.0 139.4 30.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 2.2 110.908 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 12' ' ' VAL . 28.8 m -62.65 121.71 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 2.26 111.206 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.5 -28.62 12.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.787 -0.721 . . . . 1.76 112.402 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -89.68 -21.41 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 2.52 111.113 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -53.42 -36.31 61.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 2.53 111.046 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -58.68 -30.91 67.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 3.25 110.878 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.79 -30.49 18.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 2.99 110.929 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.73 87.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 1.33 111.08 -179.984 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.456 ' NZ ' HD11 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -60.42 -49.06 79.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 3.36 110.827 179.995 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.95 -46.06 72.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 1.7 111.045 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -60.25 -31.1 69.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 1.9 110.824 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.729 HD11 HG22 ' A' ' 85' ' ' VAL . 54.4 tp -81.47 -55.89 4.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 1.62 110.85 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.02 -32.91 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.236 -0.438 . . . . 2.45 111.193 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -71.02 -40.95 71.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 3.51 110.734 179.803 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.733 ' HG3' HG22 ' A' ' 88' ' ' THR . 13.5 mmt180 -68.89 -38.13 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 3.38 110.675 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.889 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.4 mm -66.76 -31.82 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 1.49 110.894 179.728 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -91.19 -29.82 17.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 3.61 110.857 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.7 -46.8 68.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 2.06 111.174 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -80.03 -28.46 39.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 2.29 111.012 179.937 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 66.01 0.98 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 1.84 112.442 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.889 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.7 mt -122.08 33.41 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 1.86 110.88 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -72.58 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 2.67 111.365 -179.975 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.87 -30.32 40.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 2.74 110.891 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 -60.33 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.325 -0.398 . . . . 2.77 110.781 179.973 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 26' ' ' ILE . 31.6 mt -82.13 128.65 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 2.11 111.094 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 3' ' ' ILE . 9.0 m-85 -118.02 -54.31 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 1.69 110.986 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.416 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -110.88 153.08 25.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.98 0.419 . . . . 1.62 111.268 -179.759 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.47 69.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 1.74 110.74 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.775 HD21 HD11 ' A' ' 118' ' ' LEU . 4.4 mm? -79.93 150.35 30.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 2.62 111.034 -179.764 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 42' ' ' THR . 18.9 mt -109.84 129.29 24.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 2.62 110.77 179.769 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 31.4 Cg_endo -63.64 73.88 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.488 2.125 . . . . 2.22 112.394 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.489 HG23 HG22 ' A' ' 40' ' ' ILE . 42.5 p -146.34 134.95 22.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 1.75 110.773 -179.993 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HA ' HG12 ' A' ' 115' ' ' VAL . 15.4 tt0 -79.98 148.2 31.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 3.05 110.873 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -126.11 113.68 17.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 4.29 110.843 179.973 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 57' ' ' VAL . 4.5 m -127.47 129.25 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 3.08 111.105 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.3 p -120.85 109.69 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 4.39 111.067 179.935 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.83 151.08 22.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 6.14 110.855 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.24 101.19 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 6.1 110.818 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.89 -177.84 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 9.32 110.913 179.931 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.52 -70.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 9.07 110.966 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.05 167.12 11.94 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 6.52 112.439 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.45 69.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.687 -0.768 . . . . 5.97 112.513 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 129.09 22.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 8.89 110.874 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.03 114.29 17.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 6.55 110.924 179.973 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -96.62 105.18 17.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 6.1 110.859 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 56' ' ' VAL . 7.5 m -91.87 99.61 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 4.18 111.22 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 45' ' ' VAL . 4.4 m -102.27 126.47 56.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 2.43 111.043 179.898 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.14 126.32 50.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 4.2 110.933 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -101.61 164.07 11.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 3.15 110.706 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -107.05 105.15 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 3.5 111.007 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.039 HD11 HG11 ' A' ' 115' ' ' VAL . 78.5 mt -72.78 -47.32 47.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 1.34 110.761 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 112' ' ' ILE . 9.9 m-85 -122.08 77.75 41.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 1.83 110.685 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.05 127.61 26.4 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.624 2.216 . . . . 1.55 112.583 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.86 52.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.84 -0.695 . . . . 1.23 112.799 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -131.24 156.42 45.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 1.92 111.016 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.46 114.34 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 1.77 110.596 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.871 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.1 m-85 -84.24 119.77 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 1.55 111.271 -179.76 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.1 mp -128.21 112.22 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.74 110.889 179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.485 ' NE2' ' CZ2' ' A' ' 5' ' ' TRP . 19.6 tt0 -79.78 75.69 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 1.77 110.521 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.558 ' CE ' HD21 ' A' ' 72' ' ' LEU . 10.3 ptm -91.59 -173.49 3.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 1.28 111.119 -179.772 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 4.3 t0 -134.07 86.71 2.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 2.09 110.929 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.953 HD12 ' CE2' ' A' ' 6' ' ' TYR . 12.9 mt -97.25 -72.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.439 -0.346 . . . . 1.69 110.806 179.69 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.94 26.72 19.46 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.848 -0.692 . . . . 2.16 112.745 179.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.93 128.7 37.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.778 0.323 . . . . 4.35 110.902 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -79.82 -44.99 19.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 6.78 110.96 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -86.74 -77.31 0.32 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.992 -0.549 . . . . 4.69 110.839 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -127.56 146.4 58.38 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.001 -0.545 . . . . 3.81 110.834 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 -172.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.504 2.136 . . . . 1.83 112.309 179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -90.08 -178.63 5.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 3.55 110.884 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.11 -21.26 58.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 2.98 111.176 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.821 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.57 -31.54 47.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 1.18 111.274 -179.843 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.435 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 14.6 t-105 -76.94 -37.41 55.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 1.05 110.956 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.58 -29.23 67.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 2.75 110.894 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG21 HD11 ' A' ' 31' ' ' LEU . 29.2 t -87.11 -51.31 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 1.31 111.097 -179.938 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 81' ' ' ALA . 33.2 t -58.81 -36.83 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.94 111.01 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.33 -20.84 59.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 2.92 111.106 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.36 9.19 38.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.655 -0.783 . . . . 1.27 113.019 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.733 HG22 ' HG3' ' A' ' 25' ' ' ARG . 1.1 p -86.34 141.12 34.46 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.928 0.364 . . . . 1.11 110.811 179.97 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.29 87.07 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.539 2.159 . . . . 2.01 112.208 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.26 -32.74 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 1.79 112.493 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.613 HD12 HG11 ' A' ' 8' ' ' VAL . 47.0 mm -80.05 127.76 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 1.72 110.952 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.82 -62.34 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 2.53 110.933 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.45 ' O ' ' CG ' ' A' ' 94' ' ' PHE . . . 177.36 49.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 2.38 112.625 179.964 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 45.3 p90 44.78 -168.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.761 0.315 . . . . 5.39 111.405 179.993 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 102' ' ' VAL . 22.0 t -47.38 -71.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.571 -0.286 . . . . 3.51 111.513 -179.618 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.54 -31.5 3.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 4.05 112.387 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.03 -32.88 65.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 4.25 111.038 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.34 -101.14 2.66 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.732 -0.747 . . . . 3.33 112.481 -179.974 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.428 ' HA ' ' CE1' ' A' ' 94' ' ' PHE . 0.5 OUTLIER -177.35 -62.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.744 0.307 . . . . 5.95 110.904 -179.998 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -89.97 174.48 4.7 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 6.21 110.89 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.435 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 75.6 Cg_exo -49.89 163.53 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.687 2.258 . . . . 1.11 112.463 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 95' ' ' VAL . 21.5 t -125.0 96.19 40.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 1.98 111.2 -179.902 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.62 120.61 7.23 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.459 2.106 . . . . 0.95 112.276 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 104' ' ' LEU . 3.1 mp -65.43 166.49 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 1.36 110.944 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 13.8 m -89.97 148.68 40.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 1.66 110.851 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.61 -30.25 44.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.528 2.152 . . . . 1.27 112.429 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.72 -31.36 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 2.75 110.949 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -88.96 -32.53 17.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 2.46 110.886 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 20.0 t -63.83 -39.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 1.07 111.102 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.4 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 3.94 110.945 -179.924 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.716 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -68.49 -54.92 13.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 2.25 110.661 179.872 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.871 HD12 ' CD2' ' A' ' 67' ' ' PHE . 15.6 pt -66.14 -24.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 1.36 110.89 179.637 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.858 ' CD2' HD12 ' A' ' 118' ' ' LEU . 5.4 mt -74.66 -34.43 62.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 1.94 110.535 179.662 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -78.02 -31.47 50.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.059 -0.519 . . . . 2.68 110.748 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 1.039 HG11 HD11 ' A' ' 61' ' ' LEU . 34.6 t -77.14 -33.05 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 1.72 110.949 179.813 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.555 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -62.52 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 2.11 110.923 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.729 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 143.86 45.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 1.78 112.643 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.858 HD12 ' CD2' ' A' ' 113' ' ' LEU . 1.6 mt -125.17 -48.94 1.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 1.99 110.818 179.86 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -31.23 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 2.44 110.866 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.31 -1.272 . . . . 2.99 112.575 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.662 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.502 0.192 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.32 156.61 38.69 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.127 0.489 . . . . 0.0 111.762 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.679 ' CD1' HG11 ' A' ' 109' ' ' VAL . 82.0 m95 -95.3 95.56 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.653 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.639 ' CE2' HD12 ' A' ' 72' ' ' LEU . 33.0 m-85 -83.4 115.47 22.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.996 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.24 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 9' ' ' HIS . 6.3 t -128.36 161.64 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.47 ' N ' HG12 ' A' ' 8' ' ' VAL . 14.8 m-70 -90.06 159.96 16.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.599 HG21 ' CD1' ' A' ' 66' ' ' LEU . 62.2 p -152.45 -174.38 4.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD13 ' N ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -85.52 139.22 31.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.502 ' N ' HD13 ' A' ' 11' ' ' LEU . 21.4 t -68.09 122.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.86 15.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -92.17 -14.87 28.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.609 0.243 . . . . 0.0 111.245 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 66' ' ' LEU . 7.3 tm-20 -52.42 -46.54 66.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 111.054 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.87 -30.85 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.887 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -30.76 22.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.15 72.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -49.3 78.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.46 50.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.172 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -60.69 -31.63 70.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.799 HD12 HG21 ' A' ' 88' ' ' THR . 5.8 tp -81.17 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -46.9 -35.42 6.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.315 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -66.22 -47.3 74.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.709 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.41 ' HD2' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -62.68 -39.38 93.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.682 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.2 mm -62.56 -29.79 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -93.59 -29.98 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -44.03 74.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.157 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.0 -30.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 66.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.2 mt -124.79 23.23 8.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 0.0 111.046 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.44 -9.14 58.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.8 -29.64 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -51.83 5.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.803 HD12 HG21 ' A' ' 26' ' ' ILE . 32.3 mt -79.92 128.16 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.662 ' CE2' HG21 ' A' ' 3' ' ' ILE . 26.0 m-85 -113.66 -53.41 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.434 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.0 mt-30 -113.27 157.39 21.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.046 0.45 . . . . 0.0 111.452 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 68' ' ' ILE . 16.5 t -152.27 71.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.8 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.4 mm? -85.87 150.06 24.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.203 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.3 pt -107.22 131.19 21.89 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.862 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 32.3 Cg_endo -64.16 72.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.605 2.203 . . . . 0.0 112.643 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.821 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.811 0.339 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.81 110.03 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.544 HD21 HG11 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -72.38 -49.33 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.537 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.436 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 18.9 m-85 -106.76 98.21 20.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.296 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.91 137.05 55.94 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.429 2.086 . . . . 0.0 112.633 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.97 26.07 65.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.704 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' CD2' ' HB3' ' A' ' 62' ' ' PHE . 14.5 m-85 -116.4 145.55 43.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.717 0.294 . . . . 0.0 111.087 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.781 HD11 ' HG2' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -142.93 112.73 6.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.764 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.675 ' CD2' HD12 ' A' ' 112' ' ' ILE . 6.4 m-85 -88.35 124.22 33.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.576 HG23 HG22 ' A' ' 38' ' ' VAL . 1.2 mp -130.04 117.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 6.8 tt0 -79.97 71.8 6.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.939 0.399 . . . . 0.0 110.196 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 72' ' ' LEU . 13.0 ptp -90.87 -174.02 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.22 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -132.66 75.45 1.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.836 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.639 HD12 ' CE2' ' A' ' 6' ' ' TYR . 86.4 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.39 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.725 0.297 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 174.82 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.508 2.139 . . . . 0.0 112.135 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.436 ' ND2' HD23 ' A' ' 72' ' ' LEU . 7.5 p30 -87.01 -172.14 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.032 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -21.51 42.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -50.66 -42.46 56.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 111.285 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -64.67 -39.2 93.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.23 -43.14 99.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.681 HG21 HD11 ' A' ' 31' ' ' LEU . 21.6 t -59.32 -51.49 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.937 0.399 . . . . 0.0 111.058 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.61 HG12 HD13 ' A' ' 91' ' ' ILE . 21.7 t -61.99 -42.63 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.122 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -17.48 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.331 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.08 -15.71 15.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.136 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.916 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -62.1 142.37 95.55 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.857 0.328 . . . . 0.0 110.972 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 88' ' ' THR . 52.7 Cg_exo -54.94 -20.21 22.16 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.19 36.34 3.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.977 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 88' ' ' THR . 2.1 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.519 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 15.1 mmm-85 . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.425 0.155 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 89.0 Cg_endo -81.72 -169.99 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.598 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -153.34 71.17 6.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.097 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.17 132.74 48.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.591 HD13 ' CD1' ' A' ' 112' ' ' ILE . 0.5 OUTLIER -88.11 161.65 17.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.9 OUTLIER -89.98 153.56 47.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.05 -48.61 20.26 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.532 2.155 . . . . 0.0 112.428 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.29 -31.9 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 112' ' ' ILE . 1.8 mp0 -81.59 -36.64 28.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 105' ' ' SER . 41.2 t -58.96 -45.7 91.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -27.13 68.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.511 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 m80 -81.64 -37.31 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.057 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.675 HD12 ' CD2' ' A' ' 67' ' ' PHE . 8.1 pt -81.33 -20.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.003 HD22 HD12 ' A' ' 118' ' ' LEU . 22.3 mt -86.94 -33.08 19.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.8 -32.79 73.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.663 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.544 HG11 HD21 ' A' ' 61' ' ' LEU . 35.2 t -80.92 -35.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.903 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.8 ' OG ' HD12 ' A' ' 39' ' ' LEU . 1.5 t -60.33 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.809 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.49 42.59 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.628 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.003 HD12 HD22 ' A' ' 113' ' ' LEU . 23.2 mt -117.29 -56.96 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -30.29 40.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.546 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.86 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.42 0.153 . . . . 0.0 110.766 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -147.91 163.15 37.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 112.105 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.774 ' CD1' HG11 ' A' ' 109' ' ' VAL . 67.8 m95 -94.27 139.3 31.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.671 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CE2' HD12 ' A' ' 72' ' ' LEU . 21.0 m-85 -125.64 110.03 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.06 151.19 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.054 0.454 . . . . 0.0 111.745 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.61 162.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 2.5 m-70 -100.31 151.52 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.056 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.4 p -149.14 -178.24 6.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -89.87 140.67 29.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' H ' HD23 ' A' ' 11' ' ' LEU . 28.3 t -62.06 125.3 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.71 -37.98 3.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 -21.55 34.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -54.76 -43.15 72.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.06 -46.53 75.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -24.72 36.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.055 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.26 74.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -33.11 71.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 -51.6 23.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.7 -33.26 71.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.651 HD11 HG22 ' A' ' 85' ' ' VAL . 56.1 tp -73.48 -55.01 6.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.58 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -30.34 8.87 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -72.35 -42.88 64.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.726 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -66.57 -34.7 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.666 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.842 HG23 ' HB2' ' A' ' 31' ' ' LEU . 36.0 mm -69.47 -31.58 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -32.68 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.52 -41.96 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -80.78 -25.39 37.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.41 5.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.402 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.842 ' HB2' HG23 ' A' ' 26' ' ' ILE . 2.3 mt -99.85 28.63 4.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.722 0.296 . . . . 0.0 110.999 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -71.88 -10.54 59.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 15.8 t70 -79.67 -24.88 41.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.01 -54.49 4.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.2 mp -87.77 137.9 20.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.707 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.86 ' CE2' HG21 ' A' ' 3' ' ' ILE . 13.1 m-85 -129.93 -56.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.513 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.575 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -109.44 134.37 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.144 0.497 . . . . 0.0 112.067 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 38' ' ' VAL . 5.1 m -125.15 99.59 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.284 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.542 HD23 ' HB3' ' A' ' 116' ' ' SER . 1.9 tm? -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.469 ' N ' HD22 ' A' ' 39' ' ' LEU . 16.5 tt -87.68 125.09 66.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' O ' HG23 ' A' ' 42' ' ' THR . 27.6 Cg_endo -62.16 76.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.651 2.234 . . . . 0.0 112.563 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 41' ' ' PRO . 25.3 p . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.9 mttm . . . . . 0 N--CA 1.459 0.024 0 CA-C-O 120.721 0.296 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.8 OUTLIER -138.66 116.88 11.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.03 -55.52 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.627 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.1 m-85 -121.31 79.51 36.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.21 144.28 81.81 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.296 . . . . 0.0 112.671 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.93 18.43 70.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.139 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 15.0 m-85 -129.13 162.7 27.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.35 122.29 8.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.353 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.739 ' CD1' HD11 ' A' ' 104' ' ' LEU . 11.6 m-30 -89.59 130.03 35.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.956 0.408 . . . . 0.0 111.217 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 6' ' ' TYR . 2.3 mt -130.73 111.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.575 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -79.71 68.42 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.673 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.469 ' CE ' HD21 ' A' ' 72' ' ' LEU . 10.2 ptm -91.66 -164.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -141.07 71.24 1.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.585 HD12 ' CE2' ' A' ' 6' ' ' TYR . 95.4 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.743 0.306 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.33 151.14 81.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.542 2.161 . . . . 0.0 112.332 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.21 -167.69 1.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -66.12 -27.44 68.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.853 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -52.18 -39.8 60.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.319 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -74.59 -33.27 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -31.41 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.72 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.83 -44.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 81' ' ' ALA . 28.9 t -64.42 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.98 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -13.56 62.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.07 -12.78 10.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.051 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.637 HG21 ' CD1' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -58.89 159.74 12.65 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.908 0.354 . . . . 0.0 110.891 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.99 122.84 9.45 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.543 2.162 . . . . 0.0 112.385 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.71 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.3 mm . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.055 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.514 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 111.406 0.15 . . . . 0.0 111.406 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 82.5 Cg_exo -47.79 127.44 14.32 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.344 2.029 . . . . 0.0 112.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 102' ' ' VAL . 9.6 p -98.07 105.26 26.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.271 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.68 124.45 8.2 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.341 2.028 . . . . 0.0 111.997 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.739 HD11 ' CD1' ' A' ' 67' ' ' PHE . 68.2 mt -59.55 134.22 56.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.928 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.5 p -76.61 150.79 82.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.81 -31.75 73.85 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.639 2.226 . . . . 0.0 112.271 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.76 -28.39 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -37.09 10.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 105' ' ' SER . 24.5 t -58.63 -29.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.17 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -60.22 -39.25 86.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.88 -55.7 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.498 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.627 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.3 pp -63.56 -22.14 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.665 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.866 ' CD2' HD12 ' A' ' 118' ' ' LEU . 1.9 mt -70.41 -39.52 74.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.26 -29.3 67.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.68 -41.19 62.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.542 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -60.22 -62.11 2.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 110.581 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.717 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 132.69 36.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.024 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.866 HD12 ' CD2' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -112.56 -27.95 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -49.98 11.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.447 -1.196 . . . . 0.0 112.562 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.617 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.492 0.187 . . . . 0.0 110.908 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.05 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.175 0.512 . . . . 0.0 111.832 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.919 ' CZ2' HD21 ' A' ' 113' ' ' LEU . 73.0 m95 -95.56 88.53 5.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.466 ' CE2' HD12 ' A' ' 72' ' ' LEU . 50.6 m-85 -81.27 123.64 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.04 127.12 53.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.94 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 91' ' ' ILE . 1.5 p -108.03 159.88 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 111.084 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.482 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 48.3 m-70 -83.86 136.48 34.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -143.55 151.57 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.31 136.6 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.75 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -57.58 111.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.262 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.59 -20.47 32.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.691 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.59 -16.96 15.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.617 0.246 . . . . 0.0 111.308 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -33.92 59.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.83 0.348 . . . . 0.0 111.133 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.82 -31.84 71.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.992 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -26.06 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.176 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -65.89 -30.67 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.86 47.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -62.12 -25.18 67.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.58 HD11 HG22 ' A' ' 85' ' ' VAL . 25.8 tp -86.7 -56.81 3.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -45.91 -37.68 6.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.426 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 -33.62 70.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.875 ' HG3' HG22 ' A' ' 88' ' ' THR . 4.9 mmt-85 -75.64 -32.37 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.636 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.837 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.7 mm -70.39 -31.4 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.734 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -84.04 -30.4 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -42.05 38.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -80.04 -25.58 40.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.962 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.07 66.52 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.468 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.837 ' HB2' HG23 ' A' ' 26' ' ' ILE . 1.5 mt -125.82 30.1 5.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.987 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -25.39 68.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.07 -1.79 41.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.365 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -99.47 -58.65 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.755 0.312 . . . . 0.0 110.748 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.441 HD12 HG21 ' A' ' 26' ' ' ILE . 37.6 mt -81.45 132.92 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 3' ' ' ILE . 3.0 m-85 -127.02 -49.99 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.19 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -117.14 156.66 27.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.107 0.479 . . . . 0.0 111.697 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.707 ' O ' HD22 ' A' ' 39' ' ' LEU . 3.6 m -159.91 114.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.841 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.5 mm? -130.04 177.32 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.406 0.622 . . . . 0.0 112.07 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 42' ' ' THR . 28.7 mt -148.56 74.25 10.52 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.785 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 87.9 Cg_exo -41.66 113.78 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.176 2.584 . . . . 0.0 113.59 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 40' ' ' ILE . 29.4 p . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.063 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.893 0.378 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HG3' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -57.48 115.2 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.582 HD12 HG11 ' A' ' 115' ' ' VAL . 17.9 mt -61.86 -44.55 96.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.309 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 41' ' ' PRO . 2.1 m-85 -115.57 76.92 5.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.563 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.54 127.77 16.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.67 2.246 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.66 72.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.579 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 48.7 m-85 -128.89 111.03 12.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.97 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 66' ' ' LEU . 18.5 mt -90.9 114.91 27.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.514 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.742 ' CE2' HD12 ' A' ' 112' ' ' ILE . 6.6 m-30 -82.47 122.85 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -128.87 110.16 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 3.6 tt0 -79.97 69.97 6.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.686 ' SD ' HD11 ' A' ' 72' ' ' LEU . 15.6 ptp -90.84 -178.13 5.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.487 ' O ' HD23 ' A' ' 72' ' ' LEU . 3.4 t0 -119.53 98.88 6.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.686 HD11 ' SD ' ' A' ' 70' ' ' MET . 39.4 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.795 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.462 0.172 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 173.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.433 2.089 . . . . 0.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.38 179.19 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.2 -25.21 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.754 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.08 -28.89 27.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 111.237 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -63.76 -48.61 76.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -58.88 -30.26 67.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.796 HG21 HD11 ' A' ' 31' ' ' LEU . 21.6 t -77.69 -49.67 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.184 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 81' ' ' ALA . 39.1 t -59.96 -52.68 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttp85 -58.03 -22.84 51.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.52 -32.39 11.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.728 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.875 HG22 ' HG3' ' A' ' 25' ' ' ARG . 65.7 p -59.13 130.64 86.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.493 0.187 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.78 -23.87 35.52 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.393 2.062 . . . . 0.0 112.314 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.41 -29.19 46.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.735 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.525 HD12 HG21 ' A' ' 8' ' ' VAL . 40.0 mm . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 111.086 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.476 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.523 0.202 . . . . 0.0 110.964 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 84.7 Cg_endo -81.18 130.43 7.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.502 2.135 . . . . 0.0 112.107 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.6 t -129.68 99.7 20.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.262 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.9 139.14 10.77 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.645 2.23 . . . . 0.0 112.252 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.889 HD22 HD13 ' A' ' 112' ' ' ILE . 1.2 mp -67.59 156.75 36.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.06 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.91 ' O ' HG23 ' A' ' 109' ' ' VAL . 47.6 p -85.44 149.97 53.15 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.757 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -45.98 -49.58 10.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.773 2.316 . . . . 0.0 112.873 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.47 -39.98 85.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.17 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.66 -33.3 47.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 105' ' ' SER . 58.4 t -58.79 -31.4 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.237 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -26.01 56.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.728 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -82.33 -29.23 31.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.108 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.889 HD13 HD22 ' A' ' 104' ' ' LEU . 34.2 pt -80.68 -32.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.111 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.955 HD22 HD12 ' A' ' 118' ' ' LEU . 97.9 mt -77.5 -25.2 50.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.23 -32.37 61.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.979 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 111' ' ' HIS . 21.3 t -75.49 -48.2 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.072 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.841 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -58.48 -59.98 4.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 137.14 67.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.597 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.955 HD12 HD22 ' A' ' 113' ' ' LEU . 23.1 mt -129.05 -47.46 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.822 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -61.73 1.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.491 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.807 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.392 0.139 . . . . 0.0 110.839 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.01 139.54 52.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.292 0.568 . . . . 0.0 112.092 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 1.097 ' CH2' HD22 ' A' ' 39' ' ' LEU . 25.7 m95 -94.94 96.23 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.047 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.466 ' O ' HD12 ' A' ' 68' ' ' ILE . 44.9 m-85 -96.67 112.96 24.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.397 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.426 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -108.14 134.88 50.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.753 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.695 HG21 HD12 ' A' ' 91' ' ' ILE . 1.5 p -134.14 160.18 41.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.196 0.522 . . . . 0.0 111.234 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.489 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 5.6 m170 -82.26 147.12 29.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -123.83 -173.83 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mt -87.7 127.61 35.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.72 114.87 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.6 -28.8 11.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.52 -7.78 37.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.622 0.249 . . . . 0.0 111.292 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -55.74 -39.72 71.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -52.45 65.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -14.34 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.359 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.536 ' HB1' ' CA ' ' A' ' 90' ' ' GLY . . . -70.44 -51.21 31.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 111.228 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -56.57 -41.56 77.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.04 -43.35 92.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -62.19 -34.49 76.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD13 HG21 ' A' ' 88' ' ' THR . 26.3 tp -84.02 -45.07 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.574 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.4 tt0 -55.23 -26.41 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -78.32 -47.61 17.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.318 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.02 -27.3 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.352 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.732 HG12 HD13 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -70.63 -29.35 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -87.38 -31.52 20.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.6 -32.36 67.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.044 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -87.89 5.7 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.53 47.49 86.63 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 26' ' ' ILE . 8.8 mt -111.08 9.63 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.536 0.207 . . . . 0.0 111.266 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -17.25 63.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 0.0 111.259 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.93 -38.53 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.041 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.37 -51.75 33.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.732 HD13 HG12 ' A' ' 26' ' ' ILE . 4.8 mp -79.87 117.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.807 ' CE2' HG21 ' A' ' 3' ' ' ILE . 31.7 m-85 -100.95 -53.17 3.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.472 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 5.1 mm-40 -107.95 169.89 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.374 0.606 . . . . 0.0 111.651 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.3 p -156.33 73.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.35 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.097 HD22 ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -79.55 139.48 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.638 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.614 HG22 HG23 ' A' ' 42' ' ' THR . 14.4 mt -100.5 138.3 20.13 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 40' ' ' ILE . 67.9 Cg_endo -72.72 59.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.543 2.162 . . . . 0.0 112.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.614 HG23 HG22 ' A' ' 40' ' ' ILE . 44.1 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.965 0.412 . . . . 0.0 111.317 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -141.92 121.21 13.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.971 HD11 HG11 ' A' ' 115' ' ' VAL . 2.1 mt -90.27 -65.78 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.592 ' HE2' HG22 ' A' ' 112' ' ' ILE . 6.6 m-85 -103.9 90.42 2.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.763 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.01 123.02 11.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.128 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.39 29.06 54.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.569 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 19.3 m-85 -117.27 177.68 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.2 tp -160.21 148.87 17.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.756 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.656 ' CE2' HG21 ' A' ' 112' ' ' ILE . 18.2 m-85 -132.5 125.62 31.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.572 HG22 HG23 ' A' ' 35' ' ' ILE . 1.3 mp -133.04 112.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.53 ' NE2' HD11 ' A' ' 3' ' ' ILE . 8.6 tt0 -79.9 72.41 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 110.675 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.419 ' HG3' ' HG ' ' A' ' 72' ' ' LEU . 2.1 ptm -91.37 -166.52 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 1.2 p30 -136.71 78.46 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 110.982 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.432 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 35.3 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.637 0.256 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.46 179.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.387 2.058 . . . . 0.0 112.185 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -171.97 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -70.79 -26.2 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.101 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.873 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.55 -28.96 34.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.323 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 101' ' ' PRO . 12.5 t-105 -69.46 -36.15 76.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.7 -30.0 70.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.583 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -82.29 -45.89 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.7 t -61.45 -50.21 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.056 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -29.91 70.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.58 -27.07 52.63 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.582 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.531 HG21 HD13 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -69.32 147.31 97.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.865 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.52 -20.79 35.52 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.378 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' CA ' ' HB1' ' A' ' 18' ' ' ALA . . . -55.89 -28.1 52.12 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.636 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 8' ' ' VAL . 41.9 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.437 0.161 . . . . 0.0 111.244 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 98.1 Cg_endo -79.93 143.75 16.55 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.348 2.032 . . . . 0.0 112.297 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -127.17 110.68 21.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.252 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 96.4 Cg_endo -79.1 132.12 10.25 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.613 2.209 . . . . 0.0 112.239 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.694 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.9 mp -86.12 147.27 26.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.858 ' O ' HG23 ' A' ' 109' ' ' VAL . 18.9 p -90.07 159.48 42.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.22 -27.23 6.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.753 2.302 . . . . 0.0 112.544 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -44.83 74.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.67 -32.4 17.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 105' ' ' SER . 38.7 t -62.22 -28.57 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.342 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -69.34 -28.21 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.648 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -72.54 -51.42 19.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.765 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.855 HD12 HD23 ' A' ' 39' ' ' LEU . 1.5 pp -68.01 -13.76 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.692 HD23 ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -83.77 -40.83 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.857 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.97 -40.35 71.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 61' ' ' LEU . 5.7 t -71.64 -44.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.487 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 15.4 p -56.18 -62.38 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.76 42.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.569 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.692 ' HB2' HD23 ' A' ' 113' ' ' LEU . 19.1 mt -111.2 -36.01 5.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.474 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -98.17 -34.4 10.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.519 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.459 HG22 ' HB2' ' A' ' 71' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.476 0.179 . . . . 0.0 110.764 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 163.88 31.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.874 ' CD1' HG11 ' A' ' 109' ' ' VAL . 72.9 m95 -88.72 96.27 10.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 4.8 m-85 -79.74 124.52 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -114.19 134.63 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.533 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.654 HG21 ' CD1' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -126.58 -166.97 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.626 ' N ' HG13 ' A' ' 8' ' ' VAL . 6.5 m-70 -132.87 160.72 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 111.213 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.6 p -156.35 174.75 14.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.53 139.1 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 t -65.34 125.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.16 -28.43 12.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -92.98 -16.52 25.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 111.162 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.79 -36.01 46.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.805 0.336 . . . . 0.0 111.207 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -59.75 -30.81 69.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.07 -28.91 19.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.955 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.52 68.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -53.28 59.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.86 -42.89 89.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -59.76 -31.14 69.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.67 HD11 HG22 ' A' ' 85' ' ' VAL . 55.5 tp -88.96 -48.89 7.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.792 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.7 tm-20 -62.58 -24.19 67.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -80.55 -38.38 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.254 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.37 -22.46 61.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 23' ' ' GLU . 1.1 tp -72.3 -28.89 30.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.016 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -89.61 -30.1 18.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.23 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -86.68 -30.29 21.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.76 41.6 4.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -101.51 25.69 8.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -66.92 -16.78 64.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.251 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.8 -25.69 40.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -79.63 -61.06 2.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 70' ' ' MET . 1.8 pt -79.86 158.86 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.1 m-85 -143.88 -49.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -118.28 145.7 44.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.376 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.622 ' CG1' HG23 ' A' ' 68' ' ' ILE . 3.0 m -150.04 102.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.876 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.698 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.4 mm? -112.76 155.7 24.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.029 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.519 HG22 HG23 ' A' ' 42' ' ' THR . 3.6 mp -103.81 126.82 30.82 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 50.4 Cg_endo -69.27 62.44 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.605 2.203 . . . . 0.0 112.486 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.519 HG23 HG22 ' A' ' 40' ' ' ILE . 55.9 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.056 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.839 0.352 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -55.5 106.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.531 HD21 HG11 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -62.76 -51.49 66.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.614 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 61' ' ' LEU . 14.6 m-85 -105.77 94.95 9.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.416 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.9 129.05 31.38 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.511 2.141 . . . . 0.0 112.495 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.06 40.36 82.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.56 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 0.8 OUTLIER -124.23 144.41 49.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.003 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.95 124.98 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.721 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.2 m-85 -96.39 133.79 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.227 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.622 HG23 ' CG1' ' A' ' 38' ' ' VAL . 3.1 mp -142.32 114.17 3.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 7.1 tt0 -79.9 76.28 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 35' ' ' ILE . 21.2 ptp -91.63 -168.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.821 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 3' ' ' ILE . 21.6 t0 -156.24 91.77 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.741 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 81.7 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.518 0.199 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.5 173.82 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.394 2.063 . . . . 0.0 112.247 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -90.09 -171.08 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.45 -27.81 68.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.99 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.782 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.2 -38.67 65.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.209 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.426 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 11.8 t-105 -66.82 -36.5 82.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.25 -32.17 69.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -85.14 -39.41 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.9 t -71.28 -33.41 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -18.01 62.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.6 -4.21 30.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.023 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -71.17 133.11 85.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.962 0.381 . . . . 0.0 110.737 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.8 121.2 9.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.152 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.02 -29.56 5.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.593 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 88' ' ' THR . 2.5 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.723 0.297 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.426 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.7 Cg_exo -54.07 174.34 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.622 2.215 . . . . 0.0 112.299 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 102' ' ' VAL . 13.2 m -139.2 94.07 9.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.221 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.11 130.98 14.84 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.564 2.176 . . . . 0.0 112.404 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 5' ' ' TRP . 3.3 mp -78.99 162.18 26.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.916 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -89.09 156.49 49.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.926 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.59 -30.57 89.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.626 2.217 . . . . 0.0 112.271 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.15 -29.01 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.16 -38.19 11.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.916 HG23 ' O ' ' A' ' 105' ' ' SER . 40.0 t -58.95 -35.52 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -25.41 68.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.754 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -80.25 -41.2 25.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.783 HD12 ' CD2' ' A' ' 67' ' ' PHE . 12.1 pt -76.13 -22.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.202 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 118' ' ' LEU . 85.6 mt -84.15 -30.18 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 110.758 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -31.01 61.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 111' ' ' HIS . 23.6 t -77.2 -38.44 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.789 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 149.12 56.63 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.66 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.048 HD12 HD22 ' A' ' 113' ' ' LEU . 41.5 mt -127.92 -60.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.006 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -34.71 38.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.528 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.578 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.452 0.168 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -154.0 150.19 28.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.267 0.555 . . . . 0.0 112.136 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 1.075 ' CH2' HD22 ' A' ' 39' ' ' LEU . 46.2 m95 -89.91 95.27 10.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.388 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.687 ' CE2' HD11 ' A' ' 72' ' ' LEU . 44.6 m-85 -91.15 116.01 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.85 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -100.84 143.27 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.453 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 9' ' ' HIS . 14.7 t -143.34 160.05 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.699 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.46 ' N ' HG12 ' A' ' 8' ' ' VAL . 4.2 p80 -131.53 152.74 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.876 0.369 . . . . 0.0 111.164 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -139.81 -165.56 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.794 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -70.53 136.03 49.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.982 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' H ' HD13 ' A' ' 11' ' ' LEU . 37.2 t -67.32 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.31 -32.02 6.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.432 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -93.59 -22.14 18.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.051 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -32.07 20.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.152 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.47 -48.06 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -27.29 60.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.04 93.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -42.93 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.96 56.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.34 -34.89 78.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.764 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.585 HD11 HG22 ' A' ' 85' ' ' VAL . 16.0 tp -69.81 -57.87 4.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.813 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -49.14 -35.21 15.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -69.55 -43.93 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -38.03 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.505 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.812 HG23 ' HB2' ' A' ' 31' ' ' LEU . 48.4 mm -67.69 -30.99 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.639 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -87.11 -29.21 22.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.99 -46.91 70.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -87.33 -25.1 24.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.3 61.5 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.324 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 84' ' ' VAL . 3.6 mm? -98.86 28.11 4.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.059 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -81.26 21.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.284 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -108.94 -15.73 14.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.979 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.843 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 2.0 mttp -116.69 -45.87 2.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.807 0.337 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.668 ' CD1' HD12 ' A' ' 26' ' ' ILE . 16.5 mt -80.29 135.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 3' ' ' ILE . 15.6 m-85 -133.06 -60.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.655 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.55 133.3 46.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.535 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.1 p -128.12 76.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.271 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.075 HD22 ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -80.0 139.41 37.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.119 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.413 HG23 ' HD2' ' A' ' 41' ' ' PRO . 27.8 mm -98.93 136.99 20.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 62' ' ' PHE . 80.0 Cg_endo -77.85 55.76 5.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.59 2.193 . . . . 0.0 112.769 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 115' ' ' VAL . 3.0 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.04 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.845 0.355 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 105.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.773 HD12 HG11 ' A' ' 115' ' ' VAL . 23.2 mt -63.98 -51.57 63.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.786 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 41' ' ' PRO . 86.8 m-85 -97.58 111.88 59.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.537 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 62' ' ' PHE . 18.0 Cg_endo -59.8 122.2 11.06 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.517 2.145 . . . . 0.0 112.73 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.17 43.65 25.81 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.198 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . 1.8 m-85 -117.11 173.99 6.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.635 HD23 HD11 ' A' ' 68' ' ' ILE . 7.5 tp -160.23 152.01 20.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' A' ' 112' ' ' ILE . 79.3 m-85 -126.21 120.64 30.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.564 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.635 HD11 HD23 ' A' ' 66' ' ' LEU . 1.1 mp -130.35 115.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.626 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.7 tt0 -83.22 70.17 10.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.314 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.725 ' SD ' HD23 ' A' ' 72' ' ' LEU . 5.4 ptm -91.51 -168.3 2.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.964 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -139.99 49.32 1.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.725 HD23 ' SD ' ' A' ' 70' ' ' MET . 4.5 pp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.976 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.682 0.277 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 85.4 Cg_endo -81.97 89.3 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.633 2.222 . . . . 0.0 112.718 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 p30 -90.26 -168.41 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.776 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 84' ' ' VAL . 5.7 tp10 56.85 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.66 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.843 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . . . -55.85 -43.35 76.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.312 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.446 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 2.6 t-105 -79.97 -35.55 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -27.65 62.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.981 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 31' ' ' LEU . 21.5 t -87.4 -51.69 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.7 t -58.56 -48.61 85.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -23.4 61.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.973 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.38 -26.0 37.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.67 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 84' ' ' VAL . 47.7 p -57.78 142.89 77.78 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.639 0.257 . . . . 0.0 110.921 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.73 -14.12 32.76 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.528 2.152 . . . . 0.0 112.558 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.03 -28.08 73.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.657 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 111.18 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.694 0.283 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HG3' ' CZ2' ' A' ' 82' ' ' TRP . 51.8 Cg_exo -54.07 -168.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.668 2.245 . . . . 0.0 112.4 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.22 109.62 6.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.371 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.34 120.39 3.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.217 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -68.09 155.43 39.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.161 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.835 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -90.07 166.94 18.3 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -51.33 -27.47 23.78 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.623 2.215 . . . . 0.0 112.443 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.47 -48.2 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.073 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -72.71 -34.31 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 105' ' ' SER . 58.5 t -62.2 -44.63 99.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.222 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -60.48 -26.68 66.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.46 -53.83 9.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.649 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 2.5 pp -67.51 -15.3 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.955 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.747 HD13 HG12 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -80.64 -40.41 25.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.86 -32.98 74.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.067 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.773 HG11 HD12 ' A' ' 61' ' ' LEU . 32.2 t -76.27 -50.03 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.474 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -56.26 -60.49 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.06 42.47 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.1 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.48 ' CB ' HD23 ' A' ' 113' ' ' LEU . 4.7 mt -109.36 -48.57 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 110.633 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tp -100.67 30.78 3.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.405 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.541 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.393 0.139 . . . . 0.0 110.853 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.49 157.22 39.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.175 0.512 . . . . 0.0 112.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.786 ' CD1' HG11 ' A' ' 109' ' ' VAL . 78.5 m95 -98.07 85.75 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.121 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.858 ' CE2' HD12 ' A' ' 72' ' ' LEU . 68.6 m-85 -80.63 124.76 29.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.988 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.572 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . -95.84 138.23 33.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.389 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.556 HG11 HD12 ' A' ' 91' ' ' ILE . 15.4 t -125.16 160.07 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.461 ' N ' HG12 ' A' ' 8' ' ' VAL . 17.8 m-70 -94.3 132.55 38.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.832 HG21 HD12 ' A' ' 66' ' ' LEU . 20.7 p -124.12 177.54 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.47 132.15 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.81 123.73 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.198 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.29 -27.91 17.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.462 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -104.65 -3.06 24.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.627 0.251 . . . . 0.0 111.376 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.551 ' OE1' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -57.38 -34.07 68.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.769 0.319 . . . . 0.0 111.038 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -58.47 -40.71 83.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.52 -24.72 31.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.28 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -37.29 79.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -53.06 15.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.034 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -59.17 -31.75 69.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.637 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.742 HD11 HG22 ' A' ' 85' ' ' VAL . 18.4 tp -77.14 -57.48 3.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.716 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -49.72 -31.18 10.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -38.66 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.637 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -36.07 72.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.601 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 35' ' ' ILE . 38.4 mm -67.44 -31.4 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -30.16 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.33 -32.32 37.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -85.02 -27.26 26.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.8 61.11 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.892 HD11 HG21 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -119.46 28.69 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.943 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -8.07 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.335 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.96 -29.05 39.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -96.11 -55.58 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.718 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -80.02 145.01 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.789 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.823 ' N ' HD13 ' A' ' 35' ' ' ILE . 8.2 m-85 -131.87 -44.45 0.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.132 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -122.09 154.93 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.619 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.708 HG23 HD11 ' A' ' 35' ' ' ILE . 26.3 t -154.4 67.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.288 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.669 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.6 mm? -79.97 152.3 29.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.263 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.551 HD11 ' OE1' ' A' ' 15' ' ' GLU . 4.5 tp -108.16 118.34 52.76 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.813 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 46.1 Cg_exo -55.33 80.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.731 2.287 . . . . 0.0 112.528 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 60' ' ' LYS . 58.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 42' ' ' THR . 5.3 mtpt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.687 0.28 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 42' ' ' THR . 8.1 mttm -103.11 123.65 47.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.048 HD11 HG11 ' A' ' 115' ' ' VAL . 10.0 mt -88.53 -48.62 7.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.515 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 2.7 m-85 -124.58 89.22 52.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.407 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.96 131.53 39.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.667 2.245 . . . . 0.0 112.934 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 9' ' ' HIS . . . 62.18 36.31 92.8 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.153 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.53 150.75 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.905 0.353 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.832 HD12 HG21 ' A' ' 10' ' ' THR . 4.4 mt -142.78 117.82 10.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.834 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 112' ' ' ILE . 12.8 m-85 -82.48 121.04 26.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.4 mp -128.57 107.5 15.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.436 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 4.5 tt0 -80.03 70.48 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -91.23 -179.78 5.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.261 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -120.83 89.86 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.846 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.858 HD12 ' CE2' ' A' ' 6' ' ' TYR . 13.3 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.609 0.243 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.98 92.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.546 2.164 . . . . 0.0 112.221 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 81' ' ' ALA . 18.5 m-80 -90.35 -176.6 4.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 51.4 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -46.56 -50.88 16.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.821 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -72.21 -32.38 66.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.063 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -33.36 72.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.993 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.892 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -90.01 -48.18 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.3 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 81' ' ' ALA . 38.0 t -61.67 -45.29 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.242 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -62.2 -18.61 61.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.275 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -102.08 -25.19 8.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.809 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.729 HG21 HD12 ' A' ' 22' ' ' LEU . 1.5 p -59.96 145.06 85.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.66 -25.96 62.62 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.566 2.178 . . . . 0.0 112.218 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.81 -34.15 56.67 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.674 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.556 HD12 HG11 ' A' ' 8' ' ' VAL . 35.5 mm . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.734 0.302 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 76.9 Cg_exo -50.59 179.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 7' ' ' ALA . 6.3 m -133.31 92.29 24.99 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.235 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 145.04 30.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.621 2.214 . . . . 0.0 112.325 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.686 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -89.94 169.17 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -90.06 150.81 44.16 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.767 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.53 -29.34 24.36 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.583 2.189 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.59 -30.97 57.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 112' ' ' ILE . 48.9 tt0 -90.3 -33.64 16.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 105' ' ' SER . 35.9 t -63.8 -35.48 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.227 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -29.16 66.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.67 ' O ' HG23 ' A' ' 115' ' ' VAL . 15.2 m80 -77.92 -40.38 39.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.784 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 12.4 pt -74.72 -29.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.032 HD22 HD12 ' A' ' 118' ' ' LEU . 62.9 mt -77.71 -32.58 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.559 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.39 -33.25 74.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 1.048 HG11 HD11 ' A' ' 61' ' ' LEU . 22.7 t -72.82 -35.29 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.949 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.669 ' HB3' HD12 ' A' ' 39' ' ' LEU . 13.5 m -64.34 -59.81 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.94 44.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.527 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.032 HD12 HD22 ' A' ' 113' ' ' LEU . 12.7 mt -115.92 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.85 -44.7 20.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.465 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.362 0.125 . . . . 0.0 110.738 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.0 158.21 44.26 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 112.281 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 1.001 ' CH2' HD12 ' A' ' 39' ' ' LEU . 78.6 m95 -93.22 91.03 7.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.487 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.675 ' O ' HD12 ' A' ' 68' ' ' ILE . 51.8 m-85 -87.48 99.12 11.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -80.45 154.97 27.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.733 HG11 HD11 ' A' ' 91' ' ' ILE . 14.3 t -139.07 159.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.48 ' N ' HG12 ' A' ' 8' ' ' VAL . 3.4 m-70 -112.92 135.82 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 91' ' ' ILE . 62.2 p -129.11 -177.49 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.01 142.34 27.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.875 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.39 129.81 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.45 -27.5 17.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.02 -20.02 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.578 0.228 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 12.2 pt-20 -56.66 -39.92 74.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.986 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -52.49 -67.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -61.72 -23.22 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.038 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -59.33 -46.92 87.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -59.85 -46.97 87.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.08 69.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.36 -43.99 95.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.76 HD11 HG22 ' A' ' 85' ' ' VAL . 37.8 tp -70.62 -48.54 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.852 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.4 tt0 -62.51 -17.33 59.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -84.67 -43.92 13.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.001 0.429 . . . . 0.0 110.227 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -23.93 66.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.355 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 23' ' ' GLU . 1.3 tp -67.91 -29.51 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.816 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 -30.57 15.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.62 62.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -79.91 -30.36 40.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.25 34.5 5.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.474 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.63 25.23 6.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.955 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -19.7 62.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.17 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -79.96 -26.27 40.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.061 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -77.89 -58.89 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.759 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.888 HD11 ' CG1' ' A' ' 38' ' ' VAL . 9.2 tt -79.94 130.91 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 3' ' ' ILE . 8.9 m-85 -117.57 -48.27 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.117 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.609 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -120.79 151.59 39.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.888 ' CG1' HD11 ' A' ' 35' ' ' ILE . 17.4 m -143.8 126.54 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.001 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -109.65 135.19 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 40' ' ' ILE . 2.1 mp -90.89 136.41 27.67 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.817 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.866 ' O ' HD12 ' A' ' 61' ' ' LEU . 28.1 Cg_endo -61.62 -15.56 42.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.624 2.216 . . . . 0.0 112.906 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 60' ' ' LYS . 16.4 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 111.13 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.3 pttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.726 0.298 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 42' ' ' THR . 1.5 mttt -71.83 111.28 6.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.004 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -89.82 -39.65 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.614 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.406 ' HB3' ' CG ' ' A' ' 65' ' ' TYR . 33.3 m-85 -111.58 94.07 21.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.99 126.34 18.58 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.384 2.056 . . . . 0.0 112.416 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.93 37.06 93.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CG ' ' HB3' ' A' ' 62' ' ' PHE . 3.0 m-85 -117.93 166.05 12.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.818 0.342 . . . . 0.0 110.97 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.441 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -160.08 151.12 19.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.415 ' HB2' ' CB ' ' A' ' 39' ' ' LEU . 4.7 m-85 -131.71 130.56 42.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.028 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.675 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.7 mp -134.52 117.31 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.496 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.609 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -83.77 65.81 8.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.411 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.437 ' CE ' HD23 ' A' ' 72' ' ' LEU . 5.8 ptm -91.57 -170.35 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.048 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD1' ' CZ ' ' A' ' 36' ' ' PHE . 6.4 p-10 -144.39 52.3 1.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.651 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 72' ' ' LEU . 4.5 pp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.9 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.763 0.316 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.45 179.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.492 2.128 . . . . 0.0 112.291 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -89.99 -177.56 5.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.52 -26.71 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.712 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -52.94 -30.06 32.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.293 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.428 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.8 t-105 -75.51 -31.01 60.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.57 -30.62 63.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.569 HG21 HD11 ' A' ' 31' ' ' LEU . 21.5 t -79.43 -52.73 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.76 HG22 HD11 ' A' ' 22' ' ' LEU . 34.1 t -59.9 -43.3 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -69.27 -15.51 63.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.26 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.29 -15.06 20.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.957 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.77 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -64.54 132.19 95.32 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.778 0.289 . . . . 0.0 110.848 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.9 137.12 40.52 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.418 2.078 . . . . 0.0 112.243 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.19 -17.39 58.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.734 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.897 ' O ' HD13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.984 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.677 0.275 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.428 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.9 Cg_exo -53.05 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.546 2.164 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.8 p -149.25 95.06 3.87 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.287 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.09 128.42 9.86 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.402 2.068 . . . . 0.0 111.912 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -79.86 157.87 26.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.19 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.6 p -80.72 160.22 67.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.525 ' O ' HG12 ' A' ' 109' ' ' VAL . 35.9 Cg_exo -59.82 -56.93 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.679 2.253 . . . . 0.0 112.564 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -52.59 -25.72 11.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.231 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -30.81 13.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -65.83 -29.56 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -32.72 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.477 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.11 -49.02 30.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.311 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.578 ' CD1' HD13 ' A' ' 39' ' ' LEU . 2.7 pp -62.24 -29.56 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.176 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.563 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -59.09 -35.78 73.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.737 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.82 -21.02 64.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.266 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.658 ' CG1' HD11 ' A' ' 61' ' ' LEU . 38.0 t -71.94 -61.93 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.421 ' HB2' HD23 ' A' ' 39' ' ' LEU . 11.3 t -52.2 -59.31 4.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.029 0.442 . . . . 0.0 111.001 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.88 42.68 0.17 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.563 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.563 HD12 ' HG ' ' A' ' 113' ' ' LEU . 5.3 mt -103.63 -31.38 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -80.0 -56.71 4.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.501 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.631 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.411 0.148 . . . . 0.0 110.9 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.97 155.82 36.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.412 0.625 . . . . 0.0 112.232 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.774 ' CD1' HG11 ' A' ' 109' ' ' VAL . 90.6 m95 -95.64 93.52 7.18 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.459 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.814 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 95.9 m-85 -86.15 108.58 18.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.839 0.352 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -93.45 140.24 29.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.115 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 9' ' ' HIS . 14.2 t -132.87 159.68 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.469 ' N ' HG12 ' A' ' 8' ' ' VAL . 11.2 m-70 -85.12 157.29 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -153.52 167.12 30.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.12 140.65 36.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.2 p -67.9 121.68 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.121 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.75 -23.42 36.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.734 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -93.23 -28.02 16.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -58.16 -33.96 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -39.82 71.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -90.02 -24.2 21.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -59.49 -35.47 74.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -59.29 -57.28 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.16 96.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -65.26 -41.55 94.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.834 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.874 HD11 HG22 ' A' ' 85' ' ' VAL . 56.7 tp -66.13 -54.45 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.837 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -34.05 62.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -67.74 -43.75 79.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -41.54 74.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.892 ' HA ' HD12 ' A' ' 31' ' ' LEU . 1.1 mp -70.31 -26.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.871 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -92.71 -31.77 14.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.6 68.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -101.14 -26.56 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.05 81.65 1.36 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.52 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.9 mt -134.91 31.05 3.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -0.94 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.604 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -23.61 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.74 0.305 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 3.3 mtmm -106.53 -52.69 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.678 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.416 HD11 ' HB1' ' A' ' 81' ' ' ALA . 32.3 mt -79.84 113.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.315 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 3' ' ' ILE . 25.5 m-85 -107.46 -56.21 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.016 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.467 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -113.39 162.39 16.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.332 0.587 . . . . 0.0 112.497 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.3 p -160.01 77.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.773 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.014 HD11 HD21 ' A' ' 118' ' ' LEU . 4.6 mm? -89.27 167.91 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.397 0.618 . . . . 0.0 112.397 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 40' ' ' ILE . 1.6 tt -155.81 74.2 5.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.008 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.444 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 82.1 Cg_exo -42.33 128.43 4.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.299 2.666 . . . . 0.0 113.841 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.397 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 tptt . . . . . 0 N--CA 1.457 -0.093 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -37.6 126.03 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.734 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.802 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.7 mt -89.9 -34.93 15.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.604 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CE2' HG22 ' A' ' 112' ' ' ILE . 59.5 m-85 -116.45 81.01 10.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 61' ' ' LEU . 24.0 Cg_exo -63.47 144.27 90.09 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.679 2.253 . . . . 0.0 112.076 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.98 24.8 15.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 22.7 m-85 -131.04 117.26 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 110.735 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mt -116.73 116.3 27.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.393 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.2 mp -117.65 114.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.467 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 12.8 tt0 -79.7 68.44 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 ptp -91.27 -167.94 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.262 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -142.35 106.37 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.452 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.814 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 23.9 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.534 0.207 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.617 ' HA ' HD22 ' A' ' 72' ' ' LEU . 57.1 Cg_endo -71.01 159.23 53.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.258 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' A' ' 81' ' ' ALA . 23.2 p30 -90.12 -179.99 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.02 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.554 ' HG3' HD22 ' A' ' 31' ' ' LEU . 15.2 pt-20 -61.97 -32.63 73.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -56.6 -31.72 64.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.01 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.457 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -64.2 -47.88 78.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -57.07 -30.21 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -80.16 -54.83 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.99 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.874 HG22 HD11 ' A' ' 22' ' ' LEU . 24.1 t -56.62 -37.24 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.64 -20.61 65.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.94 -17.16 12.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.921 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.543 HG21 ' CD1' ' A' ' 22' ' ' LEU . 29.2 p -55.85 141.02 67.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.775 0.287 . . . . 0.0 111.095 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 52.7 Cg_exo -55.07 95.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.098 . . . . 0.0 112.279 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.77 -30.29 0.28 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.624 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.988 -179.917 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.781 0.324 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.529 ' O ' HG13 ' A' ' 102' ' ' VAL . 50.8 Cg_exo -55.91 -164.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.686 2.258 . . . . 0.0 112.416 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 101' ' ' PRO . 4.5 m -158.72 93.44 1.92 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.13 126.36 13.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.51 2.14 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 7' ' ' ALA . 4.5 mp -76.57 154.12 34.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.881 ' O ' HG23 ' A' ' 109' ' ' VAL . 3.5 m -82.34 157.9 67.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -29.84 87.79 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.748 2.299 . . . . 0.0 112.274 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -29.29 65.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 -34.82 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 105' ' ' SER . 22.5 t -68.83 -26.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.198 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -73.22 -37.14 66.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -44.49 64.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.614 HG22 ' CE2' ' A' ' 62' ' ' PHE . 2.6 pp -67.9 -23.26 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.802 HD23 HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -72.46 -31.08 65.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.2 -53.81 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.802 HG11 ' CD1' ' A' ' 61' ' ' LEU . 21.3 t -58.16 -37.27 61.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.709 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -55.97 -64.95 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.32 42.82 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.014 HD21 HD11 ' A' ' 39' ' ' LEU . 6.0 mt -115.14 -33.83 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 119' ' ' LEU . 1.3 tt -94.95 42.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.459 179.884 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.544 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.464 0.173 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.72 143.84 30.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.177 0.513 . . . . 0.0 112.042 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.856 ' CH2' HD12 ' A' ' 39' ' ' LEU . 63.9 m95 -100.79 92.29 5.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.167 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.688 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 58.3 m-85 -91.69 106.2 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.788 0.328 . . . . 0.0 111.33 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.86 124.96 32.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.558 HG11 HD12 ' A' ' 91' ' ' ILE . 5.2 t -100.0 162.05 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.51 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -122.66 133.27 54.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -136.78 -174.74 3.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 151.84 23.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.1 p -66.47 124.89 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.82 -27.61 18.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.61 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.07 -27.69 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.98 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.65 -35.11 70.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.98 -39.69 66.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -87.82 -27.94 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.024 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.0 69.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -58.36 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.027 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.87 -47.95 81.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.274 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.11 -40.51 73.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.992 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.927 HD11 HG22 ' A' ' 85' ' ' VAL . 31.6 tp -65.91 -53.41 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -58.77 -45.81 88.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.014 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -58.58 -41.91 86.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.658 ' HG3' HG22 ' A' ' 88' ' ' THR . 8.7 mmt85 -65.38 -46.91 78.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.759 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.788 HG23 HD12 ' A' ' 31' ' ' LEU . 81.1 mt -65.52 -32.05 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.936 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -31.66 39.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -36.54 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -82.64 -24.68 33.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.045 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.615 ' O ' HD23 ' A' ' 31' ' ' LEU . . . 87.66 77.35 1.27 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.376 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -139.61 38.76 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 110.726 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -8.74 56.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.402 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.2 m-20 -79.99 -28.06 39.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.41 -59.58 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.766 HG12 HG21 ' A' ' 26' ' ' ILE . 1.1 pt -79.92 122.02 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 3' ' ' ILE . 14.1 m-85 -110.0 -45.1 3.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.237 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.589 HE22 HD13 ' A' ' 118' ' ' LEU . 2.4 mm100 -120.35 170.25 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.218 0.532 . . . . 0.0 111.89 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 t -154.31 88.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.149 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.856 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -79.72 157.15 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.758 HD12 ' OG1' ' A' ' 42' ' ' THR . 7.6 pt -120.2 145.37 40.03 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.939 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.47 -15.4 45.16 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.651 2.234 . . . . 0.0 113.002 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.758 ' OG1' HD12 ' A' ' 40' ' ' ILE . 80.5 p . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.075 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.8 pttt . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.826 0.346 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.741 ' HG3' HG22 ' A' ' 42' ' ' THR . 0.0 OUTLIER -81.37 109.18 15.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.408 HD12 HG21 ' A' ' 115' ' ' VAL . 47.4 mt -76.41 -68.61 0.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.651 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.412 ' CB ' ' HB2' ' A' ' 65' ' ' TYR . 46.6 m-85 -100.47 96.89 5.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.644 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.61 115.28 2.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.55 2.166 . . . . 0.0 112.635 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.58 38.39 51.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.821 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HB2' ' CB ' ' A' ' 62' ' ' PHE . 88.1 m-85 -132.61 109.98 10.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD21 ' HB ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -103.67 137.24 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.549 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.685 ' CE2' HD12 ' A' ' 112' ' ' ILE . 3.9 m-85 -106.37 135.59 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -135.08 110.43 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.473 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 tt0 -85.53 74.34 10.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 110.224 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.4 ptp -91.42 -167.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.499 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.471 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.7 t70 -137.48 94.98 2.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.655 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.688 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 15.5 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.047 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.529 0.204 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HA ' HD22 ' A' ' 72' ' ' LEU . 72.1 Cg_endo -77.11 162.1 31.95 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.466 2.111 . . . . 0.0 112.365 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.1 -178.0 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -61.78 -29.49 70.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -57.41 -44.83 84.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.444 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.5 t-105 -61.06 -35.53 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -32.25 72.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.616 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 31' ' ' LEU . 21.5 t -87.62 -49.9 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.064 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.927 HG22 HD11 ' A' ' 22' ' ' LEU . 25.2 t -57.17 -38.26 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -71.32 -22.5 61.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.48 20.83 10.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.933 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.658 HG22 ' HG3' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -87.95 145.7 37.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.632 0.253 . . . . 0.0 110.844 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.2 84.85 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.486 2.124 . . . . 0.0 112.222 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.37 -32.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.558 HD12 HG11 ' A' ' 8' ' ' VAL . 47.5 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.377 . . . . 0.0 111.017 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.411 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 4.6 mtt85 . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.639 0.257 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.444 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 91.5 Cg_exo -44.91 166.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.707 2.271 . . . . 0.0 112.65 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.09 111.47 33.9 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.493 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.01 145.93 10.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.643 2.229 . . . . 0.0 112.239 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.613 HD13 ' N ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -87.21 171.31 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 111.004 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.807 ' O ' HG23 ' A' ' 109' ' ' VAL . 24.1 p -90.06 152.57 46.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.788 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.22 -32.48 70.93 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.722 2.281 . . . . 0.0 112.447 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 -41.4 58.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -78.91 -30.18 44.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 105' ' ' SER . 66.3 t -62.82 -42.48 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.211 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -36.89 80.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -49.92 30.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.859 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.685 HD12 ' CE2' ' A' ' 67' ' ' PHE . 2.8 pt -67.28 -16.38 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.821 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -70.61 -32.64 70.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.836 0.35 . . . . 0.0 110.526 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.47 -10.74 57.42 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.408 HG21 HD12 ' A' ' 61' ' ' LEU . 40.4 t -75.87 -48.59 28.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 111.509 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 4.3 t -65.83 -56.61 11.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.428 . . . . 0.0 110.656 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.621 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 142.81 42.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.821 HD12 ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -108.65 -28.3 9.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.36 -31.2 7.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.424 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.313 0.102 . . . . 0.0 110.837 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 153.8 37.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.243 0.544 . . . . 0.0 112.206 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.698 ' HH2' HD23 ' A' ' 39' ' ' LEU . 73.9 m95 -97.46 88.84 4.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.356 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.765 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 50.2 m-85 -79.82 125.58 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.828 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -107.19 148.31 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 9' ' ' HIS . 21.7 t -135.67 162.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.528 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.52 ' N ' HG12 ' A' ' 8' ' ' VAL . 3.0 m-70 -101.37 147.79 25.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.7 p -141.26 -176.96 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.55 130.78 34.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.725 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.0 p -57.69 118.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.58 -23.5 35.55 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.79 -20.54 18.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.237 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -44.32 70.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.79 -46.03 74.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -79.6 -27.29 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.819 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.8 97.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -49.8 -48.53 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.204 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.48 74.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.67 -38.45 89.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.532 HD22 HG21 ' A' ' 88' ' ' THR . 2.1 mt -74.39 -56.64 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.031 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -41.69 -36.58 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -77.67 -37.87 48.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -75.75 -27.84 58.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.644 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 31' ' ' LEU . 37.9 mm -73.44 -30.18 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.626 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -80.86 -29.82 35.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.17 -43.12 44.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -81.65 -3.46 53.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.372 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 81.04 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.607 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.2 mt -136.48 23.06 3.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.98 -15.87 58.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.131 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.45 -7.33 59.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.492 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' CE ' ' HB2' ' A' ' 81' ' ' ALA . 4.9 ptmm? -115.99 -46.66 2.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.731 0.3 . . . . 0.0 110.854 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.85 108.63 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.652 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 3' ' ' ILE . 8.5 m-85 -94.5 -60.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.455 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -108.92 146.48 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.108 0.48 . . . . 0.0 111.298 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG22 HG23 ' A' ' 68' ' ' ILE . 21.6 t -146.51 89.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.55 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 118' ' ' LEU . 4.5 mm? -102.59 166.86 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.429 HD12 ' OG1' ' A' ' 42' ' ' THR . 19.9 pt -120.69 134.91 24.33 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.748 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 36.9 Cg_endo -66.16 65.29 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.521 2.147 . . . . 0.0 112.547 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.429 ' OG1' HD12 ' A' ' 40' ' ' ILE . 35.9 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.772 0.32 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 42' ' ' THR . 1.9 mtmt -58.96 102.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.809 HD11 HG11 ' A' ' 115' ' ' VAL . 77.4 mt -73.23 -48.28 36.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 1.7 m-85 -116.64 88.9 26.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.97 125.69 20.03 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.67 2.247 . . . . 0.0 112.779 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.65 35.53 74.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.123 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 66' ' ' LEU . 6.4 m-85 -126.69 164.19 21.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -153.32 120.8 5.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.484 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.771 ' CD1' HD11 ' A' ' 104' ' ' LEU . 12.4 m-85 -94.65 138.09 32.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.561 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 38' ' ' VAL . 2.2 mp -141.68 116.1 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.979 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 5.3 tt0 -81.04 66.66 6.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.645 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.499 ' CE ' HD21 ' A' ' 72' ' ' LEU . 3.4 ptm -91.15 -171.08 2.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -148.48 99.5 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.765 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 9.2 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.545 0.212 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.32 172.52 14.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.4 2.067 . . . . 0.0 112.288 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.35 176.62 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -57.7 -21.36 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.265 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.22 -48.8 67.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.245 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -59.47 -38.36 80.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -86.05 -51.54 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 81' ' ' ALA . 22.7 t -62.65 -48.8 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.045 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -9.33 58.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.361 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.46 24.17 4.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.918 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -76.32 144.32 74.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.649 0.261 . . . . 0.0 110.707 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.04 96.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.604 2.203 . . . . 0.0 112.695 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.86 52.77 4.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.083 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.818 ' O ' HD13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.581 0.229 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.46 -169.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.582 2.188 . . . . 0.0 112.418 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.44 88.54 4.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.8 148.58 71.49 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.616 2.211 . . . . 0.0 112.379 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.771 HD11 ' CD1' ' A' ' 67' ' ' PHE . 8.9 mt -90.0 169.56 11.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.901 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -90.01 148.51 39.7 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.682 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.67 -46.1 35.92 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.686 2.257 . . . . 0.0 112.248 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -64.97 -27.96 69.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -85.73 -37.9 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 105' ' ' SER . 48.2 t -57.65 -29.35 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.104 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -77.94 -28.59 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.805 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.5 t-160 -79.2 -40.16 31.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.564 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.477 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.3 pp -72.06 -24.85 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.8 ' CD2' HD12 ' A' ' 118' ' ' LEU . 20.0 mt -73.87 -34.89 64.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.83 -31.36 59.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.982 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.809 HG11 HD11 ' A' ' 61' ' ' LEU . 25.0 t -71.93 -43.08 68.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.132 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.691 ' HB2' HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -58.68 -61.59 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.913 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.66 43.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.559 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.8 HD12 ' CD2' ' A' ' 113' ' ' LEU . 16.2 mt -113.38 -35.69 5.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.14 36.27 3.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.776 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.329 -1.261 . . . . 0.0 112.517 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.824 HG21 ' CE1' ' A' ' 36' ' ' PHE . 1.3 pp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.773 0.32 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -143.36 161.11 39.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.286 0.565 . . . . 0.0 111.582 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.681 ' O ' HD12 ' A' ' 104' ' ' LEU . 94.9 m95 -86.82 86.64 7.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.593 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.673 ' O ' HD12 ' A' ' 68' ' ' ILE . 57.1 m-85 -79.69 113.54 17.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.376 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -105.43 135.51 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 111.822 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 9' ' ' HIS . 0.6 OUTLIER -125.66 -167.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.399 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.631 ' N ' HG13 ' A' ' 8' ' ' VAL . 8.1 m-70 -126.39 167.22 15.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.061 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -151.42 -174.61 4.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.13 133.63 35.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 12' ' ' VAL . 26.1 m -58.8 117.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.003 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.41 -28.99 12.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -84.47 -21.18 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 111.195 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -54.37 -32.29 56.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.126 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -50.95 -60.8 2.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.287 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -75.26 -19.79 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . . . -67.2 -31.89 72.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.769 0.319 . . . . 0.0 111.067 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.742 ' HD2' HD11 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -59.82 -55.84 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.83 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.58 -32.79 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.489 HD12 HG21 ' A' ' 88' ' ' THR . 58.0 tp -80.06 -50.28 10.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' OE1' HG11 ' A' ' 38' ' ' VAL . 12.6 tp10 -59.97 -52.51 65.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.104 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -39.98 75.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -40.14 90.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.566 HG12 HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -62.29 -35.01 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.75 -10.21 40.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.422 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 81.92 73.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.344 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 80' ' ' GLU . 3.8 mm? -126.12 23.35 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.293 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -79.45 24.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.107 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.53 -23.93 10.85 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.883 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -107.96 -42.95 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.706 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.663 HD11 ' HB1' ' A' ' 81' ' ' ALA . 4.3 mp -84.89 93.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.824 ' CE1' HG21 ' A' ' 3' ' ' ILE . 30.4 m-85 -82.0 -49.02 10.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.36 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.465 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mt-30 -121.86 156.87 32.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.2 p -153.66 76.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.465 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.935 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.3 mm? -80.02 142.53 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.141 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.545 HD12 ' CG ' ' A' ' 19' ' ' LYS . 30.4 mm -98.09 110.92 57.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.983 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 31.5 Cg_exo -57.75 79.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.586 2.191 . . . . 0.0 112.437 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 16.7 p . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.429 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.656 0.265 . . . . 0.0 110.852 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.64 115.21 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 115' ' ' VAL . 76.0 mt -90.22 -53.12 4.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.53 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 18.9 m-85 -114.24 86.13 11.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.369 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.51 119.35 4.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.064 2.51 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.87 -13.67 29.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.778 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 2.5 m-85 -79.94 152.82 29.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.051 0.425 . . . . 0.0 111.412 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.742 HD11 ' HD2' ' A' ' 19' ' ' LYS . 1.2 mt -146.89 121.27 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.548 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.776 ' CD2' HD12 ' A' ' 112' ' ' ILE . 6.2 m-85 -91.21 125.4 35.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.0 OUTLIER -136.24 114.37 14.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.256 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.599 ' CG ' HD13 ' A' ' 3' ' ' ILE . 28.1 tt0 -79.89 68.81 6.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.2 ptm -91.39 -170.73 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.699 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.482 ' CB ' HG22 ' A' ' 3' ' ' ILE . 16.9 t0 -129.28 101.0 5.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.723 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.568 HD12 ' CG ' ' A' ' 6' ' ' TYR . 31.7 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.395 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.549 0.214 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.86 -171.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.289 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -89.95 -174.15 4.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.588 ' HG3' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -60.8 -22.87 64.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.663 ' HB1' HD11 ' A' ' 35' ' ' ILE . . . -53.32 -46.59 69.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.322 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.8 t-105 -61.24 -38.33 86.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -31.11 69.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.44 HG21 ' CD2' ' A' ' 31' ' ' LEU . 21.5 t -81.34 -46.27 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.643 HG12 HG13 ' A' ' 91' ' ' ILE . 22.0 t -64.17 -32.83 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -23.05 62.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.036 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -100.39 -8.88 48.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.009 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.489 HG21 HD12 ' A' ' 22' ' ' LEU . 1.2 p -74.94 114.61 36.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.852 0.326 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.75 115.48 2.14 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.405 2.07 . . . . 0.0 112.356 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.11 -18.42 5.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.643 HG13 HG12 ' A' ' 85' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.731 0.3 . . . . 0.0 111.096 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.482 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 2.0 mmp_? . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.496 0.189 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.3 Cg_exo -67.24 157.68 60.6 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.638 2.225 . . . . 0.0 112.08 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 102' ' ' VAL . 5.9 m -154.17 98.23 2.57 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 41.4 Cg_exo -56.39 145.24 79.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.421 2.081 . . . . 0.0 112.244 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.727 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.9 mp -83.39 160.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.878 ' O ' HG23 ' A' ' 109' ' ' VAL . 60.0 p -77.04 145.38 73.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.46 -29.24 39.0 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.526 2.151 . . . . 0.0 112.228 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -77.13 -37.34 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.66 -35.73 33.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 105' ' ' SER . 36.2 t -60.95 -51.54 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.17 68.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.471 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -73.72 -51.27 17.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.614 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.776 HD12 ' CD2' ' A' ' 67' ' ' PHE . 22.6 pt -66.48 -19.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.754 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.885 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.79 -38.97 61.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.746 179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.28 -34.31 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.001 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 61' ' ' LEU . 11.3 t -83.91 -33.18 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.253 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.935 ' HB3' HD12 ' A' ' 39' ' ' LEU . 4.2 m -59.84 -60.77 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.22 41.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.645 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.885 HD12 ' HG ' ' A' ' 113' ' ' LEU . 45.6 mt -120.9 -57.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.75 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.72 31.11 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.332 -1.26 . . . . 0.0 112.432 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.606 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.43 0.157 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.38 150.78 27.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.331 0.586 . . . . 0.0 112.154 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 1.025 ' CH2' HD12 ' A' ' 39' ' ' LEU . 72.1 m95 -92.63 85.96 5.43 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.264 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.601 ' CE1' HD12 ' A' ' 72' ' ' LEU . 57.5 m-85 -81.19 129.06 34.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -111.38 124.7 52.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.354 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.516 HG11 HD11 ' A' ' 91' ' ' ILE . 13.6 t -101.1 159.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.474 ' N ' HG12 ' A' ' 8' ' ' VAL . 1.7 m-70 -106.56 151.83 24.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.9 p -157.11 170.25 22.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.23 143.77 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.97 127.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.48 -27.81 17.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.485 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -99.18 -24.0 15.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 111.06 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.45 -53.75 53.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.051 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.42 -41.56 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -72.61 -33.66 66.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.225 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -47.39 -55.56 8.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -43.96 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.972 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mt -69.16 -63.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -40.86 -32.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.749 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -43.32 30.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 110.624 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -77.39 -26.59 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.777 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.529 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.6 mm -83.97 -25.53 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -96.48 -29.91 13.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.82 -44.53 63.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.91 -24.59 40.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.978 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.08 53.32 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.382 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.529 ' HB2' HG23 ' A' ' 26' ' ' ILE . 2.9 mm? -99.98 32.04 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.963 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -79.17 8.93 5.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -97.48 -21.07 17.34 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -103.66 -55.08 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.596 HG23 ' CG2' ' A' ' 68' ' ' ILE . 18.8 mm -81.49 94.54 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.673 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.606 ' CE2' HG21 ' A' ' 3' ' ' ILE . 11.7 m-85 -79.99 -55.33 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.351 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.498 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt-30 -114.36 166.73 11.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.161 0.505 . . . . 0.0 111.709 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.2 t -150.32 89.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.025 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -80.59 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.171 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.594 HD12 ' O ' ' A' ' 42' ' ' THR . 1.4 pt -104.54 104.24 44.13 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.811 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 35.8 Cg_exo -57.67 -9.09 4.94 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.698 2.265 . . . . 0.0 113.147 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.594 ' O ' HD12 ' A' ' 40' ' ' ILE . 32.8 p . . . . . 0 C--N 1.332 -0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 110.534 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 32.1 mtmt -145.37 92.38 2.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.343 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' HG21 ' A' ' 115' ' ' VAL . 15.1 mt -64.12 -51.84 61.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.334 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 41' ' ' PRO . 10.9 m-85 -116.64 81.69 11.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.702 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 53.1 Cg_exo -54.94 141.73 77.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.604 2.203 . . . . 0.0 112.557 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.74 27.36 66.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.774 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 61.8 m-85 -134.23 151.62 51.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 6.0 mt -147.78 126.68 12.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.388 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.909 ' CD2' HD12 ' A' ' 112' ' ' ILE . 8.9 m-85 -93.96 131.66 39.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 111.219 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.596 ' CG2' HG23 ' A' ' 35' ' ' ILE . 1.3 mp -138.14 113.99 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 3.3 tt0 -79.88 71.73 6.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.106 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.607 ' CE ' HD21 ' A' ' 72' ' ' LEU . 3.8 ptm -91.66 -171.15 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.342 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -129.71 79.08 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.545 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.607 HD21 ' CE ' ' A' ' 70' ' ' MET . 20.5 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.775 0.321 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.6 165.87 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.493 2.128 . . . . 0.0 112.281 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 81' ' ' ALA . 8.1 p-10 -90.11 -177.9 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.69 -28.22 68.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . . . -54.8 -45.61 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.194 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -62.61 -31.93 72.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -33.63 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.701 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.009 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.559 ' O ' HG21 ' A' ' 91' ' ' ILE . 21.9 t -59.24 -39.19 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -74.75 -20.78 59.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.01 6.23 43.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.117 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.865 ' O ' HG22 ' A' ' 91' ' ' ILE . 12.7 p -74.79 143.64 78.67 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.858 0.329 . . . . 0.0 110.672 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.15 104.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.459 2.106 . . . . 0.0 112.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.5 17.51 6.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.791 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.865 HG22 ' O ' ' A' ' 88' ' ' THR . 7.6 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 0.0 110.979 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.735 0.302 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.441 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_exo -49.81 143.35 23.41 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.587 2.191 . . . . 0.0 112.32 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.71 118.95 29.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.92 163.1 13.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.0 112.292 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.494 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.4 mt -90.0 168.41 12.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.918 ' O ' HG23 ' A' ' 109' ' ' VAL . 57.4 p -88.74 147.04 38.3 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.49 -33.96 93.72 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.249 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -26.71 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -95.48 -36.7 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.952 HG11 ' CD1' ' A' ' 5' ' ' TRP . 40.9 t -59.39 -31.77 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -59.74 -43.12 94.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -53.91 34.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.67 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.909 HD12 ' CD2' ' A' ' 67' ' ' PHE . 9.9 pt -61.23 -23.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.259 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.797 ' HA ' HD21 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -59.57 -36.71 76.74 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.29 -17.71 59.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 61' ' ' LEU . 21.4 t -77.5 -60.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.483 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.544 ' HB3' HD23 ' A' ' 39' ' ' LEU . 86.1 p -51.81 -59.96 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.513 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 139.79 46.16 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.742 HD12 ' HG ' ' A' ' 113' ' ' LEU . 2.6 mt -114.92 -43.82 3.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tp -98.7 30.88 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.428 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.75 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.439 0.162 . . . . 0.0 110.862 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -141.15 147.6 38.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 112.225 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.705 ' CZ2' HD11 ' A' ' 113' ' ' LEU . 78.1 m95 -92.61 93.06 8.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.185 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.873 ' CE2' HD12 ' A' ' 72' ' ' LEU . 29.1 m-85 -80.03 112.74 17.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 111.087 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -104.55 145.06 30.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.63 178.24 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -107.91 143.65 36.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 p -138.59 174.19 10.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.93 144.47 25.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 12' ' ' VAL . 30.7 m -58.68 119.03 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -27.76 15.85 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.475 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.04 -30.26 39.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.652 0.263 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -40.14 86.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.58 -43.07 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 tttm -86.99 -25.48 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.88 -30.7 70.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' NZ ' HD11 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -63.36 -50.49 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 -41.37 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.45 -44.9 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.52 -47.09 67.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.773 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -57.86 -21.77 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.63 -46.23 14.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.965 0.412 . . . . 0.0 110.289 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -67.31 -23.36 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.413 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -71.06 -28.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -98.08 -31.93 11.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.37 87.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -82.77 -42.06 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' C ' HD23 ' A' ' 31' ' ' LEU . . . 106.99 77.41 1.06 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -155.18 29.37 0.4 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 110.823 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -15.43 61.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.137 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -24.55 42.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -53.62 6.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.568 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.03 153.06 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.474 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.75 ' CE2' HG21 ' A' ' 3' ' ' ILE . 25.8 m-85 -135.38 -54.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 0.0 111.402 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.28 157.92 25.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.382 0.611 . . . . 0.0 111.605 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.39 62.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.06 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' A' ' 116' ' ' SER . 1.9 tm? -79.58 129.37 34.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.586 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.482 HG22 HG23 ' A' ' 42' ' ' THR . 1.8 mp -105.28 128.36 26.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.666 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 30.7 Cg_endo -63.85 78.84 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.564 2.176 . . . . 0.0 112.635 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.482 HG23 HG22 ' A' ' 40' ' ' ILE . 48.5 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.792 0.33 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -63.66 101.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.949 HD11 HG11 ' A' ' 115' ' ' VAL . 83.1 mt -61.62 -31.77 71.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 9.0 m-85 -139.59 83.97 16.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.631 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.46 139.47 90.25 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.59 2.193 . . . . 0.0 112.509 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.64 72.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.744 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -131.58 136.63 47.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.749 0.309 . . . . 0.0 110.954 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -131.53 128.76 39.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.465 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.967 ' CD2' HD12 ' A' ' 112' ' ' ILE . 5.3 m-85 -99.09 121.63 41.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.4 mp -125.48 111.43 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.537 ' NE2' HD11 ' A' ' 3' ' ' ILE . 4.7 tt0 -79.9 72.19 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.663 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 ptp -91.63 -163.23 1.01 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.177 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -147.77 89.2 1.73 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.662 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.873 HD12 ' CE2' ' A' ' 6' ' ' TYR . 11.2 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.704 0.287 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.24 150.25 20.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.513 2.142 . . . . 0.0 112.256 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -165.83 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.468 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.3 pt-20 -57.81 -21.29 41.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.164 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -49.26 -35.9 19.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.431 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -80.46 -29.72 37.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.07 -28.24 63.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 80' ' ' GLU . 22.7 t -84.83 -51.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 81' ' ' ALA . 39.2 t -58.63 -37.36 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -73.97 -26.35 60.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.175 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.5 6.13 60.86 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.008 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 120.68 69.22 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.774 0.287 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 115.18 2.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.26 -13.16 6.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.791 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 111.064 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.572 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.405 0.145 . . . . 0.0 111.011 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 100' ' ' ARG . 65.6 Cg_endo -85.12 155.07 11.1 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.698 2.266 . . . . 0.0 111.959 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 63.4 t -155.71 114.61 2.22 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.102 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.62 156.54 40.27 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.476 2.118 . . . . 0.0 112.388 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.2 mp -89.72 147.81 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -70.95 153.3 94.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.53 -36.45 59.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.55 2.166 . . . . 0.0 112.311 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.63 -35.62 81.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.72 -38.81 20.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 105' ' ' SER . 38.3 t -58.84 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.056 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -53.68 -30.02 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.032 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 -54.91 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.707 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.967 HD12 ' CD2' ' A' ' 67' ' ' PHE . 15.7 pt -66.95 -26.2 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 ' CZ2' ' A' ' 5' ' ' TRP . 1.1 mp -72.2 -31.33 65.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.249 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -41.88 73.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.949 HG11 HD11 ' A' ' 61' ' ' LEU . 19.1 t -84.64 -27.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.481 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t -52.23 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.819 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 150.96 38.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.349 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.819 HD23 ' C ' ' A' ' 117' ' ' GLY . 2.4 mt -122.31 -37.74 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.88 -34.58 39.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.434 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.581 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.622 0.248 . . . . 0.0 110.995 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.29 164.0 34.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.98 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.882 ' CZ2' HD21 ' A' ' 113' ' ' LEU . 76.1 m95 -94.8 132.72 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.814 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 28.0 m-85 -119.11 122.81 42.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.803 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -101.55 131.52 47.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.481 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 HD12 ' A' ' 91' ' ' ILE . 15.6 t -117.59 159.54 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.788 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.477 ' N ' HG12 ' A' ' 8' ' ' VAL . 15.8 m-70 -94.27 133.52 37.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.046 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.51 HG21 HD13 ' A' ' 66' ' ' LEU . 36.7 p -144.74 -177.5 5.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.14 140.65 29.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.1 p -60.62 123.91 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.52 5.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.235 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -81.57 -18.14 45.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.913 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -44.96 -40.43 6.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.286 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -37.9 80.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -33.74 64.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.58 -43.77 88.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -66.1 -35.98 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.78 -54.92 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.003 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -60.26 -31.68 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.577 HD12 HG21 ' A' ' 88' ' ' THR . 38.0 tp -74.96 -57.25 4.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.91 -32.39 6.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -71.64 -41.3 68.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.761 ' HG3' HG22 ' A' ' 88' ' ' THR . 2.3 mmp_? -68.23 -39.33 82.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.587 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.767 ' HA ' HD12 ' A' ' 31' ' ' LEU . 37.5 mm -64.83 -31.46 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.828 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -83.99 -30.17 26.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.65 -44.87 76.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.04 -29.77 39.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.23 43.63 3.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.449 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.918 HD11 HG21 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -99.84 28.9 4.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 110.825 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -69.54 -13.11 62.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.409 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 1.1 m-20 -79.75 -23.8 42.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.565 ' CE ' ' HB2' ' A' ' 81' ' ' ALA . 13.8 mtpp -94.56 -56.3 2.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.843 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.01 136.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.669 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.1 m-85 -132.27 -64.13 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.449 . . . . 0.0 111.447 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.02 151.74 21.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.82 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.7 HG12 HG23 ' A' ' 68' ' ' ILE . 5.2 m -159.81 106.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.494 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.734 HD11 HD21 ' A' ' 118' ' ' LEU . 4.4 mm? -118.82 160.45 21.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.378 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 pt -103.54 131.78 21.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 37.1 Cg_endo -65.65 83.28 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.555 2.17 . . . . 0.0 112.806 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.9 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.866 179.756 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 mttm . . . . . 0 CA--C 1.524 -0.024 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -133.1 100.94 5.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.788 HD11 HG11 ' A' ' 115' ' ' VAL . 63.1 mt -76.45 -31.71 58.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.652 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.0 m-85 -140.42 67.65 31.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.557 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.39 120.19 7.89 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.63 2.22 . . . . 0.0 112.213 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 16.07 22.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.661 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.46 154.16 50.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 10' ' ' THR . 0.3 OUTLIER -136.38 115.02 11.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.529 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.882 ' CD2' HD13 ' A' ' 112' ' ' ILE . 14.5 m-85 -79.83 125.01 29.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.276 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 38' ' ' VAL . 1.9 mp -134.03 112.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.142 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.4 tt0 -80.81 74.54 7.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.798 0.333 . . . . 0.0 110.936 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptp -91.24 -169.65 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.011 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -147.02 89.01 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.814 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 62.6 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.574 0.226 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.08 177.82 8.33 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.477 2.118 . . . . 0.0 112.506 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -90.09 -164.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.64 -27.16 57.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.565 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . . . -51.43 -34.97 37.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.399 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -66.21 -33.75 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.8 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -31.82 72.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.743 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -72.64 -49.58 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.85 HG12 HG13 ' A' ' 91' ' ' ILE . 21.6 t -58.17 -53.85 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp-105 -58.69 -29.35 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.64 -28.13 52.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.532 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 84' ' ' VAL . 44.9 p -69.58 130.4 90.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.55 0.214 . . . . 0.0 110.756 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.76 -23.8 28.04 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.418 2.078 . . . . 0.0 112.348 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.78 -27.32 55.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.619 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.85 HG13 HG12 ' A' ' 85' ' ' VAL . 38.0 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.427 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.511 0.196 . . . . 0.0 111.019 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 6.1 Cg_exo -79.05 -174.74 2.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.828 2.352 . . . . 0.0 112.226 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -150.74 72.21 8.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.06 133.94 37.69 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.524 2.149 . . . . 0.0 112.522 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 67' ' ' PHE . 3.2 mt -88.84 167.85 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -89.98 148.06 38.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.36 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.513 2.142 . . . . 0.0 112.277 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.97 -27.71 61.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -90.4 -33.5 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 105' ' ' SER . 33.5 t -60.53 -40.73 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.167 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -19.4 62.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.743 ' O ' HG23 ' A' ' 115' ' ' VAL . 44.5 m-70 -83.34 -44.06 15.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.96 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.882 HD13 ' CD2' ' A' ' 67' ' ' PHE . 1.8 pp -74.96 -20.19 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.134 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.882 HD21 ' CZ2' ' A' ' 5' ' ' TRP . 97.4 mt -84.95 -34.01 22.54 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.863 0.363 . . . . 0.0 110.591 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -73.13 -28.23 62.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.693 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 HD11 ' A' ' 61' ' ' LEU . 16.0 t -89.51 -31.11 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.999 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.67 ' HB3' HD12 ' A' ' 39' ' ' LEU . 3.2 m -60.28 -64.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 149.09 55.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.722 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.734 HD21 HD11 ' A' ' 39' ' ' LEU . 1.2 mt -135.5 -48.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.684 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -4.06 50.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.439 -1.2 . . . . 0.0 112.439 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.63 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.603 0.239 . . . . 0.0 110.797 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.86 164.68 37.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.258 0.551 . . . . 0.0 111.829 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.692 ' HH2' HD23 ' A' ' 39' ' ' LEU . 79.0 m95 -89.74 129.77 36.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.858 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.497 ' OH ' HD12 ' A' ' 72' ' ' LEU . 4.7 m-30 -112.61 108.35 17.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.286 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.42 137.56 32.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.73 158.16 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.632 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 1.1 m-70 -104.32 132.98 49.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.911 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.8 p -128.04 -173.78 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.66 131.4 41.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 12' ' ' VAL . 19.1 m -59.17 115.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.41 -28.73 12.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -20.04 35.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.543 ' OE2' HD12 ' A' ' 40' ' ' ILE . 1.5 tm-20 -53.87 -32.62 53.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.855 0.359 . . . . 0.0 111.154 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.65 -38.64 72.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -24.11 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.97 -51.27 70.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.303 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -50.66 -41.46 55.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.41 75.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -65.31 -36.27 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.476 HD22 HG21 ' A' ' 88' ' ' THR . 2.5 mt -79.5 -54.43 5.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -43.99 -31.32 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.615 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.5 -35.81 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.686 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -79.92 -25.29 40.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.821 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.793 ' HA ' HD12 ' A' ' 31' ' ' LEU . 38.0 mm -80.73 -28.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.698 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -91.47 -30.33 16.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.33 -42.94 61.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -80.21 -28.09 38.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 58.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -114.39 30.96 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.97 -10.72 60.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.233 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.406 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -79.97 -24.73 40.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.739 0.304 . . . . 0.0 110.983 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -61.94 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 68' ' ' ILE . 18.1 mm -79.96 111.92 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.63 ' CE2' HG21 ' A' ' 3' ' ' ILE . 12.3 m-85 -99.53 -58.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.197 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -109.29 146.14 34.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.45 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' HD22 ' A' ' 39' ' ' LEU . 22.5 t -153.81 117.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.698 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.692 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.4 mm? -126.1 156.61 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.973 0.416 . . . . 0.0 111.278 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.543 HD12 ' OE2' ' A' ' 15' ' ' GLU . 3.5 tt -106.76 124.68 34.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.638 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 33.9 Cg_endo -64.7 69.78 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.54 2.16 . . . . 0.0 112.758 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.512 179.642 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.783 0.325 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -51.6 119.17 3.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.853 HD11 HG11 ' A' ' 115' ' ' VAL . 28.9 mt -90.1 -44.09 10.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 3.7 m-85 -115.73 91.36 29.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.23 117.75 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.909 2.406 . . . . 0.0 112.968 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.92 45.09 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.962 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.402 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -132.29 149.16 52.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.757 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.39 118.0 9.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.932 ' CD2' HD12 ' A' ' 112' ' ' ILE . 7.5 m-85 -88.25 133.9 33.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.795 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 35' ' ' ILE . 5.3 mt -135.37 111.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.128 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 7.8 tt0 -79.65 67.22 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.418 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.402 ' CB ' HD13 ' A' ' 35' ' ' ILE . 2.8 ptm -91.2 -168.6 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.279 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -145.6 108.56 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.777 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.497 HD12 ' OH ' ' A' ' 6' ' ' TYR . 4.4 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.502 0.191 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.76 166.6 28.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.464 2.109 . . . . 0.0 112.345 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.83 173.55 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 84' ' ' VAL . 9.1 pt-20 -59.14 -25.16 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.36 -50.55 67.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.306 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.431 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.0 t-105 -58.3 -42.02 85.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -59.85 -30.87 69.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.855 ' O ' HG23 ' A' ' 88' ' ' THR . 22.1 t -84.07 -52.34 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.694 ' O ' HG21 ' A' ' 91' ' ' ILE . 23.5 t -62.13 -49.03 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.46 -11.87 61.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.251 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.83 -17.18 15.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.872 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.871 ' O ' HG22 ' A' ' 91' ' ' ILE . 30.7 p -56.47 147.58 48.64 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.717 0.294 . . . . 0.0 110.985 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.48 109.73 1.89 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.587 2.192 . . . . 0.0 112.258 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.56 10.42 9.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.722 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.871 HG22 ' O ' ' A' ' 88' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 111.04 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.456 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.657 0.265 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 100' ' ' ARG . 85.6 Cg_exo -42.89 141.62 2.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.78 2.32 . . . . 0.0 112.572 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.8 t -99.92 102.3 17.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.76 150.38 27.29 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.145 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -90.06 153.91 20.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.851 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.6 p -80.97 161.16 64.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.06 -26.89 77.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.696 2.264 . . . . 0.0 112.323 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.85 -31.87 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 112' ' ' ILE . 12.4 tt0 -88.0 -35.22 17.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 105' ' ' SER . 58.3 t -58.68 -48.92 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -25.16 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -80.99 -38.84 26.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.959 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.932 HD12 ' CD2' ' A' ' 67' ' ' PHE . 14.4 pt -78.09 -26.95 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.991 HD22 HD12 ' A' ' 118' ' ' LEU . 90.7 mt -82.11 -26.91 33.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -70.67 -30.09 66.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.853 HG11 HD11 ' A' ' 61' ' ' LEU . 27.9 t -82.6 -38.02 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.656 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -59.25 -62.76 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.632 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 153.21 45.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.557 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.991 HD12 HD22 ' A' ' 113' ' ' LEU . 12.0 mt -128.16 -54.23 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.794 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.37 -31.75 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.503 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.64 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.576 0.227 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.89 159.91 41.26 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 111.705 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.606 ' CD1' HG11 ' A' ' 109' ' ' VAL . 69.2 m95 -101.05 111.51 23.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.69 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 18.9 m-85 -94.96 124.43 39.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.817 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.613 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . -99.53 143.67 29.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.434 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' HD23 ' A' ' 66' ' ' LEU . 6.1 t -140.65 162.03 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.073 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.476 ' N ' HG12 ' A' ' 8' ' ' VAL . 10.2 m170 -86.79 155.87 20.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.271 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.681 ' CG2' HD22 ' A' ' 66' ' ' LEU . 28.6 p -146.56 -176.64 5.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.65 127.81 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.811 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 12' ' ' VAL . 18.6 m -59.24 102.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.097 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.97 -17.67 27.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.631 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -112.87 2.21 15.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 37.3 tt0 -54.96 -45.07 74.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.822 0.344 . . . . 0.0 111.071 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -54.12 -61.54 2.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -66.08 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -58.99 -47.43 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.85 0.357 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -55.53 -41.03 72.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.14 80.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.41 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.413 HD22 ' CB ' ' A' ' 88' ' ' THR . 2.8 mt -83.07 -60.72 2.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -37.53 -34.68 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.778 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -72.85 -51.23 19.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.71 ' HD3' HG22 ' A' ' 88' ' ' THR . 1.2 mtt-85 -69.31 -24.96 64.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.478 HG21 ' CD1' ' A' ' 35' ' ' ILE . 31.9 mm -73.38 -31.06 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.561 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -32.91 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.35 -29.52 65.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.022 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.422 ' CZ ' ' NH1' ' A' ' 25' ' ' ARG . 5.5 m-85 -80.55 -39.59 27.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.78 67.72 0.8 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.947 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.845 HD13 ' HA ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -144.86 34.86 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -13.26 61.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.407 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.64 -22.69 43.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.881 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.5 -49.71 8.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.478 ' CD1' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -95.59 149.48 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.64 ' CE2' HG21 ' A' ' 3' ' ' ILE . 7.8 m-85 -140.12 -47.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.252 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -118.01 157.53 26.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.098 0.475 . . . . 0.0 111.703 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.507 HG12 HG23 ' A' ' 68' ' ' ILE . 2.6 m -156.56 102.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.566 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.985 HD11 HD21 ' A' ' 118' ' ' LEU . 4.3 mm? -113.23 152.84 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.2 mt -99.24 127.03 35.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 26.7 Cg_endo -62.54 78.56 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.536 2.158 . . . . 0.0 112.388 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.594 HG22 ' CG ' ' A' ' 60' ' ' LYS . 42.0 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.805 0.336 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.594 ' CG ' HG22 ' A' ' 42' ' ' THR . 8.5 mtmt -100.73 120.07 39.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.852 HD11 HG11 ' A' ' 115' ' ' VAL . 44.6 mt -76.0 -44.91 37.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.458 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.526 ' CE1' HG22 ' A' ' 112' ' ' ILE . 3.5 m-85 -118.9 70.16 9.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.427 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.85 139.07 83.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.754 2.303 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.5 15.39 79.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.19 160.49 37.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.839 0.352 . . . . 0.0 111.179 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.778 ' CD1' HD11 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -144.91 131.15 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.651 ' CD2' HD13 ' A' ' 112' ' ' ILE . 17.3 m-85 -93.6 123.41 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.2 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.778 HD11 ' CD1' ' A' ' 66' ' ' LEU . 1.6 mt -126.14 116.43 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 5.7 tt0 -79.74 69.89 6.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.6 ptp -91.0 -166.55 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.811 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -160.06 96.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.363 . . . . 0.0 110.889 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.69 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 51.9 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.762 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.581 0.229 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.64 176.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.477 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -90.07 -170.2 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.974 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -29.05 68.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.845 ' HA ' HD13 ' A' ' 31' ' ' LEU . . . -52.86 -27.98 20.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.475 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -78.98 -33.39 45.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.039 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -62.15 -29.73 70.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.9 t -82.96 -40.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 81' ' ' ALA . 31.9 t -67.05 -45.72 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -15.82 62.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.308 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.0 -18.61 9.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.028 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.71 HG22 ' HD3' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -59.19 134.17 87.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.783 0.291 . . . . 0.0 110.945 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 88' ' ' THR . 31.6 Cg_exo -58.3 -30.05 89.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.47 2.114 . . . . 0.0 112.28 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.06 -33.28 60.59 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.701 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 179.836 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 10.6 mtm-85 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.459 0.171 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 34.2 Cg_endo -64.49 148.45 90.64 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.292 1.994 . . . . 0.0 112.296 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 7' ' ' ALA . 7.8 m -145.15 89.01 6.56 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.81 133.01 26.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.49 2.127 . . . . 0.0 112.218 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.6 OUTLIER -84.74 159.07 20.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.048 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.2 m -81.2 160.43 65.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.79 -24.86 79.98 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.374 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.44 -37.12 63.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.052 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.37 -37.35 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.8 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 105' ' ' SER . 94.8 t -58.54 -38.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.19 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -25.92 65.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 115' ' ' VAL . 13.0 m-70 -74.69 -50.62 16.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.707 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.651 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.4 pp -68.16 -16.78 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.701 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -79.05 -41.76 28.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -33.16 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.793 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.852 HG11 HD11 ' A' ' 61' ' ' LEU . 33.5 t -73.46 -30.93 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.989 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.729 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.2 m -70.02 -58.77 3.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 140.97 59.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 39' ' ' LEU . 4.4 mt -133.14 -56.7 0.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -79.87 -50.93 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.535 179.973 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.73 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.469 0.175 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -131.35 148.13 52.64 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.325 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.9 ' CD1' HG11 ' A' ' 109' ' ' VAL . 79.5 m95 -99.95 94.4 6.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.004 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.468 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 77.7 m-85 -84.15 126.62 33.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -104.39 124.78 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.5 p -108.37 159.46 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.193 0.52 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.479 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 21.1 m-70 -96.98 119.11 34.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.6 p -121.84 169.88 10.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.2 mm? -84.84 153.61 22.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 12' ' ' VAL . 12.1 p -66.34 120.86 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.31 21.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.529 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -86.0 -25.63 25.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.16 -45.16 79.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 0.0 111.047 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.05 -42.42 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.61 -28.63 45.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.98 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.487 ' HB1' ' HA3' ' A' ' 90' ' ' GLY . . . -65.14 -35.39 80.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -61.61 -50.87 70.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.63 81.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.1 -37.77 77.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.83 -54.76 5.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.52 -30.54 20.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -44.44 43.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.753 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -73.8 -27.6 61.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.98 -16.27 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -108.06 -29.94 8.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.14 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.87 25.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.175 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CD2' ' HG3' ' A' ' 25' ' ' ARG . 71.1 m-85 -79.88 -2.99 46.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.335 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 76.11 77.47 0.74 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.751 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 30' ' ' GLY . 2.4 mm? -134.99 30.96 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.962 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -77.51 6.18 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.338 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.5 -25.27 22.66 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.739 0.304 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -106.14 -58.0 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mm -81.86 110.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.808 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.5 m-85 -100.81 -53.15 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.216 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.414 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 3.8 mt-30 -116.6 157.43 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 0.0 111.646 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -148.54 67.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.271 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.819 HD11 HD21 ' A' ' 118' ' ' LEU . 3.8 mm? -80.36 156.8 26.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.429 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.522 HD12 ' HD2' ' A' ' 41' ' ' PRO . 4.2 tp -113.78 131.42 23.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.708 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 40' ' ' ILE . 43.5 Cg_endo -67.86 74.18 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.335 2.024 . . . . 0.0 112.548 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.0 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.944 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tptm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.788 0.327 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -53.81 120.54 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.217 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.832 HD11 HG11 ' A' ' 115' ' ' VAL . 48.0 mt -90.18 -40.65 12.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 32.8 m-85 -123.12 76.38 51.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.4 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 46.7 Cg_exo -56.28 141.39 88.66 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.636 2.224 . . . . 0.0 112.496 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.08 20.41 76.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.709 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 96.3 m-85 -131.02 145.02 51.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -134.21 122.1 22.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.527 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.477 ' CE2' HD12 ' A' ' 112' ' ' ILE . 17.5 m-85 -84.73 115.07 22.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.3 mp -123.59 108.81 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.055 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.423 ' HG2' ' CG1' ' A' ' 3' ' ' ILE . 3.0 tt0 -79.85 74.3 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.54 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.1 ptp -91.19 -174.35 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.128 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.7 t0 -125.47 78.15 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.468 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.681 0.277 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.61 165.2 32.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.62 2.213 . . . . 0.0 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.87 178.89 7.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.607 ' O ' HG23 ' A' ' 84' ' ' VAL . 6.0 pt-20 -61.86 -18.79 61.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.241 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.74 -46.72 64.13 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.387 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -59.39 -43.79 92.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.44 -30.17 69.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.674 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 80' ' ' GLU . 34.5 t -71.34 -49.51 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.838 HG12 HG13 ' A' ' 91' ' ' ILE . 19.3 t -61.23 -45.31 98.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -59.75 -23.12 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.64 -32.86 8.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.756 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.58 146.76 79.38 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.27 -25.07 26.62 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.412 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.487 ' HA3' ' HB1' ' A' ' 18' ' ' ALA . . . -55.74 -25.45 43.95 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.643 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.838 HG13 HG12 ' A' ' 85' ' ' VAL . 37.8 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.8 ptt-85 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.67 0.271 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.63 -166.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.584 2.189 . . . . 0.0 112.061 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 102' ' ' VAL . 5.9 m -143.0 99.37 5.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.01 135.17 16.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.128 . . . . 0.0 112.327 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' A' ' 5' ' ' TRP . 1.9 mt -72.65 169.36 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.91 ' O ' HG23 ' A' ' 109' ' ' VAL . 6.6 m -89.14 145.84 35.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.723 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.24 -33.34 97.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.54 2.16 . . . . 0.0 112.393 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.96 -32.91 67.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -34.46 26.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 105' ' ' SER . 48.9 t -57.33 -45.63 85.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -29.99 40.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.15 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.429 ' O ' HG23 ' A' ' 115' ' ' VAL . 20.6 t60 -74.93 -52.4 11.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.542 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.477 HD12 ' CE2' ' A' ' 67' ' ' PHE . 11.6 pt -67.85 -19.38 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.852 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.2 mp -77.17 -38.38 51.82 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.479 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -69.67 -27.67 65.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.832 HG11 HD11 ' A' ' 61' ' ' LEU . 22.4 t -86.68 -31.97 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.565 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -60.08 -64.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.491 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 150.89 43.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.662 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.852 HD12 ' HG ' ' A' ' 113' ' ' LEU . 13.5 mt -120.04 -47.39 2.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.96 -36.55 6.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.351 -1.25 . . . . 0.0 112.485 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.71 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.368 0.128 . . . . 0.0 110.91 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 159.37 39.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.386 0.612 . . . . 0.0 112.481 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.898 ' CD1' HG11 ' A' ' 109' ' ' VAL . 89.7 m95 -97.42 91.77 5.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.476 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.815 ' O ' HD12 ' A' ' 68' ' ' ILE . 62.7 m-85 -83.67 111.17 18.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.353 . . . . 0.0 110.737 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . -90.48 159.04 16.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.35 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.91 162.99 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.897 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -101.3 149.42 24.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.1 p -149.36 -174.36 4.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.1 141.79 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 12' ' ' VAL . 12.2 p -66.98 120.04 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.38 -29.42 10.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -85.71 -23.41 27.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.791 0.329 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -54.84 -34.91 63.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.38 -47.14 79.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.011 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -75.7 -27.13 58.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.84 85.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.195 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -47.25 -48.25 24.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.05 73.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.946 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -67.16 -49.79 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.94 -62.45 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -42.84 -31.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.623 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.25 -39.6 25.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.861 0.363 . . . . 0.0 110.474 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.22 51.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.63 -27.12 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.692 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.45 -31.99 11.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.027 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.06 -46.05 68.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.96 -16.97 54.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.76 49.83 4.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.29 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 80' ' ' GLU . 3.1 mm? -96.68 24.57 5.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -80.3 19.4 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.241 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.2 -21.32 16.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -116.49 -49.22 2.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.797 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.471 HG23 ' CG2' ' A' ' 68' ' ' ILE . 5.4 mp -79.9 125.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.876 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HE2' HG21 ' A' ' 3' ' ' ILE . 20.3 m-85 -116.07 -62.13 1.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.491 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -106.71 156.01 19.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 111.224 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.5 p -150.36 73.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.847 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.5 mm? -79.9 139.44 37.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.277 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.423 HG22 HG23 ' A' ' 42' ' ' THR . 33.5 mm -96.43 118.55 65.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.702 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 27.2 Cg_endo -62.31 90.03 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.352 2.034 . . . . 0.0 112.565 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 40.0 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.447 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.799 0.333 . . . . 0.0 110.653 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -112.55 113.14 25.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 111.102 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.011 HD11 HG11 ' A' ' 115' ' ' VAL . 4.9 mt -90.26 -57.62 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.651 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 69.9 m-85 -119.18 87.54 35.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.603 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.37 115.34 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.673 2.249 . . . . 0.0 112.624 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.05 19.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.788 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.462 ' C ' HD12 ' A' ' 66' ' ' LEU . 25.3 m-85 -138.03 147.82 44.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.069 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 65' ' ' TYR . 3.9 mp -145.5 112.91 6.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.844 ' CD2' HD12 ' A' ' 112' ' ' ILE . 5.1 m-85 -84.96 126.13 33.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 111.201 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -130.36 115.61 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 1.9 tp-100 -79.75 71.73 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 0.0 110.354 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.698 ' HE2' HD21 ' A' ' 72' ' ' LEU . 4.6 ptm -91.56 -177.93 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' OD1' HG22 ' A' ' 3' ' ' ILE . 22.8 t70 -121.51 82.84 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.728 HD22 ' HB3' ' A' ' 78' ' ' PRO . 13.7 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.773 0.32 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.728 ' HB3' HD22 ' A' ' 72' ' ' LEU . 61.0 Cg_endo -72.21 108.1 2.41 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.697 2.264 . . . . 0.0 112.275 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -90.15 -77.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.506 ' HB3' HD11 ' A' ' 31' ' ' LEU . 13.5 mt-10 -54.06 -64.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.604 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.723 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -47.59 -32.85 5.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.853 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.401 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 4.7 t-105 -87.44 -29.23 21.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.141 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.81 -29.55 70.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.0 -49.25 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 81' ' ' ALA . 37.3 t -60.15 -41.24 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.33 -21.85 60.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.02 10.3 37.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.114 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.22 135.93 29.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.814 0.307 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.56 120.6 8.5 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.077 . . . . 0.0 112.258 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.24 -8.96 9.6 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.944 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 91' ' ' ILE . 7.8 tp . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 111.082 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.498 0.19 . . . . 0.0 110.934 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.1 Cg_exo -66.92 -179.53 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.647 2.232 . . . . 0.0 112.151 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.82 HG13 ' HB3' ' A' ' 7' ' ' ALA . 7.3 p -160.12 81.86 2.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.9 124.7 9.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.633 ' H ' HD22 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -78.68 172.19 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 109' ' ' VAL . 79.0 p -90.17 147.78 37.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -50.82 -29.39 26.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.605 2.204 . . . . 0.0 112.261 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.91 -42.43 39.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -74.02 -38.27 64.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.898 HG11 ' CD1' ' A' ' 5' ' ' TRP . 40.1 t -59.07 -42.53 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -57.54 -31.37 66.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.954 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -70.04 -56.08 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.844 HD12 ' CD2' ' A' ' 67' ' ' PHE . 21.8 pt -63.56 -24.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.91 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.9 mp -72.71 -38.9 67.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.721 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.18 -33.03 67.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 1.011 HG11 HD11 ' A' ' 61' ' ' LEU . 13.0 t -79.37 -37.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.847 ' OG ' HD12 ' A' ' 39' ' ' LEU . 8.2 t -58.46 -63.5 1.26 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.858 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 150.66 54.94 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.537 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.91 HD12 ' HG ' ' A' ' 113' ' ' LEU . 17.6 mt -133.02 -54.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.37 -31.36 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.405 -1.219 . . . . 0.0 112.535 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.724 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.446 0.165 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.36 150.14 24.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 112.232 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.771 ' CD1' HG11 ' A' ' 109' ' ' VAL . 75.1 m95 -86.09 92.43 8.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.446 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.804 ' CE2' HD12 ' A' ' 72' ' ' LEU . 40.1 m-85 -84.23 114.53 21.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.403 . . . . 0.0 110.87 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.28 154.73 19.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.567 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 66' ' ' LEU . 13.8 m -142.35 179.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 16.1 m-70 -130.75 149.86 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.2 p -145.96 -173.84 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.83 149.83 22.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.6 p -71.45 124.45 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -24.77 27.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.624 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.54 -22.73 17.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.0 111.077 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -54.49 -35.56 63.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.19 -30.97 68.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.91 -28.84 18.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -42.05 81.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.094 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HG3' HG21 ' A' ' 40' ' ' ILE . 2.6 tmtt? -59.77 -38.21 81.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 -44.93 28.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -60.75 -35.08 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 85' ' ' VAL . 67.5 tp -73.78 -57.91 3.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -29.71 15.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -41.94 71.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.75 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HD3' HG22 ' A' ' 88' ' ' THR . 3.1 mpt_? -70.23 -36.89 74.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.89 ' HA ' HD12 ' A' ' 31' ' ' LEU . 29.8 mm -74.5 -29.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.93 -36.6 14.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.177 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.95 -44.74 72.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.32 -26.62 35.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.63 70.43 1.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 26' ' ' ILE . 2.2 mt -123.3 38.93 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 110.857 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.2 -1.12 24.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.538 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.72 -25.22 41.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -55.05 2.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.458 HD13 ' CB ' ' A' ' 70' ' ' MET . 26.4 mm -82.99 127.92 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.636 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 3' ' ' ILE . 23.3 m-85 -120.57 -64.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -102.89 122.29 44.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.433 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 38' ' ' VAL . 6.6 m -114.83 77.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.607 HD23 ' OG ' ' A' ' 116' ' ' SER . 2.6 tm? -91.76 127.59 37.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.95 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 42' ' ' THR . 3.4 pt -102.67 128.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 78.1 Cg_exo -52.2 69.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.991 2.461 . . . . 0.0 113.216 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 40' ' ' ILE . 68.2 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.525 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -67.2 117.63 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.042 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.689 ' CD1' HG21 ' A' ' 115' ' ' VAL . 11.0 mt -81.81 -52.71 6.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.742 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.9 m-85 -129.91 86.89 53.53 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.5 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 147.99 89.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.788 2.325 . . . . 0.0 112.596 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.6 9.1 64.54 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.078 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 22.4 m-85 -119.08 161.97 19.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.977 0.417 . . . . 0.0 111.058 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -154.49 112.56 3.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.415 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CD1' HD11 ' A' ' 104' ' ' LEU . 5.9 m-85 -89.44 122.23 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -129.25 110.49 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.999 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.74 74.87 6.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.301 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.458 ' CB ' HD13 ' A' ' 35' ' ' ILE . 20.9 ptm -91.36 -173.19 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.136 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -126.7 82.86 2.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.804 HD12 ' CE2' ' A' ' 6' ' ' TYR . 62.5 mt . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.497 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.75 0.309 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.83 139.32 36.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.634 2.223 . . . . 0.0 112.26 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.54 178.54 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 84' ' ' VAL . 4.2 pt-20 -58.93 -23.61 61.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.59 -49.33 67.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.328 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -66.3 -35.09 79.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -60.24 -31.44 70.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 88' ' ' THR . 21.8 t -85.09 -46.96 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 81' ' ' ALA . 36.3 t -59.8 -49.32 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -70.82 -18.1 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.031 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.02 -22.67 44.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.793 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 84' ' ' VAL . 54.4 p -54.1 108.38 1.12 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.586 0.231 . . . . 0.0 111.079 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.27 119.27 5.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.77 15.86 19.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.704 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.536 HD13 ' C ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.664 0.269 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.12 178.87 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.627 2.218 . . . . 0.0 112.078 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.37 96.76 8.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.87 125.55 12.22 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.377 2.052 . . . . 0.0 112.207 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 67' ' ' PHE . 1.2 mt -60.69 158.87 11.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.044 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.2 m -89.96 147.36 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.89 -31.31 42.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.436 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -31.38 69.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.974 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.09 -31.08 13.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 105' ' ' SER . 22.0 t -66.39 -29.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.213 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -39.38 93.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -52.28 29.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.566 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.742 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.0 pp -65.06 -21.4 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.69 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.729 HD22 HD12 ' A' ' 118' ' ' LEU . 7.5 mt -69.05 -34.8 75.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -59.66 -22.07 61.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.994 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.689 HG21 ' CD1' ' A' ' 61' ' ' LEU . 23.6 t -73.89 -56.58 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.243 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.607 ' OG ' HD23 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -51.4 -48.46 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.06 21.01 3.57 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.808 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.729 HD12 HD22 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -83.67 -27.7 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.709 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.19 -42.06 4.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.813 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.473 -179.948 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.494 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.454 0.168 . . . . 0.0 110.858 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -157.88 152.11 24.49 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.217 0.532 . . . . 0.0 111.789 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.779 ' CD1' HG11 ' A' ' 109' ' ' VAL . 87.1 m95 -94.97 92.72 7.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.568 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.945 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 40.1 m-85 -81.48 113.13 19.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 110.786 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -93.84 146.68 23.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.445 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.2 p -123.34 159.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.727 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 5.1 m170 -117.27 103.39 10.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.933 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 p -110.08 -174.29 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.96 150.99 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -71.35 126.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.11 26.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.575 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -23.54 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.064 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.48 -33.43 63.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.059 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.87 -34.74 68.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.07 -28.49 20.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.57 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.093 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.736 ' HB3' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -60.1 -38.51 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -179.973 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.27 79.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.022 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -61.62 -32.02 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.576 HD11 HG22 ' A' ' 85' ' ' VAL . 64.2 tp -76.17 -57.65 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -28.94 10.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.47 -41.63 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -37.7 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.798 HG23 ' HB2' ' A' ' 31' ' ' LEU . 35.0 mm -72.53 -30.41 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -89.81 -33.72 16.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.7 -40.01 66.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.91 -26.73 27.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.2 47.51 3.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.798 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.5 mt -99.92 40.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.25 -6.38 49.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.406 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.81 -26.12 40.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.995 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.648 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -95.53 -55.38 3.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.715 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.41 HG23 ' CG2' ' A' ' 68' ' ' ILE . 11.1 mm -88.2 122.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.81 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.494 ' CE2' HG21 ' A' ' 3' ' ' ILE . 10.3 m-85 -112.68 -54.37 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.454 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -111.4 156.5 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.544 HG22 HG23 ' A' ' 68' ' ' ILE . 38.5 t -156.4 75.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.122 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.734 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.5 mm? -91.04 168.06 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.712 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.719 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -123.25 139.41 31.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.805 179.597 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 72.3 Cg_endo -77.1 86.4 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.711 2.274 . . . . 0.0 113.202 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.797 ' O ' HG12 ' A' ' 115' ' ' VAL . 24.3 p . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.14 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.859 0.361 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 41' ' ' PRO . 54.3 mttt -48.53 108.67 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.691 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.473 HD12 HG11 ' A' ' 115' ' ' VAL . 71.1 mt -79.6 -31.88 41.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.471 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 26.7 m-85 -132.06 69.62 80.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.434 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.01 134.6 60.52 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.681 2.254 . . . . 0.0 112.608 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.31 -2.37 82.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.485 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 3.1 m-85 -106.26 110.87 23.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.946 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -101.27 122.28 43.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.488 179.714 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.728 ' CD2' HD12 ' A' ' 112' ' ' ILE . 12.9 m-85 -89.66 119.68 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.2 mp -127.73 106.8 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 8.2 tt0 -79.83 72.99 6.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.434 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -91.11 -174.83 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.194 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.459 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.9 t0 -131.01 110.36 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.945 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 34.8 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.706 0.288 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.45 166.42 2.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.556 2.171 . . . . 0.0 112.235 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -83.52 173.28 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 84' ' ' VAL . 11.6 pt-20 -59.15 -25.44 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.04 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.812 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -55.48 -42.63 74.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.213 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -63.67 -44.01 95.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.95 -37.57 77.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -72.83 -45.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 81' ' ' ALA . 26.9 t -64.34 -41.04 91.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -22.84 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.036 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.79 -24.27 30.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 84' ' ' VAL . 78.0 p -58.2 115.99 13.22 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.57 0.224 . . . . 0.0 110.899 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 131.07 39.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.411 2.074 . . . . 0.0 112.293 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.14 59.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.836 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 88' ' ' THR . 5.3 tp . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.979 0.418 . . . . 0.0 111.201 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.508 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 71.1 mtt85 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.636 0.255 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 51.4 Cg_endo -68.77 136.44 35.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.096 . . . . 0.0 112.248 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.1 p -135.78 87.31 25.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.979 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.22 130.38 23.94 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.53 2.154 . . . . 0.0 112.222 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mt -79.16 163.95 24.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.917 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.0 t -86.82 140.81 33.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.8 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.78 -30.5 23.2 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 0.0 112.529 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -43.07 73.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.18 -30.53 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 105' ' ' SER . 26.4 t -61.29 -44.11 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -29.03 69.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.701 ' O ' HG23 ' A' ' 115' ' ' VAL . 11.6 m-70 -76.29 -45.33 33.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.786 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.728 HD12 ' CD2' ' A' ' 67' ' ' PHE . 20.0 pt -71.88 -26.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.882 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.912 HD22 HD12 ' A' ' 118' ' ' LEU . 70.8 mt -76.86 -36.26 56.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.397 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.65 -27.45 67.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 42' ' ' THR . 25.3 t -77.19 -41.98 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.734 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -57.55 -62.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.074 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.467 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 151.08 44.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.559 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.912 HD12 HD22 ' A' ' 113' ' ' LEU . 7.6 mt -119.59 -52.87 2.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.807 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -31.07 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.496 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.694 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.443 0.163 . . . . 0.0 110.796 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -141.19 151.57 43.91 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 112.068 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.524 ' O ' HD12 ' A' ' 104' ' ' LEU . 84.6 m95 -98.92 93.61 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.704 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 50.5 m-85 -85.51 126.07 33.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.886 0.374 . . . . 0.0 110.772 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -105.69 142.2 35.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.598 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.71 150.67 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.629 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -94.25 147.88 22.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.969 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -141.01 177.06 8.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.01 141.38 28.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 12' ' ' VAL . 6.0 m -70.17 104.89 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.41 -27.44 5.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -101.89 -17.39 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 111.206 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.52 -38.73 64.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.103 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -42.63 73.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.943 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.06 92.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -56.55 20.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.57 98.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.55 -43.23 97.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 tp -72.62 -48.79 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.716 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -58.54 -24.76 61.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.072 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -81.82 -44.56 16.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HG3' HG22 ' A' ' 88' ' ' THR . 8.3 mmt85 -68.84 -24.99 64.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.204 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -69.45 -28.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.737 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.45 -33.65 15.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.82 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.063 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -79.94 -37.81 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.23 65.26 0.84 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.739 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 35' ' ' ILE . 1.1 pt? -149.57 27.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 0.0 110.881 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -11.71 61.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.3 m-20 -79.7 -29.66 40.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.824 0.345 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -77.16 -49.84 14.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.773 HD11 HD12 ' A' ' 31' ' ' LEU . 4.1 mp -84.78 109.05 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.694 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.1 m-85 -94.08 -52.77 4.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.439 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.415 ' HG3' ' NE2' ' A' ' 69' ' ' GLN . 2.0 mt-30 -111.99 156.36 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.79 -179.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.857 HG12 HG23 ' A' ' 68' ' ' ILE . 3.9 m -153.1 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.967 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.926 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.2 mm? -85.57 142.29 29.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.535 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.516 HG22 HG23 ' A' ' 42' ' ' THR . 3.7 mp -97.04 127.56 38.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.604 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 26.1 Cg_endo -62.18 75.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.554 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.693 HG22 ' HG2' ' A' ' 60' ' ' LYS . 60.8 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.2 ptmt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.848 0.356 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.693 ' HG2' HG22 ' A' ' 42' ' ' THR . 4.1 mmtm -92.61 121.7 34.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.772 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.0 mt -79.23 -49.51 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.728 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.458 ' CE1' HG22 ' A' ' 112' ' ' ILE . 35.6 m-85 -102.06 97.89 9.18 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.41 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.49 124.46 16.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.547 2.165 . . . . 0.0 112.509 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.71 42.97 99.58 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.83 151.58 48.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.985 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 11.3 mt -147.09 114.23 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.666 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD2' HD13 ' A' ' 112' ' ' ILE . 8.4 m-85 -90.33 123.15 33.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 38' ' ' VAL . 1.2 mp -128.47 113.93 31.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.451 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 4.5 tt0 -80.87 72.88 7.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.467 ' SD ' HD21 ' A' ' 72' ' ' LEU . 21.5 ptp -91.35 -169.36 2.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.99 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.57 80.2 1.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.771 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.704 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.945 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.418 0.151 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HB3' HD22 ' A' ' 72' ' ' LEU . 18.4 Cg_exo -65.67 66.64 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.65 2.234 . . . . 0.0 112.192 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -55.7 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 60.03 -82.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.945 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -58.43 -41.04 84.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -83.61 -30.16 27.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -61.62 -31.8 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 80' ' ' GLU . 32.8 t -82.57 -44.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 81' ' ' ALA . 35.9 t -60.54 -49.98 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.56 -24.52 61.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.72 70.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.827 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -79.0 120.33 80.41 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.802 0.301 . . . . 0.0 110.7 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.26 -14.18 43.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.475 2.117 . . . . 0.0 112.479 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.56 25.67 21.81 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.626 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.687 0.28 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.96 163.95 31.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.538 2.159 . . . . 0.0 112.17 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 t -125.41 116.41 25.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.32 171.38 17.83 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.452 2.101 . . . . 0.0 112.16 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.592 ' HB2' HG22 ' A' ' 109' ' ' VAL . 3.2 mp -89.88 157.42 17.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.895 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.859 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.0 m -80.36 150.67 71.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.2 -31.58 22.3 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.598 2.199 . . . . 0.0 112.43 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -45.32 24.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.09 -32.58 69.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 105' ' ' SER . 72.0 t -61.87 -52.41 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.008 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -24.62 66.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.731 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -76.93 -51.27 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.683 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.608 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.2 pp -69.78 -15.62 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.855 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.04 -36.31 35.94 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.682 179.477 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -80.56 -34.88 35.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.772 HG11 ' CD1' ' A' ' 61' ' ' LEU . 27.8 t -75.38 -46.35 38.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.004 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.926 ' HB3' HD12 ' A' ' 39' ' ' LEU . 72.4 m -60.75 -51.17 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.689 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.47 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.43 64.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.627 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.855 HD12 ' HG ' ' A' ' 113' ' ' LEU . 21.8 mt -136.74 -49.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.891 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -51.99 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.854 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.333 -1.259 . . . . 0.0 112.482 -179.967 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.521 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.469 0.176 . . . . 0.0 110.901 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -160.05 160.79 33.59 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 112.134 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.666 ' HH2' HD23 ' A' ' 39' ' ' LEU . 89.6 m95 -91.76 90.87 7.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.967 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 58.5 m-85 -83.67 108.72 16.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.11 148.87 27.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.467 HG22 HD11 ' A' ' 68' ' ' ILE . 26.9 m -140.44 -178.9 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.072 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -107.94 137.38 46.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -130.9 -178.62 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.73 120.44 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.2 p -58.5 119.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.072 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -28.83 11.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -0.34 43.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.57 -43.32 25.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.823 0.344 . . . . 0.0 111.224 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -37.89 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.018 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.6 -28.49 20.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.794 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -61.06 2.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB3' HD11 ' A' ' 66' ' ' LEU . 2.1 pttp -63.02 -38.62 91.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.86 94.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.45 -39.41 93.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.636 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.694 ' CD1' HG21 ' A' ' 88' ' ' THR . 64.1 tp -66.47 -51.89 52.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.69 -31.58 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.0 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.31 -41.86 69.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -70.5 -37.21 74.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.66 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.745 HD12 HD11 ' A' ' 31' ' ' LEU . 41.4 mm -70.07 -30.35 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.849 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -88.58 -33.32 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.54 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.9 -35.56 32.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 85.96 1.27 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.69 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -153.09 48.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.821 179.793 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.31 -7.77 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.358 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 p-10 -79.62 -20.16 47.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.956 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -96.05 -55.55 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.614 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 HG21 ' A' ' 26' ' ' ILE . 32.6 mt -91.36 130.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.5 m-85 -121.57 -54.8 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.717 -179.369 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.45 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mm100 -117.12 158.38 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 112.345 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.746 HG22 HG23 ' A' ' 68' ' ' ILE . 38.8 t -157.18 83.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.84 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.666 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.6 mm? -95.94 164.0 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.274 0.559 . . . . 0.0 112.207 -178.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.753 HG22 ' HG ' ' A' ' 66' ' ' LEU . 1.3 pp -143.83 69.93 16.82 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.094 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HG2' ' CE2' ' A' ' 67' ' ' PHE . 72.5 Cg_exo -41.07 115.45 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.273 2.649 . . . . 0.0 113.749 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.448 HG23 HD12 ' A' ' 40' ' ' ILE . 17.2 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.052 179.049 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.423 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.4 mtpt . . . . . 0 CA--C 1.528 0.128 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 119.71 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.739 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.3 mt -83.25 -42.61 17.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.364 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 41' ' ' PRO . 26.7 m-85 -122.99 74.32 48.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.873 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.95 142.8 93.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.596 2.197 . . . . 0.0 112.246 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.31 25.23 18.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.625 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.96 112.58 10.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.753 ' HG ' HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -113.7 130.08 56.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.967 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.988 ' CE2' HD12 ' A' ' 112' ' ' ILE . 13.8 m-30 -92.48 130.9 38.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.723 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.746 HG23 HG22 ' A' ' 38' ' ' VAL . 1.2 mp -130.39 111.46 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.211 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -79.72 70.86 6.31 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 ptm -91.55 -175.84 4.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.293 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -124.11 86.86 2.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.967 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 13.2 mt . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.745 0.307 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.33 173.5 14.39 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.457 2.105 . . . . 0.0 112.436 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.99 -165.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.589 ' OE2' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -57.7 -24.0 54.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -51.89 -44.62 63.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.369 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.9 t-105 -73.56 -30.19 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -37.7 86.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 88' ' ' THR . 34.8 t -70.06 -40.18 78.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 81' ' ' ALA . 34.4 t -67.14 -45.63 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -63.23 -17.92 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.98 -28.32 8.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.796 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.694 HG21 ' CD1' ' A' ' 22' ' ' LEU . 16.3 p -58.75 155.84 28.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.24 -25.29 31.15 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.51 -26.24 51.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.59 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.0 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.937 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.542 0.21 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.25 172.07 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.519 2.146 . . . . 0.0 112.309 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 t -128.95 122.97 21.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.22 142.59 15.23 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.529 2.153 . . . . 0.0 112.405 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' A' ' 112' ' ' ILE . 2.0 mt -74.54 168.96 18.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -89.79 142.83 29.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.93 179.935 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.01 -51.24 11.29 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.569 2.179 . . . . 0.0 112.615 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -56.95 -28.19 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -89.99 -36.29 15.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 105' ' ' SER . 30.3 t -57.42 -33.13 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.361 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -27.98 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.052 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -82.96 -34.59 26.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.904 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.988 HD12 ' CE2' ' A' ' 67' ' ' PHE . 15.2 pt -81.48 -19.11 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.122 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.071 HD22 HD12 ' A' ' 118' ' ' LEU . 29.9 mt -84.99 -25.08 27.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.719 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.35 -32.91 58.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.739 HG11 ' CD1' ' A' ' 61' ' ' LEU . 22.6 t -77.81 -37.47 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.182 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -57.54 -52.86 63.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.87 38.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.897 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.071 HD12 HD22 ' A' ' 113' ' ' LEU . 15.8 mt -117.72 -55.68 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.34 -42.82 14.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.516 179.994 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.732 HD13 ' HG2' ' A' ' 69' ' ' GLN . 2.0 pp . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.88 0.371 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -154.96 165.77 35.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.924 ' CD1' HG11 ' A' ' 109' ' ' VAL . 92.4 m95 -86.56 91.34 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.727 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.767 ' O ' HD12 ' A' ' 68' ' ' ILE . 79.8 m-85 -87.08 116.42 25.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.422 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -103.5 146.84 27.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.023 0.439 . . . . 0.0 111.763 -179.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.3 p -117.13 159.33 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.584 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.468 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 2.1 m-70 -107.01 142.21 37.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.932 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.5 p -155.12 174.8 14.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.81 162.35 15.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.62 125.85 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.72 -32.06 6.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.533 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.75 -30.72 36.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.564 ' CD ' HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -59.32 -37.19 77.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -59.97 -30.85 69.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.17 -29.88 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -50.16 75.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HB3' HD21 ' A' ' 66' ' ' LEU . 4.7 ptmt -60.16 -43.05 96.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.34 -51.98 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.67 -31.01 72.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.716 HD11 HG22 ' A' ' 85' ' ' VAL . 60.2 tp -78.23 -56.55 4.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -48.97 -31.29 7.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -43.87 68.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -36.09 82.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.742 ' HA ' HD21 ' A' ' 31' ' ' LEU . 37.7 mm -64.84 -29.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.997 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.76 -31.38 14.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.52 68.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CE2' HG13 ' A' ' 84' ' ' VAL . 15.3 m-85 -80.01 -34.46 38.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.35 59.0 1.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.641 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -122.66 47.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.809 179.938 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -65.69 -15.4 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.308 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.71 -2.34 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -113.13 -59.1 2.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 179.853 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.607 HG13 HD12 ' A' ' 26' ' ' ILE . 30.1 mm -79.95 120.29 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.719 ' CE2' HG21 ' A' ' 3' ' ' ILE . 63.3 m-85 -116.03 -56.23 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.571 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HB2' ' CB ' ' A' ' 69' ' ' GLN . 1.8 mm100 -112.95 156.17 23.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.247 0.546 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.816 HG22 HG23 ' A' ' 68' ' ' ILE . 24.8 t -154.89 79.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.137 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.853 HD21 HD11 ' A' ' 118' ' ' LEU . 3.5 mm? -87.29 157.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.518 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 40' ' ' ILE . 16.1 tt -111.15 120.37 43.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.926 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 30.6 Cg_endo -64.64 80.6 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.545 2.163 . . . . 0.0 112.877 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.445 HG23 HG12 ' A' ' 40' ' ' ILE . 11.4 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.875 0.369 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.08 122.46 11.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.837 HD11 HG11 ' A' ' 115' ' ' VAL . 20.9 mt -80.64 -51.05 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.4 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 33.1 m-85 -111.11 89.65 10.18 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 37.9 Cg_endo -66.69 128.39 18.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 22.87 73.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 97.1 m-85 -129.44 139.78 51.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.701 0.286 . . . . 0.0 110.984 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' A' ' 19' ' ' LYS . 4.1 tp -130.89 134.57 46.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.726 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.5 m-85 -99.85 123.9 44.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.816 HG23 HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -134.28 112.9 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 179.882 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.732 ' HG2' HD13 ' A' ' 3' ' ' ILE . 19.5 tt0 -79.95 72.64 6.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.156 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.636 ' SD ' HD11 ' A' ' 72' ' ' LEU . 15.8 ptm -91.56 -173.47 3.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.375 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.717 ' CA ' HG22 ' A' ' 3' ' ' ILE . 32.8 t0 -119.22 99.64 6.83 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.922 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.636 HD11 ' SD ' ' A' ' 70' ' ' MET . 54.1 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.31 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.685 0.279 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.6 151.88 72.63 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.662 2.241 . . . . 0.0 112.176 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.402 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . 1.3 m-80 -69.11 -175.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.86 -27.58 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.945 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.03 -29.02 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.345 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.81 -34.72 62.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -68.02 -31.5 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 88' ' ' THR . 21.7 t -76.99 -45.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.214 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 81' ' ' ALA . 37.9 t -59.01 -40.25 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.72 -12.97 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.325 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.95 -15.66 12.64 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.805 ' O ' HG22 ' A' ' 91' ' ' ILE . 40.2 p -57.4 112.01 4.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.736 0.268 . . . . 0.0 110.984 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.62 121.43 7.92 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.373 2.049 . . . . 0.0 112.299 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.26 -19.57 17.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.692 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 88' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.689 0.281 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.12 172.63 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.97 80.04 1.66 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.413 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.414 ' HB3' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_endo -77.87 139.76 17.77 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.537 2.158 . . . . 0.0 112.265 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.628 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.6 OUTLIER -84.96 130.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.846 179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.907 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -64.32 150.26 93.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.84 -40.0 57.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.577 2.185 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -31.24 72.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -87.64 -34.32 18.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.924 HG11 ' CD1' ' A' ' 5' ' ' TRP . 22.8 t -61.9 -31.73 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.303 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -64.33 -29.97 71.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.5 t60 -74.36 -47.4 34.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.806 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.726 HD12 ' CD2' ' A' ' 67' ' ' PHE . 17.1 pt -69.8 -27.38 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.033 HD22 HD12 ' A' ' 118' ' ' LEU . 14.2 mt -74.85 -34.28 62.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -70.23 -32.5 70.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.594 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.837 HG11 HD11 ' A' ' 61' ' ' LEU . 22.5 t -81.83 -33.3 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -61.32 -63.63 1.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.586 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 145.44 44.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.698 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.033 HD12 HD22 ' A' ' 113' ' ' LEU . 12.6 mt -121.59 -45.44 2.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.749 0.309 . . . . 0.0 110.92 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.22 30.33 2.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.33 -1.261 . . . . 0.0 112.475 -179.957 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.661 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.452 0.168 . . . . 0.0 110.882 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.21 160.3 43.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.165 0.507 . . . . 0.0 111.88 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.896 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 90.0 m95 -93.96 119.8 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.774 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.964 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 22.3 m-85 -114.3 105.64 13.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.441 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -99.14 169.09 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.097 0.475 . . . . 0.0 111.724 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.649 HG11 HD12 ' A' ' 91' ' ' ILE . 2.4 p -156.26 161.41 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.57 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.506 ' CE1' ' CE2' ' A' ' 65' ' ' TYR . 5.8 m170 -93.43 157.07 16.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.108 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p -150.35 -176.54 5.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.09 145.79 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.16 129.55 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.2 -23.97 31.0 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.618 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.68 -19.62 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.569 0.223 . . . . 0.0 111.167 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.45 -38.45 66.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.7 -36.61 72.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.947 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -24.83 21.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.025 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.24 -38.1 89.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -61.2 -35.15 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 -41.89 34.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.65 -34.88 73.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HG21 ' A' ' 88' ' ' THR . 36.8 tp -77.31 -53.01 8.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.09 -35.37 59.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -63.42 -42.11 98.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.682 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HD3' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -66.17 -38.15 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 179.8 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.8 HG23 ' HB2' ' A' ' 31' ' ' LEU . 46.7 mm -64.06 -33.26 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -89.8 -33.81 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -40.4 77.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.07 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.417 ' CE2' ' HG3' ' A' ' 25' ' ' ARG . 29.3 m-85 -92.32 -24.81 18.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 88.07 78.29 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.404 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.8 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.9 mm? -123.18 35.26 4.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.89 16.21 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.478 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.8 -12.88 15.71 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.52 0.2 . . . . 0.0 111.115 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 2.3 mptt -116.28 -44.23 2.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.321 . . . . 0.0 111.125 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.675 HD11 HG22 ' A' ' 38' ' ' VAL . 19.4 tt -82.2 153.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.195 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.661 ' CE2' HG21 ' A' ' 3' ' ' ILE . 28.9 m-85 -143.23 -52.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.431 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.9 mt-30 -120.33 146.52 46.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 111.108 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.706 HG22 HG23 ' A' ' 68' ' ' ILE . 3.5 t -143.22 70.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.222 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.896 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -88.69 143.59 26.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.576 -179.121 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 42' ' ' THR . 4.9 tt -108.58 123.58 36.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.231 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 14.0 Cg_endo -57.84 87.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.659 2.24 . . . . 0.0 112.894 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.512 HG23 HG12 ' A' ' 40' ' ' ILE . 76.2 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.776 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.802 0.335 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -58.07 108.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.057 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.891 HD11 ' CG1' ' A' ' 115' ' ' VAL . 39.6 mt -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.474 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 3.3 m-85 -132.56 88.4 38.97 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.623 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.22 108.4 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.763 2.309 . . . . 0.0 112.857 -179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 47.82 9.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.848 179.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.506 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 62.6 m-85 -144.96 145.15 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.593 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.3 pp -150.61 120.27 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.413 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.963 ' CD2' HD13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -96.25 126.88 41.77 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 111.366 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -119.13 121.53 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.579 179.73 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -79.87 78.9 6.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.362 . . . . 0.0 110.712 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 72' ' ' LEU . 20.3 ptp -91.0 -175.71 4.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.244 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 5.9 t0 -122.17 77.88 1.44 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.964 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 19.9 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.652 0.263 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.38 104.74 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.666 2.244 . . . . 0.0 112.218 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.2 -167.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.7 OUTLIER 56.47 -85.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.52 179.609 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.823 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.41 -44.95 69.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.591 -179.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.411 ' HA ' ' CE3' ' A' ' 82' ' ' TRP . 2.0 t-105 -74.81 -30.51 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.119 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.94 -30.16 69.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.748 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 80' ' ' GLU . 23.1 t -84.57 -48.7 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.045 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 81' ' ' ALA . 36.8 t -59.72 -49.61 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.48 -22.41 66.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.247 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.38 -22.45 24.47 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.83 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.632 HG22 ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -65.24 145.73 99.04 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 110.93 -179.878 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.77 -25.59 28.37 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.469 2.113 . . . . 0.0 112.301 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.38 -28.17 54.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.649 HD12 HG11 ' A' ' 8' ' ' VAL . 35.6 mm . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 1.3 mmp_? . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.515 0.198 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.4 Cg_endo -59.46 152.61 60.23 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.437 2.091 . . . . 0.0 112.064 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.35 82.18 31.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.191 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.3 115.6 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.38 2.053 . . . . 0.0 112.091 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -70.57 149.01 47.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.994 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.896 ' O ' HG23 ' A' ' 109' ' ' VAL . 56.3 m -87.49 148.31 43.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.88 -37.1 54.95 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.764 2.309 . . . . 0.0 112.458 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -68.93 -29.41 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 112' ' ' ILE . 3.5 tt0 -91.48 -32.18 15.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 105' ' ' SER . 24.3 t -64.28 -36.67 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.113 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.411 ' HG3' HD13 ' A' ' 119' ' ' LEU . 2.5 ttt-85 -69.48 -30.73 68.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.942 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.665 ' O ' HG23 ' A' ' 115' ' ' VAL . 7.9 t-80 -77.91 -42.36 33.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.728 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.963 HD13 ' CD2' ' A' ' 67' ' ' PHE . 1.9 pp -74.89 -29.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.884 ' CD2' HD12 ' A' ' 118' ' ' LEU . 19.0 mt -75.34 -30.68 60.33 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.493 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.12 -27.78 64.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.195 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.891 ' CG1' HD11 ' A' ' 61' ' ' LEU . 2.1 t -88.23 -50.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.785 0.326 . . . . 0.0 111.34 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.698 ' CB ' HD23 ' A' ' 39' ' ' LEU . 33.8 t -52.92 -63.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.836 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.904 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 142.21 48.68 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.843 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.904 HD23 ' O ' ' A' ' 117' ' ' GLY . 15.7 mt -133.17 5.77 3.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.47 0.176 . . . . 0.0 111.455 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.411 HD13 ' HG3' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -135.84 40.69 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.874 0.368 . . . . 0.0 110.809 179.931 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.396 -1.225 . . . . 0.0 112.531 -179.987 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 69' ' ' GLN . 2.7 pp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.518 0.199 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -142.7 169.8 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 112.21 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.664 ' HH2' HD23 ' A' ' 39' ' ' LEU . 87.8 m95 -94.05 91.55 6.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.462 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.688 ' O ' HD12 ' A' ' 68' ' ' ILE . 63.3 m-85 -79.96 116.12 19.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 110.647 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.73 151.5 19.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.709 -179.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -134.51 159.95 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.563 179.671 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.482 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 3.5 m-70 -110.56 87.36 2.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.5 p -83.73 -174.35 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.794 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.72 134.02 34.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 12' ' ' VAL . 4.9 m -60.47 104.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.61 -30.45 5.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.405 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -92.79 -19.63 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.587 0.232 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.03 -40.73 64.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 111.005 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.32 -37.24 69.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.828 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -89.84 -26.22 20.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.981 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.16 86.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -59.45 -48.01 83.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.88 74.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -60.22 -32.62 71.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.769 HD12 HG21 ' A' ' 88' ' ' THR . 8.8 tp -78.3 -56.1 4.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.728 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -29.41 2.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.294 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -46.52 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -33.15 68.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.59 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.498 HG23 ' HB2' ' A' ' 31' ' ' LEU . 34.3 mm -75.16 -25.21 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -97.78 -29.95 13.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.41 -40.79 64.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.989 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -79.99 -25.34 40.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.39 51.55 1.7 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.595 HD11 ' CG ' ' A' ' 80' ' ' GLU . 3.4 mm? -104.48 31.9 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.59 9.78 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -104.01 -21.71 13.57 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.711 0.291 . . . . 0.0 111.025 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HG3' HD12 ' A' ' 31' ' ' LEU . 2.2 mtpt -96.46 -51.23 4.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.677 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pt -79.82 151.25 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.765 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.717 ' HE2' HG21 ' A' ' 3' ' ' ILE . 56.4 m-85 -141.72 -44.96 0.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.344 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 2.6 mt-30 -129.52 158.33 39.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.221 0.534 . . . . 0.0 112.035 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 68' ' ' ILE . 20.8 t -154.97 82.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.114 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.85 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.5 mm? -92.65 157.94 16.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.62 -179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.16 124.08 32.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.753 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 37.5 Cg_endo -66.83 81.1 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.586 2.191 . . . . 0.0 112.855 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.588 HG22 ' HG2' ' A' ' 60' ' ' LYS . 15.9 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.874 0.369 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.588 ' HG2' HG22 ' A' ' 42' ' ' THR . 9.4 mtmm -59.93 115.62 3.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.852 ' CD1' HG11 ' A' ' 115' ' ' VAL . 37.4 mt -72.93 -44.98 60.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.74 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 41.0 m-85 -119.28 88.26 37.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.616 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.08 136.62 53.07 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.493 2.128 . . . . 0.0 112.313 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.83 22.1 69.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.547 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.19 127.95 52.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.824 0.345 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 124.86 45.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.608 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.978 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.4 m-85 -93.19 123.63 36.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.1 mp -129.42 110.42 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.454 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.904 ' HG2' HD13 ' A' ' 3' ' ' ILE . 15.4 tt0 -79.81 72.24 6.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.595 ' SD ' HD11 ' A' ' 72' ' ' LEU . 25.1 ptp -92.02 -176.85 4.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.851 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.577 ' HA ' HG22 ' A' ' 3' ' ' ILE . 14.5 t0 -118.27 99.23 6.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.703 179.382 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.595 HD11 ' SD ' ' A' ' 70' ' ' MET . 80.2 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.337 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.606 0.241 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 169.87 17.43 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.482 2.121 . . . . 0.0 112.292 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.38 -165.78 1.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.5 pt-20 -57.64 -21.46 39.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -47.88 -44.78 29.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.412 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -68.94 -35.42 76.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.41 -30.19 68.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 88' ' ' THR . 22.9 t -79.24 -51.51 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.5 t -59.84 -46.31 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -26.83 66.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.71 -27.28 57.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.621 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.769 HG21 HD12 ' A' ' 22' ' ' LEU . 45.7 p -59.89 142.91 88.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.682 0.277 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.87 -13.93 21.6 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.533 2.155 . . . . 0.0 112.627 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.64 -6.41 65.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.047 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.889 ' O ' HD13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.63 0.252 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 112.78 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.511 2.141 . . . . 0.0 112.004 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.95 123.68 62.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.17 148.55 10.44 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.764 2.309 . . . . 0.0 112.202 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -77.8 141.56 39.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.852 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.9 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -77.62 157.66 79.53 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.948 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.1 -35.62 95.19 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.589 2.193 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.44 -29.54 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -87.03 -36.46 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 105' ' ' SER . 39.8 t -60.72 -51.98 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 HD21 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -56.11 -29.56 60.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -53.79 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.576 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.978 HD12 ' CD2' ' A' ' 67' ' ' PHE . 18.9 pt -66.2 -25.07 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.732 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.861 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.9 mp -71.67 -38.07 70.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.486 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -30.56 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.704 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.852 HG11 ' CD1' ' A' ' 61' ' ' LEU . 21.8 t -83.39 -40.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.042 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.85 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.9 m -58.93 -62.02 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.566 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 144.73 48.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.526 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.861 HD12 ' HG ' ' A' ' 113' ' ' LEU . 27.8 mt -124.12 -45.26 2.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.995 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.42 HD21 HH11 ' A' ' 110' ' ' ARG . 0.1 OUTLIER -98.48 29.85 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.395 179.988 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.54 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.541 0.21 . . . . 0.0 110.852 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -153.3 161.9 41.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.826 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.632 ' CZ2' HD11 ' A' ' 113' ' ' LEU . 68.2 m95 -88.49 92.71 9.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.661 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.841 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 67.0 m-85 -87.99 114.12 24.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -100.77 147.49 26.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.525 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 9' ' ' HIS . 16.1 t -127.93 160.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.497 ' CE1' ' CE2' ' A' ' 65' ' ' TYR . 3.2 m-70 -114.72 156.58 24.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -156.63 -174.74 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 145.8 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.48 130.5 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.42 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -94.01 -22.05 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 0.0 111.066 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -53.65 -43.78 69.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -33.51 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -80.87 -31.06 35.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.54 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -60.31 -37.67 81.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.973 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.68 -53.76 42.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -30.33 69.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.535 HD11 HG22 ' A' ' 85' ' ' VAL . 31.5 tp -76.3 -56.53 4.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -48.76 -30.33 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -38.4 61.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.56 ' HG3' HG22 ' A' ' 88' ' ' THR . 21.9 mmt180 -73.67 -37.35 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.569 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.836 HD12 HD11 ' A' ' 31' ' ' LEU . 41.4 mm -72.92 -28.05 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.987 179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -89.63 -32.8 16.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.773 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -39.55 79.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.993 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.98 -37.29 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.83 41.71 5.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.836 HD11 HD12 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -99.52 51.18 0.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.79 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.3 -5.15 43.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.4 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -79.69 -24.27 41.85 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.824 179.939 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -94.3 -52.17 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.9 mt -95.16 111.61 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.5 m-85 -102.46 -60.23 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.382 -179.451 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.39 130.03 49.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 -179.146 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.8 p -126.07 72.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.497 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.688 HD23 ' OG ' ' A' ' 116' ' ' SER . 2.5 tm? -83.64 133.47 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.945 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' THR . 0.1 OUTLIER -109.22 124.51 33.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.925 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 88.1 Cg_exo -49.19 77.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.138 2.559 . . . . 0.0 113.305 -179.652 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 40' ' ' ILE . 36.8 p . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.775 179.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.3 tptt . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.604 0.24 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -139.82 113.53 8.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 115' ' ' VAL . 3.6 mt -85.26 -47.76 9.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CE1' HG22 ' A' ' 112' ' ' ILE . 7.6 m-85 -135.99 84.36 31.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.584 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.79 141.93 92.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.496 -179.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.86 77.81 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.069 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 6.2 m-85 -117.99 156.74 28.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.8 0.334 . . . . 0.0 110.953 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD12 ' C ' ' A' ' 65' ' ' TYR . 5.2 mp -150.64 107.7 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.68 ' CD1' HD11 ' A' ' 104' ' ' LEU . 4.4 m-85 -81.79 124.32 29.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.0 OUTLIER -127.86 114.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 4.6 tt0 -80.71 71.09 7.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 0.0 110.345 179.433 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.3 ptp -91.2 -175.02 4.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.434 ' OD1' HG22 ' A' ' 3' ' ' ILE . 26.6 t70 -124.32 92.02 3.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.73 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.841 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 20.3 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.654 0.264 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.7 171.64 6.79 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.687 2.258 . . . . 0.0 112.235 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 -177.25 5.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.97 -28.91 64.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.53 -41.16 69.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -59.86 -39.74 86.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.27 -40.22 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -65.45 -47.87 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.7 t -63.43 -45.33 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.091 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.413 ' HA ' HG21 ' A' ' 91' ' ' ILE . 2.1 ttt180 -60.67 -28.99 69.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.68 -31.28 56.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 25' ' ' ARG . 20.9 p -60.76 111.35 3.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.616 0.246 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.16 133.73 35.96 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.445 2.097 . . . . 0.0 112.366 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.14 -11.45 48.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.703 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.413 HG21 ' HA ' ' A' ' 86' ' ' ARG . 8.8 tp . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.739 0.304 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.13 171.58 14.6 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.205 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 102' ' ' VAL . 6.4 m -142.52 101.69 5.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.187 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.79 157.84 54.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.397 2.064 . . . . 0.0 112.169 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.68 HD11 ' CD1' ' A' ' 67' ' ' PHE . 16.2 mt -89.99 163.68 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.7 p -86.67 141.38 33.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.95 -33.9 35.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.572 2.181 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.37 -41.63 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -81.58 -31.08 32.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 105' ' ' SER . 58.5 t -63.36 -43.68 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -61.25 -30.42 70.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -52.88 11.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.609 179.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.595 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.5 pp -66.42 -16.48 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.59 179.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.757 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -72.65 -36.73 68.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.316 179.173 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.52 -22.43 44.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.767 HG21 HD13 ' A' ' 61' ' ' LEU . 38.5 t -70.26 -60.93 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.688 ' OG ' HD23 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -52.49 -53.66 42.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.42 38.17 0.42 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.545 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.757 HD12 ' HG ' ' A' ' 113' ' ' LEU . 2.7 mt -100.06 0.62 41.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.591 0.234 . . . . 0.0 111.366 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 113' ' ' LEU . 2.8 mp -131.4 -63.02 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.385 -1.23 . . . . 0.0 112.438 -179.959 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.819 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.431 0.158 . . . . 0.0 110.813 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 103' ' ' PRO . 2.1 mt-10 -139.91 163.71 31.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.416 0.627 . . . . 0.0 112.294 -179.318 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.872 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 74.7 m95 -91.09 92.21 8.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.583 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.548 ' O ' HD12 ' A' ' 68' ' ' ILE . 64.9 m-85 -79.8 107.61 12.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.895 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -87.0 146.66 26.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -146.55 177.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.555 179.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.509 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 2.9 m-70 -122.48 160.7 25.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -136.83 158.79 43.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.622 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.26 127.43 27.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.3 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -63.66 128.73 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.852 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.68 -30.63 8.56 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.205 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -97.36 -9.41 27.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 0.0 110.96 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.8 -39.04 4.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 111.238 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -54.94 -44.17 74.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.33 34.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.76 85.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.067 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.0 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.73 -50.97 8.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.099 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.04 -34.86 72.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.639 HD11 HG13 ' A' ' 85' ' ' VAL . 41.3 tp -71.98 -56.96 4.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -33.34 60.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -67.88 -40.9 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.709 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.666 ' HG3' HG22 ' A' ' 88' ' ' THR . 2.1 mmt180 -68.0 -38.25 82.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.0 mm -69.42 -30.09 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.017 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -89.0 -33.62 17.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.62 68.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.45 -27.07 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.06 56.94 2.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.456 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -103.88 35.33 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 0.0 110.846 -179.916 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.21 -4.19 37.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.515 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.78 -28.06 40.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.839 0.352 . . . . 0.0 110.77 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -54.29 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.686 HG23 ' CG2' ' A' ' 68' ' ' ILE . 2.5 mp -86.66 94.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.657 179.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.819 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.8 m-85 -83.01 -50.05 8.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.486 ' HB3' ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -115.67 138.94 50.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.166 0.508 . . . . 0.0 111.705 -179.207 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.39 138.56 26.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.459 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.872 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -160.23 155.56 25.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 111.356 -179.731 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.47 ' N ' HD22 ' A' ' 39' ' ' LEU . 14.9 tt -114.6 128.26 26.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 11.2 Cg_endo -55.71 80.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.673 2.248 . . . . 0.0 112.8 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 41' ' ' PRO . 36.6 p . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.48 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -63.72 115.19 4.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.832 ' CD1' HG21 ' A' ' 115' ' ' VAL . 37.9 mt -90.09 -39.82 12.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.204 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 1.4 m-85 -131.4 95.49 23.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.917 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.16 133.22 48.54 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.527 2.152 . . . . 0.0 112.145 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.54 23.29 62.56 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.793 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.669 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.2 m-85 -116.49 154.07 31.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -160.49 130.92 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.72 179.802 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.782 ' HD2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.13 142.72 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.557 179.618 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.686 ' CG2' HG23 ' A' ' 35' ' ' ILE . 2.7 mp -138.32 122.36 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.393 -179.644 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.3 tt0 -79.81 65.17 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 110.256 179.43 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.781 ' SD ' HD23 ' A' ' 72' ' ' LEU . 11.6 ptp -91.77 -169.34 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' CG ' HG22 ' A' ' 3' ' ' ILE . 5.2 t0 -148.62 80.49 1.44 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.81 179.64 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.781 HD23 ' SD ' ' A' ' 70' ' ' MET . 4.1 pp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.166 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.699 0.285 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.91 177.96 7.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -90.07 -179.98 5.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.2 tp10 -61.33 -24.35 66.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.187 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.28 -47.39 72.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.343 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.452 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -59.31 -42.36 91.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.967 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -59.98 -32.21 70.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 31' ' ' LEU . 24.1 t -82.58 -49.17 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.6 t -59.91 -51.28 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.982 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -66.35 -25.76 66.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.072 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.97 -32.64 63.27 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.701 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 25' ' ' ARG . 81.7 p -61.78 143.69 93.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 91.18 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.42 -36.41 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.451 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.14 179.913 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.477 0.179 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.0 Cg_exo -53.99 -171.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.492 2.128 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -150.6 115.46 3.29 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.281 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 4' ' ' GLU . 15.6 Cg_exo -68.0 145.06 66.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.465 2.11 . . . . 0.0 112.068 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.1 mp -86.29 159.1 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 69.6 m -89.54 141.66 28.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.66 -37.14 26.74 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 112.574 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -48.74 80.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.07 -33.97 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 62.3 t -58.5 -50.5 78.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.91 -37.95 54.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.224 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.459 ' O ' HG23 ' A' ' 115' ' ' VAL . 3.0 m-70 -68.4 -52.69 30.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.669 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.748 HD12 ' CD2' ' A' ' 67' ' ' PHE . 27.5 pt -66.36 -26.11 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.835 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.746 ' HG ' HD12 ' A' ' 118' ' ' LEU . 3.2 mp -73.83 -41.16 62.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -23.41 65.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.832 HG21 ' CD1' ' A' ' 61' ' ' LEU . 33.9 t -76.59 -59.09 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.7 ' HB2' HD23 ' A' ' 39' ' ' LEU . 1.5 t -59.4 -57.03 14.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.546 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.03 63.13 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.914 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.746 HD12 ' HG ' ' A' ' 113' ' ' LEU . 12.6 mt -133.46 5.62 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.514 0.197 . . . . 0.0 111.441 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.34 -36.38 11.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.412 -179.941 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.629 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.417 0.151 . . . . 0.0 110.932 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.76 150.13 50.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.276 0.56 . . . . 0.0 111.971 -179.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.699 ' CD1' HG11 ' A' ' 109' ' ' VAL . 71.8 m95 -99.75 110.14 22.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.529 179.349 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 30.3 m-85 -99.67 137.08 38.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 0.0 110.722 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.538 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . -111.49 146.75 36.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.033 0.444 . . . . 0.0 111.861 -179.407 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.5 OUTLIER -137.3 159.31 35.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.191 179.583 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -119.58 126.28 50.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.914 -179.857 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -132.06 -177.22 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 141.07 35.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -58.28 114.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.021 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.76 -34.05 5.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.295 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.41 -30.02 37.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 110.762 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.18 -39.15 66.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.12 -41.18 83.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -81.01 -26.69 36.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.61 56.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.152 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -35.44 74.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.81 -57.2 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.94 -36.29 82.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.488 HD11 HG22 ' A' ' 85' ' ' VAL . 59.6 tp -70.09 -47.87 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.765 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.707 ' O ' HG22 ' A' ' 26' ' ' ILE . 31.3 mt-10 -59.33 -22.13 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -45.97 14.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.877 0.37 . . . . 0.0 110.296 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -68.35 -24.46 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.4 tp -70.94 -28.07 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -97.39 -31.3 12.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.23 74.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -79.93 -25.61 40.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.987 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 30.19 6.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.287 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.6 mt -97.04 25.38 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -24.32 66.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.75 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.85 -3.44 47.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.161 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.727 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -100.01 -67.55 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 179.813 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.681 HD12 HG21 ' A' ' 68' ' ' ILE . 28.9 mm -80.71 130.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.711 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 3' ' ' ILE . 10.4 m-85 -124.24 -50.43 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -119.46 161.48 20.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.423 0.63 . . . . 0.0 112.489 -178.522 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.564 ' O ' HD22 ' A' ' 39' ' ' LEU . 40.5 t -157.84 110.85 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.956 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 116' ' ' SER . 4.1 mm? -126.16 175.06 8.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.529 0.68 . . . . 0.0 112.292 -178.743 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 39' ' ' LEU . 9.2 pt -161.87 66.95 2.08 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.703 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 62' ' ' PHE . 9.6 Cg_endo -52.88 150.52 22.77 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.451 2.767 . . . . 0.0 114.359 -178.445 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 60' ' ' LYS . 22.3 p . . . . . 0 N--CA 1.456 -0.165 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.139 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.027 0 CA-C-O 120.696 0.284 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.711 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.0 OUTLIER -47.21 132.97 12.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.274 -179.909 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 1.1 mt -90.39 -58.82 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 179.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 51.9 m-85 -113.04 64.39 0.88 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.777 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.2 135.46 54.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.562 2.175 . . . . 0.0 112.168 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.91 6.2 72.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 4.7 m-85 -113.69 126.72 55.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.82 116.62 32.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.784 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.758 ' CD2' HD12 ' A' ' 112' ' ' ILE . 14.0 m-30 -90.27 95.3 10.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.681 HG21 HD12 ' A' ' 35' ' ' ILE . 4.1 mt -95.25 113.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.279 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 10.5 tt0 -83.21 68.63 9.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.744 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.577 ' HE2' ' HG ' ' A' ' 72' ' ' LEU . 1.9 ptt? -91.45 -165.49 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.473 179.501 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -149.43 84.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.895 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.585 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 44.0 mt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.004 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.509 0.195 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.92 159.32 2.51 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.414 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -90.05 -169.96 2.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 84' ' ' VAL . 34.0 tt0 -54.88 -23.58 19.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.727 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . . . -52.62 -52.46 55.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.198 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 -58.06 -30.8 66.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -71.9 -31.03 66.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.798 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 31' ' ' LEU . 29.9 t -83.37 -51.41 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.948 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.4 t -57.22 -41.98 79.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.478 ' HA ' HG21 ' A' ' 91' ' ' ILE . 1.3 ttt180 -71.87 -22.76 61.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.16 -17.79 64.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.945 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.443 HG21 HD13 ' A' ' 22' ' ' LEU . 73.9 p -58.97 139.32 87.32 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.744 0.272 . . . . 0.0 110.95 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.36 105.48 2.05 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.464 2.109 . . . . 0.0 112.239 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.24 -17.09 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.725 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.642 0.258 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.74 175.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.5 p -132.56 79.33 65.09 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.853 0.358 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.98 146.1 22.82 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.548 2.165 . . . . 0.0 111.973 179.642 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.672 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -85.05 163.87 18.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.753 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -89.76 150.49 44.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.5 -27.31 7.25 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.638 2.225 . . . . 0.0 112.503 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.85 -46.85 17.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.96 -30.64 63.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 105' ' ' SER . 50.4 t -62.86 -55.18 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.506 ' HD2' HD11 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -55.54 -24.95 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.151 -179.898 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -77.96 -44.87 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.779 179.89 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.758 HD12 ' CD2' ' A' ' 67' ' ' PHE . 27.4 pt -72.43 -28.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.966 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.69 HD22 HD12 ' A' ' 118' ' ' LEU . 25.9 mt -76.24 -30.78 58.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.65 -32.5 69.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.495 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' HIS . 25.5 t -84.19 -26.42 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.808 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.861 ' HB2' HD12 ' A' ' 39' ' ' LEU . 20.4 p -68.4 -43.25 77.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.63 4.24 3.95 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.164 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.69 HD12 HD22 ' A' ' 113' ' ' LEU . 34.8 mt -80.0 -58.48 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.91 0.355 . . . . 0.0 110.728 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.506 HD11 ' HD2' ' A' ' 110' ' ' ARG . 71.3 mt -95.07 -29.13 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.493 179.978 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.671 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.442 0.163 . . . . 0.0 110.909 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.0 152.18 49.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.161 0.505 . . . . 0.0 111.855 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.893 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 73.0 m95 -97.58 96.76 8.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.637 179.575 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.976 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 27.1 m-85 -86.86 123.62 32.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 110.728 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -106.39 159.67 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.568 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 91' ' ' ILE . 10.6 t -141.49 160.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.472 ' N ' HG12 ' A' ' 8' ' ' VAL . 14.0 m-70 -88.9 134.88 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.98 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 p -139.4 160.98 38.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.13 151.13 21.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.49 127.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -25.51 24.54 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.31 -26.9 19.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.71 0.291 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' HB2' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -56.52 -41.22 76.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.96 -37.84 67.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.973 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -86.71 -29.82 22.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.841 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.19 83.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.024 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.79 -43.58 94.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.54 -42.91 28.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.32 -31.51 69.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 88' ' ' THR . 21.1 tp -82.87 -57.6 3.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.35 -45.31 17.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.439 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -61.11 -41.91 97.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -43.23 91.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.661 HG23 ' HB2' ' A' ' 31' ' ' LEU . 35.7 mm -64.39 -28.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.855 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -91.41 -29.72 16.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 -46.46 30.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.339 -179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -79.95 -21.63 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.207 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.13 65.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.176 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.661 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.8 mm? -115.08 26.65 9.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.301 . . . . 0.0 111.154 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -80.19 22.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.38 -21.45 13.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.696 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.2 -48.01 2.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.9 mp -79.86 128.28 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.671 ' CE2' HG21 ' A' ' 3' ' ' ILE . 33.0 m-85 -115.3 -56.74 2.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.424 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -115.83 170.02 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 68' ' ' ILE . 34.7 t -157.79 120.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.983 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.893 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -144.58 150.3 37.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.334 0.588 . . . . 0.0 112.295 -178.533 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 pt -113.05 124.83 30.8 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.568 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' CG ' ' HB2' ' A' ' 62' ' ' PHE . 50.7 Cg_endo -68.9 85.71 0.49 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.651 2.234 . . . . 0.0 112.885 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 7.1 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.421 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.557 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.3 mmtp . . . . . 0 C--O 1.226 -0.169 0 CA-C-O 120.704 0.287 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.51 117.55 19.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.872 0.368 . . . . 0.0 111.028 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.858 ' CD1' HG11 ' A' ' 115' ' ' VAL . 18.1 mt -87.63 -55.45 3.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.668 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 1.1 m-85 -112.3 91.47 16.45 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 127.8 27.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.475 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.39 40.78 96.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.66 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -133.42 115.28 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -124.01 121.45 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.206 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.736 ' HD2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -97.36 133.9 41.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 111.246 -179.573 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.6 mp -123.56 122.06 64.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.591 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.455 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 2.5 tt0 -79.77 75.66 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptp -90.92 -175.17 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.153 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.461 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.3 t0 -130.52 100.03 5.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.976 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 13.9 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.054 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.627 0.251 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 82' ' ' TRP . 51.0 Cg_endo -69.08 77.89 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.481 2.121 . . . . 0.0 112.203 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.9 m120 -90.24 -173.06 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 51.91 -84.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.866 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -46.94 -48.9 21.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.719 -179.719 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 6.1 t-105 -76.2 -28.87 57.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.79 -37.79 74.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 31' ' ' LEU . 21.6 t -90.06 -47.44 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 81' ' ' ALA . 57.6 t -59.56 -42.29 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.089 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.67 -19.32 62.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.306 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -120.53 22.57 8.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.611 HG21 HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -75.62 134.24 72.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.714 0.257 . . . . 0.0 110.821 179.924 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.03 -8.61 23.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.414 2.076 . . . . 0.0 112.669 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -103.82 -18.53 13.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.828 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.639 HD11 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.34 . . . . 0.0 111.056 -179.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 1.8 mtt-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.537 0.208 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 5.5 Cg_exo -74.07 116.89 4.8 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.707 2.271 . . . . 0.0 112.006 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 102' ' ' VAL . 4.6 m -115.58 97.39 48.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.262 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.35 123.89 9.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.493 2.129 . . . . 0.0 112.187 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.77 HD22 HD13 ' A' ' 112' ' ' ILE . 2.2 mp -71.99 157.98 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -85.66 151.47 55.62 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 -179.935 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.13 -30.25 18.34 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.698 2.266 . . . . 0.0 112.464 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -71.45 -47.44 55.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -74.41 -31.9 62.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 48.7 t -61.18 -52.47 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -55.53 -38.46 69.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.21 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -68.79 -46.61 68.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.054 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.77 HD13 HD22 ' A' ' 104' ' ' LEU . 31.1 pt -72.53 -27.09 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.954 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.052 HD22 HD12 ' A' ' 118' ' ' LEU . 15.6 mt -79.45 -29.21 41.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -67.05 -21.76 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.925 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.858 HG11 ' CD1' ' A' ' 61' ' ' LEU . 13.7 t -86.31 -54.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.157 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.688 ' HB2' HD23 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -55.88 -60.44 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.672 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.58 64.83 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.903 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.052 HD12 HD22 ' A' ' 113' ' ' LEU . 30.4 mt -128.93 -43.78 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 0.0 110.891 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.4 tp -80.14 -63.33 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.572 -179.996 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.544 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.525 0.202 . . . . 1.1599999999999999 110.941 . . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -156.07 155.79 33.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 2.0699999999999998 111.507 -179.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.844 ' CD1' HG11 ' A' ' 109' ' ' VAL . 93.8 m95 -96.28 96.64 8.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.94999999999999996 110.692 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.953 ' CE2' HD12 ' A' ' 72' ' ' LEU . 3.3 m-85 -86.17 117.35 24.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 1.4299999999999999 111.029 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -92.95 147.71 22.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.71999999999999997 111.144 -179.823 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.613 HG11 HD12 ' A' ' 91' ' ' ILE . 15.2 t -134.46 159.96 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 1.6899999999999999 111.025 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.475 ' N ' HG12 ' A' ' 8' ' ' VAL . 10.7 m-70 -102.01 149.65 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 1.3600000000000001 111.013 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.2 p -151.3 -177.6 6.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 1.1100000000000001 110.86 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.0 139.4 30.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 2.2000000000000002 110.908 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 12' ' ' VAL . 28.8 m -62.65 121.71 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 2.2599999999999998 111.206 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.5 -28.62 12.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.787 -0.721 . . . . 1.76 112.402 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -89.68 -21.41 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 2.52 111.113 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -53.42 -36.31 61.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 2.5299999999999998 111.046 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -58.68 -30.91 67.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 3.25 110.878 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.79 -30.49 18.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 2.9900000000000002 110.929 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.73 87.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 1.3300000000000001 111.08 -179.984 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.456 ' NZ ' HD11 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -60.42 -49.06 79.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 3.3599999999999999 110.827 179.995 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.95 -46.06 72.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 1.7 111.045 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -60.25 -31.1 69.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 1.8999999999999999 110.824 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.729 HD11 HG22 ' A' ' 85' ' ' VAL . 54.4 tp -81.47 -55.89 4.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 1.6200000000000001 110.85 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.02 -32.91 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.236 -0.438 . . . . 2.4500000000000002 111.193 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -71.02 -40.95 71.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 3.5099999999999998 110.734 179.803 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.733 ' HG3' HG22 ' A' ' 88' ' ' THR . 13.5 mmt180 -68.89 -38.13 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 3.3799999999999999 110.675 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.889 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.4 mm -66.76 -31.82 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 1.49 110.894 179.728 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -91.19 -29.82 17.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 3.6099999999999999 110.857 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.7 -46.8 68.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 2.0600000000000001 111.174 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -80.03 -28.46 39.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 2.29 111.012 179.937 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 66.01 0.98 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 1.8400000000000001 112.442 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.889 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.7 mt -122.08 33.41 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 1.8600000000000001 110.88 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -72.58 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 2.6699999999999999 111.365 -179.975 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.87 -30.32 40.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 2.7400000000000002 110.891 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 -60.33 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.325 -0.398 . . . . 2.77 110.781 179.973 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 26' ' ' ILE . 31.6 mt -82.13 128.65 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 2.1099999999999999 111.094 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 3' ' ' ILE . 9.0 m-85 -118.02 -54.31 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 1.6899999999999999 110.986 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.416 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -110.88 153.08 25.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.98 0.419 . . . . 1.6200000000000001 111.268 -179.759 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.47 69.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 1.74 110.74 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.775 HD21 HD11 ' A' ' 118' ' ' LEU . 4.4 mm? -79.93 150.35 30.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 2.6200000000000001 111.034 -179.764 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 42' ' ' THR . 18.9 mt -109.84 129.29 24.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 2.6200000000000001 110.77 179.769 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 31.4 Cg_endo -63.64 73.88 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.488 2.125 . . . . 2.2200000000000002 112.394 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.489 HG23 HG22 ' A' ' 40' ' ' ILE . 42.5 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 1.75 110.773 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.86 0.362 . . . . 3.1499999999999999 110.706 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -107.05 105.15 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 3.5 111.007 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.039 HD11 HG11 ' A' ' 115' ' ' VAL . 78.5 mt -72.78 -47.32 47.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 1.3400000000000001 110.761 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 112' ' ' ILE . 9.9 m-85 -122.08 77.75 41.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 1.8300000000000001 110.685 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.05 127.61 26.4 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.624 2.216 . . . . 1.55 112.583 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.86 52.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.84 -0.695 . . . . 1.23 112.799 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -131.24 156.42 45.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 1.9199999999999999 111.016 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.46 114.34 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 1.77 110.596 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.871 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.1 m-85 -84.24 119.77 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 1.55 111.271 -179.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.1 mp -128.21 112.22 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.73999999999999999 110.889 179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 6.2 tt0 -79.78 75.69 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 1.77 110.521 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.558 ' CE ' HD21 ' A' ' 72' ' ' LEU . 10.3 ptm -91.59 -173.49 3.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 1.28 111.119 -179.772 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 4.3 t0 -134.07 86.71 2.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 2.0899999999999999 110.929 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.953 HD12 ' CE2' ' A' ' 6' ' ' TYR . 12.9 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.439 -0.346 . . . . 1.6899999999999999 110.806 179.69 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.62 0.247 . . . . 3.8100000000000001 110.834 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 -172.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.504 2.136 . . . . 1.8300000000000001 112.309 179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -90.08 -178.63 5.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 3.5499999999999998 110.884 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.11 -21.26 58.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 2.98 111.176 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.821 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.57 -31.54 47.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 1.1799999999999999 111.274 -179.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.435 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 14.6 t-105 -76.94 -37.41 55.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 1.05 110.956 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.58 -29.23 67.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 2.75 110.894 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG21 HD11 ' A' ' 31' ' ' LEU . 29.2 t -87.11 -51.31 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 1.3100000000000001 111.097 -179.938 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 81' ' ' ALA . 33.2 t -58.81 -36.83 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.93999999999999995 111.01 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.33 -20.84 59.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 2.9199999999999999 111.106 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.36 9.19 38.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.655 -0.783 . . . . 1.27 113.019 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.733 HG22 ' HG3' ' A' ' 25' ' ' ARG . 1.1 p -86.34 141.12 34.46 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.928 0.364 . . . . 1.1100000000000001 110.811 179.97 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.29 87.07 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.539 2.159 . . . . 2.0099999999999998 112.208 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.26 -32.74 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 1.79 112.493 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.613 HD12 HG11 ' A' ' 8' ' ' VAL . 47.0 mm . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 1.72 110.952 -179.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.781 0.324 . . . . 6.21 110.89 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.435 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 75.6 Cg_exo -49.89 163.53 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.687 2.258 . . . . 1.1100000000000001 112.463 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.0 96.19 40.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 1.98 111.2 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.62 120.61 7.23 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.459 2.106 . . . . 0.94999999999999996 112.276 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 104' ' ' LEU . 3.1 mp -65.43 166.49 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 1.3600000000000001 110.944 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 13.8 m -89.97 148.68 40.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 1.6599999999999999 110.851 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.61 -30.25 44.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.528 2.152 . . . . 1.27 112.429 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.72 -31.36 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 2.75 110.949 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -88.96 -32.53 17.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 2.46 110.886 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 20.0 t -63.83 -39.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 1.0700000000000001 111.102 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.4 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 3.9399999999999999 110.945 -179.924 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.716 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -68.49 -54.92 13.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 2.25 110.661 179.872 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.871 HD12 ' CD2' ' A' ' 67' ' ' PHE . 15.6 pt -66.14 -24.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 1.3600000000000001 110.89 179.637 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.858 ' CD2' HD12 ' A' ' 118' ' ' LEU . 5.4 mt -74.66 -34.43 62.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 1.9399999999999999 110.535 179.662 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -78.02 -31.47 50.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.059 -0.519 . . . . 2.6800000000000002 110.748 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 1.039 HG11 HD11 ' A' ' 61' ' ' LEU . 34.6 t -77.14 -33.05 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 1.72 110.949 179.813 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.555 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -62.52 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 2.1099999999999999 110.923 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.729 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 143.86 45.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 1.78 112.643 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.858 HD12 ' CD2' ' A' ' 113' ' ' LEU . 1.6 mt -125.17 -48.94 1.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 1.99 110.818 179.86 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -31.23 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 2.4399999999999999 110.866 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.31 -1.272 . . . . 2.9900000000000002 112.575 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.844 0.354 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.662 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -79.94 -167.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.32 156.61 38.69 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.127 0.489 . . . . 0.0 111.762 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.679 ' CD1' HG11 ' A' ' 109' ' ' VAL . 82.0 m95 -95.3 95.56 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.653 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.639 ' CE2' HD12 ' A' ' 72' ' ' LEU . 33.0 m-85 -83.4 115.47 22.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.996 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.71 133.24 50.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.235 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 9' ' ' HIS . 6.3 t -128.36 161.64 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.55 ' NE2' HG12 ' A' ' 95' ' ' VAL . 14.8 m-70 -90.06 159.96 16.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.599 HG21 ' CD1' ' A' ' 66' ' ' LEU . 62.2 p -152.45 -174.38 4.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.522 HD23 HG21 ' A' ' 92' ' ' THR . 0.2 OUTLIER -85.52 139.22 31.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' N ' HD13 ' A' ' 11' ' ' LEU . 21.4 t -68.09 122.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.33 -27.86 15.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -92.17 -14.87 28.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.609 0.243 . . . . 0.0 111.245 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 66' ' ' LEU . 7.3 tm-20 -52.42 -46.54 66.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.754 0.311 . . . . 0.0 111.054 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.87 -30.85 69.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.887 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.06 -30.76 22.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.848 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.15 72.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -49.3 78.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.98 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.46 50.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.172 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -60.69 -31.63 70.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.74 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.799 HD12 HG21 ' A' ' 88' ' ' THR . 5.8 tp -81.17 -60.43 2.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.826 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -46.9 -35.42 6.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.315 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -66.22 -47.3 74.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.709 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.41 ' HD2' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -62.68 -39.38 93.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.682 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.2 mm -62.56 -29.79 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -93.59 -29.98 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.815 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -44.03 74.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.157 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.0 -30.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 66.09 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.2 mt -124.79 23.23 8.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.734 0.302 . . . . 0.0 111.046 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -73.44 -9.14 58.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -79.8 -29.64 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.778 0.323 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -51.83 5.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.803 HD12 HG21 ' A' ' 26' ' ' ILE . 32.3 mt -79.92 128.16 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.662 ' CE2' HG21 ' A' ' 3' ' ' ILE . 26.0 m-85 -113.66 -53.41 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.303 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.434 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.0 mt-30 -113.27 157.39 21.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.046 0.45 . . . . 0.0 111.452 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 68' ' ' ILE . 16.5 t -152.27 71.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.8 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.4 mm? -85.87 150.06 24.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.203 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.3 pt -107.22 131.19 21.89 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.862 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 32.3 Cg_endo -64.16 72.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.605 2.203 . . . . 0.0 112.643 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.0 p -147.73 130.69 16.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -79.95 142.05 35.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -96.71 145.04 26.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 45' ' ' VAL . 15.7 m -149.56 116.63 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.81 138.48 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.256 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.91 120.18 10.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.73 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -124.53 149.02 47.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.012 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -121.0 -45.35 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -129.85 176.33 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.88 131.91 11.01 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.57 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.48 -45.32 1.33 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -111.16 127.2 55.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.26 137.85 41.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -126.21 115.25 19.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.74 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.6 m -111.78 135.21 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.329 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.39 -179.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.96 138.17 14.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.857 0.361 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -98.2 129.07 44.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.751 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.81 110.03 11.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.544 HD21 HG11 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -72.38 -49.33 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.537 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.436 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 18.9 m-85 -106.76 98.21 20.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.296 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.91 137.05 55.94 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.429 2.086 . . . . 0.0 112.633 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.97 26.07 65.05 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.704 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' CD2' ' HB3' ' A' ' 62' ' ' PHE . 14.5 m-85 -116.4 145.55 43.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.717 0.294 . . . . 0.0 111.087 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.781 HD11 ' HG2' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -142.93 112.73 6.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.764 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.675 ' CD2' HD12 ' A' ' 112' ' ' ILE . 6.4 m-85 -88.35 124.22 33.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.576 HG23 HG22 ' A' ' 38' ' ' VAL . 1.2 mp -130.04 117.61 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 6.8 tt0 -79.97 71.8 6.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.939 0.399 . . . . 0.0 110.196 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 72' ' ' LEU . 13.0 ptp -90.87 -174.02 3.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.22 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -132.66 75.45 1.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.836 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.639 HD12 ' CE2' ' A' ' 6' ' ' TYR . 86.4 mt -88.37 7.3 33.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.39 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.72 61.08 3.69 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.611 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.06 -68.29 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 110.768 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.89 -85.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.797 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -90.24 -70.03 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -110.0 157.95 36.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.876 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 174.82 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.508 2.139 . . . . 0.0 112.135 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.436 ' ND2' HD23 ' A' ' 72' ' ' LEU . 7.5 p30 -87.01 -172.14 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.032 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -21.51 42.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -50.66 -42.46 56.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.851 0.358 . . . . 0.0 111.285 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -64.67 -39.2 93.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.966 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.23 -43.14 99.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.681 HG21 HD11 ' A' ' 31' ' ' LEU . 21.6 t -59.32 -51.49 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.937 0.399 . . . . 0.0 111.058 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.61 HG12 HD13 ' A' ' 91' ' ' ILE . 21.7 t -61.99 -42.63 95.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.122 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -17.48 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.331 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.08 -15.71 15.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.136 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.916 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -62.1 142.37 95.55 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.857 0.328 . . . . 0.0 110.972 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 88' ' ' THR . 52.7 Cg_exo -54.94 -20.21 22.16 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.469 2.113 . . . . 0.0 112.569 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.19 36.34 3.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.977 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 88' ' ' THR . 2.1 tp -137.31 135.78 47.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.522 HG21 HD23 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -112.08 -42.18 3.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.64 -126.6 1.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.548 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 94' ' ' PHE . 1.4 p90 -153.17 179.15 8.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 0.0 110.769 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.55 HG12 ' NE2' ' A' ' 9' ' ' HIS . 10.6 m -55.29 -40.73 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.263 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.83 43.13 7.84 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.491 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.02 -78.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.83 0.348 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.09 -56.79 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.334 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.4 ttp -111.74 -174.23 2.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.782 0.325 . . . . 0.0 110.601 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 15.1 mmm-85 -81.46 -49.69 0.96 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.352 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 89.0 Cg_endo -81.72 -169.99 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.515 2.143 . . . . 0.0 112.598 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -153.34 71.17 6.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.097 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.17 132.74 48.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.687 2.258 . . . . 0.0 112.365 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.591 HD13 ' CD1' ' A' ' 112' ' ' ILE . 0.5 OUTLIER -88.11 161.65 17.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.9 OUTLIER -89.98 153.56 47.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.05 -48.61 20.26 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.532 2.155 . . . . 0.0 112.428 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.29 -31.9 71.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 112' ' ' ILE . 1.8 mp0 -81.59 -36.64 28.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 105' ' ' SER . 41.2 t -58.96 -45.7 91.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -27.13 68.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.511 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 m80 -81.64 -37.31 27.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.057 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.675 HD12 ' CD2' ' A' ' 67' ' ' PHE . 8.1 pt -81.33 -20.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.003 HD22 HD12 ' A' ' 118' ' ' LEU . 22.3 mt -86.94 -33.08 19.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.8 -32.79 73.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.663 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.544 HG11 HD21 ' A' ' 61' ' ' LEU . 35.2 t -80.92 -35.87 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.903 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.8 ' OG ' HD12 ' A' ' 39' ' ' LEU . 1.5 t -60.33 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.809 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.49 42.59 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.628 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.003 HD12 HD22 ' A' ' 113' ' ' LEU . 23.2 mt -117.29 -56.96 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.879 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -30.29 40.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.546 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.786 0.326 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.86 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -132.52 -170.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.766 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -147.91 163.15 37.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.282 0.563 . . . . 0.0 112.105 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.774 ' CD1' HG11 ' A' ' 109' ' ' VAL . 67.8 m95 -94.27 139.3 31.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.671 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CE2' HD12 ' A' ' 72' ' ' LEU . 21.0 m-85 -125.64 110.03 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.357 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.06 151.19 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.054 0.454 . . . . 0.0 111.745 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.61 162.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.595 ' HD2' HG22 ' A' ' 95' ' ' VAL . 2.5 m-70 -100.31 151.52 21.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.056 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.4 p -149.14 -178.24 6.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -89.87 140.67 29.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' H ' HD23 ' A' ' 11' ' ' LEU . 28.3 t -62.06 125.3 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.71 -37.98 3.25 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 -21.55 34.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.063 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -54.76 -43.15 72.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.06 -46.53 75.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -24.72 36.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.055 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -50.26 74.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -33.11 71.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.4 -51.6 23.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.092 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.7 -33.26 71.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.651 HD11 HG22 ' A' ' 85' ' ' VAL . 56.1 tp -73.48 -55.01 6.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.58 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -30.34 8.87 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -72.35 -42.88 64.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.726 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -66.57 -34.7 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.666 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.842 HG23 ' HB2' ' A' ' 31' ' ' LEU . 36.0 mm -69.47 -31.58 49.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -32.68 24.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.52 -41.96 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -80.78 -25.39 37.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.994 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.41 5.63 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.402 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.842 ' HB2' HG23 ' A' ' 26' ' ' ILE . 2.3 mt -99.85 28.63 4.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.722 0.296 . . . . 0.0 110.999 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -71.88 -10.54 59.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 15.8 t70 -79.67 -24.88 41.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.01 -54.49 4.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.2 mp -87.77 137.9 20.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.707 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.86 ' CE2' HG21 ' A' ' 3' ' ' ILE . 13.1 m-85 -129.93 -56.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.513 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.575 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -109.44 134.37 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.144 0.497 . . . . 0.0 112.067 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 38' ' ' VAL . 5.1 m -125.15 99.59 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.284 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.542 HD23 ' HB3' ' A' ' 116' ' ' SER . 1.9 tm? -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.469 ' N ' HD22 ' A' ' 39' ' ' LEU . 16.5 tt -87.68 125.09 66.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' O ' HG23 ' A' ' 42' ' ' THR . 27.6 Cg_endo -62.16 76.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.651 2.234 . . . . 0.0 112.563 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 41' ' ' PRO . 25.3 p -159.61 153.06 22.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -92.4 141.51 28.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.567 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -119.49 108.77 14.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.898 0.38 . . . . 0.0 111.007 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 3.7 m -137.63 130.36 42.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.01 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -160.3 134.8 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.39 -176.17 2.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 0.0 110.936 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.51 162.67 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.6 30.97 2.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -31.75 29.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.52 93.43 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.26 -57.93 0.43 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.526 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -125.03 -176.95 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.34 . . . . 0.0 110.863 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -117.83 160.96 20.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -79.9 154.4 28.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -116.48 -151.46 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.385 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 56' ' ' VAL . 3.1 m -160.36 -177.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.067 0 CA-C-O 120.905 0.383 . . . . 0.0 111.474 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -90.8 138.22 31.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.9 mttm -102.82 -166.61 1.29 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.707 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.8 OUTLIER -138.66 116.88 11.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.03 -55.52 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.627 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.1 m-85 -121.31 79.51 36.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.21 144.28 81.81 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.745 2.296 . . . . 0.0 112.671 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.93 18.43 70.64 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.139 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 15.0 m-85 -129.13 162.7 27.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.981 0.42 . . . . 0.0 111.113 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.35 122.29 8.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.353 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.739 ' CD1' HD11 ' A' ' 104' ' ' LEU . 11.6 m-30 -89.59 130.03 35.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.956 0.408 . . . . 0.0 111.217 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 6' ' ' TYR . 2.3 mt -130.73 111.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.575 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -79.71 68.42 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.673 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.469 ' CE ' HD21 ' A' ' 72' ' ' LEU . 10.2 ptm -91.66 -164.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.675 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -141.07 71.24 1.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.585 HD12 ' CE2' ' A' ' 6' ' ' TYR . 95.4 mt -80.51 -33.65 36.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.64 74.75 0.15 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.484 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -133.47 -77.92 0.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.874 0.368 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -91.14 -178.55 5.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.04 -31.62 71.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.5 166.55 26.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.33 151.14 81.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.542 2.161 . . . . 0.0 112.332 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.21 -167.69 1.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -66.12 -27.44 68.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.853 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -52.18 -39.8 60.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.319 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -74.59 -33.27 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -31.41 71.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.72 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.83 -44.38 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.986 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 81' ' ' ALA . 28.9 t -64.42 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.98 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.76 -13.56 62.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.07 -12.78 10.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.051 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.637 HG21 ' CD1' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -58.89 159.74 12.65 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.908 0.354 . . . . 0.0 110.891 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.99 122.84 9.45 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.543 2.162 . . . . 0.0 112.385 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.51 -26.71 9.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.577 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' A' ' 92' ' ' THR . 45.3 mm -84.96 106.63 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.055 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER 168.5 63.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.575 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.98 -55.56 0.23 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.706 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.479 ' HB2' ' CG ' ' A' ' 9' ' ' HIS . 1.4 t80 -138.73 -70.21 0.42 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.595 HG22 ' HD2' ' A' ' 9' ' ' HIS . 30.0 m -84.0 174.59 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.71 67.98 0.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.333 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.01 -51.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 111.137 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.11 -45.69 0.36 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.37 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -106.31 -29.51 9.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.845 0.355 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -57.02 -44.13 99.66 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.406 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 82.5 Cg_exo -47.79 127.44 14.32 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.344 2.029 . . . . 0.0 112.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 102' ' ' VAL . 9.6 p -98.07 105.26 26.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.271 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.68 124.45 8.2 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.341 2.028 . . . . 0.0 111.997 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.739 HD11 ' CD1' ' A' ' 67' ' ' PHE . 68.2 mt -59.55 134.22 56.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.081 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.928 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.5 p -76.61 150.79 82.33 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.81 -31.75 73.85 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.639 2.226 . . . . 0.0 112.271 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.76 -28.39 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.75 -37.09 10.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 105' ' ' SER . 24.5 t -58.63 -29.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.17 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttt-85 -60.22 -39.25 86.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.827 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.88 -55.7 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.498 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.627 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.3 pp -63.56 -22.14 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.665 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.866 ' CD2' HD12 ' A' ' 118' ' ' LEU . 1.9 mt -70.41 -39.52 74.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.469 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.26 -29.3 67.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.68 -41.19 62.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.542 ' HB3' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -60.22 -62.11 2.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 110.581 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.717 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 132.69 36.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.024 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.866 HD12 ' CD2' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -112.56 -27.95 8.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -49.98 11.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.875 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.447 -1.196 . . . . 0.0 112.562 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 t . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.7 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.91 -168.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.908 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.38 150.05 40.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.175 0.512 . . . . 0.0 111.832 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.919 ' CZ2' HD21 ' A' ' 113' ' ' LEU . 73.0 m95 -95.56 88.53 5.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.409 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.466 ' CE2' HD12 ' A' ' 72' ' ' LEU . 50.6 m-85 -81.27 123.64 28.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.04 127.12 53.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.94 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 91' ' ' ILE . 1.5 p -108.03 159.88 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 111.084 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.482 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 48.3 m-70 -83.86 136.48 34.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -143.55 151.57 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.31 136.6 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.75 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -57.58 111.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.262 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.59 -20.47 32.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.691 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.59 -16.96 15.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.617 0.246 . . . . 0.0 111.308 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -33.92 59.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.83 0.348 . . . . 0.0 111.133 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.82 -31.84 71.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.992 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -26.06 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -43.69 98.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.176 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -65.89 -30.67 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.86 47.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -62.12 -25.18 67.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.58 HD11 HG22 ' A' ' 85' ' ' VAL . 25.8 tp -86.7 -56.81 3.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -45.91 -37.68 6.65 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.426 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 -33.62 70.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.875 ' HG3' HG22 ' A' ' 88' ' ' THR . 4.9 mmt-85 -75.64 -32.37 60.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.636 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.837 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.7 mm -70.39 -31.4 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.734 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -84.04 -30.4 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 -42.05 38.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -80.04 -25.58 40.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.962 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.07 66.52 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.468 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.837 ' HB2' HG23 ' A' ' 26' ' ' ILE . 1.5 mt -125.82 30.1 5.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.987 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -25.39 68.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.07 -1.79 41.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.365 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -99.47 -58.65 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.755 0.312 . . . . 0.0 110.748 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.441 HD12 HG21 ' A' ' 26' ' ' ILE . 37.6 mt -81.45 132.92 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.617 ' CE2' HG21 ' A' ' 3' ' ' ILE . 3.0 m-85 -127.02 -49.99 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.19 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -117.14 156.66 27.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.107 0.479 . . . . 0.0 111.697 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.707 ' O ' HD22 ' A' ' 39' ' ' LEU . 3.6 m -159.91 114.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.231 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.841 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.5 mm? -130.04 177.32 7.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.406 0.622 . . . . 0.0 112.07 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 42' ' ' THR . 28.7 mt -148.56 74.25 10.52 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.785 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 87.9 Cg_exo -41.66 113.78 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.176 2.584 . . . . 0.0 113.59 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 40' ' ' ILE . 29.4 p -128.25 127.88 43.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.063 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.805 ' OE2' HD21 ' A' ' 61' ' ' LEU . 1.8 tp10 -79.82 135.72 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.878 0.37 . . . . 0.0 111.105 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.54 145.44 48.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.886 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 m -142.68 147.75 20.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.58 ' HA ' HG12 ' A' ' 56' ' ' VAL . 10.3 p -121.65 141.76 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -123.66 149.92 44.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.64 164.93 24.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.21 -47.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.834 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.27 -46.71 0.22 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.06 -22.19 1.93 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.603 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.72 -70.05 1.29 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.66 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -84.08 151.52 24.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 110.961 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 130.93 46.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -117.12 115.21 24.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.0 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 46' ' ' VAL . 31.6 m -138.09 139.45 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.995 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.475 ' CG2' ' N ' ' A' ' 58' ' ' ARG . 1.3 p -136.5 159.55 37.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.14 0.495 . . . . 0.0 110.99 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.475 ' N ' ' CG2' ' A' ' 57' ' ' VAL . 4.4 mtt85 -129.19 122.14 29.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.788 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HG3' ' HB3' ' A' ' 43' ' ' GLU . 1.8 ptmm? -114.82 116.55 28.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.704 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HG3' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -57.48 115.2 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.805 HD21 ' OE2' ' A' ' 43' ' ' GLU . 17.9 mt -61.86 -44.55 96.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.309 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 41' ' ' PRO . 2.1 m-85 -115.57 76.92 5.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.563 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.54 127.77 16.12 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.67 2.246 . . . . 0.0 112.419 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.68 19.66 72.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.579 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 48.7 m-85 -128.89 111.03 12.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.97 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 66' ' ' LEU . 18.5 mt -90.9 114.91 27.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.514 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.742 ' CE2' HD12 ' A' ' 112' ' ' ILE . 6.6 m-30 -82.47 122.85 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 mp -128.87 110.16 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.181 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 3.6 tt0 -79.97 69.97 6.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.686 ' SD ' HD11 ' A' ' 72' ' ' LEU . 15.6 ptp -90.84 -178.13 5.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.487 ' O ' HD23 ' A' ' 72' ' ' LEU . 3.4 t0 -119.53 98.88 6.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.099 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.686 HD11 ' SD ' ' A' ' 70' ' ' MET . 39.4 mt -128.57 -44.07 1.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.795 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.9 91.5 0.01 OUTLIER Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.624 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -151.25 -46.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -138.92 -174.58 3.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.81 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -77.88 -22.48 49.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.088 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.51 106.87 54.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 173.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.433 2.089 . . . . 0.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -84.38 179.19 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.2 -25.21 65.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.754 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.08 -28.89 27.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.321 . . . . 0.0 111.237 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -63.76 -48.61 76.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -58.88 -30.26 67.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.796 HG21 HD11 ' A' ' 31' ' ' LEU . 21.6 t -77.69 -49.67 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.184 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 81' ' ' ALA . 39.1 t -59.96 -52.68 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttp85 -58.03 -22.84 51.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -88.52 -32.39 11.72 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.728 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.875 HG22 ' HG3' ' A' ' 25' ' ' ARG . 65.7 p -59.13 130.64 86.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.493 0.187 . . . . 0.0 110.99 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.78 -23.87 35.52 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.393 2.062 . . . . 0.0 112.314 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.41 -29.19 46.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.735 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.525 HD12 HG21 ' A' ' 8' ' ' VAL . 40.0 mm -82.89 135.05 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 111.086 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.47 -36.21 5.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.844 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.46 101.66 0.15 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.407 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.44 ' CE2' ' HB ' ' A' ' 8' ' ' VAL . 7.2 m-85 -56.38 -175.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 110.915 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.8 HG21 ' CG2' ' A' ' 102' ' ' VAL . 20.8 t -54.97 139.36 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.226 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -99.46 27.52 19.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.605 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.527 ' H ' HG12 ' A' ' 95' ' ' VAL . . . -117.16 96.03 5.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 111.027 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.16 -86.5 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.352 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.89 137.49 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 0.0 110.682 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.476 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -66.12 -50.35 51.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.964 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 84.7 Cg_endo -81.18 130.43 7.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.502 2.135 . . . . 0.0 112.107 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.8 ' CG2' HG21 ' A' ' 95' ' ' VAL . 37.6 t -129.68 99.7 20.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.262 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.9 139.14 10.77 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.645 2.23 . . . . 0.0 112.252 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.889 HD22 HD13 ' A' ' 112' ' ' ILE . 1.2 mp -67.59 156.75 36.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.06 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.91 ' O ' HG23 ' A' ' 109' ' ' VAL . 47.6 p -85.44 149.97 53.15 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.757 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -45.98 -49.58 10.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.773 2.316 . . . . 0.0 112.873 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.47 -39.98 85.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.17 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -78.66 -33.3 47.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 105' ' ' SER . 58.4 t -58.79 -31.4 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.237 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -26.01 56.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.728 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -82.33 -29.23 31.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.108 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.889 HD13 HD22 ' A' ' 104' ' ' LEU . 34.2 pt -80.68 -32.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.111 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.955 HD22 HD12 ' A' ' 118' ' ' LEU . 97.9 mt -77.5 -25.2 50.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.23 -32.37 61.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.979 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 111' ' ' HIS . 21.3 t -75.49 -48.2 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.072 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.841 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -58.48 -59.98 4.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 137.14 67.28 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.597 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.955 HD12 HD22 ' A' ' 113' ' ' LEU . 23.1 mt -129.05 -47.46 1.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.822 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -61.73 1.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.491 179.943 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.802 0.334 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.807 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -133.7 -165.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -128.01 139.54 52.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.292 0.568 . . . . 0.0 112.092 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 1.097 ' CH2' HD22 ' A' ' 39' ' ' LEU . 25.7 m95 -94.94 96.23 9.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.047 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.466 ' O ' HD12 ' A' ' 68' ' ' ILE . 44.9 m-85 -96.67 112.96 24.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 0.0 111.397 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.426 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -108.14 134.88 50.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.753 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.695 HG21 HD12 ' A' ' 91' ' ' ILE . 1.5 p -134.14 160.18 41.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.196 0.522 . . . . 0.0 111.234 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.489 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 5.6 m170 -82.26 147.12 29.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -123.83 -173.83 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mt -87.7 127.61 35.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.72 114.87 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.6 -28.8 11.9 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.44 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.52 -7.78 37.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.622 0.249 . . . . 0.0 111.292 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -55.74 -39.72 71.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.928 0.394 . . . . 0.0 111.136 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -52.45 65.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.096 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -14.34 56.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.359 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.536 ' HB1' ' CA ' ' A' ' 90' ' ' GLY . . . -70.44 -51.21 31.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 111.228 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -56.57 -41.56 77.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.04 -43.35 92.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.133 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -62.19 -34.49 76.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD13 HG21 ' A' ' 88' ' ' THR . 26.3 tp -84.02 -45.07 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.574 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.4 tt0 -55.23 -26.41 39.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.12 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -78.32 -47.61 17.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.318 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.02 -27.3 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.352 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.732 HG12 HD13 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -70.63 -29.35 37.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -87.38 -31.52 20.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.6 -32.36 67.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.044 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -87.89 5.7 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.53 47.49 86.63 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 26' ' ' ILE . 8.8 mt -111.08 9.63 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.536 0.207 . . . . 0.0 111.266 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -17.25 63.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 0.0 111.259 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.93 -38.53 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.041 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.37 -51.75 33.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.732 HD13 HG12 ' A' ' 26' ' ' ILE . 4.8 mp -79.87 117.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.756 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.807 ' CE2' HG21 ' A' ' 3' ' ' ILE . 31.7 m-85 -100.95 -53.17 3.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.333 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.472 ' CG ' ' HB3' ' A' ' 69' ' ' GLN . 5.1 mm-40 -107.95 169.89 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.374 0.606 . . . . 0.0 111.651 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.3 p -156.33 73.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.35 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.097 HD22 ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -79.55 139.48 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.638 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.614 HG22 HG23 ' A' ' 42' ' ' THR . 14.4 mt -100.5 138.3 20.13 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.818 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 40' ' ' ILE . 67.9 Cg_endo -72.72 59.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.543 2.162 . . . . 0.0 112.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.614 HG23 HG22 ' A' ' 40' ' ' ILE . 44.1 p -139.67 171.37 14.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.965 0.412 . . . . 0.0 111.317 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.638 ' HA ' HG12 ' A' ' 115' ' ' VAL . 8.0 tp10 -103.92 148.71 25.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.8 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -135.88 112.39 9.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.97 120.09 63.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.458 HG22 ' N ' ' A' ' 47' ' ' GLU . 7.5 p -102.31 157.54 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.167 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.604 ' HB2' HG22 ' A' ' 56' ' ' VAL . 2.2 mt-10 -120.42 -167.5 1.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.05 118.06 19.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -178.65 4.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.39 86.09 5.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.27 53.6 3.82 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.502 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.1 -173.88 46.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.513 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -122.53 119.83 32.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 110.815 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.15 143.56 50.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.34 178.67 7.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.604 HG22 ' HB2' ' A' ' 47' ' ' GLU . 24.9 t -120.67 -71.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.25 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 56' ' ' VAL . 3.1 m -160.19 179.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.325 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -139.98 120.54 14.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.967 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -97.08 -160.99 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.358 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -141.92 121.21 13.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.971 HD11 HG11 ' A' ' 115' ' ' VAL . 2.1 mt -90.27 -65.78 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.592 ' HE2' HG22 ' A' ' 112' ' ' ILE . 6.6 m-85 -103.9 90.42 2.93 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.763 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.01 123.02 11.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.128 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.39 29.06 54.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.569 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 19.3 m-85 -117.27 177.68 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.2 tp -160.21 148.87 17.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.756 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.656 ' CE2' HG21 ' A' ' 112' ' ' ILE . 18.2 m-85 -132.5 125.62 31.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.572 HG22 HG23 ' A' ' 35' ' ' ILE . 1.3 mp -133.04 112.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.016 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.53 ' NE2' HD11 ' A' ' 3' ' ' ILE . 8.6 tt0 -79.9 72.41 6.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.943 0.401 . . . . 0.0 110.675 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.419 ' HG3' ' HG ' ' A' ' 72' ' ' LEU . 2.1 ptm -91.37 -166.52 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.408 ' OD2' ' CE2' ' A' ' 36' ' ' PHE . 1.2 p30 -136.71 78.46 1.7 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 110.982 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.432 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 35.3 mt -99.73 -48.64 4.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.44 -85.37 0.43 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.384 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.9 -80.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 110.859 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 55.63 -175.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -59.78 -33.27 71.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.21 144.45 10.66 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.815 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.46 179.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.387 2.058 . . . . 0.0 112.185 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -171.97 3.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -70.79 -26.2 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.101 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.873 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.55 -28.96 34.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.323 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 101' ' ' PRO . 12.5 t-105 -69.46 -36.15 76.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.7 -30.0 70.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.583 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -82.29 -45.89 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.134 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.7 t -61.45 -50.21 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.056 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -29.91 70.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.913 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.58 -27.07 52.63 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.582 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.531 HG21 HD13 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -69.32 147.31 97.11 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.865 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.52 -20.79 35.52 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.485 2.123 . . . . 0.0 112.378 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' CA ' ' HB1' ' A' ' 18' ' ' ALA . . . -55.89 -28.1 52.12 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.636 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.695 HD12 HG21 ' A' ' 8' ' ' VAL . 41.9 mm -93.27 122.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 t -122.76 -43.65 2.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -137.05 161.3 25.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.453 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -125.16 -177.28 3.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.387 . . . . 0.0 110.833 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.403 ' HB ' HG21 ' A' ' 102' ' ' VAL . 21.3 t -80.28 -67.09 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.53 -146.09 17.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.393 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.76 49.34 8.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 111.115 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.09 -82.26 1.63 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.93 155.3 35.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.2 OUTLIER -77.35 -48.74 2.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.244 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 98.1 Cg_endo -79.93 143.75 16.55 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.348 2.032 . . . . 0.0 112.297 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.403 HG21 ' HB ' ' A' ' 95' ' ' VAL . 31.8 t -127.17 110.68 21.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.252 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 96.4 Cg_endo -79.1 132.12 10.25 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.613 2.209 . . . . 0.0 112.239 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.694 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.9 mp -86.12 147.27 26.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.858 ' O ' HG23 ' A' ' 109' ' ' VAL . 18.9 p -90.07 159.48 42.4 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.821 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.22 -27.23 6.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.753 2.302 . . . . 0.0 112.544 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -44.83 74.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.67 -32.4 17.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 105' ' ' SER . 38.7 t -62.22 -28.57 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.342 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -69.34 -28.21 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.648 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -72.54 -51.42 19.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.765 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.855 HD12 HD23 ' A' ' 39' ' ' LEU . 1.5 pp -68.01 -13.76 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.692 HD23 ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -83.77 -40.83 18.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.857 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.97 -40.35 71.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.971 HG11 HD11 ' A' ' 61' ' ' LEU . 5.7 t -71.64 -44.89 69.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.194 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.487 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 15.4 p -56.18 -62.38 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.76 42.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.569 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.692 ' HB2' HD23 ' A' ' 113' ' ' LEU . 19.1 mt -111.2 -36.01 5.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.474 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -98.17 -34.4 10.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.519 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.831 0.348 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.561 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -132.05 162.76 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.764 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 163.88 31.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.874 ' CD1' HG11 ' A' ' 109' ' ' VAL . 72.9 m95 -88.72 96.27 10.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.825 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE2' ' CD1' ' A' ' 72' ' ' LEU . 4.8 m-85 -79.74 124.52 28.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -114.19 134.63 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.908 0.385 . . . . 0.0 111.533 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.654 HG21 ' CD1' ' A' ' 91' ' ' ILE . 0.7 OUTLIER -126.58 -166.97 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.626 ' N ' HG13 ' A' ' 8' ' ' VAL . 6.5 m-70 -132.87 160.72 36.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.917 0.389 . . . . 0.0 111.213 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.6 p -156.35 174.75 14.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.766 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.53 139.1 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 t -65.34 125.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.16 -28.43 12.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -92.98 -16.52 25.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.554 0.216 . . . . 0.0 111.162 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.79 -36.01 46.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.805 0.336 . . . . 0.0 111.207 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -59.75 -30.81 69.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.07 -28.91 19.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.955 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.52 68.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -53.28 59.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.86 -42.89 89.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -59.76 -31.14 69.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.67 HD11 HG22 ' A' ' 85' ' ' VAL . 55.5 tp -88.96 -48.89 7.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.819 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.792 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.7 tm-20 -62.58 -24.19 67.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -80.55 -38.38 29.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.254 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -72.37 -22.46 61.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 23' ' ' GLU . 1.1 tp -72.3 -28.89 30.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.016 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -89.61 -30.1 18.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.23 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -86.68 -30.29 21.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.76 41.6 4.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -101.51 25.69 8.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -66.92 -16.78 64.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.251 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.8 -25.69 40.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -79.63 -61.06 2.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 70' ' ' MET . 1.8 pt -79.86 158.86 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.1 m-85 -143.88 -49.72 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.195 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -118.28 145.7 44.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.376 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.622 ' CG1' HG23 ' A' ' 68' ' ' ILE . 3.0 m -150.04 102.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.876 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.698 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.4 mm? -112.76 155.7 24.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.029 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.519 HG22 HG23 ' A' ' 42' ' ' THR . 3.6 mp -103.81 126.82 30.82 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 50.4 Cg_endo -69.27 62.44 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.605 2.203 . . . . 0.0 112.486 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.519 HG23 HG22 ' A' ' 40' ' ' ILE . 55.9 p -132.45 141.21 48.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.056 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -89.36 148.66 23.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.774 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.55 115.26 13.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 45' ' ' VAL . 32.9 m -124.34 120.54 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.324 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 56' ' ' VAL . 3.7 m -146.81 145.72 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.81 -174.42 4.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.172 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 49' ' ' ARG . 4.9 tt -93.02 141.16 28.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.705 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -87.65 149.22 24.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.25 -29.72 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -95.27 -38.58 4.76 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.545 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.82 31.95 0.33 Allowed Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.876 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.1 119.91 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.758 0.313 . . . . 0.0 110.947 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.55 159.03 36.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.689 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -129.46 150.51 50.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.117 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.532 HG13 ' CG1' ' A' ' 46' ' ' VAL . 36.5 t -105.19 122.28 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.03 155.38 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.9 mtp85 -149.2 123.52 9.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.815 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -123.5 98.84 6.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -55.5 106.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.531 HD21 HG11 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -62.76 -51.49 66.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.614 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 61' ' ' LEU . 14.6 m-85 -105.77 94.95 9.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.416 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.9 129.05 31.38 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.511 2.141 . . . . 0.0 112.495 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.06 40.36 82.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.56 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 0.8 OUTLIER -124.23 144.41 49.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.795 0.331 . . . . 0.0 111.003 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.95 124.98 21.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.721 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.2 m-85 -96.39 133.79 40.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.227 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.622 HG23 ' CG1' ' A' ' 38' ' ' VAL . 3.1 mp -142.32 114.17 3.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.848 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 7.1 tt0 -79.9 76.28 6.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 35' ' ' ILE . 21.2 ptp -91.63 -168.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.821 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 3' ' ' ILE . 21.6 t0 -156.24 91.77 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.741 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 81.7 mt -79.98 -29.38 39.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.33 -49.25 3.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.544 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.69 177.3 8.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -105.81 -25.42 12.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -78.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.413 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -123.12 108.51 32.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.957 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.5 173.82 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.394 2.063 . . . . 0.0 112.247 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -90.09 -171.08 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -66.45 -27.81 68.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.99 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.782 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.2 -38.67 65.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.209 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.426 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 11.8 t-105 -66.82 -36.5 82.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.25 -32.17 69.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -85.14 -39.41 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.9 t -71.28 -33.41 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -18.01 62.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.6 -4.21 30.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.023 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -71.17 133.11 85.8 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.962 0.381 . . . . 0.0 110.737 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.8 121.2 9.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.152 . . . . 0.0 112.306 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.02 -29.56 5.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.593 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 88' ' ' THR . 2.5 tp -80.09 115.99 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.7 p -137.81 27.14 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.035 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.56 159.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.496 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.461 ' HB3' ' CG ' ' A' ' 9' ' ' HIS . 0.1 OUTLIER 178.93 -37.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.975 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 100' ' ' ARG . 19.7 m -53.65 -27.13 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.407 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.46 -171.28 29.54 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 57.98 73.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.783 0.325 . . . . 0.0 111.08 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.49 86.62 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.737 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.0 mpp? 61.0 19.58 10.02 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.756 -0.261 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.618 ' O ' HG21 ' A' ' 95' ' ' VAL . 2.3 ptt180 -90.17 153.18 46.66 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.723 0.297 . . . . 0.0 110.988 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.426 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.7 Cg_exo -54.07 174.34 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.622 2.215 . . . . 0.0 112.299 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.568 HG22 HG11 ' A' ' 95' ' ' VAL . 13.2 m -139.2 94.07 9.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.221 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.11 130.98 14.84 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.564 2.176 . . . . 0.0 112.404 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 5' ' ' TRP . 3.3 mp -78.99 162.18 26.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.916 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -89.09 156.49 49.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.926 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.59 -30.57 89.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.626 2.217 . . . . 0.0 112.271 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.15 -29.01 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -94.16 -38.19 11.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.916 HG23 ' O ' ' A' ' 105' ' ' SER . 40.0 t -58.95 -35.52 57.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.254 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -25.41 68.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.976 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.754 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -80.25 -41.2 25.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.783 HD12 ' CD2' ' A' ' 67' ' ' PHE . 12.1 pt -76.13 -22.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.202 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 118' ' ' LEU . 85.6 mt -84.15 -30.18 26.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 110.758 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -31.01 61.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 111' ' ' HIS . 23.6 t -77.2 -38.44 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.789 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 149.12 56.63 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.66 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.048 HD12 HD22 ' A' ' 113' ' ' LEU . 41.5 mt -127.92 -60.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.006 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -34.71 38.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.528 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.772 0.32 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.578 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -85.48 -170.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.794 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -154.0 150.19 28.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.267 0.555 . . . . 0.0 112.136 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 1.075 ' CH2' HD22 ' A' ' 39' ' ' LEU . 46.2 m95 -89.91 95.27 10.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.388 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.687 ' CE2' HD11 ' A' ' 72' ' ' LEU . 44.6 m-85 -91.15 116.01 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.85 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -100.84 143.27 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.453 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 9' ' ' HIS . 14.7 t -143.34 160.05 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.699 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.46 ' N ' HG12 ' A' ' 8' ' ' VAL . 4.2 p80 -131.53 152.74 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.876 0.369 . . . . 0.0 111.164 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -139.81 -165.56 1.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.794 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -70.53 136.03 49.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.982 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.48 ' H ' HD13 ' A' ' 11' ' ' LEU . 37.2 t -67.32 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.31 -32.02 6.86 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.432 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -93.59 -22.14 18.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.051 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -32.07 20.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.152 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -56.47 -48.06 77.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -27.29 60.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.04 93.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -42.93 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.964 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.95 -36.96 56.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.34 -34.89 78.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.764 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.585 HD11 HG22 ' A' ' 85' ' ' VAL . 16.0 tp -69.81 -57.87 4.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.813 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -49.14 -35.21 15.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -69.55 -43.93 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.712 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -38.03 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.505 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.812 HG23 ' HB2' ' A' ' 31' ' ' LEU . 48.4 mm -67.69 -30.99 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.639 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -87.11 -29.21 22.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.99 -46.91 70.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -87.33 -25.1 24.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.3 61.5 1.25 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.324 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 84' ' ' VAL . 3.6 mm? -98.86 28.11 4.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.059 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -81.26 21.02 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.284 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -108.94 -15.73 14.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.979 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.843 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 2.0 mttp -116.69 -45.87 2.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.807 0.337 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.668 ' CD1' HD12 ' A' ' 26' ' ' ILE . 16.5 mt -80.29 135.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 3' ' ' ILE . 15.6 m-85 -133.06 -60.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.154 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.655 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.55 133.3 46.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.535 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.1 p -128.12 76.3 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.271 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.075 HD22 ' CH2' ' A' ' 5' ' ' TRP . 1.3 mp -80.0 139.41 37.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.119 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.413 HG23 ' HD2' ' A' ' 41' ' ' PRO . 27.8 mm -98.93 136.99 20.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 62' ' ' PHE . 80.0 Cg_endo -77.85 55.76 5.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.59 2.193 . . . . 0.0 112.769 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 115' ' ' VAL . 3.0 p -126.0 147.3 49.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.04 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.548 ' HG2' HG13 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -95.48 172.3 8.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -127.53 107.99 10.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.935 HG23 HG23 ' A' ' 57' ' ' VAL . 5.0 m -123.7 161.95 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.075 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 46' ' ' VAL . 30.8 m -131.07 109.34 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -130.78 151.45 51.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.781 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 pp -160.07 168.39 25.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.15 -169.35 1.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.866 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.75 -31.51 61.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.75 -81.13 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.436 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.24 60.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.556 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.98 24.93 11.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.46 0.648 . . . . 0.0 111.144 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -158.51 167.93 28.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.759 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 56' ' ' VAL . 1.3 pt-20 -160.03 -52.08 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 55' ' ' GLU . 16.9 m -148.91 139.45 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.226 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.935 HG23 HG23 ' A' ' 45' ' ' VAL . 15.3 m -141.19 167.45 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.075 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -134.83 154.94 51.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.64 111.36 9.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 105.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.773 HD12 HG11 ' A' ' 115' ' ' VAL . 23.2 mt -63.98 -51.57 63.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.786 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 41' ' ' PRO . 86.8 m-85 -97.58 111.88 59.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.537 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 62' ' ' PHE . 18.0 Cg_endo -59.8 122.2 11.06 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.517 2.145 . . . . 0.0 112.73 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.17 43.65 25.81 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.198 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . 1.8 m-85 -117.11 173.99 6.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.635 HD23 HD11 ' A' ' 68' ' ' ILE . 7.5 tp -160.23 152.01 20.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' A' ' 112' ' ' ILE . 79.3 m-85 -126.21 120.64 30.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.564 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.635 HD11 HD23 ' A' ' 66' ' ' LEU . 1.1 mp -130.35 115.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 111.626 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.7 tt0 -83.22 70.17 10.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.314 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.725 ' SD ' HD23 ' A' ' 72' ' ' LEU . 5.4 ptm -91.51 -168.3 2.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.964 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -139.99 49.32 1.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.532 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.725 HD23 ' SD ' ' A' ' 70' ' ' MET . 4.5 pp -79.9 -31.09 40.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.976 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.509 ' N ' HD12 ' A' ' 72' ' ' LEU . . . -57.52 88.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.486 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -98.81 -78.97 0.49 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -164.16 -69.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.56 -82.35 0.08 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.21 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 137.68 28.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.98 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 85.4 Cg_endo -81.97 89.3 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.633 2.222 . . . . 0.0 112.718 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 p30 -90.26 -168.41 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.776 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 84' ' ' VAL . 5.7 tp10 56.85 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.66 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.843 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . . . -55.85 -43.35 76.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.756 0.312 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.446 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 2.6 t-105 -79.97 -35.55 37.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -27.65 62.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.981 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 31' ' ' LEU . 21.5 t -87.4 -51.69 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.7 t -58.56 -48.61 85.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -23.4 61.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.973 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.38 -26.0 37.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.67 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 84' ' ' VAL . 47.7 p -57.78 142.89 77.78 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.639 0.257 . . . . 0.0 110.921 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.73 -14.12 32.76 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.528 2.152 . . . . 0.0 112.558 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.03 -28.08 73.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.657 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm -84.52 152.13 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 111.18 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.72 -51.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.22 162.01 22.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -134.42 -177.93 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.576 HG21 HG13 ' A' ' 102' ' ' VAL . 4.7 m -59.14 126.96 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.244 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.77 -17.19 76.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.677 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.74 -28.87 51.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.739 0.304 . . . . 0.0 111.264 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.11 -133.86 1.67 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.435 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -124.24 -48.92 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.811 0.338 . . . . 0.0 110.839 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -81.06 161.91 61.3 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HG3' ' CZ2' ' A' ' 82' ' ' TRP . 51.8 Cg_exo -54.07 -168.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.668 2.245 . . . . 0.0 112.4 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.576 HG13 HG21 ' A' ' 95' ' ' VAL . 5.2 m -141.22 109.62 6.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.371 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.34 120.39 3.25 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.217 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -68.09 155.43 39.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.161 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.835 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -90.07 166.94 18.3 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -51.33 -27.47 23.78 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.623 2.215 . . . . 0.0 112.443 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.47 -48.2 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.073 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -72.71 -34.31 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 105' ' ' SER . 58.5 t -62.2 -44.63 99.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.222 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -60.48 -26.68 66.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.46 -53.83 9.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.649 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 2.5 pp -67.51 -15.3 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.955 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.747 HD13 HG12 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -80.64 -40.41 25.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.86 -32.98 74.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.067 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.773 HG11 HD12 ' A' ' 61' ' ' LEU . 32.2 t -76.27 -50.03 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.474 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -56.26 -60.49 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.06 42.47 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.1 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.48 ' CB ' HD23 ' A' ' 113' ' ' LEU . 4.7 mt -109.36 -48.57 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 110.633 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tp -100.67 30.78 3.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.405 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.878 0.371 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.664 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.52 -178.97 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.853 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.49 157.22 39.52 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.175 0.512 . . . . 0.0 112.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.786 ' CD1' HG11 ' A' ' 109' ' ' VAL . 78.5 m95 -98.07 85.75 3.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.121 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.858 ' CE2' HD12 ' A' ' 72' ' ' LEU . 68.6 m-85 -80.63 124.76 29.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.988 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.572 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . -95.84 138.23 33.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.389 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.556 HG11 HD12 ' A' ' 91' ' ' ILE . 15.4 t -125.16 160.07 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.724 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.461 ' N ' HG12 ' A' ' 8' ' ' VAL . 17.8 m-70 -94.3 132.55 38.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.832 HG21 HD12 ' A' ' 66' ' ' LEU . 20.7 p -124.12 177.54 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.47 132.15 34.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.81 123.73 18.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.198 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.29 -27.91 17.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.462 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -104.65 -3.06 24.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.627 0.251 . . . . 0.0 111.376 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.551 ' OE1' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -57.38 -34.07 68.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.769 0.319 . . . . 0.0 111.038 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -58.47 -40.71 83.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.52 -24.72 31.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -51.14 70.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.28 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -37.29 79.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -53.06 15.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.034 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -59.17 -31.75 69.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.637 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.742 HD11 HG22 ' A' ' 85' ' ' VAL . 18.4 tp -77.14 -57.48 3.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.716 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -49.72 -31.18 10.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -38.66 73.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.637 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -36.07 72.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.601 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 35' ' ' ILE . 38.4 mm -67.44 -31.4 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.838 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -30.16 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.33 -32.32 37.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.057 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -85.02 -27.26 26.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.8 61.11 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.892 HD11 HG21 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -119.46 28.69 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 0.0 110.943 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -8.07 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.335 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.96 -29.05 39.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -96.11 -55.58 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.718 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.889 HG21 HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -80.02 145.01 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.789 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.823 ' N ' HD13 ' A' ' 35' ' ' ILE . 8.2 m-85 -131.87 -44.45 0.97 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.132 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -122.09 154.93 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.132 0.491 . . . . 0.0 111.619 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.708 HG23 HD11 ' A' ' 35' ' ' ILE . 26.3 t -154.4 67.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.288 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.669 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.6 mm? -79.97 152.3 29.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.263 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.551 HD11 ' OE1' ' A' ' 15' ' ' GLU . 4.5 tp -108.16 118.34 52.76 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.813 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 46.1 Cg_exo -55.33 80.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.731 2.287 . . . . 0.0 112.528 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 60' ' ' LYS . 58.5 p -158.91 128.12 5.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.794 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -79.95 107.01 12.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.942 0.401 . . . . 0.0 110.4 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.02 141.79 40.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.173 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.61 130.23 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.753 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' HA ' HG23 ' A' ' 56' ' ' VAL . 34.9 m -137.62 175.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.315 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' C ' HD22 ' A' ' 48' ' ' LEU . 1.6 mt-10 -133.74 -176.72 4.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.498 HD22 ' C ' ' A' ' 47' ' ' GLU . 4.2 mm? -114.31 136.91 52.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -134.29 34.72 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.52 163.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.926 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.84 -54.5 4.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.442 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.63 -81.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -157.44 168.3 27.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 110.887 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -139.74 167.93 20.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -129.16 153.43 47.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.578 HG12 HG22 ' A' ' 57' ' ' VAL . 25.4 t -130.43 -73.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.29 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.578 HG22 HG12 ' A' ' 56' ' ' VAL . 3.8 m -160.03 173.34 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.444 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 128.56 4.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 42' ' ' THR . 5.3 mtpt -99.38 170.97 8.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.663 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 42' ' ' THR . 8.1 mttm -103.11 123.65 47.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.368 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.048 HD11 HG11 ' A' ' 115' ' ' VAL . 10.0 mt -88.53 -48.62 7.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.515 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 2.7 m-85 -124.58 89.22 52.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.407 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.96 131.53 39.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.667 2.245 . . . . 0.0 112.934 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 9' ' ' HIS . . . 62.18 36.31 92.8 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.153 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.53 150.75 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.905 0.353 . . . . 0.0 110.967 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.832 HD12 HG21 ' A' ' 10' ' ' THR . 4.4 mt -142.78 117.82 10.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.834 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 112' ' ' ILE . 12.8 m-85 -82.48 121.04 26.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.4 mp -128.57 107.5 15.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.436 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 4.5 tt0 -80.03 70.48 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.331 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -91.23 -179.78 5.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.261 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -120.83 89.86 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.846 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.858 HD12 ' CE2' ' A' ' 6' ' ' TYR . 13.3 mt -83.47 -69.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.24 -80.79 1.18 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.49 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.48 141.13 28.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 111.016 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.42 31.96 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -84.69 -54.28 4.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -160.08 93.31 1.66 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.98 92.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.546 2.164 . . . . 0.0 112.221 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 81' ' ' ALA . 18.5 m-80 -90.35 -176.6 4.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 51.4 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -46.56 -50.88 16.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.821 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.42 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -72.21 -32.38 66.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.063 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -33.36 72.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.993 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.892 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -90.01 -48.18 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.3 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 81' ' ' ALA . 38.0 t -61.67 -45.29 98.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.242 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -62.2 -18.61 61.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.275 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -102.08 -25.19 8.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.809 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.729 HG21 HD12 ' A' ' 22' ' ' LEU . 1.5 p -59.96 145.06 85.4 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.239 . . . . 0.0 111.032 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.66 -25.96 62.62 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.566 2.178 . . . . 0.0 112.218 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -54.81 -34.15 56.67 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.674 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.556 HD12 HG11 ' A' ' 8' ' ' VAL . 35.5 mm -97.13 152.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 t -176.51 -39.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 94' ' ' PHE . . . -96.83 -37.57 4.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.512 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 39.6 p90 46.3 -172.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.853 0.358 . . . . 0.0 111.487 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 95' ' ' VAL . 29.1 m -66.77 104.33 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.07 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.97 -32.04 82.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.5 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.31 80.47 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.51 -147.07 18.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.41 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -154.86 -57.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.948 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 149.6 88.93 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.006 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 76.9 Cg_exo -50.59 179.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 7' ' ' ALA . 6.3 m -133.31 92.29 24.99 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.235 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 145.04 30.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.621 2.214 . . . . 0.0 112.325 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.686 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -89.94 169.17 11.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -90.06 150.81 44.16 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.767 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.53 -29.34 24.36 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.583 2.189 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.59 -30.97 57.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 112' ' ' ILE . 48.9 tt0 -90.3 -33.64 16.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 105' ' ' SER . 35.9 t -63.8 -35.48 73.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.227 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -29.16 66.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.67 ' O ' HG23 ' A' ' 115' ' ' VAL . 15.2 m80 -77.92 -40.38 39.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.784 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 67' ' ' PHE . 12.4 pt -74.72 -29.1 22.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.032 HD22 HD12 ' A' ' 118' ' ' LEU . 62.9 mt -77.71 -32.58 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.559 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.39 -33.25 74.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 1.048 HG11 HD11 ' A' ' 61' ' ' LEU . 22.7 t -72.82 -35.29 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.949 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.669 ' HB3' HD12 ' A' ' 39' ' ' LEU . 13.5 m -64.34 -59.81 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.94 44.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.527 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.032 HD12 HD22 ' A' ' 113' ' ' LEU . 12.7 mt -115.92 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.85 -44.7 20.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.465 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.814 0.34 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -133.24 176.25 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -141.0 158.21 44.26 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 112.281 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 1.001 ' CH2' HD12 ' A' ' 39' ' ' LEU . 78.6 m95 -93.22 91.03 7.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.487 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.675 ' O ' HD12 ' A' ' 68' ' ' ILE . 51.8 m-85 -87.48 99.12 11.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -80.45 154.97 27.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.733 HG11 HD11 ' A' ' 91' ' ' ILE . 14.3 t -139.07 159.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.507 ' CG ' HG13 ' A' ' 95' ' ' VAL . 3.4 m-70 -112.92 135.82 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 91' ' ' ILE . 62.2 p -129.11 -177.49 4.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.022 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.01 142.34 27.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.875 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.39 129.81 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.45 -27.5 17.05 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.609 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -98.02 -20.02 17.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.578 0.228 . . . . 0.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 12.2 pt-20 -56.66 -39.92 74.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.986 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -52.49 -67.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -61.72 -23.22 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.038 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -59.33 -46.92 87.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.076 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -59.85 -46.97 87.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -50.08 69.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.36 -43.99 95.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.76 HD11 HG22 ' A' ' 85' ' ' VAL . 37.8 tp -70.62 -48.54 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.852 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.4 tt0 -62.51 -17.33 59.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -84.67 -43.92 13.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.001 0.429 . . . . 0.0 110.227 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -23.93 66.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.355 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 23' ' ' GLU . 1.3 tp -67.91 -29.51 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.816 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 -30.57 15.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.62 62.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -79.91 -30.36 40.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.25 34.5 5.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.474 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.63 25.23 6.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.955 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -19.7 62.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.17 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -79.96 -26.27 40.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.061 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -77.89 -58.89 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.759 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.888 HD11 ' CG1' ' A' ' 38' ' ' VAL . 9.2 tt -79.94 130.91 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 3' ' ' ILE . 8.9 m-85 -117.57 -48.27 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.117 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.609 ' CB ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -120.79 151.59 39.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.683 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.888 ' CG1' HD11 ' A' ' 35' ' ' ILE . 17.4 m -143.8 126.54 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.001 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -109.65 135.19 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 40' ' ' ILE . 2.1 mp -90.89 136.41 27.67 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.817 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.866 ' O ' HD12 ' A' ' 61' ' ' LEU . 28.1 Cg_endo -61.62 -15.56 42.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.624 2.216 . . . . 0.0 112.906 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 60' ' ' LYS . 16.4 p -98.55 137.76 36.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 111.13 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HB2' HD21 ' A' ' 61' ' ' LEU . 5.0 tt0 -87.05 150.37 24.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.679 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -119.87 121.23 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.995 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 56' ' ' VAL . 14.8 t -144.55 159.75 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.466 ' N ' HG12 ' A' ' 45' ' ' VAL . 13.3 p -89.96 125.88 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.172 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -159.92 171.18 19.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 24.6 tp -138.48 122.3 17.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -128.95 -76.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.956 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -107.97 -165.16 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.845 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.7 27.78 11.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.673 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.95 -28.34 5.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.375 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -135.46 137.1 41.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -146.71 26.18 1.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.337 0.589 . . . . 0.0 111.183 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -136.52 -58.38 0.74 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.871 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 45' ' ' VAL . 12.6 p -157.39 135.5 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.25 174.18 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 mtt85 -136.06 124.04 22.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.965 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -125.31 113.41 17.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 42' ' ' THR . 1.5 mttt -71.83 111.28 6.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.004 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -89.82 -39.65 12.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.614 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.406 ' HB3' ' CG ' ' A' ' 65' ' ' TYR . 33.3 m-85 -111.58 94.07 21.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.658 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.99 126.34 18.58 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.384 2.056 . . . . 0.0 112.416 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.93 37.06 93.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CG ' ' HB3' ' A' ' 62' ' ' PHE . 3.0 m-85 -117.93 166.05 12.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.818 0.342 . . . . 0.0 110.97 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.441 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -160.08 151.12 19.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.415 ' HB2' ' CB ' ' A' ' 39' ' ' LEU . 4.7 m-85 -131.71 130.56 42.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.028 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.675 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.7 mp -134.52 117.31 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.496 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.609 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -83.77 65.81 8.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.411 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.437 ' CE ' HD23 ' A' ' 72' ' ' LEU . 5.8 ptm -91.57 -170.35 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.048 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD1' ' CZ ' ' A' ' 36' ' ' PHE . 6.4 p-10 -144.39 52.3 1.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.651 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 73' ' ' GLY . 4.5 pp -79.9 -31.21 40.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.9 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.726 ' N ' HD12 ' A' ' 72' ' ' LEU . . . -55.27 90.57 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.594 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.03 154.49 3.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 110.768 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.16 -171.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.814 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -70.52 -30.5 67.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.002 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -138.99 149.22 60.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.45 179.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.492 2.128 . . . . 0.0 112.291 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -89.99 -177.56 5.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.52 -26.71 68.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.712 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -52.94 -30.06 32.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.293 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.428 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.8 t-105 -75.51 -31.01 60.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.57 -30.62 63.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.569 HG21 HD11 ' A' ' 31' ' ' LEU . 21.5 t -79.43 -52.73 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.76 HG22 HD11 ' A' ' 22' ' ' LEU . 34.1 t -59.9 -43.3 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -69.27 -15.51 63.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.26 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.29 -15.06 20.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.957 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.77 ' O ' HG22 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -64.54 132.19 95.32 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.778 0.289 . . . . 0.0 110.848 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.9 137.12 40.52 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.418 2.078 . . . . 0.0 112.243 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.19 -17.39 58.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.734 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.897 ' O ' HD13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -80.0 -31.96 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.984 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 p 68.42 -61.95 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.294 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.09 83.76 1.66 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.394 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.85 171.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.507 HG13 ' CG ' ' A' ' 9' ' ' HIS . 31.1 m -70.51 -29.69 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.76 26.83 3.47 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.519 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.22 39.04 1.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 110.963 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.14 -37.14 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 41.5 mtp 69.45 -66.28 0.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.788 0.328 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.39 147.62 67.53 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.759 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.428 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.9 Cg_exo -53.05 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.546 2.164 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.8 p -149.25 95.06 3.87 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.287 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.09 128.42 9.86 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.402 2.068 . . . . 0.0 111.912 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -79.86 157.87 26.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.19 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 72.6 p -80.72 160.22 67.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.833 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.525 ' O ' HG12 ' A' ' 109' ' ' VAL . 35.9 Cg_exo -59.82 -56.93 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.679 2.253 . . . . 0.0 112.564 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -52.59 -25.72 11.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.231 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -30.81 13.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.088 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -65.83 -29.56 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -32.72 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.477 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.11 -49.02 30.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.311 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.578 ' CD1' HD13 ' A' ' 39' ' ' LEU . 2.7 pp -62.24 -29.56 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.176 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.563 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -59.09 -35.78 73.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.737 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -61.82 -21.02 64.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.266 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.658 ' CG1' HD11 ' A' ' 61' ' ' LEU . 38.0 t -71.94 -61.93 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 0.0 111.321 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.421 ' HB2' HD23 ' A' ' 39' ' ' LEU . 11.3 t -52.2 -59.31 4.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.029 0.442 . . . . 0.0 111.001 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.88 42.68 0.17 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.563 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.563 HD12 ' HG ' ' A' ' 113' ' ' LEU . 5.3 mt -103.63 -31.38 9.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -80.0 -56.71 4.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.796 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.501 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.909 0.385 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.683 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.76 -165.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.97 155.82 36.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.412 0.625 . . . . 0.0 112.232 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.774 ' CD1' HG11 ' A' ' 109' ' ' VAL . 90.6 m95 -95.64 93.52 7.18 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.459 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.814 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 95.9 m-85 -86.15 108.58 18.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.839 0.352 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -93.45 140.24 29.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.115 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 9' ' ' HIS . 14.2 t -132.87 159.68 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.653 ' NE2' HG12 ' A' ' 95' ' ' VAL . 11.2 m-70 -85.12 157.29 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -153.52 167.12 30.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.12 140.65 36.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.2 p -67.9 121.68 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.121 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.75 -23.42 36.4 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.734 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -93.23 -28.02 16.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.72 0.295 . . . . 0.0 111.016 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -58.16 -33.96 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -39.82 71.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -90.02 -24.2 21.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' PRO . . . -59.49 -35.47 74.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.211 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -59.29 -57.28 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.16 96.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.032 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -65.26 -41.55 94.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.834 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.874 HD11 HG22 ' A' ' 85' ' ' VAL . 56.7 tp -66.13 -54.45 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.837 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.8 -34.05 62.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -67.74 -43.75 79.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.84 -41.54 74.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.53 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.892 ' HA ' HD12 ' A' ' 31' ' ' LEU . 1.1 mp -70.31 -26.51 29.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.871 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -92.71 -31.77 14.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.6 68.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.889 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -101.14 -26.56 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.05 81.65 1.36 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.52 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.9 mt -134.91 31.05 3.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -0.94 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.604 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -23.61 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.74 0.305 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HD3' ' CB ' ' A' ' 79' ' ' ASN . 3.3 mtmm -106.53 -52.69 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.678 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.416 HD11 ' HB1' ' A' ' 81' ' ' ALA . 32.3 mt -79.84 113.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.315 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 3' ' ' ILE . 25.5 m-85 -107.46 -56.21 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.016 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.467 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -113.39 162.39 16.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.332 0.587 . . . . 0.0 112.497 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.3 p -160.01 77.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.773 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.014 HD11 HD21 ' A' ' 118' ' ' LEU . 4.6 mm? -89.27 167.91 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.397 0.618 . . . . 0.0 112.397 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 40' ' ' ILE . 1.6 tt -155.81 74.2 5.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.008 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.444 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 82.1 Cg_exo -42.33 128.43 4.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.299 2.666 . . . . 0.0 113.841 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.28 160.59 38.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.397 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.6 mt-10 -80.3 107.86 13.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.89 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -82.61 114.08 20.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.697 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 46' ' ' VAL . 13.7 t -106.93 159.42 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.201 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.462 ' N ' HG12 ' A' ' 45' ' ' VAL . 11.2 p -145.93 126.68 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.064 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.22 167.57 22.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 54' ' ' LYS . 5.8 mt -137.33 148.31 46.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.1 mmm-85 -81.14 -66.51 0.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -162.23 -56.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.796 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.42 90.75 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.524 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.96 -59.6 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -145.19 153.75 41.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.806 0.336 . . . . 0.0 110.895 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HB3' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -124.84 166.89 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -146.6 169.03 19.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.54 145.83 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.7 t -116.07 159.91 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.481 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -137.79 111.56 8.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.026 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 43' ' ' GLU . 1.4 tptt -104.68 99.32 8.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.213 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -37.6 126.03 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.965 0.412 . . . . 0.0 111.734 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.802 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.7 mt -89.9 -34.93 15.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.604 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CE2' HG22 ' A' ' 112' ' ' ILE . 59.5 m-85 -116.45 81.01 10.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 61' ' ' LEU . 24.0 Cg_exo -63.47 144.27 90.09 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.679 2.253 . . . . 0.0 112.076 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.98 24.8 15.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 22.7 m-85 -131.04 117.26 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 110.735 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mt -116.73 116.3 27.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -88.46 114.71 25.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.393 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.2 mp -117.65 114.17 44.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.467 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 12.8 tt0 -79.7 68.44 5.76 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 ptp -91.27 -167.94 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.262 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -142.35 106.37 4.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.452 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.814 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 23.9 mt -79.85 -1.82 40.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.447 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.12 -159.48 28.84 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.748 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -77.76 -77.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -53.58 179.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.74 7.2 31.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.352 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -80.03 123.92 83.26 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.891 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.617 ' HA ' HD22 ' A' ' 72' ' ' LEU . 57.1 Cg_endo -71.01 159.23 53.1 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.376 2.051 . . . . 0.0 112.258 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' A' ' 81' ' ' ALA . 23.2 p30 -90.12 -179.99 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.02 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.554 ' HG3' HD22 ' A' ' 31' ' ' LEU . 15.2 pt-20 -61.97 -32.63 73.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.76 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -56.6 -31.72 64.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.01 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.457 ' CZ2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -64.2 -47.88 78.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -57.07 -30.21 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.776 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -80.16 -54.83 10.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.99 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.874 HG22 HD11 ' A' ' 22' ' ' LEU . 24.1 t -56.62 -37.24 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -63.64 -20.61 65.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.183 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.94 -17.16 12.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.921 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.543 HG21 ' CD1' ' A' ' 22' ' ' LEU . 29.2 p -55.85 141.02 67.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.775 0.287 . . . . 0.0 111.095 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 52.7 Cg_exo -55.07 95.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.448 2.098 . . . . 0.0 112.279 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.77 -30.29 0.28 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.624 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 50.5 mm -79.93 131.88 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.988 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.08 -66.14 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.47 30.23 0.13 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.722 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 53.18 -173.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 111.048 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.653 HG12 ' NE2' ' A' ' 9' ' ' HIS . 17.3 m -51.97 171.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.316 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.07 -49.3 7.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.542 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.35 39.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.936 0.398 . . . . 0.0 111.191 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -177.61 134.13 2.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.44 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.84 -29.97 11.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.906 0.384 . . . . 0.0 110.928 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -79.6 161.93 65.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.529 ' O ' HG13 ' A' ' 102' ' ' VAL . 50.8 Cg_exo -55.91 -164.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.686 2.258 . . . . 0.0 112.416 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 101' ' ' PRO . 4.5 m -158.72 93.44 1.92 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.13 126.36 13.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.51 2.14 . . . . 0.0 112.148 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 7' ' ' ALA . 4.5 mp -76.57 154.12 34.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.881 ' O ' HG23 ' A' ' 109' ' ' VAL . 3.5 m -82.34 157.9 67.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.93 -29.84 87.79 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.748 2.299 . . . . 0.0 112.274 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.66 -29.29 65.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.9 -34.82 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 105' ' ' SER . 22.5 t -68.83 -26.91 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.198 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -73.22 -37.14 66.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.734 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -44.49 64.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.653 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.614 HG22 ' CE2' ' A' ' 62' ' ' PHE . 2.6 pp -67.9 -23.26 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.802 HD23 HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -72.46 -31.08 65.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.2 -53.81 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.212 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.802 HG11 ' CD1' ' A' ' 61' ' ' LEU . 21.3 t -58.16 -37.27 61.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.3 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.709 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -55.97 -64.95 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.32 42.82 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.014 HD21 HD11 ' A' ' 39' ' ' LEU . 6.0 mt -115.14 -33.83 5.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 119' ' ' LEU . 1.3 tt -94.95 42.01 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.459 179.884 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.875 0.369 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.544 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -79.94 -165.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.72 143.84 30.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.177 0.513 . . . . 0.0 112.042 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.856 ' CH2' HD12 ' A' ' 39' ' ' LEU . 63.9 m95 -100.79 92.29 5.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.167 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.688 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 58.3 m-85 -91.69 106.2 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.788 0.328 . . . . 0.0 111.33 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.86 124.96 32.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.558 HG11 HD12 ' A' ' 91' ' ' ILE . 5.2 t -100.0 162.05 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.513 ' CG ' HG22 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -122.66 133.27 54.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.107 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -136.78 -174.74 3.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 151.84 23.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.1 p -66.47 124.89 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.19 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.82 -27.61 18.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.61 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.07 -27.69 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.98 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.65 -35.11 70.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.082 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.98 -39.69 66.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -87.82 -27.94 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.024 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.0 69.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -58.36 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.027 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.87 -47.95 81.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.274 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.11 -40.51 73.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.992 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.927 HD11 HG22 ' A' ' 85' ' ' VAL . 31.6 tp -65.91 -53.41 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.877 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -58.77 -45.81 88.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.014 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -58.58 -41.91 86.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.658 ' HG3' HG22 ' A' ' 88' ' ' THR . 8.7 mmt85 -65.38 -46.91 78.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.759 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.788 HG23 HD12 ' A' ' 31' ' ' LEU . 81.1 mt -65.52 -32.05 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.936 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -31.66 39.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -36.54 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.067 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -82.64 -24.68 33.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.045 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.615 ' O ' HD23 ' A' ' 31' ' ' LEU . . . 87.66 77.35 1.27 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.376 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -139.61 38.76 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 110.726 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -8.74 56.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.2 m-20 -79.99 -28.06 39.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.806 0.336 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.41 -59.58 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.862 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.766 HG12 HG21 ' A' ' 26' ' ' ILE . 1.1 pt -79.92 122.02 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 3' ' ' ILE . 14.1 m-85 -110.0 -45.1 3.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.237 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.589 HE22 HD13 ' A' ' 118' ' ' LEU . 2.4 mm100 -120.35 170.25 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.218 0.532 . . . . 0.0 111.89 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.8 t -154.31 88.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.149 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.856 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -79.72 157.15 27.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.456 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.758 HD12 ' OG1' ' A' ' 42' ' ' THR . 7.6 pt -120.2 145.37 40.03 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.939 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.47 -15.4 45.16 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.651 2.234 . . . . 0.0 113.002 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.758 ' OG1' HD12 ' A' ' 40' ' ' ILE . 80.5 p -87.07 128.79 35.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.075 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' A' ' 61' ' ' LEU . 1.3 tt0 -95.05 144.09 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -107.2 141.38 38.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.004 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.84 161.35 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.108 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.11 91.59 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -159.99 -177.82 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.34 172.79 12.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -149.23 -176.89 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.81 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -56.5 153.48 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.06 60.54 1.75 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.461 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 -135.92 13.03 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.514 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -149.15 152.01 35.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.808 0.337 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -115.81 -171.89 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.773 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -148.32 -65.78 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.18 112.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.7 t -131.32 160.07 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.466 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -140.03 137.85 34.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 111.011 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -111.57 149.91 30.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.741 ' HG3' HG22 ' A' ' 42' ' ' THR . 0.0 OUTLIER -81.37 109.18 15.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.019 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 43' ' ' GLU . 47.4 mt -76.41 -68.61 0.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.651 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.412 ' CB ' ' HB2' ' A' ' 65' ' ' TYR . 46.6 m-85 -100.47 96.89 5.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.644 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.61 115.28 2.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.55 2.166 . . . . 0.0 112.635 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.58 38.39 51.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.821 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HB2' ' CB ' ' A' ' 62' ' ' PHE . 88.1 m-85 -132.61 109.98 10.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD21 ' HB ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -103.67 137.24 41.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.549 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.685 ' CE2' HD12 ' A' ' 112' ' ' ILE . 3.9 m-85 -106.37 135.59 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.4 mt -135.08 110.43 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.219 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.473 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 tt0 -85.53 74.34 10.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.993 0.425 . . . . 0.0 110.224 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.4 ptp -91.42 -167.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.499 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.471 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.7 t70 -137.48 94.98 2.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.655 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.688 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 15.5 mt -79.98 -29.35 39.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.047 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.45 -153.88 27.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.591 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.08 176.05 6.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.986 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.36 177.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.92 6.84 37.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.309 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.93 116.31 60.27 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.868 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HA ' HD22 ' A' ' 72' ' ' LEU . 72.1 Cg_endo -77.11 162.1 31.95 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.466 2.111 . . . . 0.0 112.365 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.1 -178.0 5.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -61.78 -29.49 70.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -57.41 -44.83 84.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.444 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.5 t-105 -61.06 -35.53 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -32.25 72.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.616 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 31' ' ' LEU . 21.5 t -87.62 -49.9 14.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.064 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.927 HG22 HD11 ' A' ' 22' ' ' LEU . 25.2 t -57.17 -38.26 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -71.32 -22.5 61.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.144 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.48 20.83 10.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.933 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.658 HG22 ' HG3' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -87.95 145.7 37.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.632 0.253 . . . . 0.0 110.844 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.2 84.85 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.486 2.124 . . . . 0.0 112.222 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.37 -32.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.558 HD12 HG11 ' A' ' 8' ' ' VAL . 47.5 mm -80.4 122.81 36.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.377 . . . . 0.0 111.017 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -167.94 32.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.17 34.08 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.533 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 94' ' ' PHE . 44.2 p90 -76.8 103.35 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.969 0.414 . . . . 0.0 110.808 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG22 ' CG ' ' A' ' 9' ' ' HIS . 11.2 m -90.15 100.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.271 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.37 33.24 5.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.425 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.27 36.88 23.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.948 0.404 . . . . 0.0 111.048 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.94 36.15 29.12 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.371 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -175.24 -168.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.411 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 4.6 mtt85 -53.97 176.66 0.11 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.444 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 91.5 Cg_exo -44.91 166.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.707 2.271 . . . . 0.0 112.65 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.09 111.47 33.9 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.493 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.01 145.93 10.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.643 2.229 . . . . 0.0 112.239 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.613 HD13 ' N ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -87.21 171.31 10.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 111.004 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.807 ' O ' HG23 ' A' ' 109' ' ' VAL . 24.1 p -90.06 152.57 46.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.788 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.22 -32.48 70.93 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.722 2.281 . . . . 0.0 112.447 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 -41.4 58.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -78.91 -30.18 44.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.929 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 105' ' ' SER . 66.3 t -62.82 -42.48 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.211 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.73 -36.89 80.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.39 -49.92 30.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.859 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.685 HD12 ' CE2' ' A' ' 67' ' ' PHE . 2.8 pt -67.28 -16.38 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.821 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -70.61 -32.64 70.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.836 0.35 . . . . 0.0 110.526 179.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.47 -10.74 57.42 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 43' ' ' GLU . 40.4 t -75.87 -48.59 28.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 111.509 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 39' ' ' LEU . 4.3 t -65.83 -56.61 11.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.428 . . . . 0.0 110.656 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.621 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 142.81 42.58 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.821 HD12 ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -108.65 -28.3 9.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 0.0 110.771 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.36 -31.2 7.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.31 -1.272 . . . . 0.0 112.424 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.883 0.373 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.713 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -135.12 -165.15 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.43 153.8 37.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.243 0.544 . . . . 0.0 112.206 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.698 ' HH2' HD23 ' A' ' 39' ' ' LEU . 73.9 m95 -97.46 88.84 4.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.356 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.765 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 50.2 m-85 -79.82 125.58 29.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.848 0.356 . . . . 0.0 110.828 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -107.19 148.31 29.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.74 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 9' ' ' HIS . 21.7 t -135.67 162.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.528 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.603 ' ND1' HG13 ' A' ' 95' ' ' VAL . 3.0 m-70 -101.37 147.79 25.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.7 p -141.26 -176.96 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.55 130.78 34.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.725 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.0 p -57.69 118.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.58 -23.5 35.55 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.523 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.79 -20.54 18.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.67 0.271 . . . . 0.0 111.237 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -44.32 70.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.79 -46.03 74.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -79.6 -27.29 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.819 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.8 97.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.119 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -49.8 -48.53 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.204 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.48 74.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.67 -38.45 89.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.041 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.532 HD22 HG21 ' A' ' 88' ' ' THR . 2.1 mt -74.39 -56.64 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.031 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -41.69 -36.58 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.715 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -77.67 -37.87 48.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.584 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -75.75 -27.84 58.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.644 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 31' ' ' LEU . 37.9 mm -73.44 -30.18 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.626 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -80.86 -29.82 35.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.17 -43.12 44.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -81.65 -3.46 53.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.372 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 81.04 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.607 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.2 mt -136.48 23.06 3.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.98 -15.87 58.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.131 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.45 -7.33 59.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.492 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' CE ' ' HB2' ' A' ' 81' ' ' ALA . 4.9 ptmm? -115.99 -46.66 2.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.731 0.3 . . . . 0.0 110.854 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.85 108.63 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.652 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 3' ' ' ILE . 8.5 m-85 -94.5 -60.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.455 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -108.92 146.48 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.108 0.48 . . . . 0.0 111.298 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG22 HG23 ' A' ' 68' ' ' ILE . 21.6 t -146.51 89.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.55 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 118' ' ' LEU . 4.5 mm? -102.59 166.86 10.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.429 HD12 ' OG1' ' A' ' 42' ' ' THR . 19.9 pt -120.69 134.91 24.33 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.748 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 36.9 Cg_endo -66.16 65.29 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.521 2.147 . . . . 0.0 112.547 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.429 ' OG1' HD12 ' A' ' 40' ' ' ILE . 35.9 p -152.28 140.28 20.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HA ' HG12 ' A' ' 115' ' ' VAL . 14.0 tt0 -79.92 156.56 27.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.658 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 129.97 16.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.97 155.75 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.549 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.8 p -159.71 115.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.053 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -107.28 158.98 16.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.962 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 48' ' ' LEU . 1.8 pt? -141.37 36.87 1.69 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.719 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -114.24 -176.48 2.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 66.14 40.32 3.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.4 -134.09 11.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.544 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.57 76.4 0.35 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.518 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -141.33 174.78 10.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.341 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.38 133.92 30.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -128.63 116.95 20.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.948 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 m -110.72 118.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.056 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.8 t -120.83 159.96 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.05 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.472 ' N ' HG12 ' A' ' 57' ' ' VAL . 5.8 mtt180 -146.72 152.48 38.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.067 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -138.5 92.66 2.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.742 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 42' ' ' THR . 1.9 mtmt -58.96 102.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.809 HD11 HG11 ' A' ' 115' ' ' VAL . 77.4 mt -73.23 -48.28 36.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' A' ' 62' ' ' PHE . 1.7 m-85 -116.64 88.9 26.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.453 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.97 125.69 20.03 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.67 2.247 . . . . 0.0 112.779 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.65 35.53 74.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.123 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 66' ' ' LEU . 6.4 m-85 -126.69 164.19 21.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 111.024 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -153.32 120.8 5.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.484 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.771 ' CD1' HD11 ' A' ' 104' ' ' LEU . 12.4 m-85 -94.65 138.09 32.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 111.561 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 38' ' ' VAL . 2.2 mp -141.68 116.1 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.979 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.554 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 5.3 tt0 -81.04 66.66 6.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.645 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.499 ' CE ' HD21 ' A' ' 72' ' ' LEU . 3.4 ptm -91.15 -171.08 2.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -148.48 99.5 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.765 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 9.2 mt -92.47 -69.99 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.72 -47.48 2.76 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.558 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.79 151.17 43.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 0.0 110.969 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -116.12 -36.83 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -66.34 -41.7 89.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.941 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -160.08 122.68 1.87 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.32 172.52 14.76 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.4 2.067 . . . . 0.0 112.288 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.35 176.62 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.797 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -57.7 -21.36 40.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.265 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.22 -48.8 67.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.245 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -59.47 -38.36 80.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -59.91 -31.36 69.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -86.05 -51.54 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 81' ' ' ALA . 22.7 t -62.65 -48.8 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.045 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.36 -9.33 58.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.361 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.46 24.17 4.44 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.918 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -76.32 144.32 74.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.649 0.261 . . . . 0.0 110.707 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.04 96.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.604 2.203 . . . . 0.0 112.695 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.86 52.77 4.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.083 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.818 ' O ' HD13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -101.5 -28.59 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m 50.61 51.7 16.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.453 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.44 125.26 25.15 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.467 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.455 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 7.5 t80 63.41 142.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.821 0.343 . . . . 0.0 110.81 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.603 HG13 ' ND1' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -47.65 -62.87 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.585 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.527 ' H ' HG23 ' A' ' 95' ' ' VAL . . . 166.33 76.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.476 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -170.33 -52.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.804 0.335 . . . . 0.0 110.989 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -123.86 168.35 16.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -25.42 10.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.706 0.289 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.93 138.95 83.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.46 -169.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.582 2.188 . . . . 0.0 112.418 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.44 88.54 4.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.8 148.58 71.49 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.616 2.211 . . . . 0.0 112.379 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.771 HD11 ' CD1' ' A' ' 67' ' ' PHE . 8.9 mt -90.0 169.56 11.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.057 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.901 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -90.01 148.51 39.7 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.682 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.67 -46.1 35.92 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.686 2.257 . . . . 0.0 112.248 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -64.97 -27.96 69.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -85.73 -37.9 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.018 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 105' ' ' SER . 48.2 t -57.65 -29.35 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.104 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -77.94 -28.59 49.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.805 ' O ' HG23 ' A' ' 115' ' ' VAL . 1.5 t-160 -79.2 -40.16 31.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.564 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.477 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.3 pp -72.06 -24.85 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.8 ' CD2' HD12 ' A' ' 118' ' ' LEU . 20.0 mt -73.87 -34.89 64.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.83 -31.36 59.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.982 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.809 HG11 HD11 ' A' ' 61' ' ' LEU . 25.0 t -71.93 -43.08 68.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.132 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.691 ' HB2' HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -58.68 -61.59 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.913 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.66 43.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.559 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.8 HD12 ' CD2' ' A' ' 113' ' ' LEU . 16.2 mt -113.38 -35.69 5.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.14 36.27 3.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.776 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.329 -1.261 . . . . 0.0 112.517 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.028 0.442 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.824 HG21 ' CE1' ' A' ' 36' ' ' PHE . 1.3 pp -110.31 174.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.031 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -143.36 161.11 39.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.286 0.565 . . . . 0.0 111.582 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.681 ' O ' HD12 ' A' ' 104' ' ' LEU . 94.9 m95 -86.82 86.64 7.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.593 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.673 ' O ' HD12 ' A' ' 68' ' ' ILE . 57.1 m-85 -79.69 113.54 17.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.376 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -105.43 135.51 46.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.057 0.456 . . . . 0.0 111.822 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 9' ' ' HIS . 0.6 OUTLIER -125.66 -167.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.399 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.631 ' N ' HG13 ' A' ' 8' ' ' VAL . 8.1 m-70 -126.39 167.22 15.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.061 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -151.42 -174.61 4.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.691 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.13 133.63 35.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.728 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 12' ' ' VAL . 26.1 m -58.8 117.55 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.003 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.41 -28.99 12.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -84.47 -21.18 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 111.195 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -54.37 -32.29 56.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.126 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -50.95 -60.8 2.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.287 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -75.26 -19.79 59.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . . . -67.2 -31.89 72.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.769 0.319 . . . . 0.0 111.067 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.742 ' HD2' HD11 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -59.82 -55.84 29.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.84 -42.83 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.205 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.58 -32.79 67.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.974 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.489 HD12 HG21 ' A' ' 88' ' ' THR . 58.0 tp -80.06 -50.28 10.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' OE1' HG11 ' A' ' 38' ' ' VAL . 12.6 tp10 -59.97 -52.51 65.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.104 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -39.98 75.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -40.14 90.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.683 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.566 HG12 HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -62.29 -35.01 67.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -91.75 -10.21 40.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.422 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 81.92 73.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.344 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' A' ' 80' ' ' GLU . 3.8 mm? -126.12 23.35 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 0.0 111.293 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -79.45 24.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.107 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.53 -23.93 10.85 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.883 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -107.96 -42.95 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.706 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.663 HD11 ' HB1' ' A' ' 81' ' ' ALA . 4.3 mp -84.89 93.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.824 ' CE1' HG21 ' A' ' 3' ' ' ILE . 30.4 m-85 -82.0 -49.02 10.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.36 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mt-30 -121.86 156.87 32.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.2 p -153.66 76.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.465 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.935 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.3 mm? -80.02 142.53 34.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.141 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.545 HD12 ' CG ' ' A' ' 19' ' ' LYS . 30.4 mm -98.09 110.92 57.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.983 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 31.5 Cg_exo -57.75 79.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.586 2.191 . . . . 0.0 112.437 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 16.7 p -141.57 164.23 30.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.501 ' HB2' HD21 ' A' ' 61' ' ' LEU . 2.6 tt0 -106.76 148.33 28.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.585 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.53 144.37 27.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.119 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.502 HG21 ' HD3' ' A' ' 59' ' ' LYS . 15.5 t -149.65 160.18 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 56' ' ' VAL . 26.9 m -126.15 155.92 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.253 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -132.52 148.51 52.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.59 121.09 39.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.7 ttm-85 -109.98 141.13 43.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.31 122.43 18.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.967 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.07 -117.68 2.37 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.46 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.66 36.25 0.74 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -113.87 -174.03 2.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.808 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -138.07 149.73 46.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -149.18 138.23 21.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.884 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 46' ' ' VAL . 16.0 m -139.69 131.86 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -107.81 171.35 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.136 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.04 124.48 43.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HD3' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.64 -169.13 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.64 115.21 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 115' ' ' VAL . 76.0 mt -90.22 -53.12 4.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.53 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 18.9 m-85 -114.24 86.13 11.45 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.369 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.51 119.35 4.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.064 2.51 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.87 -13.67 29.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.778 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 2.5 m-85 -79.94 152.82 29.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.051 0.425 . . . . 0.0 111.412 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.742 HD11 ' HD2' ' A' ' 19' ' ' LYS . 1.2 mt -146.89 121.27 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.548 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.776 ' CD2' HD12 ' A' ' 112' ' ' ILE . 6.2 m-85 -91.21 125.4 35.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.0 OUTLIER -136.24 114.37 14.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.256 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.599 ' CG ' HD13 ' A' ' 3' ' ' ILE . 28.1 tt0 -79.89 68.81 6.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.2 ptm -91.39 -170.73 2.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.699 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.482 ' CB ' HG22 ' A' ' 3' ' ' ILE . 16.9 t0 -129.28 101.0 5.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.723 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.568 HD12 ' CG ' ' A' ' 6' ' ' TYR . 31.7 mt -118.97 6.73 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.395 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.74 61.08 1.0 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.507 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -115.88 -37.87 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 0.0 111.008 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -174.21 -168.69 0.41 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.05 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -60.38 -34.58 74.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -112.85 116.26 47.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.86 -171.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.438 2.092 . . . . 0.0 112.289 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -89.95 -174.15 4.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.588 ' HG3' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -60.8 -22.87 64.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.663 ' HB1' HD11 ' A' ' 35' ' ' ILE . . . -53.32 -46.59 69.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.322 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 12.8 t-105 -61.24 -38.33 86.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -31.11 69.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.44 HG21 ' CD2' ' A' ' 31' ' ' LEU . 21.5 t -81.34 -46.27 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.154 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.643 HG12 HG13 ' A' ' 91' ' ' ILE . 22.0 t -64.17 -32.83 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -23.05 62.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.036 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -100.39 -8.88 48.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.009 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.489 HG21 HD12 ' A' ' 22' ' ' LEU . 1.2 p -74.94 114.61 36.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.852 0.326 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -51.75 115.48 2.14 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.405 2.07 . . . . 0.0 112.356 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.11 -18.42 5.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.682 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.643 HG13 HG12 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -79.89 129.72 37.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.731 0.3 . . . . 0.0 111.096 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.586 ' N ' HD13 ' A' ' 91' ' ' ILE . 1.6 m -140.43 125.16 18.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.973 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -81.08 81.87 1.59 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.463 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.83 -57.74 3.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.0 110.956 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.83 HG21 HG22 ' A' ' 102' ' ' VAL . 3.5 m -58.29 131.57 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.168 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -104.46 -129.4 6.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.541 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.1 46.98 12.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.093 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.47 -126.18 7.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.349 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 176.14 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.801 0.334 . . . . 0.0 110.752 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.672 ' O ' HG23 ' A' ' 95' ' ' VAL . 2.0 mmp_? -78.9 -46.58 1.76 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.065 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.3 Cg_exo -67.24 157.68 60.6 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.638 2.225 . . . . 0.0 112.08 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.83 HG22 HG21 ' A' ' 95' ' ' VAL . 5.9 m -154.17 98.23 2.57 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HG3' ' CE1' ' A' ' 6' ' ' TYR . 41.4 Cg_exo -56.39 145.24 79.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.421 2.081 . . . . 0.0 112.244 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.727 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.9 mp -83.39 160.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.878 ' O ' HG23 ' A' ' 109' ' ' VAL . 60.0 p -77.04 145.38 73.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.46 -29.24 39.0 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.526 2.151 . . . . 0.0 112.228 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -77.13 -37.34 54.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.66 -35.73 33.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 105' ' ' SER . 36.2 t -60.95 -51.54 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.227 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -29.17 68.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.706 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.471 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -73.72 -51.27 17.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.614 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.776 HD12 ' CD2' ' A' ' 67' ' ' PHE . 22.6 pt -66.48 -19.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.754 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.885 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.79 -38.97 61.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.746 179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -73.28 -34.31 65.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.001 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.623 ' CG1' HD11 ' A' ' 61' ' ' LEU . 11.3 t -83.91 -33.18 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.253 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.935 ' HB3' HD12 ' A' ' 39' ' ' LEU . 4.2 m -59.84 -60.77 3.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 150.22 41.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.645 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.885 HD12 ' HG ' ' A' ' 113' ' ' LEU . 45.6 mt -120.9 -57.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 110.75 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.72 31.11 3.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.332 -1.26 . . . . 0.0 112.432 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.769 0.319 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.642 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.3 -165.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.878 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.38 150.78 27.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.331 0.586 . . . . 0.0 112.154 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 1.025 ' CH2' HD12 ' A' ' 39' ' ' LEU . 72.1 m95 -92.63 85.96 5.43 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.264 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.601 ' CE1' HD12 ' A' ' 72' ' ' LEU . 57.5 m-85 -81.19 129.06 34.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -111.38 124.7 52.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.354 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.516 HG11 HD11 ' A' ' 91' ' ' ILE . 13.6 t -101.1 159.43 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.872 ' HB2' HG13 ' A' ' 95' ' ' VAL . 1.7 m-70 -106.56 151.83 24.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.9 p -157.11 170.25 22.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.23 143.77 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.791 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.97 127.24 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.48 -27.81 17.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.485 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -99.18 -24.0 15.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 111.06 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.45 -53.75 53.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.051 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -57.42 -41.56 80.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -72.61 -33.66 66.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.225 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -47.39 -55.56 8.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -43.96 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.972 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mt -69.16 -63.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -40.86 -32.21 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.749 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -43.32 30.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 110.624 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -77.39 -26.59 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.777 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.529 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.6 mm -83.97 -25.53 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.838 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -96.48 -29.91 13.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.82 -44.53 63.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.91 -24.59 40.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.978 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.08 53.32 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.382 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.529 ' HB2' HG23 ' A' ' 26' ' ' ILE . 2.9 mm? -99.98 32.04 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.963 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -79.17 8.93 5.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -97.48 -21.07 17.34 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -103.66 -55.08 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.596 HG23 ' CG2' ' A' ' 68' ' ' ILE . 18.8 mm -81.49 94.54 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.673 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.606 ' CE2' HG21 ' A' ' 3' ' ' ILE . 11.7 m-85 -79.99 -55.33 5.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.351 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.498 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 mt-30 -114.36 166.73 11.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.161 0.505 . . . . 0.0 111.709 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.2 t -150.32 89.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.025 HD12 ' CH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -80.59 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.171 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.594 HD12 ' O ' ' A' ' 42' ' ' THR . 1.4 pt -104.54 104.24 44.13 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.811 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 35.8 Cg_exo -57.67 -9.09 4.94 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.698 2.265 . . . . 0.0 113.147 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.594 ' O ' HD12 ' A' ' 40' ' ' ILE . 32.8 p -92.1 138.33 31.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.734 0.302 . . . . 0.0 110.534 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.41 ' HB2' ' CB ' ' A' ' 59' ' ' LYS . 1.4 mm-40 -80.23 108.28 13.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.793 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' HG13 ' A' ' 45' ' ' VAL . 50.9 mt-10 -94.88 110.5 22.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.223 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.563 HG23 ' HB ' ' A' ' 56' ' ' VAL . 3.3 m -156.14 113.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 47' ' ' GLU . 11.0 p -160.35 160.03 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.919 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' N ' HG22 ' A' ' 46' ' ' VAL . 17.7 tp10 -144.5 -68.0 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.965 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.27 -175.82 4.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.964 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -120.74 -67.54 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -139.12 132.67 30.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.17 40.72 0.67 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.92 -76.47 0.21 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.404 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.09 142.92 13.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.99 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -101.49 125.93 48.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.667 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.41 ' HB2' ' CB ' ' A' ' 47' ' ' GLU . 6.0 tt0 -88.38 -97.7 0.09 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.941 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 45' ' ' VAL . 1.5 t -153.79 -140.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 122.498 -0.126 . . . . 0.0 110.674 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 45' ' ' VAL . 27.0 m -157.93 -172.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -91.21 107.58 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -87.09 -175.01 5.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.342 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 32.1 mtmt -145.37 92.38 2.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.343 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' HG21 ' A' ' 115' ' ' VAL . 15.1 mt -64.12 -51.84 61.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.334 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 41' ' ' PRO . 10.9 m-85 -116.64 81.69 11.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.702 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 53.1 Cg_exo -54.94 141.73 77.51 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.604 2.203 . . . . 0.0 112.557 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.74 27.36 66.37 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.774 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 61.8 m-85 -134.23 151.62 51.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.9 0.381 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 6.0 mt -147.78 126.68 12.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.388 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.909 ' CD2' HD12 ' A' ' 112' ' ' ILE . 8.9 m-85 -93.96 131.66 39.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 111.219 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.596 ' CG2' HG23 ' A' ' 35' ' ' ILE . 1.3 mp -138.14 113.99 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.213 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 3.3 tt0 -79.88 71.73 6.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.106 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.607 ' CE ' HD21 ' A' ' 72' ' ' LEU . 3.8 ptm -91.66 -171.15 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.342 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -129.71 79.08 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.545 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.607 HD21 ' CE ' ' A' ' 70' ' ' MET . 20.5 mt -80.0 -43.34 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.57 110.49 2.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.637 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -167.26 -67.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.957 0.408 . . . . 0.0 110.999 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -117.74 -179.49 3.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -67.19 -27.69 67.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.971 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.88 148.28 48.17 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.6 165.87 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.493 2.128 . . . . 0.0 112.281 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 81' ' ' ALA . 8.1 p-10 -90.11 -177.9 5.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.974 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -60.69 -28.22 68.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . . . -54.8 -45.61 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.194 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -62.61 -31.93 72.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.808 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -33.63 75.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.701 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -80.05 -53.59 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.009 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.559 ' O ' HG21 ' A' ' 91' ' ' ILE . 21.9 t -59.24 -39.19 78.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -74.75 -20.78 59.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.036 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -105.01 6.23 43.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.117 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.865 ' O ' HG22 ' A' ' 91' ' ' ILE . 12.7 p -74.79 143.64 78.67 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.858 0.329 . . . . 0.0 110.672 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.15 104.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.459 2.106 . . . . 0.0 112.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.5 17.51 6.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.791 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.865 HG22 ' O ' ' A' ' 88' ' ' THR . 7.6 tp -113.57 103.27 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 0.0 110.979 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.13 -27.94 67.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.972 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.91 57.31 2.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.439 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 63.85 128.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.328 . . . . 0.0 110.942 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.872 HG13 ' HB2' ' A' ' 9' ' ' HIS . 35.3 m -79.54 -1.7 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.642 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -55.56 -23.17 34.68 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.68 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 62.66 51.52 3.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.397 . . . . 0.0 111.031 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.21 45.43 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.531 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.4 ttt -142.47 146.08 34.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -72.66 154.48 91.37 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.441 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_exo -49.81 143.35 23.41 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.587 2.191 . . . . 0.0 112.32 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.71 118.95 29.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.225 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.92 163.1 13.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.0 112.292 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.494 ' HB2' HG22 ' A' ' 109' ' ' VAL . 1.4 mt -90.0 168.41 12.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.918 ' O ' HG23 ' A' ' 109' ' ' VAL . 57.4 p -88.74 147.04 38.3 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.773 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.49 -33.96 93.72 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.682 2.255 . . . . 0.0 112.249 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -26.71 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.07 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -95.48 -36.7 11.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.136 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.952 HG11 ' CD1' ' A' ' 5' ' ' TRP . 40.9 t -59.39 -31.77 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.114 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -59.74 -43.12 94.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -53.91 34.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.67 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.909 HD12 ' CD2' ' A' ' 67' ' ' PHE . 9.9 pt -61.23 -23.79 31.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.259 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.797 ' HA ' HD21 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -59.57 -36.71 76.74 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.15 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.29 -17.71 59.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.12 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 61' ' ' LEU . 21.4 t -77.5 -60.01 2.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.483 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.544 ' HB3' HD23 ' A' ' 39' ' ' LEU . 86.1 p -51.81 -59.96 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.513 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 139.79 46.16 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.742 HD12 ' HG ' ' A' ' 113' ' ' LEU . 2.6 mt -114.92 -43.82 3.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.5 tp -98.7 30.88 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.428 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.836 0.35 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.75 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -133.7 -165.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -141.15 147.6 38.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 112.225 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.705 ' CZ2' HD11 ' A' ' 113' ' ' LEU . 78.1 m95 -92.61 93.06 8.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.185 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.873 ' CE2' HD12 ' A' ' 72' ' ' LEU . 29.1 m-85 -80.03 112.74 17.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 111.087 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -104.55 145.06 30.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.302 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.63 178.24 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 11.0 m-70 -107.91 143.65 36.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 p -138.59 174.19 10.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.93 144.47 25.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 12' ' ' VAL . 30.7 m -58.68 119.03 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -27.76 15.85 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.475 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -80.04 -30.26 39.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.652 0.263 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.62 -40.14 86.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -53.58 -43.07 68.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 tttm -86.99 -25.48 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.88 -30.7 70.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' NZ ' HD11 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -63.36 -50.49 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 -41.37 65.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.141 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -59.45 -44.9 92.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.52 -47.09 67.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.773 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -57.86 -21.77 44.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.192 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.63 -46.23 14.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.965 0.412 . . . . 0.0 110.289 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -67.31 -23.36 65.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.413 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -71.06 -28.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -98.08 -31.93 11.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.37 87.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -82.77 -42.06 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' C ' HD23 ' A' ' 31' ' ' LEU . . . 106.99 77.41 1.06 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -155.18 29.37 0.4 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 110.823 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -15.43 61.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.137 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.56 -24.55 42.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.18 -53.62 6.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.568 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.03 153.06 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.474 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.75 ' CE2' HG21 ' A' ' 3' ' ' ILE . 25.8 m-85 -135.38 -54.53 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.686 0.279 . . . . 0.0 111.402 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -117.28 157.92 25.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.382 0.611 . . . . 0.0 111.605 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.39 62.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.06 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' A' ' 116' ' ' SER . 1.9 tm? -79.58 129.37 34.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.586 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.482 HG22 HG23 ' A' ' 42' ' ' THR . 1.8 mp -105.28 128.36 26.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.666 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 30.7 Cg_endo -63.85 78.84 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.564 2.176 . . . . 0.0 112.635 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.482 HG23 HG22 ' A' ' 40' ' ' ILE . 48.5 p -141.04 135.49 31.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.995 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -82.97 156.5 23.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.787 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -137.01 119.99 16.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.4 m -148.71 164.79 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.85 149.33 33.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -112.45 -63.09 1.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.98 149.52 23.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.815 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -151.65 -50.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -65.74 157.26 30.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.38 -122.21 5.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.439 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -143.62 28.86 2.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.576 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.75 119.99 28.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -113.95 130.08 56.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -135.8 139.53 43.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 56' ' ' VAL . 28.9 m -130.52 123.74 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.062 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.7 t -98.36 155.66 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.255 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.33 113.88 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.725 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -110.24 106.87 16.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -63.66 101.11 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.949 HD11 HG11 ' A' ' 115' ' ' VAL . 83.1 mt -61.62 -31.77 71.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 9.0 m-85 -139.59 83.97 16.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.631 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.46 139.47 90.25 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.59 2.193 . . . . 0.0 112.509 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.5 24.64 72.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.744 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -131.58 136.63 47.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.749 0.309 . . . . 0.0 110.954 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -131.53 128.76 39.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.465 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.967 ' CD2' HD12 ' A' ' 112' ' ' ILE . 5.3 m-85 -99.09 121.63 41.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.4 mp -125.48 111.43 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.748 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.537 ' NE2' HD11 ' A' ' 3' ' ' ILE . 4.7 tt0 -79.9 72.19 6.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.663 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 ptp -91.63 -163.23 1.01 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.177 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -147.77 89.2 1.73 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.662 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.873 HD12 ' CE2' ' A' ' 6' ' ' TYR . 11.2 mt -79.98 -16.41 55.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.66 78.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.468 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -156.78 120.96 4.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.758 0.313 . . . . 0.0 110.705 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 61.85 -175.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.906 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -31.6 61.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -123.1 149.89 58.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.24 150.25 20.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.513 2.142 . . . . 0.0 112.256 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -165.83 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.468 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.3 pt-20 -57.81 -21.29 41.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.164 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -49.26 -35.9 19.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.431 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -80.46 -29.72 37.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.07 -28.24 63.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 80' ' ' GLU . 22.7 t -84.83 -51.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 81' ' ' ALA . 39.2 t -58.63 -37.36 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -73.97 -26.35 60.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.175 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.5 6.13 60.86 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.008 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.1 120.68 69.22 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.774 0.287 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.84 115.18 2.24 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.26 -13.16 6.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.791 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.1 tp -79.95 132.82 31.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 111.064 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.8 p -123.69 -68.96 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.98 165.0 28.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.523 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.456 ' HB3' ' CD2' ' A' ' 9' ' ' HIS . 1.5 t80 -175.3 -42.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.869 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 100' ' ' ARG . 4.4 m -55.25 100.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.32 -95.56 0.51 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.795 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 63.56 -79.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.321 . . . . 0.0 110.971 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -127.22 -48.56 0.18 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.1 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.402 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 1.3 ttm -129.1 174.4 9.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -54.24 -51.19 79.84 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.011 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 100' ' ' ARG . 65.6 Cg_endo -85.12 155.07 11.1 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.698 2.266 . . . . 0.0 111.959 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.417 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 63.4 t -155.71 114.61 2.22 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.102 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.62 156.54 40.27 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.476 2.118 . . . . 0.0 112.388 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.772 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.2 mp -89.72 147.81 23.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.824 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -70.95 153.3 94.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.53 -36.45 59.75 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.55 2.166 . . . . 0.0 112.311 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.63 -35.62 81.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.72 -38.81 20.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 105' ' ' SER . 38.3 t -58.84 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.056 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -53.68 -30.02 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.032 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 -54.91 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.707 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.967 HD12 ' CD2' ' A' ' 67' ' ' PHE . 15.7 pt -66.95 -26.2 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 ' CZ2' ' A' ' 5' ' ' TRP . 1.1 mp -72.2 -31.33 65.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.249 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -41.88 73.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.656 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.949 HG11 HD11 ' A' ' 61' ' ' LEU . 19.1 t -84.64 -27.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.727 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.481 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . 3.8 t -52.23 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.737 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.819 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 150.96 38.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.349 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.819 HD23 ' C ' ' A' ' 117' ' ' GLY . 2.4 mt -122.31 -37.74 2.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.88 -34.58 39.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.818 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.434 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.856 0.36 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.655 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -139.46 178.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.29 164.0 34.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.174 0.511 . . . . 0.0 111.98 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.882 ' CZ2' HD21 ' A' ' 113' ' ' LEU . 76.1 m95 -94.8 132.72 39.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.814 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 28.0 m-85 -119.11 122.81 42.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.803 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -101.55 131.52 47.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.481 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 HD12 ' A' ' 91' ' ' ILE . 15.6 t -117.59 159.54 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.788 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.477 ' N ' HG12 ' A' ' 8' ' ' VAL . 15.8 m-70 -94.27 133.52 37.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.046 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.51 HG21 HD13 ' A' ' 66' ' ' LEU . 36.7 p -144.74 -177.5 5.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.796 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.14 140.65 29.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.1 p -60.62 123.91 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.52 5.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.235 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -81.57 -18.14 45.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.713 0.292 . . . . 0.0 110.913 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -44.96 -40.43 6.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.286 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -37.9 80.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -33.74 64.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.58 -43.77 88.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -66.1 -35.98 81.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.78 -54.92 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.003 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -60.26 -31.68 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.577 HD12 HG21 ' A' ' 88' ' ' THR . 38.0 tp -74.96 -57.25 4.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.809 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.91 -32.39 6.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -71.64 -41.3 68.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.503 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.761 ' HG3' HG22 ' A' ' 88' ' ' THR . 2.3 mmp_? -68.23 -39.33 82.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.587 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.767 ' HA ' HD12 ' A' ' 31' ' ' LEU . 37.5 mm -64.83 -31.46 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.828 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -83.99 -30.17 26.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.65 -44.87 76.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -80.04 -29.77 39.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.23 43.63 3.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.449 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.918 HD11 HG21 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -99.84 28.9 4.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 110.825 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -69.54 -13.11 62.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.274 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.409 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 1.1 m-20 -79.75 -23.8 42.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.738 0.304 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.565 ' CE ' ' HB2' ' A' ' 81' ' ' ALA . 13.8 mtpp -94.56 -56.3 2.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.843 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.5 mm -80.01 136.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.669 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.1 m-85 -132.27 -64.13 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.449 . . . . 0.0 111.447 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.02 151.74 21.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.82 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.7 HG12 HG23 ' A' ' 68' ' ' ILE . 5.2 m -159.81 106.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.494 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.734 HD11 HD21 ' A' ' 118' ' ' LEU . 4.4 mm? -118.82 160.45 21.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.378 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.8 pt -103.54 131.78 21.71 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.767 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 37.1 Cg_endo -65.65 83.28 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.555 2.17 . . . . 0.0 112.806 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.9 p -125.06 163.28 22.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.866 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.716 ' CG ' HD21 ' A' ' 61' ' ' LEU . 37.2 tt0 -114.55 20.3 15.46 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.175 0.512 . . . . 0.0 112.139 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 58' ' ' ARG . 3.2 mt-10 -160.48 167.69 26.71 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.515 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 56' ' ' VAL . 3.8 m -160.01 -48.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.702 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 45' ' ' VAL . 5.6 m -159.81 137.63 2.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.938 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -148.37 160.77 42.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.046 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -114.9 124.74 52.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.73 -178.32 7.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.812 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 68.88 -68.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.39 -128.08 0.93 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.589 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.78 30.38 9.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.534 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.72 151.95 24.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.923 0.392 . . . . 0.0 110.795 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -104.07 121.8 43.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -120.43 143.62 48.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 45' ' ' VAL . 11.8 p -109.49 135.52 48.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.184 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 44' ' ' GLU . 5.8 m -151.57 152.57 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.584 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.566 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . 10.1 mtt180 -150.56 127.06 10.79 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.579 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 43' ' ' GLU . 3.5 mttm -92.61 -163.55 1.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -133.1 100.94 5.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.788 HD11 HG11 ' A' ' 115' ' ' VAL . 63.1 mt -76.45 -31.71 58.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.652 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.0 m-85 -140.42 67.65 31.44 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.557 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.39 120.19 7.89 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.63 2.22 . . . . 0.0 112.213 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 16.07 22.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.661 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.46 154.16 50.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 10' ' ' THR . 0.3 OUTLIER -136.38 115.02 11.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.529 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.882 ' CD2' HD13 ' A' ' 112' ' ' ILE . 14.5 m-85 -79.83 125.01 29.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.276 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 38' ' ' VAL . 1.9 mp -134.03 112.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.142 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.4 tt0 -80.81 74.54 7.77 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.798 0.333 . . . . 0.0 110.936 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptp -91.24 -169.65 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.011 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -147.02 89.01 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.814 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 62.6 mt -83.35 -46.09 12.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.826 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.37 -29.71 9.81 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.603 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -130.87 162.34 29.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.923 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -111.17 -28.8 8.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.961 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.06 -47.2 86.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.001 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -154.16 131.25 5.97 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.941 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.08 177.82 8.33 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.477 2.118 . . . . 0.0 112.506 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -90.09 -164.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.64 -27.16 57.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.565 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . . . -51.43 -34.97 37.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.399 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -66.21 -33.75 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.8 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -31.82 72.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.743 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 31' ' ' LEU . 21.4 t -72.64 -49.58 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.85 HG12 HG13 ' A' ' 91' ' ' ILE . 21.6 t -58.17 -53.85 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp-105 -58.69 -29.35 66.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.64 -28.13 52.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.532 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 84' ' ' VAL . 44.9 p -69.58 130.4 90.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.55 0.214 . . . . 0.0 110.756 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.76 -23.8 28.04 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.418 2.078 . . . . 0.0 112.348 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.78 -27.32 55.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.619 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.85 HG13 HG12 ' A' ' 85' ' ' VAL . 38.0 mm -90.94 139.24 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 111.115 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 p -113.7 -36.21 4.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.687 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.44 -111.32 0.25 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.432 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.449 ' CE2' ' HA2' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -174.99 175.11 2.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.765 0.317 . . . . 0.0 110.848 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 96' ' ' GLY . 14.3 p -53.9 -46.41 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.644 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 98.07 -31.1 8.33 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.596 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.0 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.721 0.296 . . . . 0.0 111.331 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -134.66 140.64 11.92 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.532 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.3 mmt 58.73 -178.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.721 0.296 . . . . 0.0 110.943 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.427 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -87.6 -50.07 0.44 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.019 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 6.1 Cg_exo -79.05 -174.74 2.41 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.828 2.352 . . . . 0.0 112.226 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -150.74 72.21 8.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.06 133.94 37.69 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.524 2.149 . . . . 0.0 112.522 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 67' ' ' PHE . 3.2 mt -88.84 167.85 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -89.98 148.06 38.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -56.36 -32.01 87.01 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.513 2.142 . . . . 0.0 112.277 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.97 -27.71 61.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -90.4 -33.5 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.98 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 105' ' ' SER . 33.5 t -60.53 -40.73 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.167 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -19.4 62.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.743 ' O ' HG23 ' A' ' 115' ' ' VAL . 44.5 m-70 -83.34 -44.06 15.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.96 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.882 HD13 ' CD2' ' A' ' 67' ' ' PHE . 1.8 pp -74.96 -20.19 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.134 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.882 HD21 ' CZ2' ' A' ' 5' ' ' TRP . 97.4 mt -84.95 -34.01 22.54 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.863 0.363 . . . . 0.0 110.591 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -73.13 -28.23 62.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.693 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.788 HG11 HD11 ' A' ' 61' ' ' LEU . 16.0 t -89.51 -31.11 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.999 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.67 ' HB3' HD12 ' A' ' 39' ' ' LEU . 3.2 m -60.28 -64.64 0.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 149.09 55.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.722 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.734 HD21 HD11 ' A' ' 39' ' ' LEU . 1.2 mt -135.5 -48.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.805 0.336 . . . . 0.0 110.684 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -4.06 50.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.392 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.439 -1.2 . . . . 0.0 112.439 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.813 0.34 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.63 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -79.94 -179.66 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.797 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.86 164.68 37.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.258 0.551 . . . . 0.0 111.829 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.692 ' HH2' HD23 ' A' ' 39' ' ' LEU . 79.0 m95 -89.74 129.77 36.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.858 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.497 ' OH ' HD12 ' A' ' 72' ' ' LEU . 4.7 m-30 -112.61 108.35 17.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.286 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.42 137.56 32.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.73 158.16 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.632 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 9' ' ' HIS . 1.1 m-70 -104.32 132.98 49.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.911 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.8 p -128.04 -173.78 3.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.66 131.4 41.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.782 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 12' ' ' VAL . 19.1 m -59.17 115.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.41 -28.73 12.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -20.04 35.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.543 ' OE2' HD12 ' A' ' 40' ' ' ILE . 1.5 tm-20 -53.87 -32.62 53.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.855 0.359 . . . . 0.0 111.154 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.65 -38.64 72.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -24.11 21.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.97 -51.27 70.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.303 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -50.66 -41.46 55.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.168 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.41 75.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -65.31 -36.27 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.476 HD22 HG21 ' A' ' 88' ' ' THR . 2.5 mt -79.5 -54.43 5.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -43.99 -31.32 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.615 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -82.5 -35.81 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.686 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -79.92 -25.29 40.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.821 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.793 ' HA ' HD12 ' A' ' 31' ' ' LEU . 38.0 mm -80.73 -28.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.698 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -91.47 -30.33 16.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.33 -42.94 61.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -80.21 -28.09 38.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 58.86 1.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -114.39 30.96 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -72.97 -10.72 60.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.233 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -79.97 -24.73 40.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.739 0.304 . . . . 0.0 110.983 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.27 -61.94 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 68' ' ' ILE . 18.1 mm -79.96 111.92 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.63 ' CE2' HG21 ' A' ' 3' ' ' ILE . 12.3 m-85 -99.53 -58.8 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.197 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -109.29 146.14 34.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.45 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' HD22 ' A' ' 39' ' ' LEU . 22.5 t -153.81 117.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.698 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.692 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.4 mm? -126.1 156.61 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.973 0.416 . . . . 0.0 111.278 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.543 HD12 ' OE2' ' A' ' 15' ' ' GLU . 3.5 tt -106.76 124.68 34.74 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.638 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 33.9 Cg_endo -64.7 69.78 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.54 2.16 . . . . 0.0 112.758 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 p -141.61 132.6 26.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.512 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HA ' HG12 ' A' ' 115' ' ' VAL . 10.9 tt0 -80.06 166.01 21.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.014 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -144.89 110.41 5.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.747 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 46' ' ' VAL . 6.5 t -153.38 161.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 55' ' ' GLU . 30.4 m -85.21 139.05 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.521 ' HB3' HG21 ' A' ' 57' ' ' VAL . 17.2 pt-20 -109.77 -46.87 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.129 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.53 -162.89 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.918 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.92 -50.14 0.64 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.832 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 55.27 26.87 9.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.978 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.71 -46.5 2.52 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.366 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.1 44.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.432 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.15 25.48 1.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.32 0.581 . . . . 0.0 111.091 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -159.62 114.11 2.34 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.757 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.814 ' O ' HG12 ' A' ' 46' ' ' VAL . 2.8 pt-20 -160.13 -43.84 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.234 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.56 HG23 ' HG3' ' A' ' 55' ' ' GLU . 27.9 t -102.26 117.0 46.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.47 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 47' ' ' GLU . 5.2 t -124.2 157.39 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.701 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -131.27 130.64 43.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.392 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.72 96.58 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.564 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -51.6 119.17 3.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.853 HD11 HG11 ' A' ' 115' ' ' VAL . 28.9 mt -90.1 -44.09 10.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.696 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 3.7 m-85 -115.73 91.36 29.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.629 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -45.23 117.75 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.909 2.406 . . . . 0.0 112.968 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.92 45.09 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.962 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.402 ' OH ' ' CE1' ' A' ' 9' ' ' HIS . 0.1 OUTLIER -132.29 149.16 52.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.757 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.39 118.0 9.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.908 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.932 ' CD2' HD12 ' A' ' 112' ' ' ILE . 7.5 m-85 -88.25 133.9 33.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.795 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 35' ' ' ILE . 5.3 mt -135.37 111.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.128 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 7.8 tt0 -79.65 67.22 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.418 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.402 ' CB ' HD13 ' A' ' 35' ' ' ILE . 2.8 ptm -91.2 -168.6 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.279 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -145.6 108.56 4.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.777 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.497 HD12 ' OH ' ' A' ' 6' ' ' TYR . 4.4 mt -79.92 -68.16 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.841 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.33 -66.62 2.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.426 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.54 158.37 29.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.53 -29.98 7.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.029 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.59 -66.71 0.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.984 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -121.91 138.03 28.13 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.76 166.6 28.95 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.464 2.109 . . . . 0.0 112.345 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.83 173.55 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.772 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 84' ' ' VAL . 9.1 pt-20 -59.14 -25.16 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.36 -50.55 67.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.306 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.431 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.0 t-105 -58.3 -42.02 85.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -59.85 -30.87 69.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.855 ' O ' HG23 ' A' ' 88' ' ' THR . 22.1 t -84.07 -52.34 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.694 ' O ' HG21 ' A' ' 91' ' ' ILE . 23.5 t -62.13 -49.03 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.46 -11.87 61.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.251 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -104.83 -17.18 15.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.872 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.871 ' O ' HG22 ' A' ' 91' ' ' ILE . 30.7 p -56.47 147.58 48.64 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.717 0.294 . . . . 0.0 110.985 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.48 109.73 1.89 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.587 2.192 . . . . 0.0 112.258 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.56 10.42 9.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.722 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.871 HG22 ' O ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -115.29 140.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 111.04 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -141.16 15.72 2.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.539 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.19 -83.45 0.02 OUTLIER Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.237 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 9' ' ' HIS . 2.3 m-85 66.68 13.01 9.17 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.617 ' HB ' HG23 ' A' ' 102' ' ' VAL . 5.7 m -89.98 65.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 0.0 110.739 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.82 -11.99 61.42 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.985 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.949 ' HB3' HG21 ' A' ' 102' ' ' VAL . . . -68.93 66.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.969 0.414 . . . . 0.0 111.117 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.84 24.38 7.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 28.6 mtt 62.6 -80.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.806 0.336 . . . . 0.0 110.969 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.456 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -57.29 161.47 5.39 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.878 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 100' ' ' ARG . 85.6 Cg_exo -42.89 141.62 2.53 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.78 2.32 . . . . 0.0 112.572 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.949 HG21 ' HB3' ' A' ' 97' ' ' ALA . 24.8 t -99.92 102.3 17.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.76 150.38 27.29 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.145 . . . . 0.0 112.205 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -90.06 153.91 20.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.851 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.6 p -80.97 161.16 64.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.06 -26.89 77.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.696 2.264 . . . . 0.0 112.323 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.85 -31.87 61.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 112' ' ' ILE . 12.4 tt0 -88.0 -35.22 17.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 105' ' ' SER . 58.3 t -58.68 -48.92 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -25.16 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -80.99 -38.84 26.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.959 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.932 HD12 ' CD2' ' A' ' 67' ' ' PHE . 14.4 pt -78.09 -26.95 14.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.157 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.991 HD22 HD12 ' A' ' 118' ' ' LEU . 90.7 mt -82.11 -26.91 33.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -70.67 -30.09 66.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.853 HG11 HD11 ' A' ' 61' ' ' LEU . 27.9 t -82.6 -38.02 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.656 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -59.25 -62.76 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.632 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 153.21 45.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.557 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.991 HD12 HD22 ' A' ' 113' ' ' LEU . 12.0 mt -128.16 -54.23 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.794 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.37 -31.75 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.503 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.841 0.353 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.89 -173.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.743 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.89 159.91 41.26 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.053 0.454 . . . . 0.0 111.705 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.606 ' CD1' HG11 ' A' ' 109' ' ' VAL . 69.2 m95 -101.05 111.51 23.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.69 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 18.9 m-85 -94.96 124.43 39.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.817 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.613 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . -99.53 143.67 29.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.434 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' HD23 ' A' ' 66' ' ' LEU . 6.1 t -140.65 162.03 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.073 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.476 ' N ' HG12 ' A' ' 8' ' ' VAL . 10.2 m170 -86.79 155.87 20.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.271 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.681 ' CG2' HD22 ' A' ' 66' ' ' LEU . 28.6 p -146.56 -176.64 5.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.65 127.81 34.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.811 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 12' ' ' VAL . 18.6 m -59.24 102.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.097 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 110.97 -17.67 27.02 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.631 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -112.87 2.21 15.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 37.3 tt0 -54.96 -45.07 74.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.822 0.344 . . . . 0.0 111.071 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -54.12 -61.54 2.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -66.08 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.001 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -58.99 -47.43 85.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.85 0.357 . . . . 0.0 111.05 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -55.53 -41.03 72.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.66 -37.14 80.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -64.41 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.413 HD22 ' CB ' ' A' ' 88' ' ' THR . 2.8 mt -83.07 -60.72 2.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -37.53 -34.68 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.778 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -72.85 -51.23 19.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.419 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.71 ' HD3' HG22 ' A' ' 88' ' ' THR . 1.2 mtt-85 -69.31 -24.96 64.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.469 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.478 HG21 ' CD1' ' A' ' 35' ' ' ILE . 31.9 mm -73.38 -31.06 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.561 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -32.91 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.784 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.35 -29.52 65.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.022 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.422 ' CZ ' ' NH1' ' A' ' 25' ' ' ARG . 5.5 m-85 -80.55 -39.59 27.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.78 67.72 0.8 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.947 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.845 HD13 ' HA ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -144.86 34.86 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -13.26 61.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.407 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 6.1 m-20 -79.64 -22.69 43.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.881 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.5 -49.71 8.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.515 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.478 ' CD1' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -95.59 149.48 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.876 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.64 ' CE2' HG21 ' A' ' 3' ' ' ILE . 7.8 m-85 -140.12 -47.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.252 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -118.01 157.53 26.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.098 0.475 . . . . 0.0 111.703 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.507 HG12 HG23 ' A' ' 68' ' ' ILE . 2.6 m -156.56 102.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.566 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.985 HD11 HD21 ' A' ' 118' ' ' LEU . 4.3 mm? -113.23 152.84 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.156 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.2 mt -99.24 127.03 35.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.72 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 26.7 Cg_endo -62.54 78.56 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.536 2.158 . . . . 0.0 112.388 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.594 HG22 ' CG ' ' A' ' 60' ' ' LYS . 42.0 p -143.95 167.19 22.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HA ' HG12 ' A' ' 115' ' ' VAL . 3.8 pt-20 -123.39 107.36 11.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' O ' HG13 ' A' ' 45' ' ' VAL . 1.3 tt0 -95.15 137.37 34.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 44' ' ' GLU . 13.7 m -156.22 144.35 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' ' 56' ' ' VAL . 28.9 m -139.01 163.05 27.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.269 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -126.43 137.49 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.85 88.91 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.44 150.63 20.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -82.28 111.56 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.964 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.74 -34.56 0.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.546 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.58 40.2 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.473 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -136.35 162.66 32.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.47 124.56 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -114.65 116.6 28.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.623 ' HA ' HG12 ' A' ' 46' ' ' VAL . 26.6 t -110.98 108.5 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.048 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.5 m -123.42 138.27 53.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.241 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.67 125.24 9.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' HG3' ' CG ' ' A' ' 43' ' ' GLU . 4.8 ptpt -113.0 172.95 6.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.762 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.594 ' CG ' HG22 ' A' ' 42' ' ' THR . 8.5 mtmt -100.73 120.07 39.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.852 HD11 HG11 ' A' ' 115' ' ' VAL . 44.6 mt -76.0 -44.91 37.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.458 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.526 ' CE1' HG22 ' A' ' 112' ' ' ILE . 3.5 m-85 -118.9 70.16 9.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.427 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.85 139.07 83.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.754 2.303 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.5 15.39 79.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -134.19 160.49 37.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.839 0.352 . . . . 0.0 111.179 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.778 ' CD1' HD11 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -144.91 131.15 19.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.651 ' CD2' HD13 ' A' ' 112' ' ' ILE . 17.3 m-85 -93.6 123.41 36.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.2 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.778 HD11 ' CD1' ' A' ' 66' ' ' LEU . 1.6 mt -126.14 116.43 45.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.698 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 5.7 tt0 -79.74 69.89 6.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.94 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.6 ptp -91.0 -166.55 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.811 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -160.06 96.43 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.363 . . . . 0.0 110.889 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.69 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 51.9 mt -83.03 -30.4 28.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.762 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.55 -63.0 4.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.55 146.67 23.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -92.59 -26.53 17.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.98 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -57.07 -78.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.968 0.413 . . . . 0.0 111.065 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -117.69 121.33 31.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.64 176.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.477 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -90.07 -170.2 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.974 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -29.05 68.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.845 ' HA ' HD13 ' A' ' 31' ' ' LEU . . . -52.86 -27.98 20.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.475 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -78.98 -33.39 45.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.039 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -62.15 -29.73 70.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.9 t -82.96 -40.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.199 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 81' ' ' ALA . 31.9 t -67.05 -45.72 86.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.247 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -15.82 62.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.308 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.0 -18.61 9.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.028 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.71 HG22 ' HD3' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -59.19 134.17 87.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.783 0.291 . . . . 0.0 110.945 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 88' ' ' THR . 31.6 Cg_exo -58.3 -30.05 89.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.47 2.114 . . . . 0.0 112.28 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.06 -33.28 60.59 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.701 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.1 mm -79.92 127.19 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.03 31.27 1.99 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.882 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.84 167.07 30.67 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.447 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.444 ' CD2' ' HG2' ' A' ' 100' ' ' ARG . 18.5 p90 -162.19 179.09 8.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.885 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG22 ' NE2' ' A' ' 9' ' ' HIS . 38.5 t -66.23 -67.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.997 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.27 -145.54 16.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.511 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 63.21 -81.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.719 0.295 . . . . 0.0 111.115 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -162.26 27.32 0.25 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.581 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.77 98.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 10.6 mtm-85 -57.86 -53.44 65.77 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.279 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 34.2 Cg_endo -64.49 148.45 90.64 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.292 1.994 . . . . 0.0 112.296 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 7' ' ' ALA . 7.8 m -145.15 89.01 6.56 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.81 133.01 26.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.49 2.127 . . . . 0.0 112.218 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.6 OUTLIER -84.74 159.07 20.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.048 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.847 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.2 m -81.2 160.43 65.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.79 -24.86 79.98 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.374 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.44 -37.12 63.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.052 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.37 -37.35 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.8 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 105' ' ' SER . 94.8 t -58.54 -38.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.19 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -25.92 65.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.9 0.381 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 115' ' ' VAL . 13.0 m-70 -74.69 -50.62 16.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.707 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.651 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.4 pp -68.16 -16.78 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.701 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -79.05 -41.76 28.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -33.16 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.793 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.852 HG11 HD11 ' A' ' 61' ' ' LEU . 33.5 t -73.46 -30.93 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.989 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.729 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.2 m -70.02 -58.77 3.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 140.97 59.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 39' ' ' LEU . 4.4 mt -133.14 -56.7 0.92 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -79.87 -50.93 9.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.535 179.973 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.889 0.376 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.73 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -137.74 -171.68 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.702 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -131.35 148.13 52.64 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.325 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.9 ' CD1' HG11 ' A' ' 109' ' ' VAL . 79.5 m95 -99.95 94.4 6.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.004 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.468 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 77.7 m-85 -84.15 126.62 33.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 111.316 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -104.39 124.78 49.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.024 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.5 p -108.37 159.46 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.193 0.52 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.605 ' CE1' HG23 ' A' ' 95' ' ' VAL . 21.1 m-70 -96.98 119.11 34.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.6 p -121.84 169.88 10.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.2 mm? -84.84 153.61 22.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 12' ' ' VAL . 12.1 p -66.34 120.86 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.14 -26.31 21.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.529 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -86.0 -25.63 25.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.16 -45.16 79.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.883 0.373 . . . . 0.0 111.047 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.05 -42.42 80.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.993 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.61 -28.63 45.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.98 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.487 ' HB1' ' HA3' ' A' ' 90' ' ' GLY . . . -65.14 -35.39 80.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -61.61 -50.87 70.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.63 81.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -59.1 -37.77 77.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.83 -54.76 5.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -51.52 -30.54 20.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -44.44 43.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.753 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -73.8 -27.6 61.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.98 -16.27 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -108.06 -29.94 8.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.14 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.87 25.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.175 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CD2' ' HG3' ' A' ' 25' ' ' ARG . 71.1 m-85 -79.88 -2.99 46.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.335 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 76.11 77.47 0.74 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.751 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 30' ' ' GLY . 2.4 mm? -134.99 30.96 3.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.962 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -77.51 6.18 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.338 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.5 -25.27 22.66 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.739 0.304 . . . . 0.0 110.724 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -106.14 -58.0 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.7 mm -81.86 110.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.808 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.5 m-85 -100.81 -53.15 3.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.216 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.414 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 3.8 mt-30 -116.6 157.43 25.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 0.0 111.646 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -148.54 67.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.271 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.819 HD11 HD21 ' A' ' 118' ' ' LEU . 3.8 mm? -80.36 156.8 26.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.429 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.522 HD12 ' HD2' ' A' ' 41' ' ' PRO . 4.2 tp -113.78 131.42 23.09 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.708 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 40' ' ' ILE . 43.5 Cg_endo -67.86 74.18 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.335 2.024 . . . . 0.0 112.548 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.0 p -131.65 133.89 45.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.057 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HA ' HG12 ' A' ' 115' ' ' VAL . 8.9 tp10 -89.6 154.08 20.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.662 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.26 138.47 50.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.045 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 46' ' ' VAL . 3.0 t -119.66 162.12 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.962 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.735 HG23 ' CD ' ' A' ' 47' ' ' GLU . 4.8 m -87.45 -31.72 6.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.44 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.735 ' CD ' HG23 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -144.2 167.33 22.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.047 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.874 HD12 HG11 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -146.03 52.39 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.833 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.49 129.12 4.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.01 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -27.04 62.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.788 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -178.65 53.59 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.3 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.81 -76.04 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.611 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -127.1 175.39 8.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 0.0 110.951 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -141.89 109.35 5.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -140.47 163.45 32.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 56' ' ' VAL . 12.3 p -80.42 123.32 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.874 HG11 HD12 ' A' ' 48' ' ' LEU . 17.7 m -121.39 179.12 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.87 159.91 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.949 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -159.93 100.33 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.747 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -53.81 120.54 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.217 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.832 HD11 HG11 ' A' ' 115' ' ' VAL . 48.0 mt -90.18 -40.65 12.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 32.8 m-85 -123.12 76.38 51.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 46.7 Cg_exo -56.28 141.39 88.66 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.636 2.224 . . . . 0.0 112.496 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.08 20.41 76.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.709 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 96.3 m-85 -131.02 145.02 51.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -134.21 122.1 22.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.527 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.477 ' CE2' HD12 ' A' ' 112' ' ' ILE . 17.5 m-85 -84.73 115.07 22.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.138 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.3 mp -123.59 108.81 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.055 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.423 ' HG2' ' CG1' ' A' ' 3' ' ' ILE . 3.0 tt0 -79.85 74.3 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.54 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.1 ptp -91.19 -174.35 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.128 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.7 t0 -125.47 78.15 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.468 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt -95.96 -46.34 6.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.52 -112.96 4.21 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.501 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -96.68 -177.61 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.95 31.38 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.988 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.14 -74.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -156.15 97.99 2.21 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.906 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.61 165.2 32.13 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.62 2.213 . . . . 0.0 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.87 178.89 7.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.607 ' O ' HG23 ' A' ' 84' ' ' VAL . 6.0 pt-20 -61.86 -18.79 61.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.241 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.74 -46.72 64.13 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.387 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -59.39 -43.79 92.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.44 -30.17 69.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.674 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 80' ' ' GLU . 34.5 t -71.34 -49.51 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.838 HG12 HG13 ' A' ' 91' ' ' ILE . 19.3 t -61.23 -45.31 98.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -59.75 -23.12 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.64 -32.86 8.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.756 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.58 146.76 79.38 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.27 -25.07 26.62 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.412 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.487 ' HA3' ' HB1' ' A' ' 18' ' ' ALA . . . -55.74 -25.45 43.95 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.643 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.838 HG13 HG12 ' A' ' 85' ' ' VAL . 37.8 mm -89.25 141.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 p -131.3 44.74 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.993 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.5 -122.81 7.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.588 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 99' ' ' MET . 0.6 OUTLIER -154.82 -177.13 6.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.336 . . . . 0.0 110.949 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.605 HG23 ' CE1' ' A' ' 9' ' ' HIS . 13.9 p -56.1 -35.68 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.16 12.18 14.37 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.721 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.527 ' H ' HG13 ' A' ' 95' ' ' VAL . . . -71.95 -29.55 64.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.786 0.327 . . . . 0.0 110.992 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -84.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.53 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.422 ' HA ' ' CE2' ' A' ' 94' ' ' PHE . 1.5 mtp -150.59 -46.57 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.835 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.8 ptt-85 -73.95 154.4 88.85 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.63 -166.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.584 2.189 . . . . 0.0 112.061 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 102' ' ' VAL . 5.9 m -143.0 99.37 5.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.01 135.17 16.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.128 . . . . 0.0 112.327 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.508 HD12 ' HB3' ' A' ' 5' ' ' TRP . 1.9 mt -72.65 169.36 16.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.91 ' O ' HG23 ' A' ' 109' ' ' VAL . 6.6 m -89.14 145.84 35.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.723 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.24 -33.34 97.5 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.54 2.16 . . . . 0.0 112.393 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.96 -32.91 67.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.97 -34.46 26.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 105' ' ' SER . 48.9 t -57.33 -45.63 85.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -29.99 40.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.15 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.429 ' O ' HG23 ' A' ' 115' ' ' VAL . 20.6 t60 -74.93 -52.4 11.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.542 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.477 HD12 ' CE2' ' A' ' 67' ' ' PHE . 11.6 pt -67.85 -19.38 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.94 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.852 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.2 mp -77.17 -38.38 51.82 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.479 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -69.67 -27.67 65.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.832 HG11 HD11 ' A' ' 61' ' ' LEU . 22.4 t -86.68 -31.97 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.565 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -60.08 -64.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.491 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 150.89 43.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.662 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.852 HD12 ' HG ' ' A' ' 113' ' ' LEU . 13.5 mt -120.04 -47.39 2.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.96 -36.55 6.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.351 -1.25 . . . . 0.0 112.485 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.71 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.71 -176.31 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.91 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.2 159.37 39.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.386 0.612 . . . . 0.0 112.481 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.898 ' CD1' HG11 ' A' ' 109' ' ' VAL . 89.7 m95 -97.42 91.77 5.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.476 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.815 ' O ' HD12 ' A' ' 68' ' ' ILE . 62.7 m-85 -83.67 111.17 18.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.84 0.353 . . . . 0.0 110.737 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.82 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . -90.48 159.04 16.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.35 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.91 162.99 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.897 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.457 ' CD2' HG22 ' A' ' 95' ' ' VAL . 14.1 m-70 -101.3 149.42 24.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.1 p -149.36 -174.36 4.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.1 141.79 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 12' ' ' VAL . 12.2 p -66.98 120.04 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.063 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.38 -29.42 10.26 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -85.71 -23.41 27.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.791 0.329 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -54.84 -34.91 63.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.38 -47.14 79.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.011 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -75.7 -27.13 58.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.84 85.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.195 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -47.25 -48.25 24.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.05 73.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.946 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -67.16 -49.79 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.991 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.94 -62.45 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -42.84 -31.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.623 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.25 -39.6 25.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.861 0.363 . . . . 0.0 110.474 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.22 51.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.4 mm -79.63 -27.12 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.692 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.45 -31.99 11.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.027 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.06 -46.05 68.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.96 -16.97 54.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.76 49.83 4.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.29 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 80' ' ' GLU . 3.1 mm? -96.68 24.57 5.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -80.3 19.4 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.241 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.2 -21.32 16.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -116.49 -49.22 2.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.797 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.471 HG23 ' CG2' ' A' ' 68' ' ' ILE . 5.4 mp -79.9 125.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.876 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HE2' HG21 ' A' ' 3' ' ' ILE . 20.3 m-85 -116.07 -62.13 1.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.491 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -106.71 156.01 19.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 111.224 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.5 p -150.36 73.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.615 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.847 HD12 ' OG ' ' A' ' 116' ' ' SER . 4.5 mm? -79.9 139.44 37.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.277 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.423 HG22 HG23 ' A' ' 42' ' ' THR . 33.5 mm -96.43 118.55 65.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.702 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 27.2 Cg_endo -62.31 90.03 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.352 2.034 . . . . 0.0 112.565 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 40.0 p -135.59 154.98 51.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 18.0 mt-10 -84.64 -171.47 3.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -145.42 130.64 18.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.791 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 46' ' ' VAL . 14.4 t -126.55 159.75 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.478 ' N ' HG12 ' A' ' 45' ' ' VAL . 10.8 p -121.16 129.45 75.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.062 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.99 159.05 42.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.9 mt -124.18 152.97 42.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -127.07 10.95 6.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.438 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 55.21 40.1 31.58 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.779 0.323 . . . . 0.0 110.997 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.4 121.38 4.4 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.91 -28.85 3.63 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.21 -170.57 3.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.903 0.382 . . . . 0.0 110.908 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.623 ' HB3' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -124.06 177.64 5.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 pm0 -100.37 26.22 6.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 54' ' ' LYS . 16.2 m -99.06 79.71 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.183 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 58' ' ' ARG . 17.4 t -102.18 160.17 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.962 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.479 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -128.32 177.22 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.447 ' O ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -160.11 -160.46 0.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.653 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -112.55 113.14 25.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 111.102 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.011 HD11 HG11 ' A' ' 115' ' ' VAL . 4.9 mt -90.26 -57.62 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.651 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.478 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 69.9 m-85 -119.18 87.54 35.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.603 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.37 115.34 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.673 2.249 . . . . 0.0 112.624 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.05 19.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.788 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.462 ' C ' HD12 ' A' ' 66' ' ' LEU . 25.3 m-85 -138.03 147.82 44.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.069 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 65' ' ' TYR . 3.9 mp -145.5 112.91 6.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.474 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.844 ' CD2' HD12 ' A' ' 112' ' ' ILE . 5.1 m-85 -84.96 126.13 33.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.86 0.362 . . . . 0.0 111.201 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -130.36 115.61 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 1.9 tp-100 -79.75 71.73 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.932 0.396 . . . . 0.0 110.354 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.698 ' HE2' HD21 ' A' ' 72' ' ' LEU . 4.6 ptm -91.56 -177.93 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' OD1' HG22 ' A' ' 3' ' ' ILE . 22.8 t70 -121.51 82.84 1.99 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.728 HD22 ' HB3' ' A' ' 78' ' ' PRO . 13.7 mt -117.66 -37.44 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.887 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.42 106.68 0.71 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.516 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -162.71 -67.46 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.005 0.431 . . . . 0.0 110.843 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 179.69 -38.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.316 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -77.89 -154.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.597 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -131.82 149.0 72.17 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.773 0.32 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.728 ' HB3' HD22 ' A' ' 72' ' ' LEU . 61.0 Cg_endo -72.21 108.1 2.41 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.697 2.264 . . . . 0.0 112.275 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -90.15 -77.13 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.185 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.506 ' HB3' HD11 ' A' ' 31' ' ' LEU . 13.5 mt-10 -54.06 -64.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.604 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.723 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -47.59 -32.85 5.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.853 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.401 ' CE3' ' HA ' ' A' ' 82' ' ' TRP . 4.7 t-105 -87.44 -29.23 21.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.141 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.81 -29.55 70.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.0 -49.25 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.083 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 81' ' ' ALA . 37.3 t -60.15 -41.24 85.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.158 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.33 -21.85 60.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.02 10.3 37.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.114 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.22 135.93 29.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.814 0.307 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.56 120.6 8.5 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.077 . . . . 0.0 112.258 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.24 -8.96 9.6 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.944 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 91' ' ' ILE . 7.8 tp -79.86 79.64 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 111.082 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -60.95 -43.89 98.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.95 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -166.07 -135.7 1.89 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.561 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -148.99 -176.23 5.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.79 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.912 HG21 ' HB ' ' A' ' 102' ' ' VAL . 38.3 t -54.73 -68.64 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 115.1 28.63 2.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.595 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.62 100.89 4.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.892 0.377 . . . . 0.0 111.014 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.61 -82.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.335 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.2 mtp -100.02 166.42 11.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.753 0.311 . . . . 0.0 110.623 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -68.69 -47.96 32.53 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.934 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 17.1 Cg_exo -66.92 -179.53 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.647 2.232 . . . . 0.0 112.151 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.912 ' HB ' HG21 ' A' ' 95' ' ' VAL . 7.3 p -160.12 81.86 2.3 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.9 124.7 9.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.193 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.633 ' H ' HD22 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -78.68 172.19 14.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.774 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 109' ' ' VAL . 79.0 p -90.17 147.78 37.78 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.797 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -50.82 -29.39 26.25 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.605 2.204 . . . . 0.0 112.261 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.91 -42.43 39.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -74.02 -38.27 64.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.898 HG11 ' CD1' ' A' ' 5' ' ' TRP . 40.1 t -59.07 -42.53 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -57.54 -31.37 66.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.954 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -70.04 -56.08 7.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.844 HD12 ' CD2' ' A' ' 67' ' ' PHE . 21.8 pt -63.56 -24.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.91 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.9 mp -72.71 -38.9 67.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.721 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.18 -33.03 67.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 1.011 HG11 HD11 ' A' ' 61' ' ' LEU . 13.0 t -79.37 -37.13 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.847 ' OG ' HD12 ' A' ' 39' ' ' LEU . 8.2 t -58.46 -63.5 1.26 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.858 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 150.66 54.94 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.537 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.91 HD12 ' HG ' ' A' ' 113' ' ' LEU . 17.6 mt -133.02 -54.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 0.0 110.83 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.37 -31.36 13.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.405 -1.219 . . . . 0.0 112.535 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.789 0.328 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.724 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -135.6 -165.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.36 150.14 24.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.177 0.513 . . . . 0.0 112.232 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.771 ' CD1' HG11 ' A' ' 109' ' ' VAL . 75.1 m95 -86.09 92.43 8.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.446 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.804 ' CE2' HD12 ' A' ' 72' ' ' LEU . 40.1 m-85 -84.23 114.53 21.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.403 . . . . 0.0 110.87 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.28 154.73 19.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.567 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 66' ' ' LEU . 13.8 m -142.35 179.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.696 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 16.1 m-70 -130.75 149.86 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.2 p -145.96 -173.84 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.83 149.83 22.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.6 p -71.45 124.45 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -24.77 27.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.624 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.54 -22.73 17.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.0 111.077 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -54.49 -35.56 63.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.19 -30.97 68.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.91 -28.84 18.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -42.05 81.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.094 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HG3' HG21 ' A' ' 40' ' ' ILE . 2.6 tmtt? -59.77 -38.21 81.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.17 -44.93 28.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -60.75 -35.08 75.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 85' ' ' VAL . 67.5 tp -73.78 -57.91 3.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -29.71 15.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.76 -41.94 71.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.75 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HD3' HG22 ' A' ' 88' ' ' THR . 3.1 mpt_? -70.23 -36.89 74.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.89 ' HA ' HD12 ' A' ' 31' ' ' LEU . 29.8 mm -74.5 -29.41 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.93 -36.6 14.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.177 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.95 -44.74 72.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.32 -26.62 35.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.63 70.43 1.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.497 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 26' ' ' ILE . 2.2 mt -123.3 38.93 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.388 . . . . 0.0 110.857 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.2 -1.12 24.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.538 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.72 -25.22 41.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.826 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -55.05 2.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.677 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.458 HD13 ' CB ' ' A' ' 70' ' ' MET . 26.4 mm -82.99 127.92 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.636 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 3' ' ' ILE . 23.3 m-85 -120.57 -64.85 1.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -102.89 122.29 44.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.433 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 38' ' ' VAL . 6.6 m -114.83 77.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.607 HD23 ' OG ' ' A' ' 116' ' ' SER . 2.6 tm? -91.76 127.59 37.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.95 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 42' ' ' THR . 3.4 pt -102.67 128.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 78.1 Cg_exo -52.2 69.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.991 2.461 . . . . 0.0 113.216 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 40' ' ' ILE . 68.2 p -158.98 136.18 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.525 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -104.1 105.78 16.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.38 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.3 135.88 44.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.31 122.89 54.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 46' ' ' VAL . 16.5 t -110.89 30.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -176.08 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.42 -169.55 3.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.842 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -170.54 2.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.804 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.81 88.52 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -157.57 -117.35 0.52 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.484 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -163.33 41.0 0.33 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.41 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -142.77 157.73 44.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.925 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.94 138.11 31.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.61 -169.33 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 56' ' ' VAL . 10.6 p -144.97 109.41 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.3 t -144.22 159.89 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.975 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.479 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -147.94 139.41 23.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.064 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -117.63 121.03 39.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.533 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -67.2 117.63 9.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.042 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.689 ' CD1' HG21 ' A' ' 115' ' ' VAL . 11.0 mt -81.81 -52.71 6.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.742 ' CE1' HG22 ' A' ' 112' ' ' ILE . 2.9 m-85 -129.91 86.89 53.53 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.5 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 147.99 89.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.788 2.325 . . . . 0.0 112.596 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.6 9.1 64.54 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.078 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 22.4 m-85 -119.08 161.97 19.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.977 0.417 . . . . 0.0 111.058 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -154.49 112.56 3.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.415 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CD1' HD11 ' A' ' 104' ' ' LEU . 5.9 m-85 -89.44 122.23 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.982 0.42 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER -129.25 110.49 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.999 179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.74 74.87 6.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.301 179.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.458 ' CB ' HD13 ' A' ' 35' ' ' ILE . 20.9 ptm -91.36 -173.19 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.136 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -126.7 82.86 2.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.804 HD12 ' CE2' ' A' ' 6' ' ' TYR . 62.5 mt -90.78 7.39 39.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.497 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.82 92.58 1.22 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.549 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -152.44 -46.3 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.335 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -152.29 -176.85 5.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.994 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.08 -32.64 74.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.93 148.5 35.68 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.83 139.32 36.25 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.634 2.223 . . . . 0.0 112.26 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.54 178.54 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 84' ' ' VAL . 4.2 pt-20 -58.93 -23.61 61.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.59 -49.33 67.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.328 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -66.3 -35.09 79.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -60.24 -31.44 70.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.822 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 88' ' ' THR . 21.8 t -85.09 -46.96 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 81' ' ' ALA . 36.3 t -59.8 -49.32 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -70.82 -18.1 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.031 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.02 -22.67 44.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.793 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 84' ' ' VAL . 54.4 p -54.1 108.38 1.12 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.586 0.231 . . . . 0.0 111.079 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.27 119.27 5.2 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.77 15.86 19.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.704 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -113.67 121.5 65.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.833 0.349 . . . . 0.0 110.926 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.62 ' N ' HD13 ' A' ' 91' ' ' ILE . 1.4 m -80.17 -64.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.826 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.13 157.95 21.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.595 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 63.66 -169.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.473 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 10.4 m -90.0 -29.74 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.16 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 115.27 -52.12 0.68 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.433 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.92 -30.32 65.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -95.93 -133.52 7.53 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.562 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.1 mtp -148.52 -64.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.57 155.32 92.66 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.863 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.12 178.87 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.627 2.218 . . . . 0.0 112.078 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.37 96.76 8.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.295 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.87 125.55 12.22 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.377 2.052 . . . . 0.0 112.207 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.731 HD11 ' CD1' ' A' ' 67' ' ' PHE . 1.2 mt -60.69 158.87 11.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.044 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.2 m -89.96 147.36 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.864 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.89 -31.31 42.38 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.661 2.241 . . . . 0.0 112.436 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -31.38 69.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.974 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.09 -31.08 13.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 105' ' ' SER . 22.0 t -66.39 -29.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.213 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -39.38 93.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -52.28 29.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.566 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.742 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.0 pp -65.06 -21.4 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.69 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.729 HD22 HD12 ' A' ' 118' ' ' LEU . 7.5 mt -69.05 -34.8 75.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.906 0.384 . . . . 0.0 110.31 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -59.66 -22.07 61.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.994 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.689 HG21 ' CD1' ' A' ' 61' ' ' LEU . 23.6 t -73.89 -56.58 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.243 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.607 ' OG ' HD23 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -51.4 -48.46 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.06 21.01 3.57 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.808 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.729 HD12 HD22 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -83.67 -27.7 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.709 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.19 -42.06 4.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.813 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.473 -179.948 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.821 0.343 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -141.68 -165.29 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -157.88 152.11 24.49 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.217 0.532 . . . . 0.0 111.789 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.779 ' CD1' HG11 ' A' ' 109' ' ' VAL . 87.1 m95 -94.97 92.72 7.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.568 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.945 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 40.1 m-85 -81.48 113.13 19.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 110.786 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -93.84 146.68 23.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.445 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.2 p -123.34 159.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.727 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.694 ' HD1' HG13 ' A' ' 95' ' ' VAL . 5.1 m170 -117.27 103.39 10.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.933 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 p -110.08 -174.29 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.96 150.99 21.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -71.35 126.48 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.65 -25.11 26.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.575 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.74 -23.54 16.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.064 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -55.48 -33.43 63.68 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.059 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.87 -34.74 68.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.07 -28.49 20.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.998 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.57 56.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.093 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.736 ' HB3' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -60.1 -38.51 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -179.973 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -47.27 79.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.022 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -61.62 -32.02 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.576 HD11 HG22 ' A' ' 85' ' ' VAL . 64.2 tp -76.17 -57.65 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -28.94 10.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.47 -41.63 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -37.7 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.822 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.798 HG23 ' HB2' ' A' ' 31' ' ' LEU . 35.0 mm -72.53 -30.41 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -89.81 -33.72 16.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.7 -40.01 66.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -84.91 -26.73 27.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.984 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.2 47.51 3.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.798 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.5 mt -99.92 40.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.852 0.358 . . . . 0.0 110.888 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.25 -6.38 49.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.406 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.81 -26.12 40.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.34 . . . . 0.0 110.995 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.648 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -95.53 -55.38 3.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.715 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.41 HG23 ' CG2' ' A' ' 68' ' ' ILE . 11.1 mm -88.2 122.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.81 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.494 ' CE2' HG21 ' A' ' 3' ' ' ILE . 10.3 m-85 -112.68 -54.37 2.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.454 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 mm100 -111.4 156.5 21.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.131 0.491 . . . . 0.0 111.774 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.544 HG22 HG23 ' A' ' 68' ' ' ILE . 38.5 t -156.4 75.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.122 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.734 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.5 mm? -91.04 168.06 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.712 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.719 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -123.25 139.41 31.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.805 179.597 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 72.3 Cg_endo -77.1 86.4 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.711 2.274 . . . . 0.0 113.202 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.797 ' O ' HG12 ' A' ' 115' ' ' VAL . 24.3 p -138.07 128.97 27.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.14 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.614 ' HA ' ' CG1' ' A' ' 115' ' ' VAL . 1.1 tt0 -91.27 22.11 4.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.285 0.564 . . . . 0.0 112.098 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.607 ' HB3' ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -160.83 164.59 31.25 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.395 179.439 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 46' ' ' VAL . 1.9 t -144.62 168.7 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.25 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.529 ' H ' HG12 ' A' ' 45' ' ' VAL . 9.3 p -127.06 126.7 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.49 -177.26 6.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mt -82.37 139.53 34.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.15 60.82 1.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.788 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -135.88 -69.08 0.49 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.03 42.76 1.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.45 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.2 -81.19 0.12 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -160.04 152.82 21.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.07 108.63 13.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.8 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -157.21 170.54 22.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 46' ' ' VAL . 21.8 t -153.94 -38.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.76 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 44' ' ' GLU . 29.3 m -156.1 -173.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.7 0.286 . . . . 0.0 111.003 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.607 ' HA ' ' HB3' ' A' ' 44' ' ' GLU . 10.2 mtt180 -122.74 146.08 47.83 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.053 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -112.6 82.68 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.362 179.828 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 41' ' ' PRO . 54.3 mttt -48.53 108.67 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.691 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 43' ' ' GLU . 71.1 mt -79.6 -31.88 41.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.471 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 26.7 m-85 -132.06 69.62 80.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.434 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.01 134.6 60.52 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.681 2.254 . . . . 0.0 112.608 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.31 -2.37 82.03 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.06 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.485 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 3.1 m-85 -106.26 110.87 23.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.946 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -101.27 122.28 43.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.488 179.714 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.728 ' CD2' HD12 ' A' ' 112' ' ' ILE . 12.9 m-85 -89.66 119.68 30.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.2 mp -127.73 106.8 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 8.2 tt0 -79.83 72.99 6.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.434 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -91.11 -174.83 4.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.194 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.459 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 3.9 t0 -131.01 110.36 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.945 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 34.8 mt -104.72 -34.32 8.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.49 -71.73 2.88 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -124.42 167.89 13.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.873 0.368 . . . . 0.0 111.0 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -97.78 -23.6 15.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.065 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -54.27 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.087 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -113.25 93.54 26.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.957 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.45 166.42 2.57 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.556 2.171 . . . . 0.0 112.235 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -83.52 173.28 11.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 84' ' ' VAL . 11.6 pt-20 -59.15 -25.44 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.04 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.812 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -55.48 -42.63 74.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.213 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -63.67 -44.01 95.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -58.95 -37.57 77.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -72.83 -45.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 81' ' ' ALA . 26.9 t -64.34 -41.04 91.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -22.84 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.036 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.79 -24.27 30.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.86 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 84' ' ' VAL . 78.0 p -58.2 115.99 13.22 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.57 0.224 . . . . 0.0 110.899 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.46 131.07 39.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.411 2.074 . . . . 0.0 112.293 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.76 -5.14 59.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.836 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 88' ' ' THR . 5.3 tp -79.94 108.06 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.979 0.418 . . . . 0.0 111.201 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 m -113.73 93.27 4.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.754 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.56 112.54 5.07 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.628 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.475 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 1.5 t80 61.85 152.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.938 0.399 . . . . 0.0 111.045 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.694 HG13 ' HD1' ' A' ' 9' ' ' HIS . 12.6 m -57.2 -30.54 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.0 64.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.362 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.83 100.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.801 0.334 . . . . 0.0 111.149 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.77 -132.4 11.24 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.552 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.66 150.1 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.749 0.309 . . . . 0.0 110.85 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.508 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 71.1 mtt85 -68.0 -57.18 9.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 51.4 Cg_endo -68.77 136.44 35.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.443 2.096 . . . . 0.0 112.248 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.1 p -135.78 87.31 25.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.979 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.22 130.38 23.94 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.53 2.154 . . . . 0.0 112.222 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mt -79.16 163.95 24.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.917 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.0 t -86.82 140.81 33.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.8 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.78 -30.5 23.2 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 0.0 112.529 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -43.07 73.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.18 -30.53 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 105' ' ' SER . 26.4 t -61.29 -44.11 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -29.03 69.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.701 ' O ' HG23 ' A' ' 115' ' ' VAL . 11.6 m-70 -76.29 -45.33 33.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.786 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.728 HD12 ' CD2' ' A' ' 67' ' ' PHE . 20.0 pt -71.88 -26.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.882 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.912 HD22 HD12 ' A' ' 118' ' ' LEU . 70.8 mt -76.86 -36.26 56.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.397 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -66.65 -27.45 67.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 42' ' ' THR . 25.3 t -77.19 -41.98 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.734 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -57.55 -62.24 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.074 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.467 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 151.08 44.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.559 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.912 HD12 HD22 ' A' ' 113' ' ' LEU . 7.6 mt -119.59 -52.87 2.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.876 0.369 . . . . 0.0 110.807 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -31.07 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.496 179.98 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.831 0.348 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.694 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -137.52 -169.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.796 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -141.19 151.57 43.91 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.283 0.563 . . . . 0.0 112.068 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.524 ' O ' HD12 ' A' ' 104' ' ' LEU . 84.6 m95 -98.92 93.61 6.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.704 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 50.5 m-85 -85.51 126.07 33.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.886 0.374 . . . . 0.0 110.772 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -105.69 142.2 35.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.598 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.71 150.67 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.629 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 95' ' ' VAL . 11.5 m-70 -94.25 147.88 22.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.969 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -141.01 177.06 8.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.01 141.38 28.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 12' ' ' VAL . 6.0 m -70.17 104.89 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.41 -27.44 5.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -101.89 -17.39 16.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 111.206 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.52 -38.73 64.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.103 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -42.63 73.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.027 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.943 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.06 92.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -56.55 20.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.57 98.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -60.55 -43.23 97.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 tp -72.62 -48.79 36.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.716 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -58.54 -24.76 61.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.072 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -81.82 -44.56 16.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HG3' HG22 ' A' ' 88' ' ' THR . 8.3 mmt85 -68.84 -24.99 64.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.204 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -69.45 -28.83 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 179.737 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.45 -33.65 15.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.82 66.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.063 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -79.94 -37.81 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.23 65.26 0.84 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.739 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 35' ' ' ILE . 1.1 pt? -149.57 27.73 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 0.0 110.881 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -11.71 61.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.212 179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 36' ' ' PHE . 1.3 m-20 -79.7 -29.66 40.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.824 0.345 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -77.16 -49.84 14.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.411 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.773 HD11 HD12 ' A' ' 31' ' ' LEU . 4.1 mp -84.78 109.05 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.694 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.1 m-85 -94.08 -52.77 4.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.439 -179.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.415 ' HG3' ' NE2' ' A' ' 69' ' ' GLN . 2.0 mt-30 -111.99 156.36 22.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 0.0 111.79 -179.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.857 HG12 HG23 ' A' ' 68' ' ' ILE . 3.9 m -153.1 74.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.967 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.926 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.2 mm? -85.57 142.29 29.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.535 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.516 HG22 HG23 ' A' ' 42' ' ' THR . 3.7 mp -97.04 127.56 38.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.604 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 26.1 Cg_endo -62.18 75.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.554 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.693 HG22 ' HG2' ' A' ' 60' ' ' LYS . 60.8 p -137.35 142.44 41.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.586 ' HA ' HG12 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -91.27 109.39 20.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.818 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -95.7 128.43 42.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.943 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 45' ' ' VAL . 27.4 m -132.3 117.52 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.5 m -141.79 144.26 25.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -152.95 165.92 34.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.659 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 48' ' ' LEU . 2.0 pp -139.93 39.5 1.98 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.986 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.1 165.25 11.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.86 90.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.49 -121.4 6.73 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.472 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.85 -44.86 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.44 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 2.3 mtmt -159.93 173.48 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.846 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.7 -169.25 1.49 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -93.18 129.82 39.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 56' ' ' VAL . 27.1 m -98.76 110.47 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.125 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.65 159.71 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 125.3 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.004 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.2 ptmt -112.58 175.83 5.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.693 ' HG2' HG22 ' A' ' 42' ' ' THR . 4.1 mmtm -92.61 121.7 34.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.772 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.0 mt -79.23 -49.51 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.728 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.458 ' CE1' HG22 ' A' ' 112' ' ' ILE . 35.6 m-85 -102.06 97.89 9.18 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.41 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.49 124.46 16.34 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.547 2.165 . . . . 0.0 112.509 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.71 42.97 99.58 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.83 151.58 48.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.985 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 11.3 mt -147.09 114.23 6.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.666 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD2' HD13 ' A' ' 112' ' ' ILE . 8.4 m-85 -90.33 123.15 33.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 38' ' ' VAL . 1.2 mp -128.47 113.93 31.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.451 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 4.5 tt0 -80.87 72.88 7.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.467 ' SD ' HD21 ' A' ' 72' ' ' LEU . 21.5 ptp -91.35 -169.36 2.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.99 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.57 80.2 1.82 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.771 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.704 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 80.5 mt -83.39 -71.55 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.74 26.09 16.55 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.657 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.16 137.91 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.777 0.322 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.92 -33.75 14.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.31 -77.65 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.28 117.08 6.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.783 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HB3' HD22 ' A' ' 72' ' ' LEU . 18.4 Cg_exo -65.67 66.64 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.65 2.234 . . . . 0.0 112.192 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -55.7 -171.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 60.03 -82.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.945 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -58.43 -41.04 84.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -83.61 -30.16 27.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -61.62 -31.8 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 80' ' ' GLU . 32.8 t -82.57 -44.32 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 81' ' ' ALA . 35.9 t -60.54 -49.98 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.56 -24.52 61.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.28 -16.72 70.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.827 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -79.0 120.33 80.41 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.802 0.301 . . . . 0.0 110.7 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.26 -14.18 43.13 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.475 2.117 . . . . 0.0 112.479 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.56 25.67 21.81 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.626 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.593 HD13 ' N ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -113.51 123.85 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.349 . . . . 0.0 110.873 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.593 ' N ' HD13 ' A' ' 91' ' ' ILE . 5.1 m -151.0 108.75 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.999 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.87 -91.87 0.12 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.425 ' N ' ' HB2' ' A' ' 9' ' ' HIS . 59.3 t80 59.52 159.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.886 0.374 . . . . 0.0 110.847 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.434 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 21.2 t -63.62 139.27 21.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.241 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.72 44.92 2.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.448 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.92 -47.34 3.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.921 0.391 . . . . 0.0 111.152 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.57 -126.84 0.89 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.506 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.67 -35.53 4.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 0.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -82.91 147.76 55.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.96 163.95 31.73 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.538 2.159 . . . . 0.0 112.17 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 t -125.41 116.41 25.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.27 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.32 171.38 17.83 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.452 2.101 . . . . 0.0 112.16 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.592 ' HB2' HG22 ' A' ' 109' ' ' VAL . 3.2 mp -89.88 157.42 17.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.895 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.859 ' O ' HG23 ' A' ' 109' ' ' VAL . 7.0 m -80.36 150.67 71.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.2 -31.58 22.3 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.598 2.199 . . . . 0.0 112.43 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.89 -45.32 24.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.09 -32.58 69.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 105' ' ' SER . 72.0 t -61.87 -52.41 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.008 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -24.62 66.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.731 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -76.93 -51.27 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.683 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.608 HD13 ' CD2' ' A' ' 67' ' ' PHE . 2.2 pp -69.78 -15.62 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.823 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.855 ' HG ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.04 -36.31 35.94 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.682 179.477 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -80.56 -34.88 35.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.772 HG11 ' CD1' ' A' ' 61' ' ' LEU . 27.8 t -75.38 -46.35 38.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.004 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.926 ' HB3' HD12 ' A' ' 39' ' ' LEU . 72.4 m -60.75 -51.17 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.689 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.47 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.43 64.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.627 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.855 HD12 ' HG ' ' A' ' 113' ' ' LEU . 21.8 mt -136.74 -49.48 0.64 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.891 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -51.99 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.854 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.333 -1.259 . . . . 0.0 112.482 -179.967 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.945 0.402 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.53 -177.41 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -160.05 160.79 33.59 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 112.134 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.666 ' HH2' HD23 ' A' ' 39' ' ' LEU . 89.6 m95 -91.76 90.87 7.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.706 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.967 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 58.5 m-85 -83.67 108.72 16.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.94 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.11 148.87 27.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.905 HG12 ' HA3' ' A' ' 96' ' ' GLY . 26.9 m -140.44 -178.9 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.072 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.451 ' ND1' ' CD2' ' A' ' 94' ' ' PHE . 27.9 m-70 -107.94 137.38 46.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -130.9 -178.62 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.73 120.44 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.2 p -58.5 119.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.072 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.35 -28.83 11.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -0.34 43.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.582 0.23 . . . . 0.0 111.31 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -47.57 -43.32 25.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.823 0.344 . . . . 0.0 111.224 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -37.89 66.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.018 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.6 -28.49 20.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.794 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.11 -61.06 2.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB3' HD11 ' A' ' 66' ' ' LEU . 2.1 pttp -63.02 -38.62 91.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.741 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.86 94.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.45 -39.41 93.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.636 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.694 ' CD1' HG21 ' A' ' 88' ' ' THR . 64.1 tp -66.47 -51.89 52.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.69 -31.58 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.0 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -71.31 -41.86 69.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.672 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -70.5 -37.21 74.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.66 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.745 HD12 HD11 ' A' ' 31' ' ' LEU . 41.4 mm -70.07 -30.35 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.849 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -88.58 -33.32 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.54 72.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -80.9 -35.56 32.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 85.96 1.27 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.69 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -153.09 48.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.821 179.793 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -72.31 -7.77 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.358 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 3.4 p-10 -79.62 -20.16 47.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.956 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -96.05 -55.55 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.614 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 HG21 ' A' ' 26' ' ' ILE . 32.6 mt -91.36 130.87 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.738 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 3' ' ' ILE . 20.5 m-85 -121.57 -54.8 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.717 -179.369 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.45 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 1.6 mm100 -117.12 158.38 24.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.0 112.345 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.746 HG22 HG23 ' A' ' 68' ' ' ILE . 38.8 t -157.18 83.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.84 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.666 HD23 ' HH2' ' A' ' 5' ' ' TRP . 4.6 mm? -95.94 164.0 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.274 0.559 . . . . 0.0 112.207 -178.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.753 HG22 ' HG ' ' A' ' 66' ' ' LEU . 1.3 pp -143.83 69.93 16.82 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.094 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HG2' ' CE2' ' A' ' 67' ' ' PHE . 72.5 Cg_exo -41.07 115.45 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.273 2.649 . . . . 0.0 113.749 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.448 HG23 HD12 ' A' ' 40' ' ' ILE . 17.2 p -124.86 162.91 23.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.052 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 58' ' ' ARG . 1.8 tm-20 -79.8 131.28 35.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.78 0.324 . . . . 0.0 110.647 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' O ' HG13 ' A' ' 45' ' ' VAL . 45.4 mt-10 -135.43 117.17 15.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 44' ' ' GLU . 5.4 m -154.82 159.83 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.311 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.514 HG11 ' HD2' ' A' ' 49' ' ' ARG . 11.2 p -100.13 154.01 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.064 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -104.03 -66.95 0.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.938 179.938 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.19 128.13 37.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.514 ' HD2' HG11 ' A' ' 46' ' ' VAL . 4.3 ttt-85 -156.26 31.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.964 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -111.81 -65.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.95 76.75 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.562 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.62 -60.4 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.2 176.2 11.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.302 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -137.59 109.86 7.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -122.81 -177.75 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 56' ' ' VAL . 8.5 p -160.12 104.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.005 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 58' ' ' ARG . 1.5 p -87.63 158.47 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.134 0.493 . . . . 0.0 111.038 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.47 ' N ' ' CG2' ' A' ' 57' ' ' VAL . 66.6 mtp180 -140.93 151.4 44.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.158 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.423 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.4 mtpt -141.43 -154.07 0.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.426 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.97 119.71 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.739 ' CD1' HG11 ' A' ' 115' ' ' VAL . 14.3 mt -83.25 -42.61 17.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.364 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 41' ' ' PRO . 26.7 m-85 -122.99 74.32 48.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.873 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.95 142.8 93.52 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.596 2.197 . . . . 0.0 112.246 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.31 25.23 18.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.625 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.96 112.58 10.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.753 ' HG ' HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -113.7 130.08 56.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 -179.967 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.988 ' CE2' HD12 ' A' ' 112' ' ' ILE . 13.8 m-30 -92.48 130.9 38.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.723 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.746 HG23 HG22 ' A' ' 38' ' ' VAL . 1.2 mp -130.39 111.46 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.211 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -79.72 70.86 6.31 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 ptm -91.55 -175.84 4.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.293 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -124.11 86.86 2.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.967 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 13.2 mt -79.87 -32.93 40.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.989 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.37 -104.95 3.2 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.579 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -123.15 -169.55 1.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.838 0.351 . . . . 0.0 111.022 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.17 -18.77 63.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.31 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.22 -174.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.868 0.366 . . . . 0.0 111.157 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.91 140.6 54.28 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.785 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.33 173.5 14.39 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.457 2.105 . . . . 0.0 112.436 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -89.99 -165.65 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.589 ' OE2' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -57.7 -24.0 54.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -51.89 -44.62 63.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.369 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.9 t-105 -73.56 -30.19 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -37.7 86.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 88' ' ' THR . 34.8 t -70.06 -40.18 78.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 81' ' ' ALA . 34.4 t -67.14 -45.63 86.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -63.23 -17.92 62.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.169 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.98 -28.32 8.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.796 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.694 HG21 ' CD1' ' A' ' 22' ' ' LEU . 16.3 p -58.75 155.84 28.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.24 -25.29 31.15 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.51 -26.24 51.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.59 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.602 HG23 ' CA ' ' A' ' 97' ' ' ALA . 47.0 mm -90.99 124.62 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 111.104 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.73 -57.81 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.896 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.06 100.2 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.39 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.48 ' N ' ' HB3' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -170.51 -159.01 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.465 0.174 . . . . 0.0 110.756 -179.775 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.732 ' CG1' HG23 ' A' ' 102' ' ' VAL . 41.0 t -42.63 -74.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.743 0.306 . . . . 0.0 111.805 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.905 ' HA3' HG12 ' A' ' 8' ' ' VAL . . . -91.13 0.17 75.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.645 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.602 ' CA ' HG23 ' A' ' 91' ' ' ILE . . . -95.67 35.98 1.32 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.805 0.336 . . . . 0.0 111.099 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 152.19 -48.07 0.55 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.441 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -94.04 -178.57 4.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.701 0.286 . . . . 0.0 110.828 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 -58.9 109.21 1.7 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.41 ' HA ' HG12 ' A' ' 95' ' ' VAL . 38.0 Cg_exo -57.25 172.07 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.519 2.146 . . . . 0.0 112.309 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.732 HG23 ' CG1' ' A' ' 95' ' ' VAL . 31.3 t -128.95 122.97 21.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.22 142.59 15.23 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.529 2.153 . . . . 0.0 112.405 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' A' ' 112' ' ' ILE . 2.0 mt -74.54 168.96 18.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -89.79 142.83 29.44 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.93 179.935 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.01 -51.24 11.29 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.569 2.179 . . . . 0.0 112.615 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -56.95 -28.19 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.124 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -89.99 -36.29 15.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 105' ' ' SER . 30.3 t -57.42 -33.13 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.361 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -27.98 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.052 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.448 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -82.96 -34.59 26.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.904 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.988 HD12 ' CE2' ' A' ' 67' ' ' PHE . 15.2 pt -81.48 -19.11 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.122 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.071 HD22 HD12 ' A' ' 118' ' ' LEU . 29.9 mt -84.99 -25.08 27.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.719 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.35 -32.91 58.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.739 HG11 ' CD1' ' A' ' 61' ' ' LEU . 22.6 t -77.81 -37.47 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.182 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -57.54 -52.86 63.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.87 38.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.897 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.071 HD12 HD22 ' A' ' 113' ' ' LEU . 15.8 mt -117.72 -55.68 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.34 -42.82 14.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.433 -1.204 . . . . 0.0 112.516 179.994 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.844 0.354 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.732 HD13 ' HG2' ' A' ' 69' ' ' GLN . 2.0 pp -136.7 170.84 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -154.96 165.77 35.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.924 ' CD1' HG11 ' A' ' 109' ' ' VAL . 92.4 m95 -86.56 91.34 8.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.727 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.767 ' O ' HD12 ' A' ' 68' ' ' ILE . 79.8 m-85 -87.08 116.42 25.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.422 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -103.5 146.84 27.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.023 0.439 . . . . 0.0 111.763 -179.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 1.3 p -117.13 159.33 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.584 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.677 ' CB ' HG13 ' A' ' 95' ' ' VAL . 2.1 m-70 -107.01 142.21 37.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.932 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.5 p -155.12 174.8 14.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.81 162.35 15.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.971 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.62 125.85 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.72 -32.06 6.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.533 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.75 -30.72 36.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.564 ' CD ' HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -59.32 -37.19 77.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -59.97 -30.85 69.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.17 -29.88 21.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.83 -50.16 75.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HB3' HD21 ' A' ' 66' ' ' LEU . 4.7 ptmt -60.16 -43.05 96.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.34 -51.98 56.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.67 -31.01 72.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.716 HD11 HG22 ' A' ' 85' ' ' VAL . 60.2 tp -78.23 -56.55 4.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -48.97 -31.29 7.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.246 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -43.87 68.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.779 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -36.09 82.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.672 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.742 ' HA ' HD21 ' A' ' 31' ' ' LEU . 37.7 mm -64.84 -29.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.997 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.76 -31.38 14.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.52 68.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.528 ' CE2' HG13 ' A' ' 84' ' ' VAL . 15.3 m-85 -80.01 -34.46 38.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.35 59.0 1.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.641 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -122.66 47.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.809 179.938 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -65.69 -15.4 62.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.308 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.71 -2.34 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.414 ' O ' ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -113.13 -59.1 2.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.764 0.316 . . . . 0.0 110.777 179.853 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.607 HG13 HD12 ' A' ' 26' ' ' ILE . 30.1 mm -79.95 120.29 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.719 ' CE2' HG21 ' A' ' 3' ' ' ILE . 63.3 m-85 -116.03 -56.23 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.571 -179.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HB2' ' CB ' ' A' ' 69' ' ' GLN . 1.8 mm100 -112.95 156.17 23.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.247 0.546 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.816 HG22 HG23 ' A' ' 68' ' ' ILE . 24.8 t -154.89 79.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.137 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.853 HD21 HD11 ' A' ' 118' ' ' LEU . 3.5 mm? -87.29 157.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.518 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 40' ' ' ILE . 16.1 tt -111.15 120.37 43.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.926 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 30.6 Cg_endo -64.64 80.6 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.545 2.163 . . . . 0.0 112.877 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.445 HG23 HG12 ' A' ' 40' ' ' ILE . 11.4 p -131.0 146.05 52.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.823 ' HG3' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -95.82 169.35 10.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.113 -179.787 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -138.52 110.75 7.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.684 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.784 HG23 HG23 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -109.01 128.92 64.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.307 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 55' ' ' GLU . 7.6 p -155.38 105.27 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.906 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -118.45 143.43 46.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -149.75 164.84 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 -70.36 0.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.903 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -172.53 162.85 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.86 -103.54 2.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.531 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.07 31.1 0.31 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 mttp -109.5 127.2 54.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.924 0.393 . . . . 0.0 110.834 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -132.05 139.88 48.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -125.08 124.22 41.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.99 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.02 93.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.784 HG23 HG23 ' A' ' 45' ' ' VAL . 16.2 m -137.0 163.04 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -125.77 134.37 51.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.074 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.57 120.33 33.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.751 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.08 122.46 11.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.178 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.837 HD11 HG11 ' A' ' 115' ' ' VAL . 20.9 mt -80.64 -51.05 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.4 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 33.1 m-85 -111.11 89.65 10.18 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 65' ' ' TYR . 37.9 Cg_endo -66.69 128.39 18.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 22.87 73.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 63' ' ' PRO . 97.1 m-85 -129.44 139.78 51.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.701 0.286 . . . . 0.0 110.984 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' A' ' 19' ' ' LYS . 4.1 tp -130.89 134.57 46.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.726 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.5 m-85 -99.85 123.9 44.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.816 HG23 HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -134.28 112.9 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 179.882 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.732 ' HG2' HD13 ' A' ' 3' ' ' ILE . 19.5 tt0 -79.95 72.64 6.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.156 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.636 ' SD ' HD11 ' A' ' 72' ' ' LEU . 15.8 ptm -91.56 -173.47 3.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.375 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.717 ' CA ' HG22 ' A' ' 3' ' ' ILE . 32.8 t0 -119.22 99.64 6.83 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.922 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.636 HD11 ' SD ' ' A' ' 70' ' ' MET . 54.1 mt -129.15 6.51 5.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.31 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.93 64.94 1.21 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.525 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.55 114.49 27.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.373 . . . . 0.0 110.933 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -58.78 -29.33 66.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.958 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.22 -69.02 0.65 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 110.989 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -159.35 157.48 27.2 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.908 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.6 151.88 72.63 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.662 2.241 . . . . 0.0 112.176 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.402 ' CB ' ' HD3' ' A' ' 34' ' ' LYS . 1.3 m-80 -69.11 -175.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.018 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.86 -27.58 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.945 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.03 -29.02 27.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.345 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -74.81 -34.72 62.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.798 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -68.02 -31.5 71.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 88' ' ' THR . 21.7 t -76.99 -45.74 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.214 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 81' ' ' ALA . 37.9 t -59.01 -40.25 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.72 -12.97 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.325 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.95 -15.66 12.64 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.805 ' O ' HG22 ' A' ' 91' ' ' ILE . 40.2 p -57.4 112.01 4.14 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.736 0.268 . . . . 0.0 110.984 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.62 121.43 7.92 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.373 2.049 . . . . 0.0 112.299 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.26 -19.57 17.21 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.692 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -79.81 125.39 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 179.978 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -94.59 -29.65 14.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.63 -177.43 42.06 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.446 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.44 ' HA ' ' CD2' ' A' ' 9' ' ' HIS . 10.3 p90 -60.6 142.01 56.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 0.0 110.999 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.677 HG13 ' CB ' ' A' ' 9' ' ' HIS . 12.9 m -56.74 -32.81 39.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.191 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.64 -142.52 13.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.367 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 59.3 29.98 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.853 0.359 . . . . 0.0 111.122 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.51 -156.06 25.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.493 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.39 -67.8 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.795 0.331 . . . . 0.0 110.823 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -67.28 158.34 82.16 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.817 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.12 172.63 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.586 2.191 . . . . 0.0 112.133 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.97 80.04 1.66 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.413 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.414 ' HB3' ' CD1' ' A' ' 6' ' ' TYR . 76.2 Cg_endo -77.87 139.76 17.77 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.537 2.158 . . . . 0.0 112.265 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.628 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.6 OUTLIER -84.96 130.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.846 179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.907 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -64.32 150.26 93.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.84 -40.0 57.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.577 2.185 . . . . 0.0 112.383 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -31.24 72.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -87.64 -34.32 18.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.924 HG11 ' CD1' ' A' ' 5' ' ' TRP . 22.8 t -61.9 -31.73 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.303 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -64.33 -29.97 71.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.896 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.5 t60 -74.36 -47.4 34.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.806 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.726 HD12 ' CD2' ' A' ' 67' ' ' PHE . 17.1 pt -69.8 -27.38 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.033 HD22 HD12 ' A' ' 118' ' ' LEU . 14.2 mt -74.85 -34.28 62.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.512 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -70.23 -32.5 70.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.594 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.837 HG11 HD11 ' A' ' 61' ' ' LEU . 22.5 t -81.83 -33.3 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.634 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.6 OUTLIER -61.32 -63.63 1.22 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 179.888 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.586 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 145.44 44.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.698 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.033 HD12 HD22 ' A' ' 113' ' ' LEU . 12.6 mt -121.59 -45.44 2.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.749 0.309 . . . . 0.0 110.92 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.22 30.33 2.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.33 -1.261 . . . . 0.0 112.475 -179.957 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.922 0.391 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -137.14 -171.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.795 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -151.21 160.3 43.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.165 0.507 . . . . 0.0 111.88 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.896 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 90.0 m95 -93.96 119.8 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.774 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.964 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 22.3 m-85 -114.3 105.64 13.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.441 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -99.14 169.09 9.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.097 0.475 . . . . 0.0 111.724 -179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.649 HG11 HD12 ' A' ' 91' ' ' ILE . 2.4 p -156.26 161.41 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.57 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.506 ' CE1' ' CE2' ' A' ' 65' ' ' TYR . 5.8 m170 -93.43 157.07 16.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.108 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 p -150.35 -176.54 5.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.796 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.09 145.79 24.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.16 129.55 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.2 -23.97 31.0 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.618 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.68 -19.62 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.569 0.223 . . . . 0.0 111.167 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.45 -38.45 66.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.7 -36.61 72.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.947 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -24.83 21.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.025 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.24 -38.1 89.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.0 ptmm? -61.2 -35.15 76.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.93 -41.89 34.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -59.65 -34.88 73.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' HA ' HG21 ' A' ' 88' ' ' THR . 36.8 tp -77.31 -53.01 8.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -53.09 -35.37 59.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -63.42 -42.11 98.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.682 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HD3' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -66.17 -38.15 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 179.8 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.8 HG23 ' HB2' ' A' ' 31' ' ' LEU . 46.7 mm -64.06 -33.26 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -89.8 -33.81 16.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -40.4 77.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.07 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' CE2' ' HG3' ' A' ' 25' ' ' ARG . 29.3 m-85 -92.32 -24.81 18.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' C ' HD22 ' A' ' 31' ' ' LEU . . . 88.07 78.29 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.404 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.8 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.9 mm? -123.18 35.26 4.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.085 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.89 16.21 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.478 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.8 -12.88 15.71 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.52 0.2 . . . . 0.0 111.115 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 2.3 mptt -116.28 -44.23 2.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.321 . . . . 0.0 111.125 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.675 HD11 HG22 ' A' ' 38' ' ' VAL . 19.4 tt -82.2 153.06 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.195 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.661 ' CE2' HG21 ' A' ' 3' ' ' ILE . 28.9 m-85 -143.23 -52.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.903 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.431 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.9 mt-30 -120.33 146.52 46.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.0 0.429 . . . . 0.0 111.108 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.706 HG22 HG23 ' A' ' 68' ' ' ILE . 3.5 t -143.22 70.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.222 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.896 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -88.69 143.59 26.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.576 -179.121 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.512 HG12 HG23 ' A' ' 42' ' ' THR . 4.9 tt -108.58 123.58 36.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.231 -179.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 14.0 Cg_endo -57.84 87.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.659 2.24 . . . . 0.0 112.894 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.512 HG23 HG12 ' A' ' 40' ' ' ILE . 76.2 p -139.93 117.77 11.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.776 179.586 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' CD ' HD21 ' A' ' 61' ' ' LEU . 7.6 tt0 -81.98 172.13 13.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.001 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.88 135.18 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 46' ' ' VAL . 11.4 t -121.23 158.95 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' N ' HG12 ' A' ' 45' ' ' VAL . 21.4 t -149.26 118.41 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.14 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -80.22 -51.16 9.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.667 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD13 ' N ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -140.77 129.06 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.778 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.708 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -113.29 104.0 11.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.06 100.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.917 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 173.17 -90.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.564 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.62 -28.02 3.37 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.556 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -149.94 166.54 29.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.819 0.342 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -139.19 120.56 14.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -148.77 122.86 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.0 p -130.58 121.1 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.011 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.3 t -119.63 159.85 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.165 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.478 ' N ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -130.16 116.07 17.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -104.88 123.23 47.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.946 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -58.07 108.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.057 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.891 HD11 ' CG1' ' A' ' 115' ' ' VAL . 39.6 mt -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.474 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 3.3 m-85 -132.56 88.4 38.97 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.623 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.22 108.4 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.763 2.309 . . . . 0.0 112.857 -179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 47.82 9.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.848 179.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.506 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 62.6 m-85 -144.96 145.15 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.593 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.3 pp -150.61 120.27 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.413 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.963 ' CD2' HD13 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -96.25 126.88 41.77 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 111.366 -179.575 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -119.13 121.53 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.579 179.73 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -79.87 78.9 6.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.859 0.362 . . . . 0.0 110.712 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.517 ' SD ' HD11 ' A' ' 72' ' ' LEU . 20.3 ptp -91.0 -175.71 4.41 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.244 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 5.9 t0 -122.17 77.88 1.44 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.964 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 19.9 mt -95.21 -29.39 14.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.938 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.47 81.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.39 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -154.96 -66.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.991 0.424 . . . . 0.0 110.809 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.35 173.55 6.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.825 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.6 -17.07 60.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.245 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -139.71 96.37 8.51 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.09 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.38 104.74 1.91 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.666 2.244 . . . . 0.0 112.218 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.2 -167.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.7 OUTLIER 56.47 -85.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.52 179.609 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.823 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.41 -44.95 69.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.591 -179.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.411 ' HA ' ' CE3' ' A' ' 82' ' ' TRP . 2.0 t-105 -74.81 -30.51 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.119 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.94 -30.16 69.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.748 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 80' ' ' GLU . 23.1 t -84.57 -48.7 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.045 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 81' ' ' ALA . 36.8 t -59.72 -49.61 83.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.48 -22.41 66.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.247 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.38 -22.45 24.47 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.83 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.632 HG22 ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -65.24 145.73 99.04 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 110.93 -179.878 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.77 -25.59 28.37 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.469 2.113 . . . . 0.0 112.301 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.38 -28.17 54.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.485 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.649 HD12 HG11 ' A' ' 8' ' ' VAL . 35.6 mm -89.06 126.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 110.847 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 m -164.03 66.13 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.84 -95.37 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.56 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 91' ' ' ILE . 13.1 m-85 62.49 138.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 0.0 110.76 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.752 HG23 HG21 ' A' ' 102' ' ' VAL . 39.6 t -79.68 141.38 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.2 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.95 -24.87 61.0 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.702 ' H ' HG12 ' A' ' 95' ' ' VAL . . . -55.81 98.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.333 . . . . 0.0 111.151 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.34 -92.93 1.8 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.469 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.2 mmt -117.18 169.16 9.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.983 0.421 . . . . 0.0 110.955 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 1.3 mmp_? -62.44 -57.21 23.93 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.192 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 100' ' ' ARG . 18.4 Cg_endo -59.46 152.61 60.23 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.437 2.091 . . . . 0.0 112.064 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.752 HG21 HG23 ' A' ' 95' ' ' VAL . 5.7 t -120.35 82.18 31.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.191 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.3 115.6 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.38 2.053 . . . . 0.0 112.091 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -70.57 149.01 47.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.994 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.896 ' O ' HG23 ' A' ' 109' ' ' VAL . 56.3 m -87.49 148.31 43.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.88 -37.1 54.95 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.764 2.309 . . . . 0.0 112.458 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -68.93 -29.41 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.461 ' O ' HG23 ' A' ' 112' ' ' ILE . 3.5 tt0 -91.48 -32.18 15.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 105' ' ' SER . 24.3 t -64.28 -36.67 77.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.113 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.411 ' HG3' HD13 ' A' ' 119' ' ' LEU . 2.5 ttt-85 -69.48 -30.73 68.68 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.942 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.665 ' O ' HG23 ' A' ' 115' ' ' VAL . 7.9 t-80 -77.91 -42.36 33.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.728 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.963 HD13 ' CD2' ' A' ' 67' ' ' PHE . 1.9 pp -74.89 -29.06 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.818 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.884 ' CD2' HD12 ' A' ' 118' ' ' LEU . 19.0 mt -75.34 -30.68 60.33 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.493 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.12 -27.78 64.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.195 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.891 ' CG1' HD11 ' A' ' 61' ' ' LEU . 2.1 t -88.23 -50.59 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.785 0.326 . . . . 0.0 111.34 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.698 ' CB ' HD23 ' A' ' 39' ' ' LEU . 33.8 t -52.92 -63.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.836 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.904 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 142.21 48.68 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.843 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.904 HD23 ' O ' ' A' ' 117' ' ' GLY . 15.7 mt -133.17 5.77 3.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.47 0.176 . . . . 0.0 111.455 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.411 HD13 ' HG3' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -135.84 40.69 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.874 0.368 . . . . 0.0 110.809 179.931 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.396 -1.225 . . . . 0.0 112.531 -179.987 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.788 0.328 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 69' ' ' GLN . 2.7 pp -125.9 168.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.954 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -142.7 169.8 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.478 0.656 . . . . 0.0 112.21 -179.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.664 ' HH2' HD23 ' A' ' 39' ' ' LEU . 87.8 m95 -94.05 91.55 6.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.462 179.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.688 ' O ' HD12 ' A' ' 68' ' ' ILE . 63.3 m-85 -79.96 116.12 19.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.933 0.397 . . . . 0.0 110.647 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.73 151.5 19.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.709 -179.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -134.51 159.95 41.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.563 179.671 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.562 ' CG ' HG13 ' A' ' 95' ' ' VAL . 3.5 m-70 -110.56 87.36 2.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.5 p -83.73 -174.35 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.794 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.72 134.02 34.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 12' ' ' VAL . 4.9 m -60.47 104.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 122.61 -30.45 5.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.405 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -92.79 -19.63 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.587 0.232 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.03 -40.73 64.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 111.005 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.32 -37.24 69.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.828 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -89.84 -26.22 20.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.981 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.16 86.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -59.45 -48.01 83.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.88 74.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -60.22 -32.62 71.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.769 HD12 HG21 ' A' ' 88' ' ' THR . 8.8 tp -78.3 -56.1 4.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.728 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -29.41 2.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.294 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -46.52 50.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -33.15 68.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.59 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.498 HG23 ' HB2' ' A' ' 31' ' ' LEU . 34.3 mm -75.16 -25.21 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -97.78 -29.95 13.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.41 -40.79 64.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.989 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -79.99 -25.34 40.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.39 51.55 1.7 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.595 HD11 ' CG ' ' A' ' 80' ' ' GLU . 3.4 mm? -104.48 31.9 4.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.853 0.359 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.59 9.78 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -104.01 -21.71 13.57 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.711 0.291 . . . . 0.0 111.025 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HG3' HD12 ' A' ' 31' ' ' LEU . 2.2 mtpt -96.46 -51.23 4.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.677 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pt -79.82 151.25 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.765 179.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.717 ' HE2' HG21 ' A' ' 3' ' ' ILE . 56.4 m-85 -141.72 -44.96 0.35 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.344 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' CB ' ' CH2' ' A' ' 5' ' ' TRP . 2.6 mt-30 -129.52 158.33 39.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.221 0.534 . . . . 0.0 112.035 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 68' ' ' ILE . 20.8 t -154.97 82.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.114 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.85 HD12 ' HB3' ' A' ' 116' ' ' SER . 4.5 mm? -92.65 157.94 16.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.62 -179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.16 124.08 32.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.753 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 37.5 Cg_endo -66.83 81.1 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.586 2.191 . . . . 0.0 112.855 -179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.588 HG22 ' HG2' ' A' ' 60' ' ' LYS . 15.9 p -139.04 141.11 38.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.683 ' HG3' HG13 ' A' ' 115' ' ' VAL . 53.0 tt0 -117.29 160.86 20.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.968 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.26 134.81 54.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.806 179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.559 HG13 ' HG2' ' A' ' 59' ' ' LYS . 27.0 m -124.66 135.01 65.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.535 HG22 HG12 ' A' ' 56' ' ' VAL . 20.5 t -145.89 85.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.145 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -80.28 152.25 29.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mt -97.97 164.47 12.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -149.05 108.46 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.1 100.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.944 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.92 31.64 69.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.517 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.8 -104.09 2.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.96 143.72 14.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.896 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -101.78 149.56 24.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -158.99 140.02 12.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG12 HG22 ' A' ' 46' ' ' VAL . 12.4 m -116.7 131.16 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.048 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 58' ' ' ARG . 14.7 t -147.73 159.82 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.472 ' N ' HG12 ' A' ' 57' ' ' VAL . 77.1 mtt85 -105.98 140.19 39.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.559 ' HG2' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -122.23 107.1 11.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 179.953 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.588 ' HG2' HG22 ' A' ' 42' ' ' THR . 9.4 mtmm -59.93 115.62 3.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.852 ' CD1' HG11 ' A' ' 115' ' ' VAL . 37.4 mt -72.93 -44.98 60.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.74 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HB2' ' CB ' ' A' ' 41' ' ' PRO . 41.0 m-85 -119.28 88.26 37.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.616 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.08 136.62 53.07 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.493 2.128 . . . . 0.0 112.313 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.83 22.1 69.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.547 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.19 127.95 52.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.824 0.345 . . . . 0.0 110.974 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 124.86 45.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.608 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.978 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.4 m-85 -93.19 123.63 36.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.746 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.1 mp -129.42 110.42 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.454 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.904 ' HG2' HD13 ' A' ' 3' ' ' ILE . 15.4 tt0 -79.81 72.24 6.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.595 ' SD ' HD11 ' A' ' 72' ' ' LEU . 25.1 ptp -92.02 -176.85 4.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.851 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.577 ' HA ' HG22 ' A' ' 3' ' ' ILE . 14.5 t0 -118.27 99.23 6.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.703 179.382 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.595 HD11 ' SD ' ' A' ' 70' ' ' MET . 80.2 mt -122.91 7.16 9.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.337 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.17 63.03 2.54 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.444 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -98.76 -178.07 3.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.3 -68.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.01 0.433 . . . . 0.0 110.939 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.65 -78.81 0.11 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.025 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -138.29 166.52 25.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.39 169.87 17.43 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.482 2.121 . . . . 0.0 112.292 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.38 -165.78 1.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.5 pt-20 -57.64 -21.46 39.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -47.88 -44.78 29.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.412 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -68.94 -35.42 76.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.41 -30.19 68.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 88' ' ' THR . 22.9 t -79.24 -51.51 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 81' ' ' ALA . 30.5 t -59.84 -46.31 93.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -26.83 66.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.71 -27.28 57.23 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.621 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.769 HG21 HD12 ' A' ' 22' ' ' LEU . 45.7 p -59.89 142.91 88.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.682 0.277 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.87 -13.93 21.6 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.533 2.155 . . . . 0.0 112.627 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.64 -6.41 65.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.047 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.889 ' O ' HD13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -79.94 -31.97 13.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.941 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 67.75 -68.65 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 123.19 58.69 0.19 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.374 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 63.14 176.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.562 HG13 ' CG ' ' A' ' 9' ' ' HIS . 30.3 m -61.89 -30.08 47.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.192 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.61 39.96 0.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.16 -29.39 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 111.064 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.73 48.62 4.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.429 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.91 149.79 38.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.348 . . . . 0.0 110.941 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.82 154.31 67.87 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 112.78 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.511 2.141 . . . . 0.0 112.004 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.9 t -91.95 123.68 62.33 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.17 148.55 10.44 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.764 2.309 . . . . 0.0 112.202 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -77.8 141.56 39.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.852 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.9 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -77.62 157.66 79.53 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.948 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.1 -35.62 95.19 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.589 2.193 . . . . 0.0 112.361 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.44 -29.54 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -87.03 -36.46 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.944 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 105' ' ' SER . 39.8 t -60.72 -51.98 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.067 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.42 HH11 HD21 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -56.11 -29.56 60.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -53.79 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.576 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.978 HD12 ' CD2' ' A' ' 67' ' ' PHE . 18.9 pt -66.2 -25.07 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.732 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.861 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.9 mp -71.67 -38.07 70.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.486 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -30.56 70.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.704 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.852 HG11 ' CD1' ' A' ' 61' ' ' LEU . 21.8 t -83.39 -40.7 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.042 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.85 ' HB3' HD12 ' A' ' 39' ' ' LEU . 1.9 m -58.93 -62.02 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.566 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 144.73 48.31 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.526 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.861 HD12 ' HG ' ' A' ' 113' ' ' LEU . 27.8 mt -124.12 -45.26 2.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.995 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.42 HD21 HH11 ' A' ' 110' ' ' ARG . 0.1 OUTLIER -98.48 29.85 3.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.289 -1.284 . . . . 0.0 112.395 179.988 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.826 0.346 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.638 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -117.52 170.74 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.852 179.792 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -153.3 161.9 41.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.826 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.632 ' CZ2' HD11 ' A' ' 113' ' ' LEU . 68.2 m95 -88.49 92.71 9.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.661 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.841 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 67.0 m-85 -87.99 114.12 24.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' LEU . . . -100.77 147.49 26.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.525 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 9' ' ' HIS . 16.1 t -127.93 160.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.497 ' CE1' ' CE2' ' A' ' 65' ' ' TYR . 3.2 m-70 -114.72 156.58 24.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.8 p -156.63 -174.74 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.96 145.8 24.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -60.48 130.5 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.42 13.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -94.01 -22.05 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 0.0 111.066 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -53.65 -43.78 69.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.024 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 -33.51 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -80.87 -31.06 35.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.37 -50.54 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -60.31 -37.67 81.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.973 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.68 -53.76 42.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -30.33 69.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.535 HD11 HG22 ' A' ' 85' ' ' VAL . 31.5 tp -76.3 -56.53 4.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -48.76 -30.33 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.218 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -38.4 61.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.56 ' HG3' HG22 ' A' ' 88' ' ' THR . 21.9 mmt180 -73.67 -37.35 65.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.569 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.836 HD12 HD11 ' A' ' 31' ' ' LEU . 41.4 mm -72.92 -28.05 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.987 179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -89.63 -32.8 16.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.773 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.03 -39.55 79.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.993 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.98 -37.29 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.83 41.71 5.89 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.836 HD11 HD12 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -99.52 51.18 0.93 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.976 0.417 . . . . 0.0 110.79 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -75.3 -5.15 43.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.4 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -79.69 -24.27 41.85 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.824 179.939 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -94.3 -52.17 4.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.9 mt -95.16 111.61 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.5 m-85 -102.46 -60.23 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.382 -179.451 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.39 130.03 49.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 -179.146 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.8 p -126.07 72.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.497 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.688 HD23 ' OG ' ' A' ' 116' ' ' SER . 2.5 tm? -83.64 133.47 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.945 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' THR . 0.1 OUTLIER -109.22 124.51 33.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.925 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 88.1 Cg_exo -49.19 77.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.138 2.559 . . . . 0.0 113.305 -179.652 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 40' ' ' ILE . 36.8 p -158.64 152.33 23.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.775 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.621 ' OE2' HD21 ' A' ' 61' ' ' LEU . 5.2 mm-40 -96.44 156.22 16.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.855 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.17 133.79 28.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.758 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 45' ' ' VAL . 15.4 m -126.35 116.09 44.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.184 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.666 HG13 ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -102.48 -161.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.534 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.666 ' N ' HG13 ' A' ' 46' ' ' VAL . 7.4 tt0 -79.49 143.33 35.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 110.722 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.28 -171.37 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.009 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.86 80.5 1.49 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.883 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -124.3 -54.46 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -167.59 36.32 0.22 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.429 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.72 27.49 8.99 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.551 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.93 139.12 49.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.895 0.378 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' CB ' ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -158.98 147.29 18.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 179.958 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -129.5 148.53 51.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.04 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 57' ' ' VAL . 7.9 m -142.91 82.39 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 56' ' ' VAL . 5.4 m -159.45 -179.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.26 169.57 17.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 42' ' ' THR . 2.3 tptt -141.23 -165.15 1.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.742 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -139.82 113.53 8.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 115' ' ' VAL . 3.6 mt -85.26 -47.76 9.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CE1' HG22 ' A' ' 112' ' ' ILE . 7.6 m-85 -135.99 84.36 31.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.584 179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.79 141.93 92.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.663 2.242 . . . . 0.0 112.496 -179.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.8 4.86 77.81 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.069 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CE2' ' CE1' ' A' ' 9' ' ' HIS . 6.2 m-85 -117.99 156.74 28.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.8 0.334 . . . . 0.0 110.953 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD12 ' C ' ' A' ' 65' ' ' TYR . 5.2 mp -150.64 107.7 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.707 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.68 ' CD1' HD11 ' A' ' 104' ' ' LEU . 4.4 m-85 -81.79 124.32 29.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.0 OUTLIER -127.86 114.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.166 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 4.6 tt0 -80.71 71.09 7.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 0.0 110.345 179.433 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.3 ptp -91.2 -175.02 4.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.434 ' OD1' HG22 ' A' ' 3' ' ' ILE . 26.6 t70 -124.32 92.02 3.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.73 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.841 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 20.3 mt -95.81 -57.8 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.63 -47.23 2.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.381 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -120.73 163.82 17.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.761 0.315 . . . . 0.0 110.759 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -112.74 -16.58 12.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.339 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -87.13 -33.17 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 0.0 111.163 -179.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.77 94.13 17.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.17 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.7 171.64 6.79 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.687 2.258 . . . . 0.0 112.235 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 -177.25 5.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.97 -28.91 64.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.557 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.53 -41.16 69.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.18 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -59.86 -39.74 86.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.27 -40.22 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 88' ' ' THR . 21.6 t -65.45 -47.87 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.027 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.7 t -63.43 -45.33 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.091 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.413 ' HA ' HG21 ' A' ' 91' ' ' ILE . 2.1 ttt180 -60.67 -28.99 69.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.68 -31.28 56.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 25' ' ' ARG . 20.9 p -60.76 111.35 3.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.616 0.246 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.16 133.73 35.96 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.445 2.097 . . . . 0.0 112.366 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.14 -11.45 48.28 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.703 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.413 HG21 ' HA ' ' A' ' 86' ' ' ARG . 8.8 tp -79.96 135.71 24.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.22 -35.05 5.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.93 -26.73 19.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.583 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.586 ' HE1' HG21 ' A' ' 102' ' ' VAL . 18.4 t80 -174.38 169.78 3.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.404 ' N ' ' HB2' ' A' ' 9' ' ' HIS . 21.4 t -56.55 -66.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.318 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.26 55.91 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.556 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.56 -46.99 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.798 0.333 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.38 169.28 24.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.488 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -101.36 -30.6 11.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.736 0.303 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.38 154.75 77.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.13 171.58 14.6 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.547 2.165 . . . . 0.0 112.205 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.586 HG21 ' HE1' ' A' ' 94' ' ' PHE . 6.4 m -142.52 101.69 5.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.187 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.79 157.84 54.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.397 2.064 . . . . 0.0 112.169 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.68 HD11 ' CD1' ' A' ' 67' ' ' PHE . 16.2 mt -89.99 163.68 14.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.876 ' O ' HG23 ' A' ' 109' ' ' VAL . 2.7 p -86.67 141.38 33.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.95 -33.9 35.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.572 2.181 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.37 -41.63 76.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -81.58 -31.08 32.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.961 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 105' ' ' SER . 58.5 t -63.36 -43.68 98.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -61.25 -30.42 70.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.9 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.92 -52.88 11.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.609 179.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.595 HG22 ' CE1' ' A' ' 62' ' ' PHE . 2.5 pp -66.42 -16.48 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.59 179.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.757 ' HG ' HD12 ' A' ' 118' ' ' LEU . 1.0 OUTLIER -72.65 -36.73 68.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.316 179.173 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.52 -22.43 44.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.767 HG21 HD13 ' A' ' 61' ' ' LEU . 38.5 t -70.26 -60.93 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.688 ' OG ' HD23 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -52.49 -53.66 42.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 127.42 38.17 0.42 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.545 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.757 HD12 ' HG ' ' A' ' 113' ' ' LEU . 2.7 mt -100.06 0.62 41.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.591 0.234 . . . . 0.0 111.366 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 113' ' ' LEU . 2.8 mp -131.4 -63.02 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.805 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.385 -1.23 . . . . 0.0 112.438 -179.959 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.83 0.347 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.819 HG21 ' CE2' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -131.51 174.65 12.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.813 179.958 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 103' ' ' PRO . 2.1 mt-10 -139.91 163.71 31.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.416 0.627 . . . . 0.0 112.294 -179.318 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.872 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 74.7 m95 -91.09 92.21 8.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.583 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.548 ' O ' HD12 ' A' ' 68' ' ' ILE . 64.9 m-85 -79.8 107.61 12.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.895 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -87.0 146.66 26.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.827 -179.035 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -146.55 177.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.555 179.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.509 ' CE1' ' CZ ' ' A' ' 65' ' ' TYR . 2.9 m-70 -122.48 160.7 25.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.126 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -136.83 158.79 43.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.622 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.26 127.43 27.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.3 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -63.66 128.73 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.852 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.68 -30.63 8.56 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.205 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -97.36 -9.41 27.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.608 0.242 . . . . 0.0 110.96 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.8 -39.04 4.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 111.238 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -54.94 -44.17 74.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.33 34.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.76 85.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.067 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.0 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.73 -50.97 8.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.099 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.04 -34.86 72.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.817 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.639 HD11 HG13 ' A' ' 85' ' ' VAL . 41.3 tp -71.98 -56.96 4.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -33.34 60.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -67.88 -40.9 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.709 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.666 ' HG3' HG22 ' A' ' 88' ' ' THR . 2.1 mmt180 -68.0 -38.25 82.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.0 mm -69.42 -30.09 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.017 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -89.0 -33.62 17.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.08 -29.62 68.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.45 -27.07 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.06 56.94 2.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.456 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -103.88 35.33 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 0.0 110.846 -179.916 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.21 -4.19 37.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.515 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.78 -28.06 40.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.839 0.352 . . . . 0.0 110.77 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -54.29 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.686 HG23 ' CG2' ' A' ' 68' ' ' ILE . 2.5 mp -86.66 94.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.657 179.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.819 ' CE2' HG21 ' A' ' 3' ' ' ILE . 6.8 m-85 -83.01 -50.05 8.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.486 ' HB3' ' CH2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -115.67 138.94 50.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.166 0.508 . . . . 0.0 111.705 -179.207 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.39 138.56 26.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.459 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.872 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -160.23 155.56 25.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.016 0.436 . . . . 0.0 111.356 -179.731 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.47 ' N ' HD22 ' A' ' 39' ' ' LEU . 14.9 tt -114.6 128.26 26.04 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.528 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' CB ' ' HB2' ' A' ' 62' ' ' PHE . 11.2 Cg_endo -55.71 80.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.673 2.248 . . . . 0.0 112.8 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 41' ' ' PRO . 36.6 p -159.87 142.64 13.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.48 179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.731 ' HG2' HG13 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -79.82 145.13 32.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.422 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.28 121.34 12.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.036 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 45' ' ' VAL . 14.1 m -144.02 117.23 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.797 179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.4 p -159.98 62.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.034 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -152.82 169.41 22.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -94.38 137.11 33.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -155.78 -46.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -95.48 86.68 4.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.39 -124.13 34.04 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -117.32 50.53 0.79 Allowed Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.542 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.63 151.84 23.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.919 0.39 . . . . 0.0 110.85 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 125.47 37.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.65 115.07 11.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 56' ' ' VAL . 9.2 p -122.97 99.88 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 56' ' ' VAL . 19.3 m -156.92 174.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.557 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 mtp-105 -142.82 150.48 40.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.737 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -130.28 105.1 7.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.735 179.956 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -63.72 115.19 4.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.832 ' CD1' HG21 ' A' ' 115' ' ' VAL . 37.9 mt -90.09 -39.82 12.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.204 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 1.4 m-85 -131.4 95.49 23.89 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.917 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.16 133.22 48.54 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.527 2.152 . . . . 0.0 112.145 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.54 23.29 62.56 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.793 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.669 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.2 m-85 -116.49 154.07 31.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -160.49 130.92 5.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.72 179.802 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.782 ' HD2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.13 142.72 39.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.557 179.618 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.686 ' CG2' HG23 ' A' ' 35' ' ' ILE . 2.7 mp -138.32 122.36 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.393 -179.644 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 9.3 tt0 -79.81 65.17 4.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 110.256 179.43 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.781 ' SD ' HD23 ' A' ' 72' ' ' LEU . 11.6 ptp -91.77 -169.34 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.051 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' CG ' HG22 ' A' ' 3' ' ' ILE . 5.2 t0 -148.62 80.49 1.44 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.81 179.64 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.781 HD23 ' SD ' ' A' ' 70' ' ' MET . 4.1 pp -113.53 -31.16 6.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.166 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -45.89 94.77 0.01 OUTLIER Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.917 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.44 7.7 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.587 0.232 . . . . 0.0 111.442 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.56 -65.84 0.31 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.96 0.409 . . . . 0.0 111.023 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.85 -69.82 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.139 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -158.94 153.16 19.96 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.91 177.96 7.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.559 2.173 . . . . 0.0 112.306 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -90.07 -179.98 5.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.2 tp10 -61.33 -24.35 66.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.187 180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.719 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -54.28 -47.39 72.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.343 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.452 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 13.7 t-105 -59.31 -42.36 91.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.967 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -59.98 -32.21 70.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 31' ' ' LEU . 24.1 t -82.58 -49.17 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.02 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.6 t -59.91 -51.28 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.982 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -66.35 -25.76 66.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.072 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.97 -32.64 63.27 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.701 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.666 HG22 ' HG3' ' A' ' 25' ' ' ARG . 81.7 p -61.78 143.69 93.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.718 0.294 . . . . 0.0 110.839 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.49 91.18 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.42 -36.41 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.451 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.71 122.47 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.4 p -143.84 30.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.26 108.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.474 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 9' ' ' HIS . 26.2 t80 -156.2 39.92 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 95' ' ' VAL . 14.2 p -90.04 10.93 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.517 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.97 -44.98 2.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.42 68.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.21 -76.23 0.41 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.601 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 mmt -124.37 -43.57 2.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 0.0 110.953 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -72.19 118.81 70.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 50.0 Cg_exo -53.99 -171.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.492 2.128 . . . . 0.0 112.341 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.472 ' HB ' HG21 ' A' ' 95' ' ' VAL . 43.5 t -150.6 115.46 3.29 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.281 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 4' ' ' GLU . 15.6 Cg_exo -68.0 145.06 66.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.465 2.11 . . . . 0.0 112.068 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 7' ' ' ALA . 1.1 mp -86.29 159.1 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 0.0 111.043 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 69.6 m -89.54 141.66 28.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.66 -37.14 26.74 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.638 2.225 . . . . 0.0 112.574 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -48.74 80.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.07 -33.97 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 62.3 t -58.5 -50.5 78.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.91 -37.95 54.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.224 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.459 ' O ' HG23 ' A' ' 115' ' ' VAL . 3.0 m-70 -68.4 -52.69 30.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.669 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.748 HD12 ' CD2' ' A' ' 67' ' ' PHE . 27.5 pt -66.36 -26.11 37.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.835 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.746 ' HG ' HD12 ' A' ' 118' ' ' LEU . 3.2 mp -73.83 -41.16 62.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.514 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.47 -23.41 65.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.128 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.832 HG21 ' CD1' ' A' ' 61' ' ' LEU . 33.9 t -76.59 -59.09 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.7 ' HB2' HD23 ' A' ' 39' ' ' LEU . 1.5 t -59.4 -57.03 14.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.546 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.03 63.13 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.914 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.746 HD12 ' HG ' ' A' ' 113' ' ' LEU . 12.6 mt -133.46 5.62 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.514 0.197 . . . . 0.0 111.441 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.34 -36.38 11.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.912 0.387 . . . . 0.0 110.794 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.412 -179.941 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.837 0.351 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.724 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -139.39 -170.76 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.932 179.873 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -134.76 150.13 50.52 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.276 0.56 . . . . 0.0 111.971 -179.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.699 ' CD1' HG11 ' A' ' 109' ' ' VAL . 71.8 m95 -99.75 110.14 22.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.529 179.349 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 30.3 m-85 -99.67 137.08 38.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 0.0 110.722 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . -111.49 146.75 36.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.033 0.444 . . . . 0.0 111.861 -179.407 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 9' ' ' HIS . 0.5 OUTLIER -137.3 159.31 35.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.191 179.583 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -119.58 126.28 50.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.914 -179.857 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -132.06 -177.22 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.703 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 141.07 35.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -58.28 114.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.021 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.76 -34.05 5.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.295 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.41 -30.02 37.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 110.762 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.18 -39.15 66.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.12 -41.18 83.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -81.01 -26.69 36.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.61 56.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.152 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -35.44 74.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.81 -57.2 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.94 -36.29 82.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.488 HD11 HG22 ' A' ' 85' ' ' VAL . 59.6 tp -70.09 -47.87 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.765 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.707 ' O ' HG22 ' A' ' 26' ' ' ILE . 31.3 mt-10 -59.33 -22.13 60.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.026 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -45.97 14.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.877 0.37 . . . . 0.0 110.296 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -68.35 -24.46 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.4 tp -70.94 -28.07 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -97.39 -31.3 12.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.23 74.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -79.93 -25.61 40.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.987 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 30.19 6.57 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.287 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.6 mt -97.04 25.38 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.65 -24.32 66.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.75 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.85 -3.44 47.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.161 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.727 ' HG2' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -100.01 -67.55 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.797 0.332 . . . . 0.0 110.8 179.813 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.681 HD12 HG21 ' A' ' 68' ' ' ILE . 28.9 mm -80.71 130.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.711 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 3' ' ' ILE . 10.4 m-85 -124.24 -50.43 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -119.46 161.48 20.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.423 0.63 . . . . 0.0 112.489 -178.522 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.564 ' O ' HD22 ' A' ' 39' ' ' LEU . 40.5 t -157.84 110.85 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.956 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 116' ' ' SER . 4.1 mm? -126.16 175.06 8.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.529 0.68 . . . . 0.0 112.292 -178.743 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 39' ' ' LEU . 9.2 pt -161.87 66.95 2.08 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.703 179.577 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 62' ' ' PHE . 9.6 Cg_endo -52.88 150.52 22.77 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.451 2.767 . . . . 0.0 114.359 -178.445 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 60' ' ' LYS . 22.3 p -125.2 152.39 44.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.139 179.207 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' OE2' HD21 ' A' ' 61' ' ' LEU . 2.7 tp10 -79.81 138.65 37.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.975 0.416 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -104.26 133.69 48.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.769 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.031 HG23 HG23 ' A' ' 57' ' ' VAL . 4.5 m -151.19 173.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.152 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.987 HG12 HG12 ' A' ' 56' ' ' VAL . 14.1 m -126.97 150.36 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.063 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -139.42 154.8 47.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.3 tp -131.79 146.7 52.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.14 174.1 7.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -42.65 94.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.63 106.71 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.474 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.32 -153.27 25.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.443 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -124.17 137.07 54.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.07 172.44 8.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.84 -168.35 1.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.758 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.987 HG12 HG12 ' A' ' 46' ' ' VAL . 4.0 m -90.08 119.03 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 1.031 HG23 HG23 ' A' ' 45' ' ' VAL . 9.1 m -89.94 159.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -140.06 139.13 35.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.46 141.73 51.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.711 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.0 OUTLIER -47.21 132.97 12.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.274 -179.909 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.602 HD21 ' OE2' ' A' ' 43' ' ' GLU . 1.1 mt -90.39 -58.82 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.106 179.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 51.9 m-85 -113.04 64.39 0.88 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.777 179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.2 135.46 54.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.562 2.175 . . . . 0.0 112.168 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.91 6.2 72.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 -179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' CZ ' ' CE1' ' A' ' 9' ' ' HIS . 4.7 m-85 -113.69 126.72 55.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.82 116.62 32.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.784 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.758 ' CD2' HD12 ' A' ' 112' ' ' ILE . 14.0 m-30 -90.27 95.3 10.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.681 HG21 HD12 ' A' ' 35' ' ' ILE . 4.1 mt -95.25 113.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.279 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . 10.5 tt0 -83.21 68.63 9.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.744 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.577 ' HE2' ' HG ' ' A' ' 72' ' ' LEU . 1.9 ptt? -91.45 -165.49 1.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.473 179.501 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -149.43 84.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.895 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.585 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 44.0 mt -79.94 -35.11 38.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.72 104.96 0.11 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.497 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.87 167.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.17 32.14 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.813 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -76.91 -78.66 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -145.85 108.89 4.37 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -50.92 159.32 2.51 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.382 2.055 . . . . 0.0 112.414 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -90.05 -169.96 2.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 84' ' ' VAL . 34.0 tt0 -54.88 -23.58 19.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.324 -179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.727 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . . . -52.62 -52.46 55.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.198 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 -58.06 -30.8 66.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -71.9 -31.03 66.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.798 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 31' ' ' LEU . 29.9 t -83.37 -51.41 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.948 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 81' ' ' ALA . 24.4 t -57.22 -41.98 79.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.478 ' HA ' HG21 ' A' ' 91' ' ' ILE . 1.3 ttt180 -71.87 -22.76 61.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.052 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -84.16 -17.79 64.17 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.945 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.443 HG21 HD13 ' A' ' 22' ' ' LEU . 73.9 p -58.97 139.32 87.32 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.744 0.272 . . . . 0.0 110.95 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.36 105.48 2.05 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.464 2.109 . . . . 0.0 112.239 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.24 -17.09 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.725 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.643 HD13 ' N ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -80.03 128.47 38.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 -179.881 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.439 ' N ' HD13 ' A' ' 91' ' ' ILE . 38.5 m -103.63 -28.38 11.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.643 ' N ' HD13 ' A' ' 91' ' ' ILE . . . 96.58 -56.24 1.4 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.262 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 101' ' ' PRO . 8.5 m-85 -155.39 175.94 13.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.818 0.342 . . . . 0.0 110.669 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.4 t -54.99 -67.72 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.404 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.62 78.66 0.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.653 -0.785 . . . . 0.0 112.542 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -175.85 162.55 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -113.24 91.49 0.58 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.503 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.32 -173.46 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.97 0.414 . . . . 0.0 110.908 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -78.68 162.12 66.7 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.912 179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.419 ' HA ' ' CE2' ' A' ' 94' ' ' PHE . 78.5 Cg_exo -49.74 175.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.202 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.5 p -132.56 79.33 65.09 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.853 0.358 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.98 146.1 22.82 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.548 2.165 . . . . 0.0 111.973 179.642 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.672 ' HB2' HG22 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -85.05 163.87 18.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.874 0.368 . . . . 0.0 110.753 -179.925 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -89.76 150.49 44.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -47.5 -27.31 7.25 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.638 2.225 . . . . 0.0 112.503 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.85 -46.85 17.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.064 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.96 -30.64 63.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 105' ' ' SER . 50.4 t -62.86 -55.18 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.506 ' HD2' HD11 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -55.54 -24.95 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.151 -179.898 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.4 OUTLIER -77.96 -44.87 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.779 179.89 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.758 HD12 ' CD2' ' A' ' 67' ' ' PHE . 27.4 pt -72.43 -28.79 29.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.966 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.69 HD22 HD12 ' A' ' 118' ' ' LEU . 25.9 mt -76.24 -30.78 58.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.65 -32.5 69.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.495 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 111' ' ' HIS . 25.5 t -84.19 -26.42 7.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.808 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.861 ' HB2' HD12 ' A' ' 39' ' ' LEU . 20.4 p -68.4 -43.25 77.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 131.63 4.24 3.95 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.164 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.69 HD12 HD22 ' A' ' 113' ' ' LEU . 34.8 mt -80.0 -58.48 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.91 0.355 . . . . 0.0 110.728 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.506 HD11 ' HD2' ' A' ' 110' ' ' ARG . 71.3 mt -95.07 -29.13 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.493 179.978 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.705 0.288 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.712 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.47 -168.1 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.909 179.968 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.0 152.18 49.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.161 0.505 . . . . 0.0 111.855 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.893 ' CZ3' HD12 ' A' ' 39' ' ' LEU . 73.0 m95 -97.58 96.76 8.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.637 179.575 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.976 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 27.1 m-85 -86.86 123.62 32.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 0.0 110.728 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -106.39 159.67 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.568 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 91' ' ' ILE . 10.6 t -141.49 160.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.634 ' NE2' HG22 ' A' ' 95' ' ' VAL . 14.0 m-70 -88.9 134.88 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.98 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 p -139.4 160.98 38.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.13 151.13 21.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -66.49 127.64 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.67 -25.51 24.54 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.31 -26.9 19.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.71 0.291 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' HB2' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -56.52 -41.22 76.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -54.96 -37.84 67.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.973 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -86.71 -29.82 22.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.841 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.19 83.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.024 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -59.79 -43.58 94.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.54 -42.91 28.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.32 -31.51 69.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 88' ' ' THR . 21.1 tp -82.87 -57.6 3.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.35 -45.31 17.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.439 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -61.11 -41.91 97.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -43.23 91.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.661 HG23 ' HB2' ' A' ' 31' ' ' LEU . 35.7 mm -64.39 -28.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.855 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -91.41 -29.72 16.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.73 -46.46 30.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.339 -179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -79.95 -21.63 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.207 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.13 65.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.176 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.661 ' HB2' HG23 ' A' ' 26' ' ' ILE . 3.8 mm? -115.08 26.65 9.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.301 . . . . 0.0 111.154 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -80.19 22.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.38 -21.45 13.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 110.696 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.2 -48.01 2.99 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.711 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 35' ' ' ILE . 4.9 mp -79.86 128.28 38.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.642 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.671 ' CE2' HG21 ' A' ' 3' ' ' ILE . 33.0 m-85 -115.3 -56.74 2.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.424 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -115.83 170.02 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 112.039 -179.427 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 68' ' ' ILE . 34.7 t -157.79 120.54 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.983 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.893 HD12 ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -144.58 150.3 37.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.334 0.588 . . . . 0.0 112.295 -178.533 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 pt -113.05 124.83 30.8 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.568 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' CG ' ' HB2' ' A' ' 62' ' ' PHE . 50.7 Cg_endo -68.9 85.71 0.49 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.651 2.234 . . . . 0.0 112.885 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 59' ' ' LYS . 7.1 p -138.46 146.8 42.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.421 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -80.13 156.7 26.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.12 -179.645 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -145.45 108.08 4.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 m -109.54 126.66 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.253 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.849 HG22 HG12 ' A' ' 56' ' ' VAL . 16.5 t -143.01 144.53 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.091 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.22 166.16 21.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 tp -103.65 147.13 27.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.694 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.72 90.02 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 63.47 -79.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.052 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.16 -55.55 5.67 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.601 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.52 -16.35 2.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.685 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 120.19 23.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.832 0.348 . . . . 0.0 110.933 -179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.99 -178.71 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.823 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.9 131.96 34.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.758 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.849 HG12 HG22 ' A' ' 46' ' ' VAL . 3.2 m -107.03 97.52 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.274 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 58' ' ' ARG . 13.0 t -82.09 159.55 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.463 ' N ' HG12 ' A' ' 57' ' ' VAL . 4.9 mtp180 -144.92 127.28 15.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.959 0.409 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.557 ' O ' ' HB ' ' A' ' 42' ' ' THR . 4.3 mmtp -107.53 -172.3 2.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.396 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.51 117.55 19.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.872 0.368 . . . . 0.0 111.028 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.858 ' CD1' HG11 ' A' ' 115' ' ' VAL . 18.1 mt -87.63 -55.45 3.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.745 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.668 ' CZ ' HG22 ' A' ' 112' ' ' ILE . 1.1 m-85 -112.3 91.47 16.45 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 127.8 27.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.475 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 59.39 40.78 96.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.66 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -133.42 115.28 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.14 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -124.01 121.45 35.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.206 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.736 ' HD2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -97.36 133.9 41.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 111.246 -179.573 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.6 mp -123.56 122.06 64.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.591 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.455 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 2.5 tt0 -79.77 75.66 6.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.6 ptp -90.92 -175.17 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.153 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.461 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 1.3 t0 -130.52 100.03 5.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.976 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 13.9 mt -108.73 -25.63 10.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.054 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.84 83.59 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.481 179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -163.81 -43.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.378 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.52 169.16 18.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.84 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -87.23 5.8 36.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.395 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -129.23 102.53 18.67 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 82' ' ' TRP . 51.0 Cg_endo -69.08 77.89 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.481 2.121 . . . . 0.0 112.203 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.9 m120 -90.24 -173.06 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 51.91 -84.52 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.866 179.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -46.94 -48.9 21.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.719 -179.719 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 6.1 t-105 -76.2 -28.87 57.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.075 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.79 -37.79 74.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 31' ' ' LEU . 21.6 t -90.06 -47.44 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 81' ' ' ALA . 57.6 t -59.56 -42.29 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.089 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -71.67 -19.32 62.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.306 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -120.53 22.57 8.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.611 HG21 HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -75.62 134.24 72.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.714 0.257 . . . . 0.0 110.821 179.924 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.03 -8.61 23.96 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.414 2.076 . . . . 0.0 112.669 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -103.82 -18.53 13.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.828 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.639 HD11 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -80.63 127.49 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.34 . . . . 0.0 111.056 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.535 ' N ' HD13 ' A' ' 91' ' ' ILE . 18.7 m -145.47 110.55 5.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.24 143.32 7.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.516 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -152.12 170.98 18.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 110.931 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.65 HG21 ' CG1' ' A' ' 102' ' ' VAL . 25.4 t -71.06 100.26 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.99 70.85 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.446 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.26 42.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.15 -99.5 2.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.414 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.6 ttm -69.61 136.39 51.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.754 0.311 . . . . 0.0 110.773 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 1.8 mtt-85 -82.04 -50.81 0.83 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 100' ' ' ARG . 5.5 Cg_exo -74.07 116.89 4.8 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.707 2.271 . . . . 0.0 112.006 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.65 ' CG1' HG21 ' A' ' 95' ' ' VAL . 4.6 m -115.58 97.39 48.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.262 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.35 123.89 9.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.493 2.129 . . . . 0.0 112.187 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.77 HD22 HD13 ' A' ' 112' ' ' ILE . 2.2 mp -71.99 157.98 36.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.025 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -85.66 151.47 55.62 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 -179.935 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.13 -30.25 18.34 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.698 2.266 . . . . 0.0 112.464 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -71.45 -47.44 55.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -74.41 -31.9 62.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 48.7 t -61.18 -52.47 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -55.53 -38.46 69.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.21 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -68.79 -46.61 68.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.054 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.77 HD13 HD22 ' A' ' 104' ' ' LEU . 31.1 pt -72.53 -27.09 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.954 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.052 HD22 HD12 ' A' ' 118' ' ' LEU . 15.6 mt -79.45 -29.21 41.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -67.05 -21.76 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.925 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.858 HG11 ' CD1' ' A' ' 61' ' ' LEU . 13.7 t -86.31 -54.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.157 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.688 ' HB2' HD23 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -55.88 -60.44 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.672 ' O ' HD23 ' A' ' 118' ' ' LEU . . . 135.58 64.83 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.903 179.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.052 HD12 HD22 ' A' ' 113' ' ' LEU . 30.4 mt -128.93 -43.78 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 0.0 110.891 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.4 tp -80.14 -63.33 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.37 -1.239 . . . . 0.0 112.572 -179.996 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.825 0.345 . . . . 2.7400000000000002 111.237 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -141.8 -166.43 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 1.1599999999999999 110.941 -179.987 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -156.07 155.79 33.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.083 0.468 . . . . 2.0699999999999998 111.507 -179.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.844 ' CD1' HG11 ' A' ' 109' ' ' VAL . 93.8 m95 -96.28 96.64 8.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.94999999999999996 110.692 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.953 ' CE2' HD12 ' A' ' 72' ' ' LEU . 3.3 m-85 -86.17 117.35 24.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.907 0.384 . . . . 1.4299999999999999 111.029 -179.925 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -92.95 147.71 22.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.71999999999999997 111.144 -179.823 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.613 HG11 HD12 ' A' ' 91' ' ' ILE . 15.2 t -134.46 159.96 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 1.6899999999999999 111.025 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.475 ' N ' HG12 ' A' ' 8' ' ' VAL . 10.7 m-70 -102.01 149.65 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 1.3600000000000001 111.013 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.2 p -151.3 -177.6 6.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 1.1100000000000001 110.86 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.0 139.4 30.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 2.2000000000000002 110.908 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 12' ' ' VAL . 28.8 m -62.65 121.71 11.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.137 -0.483 . . . . 2.2599999999999998 111.206 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.5 -28.62 12.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.787 -0.721 . . . . 1.76 112.402 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -89.68 -21.41 22.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.732 0.301 . . . . 2.52 111.113 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -53.42 -36.31 61.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 2.5299999999999998 111.046 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -58.68 -30.91 67.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 3.25 110.878 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.79 -30.49 18.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 2.9900000000000002 110.929 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.73 87.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 1.3300000000000001 111.08 -179.984 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.456 ' NZ ' HD11 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -60.42 -49.06 79.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 3.3599999999999999 110.827 179.995 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.95 -46.06 72.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 1.7 111.045 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -60.25 -31.1 69.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 1.8999999999999999 110.824 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.729 HD11 HG22 ' A' ' 85' ' ' VAL . 54.4 tp -81.47 -55.89 4.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 1.6200000000000001 110.85 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.02 -32.91 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.236 -0.438 . . . . 2.4500000000000002 111.193 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -71.02 -40.95 71.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 3.5099999999999998 110.734 179.803 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.733 ' HG3' HG22 ' A' ' 88' ' ' THR . 13.5 mmt180 -68.89 -38.13 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 3.3799999999999999 110.675 179.845 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.889 ' HA ' HD12 ' A' ' 31' ' ' LEU . 35.4 mm -66.76 -31.82 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 1.49 110.894 179.728 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -91.19 -29.82 17.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.14 -0.482 . . . . 3.6099999999999999 110.857 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.7 -46.8 68.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 2.0600000000000001 111.174 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -80.03 -28.46 39.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 2.29 111.012 179.937 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 66.01 0.98 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 1.8400000000000001 112.442 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.889 HD12 ' HA ' ' A' ' 26' ' ' ILE . 1.7 mt -122.08 33.41 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 1.8600000000000001 110.88 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -72.58 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 2.6699999999999999 111.365 -179.975 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.87 -30.32 40.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 2.7400000000000002 110.891 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 -60.33 1.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.325 -0.398 . . . . 2.77 110.781 179.973 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 26' ' ' ILE . 31.6 mt -82.13 128.65 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 2.1099999999999999 111.094 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 3' ' ' ILE . 9.0 m-85 -118.02 -54.31 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 1.6899999999999999 110.986 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.416 ' HB2' ' CH2' ' A' ' 5' ' ' TRP . 2.7 mt-30 -110.88 153.08 25.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.98 0.419 . . . . 1.6200000000000001 111.268 -179.759 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.47 69.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 1.74 110.74 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.775 HD21 HD11 ' A' ' 118' ' ' LEU . 4.4 mm? -79.93 150.35 30.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.991 -0.55 . . . . 2.6200000000000001 111.034 -179.764 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 42' ' ' THR . 18.9 mt -109.84 129.29 24.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 2.6200000000000001 110.77 179.769 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 31.4 Cg_endo -63.64 73.88 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.488 2.125 . . . . 2.2200000000000002 112.394 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.489 HG23 HG22 ' A' ' 40' ' ' ILE . 42.5 p -146.34 134.95 22.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 1.75 110.773 -179.993 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HA ' HG12 ' A' ' 115' ' ' VAL . 15.4 tt0 -79.98 148.2 31.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 3.0499999999999998 110.873 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -126.11 113.68 17.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 4.29 110.843 179.973 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 57' ' ' VAL . 4.5 m -127.47 129.25 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 3.0800000000000001 111.105 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.3 p -120.85 109.69 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 4.3899999999999997 111.067 179.935 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.83 151.08 22.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 6.1399999999999997 110.855 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.24 101.19 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 6.0999999999999996 110.818 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.89 -177.84 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 9.3200000000000003 110.913 179.931 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.52 -70.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 9.0700000000000003 110.966 179.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.05 167.12 11.94 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 6.5199999999999996 112.439 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.45 69.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.687 -0.768 . . . . 5.9699999999999998 112.513 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 129.09 22.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.786 0.327 . . . . 8.8900000000000006 110.874 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.03 114.29 17.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 6.5499999999999998 110.924 179.973 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -96.62 105.18 17.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 6.0999999999999996 110.859 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 56' ' ' VAL . 7.5 m -91.87 99.61 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 4.1799999999999997 111.22 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 45' ' ' VAL . 4.4 m -102.27 126.47 56.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 2.4300000000000002 111.043 179.898 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.14 126.32 50.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 4.2000000000000002 110.933 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -101.61 164.07 11.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 3.1499999999999999 110.706 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -107.05 105.15 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 3.5 111.007 -179.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.039 HD11 HG11 ' A' ' 115' ' ' VAL . 78.5 mt -72.78 -47.32 47.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 1.3400000000000001 110.761 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' A' ' 112' ' ' ILE . 9.9 m-85 -122.08 77.75 41.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 1.8300000000000001 110.685 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.05 127.61 26.4 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.624 2.216 . . . . 1.55 112.583 -179.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.52 25.86 52.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.84 -0.695 . . . . 1.23 112.799 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -131.24 156.42 45.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 1.9199999999999999 111.016 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.46 114.34 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 1.77 110.596 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.871 ' CD2' HD12 ' A' ' 112' ' ' ILE . 11.1 m-85 -84.24 119.77 25.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 1.55 111.271 -179.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 6' ' ' TYR . 1.1 mp -128.21 112.22 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 0.73999999999999999 110.889 179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 6.2 tt0 -79.78 75.69 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 1.77 110.521 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.558 ' CE ' HD21 ' A' ' 72' ' ' LEU . 10.3 ptm -91.59 -173.49 3.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 1.28 111.119 -179.772 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 4.3 t0 -134.07 86.71 2.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 2.0899999999999999 110.929 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.953 HD12 ' CE2' ' A' ' 6' ' ' TYR . 12.9 mt -97.25 -72.3 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.439 -0.346 . . . . 1.6899999999999999 110.806 179.69 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 51.94 26.72 19.46 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.848 -0.692 . . . . 2.1600000000000001 112.745 179.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.93 128.7 37.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.778 0.323 . . . . 4.3499999999999996 110.902 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -79.82 -44.99 19.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 6.7800000000000002 110.96 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -86.74 -77.31 0.32 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.992 -0.549 . . . . 4.6900000000000004 110.839 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -127.56 146.4 58.38 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.001 -0.545 . . . . 3.8100000000000001 110.834 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 -172.17 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.504 2.136 . . . . 1.8300000000000001 112.309 179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -90.08 -178.63 5.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 3.5499999999999998 110.884 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.11 -21.26 58.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 2.98 111.176 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.821 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -53.57 -31.54 47.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 1.1799999999999999 111.274 -179.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.435 ' CH2' ' HG3' ' A' ' 101' ' ' PRO . 14.6 t-105 -76.94 -37.41 55.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 1.05 110.956 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.58 -29.23 67.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 2.75 110.894 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG21 HD11 ' A' ' 31' ' ' LEU . 29.2 t -87.11 -51.31 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 1.3100000000000001 111.097 -179.938 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 81' ' ' ALA . 33.2 t -58.81 -36.83 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.93999999999999995 111.01 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -74.33 -20.84 59.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 2.9199999999999999 111.106 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.36 9.19 38.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.655 -0.783 . . . . 1.27 113.019 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.733 HG22 ' HG3' ' A' ' 25' ' ' ARG . 1.1 p -86.34 141.12 34.46 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.928 0.364 . . . . 1.1100000000000001 110.811 179.97 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.29 87.07 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.539 2.159 . . . . 2.0099999999999998 112.208 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.26 -32.74 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.733 -0.746 . . . . 1.79 112.493 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.613 HD12 HG11 ' A' ' 8' ' ' VAL . 47.0 mm -80.05 127.76 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 1.72 110.952 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.82 -62.34 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 2.5299999999999998 110.933 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.45 ' O ' ' CG ' ' A' ' 94' ' ' PHE . . . 177.36 49.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 2.3799999999999999 112.625 179.964 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.45 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 45.3 p90 44.78 -168.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.761 0.315 . . . . 5.3899999999999997 111.405 179.993 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 102' ' ' VAL . 22.0 t -47.38 -71.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.571 -0.286 . . . . 3.5099999999999998 111.513 -179.618 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.54 -31.5 3.39 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 4.0499999999999998 112.387 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.03 -32.88 65.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 4.25 111.038 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.34 -101.14 2.66 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.732 -0.747 . . . . 3.3300000000000001 112.481 -179.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.428 ' HA ' ' CE1' ' A' ' 94' ' ' PHE . 0.5 OUTLIER -177.35 -62.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.744 0.307 . . . . 5.9500000000000002 110.904 -179.998 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -89.97 174.48 4.7 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 6.21 110.89 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.435 ' HG3' ' CH2' ' A' ' 82' ' ' TRP . 75.6 Cg_exo -49.89 163.53 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.687 2.258 . . . . 1.1100000000000001 112.463 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 95' ' ' VAL . 21.5 t -125.0 96.19 40.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 1.98 111.2 -179.902 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.62 120.61 7.23 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.459 2.106 . . . . 0.94999999999999996 112.276 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.566 ' H ' HD12 ' A' ' 104' ' ' LEU . 3.1 mp -65.43 166.49 10.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 1.3600000000000001 110.944 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 109' ' ' VAL . 13.8 m -89.97 148.68 40.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 1.6599999999999999 110.851 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.61 -30.25 44.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.528 2.152 . . . . 1.27 112.429 179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.72 -31.36 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 2.75 110.949 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -88.96 -32.53 17.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 2.46 110.886 -179.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 105' ' ' SER . 20.0 t -63.83 -39.85 86.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 1.0700000000000001 111.102 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.4 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 3.9399999999999999 110.945 -179.924 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.716 ' O ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -68.49 -54.92 13.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 2.25 110.661 179.872 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.871 HD12 ' CD2' ' A' ' 67' ' ' PHE . 15.6 pt -66.14 -24.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 1.3600000000000001 110.89 179.637 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.858 ' CD2' HD12 ' A' ' 118' ' ' LEU . 5.4 mt -74.66 -34.43 62.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 1.9399999999999999 110.535 179.662 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -78.02 -31.47 50.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.059 -0.519 . . . . 2.6800000000000002 110.748 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 1.039 HG11 HD11 ' A' ' 61' ' ' LEU . 34.6 t -77.14 -33.05 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 1.72 110.949 179.813 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.555 ' HB3' HD12 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -62.52 -62.92 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 2.1099999999999999 110.923 179.953 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.729 ' C ' HD23 ' A' ' 118' ' ' LEU . . . 143.86 45.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 1.78 112.643 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.858 HD12 ' CD2' ' A' ' 113' ' ' LEU . 1.6 mt -125.17 -48.94 1.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 1.99 110.818 179.86 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.61 -31.23 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 2.4399999999999999 110.866 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.31 -1.272 . . . . 2.9900000000000002 112.575 179.943 . . . . . . . . 0 0 . 1 stop_ save_